Category ID,Category,Event,Event description,Timepoint start,Timepoint end,Quantity outcome 1,Reference/link to data,Accessed on
G10,FDA Drug and Biologic Recalls,Event ID #91089 - Class II - Biologics - 3M Company - Health Care Business,"3M is recalling their 2022 3M"" Ranger"" Blood/Fluid Warming Sets (Cat. Nos. 24355 and 24370) due to cold welds in the auto-venting bubble trap component could lead to leaking of the sets during use. Leaking sets during use could lead to an inability to deliver therapy to the patient per intended use. They also could expose the healthcare worker to blood, blood products, and IV fluids during a leak event.",2022-12-16,2022-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71837 - Class II - Drugs - 3M Company - Health Care Business,Chemical contamination: Product may be contaminated with a toxic compound.,2015-09-08,2015-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70261 - Class III - Drugs - 3M Company/3m Espe Dental Products,Labeling: Incorrect or Missing Lot and/or Exp. Date - The subject lot is missing the lot number and expiration date stamp on the primary box..,2015-01-20,2015-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86022 - Class I - Drugs - 4e Brands North America, Llc","Chemical Contamination and Subpotent Drug: Product tested to contain methanol as well as below the labeled claim for ethanol content., CGMP Deviations: recalled because it was manufactured in the same facility as the product found to contain methanol which represents poor Current Good Manufacturing Practices.",2020-10-07,2020-10-07,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84055 - Class II - Drugs - 8046255 Canada Inc. DBA Viatrexx,Lack of Assurance of Sterility: products manufactured in a manner than cannot guarantee its sterility.,2019-11-14,2019-11-14,23,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80748 - Class II - Drugs - A-S Medication Solutions LLC.,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-18,2018-08-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87436 - Class I - Drugs - A-S Medication Solutions LLC.,"Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label instead of an OTC drug label.",2021-04-30,2021-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74011 - Class III - Drugs - A-S Medication Solutions LLC.,Labeling: Not elsewhere classified - count on the label was incorrect.,2016-05-05,2016-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88853 - Class III - Drugs - A-S Medication Solutions LLC.,Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.,2021-11-05,2021-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59001 - Class II - Drugs - A B Nutrition, Inc.",Marketed Without an Approved NDA/ANDA: The product is an unapproved new drug.,2013-03-08,2013-03-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76644 - Class I - Drugs - A&H Focal Inc.,"Marked Without An Approved NDA/ANDA: FDA analysis found these products to contain sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making these products unapproved drugs for which safety and efficacy have not been establish and therefore, subject to recall., Marked Without An Approved NDA/ANDA: FDA analysis found this product to contain diethyl phthalate, an inactive ingredient in several modified release solid oral dosage forms,  making this product unapproved drug for which safety and efficacy have not been establish and therefore, subject to recall.",2018-02-28,2018-02-28,21,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85806 - Class II - Drugs - A.P. Deauville, LLC",cGMP Deviations: Soft Whisper Dandruff Shampoo was produced with water that failed USP specifications.,2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90298 - Class II - Drugs - A.P. Nonweiler,CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.,2022-06-10,2022-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86497 - Class II - Drugs - AA PRODUCTS INC,CGMP Deviations: product manufactured at the same facility that produced product that FDA sampled and found to be subpotent for ethanol and contained methanol.,2020-11-23,2020-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86037 - Class I - Drugs - AAA Cosmetica, SA de CV","Chemical Contamination: Product contains methanol., CGMP Deviations",2020-09-11,2020-09-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84938 - Class III - Drugs - AAA Pharmaceutical, Inc.",Labeling: Incorrect or Missing Lot and/or Expiration date.,2020-03-04,2020-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83210 - Class III - Drugs - AAA Pharmaceutical, Inc.","Labeling; Incorrect or Missing Lot Number and/or Exp Date; Product has an incorrect expiration date of 9/2022 applied to the labeling, where the actual expiration date is 10/2021.",2019-08-02,2019-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84583 - Class II - Drugs - AAA Pharmaceutical, Inc.",CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API,2020-01-06,2020-01-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91019 - Class III - Drugs - Aadi Bioscience,Failed Stability Specifications,2022-11-14,2022-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64298 - Class III - Drugs - Aaron Industries Inc,"Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.  If the product is shaken or warmed the white particles goes into the solution.",2013-03-07,2013-03-07,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52863 - Class III - Drugs - Aaron Industries Inc,"Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles. If the product is shaken or warmed the white particles goes into the solution.",2013-05-17,2013-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67434 - Class III - Drugs - Aaron Industries Inc,"Presence of Precipitate: Recall is due to complaints of a white substance, confirmed as Guaifenesin, an active ingredient in the product which is precipitating out.",2014-02-28,2014-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68003 - Class III - Drugs - Aaron Industries Inc,"Presence of Precipitate; white substance confirmed as Guaifenesin, an active ingredient was observed in some bottles.",2014-04-29,2014-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73090 - Class II - Drugs - Abbott's Compounding Pharmacy, Inc.",Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.,2016-02-17,2016-02-17,43,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61878 - Class II - Drugs - Abbott Laboratories,"CGMP Deviations: There is potential that Abbott's third party manufacturer, Hospira, may have applied a foreign (incorrect) stopper to vials in a specific lot of Zemplar Injection.",2012-06-18,2012-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62674 - Class II - Drugs - Abbott Laboratories,Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.,2012-09-26,2012-09-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63791 - Class II - Drugs - Abbott Laboratories,Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.,2012-12-28,2012-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90459 - Class II - Biologics - Abbott Laboratories, Inc","Due to an issue with the Alinity s System software, there is a potential for the assay Quality Control (QC) requirement to be bypassed for the first use of an Alinity s HBsAG Confirmatory Reagent Kit.  Distributed Alinity S Systems with software version 2.8.0 are impacted by this recall.",2022-12-16,2022-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77861 - Class II - Biologics - Abbott Molecular,"Abbott RealTime HIV-1 assays, with a potential in certain circumstances to exhibit false results, were distributed.",2017-08-24,2017-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67709 - Class II - Drugs - AbbVie Inc,"Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device., Defective Delivery System: Some Lupron Depot Kits may containin a syringe with a potentially defective LuproLoc needle stick protection device.",2014-04-29,2014-04-29,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69285 - Class II - Drugs - AbbVie Inc,Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.,2014-09-26,2014-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65851 - Class III - Drugs - AbbVie Inc.,Labeling: Incorrect Package Insert; product packaged with outdated version of the insert,2013-08-20,2013-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73611 - Class III - Drugs - AbbVie Inc.,Failed Content Uniformity Specifications,2016-04-21,2016-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76199 - Class II - Drugs - AbbVie Inc.,Failed Stability Specifications: confirmed out of specification results obtained during refrigerated material stability testing indicating that drug may settle within drug cassettes nearing the end of their refrigerated shelf-life,2017-02-27,2017-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78143 - Class III - Drugs - AbbVie Inc.,Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.,2017-10-25,2017-10-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78969 - Class III - Drugs - AbbVie Inc.,"Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.",2018-02-09,2018-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63395 - Class III - Drugs - ABC Compounding Co., Inc.","Chemical Contamination: QS Plus wipes were found to be contaminated with different substance (7820, Graffiti Remover).",2012-10-22,2012-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89558 - Class I - Drugs - ABC Sales 1 Inc,"Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil and/or sildenafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making these unapproved drugs.",2022-02-17,2022-02-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67135 - Class I - Drugs - Abrams Royal Pharamacy,"Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis, Lack of Assurance of Sterility",2014-08-25,2014-08-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68283 - Class I - Drugs - Abrams Royal Pharmacy,Non-Sterility: The firm's contract testing laboratory found sterility failures.,2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68342 - Class I - Drugs - Abrams Royal Pharmacy,Non-Sterility,2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68345 - Class I - Drugs - Abrams Royal Pharmacy,Non-Sterility; contract laboratory identified Staphylococcus warneri in the product,2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71598 - Class III - Drugs - Abrams Royal Pharmacy II, LLC",Failed Content Uniformity Specifications: Failed Uniformity of Dosage Units specifications.,2015-07-08,2015-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91228 - Class I - Drugs - Accord Healthcare, Inc.",Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial,2023-01-13,2023-01-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91499 - Class II - Drugs - Accord Healthcare, Inc.",Presence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.,2023-01-20,2023-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76105 - Class II - Drugs - Accord Healthcare, Inc.",Failed tablet/capsule specification: missing break line on the 5mg tablet.,2017-02-16,2017-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80850 - Class I - Drugs - Accord Healthcare, Inc.",Product Mix-Up: customer complaint that a sealed bottle labeled as Hydrochlorothiazide Tablets USP 12.5 mg contained only Spironolactone Tablets USP 25 mg.,2018-09-21,2018-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87233 - Class III - Drugs - Accord Healthcare, Inc.",Labeling; Label Mix-up; correctly labeled 2 mL vials were packaged into blister strips labeled for 1 mL vials,2021-02-08,2021-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87944 - Class II - Drugs - Accupac, Inc.",Labeling: Not Elsewhere Classified; the primary label (tube) may be incorrectly labeled as Fluoride-Free instead of With Fluoride,2021-05-26,2021-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78376 - Class II - Drugs - Ace Surgical Supply Co., Inc.",Labeling: Incorrect or Missing Lot and/or Exp Date;  incorrect expiration date on the labeling of the outer poly bag,2017-11-07,2017-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87843 - Class I - Drugs - Acella Pharmaceuticals, LLC",Subpotent Drug,2021-05-24,2021-05-24,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91149 - Class III - Drugs - Acella Pharmaceuticals, LLC",Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.,2022-11-23,2022-11-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91150 - Class III - Drugs - Acella Pharmaceuticals, LLC",Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.,2022-12-01,2022-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85721 - Class I - Drugs - Acella Pharmaceuticals, LLC",Superpotent Drug.,2020-06-08,2020-06-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86467 - Class I - Drugs - Acella Pharmaceuticals, LLC",Subpotent Drug: FDA analysis found these products to be less than the labeled claim for the levothyroxine (T4) portion of the product.,2020-10-19,2020-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80878 - Class III - Drugs - ACP Nimble Buyer, Inc.",Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.,2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62384 - Class II - Drugs - Actavis,Subpotent; some patches may not contain fentanyl gel,2012-09-25,2012-09-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65334 - Class III - Drugs - Actavis,Failed Impurities/Degradation Specifications,2013-06-12,2013-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67457 - Class III - Drugs - Actavis,Subpotent Drug: Drug potency was compromised during shipment.,2014-02-25,2014-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64506 - Class III - Drugs - Actavis Elizabeth LLC,Failed Dissolution Specification: This product recall is due to the product lot # 50077231 exceeding dissolution specifications.  All other test specifications were met.,2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66528 - Class II - Drugs - Actavis Elizabeth LLC,Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets,2013-11-22,2013-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67053 - Class II - Drugs - Actavis Elizabeth LLC,Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.,2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67518 - Class II - Drugs - Actavis Elizabeth LLC,Failed Dissolution Specifications: Product did not meet specification requirements for dissolution.,2014-02-28,2014-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67519 - Class II - Drugs - Actavis Elizabeth LLC,Failed Tablet/Capsule Specifications: Complaints were received for significant tablet erosion for Alprazolam 1 mg.,2014-03-10,2014-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70001 - Class II - Drugs - Actavis Elizabeth LLC,Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.,2015-01-08,2015-01-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70522 - Class II - Drugs - Actavis Elizabeth LLC,Failed Dissolution Specifications,2015-02-27,2015-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73474 - Class II - Drugs - Actavis Elizabeth LLC,Failed Impurities/Degradation Specifications: Out of specification for impurities.,2016-04-07,2016-04-07,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75445 - Class III - Drugs - Actavis Elizabeth LLC,Presence of Foreign Tablets/Capsules,2016-11-18,2016-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65881 - Class III - Drugs - Actavis Inc,Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.,2013-08-08,2013-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66961 - Class III - Drugs - Actavis Inc,Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.,2014-01-29,2014-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66380 - Class II - Drugs - Actavis Inc,Failed Tablet/Capsule Specifications: Broken tablets,2014-02-03,2014-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67386 - Class II - Drugs - Actavis Inc,Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.,2014-02-11,2014-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68453 - Class II - Drugs - Actavis Inc,Subpotent Drug.,2014-06-17,2014-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69553 - Class II - Drugs - Actavis Inc,Subpotent Drug,2014-10-30,2014-10-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70555 - Class II - Drugs - Actavis Inc,Subpotent Drug,2015-03-03,2015-03-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71495 - Class III - Drugs - Actavis Inc,Labeling: Incorrect or Missing Package Insert; Product is being recalled because the birth control packs were distributed with out-dated package inserts.,2015-06-24,2015-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74713 - Class II - Drugs - Actavis Inc,Failed Dissolution Specifications,2016-07-26,2016-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74702 - Class II - Drugs - Actavis Inc,Failed Dissolution Specifications: Glipizide 2.5 mg ER  Tablets exceeded  dissolution specification rates for the 10 hour testing point.,2016-08-15,2016-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74902 - Class III - Drugs - Actavis Inc,Failed Impurities/Degradation Specifications: Out of specification (OOS) results for related compound G were obtained at 12-month (at expiry) stability time-point for room temperature sample(s).,2016-08-24,2016-08-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76229 - Class III - Drugs - Actavis Inc,Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.,2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76406 - Class II - Drugs - Actavis Inc,Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.,2017-02-15,2017-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76421 - Class III - Drugs - Actavis Inc,"Failed Impurities/ Degradation Specifications: OOS for related compound (levofloxacin n-oxide) at the 18
month stability time point.",2017-03-09,2017-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64317 - Class III - Drugs - Actavis Inc.,Failed Dissolution Specifications; 8-hours for the 18-month stability testing point.,2013-02-27,2013-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70987 - Class III - Drugs - Actavis Laboratories UT, Inc.",Subpotent Drug: Flurandrenolide is subpotent.,2015-04-15,2015-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75042 - Class III - Drugs - Actavis Laboratories, FL, Inc.",Labeling: Incorrect or Missing Lot And/or Exp Date: Bottles labeled with the incorrect expiration date of 03/18 rather than 09/17.,2016-11-01,2016-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69237 - Class II - Drugs - Actavis Laboratories, FL, Inc.",Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.,2014-09-30,2014-09-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69495 - Class II - Drugs - Actavis Laboratories, FL, Inc.",Failed Tablet/Capsule Specifications: Presence of split or broken tablets.,2014-11-21,2014-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70849 - Class III - Drugs - Actavis Laboratories, FL, Inc.",Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell,2015-04-15,2015-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71755 - Class III - Drugs - Actavis Laboratories, FL, Inc.",Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.,2015-08-04,2015-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72308 - Class II - Drugs - Actavis Laboratories, FL, Inc.",Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint.,2015-10-13,2015-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62827 - Class III - Drugs - Actavis Mid Atlantic LLC,Impurities/Degradation Products: Recalled lots do not meet room temperature stability specification for unknown degradant.,2012-10-09,2012-10-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64846 - Class III - Drugs - Actavis South Atlantic LLC,Failed USP Dissolution Test Requirements: Out-of-specification dissolution results at the 8 hour stability testing point.,2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65338 - Class II - Drugs - Actavis South Atlantic LLC,"Failed Impurity/Degradation Specification; ""Related Compound C""",2013-07-30,2013-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66054 - Class III - Drugs - Actavis South Atlantic LLC,"Failed Dissolution Specifications: This recall is an extension of the recall initiated on 07/31/2013 for Bupropion HCl Extended-Release Tablets
(XL) 300 mg, because another lot was shown to have similar failing results for dissolution at the 8-hour timepoint.",2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64151 - Class III - Drugs - Actelion Pharmaceuticals U.S., Inc.","Subpotent Drug: OOS (out of specification) assay result at the 12 month stability time point. 
",2013-02-01,2013-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91084 - Class I - Drugs - Adam's Polishes LLC,"Chemical Contamination: FDA analysis found 1 lot of Adam's Polishes ALCOHOL BASED HAND SANITIZER isopropyl alcohol 75% v/v to contain methanol., CGMP Deviations: Other lots of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.",2022-11-22,2022-11-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89778 - Class I - Drugs - Adamis Pharmaceuticals Corporation,Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.,2022-04-08,2022-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87324 - Class I - Drugs - Adams.Secret.co,"Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of  tadalafil and sildenafil.
",2021-03-19,2021-03-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86091 - Class III - Biologics - ADMA BioCenters Georgia Inc.,"Source Plasma, for which donor eligibility screening was incomplete, were distributed.",2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63988 - Class I - Drugs - Advance Pharmaceutical Inc,Labeling; Label Mixup; bottles of Ferrous Sulfate actually contains Meclizine HCl (indicated for motion sickness),2013-06-13,2013-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65484 - Class I - Drugs - Advance Pharmaceutical Inc,Labeling: Label Mix-Up: A complaint from a pharmacist was received that the entire contents of 1 bottle labeled as Rugby label Enteric Coated Aspirin 81 mg Tablets actually contained Acetaminophen 500 mg Tablets.,2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84685 - Class II - Drugs - Advanced Accelerator Applications USA, Inc.",Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).,2020-01-22,2020-01-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89885 - Class III - Drugs - Advanced Accelerator Applications USA, Inc.",Subpotent Drug: low out-of-specification results for Vial 1  assay obtained during stability studies.,2022-04-06,2022-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86799 - Class II - Drugs - Advanced Nutriceuticals, LLC",Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.,2020-12-11,2020-12-11,17,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76561 - Class II - Drugs - Advanced Pharma Inc.,Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.,2017-05-23,2017-05-23,60,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77595 - Class II - Drugs - Advanced Pharma Inc.,Lack of Assurance of Sterility,2017-07-07,2017-07-07,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77503 - Class I - Drugs - Advanced Pharma Inc.,"Subpotent Drug: found to be below the specification for labeled assay., Stability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.",2017-12-20,2017-12-20,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78889 - Class I - Drugs - Advanced Pharma Inc.,Subpotent,2018-03-01,2018-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80354 - Class II - Drugs - Advanced Pharma Inc.,Subpotent Drug: final drug concentration is subpotent as compared to the concentration indicated on the label.,2018-06-25,2018-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81685 - Class I - Drugs - Advanced Pharma Inc.,"Labeling: Label Error on Declared Strength: Label incorrectly lists concentration as ""10 mcg per mL"" rather than the correct concentration of ""100 mcg per mL"".",2019-01-07,2019-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81941 - Class II - Drugs - Advanced Pharma Inc.,Labeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50 Units/50 mL (1 Unit/mL),2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82089 - Class III - Drugs - Advanced Pharma Inc.,Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.,2019-02-15,2019-02-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82130 - Class II - Drugs - Advanced Pharma Inc.,Labeling: Incorrect expiration date.,2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82398 - Class II - Drugs - Advanced Pharma Inc.,Lack of Assurance of Sterility,2019-03-21,2019-03-21,19,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82718 - Class II - Drugs - Advanced Pharma Inc.,Sub-potency,2019-04-29,2019-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71205 - Class II - Drugs - Advanced Physician Solutions, Inc.",Lack of Assurance of Sterility,2015-05-28,2015-05-28,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82709 - Class III - Drugs - Advantice Health,"Labeling: Not Elsewhere Classified: canisters incorrectly  state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz., Labeling: Not Elsewhere Classified: Full cases may contain canisters that incorrectly state the net weight is 2.75 oz. rather than the correct net weight of 2.0 oz.",2019-05-14,2019-05-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91581 - Class III - Drugs - Advantice Health, Llc",Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.,2023-02-17,2023-02-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64878 - Class I - Drugs - Affirm XL, Inc.","Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain sulfoaildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.",2013-11-20,2013-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72796 - Class II - Drugs - AGA Gas Inc,cGMP Deviations; trailer may not have met GMP requirements prior to filling,2016-03-18,2016-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67580 - Class II - Drugs - Agila Specialties Private Ltd.,"Presence of Particulate Matter: Potential for small black particles to be present in individual vials, the potential for missing lot number and/or expiry date on the outer carton and the potential for illegible/missing lot number and expiry on individual vials.",2014-04-08,2014-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65707 - Class II - Drugs - Aidapak Services, LLC","Labeling: Label Mixup; ZINC GLUCONATE, Tablet, 50 mg may be potentially mis-labeled as 
ASCORBIC ACID, Chew Tablet, 500 mg, NDC 00904052660, Pedigree: AD60240_54, EXP: 5/22/2014 and
ASCORBIC ACID, Chew Tablet, 250 mg, NDC 00904052260, Pedigree: W003027, EXP: 6/12/2014.
, Labeling: Label Mixup; CALCIUM CARBONATE +D3, Tablet, 600 mg/400 units may be potentially mis-labeled as
DIGOXIN, Tablet, 125 mcg, NDC 00527132401, Pedigree: AD76675_4, EXP: 6/3/2014; or 
AMANTADINE HCL, Tablet, 100 mg, NDC 00832011100, Pedigree: AD54475_4, EXP: 5/20/2014.
, Labeling: Label Mixup; OMEGA-3 FATTY ACID, Capsule, 1000 mg may be potentially mis-labeled as
DOCUSATE CALCIUM, Capsule, 240 mg, NDC 00536375501, Pedigree: AD33897_16, EXP: 5/9/2014;
OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 00904404360, Pedigree: AD33897_19, EXP: 5/9/2014;
PSEUDOEPHEDRINE HCL, Tablet, 60 mg, NDC 00904512559, Pedigree: W002856, EXP: 6/7/2014;
DOCUSATE SODIUM, Capsule, 50 mg, N, Labeling: Label Mixup; CYANOCOBALAMIN, Table",2014-01-16,2014-01-16,273,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65690 - Class II - Drugs - Aidapak Services, LLC","Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 40 mg may be potentially mis-labeled as OLANZAPINE, Tablet, 7.5 mg, NDC 60505311203, Pedigree: AD21790_76, EXP: 5/1/2014;
ARIPiprazole, Tablet, 2 mg, NDC 59148000613, Pedigree: AD46265_19, EXP: 5/15/2014;
OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree: AD60272_79, EXP: 5/22/2014;
OLANZapine, Tablet, 7.5 mg, NDC 55111016530, Pedigree:  AD73, Labeling: Label Mixup: DULoxetine HCl DR, Capsule, 20 mg, may be potentially mis-labeled with one of the following drugs:
ENTECAVIR, Tablet, 0.5 mg, NDC 00003161112, Pedigree: AD30140_28, EXP: 5/7/2014;
CALCIUM ACETATE, Capsule,  667 mg, NDC 00054008826, Pedigree:  AD54587_1, EXP: 5/21/2014;
FLUoxetine HCl, Capsule, 10 mg	, NDC 16714035103, Pedigree: AD70585_13, EXP: 5/29/2014;
CHOLECALCIFEROL, Labeling: Label Mixup: ATOMOXETINE HCL, Capsule, 18 mg, may be potentially mis-labeled as the following drug:

LOVASTATIN, Tablet, 20 mg, NDC 00185007201, Pedigree: AD28369_1, EXP: 5/7/2014.

",2014-01-20,2014-01-20,265,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68375 - Class II - Drugs - Aidarex Pharmaceuticals LLC,Presence of Foreign Tablets/Capsules: Tramodol 50 mg tablet has been found in a bottle of Ciprofloxacin 500 mg,2014-10-23,2014-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74316 - Class III - Drugs - Aidarex Pharmaceuticals LLC,CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.,2016-06-07,2016-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74315 - Class II - Drugs - Aidarex Pharmaceuticals LLC,Failed Impurity/Degradation Specifications: Out of specifications for unknown impurity.,2016-06-08,2016-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74314 - Class III - Drugs - Aidarex Pharmaceuticals LLC,Failed Impurities/Degradation Specifications: Out of specification results for unknown impurity.,2016-06-30,2016-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78067 - Class III - Drugs - Aidarex Pharmaceuticals LLC,Failed Impurities/Degradation Specification; out-of-specification results for individual unknown impurities at the 30 month Room Temperature Retained Sample stability test,2017-09-13,2017-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78106 - Class III - Drugs - Aidarex Pharmaceuticals LLC,Failed Impurities/Degradation Specifications: manufacturer of product recalled this repackaged lot due to out of specification results for related compound.,2017-10-26,2017-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79835 - Class III - Drugs - Aidarex Pharmaceuticals LLC,Presence of Foreign Tablets/Capsules,2018-05-15,2018-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80397 - Class III - Drugs - Aidarex Pharmaceuticals LLC,Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.,2018-07-25,2018-07-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90644 - Class II - Drugs - Aire-Master of America Inc,"CGMP Deviations: product manufactured using deionized water from a system lacking appropriate microbial control post deionization.
",2022-08-18,2022-08-18,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61947 - Class II - Drugs - Airgas Medical Services,Impurities/Degradation Products: Out Of Specification levels of nitrogen dioxide.,2012-06-12,2012-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66929 - Class II - Drugs - Airgas Medical Services,"Labeling: Not Elsewhere Classified; Due to an error in the manufacturing procedure, a cylinder in liquid withdrawal service was not marked Syphon Tube indicating liquid withdrawal and shipped as a gas withdrawal cylinder.",2013-12-13,2013-12-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66695 - Class II - Drugs - Airgas Medical Services,"Short Fill: Due to an error in the manufacturing process, cylinders in this lot may be empty and contain no medical oxygen.",2013-12-23,2013-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86388 - Class II - Drugs - AJR TRADING LLC,CGMP Deviations: Product manufactured in a facility where methanol was found in other distributed lots of product.,2020-09-24,2020-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91086 - Class II - Biologics - Akan Biosciences, Inc.","Akan Biosciences is recalling a distributed human adipose tissue product, Ayama, recovered from a donor in which donor suitability was not adequately determined.",2022-12-14,2022-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90245 - Class I - Drugs - Akcea Therapeutics, Inc.",Superpotent: High Out of specification (OOS) test result for percent label claim (%LC).,2022-06-27,2022-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86955 - Class II - Drugs - Akebia Therapeutics dba Keryx Biopharmaceutials, Inc",CGMP Deviations,2020-12-18,2020-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87256 - Class III - Drugs - Akebia Therapeutics dba Keryx Biopharmaceutials, Inc",Failed Dissolution Specifications,2021-02-17,2021-02-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89836 - Class II - Drugs - Akorn, Inc.",Lack of Assurance of Sterility,2022-03-24,2022-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89993 - Class III - Drugs - Akorn, Inc.",Failed viscosity specification - product was below specificcation,2022-05-05,2022-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90344 - Class III - Drugs - Akorn, Inc.",Failed impurity/degradation specifications: Out of specification for 2-HMP (a product leachable) measured in retention samples,2022-06-29,2022-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90442 - Class II - Drugs - Akorn, Inc.",Defective Delivery System: Potential defect that could prevent the product from dispensing as intended.,2022-06-29,2022-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90405 - Class II - Drugs - Akorn, Inc.",Defective container: defect prevents product from dispensing as intended.,2022-06-30,2022-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90676 - Class II - Drugs - Akorn, Inc.",Defective Container: Product has incomplete induction seals.,2022-08-19,2022-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90720 - Class III - Drugs - Akorn, Inc.",Identification of an unknown impurity at the 12-month stability point. Further investigation has identified the impurity as Timolol Phenol S-Oxide.,2022-08-29,2022-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90813 - Class II - Drugs - Akorn, Inc.",cGMP Deviations: Turbidity discovered in Artificial Tears Ointment during sterility testing. Scope expanded to include other lots and products which potentially share the same root cause.,2022-09-06,2022-09-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90880 - Class II - Drugs - Akorn, Inc.",Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).,2022-09-28,2022-09-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90948 - Class II - Drugs - Akorn, Inc.",CGMP Deviations:,2023-01-13,2023-01-13,27,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91580 - Class III - Drugs - Akorn, Inc.",Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.,2023-02-08,2023-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69013 - Class III - Drugs - Akorn, Inc.",Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point,2014-09-22,2014-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70041 - Class III - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications: The known impurity went out of specification at 12 months stability point.,2015-01-06,2015-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70390 - Class II - Drugs - Akorn, Inc.",Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.,2015-02-10,2015-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70625 - Class II - Drugs - Akorn, Inc.","Failed Stability Specifications: Out of specification for preservative, benazalkonium chloride.",2015-03-05,2015-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70743 - Class II - Drugs - Akorn, Inc.",Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole.,2015-05-08,2015-05-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71033 - Class II - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications,2015-06-09,2015-06-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71737 - Class III - Drugs - Akorn, Inc.",Subpotent Drug: Low out-of-specification potency result of the drug product.,2015-09-11,2015-09-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72192 - Class III - Drugs - Akorn, Inc.",Failed Impurity/Degradation Specifications:  Out of Specifications result obtained for a known impurity.,2015-11-13,2015-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72351 - Class III - Drugs - Akorn, Inc.","Defective Container: Product missing safety seal around the neck of the bottle.  The product label indicates, ""Tamper Evident: Do not use if printed seal around cap is broken or missing.""  Because the product is missing the approved component and is not consistent with the labeling, the lot is being recalled.",2015-11-16,2015-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73642 - Class II - Drugs - Akorn, Inc.",Presence of Particulate Matter,2016-05-04,2016-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73491 - Class II - Drugs - Akorn, Inc.",Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) for an unknown impurity of Chlorhexidine gluconate.,2016-05-25,2016-05-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74099 - Class II - Drugs - Akorn, Inc.",Lack of Assurance of Sterility; some lots failed Antimicrobial Effectiveness Testing on stability,2016-05-29,2016-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74794 - Class III - Drugs - Akorn, Inc.",Failed impurities/degradation specifications: product was out of specification for unknown impurity at the 9 month stability time point,2016-08-24,2016-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75418 - Class II - Drugs - Akorn, Inc.",Subpotent Drug: concentration of product is less than labeled amount.,2016-11-02,2016-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75628 - Class II - Drugs - Akorn, Inc.",Failed Stability Specifications; out-of specification value for homogeneity / phase separation.,2016-11-23,2016-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76732 - Class II - Drugs - Akorn, Inc.","Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.",2017-04-11,2017-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76831 - Class II - Drugs - Akorn, Inc.",Failed Dissolution Specifications,2017-05-04,2017-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77071 - Class III - Drugs - Akorn, Inc.",Product is being recalled due to low pH value.,2017-05-09,2017-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77822 - Class III - Drugs - Akorn, Inc.","Crystallization with subpotent out of
specification assay results for chlorhexidine.",2017-08-14,2017-08-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78730 - Class III - Drugs - Akorn, Inc.",CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.,2018-01-08,2018-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79278 - Class III - Drugs - Akorn, Inc.",Failed Stability Specification: OOS low viscosity results discovered during retain testing.,2018-03-05,2018-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79635 - Class III - Drugs - Akorn, Inc.",Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.,2018-03-29,2018-03-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79466 - Class III - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications: High out of specification results for an impurity.,2018-04-03,2018-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80310 - Class II - Drugs - Akorn, Inc.",CGMP Deviations,2018-07-09,2018-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80629 - Class II - Drugs - Akorn, Inc.",Failed Impurities/Degredation Specifications:  Out of Specification results for an unknown impurity was found during routine stability testing at 12 months.,2018-08-07,2018-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80767 - Class III - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-oxide,2018-08-29,2018-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80880 - Class II - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified impurity.,2018-09-07,2018-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81193 - Class II - Drugs - Akorn, Inc.",Presence of Particulate Matter: Crystalline particles were noticed at the 24 month clarity testing.,2019-01-28,2019-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81836 - Class III - Drugs - Akorn, Inc.",Failed Stability Specifications: out of specification results for opalescence at 7 month stability study.,2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82177 - Class II - Drugs - Akorn, Inc.",Failed Stability Specification: out of specification results for Sodium Perborate,2019-02-19,2019-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82092 - Class III - Drugs - Akorn, Inc.",Failed Stability Specification; out of specification (OOS) results for a preservative at 9 month stability study.,2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82200 - Class II - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point.,2019-03-11,2019-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82375 - Class II - Drugs - Akorn, Inc.",Sub Potent Drug: OOS results observed for the Hydrocortisone assay during routine stability testing at 12 month controlled room temperature.,2019-03-20,2019-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82510 - Class III - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was observed during the 18 month stability testing.,2019-04-04,2019-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81426 - Class III - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications; out of specification results observed for other individual impurities,2019-04-23,2019-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82657 - Class III - Drugs - Akorn, Inc.",Failed impurities/degradation specification: Out of Specification result for total impurity at 4.0% (Limit:  NMT 3.0%) at 12 months stability testing.,2019-04-24,2019-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83073 - Class III - Drugs - Akorn, Inc.","Labeling: Label mix-up: Product secondary carton erroneously states 40mg instead of 30 mg, primary carton is label correctly.",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83497 - Class III - Drugs - Akorn, Inc.","Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid., Short Fill: fill volume was out of specification at 94 mL (specification: no less than 100 mL) and Failed Impurities/Degradation Specifications: Out of Specification (OOS) for known impurity, D-aspartic acid.",2019-08-23,2019-08-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83721 - Class II - Drugs - Akorn, Inc.","cGMP Deviations:  firm reported finding metal particulate matter in the filling room near the tube feeder during the filling operation of the product. No particulates were identified in the product, but rather were identified on the filling line.",2019-09-24,2019-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83843 - Class II - Drugs - Akorn, Inc.",Lack of Assurance of Sterility: Out of specification results for container closure test which cannot guarantee the sterility of the product.,2019-09-30,2019-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84261 - Class II - Drugs - Akorn, Inc.","Unit Dose Mispackaging: Customer complaint that a carton labeled as Myorisan 20 mg Capsules, USP erroneously contained one 10-count blister card of the 40 mg product in addition to two 10-count blister cards of the 20 mg product.",2020-01-06,2020-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84913 - Class II - Drugs - Akorn, Inc.",Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product.,2020-02-11,2020-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85018 - Class III - Drugs - Akorn, Inc.","Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identified as tin with trace copper, which are the base of the materials of construction for the tube.",2020-02-27,2020-02-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85239 - Class III - Drugs - Akorn, Inc.",Failed impurities/degradation specification: Out-of-Specification result for total impurity at 4.1% (Limit: NMT 3.0%) during retained sample testing.,2020-05-01,2020-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85801 - Class III - Drugs - Akorn, Inc.",Discoloration: Out of Specification (OOS) result for APHA Color Test.,2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86019 - Class III - Drugs - Akorn, Inc.",Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample,2020-07-14,2020-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86361 - Class II - Drugs - Akorn, Inc.",CGMP Deviations,2020-09-30,2020-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87051 - Class II - Drugs - Akorn, Inc.",Defective container: Customer complaints for oral solution leaking from bottles.,2021-01-11,2021-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87462 - Class II - Drugs - Akorn, Inc.",Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing,2021-03-16,2021-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88594 - Class II - Drugs - Akorn, Inc.",Non-Sterility - OOS sterility testing observed during 12-month controlled room temperature stability testing. The microbiological investigation identified the organism as a member of the Bacillus cereus group.,2021-08-31,2021-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88488 - Class II - Drugs - Akorn, Inc.",Failed impurities/degradation specification: Out of Specification for an unknown impurity observed in topical product.,2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88823 - Class II - Drugs - Akorn, Inc.",Microbial Contamination of Sterile Products: Confirmed sterility failure identified during stability testing at the 12-month time point.,2021-10-07,2021-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89142 - Class III - Drugs - Akorn, Inc.",Labeling: Missing Label,2022-01-13,2022-01-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89361 - Class II - Drugs - Akorn, Inc.",Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.,2022-01-27,2022-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90682 - Class III - Drugs - Akron Pharma, Inc.","Failed Tablet/Capsule Specifications: Imprint ""AP 325"" is missing from the tablet.",2022-08-17,2022-08-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72919 - Class II - Biologics - Alabama Eye Bank,"Human cornea, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, was distributed.",2016-01-28,2016-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63608 - Class II - Drugs - Alara Pharmaceutical Co,Subpotent; 15 month stability,2012-12-21,2012-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65282 - Class III - Biologics - Alba Bioscience Limited,"Antibody Screening Cells, misbranded with incorrect Antigen Profile, were distributed.",2013-06-11,2013-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67708 - Class III - Biologics - Alba Bioscience Limited,Misbranded Reagent Red Blood Cells were distributed.,2014-03-13,2014-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70655 - Class III - Biologics - Alba Bioscience Limited,"Blood Grouping Reagent, associated with false positive test results, was distributed.",2015-03-12,2015-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72389 - Class III - Biologics - Alba Bioscience Limited,Misbranded Anitbody Identification Panel was distributed.,2015-10-15,2015-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80991 - Class III - Biologics - ALBA Bioscience Limited dba Quotient Biodiagnostics Inc.,"Misbranded reagent red blood cells, were distributed.",2018-09-11,2018-09-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86162 - Class II - Drugs - Albek De Mexico S.A. De C.V.,CGMP Deviations: Next Advanced Antibacterial Hand Sanitizer was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.,2020-11-17,2020-11-17,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73275 - Class II - Drugs - Alcon Research, Ltd.",Lack of Assurance of Sterility: Some single-use vials may be filled with water rather than the product solution and the firm cannot guarantee the sterility of the water-filled vials.,2016-02-16,2016-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85835 - Class II - Drugs - Alembic Pharmaceuticals Limited,"Labeling: Label mix up: Bottles labeled as aripiprazole 2 mg, 30 count had aripiprazole 5 mg tablets, 100 count.",2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87533 - Class I - Drugs - Alembic Pharmaceuticals Limited,Labeling: Label-mixup,2021-04-07,2021-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66771 - Class I - Drugs - Alexion Pharmaceuticals, Inc.",Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.,2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68401 - Class I - Drugs - Alexion Pharmaceuticals, Inc.",Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.,2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73545 - Class III - Biologics - Alk-abello, Inc.","Misbranded allergenic extracts, were distributed.",2016-03-24,2016-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80409 - Class III - Biologics - Alk-abello, Inc.",Misbranded Allergenic Extract was distributed.,2018-08-20,2018-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81538 - Class III - Biologics - Alk-abello, Inc.",Misbranded allergenic extracts for diagnostic testing were distributed.,2018-11-15,2018-11-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68220 - Class III - Biologics - ALK-Abello, Inc.","Short Ragweed Pollen Allergenic Extracts, with an out of specification Antigen E content, were distributed.",2015-04-21,2015-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81147 - Class II - Drugs - Alkano Chemicals, Inc",CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.,2018-10-05,2018-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83511 - Class II - Drugs - Alkermes Inc,Labeling: Not  Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.,2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65092 - Class II - Drugs - Alkermes, Inc.",Lack of Assurance of Sterility: Product did not meet the criteria for container closure integrity testing during routine 24 month stability testing.,2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67838 - Class II - Drugs - Alkermes, Inc.",Customer complaints for failure to deliver the dose.,2014-08-22,2014-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83878 - Class II - Drugs - Alkermes, Inc.",Labeling: Not Elsewhere Classified. Drug product kit recalled due to 1 inch needles being placed in the 1 1/2 inch needle cardboard sleeve labelled as administration needles. The product vial is not impacted.,2019-10-02,2019-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71266 - Class II - Drugs - Allegiant Health,"CGMP Deviations: Failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints.",2015-06-12,2015-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73569 - Class III - Drugs - Allegiant Health,Superpotent Drug: High out of specification results for assay at the 6 month time point interval.,2016-05-17,2016-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76495 - Class II - Drugs - Allegiant Health,cGMP deviations - presence of rubber particles found loose in the bulk product.,2017-02-28,2017-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78652 - Class II - Drugs - ALLERGAN,Subpotent Drug: One lot of Viokace is being recalled since product stability testing results did not meet the specifications for enzyme profile.,2018-01-05,2018-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79080 - Class III - Drugs - ALLERGAN,"Labeling: Not Elsewhere Classified: does not have the required ""CII"" controlled drug classification indication on the primary label.",2018-02-09,2018-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78755 - Class II - Drugs - ALLERGAN,Failed Stability Specifications: Product stability testing results did not meet specifications for iron content.,2018-02-23,2018-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81535 - Class II - Drugs - ALLERGAN,Failed Stability Specification: out of specification for iron content.,2018-11-23,2018-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85924 - Class III - Drugs - Allergan PLC,SUBPOTENT DRUG: Products failed assay results at the 12 and 24 month timepoints.,2020-07-27,2020-07-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72016 - Class II - Drugs - Allergan Sales, LLC","Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.",2015-09-22,2015-09-22,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74126 - Class II - Drugs - Allergan Sales, LLC",Failed Content Uniformity Specifications.,2016-07-06,2016-07-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74623 - Class II - Drugs - Allergan Sales, LLC",Failed Content Uniformity Specifications,2016-10-13,2016-10-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76748 - Class III - Drugs - Allergan Sales, LLC",Failed Impurities/Degradation Specifications,2017-04-12,2017-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77143 - Class II - Drugs - Allergan Sales, LLC",Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.,2017-06-29,2017-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78325 - Class III - Drugs - Allergan Sales, LLC",Failed Impurities/Degradation Specifications.,2017-11-13,2017-11-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82424 - Class II - Drugs - Allergan Sales, LLC",cGMP Deviations,2019-03-22,2019-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87016 - Class II - Drugs - ALLERGAN SALES, LLC",Labeling: Missing instructions for use insert,2021-01-19,2021-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81855 - Class II - Drugs - ALLERGAN SALES, LLC",GMP Deviations: A silicone particulate was noted in Ozurdex.,2019-01-18,2019-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80136 - Class I - Drugs - ALLERGAN SALES, LLC",Contraceptive Tablets Out of Sequence.,2018-06-15,2018-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71669 - Class III - Biologics - Allergy Laboratories, Inc.",Misbranded Allergenic Extracts were distributed.,2015-07-22,2015-07-22,26,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74883 - Class II - Drugs - Allergy Laboratories, Inc.",Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.,2016-09-07,2016-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72150 - Class III - Biologics - Allermed Laboratories Inc,Misbranded allergenic extracts were distributed.,2015-09-10,2015-09-10,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #60112 - Class II - Biologics - Allograft Innovations, LLC","Human allografts, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-06-29,2012-06-29,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #60098 - Class III - Biologics - Allograft Innovations, LLC","Human allografts, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-07-24,2012-07-24,36,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65027 - Class I - Biologics - AlloSource, Inc.","Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed.",2013-06-05,2013-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69003 - Class II - Biologics - AlloSource, Inc.","Human tissue allograft, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, was distributed.",2014-08-14,2014-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69244 - Class II - Biologics - AlloSource, Inc.","Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed.",2014-10-23,2014-10-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69428 - Class I - Biologics - AlloSource, Inc.","Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69612 - Class III - Biologics - AlloSource, Inc.","Human tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-12-03,2014-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70380 - Class III - Biologics - AlloSource, Inc.","Human bone allografts, mislabeled with an incorrect expiration date, were distributed.",2015-03-03,2015-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70903 - Class III - Biologics - AlloSource, Inc.","HCTP allografts, mislabeled with an extended expiration date, were distributed.",2015-04-02,2015-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75532 - Class II - Biologics - AlloSource, Inc.","Human tissue allograft, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, was distributed.",2016-11-01,2016-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77013 - Class II - Biologics - AlloSource, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2017-04-20,2017-04-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80332 - Class II - Biologics - AlloSource, Inc.","Human tissue allografts, where in process controls were not followed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2018-06-29,2018-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80744 - Class II - Biologics - AlloSource, Inc.","Human tissue allografts, where in-process controls were not followed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2018-08-16,2018-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80637 - Class I - Biologics - AlloSource, Inc.","Human tissue allografts, where in-process controls were not followed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2018-10-23,2018-10-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80910 - Class I - Biologics - AlloSource, Inc.","Human tissue allografts, where in-process controls were not followed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2018-10-23,2018-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83975 - Class III - Biologics - AlloSource, Inc.",Human tendons were distributed prior to determining and documenting donor eligibility.,2019-10-04,2019-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83976 - Class II - Biologics - AlloSource, Inc.",Mislabeled human skin allografts were distributed.,2019-10-04,2019-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85281 - Class II - Biologics - AlloSource, Inc.","Human cartilage allografts, which did not meet release criteria designed to prevent contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2020-03-20,2020-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86641 - Class II - Biologics - AlloSource, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2020-10-22,2020-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90877 - Class III - Drugs - ALMIRALL, LLC",Failed Viscosity specification: Slightly higher OOS results obtained for viscosity,2022-09-29,2022-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88335 - Class I - Drugs - Alpha-Tek LLC,Marketed Without an Approved NDA/ANDA: FDA analysis determined the presence of tadalafil,2021-10-04,2021-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83265 - Class II - Drugs - Altaire Pharmaceuticals, Inc.",Lack of Assurance of Sterility,2019-11-15,2019-11-15,134,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66217 - Class I - Drugs - Altaire Pharmaceuticals, Inc.","Non-Sterility: Customer complaints of mold in the product after use and handling due to the fact that the preservative used in the lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution may not be effective through expiry.  
",2013-12-18,2013-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74049 - Class III - Biologics - Altru Health Systems, Inc.","Blood product, for which donor suitability was not adequately determined, was distributed.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79450 - Class III - Drugs - Alva-Amco Pharmacal Companies., Inc.",Subpotent Drug: The product has failed to maintain its label claim of coal tar throughout its labeled 24-month expiry period.,2018-03-12,2018-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69159 - Class II - Drugs - Alvogen, Inc",Failed Content Uniformity Specifications - The lot failed to meet the acceptance criteria for Uniformity of Dosage Units at the time of release for the oxycodone component.,2014-09-23,2014-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71003 - Class II - Drugs - Alvogen, Inc",Failed Dissolution Specification; 6 month time point,2015-05-14,2015-05-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76664 - Class III - Drugs - Alvogen, Inc",Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib,2017-04-04,2017-04-04,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77545 - Class II - Drugs - Alvogen, Inc",Lack of Assurance of Sterility,2017-07-03,2017-07-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82669 - Class I - Drugs - Alvogen, Inc","Product Mix-Up: Customer complaint that their carton labeled as Fentanyl Transdermal Systems, 12 mcg/h contained five patches labeled and containing 50 mcg/h.",2019-05-13,2019-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83434 - Class II - Drugs - Alvogen, Inc",Failed dissolution specifications,2019-08-12,2019-08-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87372 - Class II - Drugs - Alvogen, Inc",Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low),2021-07-02,2021-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79852 - Class I - Drugs - AMA Wholesale,"Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared tadalafil. The presence of tadalafil makes Rhino Extreme 50000 an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.",2018-05-18,2018-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90627 - Class I - Drugs - Amazon.com, Inc.",Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac.,2022-07-27,2022-07-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63926 - Class II - Drugs - Amedra Pharmaceuticals LLC,Failed Dissolution Specifications: The affected lots may not meet the specifications for dissolution over the product shelf life.,2013-02-27,2013-02-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66593 - Class II - Drugs - Amedra Pharmaceuticals LLC,Failed Dissolution Specifications: Out of Specification (OOS) test results for Hour-4 at the 32 month CRT Stability Level.,2013-12-23,2013-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62363 - Class III - Biologics - Amer.  National Red Cross-Greater Chesapeake & Potomac Reg.,"Blood product, which was incorrectly labeled as negative for the N red cell antigen, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63035 - Class II - Biologics - Amer.  National Red Cross-Greater Chesapeake & Potomac Reg.,"Blood products, which did not meet acceptable product specifications, were distributed.",2012-10-01,2012-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63789 - Class II - Biologics - Amer.  National Red Cross-Greater Chesapeake & Potomac Reg.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2012-12-31,2012-12-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65311 - Class III - Biologics - Amer.  National Red Cross-Greater Chesapeake & Potomac Reg.,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69522 - Class III - Biologics - Amer.  National Red Cross-Greater Chesapeake & Potomac Reg.,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70497 - Class II - Biologics - Amer.  National Red Cross-Greater Chesapeake & Potomac Reg.,"Blood product, testing positive for the antigen but labeled as antigen negative, was distributed.",2015-03-25,2015-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63550 - Class II - Drugs - American Enterprises LLC dba Sterling Gelatin,Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.,2012-11-21,2012-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69248 - Class II - Drugs - American Family Pharmacy, LLC","Subpotent Drug: Product failed to meet USP Specifications on assay, content uniformity, and dissolution.",2014-10-21,2014-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88734 - Class II - Drugs - American Health Packaging,Failed Dissolution Specifications: results were above specification.,2021-10-20,2021-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89377 - Class II - Drugs - American Health Packaging,Failed Dissolution Specifications,2022-01-25,2022-01-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88696 - Class II - Drugs - American Health Packaging,CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.,2021-09-24,2021-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89670 - Class II - Drugs - American Health Packaging,Impurity failure at 0-time of the repackaged lot.,2022-03-11,2022-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90191 - Class III - Drugs - American Health Packaging,Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to dissolution failure at 0-time of the repackaged lot. Drug release results were above specification at 0-time.,2022-05-18,2022-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62792 - Class III - Drugs - American Health Packaging,"Labeling: Label Mix-Up: A typographical error in the product form on the carton label incorrectly lists the configuration as 30 ""Capsules"" (3 x 10) rather than ""Tablets"".",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62748 - Class II - Drugs - American Health Packaging,Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.,2012-08-29,2012-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65683 - Class II - Drugs - American Health Packaging,"Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time
point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.",2013-07-15,2013-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65495 - Class II - Drugs - American Health Packaging,Unit Dose Mispackaging: This recall event is due to a random undetected packaging issue which could increase the potential for a small number of individual unit dose blisters to be packed with more than one tablet.,2013-08-08,2013-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65457 - Class III - Drugs - American Health Packaging,"Failed Stability Specifications; out of specification results at the 9 month stability time point for color, dissolution and related compounds.",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66451 - Class II - Drugs - American Health Packaging,Subpotent,2013-12-05,2013-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67881 - Class II - Drugs - American Health Packaging,"Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an
unapproved source.",2014-04-03,2014-04-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68779 - Class I - Drugs - American Health Packaging,"Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled  with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544, Labeling: Label Mix-Up: Some cartons of AHP Ibuprofen Tablets, USP, 600mg, lot #142588 that contain blister cards filled with Ibuprofen tablets, 600mg drug product, were found to be mis-labeled  with blister card print identifying the product as AHP Oxcarbazepine Tablets, 300mg, lot #142544.",2014-09-18,2014-09-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69511 - Class III - Drugs - American Health Packaging,Subpotent; 6 month stability time point,2014-10-23,2014-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69972 - Class II - Drugs - American Health Packaging,Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.,2014-12-16,2014-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70320 - Class II - Drugs - American Health Packaging,Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules,2015-04-01,2015-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71219 - Class II - Drugs - American Health Packaging,Failed dissolution specifications,2015-06-16,2015-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71553 - Class II - Drugs - American Health Packaging,CGMP Deviations: Firm did not adequately investigate customer complaints.,2015-07-08,2015-07-08,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71634 - Class III - Drugs - American Health Packaging,Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.,2015-07-14,2015-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82316 - Class II - Drugs - American Health Packaging,"CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.",2019-03-21,2019-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82593 - Class II - Drugs - American Health Packaging,Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.,2019-05-10,2019-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82854 - Class II - Drugs - American Health Packaging,GMP Deviations: Potential cross contamination due to cleaning procedure failure.,2019-06-19,2019-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82863 - Class II - Drugs - American Health Packaging,GMP Deviations; possible cross contamination of product due to cleaning procedure failure.,2019-06-27,2019-06-27,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83290 - Class II - Drugs - American Health Packaging,GMP Deviations: Potential cross contamination due to cleaning procedure failure.,2019-07-10,2019-07-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83466 - Class II - Drugs - American Health Packaging,Failed Dissolution Specifications: Out of specification result for the dissolution test.,2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83471 - Class III - Drugs - American Health Packaging,CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.,2019-08-02,2019-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83479 - Class II - Drugs - American Health Packaging,Failed Impurities/Degradation Specifications; out of specification result for an unknown impurity in stability samples.,2019-08-15,2019-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83559 - Class II - Drugs - American Health Packaging,Failed Dissolution Specifications,2019-08-15,2019-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83672 - Class III - Drugs - American Health Packaging,Labeling: Incorrect or Missing Package Insert; an error in the  Dosage Forms and Strengths  section of the insert that incorrectly lists the tablet description coding for the tablets.,2019-09-06,2019-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84208 - Class II - Drugs - American Health Packaging,CGMP Deviations: Presence of NDMA impurity detected in product.,2019-12-29,2019-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84990 - Class II - Drugs - American Health Packaging,GMP Deviations: Product bottle may be absent of desiccant.,2020-02-18,2020-02-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84898 - Class II - Drugs - American Health Packaging,Failed Dissolution Specifications: Low out of specification results obtained during stability testing.,2020-02-21,2020-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85070 - Class II - Drugs - American Health Packaging,CGMP Deviations: Potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.,2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85745 - Class II - Drugs - American Health Packaging,Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).,2020-06-08,2020-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85842 - Class III - Drugs - American Health Packaging,Labeling Not Elsewhere Classified: The statement  Pharmacist: Dispense with the accompanying Medication Guide  was not included on the carton label.,2020-07-01,2020-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87154 - Class II - Drugs - American Health Packaging,Failed Dissolution Specifications,2021-01-15,2021-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88650 - Class III - Drugs - American Health Packaging,Failed Impurities/Degradation Specifications,2021-09-20,2021-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90003 - Class III - Drugs - American Health Packaging,Subpotent Drug: Out of specification for assay.,2022-04-26,2022-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79036 - Class II - Drugs - AMERICAN HEALTH PACKAGING,CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.,2018-03-13,2018-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80389 - Class III - Drugs - AMERICAN HEALTH PACKAGING,Failed Impurities/Degradation Specification; out-of-specification results for the Enalapril DKT degradant,2018-07-09,2018-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81553 - Class III - Drugs - AMERICAN HEALTH PACKAGING,"Cross contamination with other products: This sub-recall is being initiated in support of the recall by the manufacturer (Sandoz) dated 11/1/18, which included lots that were repackaged by American Health Packaging. Sandoz stated that ""These lots are being recalled due to the potential presence of unrelated ingredients (i.e. traces of active ingredients of Benazepril, Haloperidol and Perphenazine), which were identified through a manufacturing investigation.""",2018-11-20,2018-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65095 - Class I - Drugs - American Lifestyle.Com,"Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil.   Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.",2014-04-07,2014-04-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40548 - Class II - Biologics - American National  Red Cross,"Blood product, collected from a donor whose health history record was incomplete, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40955 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-11-01,2012-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41190 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor with a history of Hepatitis, were distributed.",2012-11-16,2012-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41935 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-16,2012-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41936 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-11-16,2012-11-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47684 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-12-07,2012-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48910 - Class II - Biologics - American National  Red Cross,"Blood product, collected from a donor who reported post donation illness, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49326 - Class II - Biologics - American National  Red Cross,"Blood products, labeled as leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49869 - Class II - Biologics - American National  Red Cross,"Blood products, labeled as leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2012-12-07,2012-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50052 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42559 - Class II - Biologics - American National  Red Cross,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45772 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-31,2012-12-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43678 - Class II - Biologics - American National  Red Cross,"Blood product, collected from a donor who lived in a country endemic for malaria, was distributed. .
",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46636 - Class II - Biologics - American National  Red Cross,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47035 - Class II - Biologics - American National  Red Cross,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-01-04,2013-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48909 - Class III - Biologics - American National  Red Cross,"Blood products, lacking assurance of having been maintained at an acceptable temperature during shipping or storage, were distributed.",2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48497 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-01-28,2013-01-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50417 - Class III - Biologics - American National  Red Cross,"Blood products, which may have reached an unacceptable temperature during shipment, were distributed..",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48908 - Class II - Biologics - American National  Red Cross,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47061 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-03-21,2013-03-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48041 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor who was in close contact with an individual diagnosed as a hepatitis B carrier, were distributed.., Blood products, collected from a donor who was in close contact with an individual diagnosed as a  hepatitis B carrier,  were distributed..",2013-03-21,2013-03-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48907 - Class II - Biologics - American National  Red Cross,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-04-22,2013-04-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47033 - Class II - Biologics - American National  Red Cross,"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2013-04-29,2013-04-29,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40418 - Class II - Biologics - American National  Red Cross,"Blood products, collected from donors whose suitability to donate was not adequately determined, were distributed.",2013-06-10,2013-06-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41931 - Class II - Biologics - American National  Red Cross,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2013-06-10,2013-06-10,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69701 - Class II - Biologics - American National  Red Cross,"Blood products, collected from ineligible donors, were distributed.",2014-12-17,2014-12-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62412 - Class II - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-08-01,2012-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39526 - Class II - Biologics - American National Red Cross,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63375 - Class II - Biologics - American National Red Cross,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-21,2012-11-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41575 - Class III - Biologics - American National Red Cross,"Blood product, leukoreduced after five day timing requirement, was distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42956 - Class II - Biologics - American National Red Cross,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64126 - Class III - Biologics - American National Red Cross,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50055 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-02-13,2013-02-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48584 - Class II - Biologics - American National Red Cross,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57786 - Class II - Biologics - American National Red Cross,"Blood products, possibly contaminated with air, were distributed.",2013-02-14,2013-02-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39654 - Class III - Biologics - American National Red Cross,"Blood products, collected using expired blood collection sets, were distributed.",2013-02-15,2013-02-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39707 - Class II - Biologics - American National Red Cross,"Blood product, collected from a donor, whose screening/donor record was incomplete, was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39897 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor who was in close contact with an individual diagnosed with viral hepatitis, were distributed.",2013-03-07,2013-03-07,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48543 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-03-07,2013-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44326 - Class II - Biologics - American National Red Cross,"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64842 - Class II - Biologics - American National Red Cross,"Blood products, collected from an ineligible donor, were distributed.",2013-04-19,2013-04-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64905 - Class III - Biologics - American National Red Cross,"Blood product, manufactured without additive solution, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55636 - Class II - Biologics - American National Red Cross,"Blood products, which were collected in a manner that may have compromised the sterility of the collection system, were distributed.",2013-05-10,2013-05-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65219 - Class III - Biologics - American National Red Cross,"Blood product,  collected from a donor in whom donor suitability was not adequately determined, was distributed.",2013-07-02,2013-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65859 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43097 - Class III - Biologics - American National Red Cross,"Blood products, collected using a scale for which the quality control results were not documented, were distributed.",2013-11-14,2013-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66643 - Class III - Biologics - American National Red Cross,"Blood products, in which leukoreduced filtering was conducted beyond the allowable time limits, were distributed.",2013-12-13,2013-12-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66681 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44236 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-01-02,2014-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67614 - Class II - Biologics - American National Red Cross,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2014-04-09,2014-04-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41388 - Class III - Biologics - American National Red Cross,"Blood products, which may have reached unacceptable temperatures during shipment, were distributed.",2014-04-24,2014-04-24,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68185 - Class III - Biologics - American National Red Cross,"Blood product, labeled with an extended expiration date following irradiation, was distributed.",2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68155 - Class III - Biologics - American National Red Cross,"Blood product, which was labeled with an incorrect expiration date, was distributed.",2014-06-11,2014-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68397 - Class III - Biologics - American National Red Cross,"Blood products, collected from a donor who reported a post donation illness, were distributed.",2014-06-26,2014-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69908 - Class II - Biologics - American National Red Cross,"Bloor products, collected from an ineligible donor, were distributed.",2015-01-14,2015-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71793 - Class III - Biologics - American National Red Cross,"Blood product, for which donor screening was performed incorrectly, was distributed.",2015-08-27,2015-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71774 - Class II - Biologics - American National Red Cross,"Blood products, in which quality control and distribution/failure to quarantine unit due to medical history, were distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72254 - Class II - Biologics - American National Red Cross,"Blood product, which was not tested for pH and platelet yield, was distributed.",2015-10-22,2015-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73110 - Class II - Biologics - American National Red Cross,"Platelet Pheresis products, labeled as leuko reduced, in which WBC testing was not performed, were distributed.",2016-02-04,2016-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73851 - Class III - Biologics - American National Red Cross,"Blood product, collected from an ineligible donor, was distributed.",2016-04-21,2016-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73852 - Class III - Biologics - American National Red Cross,"Blood product, collected from an ineligible donor, was distributed.",2016-04-21,2016-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73806 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-05-04,2016-05-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74050 - Class II - Biologics - American National Red Cross,"Blood products, mislabeled and/ or missing labeling  information, were distributed.",2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74104 - Class III - Biologics - American National Red Cross,"Blood product, in which labels applied to blood unit or product incorrect or missing information, was distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74386 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75345 - Class II - Biologics - American National Red Cross,"Blood products, which did not meet the acceptable product specifications, were distributed.",2016-10-18,2016-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75579 - Class III - Biologics - American National Red Cross,Misbranded platelet product was distributed.,2016-11-11,2016-11-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75597 - Class III - Biologics - American National Red Cross,"Blood product, that was irradiated twice, was distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77044 - Class III - Biologics - American National Red Cross,"Blood products, collected in a manner that lacked assurance of sterility, were distributed.",2017-04-27,2017-04-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77057 - Class II - Biologics - American National Red Cross,"Plateletpheresis products, lacking proper WBC quality control testing, were distributed.",2017-04-27,2017-04-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77347 - Class II - Biologics - American National Red Cross,"Apheresis product, in which residual WBC count was not performed, was distributed.",2017-06-05,2017-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77449 - Class II - Biologics - American National Red Cross,"Blood product, in which quality control and distribution of product  did not meet specifications, was distributed.",2017-07-03,2017-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77497 - Class II - Biologics - American National Red Cross,"Blood products, which did not meet the acceptable product specifications, were distributed.",2017-07-03,2017-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77578 - Class II - Biologics - American National Red Cross,"Platelet product, that was not quarantined  after receiving information concerning post-donation illness, was distributed.",2017-07-12,2017-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77884 - Class III - Biologics - American National Red Cross,"Blood product, collected in a manner where the sterility of the unit may have been compromised, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78560 - Class III - Biologics - American National Red Cross,"Blood product, labeled with an incorrect expiration date, was distributed.
",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78743 - Class III - Biologics - American National Red Cross,"Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78746 - Class III - Biologics - American National Red Cross,"Blood product, labeled with an incorrect volume, was distributed",2018-01-23,2018-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78907 - Class III - Biologics - American National Red Cross,"Blood product, for which donor suitability  was not adequately  determined, was distributed.",2018-02-12,2018-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79124 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.
",2018-02-21,2018-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79283 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79282 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-03-15,2018-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79520 - Class III - Biologics - American National Red Cross,"Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-03-22,2018-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79722 - Class III - Biologics - American National Red Cross,"Blood product, for which a unit received inadequate additive solution, was distributed.
",2018-04-13,2018-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79727 - Class II - Biologics - American National Red Cross,"Red blood cell, for which the donor gave travel history  to an area considered endemic for  malaria, was distributed.",2018-04-30,2018-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79870 - Class III - Biologics - American National Red Cross,"Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-04-30,2018-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80037 - Class III - Biologics - American National Red Cross,"Plasma product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2018-05-30,2018-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80808 - Class III - Biologics - American National Red Cross,"Plasma product, collected from a donor, for whom screening was incorrectly performed, was distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81290 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-30,2018-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81155 - Class III - Biologics - American National Red Cross,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82042 - Class III - Biologics - American National Red Cross,"Blood product, collected from an ineligible donor, was distributed.",2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82204 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-02-28,2019-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82427 - Class III - Biologics - American National Red Cross,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82698 - Class II - Biologics - American National Red Cross,"Blood product, for which donor eligibility screening was incorrectly performed, was distributed.",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82724 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility screening was incorrectly performed, was distributed.",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83167 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2019-07-31,2019-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83555 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-09-19,2019-09-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83824 - Class II - Biologics - American National Red Cross,"Blood products, not meeting product specifications, were distributed.",2019-09-19,2019-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83988 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-10-11,2019-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83989 - Class III - Biologics - American National Red Cross,"Apheresis red blood cell product, not prepared in accordance with specifications, was distributed.
",2019-10-11,2019-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84002 - Class II - Biologics - American National Red Cross,"Blood products, for which the quality control testing was incomplete, were distributed.",2019-11-26,2019-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84003 - Class III - Biologics - American National Red Cross,"Blood products, which may have been exposed to unacceptable temperature during storage, was distributed.",2019-11-26,2019-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84340 - Class II - Biologics - American National Red Cross,"Plateletpheresis products, not meeting products specifications, were distributed.",2019-12-05,2019-12-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84629 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2020-02-10,2020-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84996 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-02-26,2020-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84877 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-03-04,2020-03-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84870 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2020-03-12,2020-03-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84922 - Class II - Biologics - American National Red Cross,"Leukoreduced Red Blood Cells, collected from a donor who traveled to a malarial endemic area, were distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85076 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility was incomplete, was distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85201 - Class III - Biologics - American National Red Cross,"Blood products, with lack of assurance of sterility, were distributed.",2020-03-12,2020-03-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85578 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility was incomplete, was distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85740 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility was incomplete, was distributed.
",2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85928 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility was incomplete, was distributed.
",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85929 - Class II - Biologics - American National Red Cross,"Plateletpheresis products in which quality control procedures were not performed, were distributed.
",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85931 - Class III - Biologics - American National Red Cross,"Plateletpheresis product, not meeting product specifications, was distributed.",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85977 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor who may have traveled to a malarial endemic area, were distributed.",2020-07-20,2020-07-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86293 - Class II - Biologics - American National Red Cross,"Blood product, collected from a donor who was previously deferred, was distributed.",2020-09-10,2020-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86296 - Class II - Biologics - American National Red Cross,"Plateletpheresis products, which did not meet the acceptable product specifications, were distributed.",2020-09-10,2020-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86298 - Class II - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2020-09-10,2020-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86810 - Class II - Biologics - American National Red Cross,"Plateletpheresis products in which quality control for residual white blood cell count testing was not performed, were distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86811 - Class II - Biologics - American National Red Cross,"Plateletpheresis products in which quality control for residual white blood cell count testing was not performed, were distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86792 - Class III - Biologics - American National Red Cross,"Apheresis Platelets, Leukoreduced and Irradiated, which were not stored under continuous agitation, were distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86793 - Class III - Biologics - American National Red Cross,"Blood product, collected from a donor with incomplete donor screening, was distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86944 - Class II - Biologics - American National Red Cross,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2020-12-21,2020-12-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86991 - Class II - Biologics - American National Red Cross,"Apheresis Platelets, Leukoreduced, not meeting product specifications, were distributed.",2020-12-23,2020-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87104 - Class II - Biologics - American National Red Cross,"Leukoreduced, Apheresis Red Blood Cells, which were labeled as leukocytes reduced but failed the monthly QC residual white cell count, were distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87123 - Class II - Biologics - American National Red Cross,"Leukoreduced, Apheresis Red Blood Cells, collected in a manner that compromises the sterility of the collection system, were distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87140 - Class III - Biologics - American National Red Cross,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-01-29,2021-01-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87252 - Class II - Biologics - American National Red Cross,"Plateletpheresis products, for which quality control for white blood cell count testing was not performed, were distributed.
",2021-02-12,2021-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87128 - Class III - Biologics - American National Red Cross,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87132 - Class III - Biologics - American National Red Cross,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87138 - Class III - Biologics - American National Red Cross,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87327 - Class II - Biologics - American National Red Cross,"Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2021-02-19,2021-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87276 - Class II - Biologics - American National Red Cross,"Blood products, which was not quarantined subsequent to receiving information regarding a post donation illness, were distributed.
",2021-02-26,2021-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87425 - Class III - Biologics - American National Red Cross,"Blood products, lacking documentation of visual inspection and proper storage temperature, were distributed.",2021-03-10,2021-03-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87398 - Class II - Biologics - American National Red Cross,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-03-11,2021-03-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87784 - Class II - Biologics - American National Red Cross,"Blood product, which did not meet the acceptable product specifications, was distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87788 - Class III - Biologics - American National Red Cross,"Blood Product for Reprocessing, for which donor eligibility screening was incomplete, was distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87791 - Class II - Biologics - American National Red Cross,"Blood product, which did not meet the acceptable product specifications, was distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87794 - Class II - Biologics - American National Red Cross,"Blood products, labeled with incorrect or missing information, were distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87781 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility was incomplete, was distributed.
",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87895 - Class II - Biologics - American National Red Cross,"Plateletpheresis products, in which platelet yield and component preparation did not meet specifications, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88299 - Class II - Biologics - American National Red Cross,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count, were distributed.",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88572 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility was incomplete, was distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88704 - Class II - Biologics - American National Red Cross,"Blood Products, for which donor eligibility was incomplete, were distributed.
",2021-09-24,2021-09-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88711 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility was incomplete, was distributed.
",2021-09-24,2021-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88702 - Class II - Biologics - American National Red Cross,"Blood products, in which relevant transfusion transmitted infection testing was incomplete, documented incorrectly and/or not performed correctly, were distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88895 - Class III - Biologics - American National Red Cross,"Blood product, for which donor eligibility was incomplete, was distributed.
",2021-11-03,2021-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88894 - Class III - Biologics - American National Red Cross,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-11-04,2021-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89002 - Class III - Biologics - American National Red Cross,"Pooled Cryoprecipitated AHF, stored at temperatures greater than -18 degrees C, were distributed.",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89261 - Class III - Biologics - American National Red Cross,"Blood and Blood Products for Reprocessing, for which donor eligibility screening was incomplete, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89295 - Class II - Biologics - American National Red Cross,"Misbranded Red Blood Cell products were distributed.
",2022-01-18,2022-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89932 - Class II - Biologics - American National Red Cross,"Red Blood Cell, lacking assurance of sterility, was distributed.
",2022-04-19,2022-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91188 - Class II - Biologics - American National Red Cross,"Blood product, collected from a donor for whom donor suitability was incomplete, was distributed.
",2022-11-25,2022-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91257 - Class II - Biologics - American National Red Cross,"Plateletpheresis products, collected from a donor who tested positive for the antibody to Hepatitis B core Antigen on more than one occasion, were distributed.
",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61929 - Class II - Biologics - American National Red Cross (the),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-06-12,2012-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39540 - Class III - Biologics - American National Red Cross (the),"Blood products, collected using expired blood collection sets, were distributed.",2012-07-23,2012-07-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62429 - Class III - Biologics - American National Red Cross (the),"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44156 - Class II - Biologics - American National Red Cross (the),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-27,2012-12-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64141 - Class II - Biologics - American National Red Cross (the),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-02-14,2013-02-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64895 - Class II - Biologics - American National Red Cross (the),"Blood products, which were not quarantined subsequent to receiving post donation information, were distributed.",2013-04-29,2013-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58357 - Class II - Biologics - American National Red Cross (the),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-05-10,2013-05-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65122 - Class II - Biologics - American National Red Cross (the),"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67062 - Class II - Biologics - American National Red Cross (the),"Blood product, which did not meet the acceptable product specifications, was distributed.",2014-01-09,2014-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67170 - Class II - Biologics - American National Red Cross (the),"Blood products, labeled leukoreduced without the assurance they met the criteria for leukoreduced products, were distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69628 - Class III - Biologics - American National Red Cross (the),Plateletphereis products lacking assurance of proper leukoreduction were distributed.,2014-10-30,2014-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70005 - Class III - Biologics - American National Red Cross (the),"Blood product, which were collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-01-26,2015-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70757 - Class III - Biologics - American National Red Cross (the),"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-04-02,2015-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70825 - Class III - Biologics - American National Red Cross (the),"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-04-13,2015-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71280 - Class III - Biologics - American National Red Cross (the),"Blood product, which was not quarantined after receiving post donation information concerning an illness following donation, was distributed.",2015-06-17,2015-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71353 - Class III - Biologics - American National Red Cross (the),"Platelet products, collected on an instrument that failed the leukoreduction quality control process, were distributed.",2015-06-19,2015-06-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71945 - Class II - Biologics - American National Red Cross (the),"Platelet products, collected on an instrument that failed leukoreduction quality control, were distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73809 - Class III - Biologics - American National Red Cross (the),"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-04-29,2016-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73810 - Class III - Biologics - American National Red Cross (the),"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-04-29,2016-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73808 - Class III - Biologics - American National Red Cross (the),"Plasma products, for which donor suitability was inadequately determined, were distributed.",2016-05-03,2016-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74336 - Class II - Biologics - American National Red Cross (the),"Apheresis products, in which quality control for residual WBC count was not performed, were distributed.",2016-06-10,2016-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75451 - Class III - Biologics - American National Red Cross (the),"Blood products, collected from an unsuitable donor due to a donor screening deviation, were distributed.",2016-11-03,2016-11-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75658 - Class III - Biologics - American National Red Cross (the),"Blood product, collected from a donor for whom donor screening was performed incorrectly, was distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75674 - Class II - Biologics - American National Red Cross (the),"Blood products, collected from a donor whose donor suitability was not adequately determined, were distributed.",2016-12-16,2016-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75934 - Class III - Biologics - American National Red Cross (the),"Blood products, not tested according to specifications, were distributed.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76316 - Class II - Biologics - American National Red Cross (the),"Platelet products, for which WBC quality control testing was not performed, were distributed.",2017-02-03,2017-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76553 - Class II - Biologics - American National Red Cross (the),"Apheresis products, collected from unsuitable donors due to a donor screening deviation, were distributed.",2017-03-06,2017-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76556 - Class II - Biologics - American National Red Cross (the),"Blood products, collected from unsuitable donors were distributed.",2017-03-06,2017-03-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76533 - Class II - Biologics - American National Red Cross (the),"Blood products, labeled as leukoreduced were not tested to verify the White Blood Cell count, were distributed.",2017-03-30,2017-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77585 - Class II - Biologics - American National Red Cross (the),"Apheresis product for which white blood cell count testing was not performed, was distributed.",2017-07-12,2017-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78647 - Class III - Biologics - American National Red Cross (the),"Blood products, which may have been exposed to unacceptable temperature during storage/transit, were distributed.",2018-01-03,2018-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79128 - Class II - Biologics - American National Red Cross (the),"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-03-05,2018-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80788 - Class II - Biologics - American National Red Cross (the),"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-09-12,2018-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82118 - Class III - Biologics - American National Red Cross (the),Misbranded blood product was distributed.,2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82699 - Class III - Biologics - American National Red Cross (the),"Misbranded blood product was distributed.
",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84631 - Class III - Biologics - American National Red Cross (the),"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84871 - Class II - Biologics - American National Red Cross (the),Misbranded red blood cells were distributed.,2020-02-19,2020-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86794 - Class II - Biologics - American National Red Cross (the),"Leukoreduced, Apheresis Platelets, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86822 - Class II - Biologics - American National Red Cross (the),"Plateletpheresis products, identified as unsuitable due to a collection deviation or unexpected event, were distributed.",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86844 - Class III - Biologics - American National Red Cross (the),"Apheresis, Red Blood Cell Products, leuko-reduced by filtration at an unacceptable temperature, were distributed.",2020-12-04,2020-12-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87142 - Class III - Biologics - American National Red Cross (the),"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87424 - Class III - Biologics - American National Red Cross (the),"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2021-03-10,2021-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88378 - Class III - Biologics - American National Red Cross (the),"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were not tested for platelet yield, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88898 - Class II - Biologics - American National Red Cross (the),"Leukoreduced Red Blood Cells, collected in a manner that compromises the sterility of the collection system, were distributed.",2021-11-04,2021-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89344 - Class II - Biologics - American National Red Cross (the),"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.
",2022-01-18,2022-01-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89435 - Class III - Biologics - American National Red Cross (the),"Red Blood Cell, identified as unsuitable due to a collection deviation, was distributed.",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91511 - Class II - Biologics - American National Red Cross (the),"Leukoreduced Red Blood Cells, collected from a donor who had recently traveled to a malarial endemic area, were distributed.",2023-01-20,2023-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40848 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.

",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43674 - Class III - Biologics - American National Red Cross (The),"Blood products, lacking assurance of having been maintained at an acceptable temperature during shipping, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44205 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-06-11,2012-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46443 - Class III - Biologics - American National Red Cross (The),"Blood product, collected from an ineligible donor, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50606 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability were not adequately determined, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62062 - Class III - Biologics - American National Red Cross (The),"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46033 - Class II - Biologics - American National Red Cross (The),"Blood products, which were labeled as leukoreduced, but did not have leukoreduction testing completed were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41766 - Class III - Biologics - American National Red Cross (The),"Blood components, processed more than 8 hours after collection, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41786 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors whose arm scrubs may have been incorrectly performed, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42143 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42331 - Class II - Biologics - American National Red Cross (The),"Blood products, collected using equipment that had not been validated, were distributed.",2012-07-13,2012-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43470 - Class III - Biologics - American National Red Cross (The),"Blood products, labeled with the incorrect expiration date, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50626 - Class II - Biologics - American National Red Cross (The),"Blood products, manufactured from overweight whole blood unit, were distributed.",2012-07-13,2012-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42933 - Class II - Biologics - American National Red Cross (The),"Blood product, collected in a manner that may have compromised the sterility of the collection system, was distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40870 - Class II - Biologics - American National Red Cross (The),"Blood products, lacking proper documentation of antigen phenotyping, were distributed.",2012-07-24,2012-07-24,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41332 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using expired blood collection sets, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41411 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using expired blood collection sets, were distributed.",2012-07-25,2012-07-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44312 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who was previously deferred, were distributed",2012-07-25,2012-07-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55592 - Class III - Biologics - American National Red Cross (The),"Blood products, which may have reached an unacceptable temperature during storage, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40082 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who was previously deferred after testing HIV-1/2 repeat reactive, were distributed.",2012-07-31,2012-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46069 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability  was not adequately determined, were distributed.",2012-08-01,2012-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47098 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-08-01,2012-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50666 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor in whom donor suitability were not adequately determined, were distributed.",2012-08-01,2012-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44298 - Class III - Biologics - American National Red Cross (The),"Blood products, manufactured from a whole blood unit that may have had an extended collection time, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47936 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2012-08-06,2012-08-06,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49223 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43665 - Class III - Biologics - American National Red Cross (The),"Blood products, for which no documentation of shipment or storage at appropriate temperatures were distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40074 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-16,2012-08-16,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48593 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-16,2012-08-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50605 - Class II - Biologics - American National Red Cross (The),"Blood products, requiring testing for separator validation, were distributed without testing.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54937 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors whose arm preparation was inadequate, were distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40113 - Class III - Biologics - American National Red Cross (The),"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40900 - Class II - Biologics - American National Red Cross (The),"Blood product, collected in a manner that may have compromised the sterility of the collection system, was distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62934 - Class II - Biologics - American National Red Cross (The),"Blood products, which were not quarantined after receiving post donation information,  were distributed.., Blood products, which were not quarantined after receiving post donation information,  were distributed.",2012-10-01,2012-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40107 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who lived in the past 3 years in an area considered endemic for malaria, were distributed.",2012-10-12,2012-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42051 - Class III - Biologics - American National Red Cross (The),"Blood product, which did not meet acceptable product specifications, was distributed. .",2012-10-12,2012-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42476 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2012-10-12,2012-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50653 - Class III - Biologics - American National Red Cross (The),"Blood products, which were incorrectly tested for human T-lymphotropic virus (HTLV), were distributed.",2012-10-12,2012-10-12,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52882 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet acceptable product specifications, were distributed.",2012-10-12,2012-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57717 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2012-10-24,2012-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41181 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who traveled to a malarial risk area, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41337 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who was previously deferred due to history of Hepatitis A, was distributed.",2012-11-01,2012-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41423 - Class III - Biologics - American National Red Cross (The),"Blood product, failed to meet the minimum specification for red blood cell percent recovery, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49613 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed",2012-11-01,2012-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41409 - Class III - Biologics - American National Red Cross (The),"Blood product, manufactured from Whole Blood unit with an extended collection time, was distributed",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49684 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40903 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor with a history of Hepatitis A, were distributed., Blood products, collected from a donor with a history of Hepatitis A,  were distributed.",2012-11-16,2012-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41419 - Class II - Biologics - American National Red Cross (The),"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41526 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-16,2012-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44449 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-16,2012-11-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45117 - Class II - Biologics - American National Red Cross (The),"Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #51265 - Class III - Biologics - American National Red Cross (The),"Blood products, which were incorrectly tested for human T-lymphotropic virus (HTLV), were distributed.",2012-11-16,2012-11-16,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40172 - Class II - Biologics - American National Red Cross (The),"Blood product, manufactured from a unit of whole blood lacking hematocrit documentation, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41499 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from an ineligible donor, were distributed., Blood products,  collected from an ineligible donor, were distributed.",2012-12-03,2012-12-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42800 - Class II - Biologics - American National Red Cross (The),"Blood products, with unacceptable, undocumented or incomplete product QC and platelet counts were distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39136 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45119 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-12-07,2012-12-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50030 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-12-07,2012-12-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50418 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor with an unacceptably low hemoglobin, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50593 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2012-12-07,2012-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53334 - Class III - Biologics - American National Red Cross (The),"Blood product, for which the red cell count and hematocrit were outside the acceptable range, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61564 - Class III - Biologics - American National Red Cross (The),"Blood products, for which the scale and Hemocue used during collection failed quality control testing, were distributed.",2012-12-07,2012-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49793 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2012-12-11,2012-12-11,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56007 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2012-12-17,2012-12-17,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40747 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who was previously deferred, were distributed.",2012-12-27,2012-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40759 - Class III - Biologics - American National Red Cross (The),"Blood product, for which Collection/Apheresis device was not used within acceptable time period, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40784 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using equipment for which quality control was not performed, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43859 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet the acceptable product specifications, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48858 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2012-12-27,2012-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50328 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-27,2012-12-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50329 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-27,2012-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50330 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-27,2012-12-27,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42486 - Class II - Biologics - American National Red Cross (The),"Blood products, which was collected in a manner that may have compromised the sterility of the collection system, were distributed.",2013-01-03,2013-01-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41895 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors whose arm scrubs may have been incorrectly performed, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43008 - Class II - Biologics - American National Red Cross (The),"Blood product, which did not meet acceptable product specifications, was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44496 - Class II - Biologics - American National Red Cross (The),"Blood products, possibly contaminated with air during collection, were distributed.",2013-01-04,2013-01-04,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45120 - Class II - Biologics - American National Red Cross (The),"Blood products, possibly contaminated with air, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50020 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-01-04,2013-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50296 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-01-04,2013-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50431 - Class II - Biologics - American National Red Cross (The),"Blood products,  which were not quarantined subsequent to receiving  post donation information, were distributed.",2013-01-04,2013-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50951 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected without  applying the metal crimp and potentially cause contamination to the blood, were distributed.",2013-01-04,2013-01-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52256 - Class II - Biologics - American National Red Cross (The),"Blood products, possibility sterility compromised and contaminated, were distributed.",2013-01-04,2013-01-04,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58358 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-01-04,2013-01-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42954 - Class III - Biologics - American National Red Cross (The),"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39800 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor whose health history screening was inadequately performed, was distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40882 - Class II - Biologics - American National Red Cross (The),"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44128 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability were not adequately determined, was distributed.",2013-01-29,2013-01-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39135 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39454 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose arm scrub procedure was performed incorrectly, were distributed.",2013-01-30,2013-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39461 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from  donors in which donor suitability was not adequately determined, were distributed.",2013-01-30,2013-01-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39798 - Class III - Biologics - American National Red Cross (The),"Blood products,  in which instrument QC or validation was unacceptable were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39999 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40111 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42790 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet the minimum requirement for total hemoglobin, were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46672 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-01-30,2013-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40412 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet acceptable product specifications, were distributed.",2013-01-31,2013-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45280 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2013-02-06,2013-02-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44031 - Class III - Biologics - American National Red Cross (The),"Blood products, which may have been transported under unacceptable temperatures after collection, were distributed.",2013-02-11,2013-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40243 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor who traveled to malarial endemic areas, were distributed",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43462 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet acceptable product specifications, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50385 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who was previously deferred after disclosing high risk behavior, were distributed.",2013-02-12,2013-02-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42560 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet acceptable product specifications, were distributed.",2013-02-13,2013-02-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43849 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who was previously deferred, were distributed.",2013-02-13,2013-02-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46548 - Class III - Biologics - American National Red Cross (The),"Blood products, in which  QC was not performed or unacceptable for West Nile Virus, were distributed.",2013-02-13,2013-02-13,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50386 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2013-02-14,2013-02-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39991 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed., Blood products, collected from donors whose suitability to donate was not adequately determined, were distributed.",2013-02-25,2013-02-25,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40757 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors whose arm scrub may have been performed incorrectly, were distributed.",2013-02-25,2013-02-25,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43847 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a deferred donor, were distributed.",2013-02-28,2013-02-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46637 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using expired blood collection sets, were distributed.
, Blood products, collected using expired blood collection sets, were distributed.",2013-02-28,2013-02-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48379 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-03-04,2013-03-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48481 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have  compromised sterility, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46052 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49228 - Class III - Biologics - American National Red Cross (The),"Blood products, collected from a donor who traveled to a malarial and leishmaniasis endemic area, were distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38596 - Class II - Biologics - American National Red Cross (The),"Blood products,  which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42908 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56466 - Class II - Biologics - American National Red Cross (The),"Blood products, which were labeled as leukoreduced, but were collected on an apheresis machine that failed quality control testing for leukoreduction, were distributed.",2013-03-22,2013-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47005 - Class III - Biologics - American National Red Cross (The),"Blood products, which may have been exposed to unacceptable temperature during storage, were distributed.",2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44633 - Class II - Biologics - American National Red Cross (The),"Blood products, which were not screened for antibodies according to the reagent manufacturer's instructions, were distributed.",2013-03-27,2013-03-27,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48545 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49180 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-03-27,2013-03-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49838 - Class II - Biologics - American National Red Cross (The),"Blood product, which may have been contaminated during collection, was distributed.",2013-04-03,2013-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49941 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-03,2013-04-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48059 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.

",2013-04-04,2013-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38597 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-04-05,2013-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38693 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors whose arm scrub procedures were performed incorrectly, were distributed.",2013-04-15,2013-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40888 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44316 - Class II - Biologics - American National Red Cross (The),"Blood products, which tested negative for HIV, but were collected from a donor who previously tested positive for HIV, were distributed.",2013-04-15,2013-04-15,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53200 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2013-04-15,2013-04-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40483 - Class II - Biologics - American National Red Cross (The),"Blood product, which tested positive for S antigen, but was labeled as S antigen negative, was distributed.distributed..",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48867 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed",2013-04-22,2013-04-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44083 - Class III - Biologics - American National Red Cross (The),"Platelets, possibly exposed to unacceptable temperatures, were distributed.",2013-04-29,2013-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48234 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-04-29,2013-04-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49895 - Class III - Biologics - American National Red Cross (The),"Blood product, in which quality control did not meet specifications, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49991 - Class III - Biologics - American National Red Cross (The),"Blood products, not prepared in accordance with specifications, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48941 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-05-08,2013-05-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57465 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2013-05-08,2013-05-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39169 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who traveled to a malaria endemic area, was distributed.",2013-05-10,2013-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39170 - Class III - Biologics - American National Red Cross (The),"Blood products, in which extra amount of red cell preservative solution was added, were distributed.",2013-05-10,2013-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42386 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors who traveled to potential malaria endemic areas,  were distributed.",2013-05-10,2013-05-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50623 - Class II - Biologics - American National Red Cross (The),"Blood products, in which routine testing interpreted or documented incorrectly,  were distributed.",2013-05-10,2013-05-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44314 - Class II - Biologics - American National Red Cross (The),"Blood products, in which donor incorrectly identified on deferral list and should have been previously deferred due to testing, were distributed., Blood products, collected from a donor who was previously deferred, were distributed.",2013-05-13,2013-05-13,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46053 - Class II - Biologics - American National Red Cross (The),"Blood products, in which donor screening and  records were incomplete or incorrect and, were distributed.",2013-05-13,2013-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50384 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-05-13,2013-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45167 - Class III - Biologics - American National Red Cross (The),"Blood products, lacking assurance of having been maintained at an acceptable temperature during shipping, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45171 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-05-24,2013-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46557 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-05-24,2013-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65037 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65039 - Class III - Biologics - American National Red Cross (The),"Blood product, with a volume significantly higher than the usual and expected amount, was distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38800 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-06-07,2013-06-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38801 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-06-07,2013-06-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46986 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2013-06-07,2013-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47998 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate were not adequately determined, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38808 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-06-12,2013-06-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38777 - Class II - Biologics - American National Red Cross (The),"Blood products, held in quarantine pending results of an investigation, were distributed",2013-06-17,2013-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40408 - Class II - Biologics - American National Red Cross (The),"Blood products, tested for communicable diseases using unsuitable samples, were distributed.",2013-06-17,2013-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41384 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not undergo the required quality control testing, were distributed.",2013-06-17,2013-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44002 - Class III - Biologics - American National Red Cross (The),"Blood product, with donor hematocrit determined using an analyzer for which the normal control was out of range, was distributed.",2013-06-17,2013-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44203 - Class II - Biologics - American National Red Cross (The),"Blood Products, collected in an apheresis kit which was not used within the specified time period after priming, were distributed.",2013-06-17,2013-06-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44226 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2013-06-17,2013-06-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44232 - Class III - Biologics - American National Red Cross (The),"Blood products, collected from donors who answered a donor screening question inappropriately, were distributed.",2013-06-17,2013-06-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44234 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-06-17,2013-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48869 - Class II - Biologics - American National Red Cross (The),"Blood product,  in which donor gave history which warranted deferral or follow up questions was not asked, was distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40055 - Class III - Biologics - American National Red Cross (The),"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41367 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who gave history which warranted deferral, was distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48388 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from  donors in which donor suitability was not adequately determined, were distributed., Blood products, collected from  donors in which donor suitability was not adequately determined, were distributed..",2013-06-19,2013-06-19,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49278 - Class III - Biologics - American National Red Cross (The),"Blood products, for which the West Nile Viral testing performed was incomplete, were distributed., Blood products, for which West Nile Viral testing was incomplete, were distributed.",2013-07-09,2013-07-09,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44365 - Class III - Biologics - American National Red Cross (The),"Blood products, which should have been quarantined pending an investigation, were distributed.",2013-07-23,2013-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38803 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2013-07-29,2013-07-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41294 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using an expired blood collection set were expired, were distributed.",2013-08-09,2013-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43663 - Class II - Biologics - American National Red Cross (The),"Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52884 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected in a collection system that may have a potential defect which could compromise the sterility of the closed system, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41607 - Class III - Biologics - American National Red Cross (The),"Fresh Frozen Plasma products, not manufactured in accordance with GMPs, were distributed.",2013-08-14,2013-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43959 - Class III - Biologics - American National Red Cross (The),"Blood products, not prepared in accordance with specifications, were distributed.",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48364 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a previously deferred donor, were distributed.",2013-08-23,2013-08-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40414 - Class III - Biologics - American National Red Cross (The),"Blood products, in which quality control and distribution  of products did not meet specifications, were distributed.",2013-09-03,2013-09-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39171 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors whose hemoglobin determination was performed using expired microcuvettes, were distributed.",2013-09-04,2013-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40906 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-09-04,2013-09-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43103 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-09-04,2013-09-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49288 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-09-04,2013-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43176 - Class III - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom there was no documentation of an arm inspection, were distributed.",2013-09-05,2013-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58193 - Class III - Biologics - American National Red Cross (The),"Blood products, which may have been exposed to unacceptable storage temperatures, were distributed.",2013-09-05,2013-09-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39172 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using scales for which the quality control results were not documented, were distributed.",2013-09-06,2013-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46127 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-09-09,2013-09-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46559 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-09-09,2013-09-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39173 - Class III - Biologics - American National Red Cross (The),"Blood products, not prepared in accordance with specifications, were distributed.",2013-09-13,2013-09-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49928 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-10-18,2013-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66378 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-10-21,2013-10-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39163 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using scales for which the quality control testing was performed incorrectly, were distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47626 - Class II - Biologics - American National Red Cross (The),"Blood products, not prepared in accordance with product specifications, were distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48287 - Class II - Biologics - American National Red Cross (The),"Blood products, possibly contaminated with air, were distributed.",2013-10-25,2013-10-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48385 - Class II - Biologics - American National Red Cross (The),"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-10-25,2013-10-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63645 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-10-31,2013-10-31,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47702 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-11-01,2013-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66386 - Class II - Biologics - American National Red Cross (The),"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2013-11-06,2013-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66730 - Class II - Biologics - American National Red Cross (The),Misbranded red blood cell was distributed.,2013-11-07,2013-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66749 - Class III - Biologics - American National Red Cross (The),"Blood product, collected from a donor whose health history screening was not adequately performed, was distributed.",2013-12-11,2013-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44445 - Class II - Biologics - American National Red Cross (The),"Blood products, for which there was a discrepancy in the sample tubes for viral marker testing, were distributed.",2014-01-02,2014-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66620 - Class II - Biologics - American National Red Cross (The),"Blood products, which failed the monthly quality control testing for Factor VIII level, were distributed.",2014-02-20,2014-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38792 - Class III - Biologics - American National Red Cross (The),"Blood product,which was out of controlled storage for an indeterminable length of time, was distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38797 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-03-07,2014-03-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41858 - Class II - Biologics - American National Red Cross (The),"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43099 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using trip scales for which the daily QC was not documented, were distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43101 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using trip scales for which the daily QC was not documented, were distributed.

",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38795 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2014-03-27,2014-03-27,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44213 - Class III - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-04-09,2014-04-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55691 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2014-05-21,2014-05-21,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68732 - Class II - Biologics - American National Red Cross (The),"Blood products, labeled leukoreduced without the assurance they met the criteria for leukoreduced products, were distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69156 - Class II - Biologics - American National Red Cross (The),"Platelet, with an unacceptable pH, was distributed.",2014-09-15,2014-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55591 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-12-01,2014-12-01,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40134 - Class III - Biologics - American National Red Cross (The),"Blood products, not properly  tested appropriately for syphilis, were distributed.",2014-12-17,2014-12-17,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58649 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed. 
, Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2015-01-05,2015-01-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43178 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using a scale for which the quality control results were not documented, were distributed.",2015-01-23,2015-01-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56465 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from donors who were not adequately evaluated for residence in areas considered endemic for malaria, were distributed.",2015-02-27,2015-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56467 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2015-03-23,2015-03-23,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70730 - Class II - Biologics - American National Red Cross (The),"Plateletpheresis products, lacking assurance of proper leukoreduction, were distributed.",2015-03-24,2015-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70731 - Class II - Biologics - American National Red Cross (The),"Blood products, which quality control and/or distribution of products did not meet specifications, were distributed.",2015-04-02,2015-04-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71283 - Class II - Biologics - American National Red Cross (The),"Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2015-06-12,2015-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71391 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet the acceptable product specifications, were distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55646 - Class II - Biologics - American National Red Cross (The),"Blood products, associated with invalid testing results, were distributed.",2015-07-23,2015-07-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56196 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor who visited a malarial endemic area, were distributed.",2015-07-28,2015-07-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71644 - Class III - Biologics - American National Red Cross (The),"Blood products, collected from inelgible donors, were distributed.",2015-08-04,2015-08-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62287 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised sterility, were distributed.",2015-08-07,2015-08-07,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71180 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner lacking assurance of sterility, were distributed.",2015-08-21,2015-08-21,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59882 - Class II - Biologics - American National Red Cross (The),"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2015-08-27,2015-08-27,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72430 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from inelieible donors, were distributed.",2015-11-16,2015-11-16,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72431 - Class III - Biologics - American National Red Cross (The),"Blood products, collected using an improper arm scrub, were distributed.",2015-12-03,2015-12-03,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72982 - Class III - Biologics - American National Red Cross (The),Mislabelled RBC was distributed.,2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73867 - Class III - Biologics - American National Red Cross (The),Mislabeled blood product was distributed.,2016-05-17,2016-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75328 - Class II - Biologics - American National Red Cross (The),"Blood product, which did not meet acceptable product specifications, was distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75529 - Class III - Biologics - American National Red Cross (The),"Plasma product, collected from a donor for whom eligibility was not adequately determined, was distributed.",2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76099 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2017-02-02,2017-02-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77383 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet the acceptable product specifications, were distributed.",2017-06-27,2017-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80206 - Class II - Biologics - American National Red Cross (The),"Platelet product that did not meet specifications for pH and platelet count, was distributed.",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83130 - Class III - Biologics - American National Red Cross (The),"Blood product, in which donor suitability was not adequately determined, was distributed.
",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84632 - Class II - Biologics - American National Red Cross (The),"Platelets, which was not tested for pH and platelet count, were distributed.",2020-01-14,2020-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84875 - Class II - Biologics - American National Red Cross (The),"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84934 - Class II - Biologics - American National Red Cross (The),"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2020-03-24,2020-03-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85680 - Class III - Biologics - American National Red Cross (The),"Misbranded Red Blood Cell product, was distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86843 - Class III - Biologics - American National Red Cross (The),"Misbranded, Leukoreduced Apheresis Platelets were distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87129 - Class III - Biologics - American National Red Cross (The),"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87793 - Class II - Biologics - American National Red Cross (The),"Leukoreduced Red Blood Cells, collected in a manner that compromises the sterility of the collection system, were distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88899 - Class II - Biologics - American National Red Cross (The),"Misbranded Plateletpheresis product was distributed.
",2021-11-03,2021-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88900 - Class II - Biologics - American National Red Cross (The),"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, not tested for pH, were distributed.",2021-11-04,2021-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89728 - Class III - Biologics - American National Red Cross (The),"Red Blood Cell product, for which a visual inspection was not performed or documented, was distributed. 
",2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91022 - Class III - Biologics - American National Red Cross (The),Leukoreduced Red Blood Cells were distributed without a final visual check.,2022-11-04,2022-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91250 - Class III - Biologics - American National Red Cross (The),"Red Blood Cell product, for which a visual inspection was not performed or documented, was distributed.
",2022-12-08,2022-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62012 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood product, incorrectly labeled for Jk(a) red cell antigen, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66087 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, possibly contaminated with air, were distributed.",2013-09-17,2013-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66489 - Class III - Biologics - American National Red Cross (The) - North Central Region,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-11-22,2013-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66998 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, labeled leukoreduced without the assurance they met the criteria for leukoreduced products, were distributed.",2014-01-09,2014-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67698 - Class III - Biologics - American National Red Cross (The) - North Central Region,-,2014-04-09,2014-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67773 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood product, in which quality control/distribution of product did not meet specifications.",2014-04-11,2014-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68126 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68253 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, collected from a donor whose health history screening was not adequately performed, were distributed.",2014-06-23,2014-06-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70982 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood product, collected from a donor who received a transfusion, was distributed.",2015-04-17,2015-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71053 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Platelet products, collected on an instrument that failed leukoreduction quality control procedures, and labeled as leukoreduced, were distributed.",2015-05-08,2015-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72503 - Class III - Biologics - American National Red Cross (The) - North Central Region,"Blood product, in which donor suitability was inadequately determined, was distributed.

",2015-11-16,2015-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73106 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Apheresis products, for which quality control testing was not performed, were distributed.",2016-02-04,2016-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74679 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, labeled as leukoreduced but failed to meet WBC QC testing requirements, were distributed.",2016-08-24,2016-08-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74674 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, with incomplete documentation of the irradiation process, were distributed.",2016-08-29,2016-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76396 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Platelet products, for which  WBC quality control testing was not performed, were distributed.",2017-02-21,2017-02-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76409 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2017-03-16,2017-03-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76794 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Platelet products, for which some quality control testing was not performed, were distributed.",2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76880 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Apheresis products, in which the platelet yield was below 3.0x10^11, were distributed.",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77775 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Platelet product, for which required WBC quality control testing was not performed, was distributed.",2017-08-08,2017-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78581 - Class III - Biologics - American National Red Cross (The) - North Central Region,-,2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79123 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Apheresis product, associated with a unit that was found to contain a leak, was distributed.
",2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79725 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, with a high platelet yield, were distributed.",2018-04-13,2018-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79947 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Apheresis products, not meeting product specifications, were distributed.
",2018-05-02,2018-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80664 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood product, lacking assurance of sterility, was distributed.
",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80741 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, for which arm prep may have been performed inappropriately, were distributed.",2018-08-24,2018-08-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80809 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Platelet components, for which the pathogen reduction process was not performed in accordance with specifications, were distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84343 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-12-20,2019-12-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84630 - Class II - Biologics - American National Red Cross (The) - North Central Region,Transfusion,2020-02-10,2020-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84894 - Class III - Biologics - American National Red Cross (The) - North Central Region,"Apheresis Red Blood Cell products, in which residual WBC count was not performed, were distributed.
",2020-02-14,2020-02-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85336 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Blood product, which failed to meet the minimum specifications, was distributed.",2020-04-30,2020-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86292 - Class III - Biologics - American National Red Cross (The) - North Central Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2020-09-10,2020-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86812 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Misbranded Red Blood Cell product, was distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86838 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Apheresis Platelets, Leukoreduced and Irradiated, which were labeled as leukocytes reduced but failed the monthly QC residual white cell count, were distributed.",2020-12-02,2020-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87137 - Class III - Biologics - American National Red Cross (The) - North Central Region,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87402 - Class III - Biologics - American National Red Cross (The) - North Central Region,"Blood Product, for which donor eligibility was incomplete, was distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87790 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Leukoreduced Apheresis Red Blood Cells,  which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87782 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Plateletpheresis product, in which quality control for residual WBC count was not performed, was distributed.
",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87897 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Leukoreduced Red Blood Cell, for which donor eligibility screening was incomplete, was distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87956 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Leukoreduced Apheresis Red Blood Cells, collected in a manner that compromises the sterility of the collection system, was distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91458 - Class II - Biologics - American National Red Cross (The) - North Central Region,"Leukoreduced Red Blood Cells, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-18,2023-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77043 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Blood products, collected from a donor who provided high-risk behavior, were distributed.",2017-05-22,2017-05-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77256 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2017-06-23,2017-06-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78211 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Platelet products, not tested for WBC count and labeled as leukoreduced, were distributed.",2017-10-19,2017-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78558 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2017-11-30,2017-11-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79916 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-05-16,2018-05-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80260 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2018-07-05,2018-07-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81621 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-11-30,2018-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83564 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-08-29,2019-08-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85370 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Plateletpheresis product, for which the pathogen reduction process was not performed in accordance with specifications, was distributed.",2020-04-09,2020-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87114 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Plateletpheresis products, in which quality control for residual WBC count was not performed, were distributed.
",2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88260 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Plateletpheresis products, for which quality control for pH testing was not performed, were distributed.


",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88358 - Class III - Biologics - American National Red Cross (The) Carolinas Region,"Blood products, which did not meet acceptable product specifications, were distributed",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89297 - Class II - Biologics - American National Red Cross (The) Carolinas Region,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75877 - Class III - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, for which donor screening was performed incorrectly, were distributed.",2016-12-20,2016-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77498 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, collected from donors in which donor suitability was not adequately  determined, were distributed.",2017-07-13,2017-07-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77981 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Plateletpheresis product, not meeting product specifications, was distributed.",2017-08-24,2017-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77993 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood product, for which unit sterility was compromised during collection, was distributed.",2017-08-29,2017-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79284 - Class III - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79948 - Class III - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82847 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-06-12,2019-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82885 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83049 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, not completely tested for relevant transfusion-transmitted infections, were distributed.",2019-06-14,2019-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83129 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-06-28,2019-06-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83276 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, collected in a manner that  compromised sterility of the closed system, were distributed., Blood products, collected in a manner that compromised sterility of the closed system, were distributed.",2019-08-05,2019-08-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83600 - Class III - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86588 - Class III - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood product, for which donor eligibility was incomplete, was distributed.
",2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86820 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Red Blood Cell products, for which syphilis testing was not performed, were distributed.",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87199 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Plateletpheresis product, identified as unsuitable due to a collection deviation, was distributed.
",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87133 - Class III - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood product, collected from a donor with a history of high risk behavior, was distributed.",2021-01-29,2021-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87401 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, collected from a donor for whom donor suitability was incomplete, were distributed.
",2021-03-03,2021-03-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87400 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-03-11,2021-03-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87792 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed., Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-05-10,2021-05-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88902 - Class III - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood product, for which donor eligibility was incomplete, was distributed.
",2021-11-03,2021-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89247 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood product, collected in a manner that may have compromised the sterility of the collection system, was distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89291 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed. 
",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90308 - Class III - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products for which a visual inspection was not performed or documented were distributed.
",2022-06-12,2022-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91400 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Blood products, for which arm prep may have been performed inappropriately, were distributed.
",2023-01-04,2023-01-04,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91464 - Class II - Biologics - American National Red Cross (The), Lewis and Clark Region","Leukoreduced Red Blood Cells, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-19,2023-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67908 - Class II - Biologics - American National Red Cross ARC Blood Services N.E. Region,"Blood products, collected in a manner that compromised the sterility of the units, were distributed.
",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68138 - Class III - Biologics - American National Red Cross ARC Blood Services N.E. Region,"Blood products, which were labeled with an incorrect expiration date, were distributed.",2014-06-05,2014-06-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81698 - Class II - Biologics - American National Red Cross Blood Services SW Region,"Blood product, which did not meet the acceptable product specifications, was distributed.",2019-01-30,2019-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81800 - Class II - Biologics - American National Red Cross Blood Services SW Region,"Blood products, for which donor eligibility screening was performed incorrectly, were distributed.",2019-02-14,2019-02-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84341 - Class III - Biologics - American National Red Cross Blood Services SW Region,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85279 - Class II - Biologics - American National Red Cross Blood Services SW Region,Misbranded Leukoreduced Red Blood Cells were distributed.,2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86372 - Class II - Biologics - American National Red Cross Blood Services SW Region,"Plateletpheresis products, in which quality control for residual WBC count was not performed, were distributed.
",2020-09-23,2020-09-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86934 - Class III - Biologics - American National Red Cross Blood Services SW Region,"Blood Product, for which donor eligibility was incomplete, was distributed.
",2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87143 - Class III - Biologics - American National Red Cross Blood Services SW Region,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-01-29,2021-01-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87278 - Class III - Biologics - American National Red Cross Blood Services SW Region,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2021-02-23,2021-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87780 - Class III - Biologics - American National Red Cross Blood Services SW Region,"Blood product, for which donor eligibility was incomplete, was distributed.
",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88567 - Class II - Biologics - American National Red Cross Blood Services SW Region,"Plateletpheresis products, for which quality control for WBC count was not performed, were distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68252 - Class III - Biologics - American National Red Cross Great Lakes Region,"Blood products, labeled with extended expiration dates, were distributed.",2014-06-23,2014-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70780 - Class III - Biologics - American National Red Cross Great Lakes Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-04-02,2015-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73003 - Class II - Biologics - American National Red Cross Great Lakes Region,"Apheresis Leukoreduced products, with an elevated WBC count, were distributed.",2016-01-20,2016-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73311 - Class II - Biologics - American National Red Cross Great Lakes Region,"Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2016-03-17,2016-03-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74237 - Class III - Biologics - American National Red Cross Great Lakes Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77146 - Class II - Biologics - American National Red Cross Great Lakes Region,"Blood products, for which the donor health history screening  questions were unanswered, were distributed.",2017-05-03,2017-05-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77321 - Class II - Biologics - American National Red Cross Great Lakes Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2017-06-23,2017-06-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77867 - Class III - Biologics - American National Red Cross Great Lakes Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-09-11,2017-09-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82061 - Class II - Biologics - American National Red Cross Great Lakes Region,Mislabeled red blood cells were distributed.,2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63964 - Class III - Biologics - American National Red Cross Southeastern Michigan Region,"Blood Products, collected from a donor who received varicella zoster vaccine less than 28 days before donating, were distributed.",2013-01-30,2013-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65752 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Blood products, labeled leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2013-08-30,2013-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66905 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Blood product, which was incorrectly labeled with respect to the red cell antigens, was distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68204 - Class III - Biologics - American National Red Cross Southeastern Michigan Region,"Blood products, labeled with extended expiration dates following irradiation, were distributed.",2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68206 - Class III - Biologics - American National Red Cross Southeastern Michigan Region,"Blood products, labeled with extended expiration dates following irradiation, were distributed.",2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69950 - Class III - Biologics - American National Red Cross Southeastern Michigan Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-01-05,2015-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69907 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Blood products, which were not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2015-01-15,2015-01-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70122 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Blood product, collected from a donor who disclosed travel history that warranted deferral, was distributed.",2015-01-23,2015-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70680 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2015-03-20,2015-03-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71155 - Class III - Biologics - American National Red Cross Southeastern Michigan Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-06-05,2015-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72785 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74247 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Apheresis product, for which the residual white blood cell count testing was not performed, was distributed.",2016-05-31,2016-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75528 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Blood products, collected from a donor for whom eligibility screening was incorrectly performed, were distributed.",2016-12-07,2016-12-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77643 - Class III - Biologics - American National Red Cross Southeastern Michigan Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-07-21,2017-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79796 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Misbranded Red Blood Cells, were distributed.",2018-04-13,2018-04-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91211 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,Misbranded Leukoreduced Red Blood Cells were distributed.,2022-12-08,2022-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91403 - Class II - Biologics - American National Red Cross Southeastern Michigan Region,"Misbranded Red Blood Cell product, was distributed.
",2023-01-04,2023-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71390 - Class II - Biologics - American National Red Cross SW Region,"Blood products, collected in a manner that lacked assurance of sterility, were distributed.",2015-07-06,2015-07-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71625 - Class III - Biologics - American National Red Cross SW Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-08-17,2015-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75723 - Class II - Biologics - American National Red Cross SW Region,"Blood products, mislabeled as to antigen phenotype, were distributed.",2016-12-20,2016-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76790 - Class III - Biologics - American National Red Cross SW Region,"Blood product, in which donor suitability was not adequately determined, was distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77792 - Class III - Biologics - American National Red Cross SW Region,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-08-28,2017-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79442 - Class II - Biologics - American National Red Cross SW Region,"Blood products in which routine testing/testing performed, interpreted, or documented incorrectly, were distributed.
",2018-03-16,2018-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63644 - Class III - Biologics - American National Red Cross SW Region - HT,"Blood products, which were labeled with an incorrect volume, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68460 - Class III - Biologics - American National Red Cross SW Region - HT,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2014-06-27,2014-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68452 - Class III - Biologics - American National Red Cross SW Region - HT,"Blood product, which was labeled with an incorrect expiration date, was distributed.",2014-07-18,2014-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63050 - Class II - Biologics - American National Red Cross The,"Blood products, collected from a donor who was previously deferred, were distributed.",2012-10-01,2012-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63281 - Class II - Biologics - American National Red Cross The,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-10-24,2012-10-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63464 - Class III - Biologics - American National Red Cross The,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63731 - Class III - Biologics - American National Red Cross The,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-12-21,2012-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64797 - Class II - Biologics - American National Red Cross The,"Blood products, which were labeled as leukoreduced, but exceeded the White Blood Cell count limit, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65178 - Class II - Biologics - American National Red Cross The,"Blood product, collected from an ineligible donor, was distributed.",2013-06-28,2013-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66178 - Class II - Biologics - American National Red Cross The,"Blood product, manufactured from an overweight whole blood unit, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66798 - Class III - Biologics - American National Red Cross The,"Red Blood Cells, with discrepant labeled volumes, were distributed.",2013-11-19,2013-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66750 - Class III - Biologics - American National Red Cross The,"Blood product, which may have been exposed to unacceptable temperature during storage, was distributed.",2013-12-11,2013-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67828 - Class II - Biologics - American National Red Cross The,"Blood products, possibly contaminated by air during collection, were distributed.",2014-04-18,2014-04-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68207 - Class III - Biologics - American National Red Cross The,"Blood product, labeled with an extended expiration date following irradiation, was distributed.",2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70190 - Class II - Biologics - American National Red Cross The,"Blood products, for which donor suitability was not adequately determined, were distributed.",2015-01-23,2015-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70448 - Class II - Biologics - American National Red Cross The,"Blood products, with lack of assurance of sterility, were distributed.",2015-03-10,2015-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70798 - Class II - Biologics - American National Red Cross The,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-04-13,2015-04-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70909 - Class III - Biologics - American National Red Cross The,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-05-06,2015-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70942 - Class III - Biologics - American National Red Cross The,"Blood products, which were not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2015-05-06,2015-05-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71795 - Class II - Biologics - American National Red Cross The,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-08-06,2015-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72568 - Class II - Biologics - American National Red Cross The,Misbranded red blood cells were distributed.,2015-11-17,2015-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72653 - Class III - Biologics - American National Red Cross The,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-12-04,2015-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72660 - Class III - Biologics - American National Red Cross The,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73759 - Class II - Biologics - American National Red Cross The,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-05-16,2016-05-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75326 - Class II - Biologics - American National Red Cross The,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76269 - Class III - Biologics - American National Red Cross The,"Blood products, tested incorrectly for communicable disease agents, were distributed.",2017-01-23,2017-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76554 - Class II - Biologics - American National Red Cross The,"Blood products, in which donor suitability was not adequately determined, were distributed.",2017-03-06,2017-03-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76777 - Class II - Biologics - American National Red Cross The,"Blood products, labeled as leukoreduced were not tested to verify White Blood Cell count, were distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78563 - Class II - Biologics - American National Red Cross The,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2017-12-05,2017-12-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79489 - Class II - Biologics - American National Red Cross The,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-03-22,2018-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79717 - Class II - Biologics - American National Red Cross The,"Blood products, for which the donor gave malarial travel history which warranted deferral and was not deferred, were distributed.",2018-04-13,2018-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79879 - Class III - Biologics - American National Red Cross The,"Blood product, which was not quarantined after receiving information concerning post-donation illness, was distributed.",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80207 - Class II - Biologics - American National Red Cross The,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-07-05,2018-07-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81064 - Class II - Biologics - American National Red Cross The,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-10-05,2018-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81801 - Class III - Biologics - American National Red Cross The,"Blood product, for which donor eligibility screening was incorrectly performed, was distributed.",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82133 - Class II - Biologics - American National Red Cross The,Mislabeled red blood cells were distributed.,2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82207 - Class II - Biologics - American National Red Cross The,"Apheresis products, lacking assurance of sterility, were distributed.

",2019-03-13,2019-03-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82418 - Class III - Biologics - American National Red Cross The,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-03-20,2019-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83626 - Class III - Biologics - American National Red Cross The,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84626 - Class II - Biologics - American National Red Cross The,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2020-02-10,2020-02-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76097 - Class III - Biologics - American National Red Cross, Biomedical Headquarters","Blood product, collected from a donor for whom donor suitability was inadequately determined, was distributed.",2017-01-23,2017-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69255 - Class II - Biologics - American National Red Cross, Greater Ozark-Arkansas Region","Plateletpheresis product, which failed a monthly product QC test, was distributed.",2014-10-03,2014-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69734 - Class III - Biologics - American National Red Cross, Greater Ozark-Arkansas Region","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71931 - Class II - Biologics - American National Red Cross, Greater Ozark-Arkansas Region",Misbranded Red Blood Cells were distributed.,2015-09-17,2015-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72533 - Class II - Biologics - American National Red Cross, Greater Ozark-Arkansas Region","Blood product, possibly contaminated by air during collection, was distributed.",2015-12-02,2015-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73638 - Class II - Biologics - American National Red Cross, Greater Ozark-Arkansas Region","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-04-08,2016-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76096 - Class II - Biologics - American National Red Cross, Greater Ozark-Arkansas Region","Blood products, collected from a donor for which donor suitability was inadequately determined, were distributed.",2017-01-23,2017-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66715 - Class III - Biologics - American National Red Cross, Northeastern","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68125 - Class III - Biologics - American National Red Cross, Northeastern Region","Blood products, labeled with extended expiration dates following irradiation, were distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63263 - Class II - Biologics - American National Red Cross, Penn-Jersey Region","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-10-24,2012-10-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63569 - Class II - Biologics - American National Red Cross, Penn-Jersey Region","Blood products, collected using equipment that had not been validated, were distributed.",2012-11-26,2012-11-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63705 - Class II - Biologics - American National Red Cross, Penn-Jersey Region","Blood product, which did not meet the acceptable product specifications, was distributed.",2012-12-21,2012-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64051 - Class II - Biologics - American National Red Cross, Penn-Jersey Region","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65537 - Class II - Biologics - American National Red Cross, Penn-Jersey Region","Blood product, mislabeled as leukoreduced, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62603 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, positive for the S antigen but labeled S negative, was distributed.
		
",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67271 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, with unacceptably high platelet yields, were distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67272 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, with platelet yields below the specified minimum requirement, were distributed.",2014-02-19,2014-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67829 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, inappropriately stored in one platelet bag instead of two, was distributed.

",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68083 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from a donor with a history of an unspecified type of hepatitis, were distributed.",2014-06-03,2014-06-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68369 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, incorrectly labeled as negative for the Jka red cell antigen, were distributed.",2014-06-23,2014-06-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68371 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, which was incorrectly labeled as negative for the S red cell antigen, was distributed.",2014-06-23,2014-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68368 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, which tested positive for Fyb red cell antigen, but was previously typed as negative for Fyb antigen, was distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69316 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-10-30,2014-10-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70392 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-03-04,2015-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72302 - Class II - Biologics - American National Red Cross, Penn Jersey Region",Misbranded red blood cell was distributed.,2015-10-28,2015-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72567 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-12-10,2015-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72813 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from donor for whom donor suitability was not adequately dertermined, were distributed.",2016-01-06,2016-01-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74370 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, collected from a donor for whom eligibility was inadequately determined, was distributed.",2016-06-28,2016-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74755 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, which did not meet the acceptable product specifications, were distributed.",2016-08-24,2016-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75689 - Class II - Biologics - American National Red Cross, Penn Jersey Region",Misbranded red blood cells were distributed.,2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75546 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-12-02,2016-12-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75980 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood product, in which donor suitability was not adequately determined, was distributed.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76968 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Platelet products, labeled as leukoreduced, for which WBC quality control testing was not performed, were distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77772 - Class II - Biologics - American National Red Cross, Penn Jersey Region",Misbranded red blood cells were distributed.,2017-08-10,2017-08-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78195 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood products whose relevant transfusion-transmitted infection testing was performed incorrectly, were distributed.",2017-10-03,2017-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78744 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78747 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80346 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-07-11,2018-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80369 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, which was labeled as antigen negative, but was collected from a donor who subsequently tested antigen positive, was distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80810 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Platelet products, for which transfusion-transmitted infection testing was performed incorrectly, were distributed.",2018-09-07,2018-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81623 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product in which routine testing/testing performed, interpreted, documented, or labeled incorrectly, was distributed.
",2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82135 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Apheresis products, collected on an instrument undergoing equipment qualification, and for which quality control testing was not performed, were distributed.
",2019-02-28,2019-02-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82286 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83257 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-08-01,2019-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83445 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from a donor who was a resident of an area considered endemic for malaria, were distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84628 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-01-15,2020-01-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84776 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Leukoreduced, Apheresis Platelets, with a platelet yield exceeding the acceptable limit, were distributed.",2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84724 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood products, which were processed with expired reagents, were distributed.",2020-02-21,2020-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85973 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Plasma Frozen within 24 Hours, for which donor eligibility screening was incomplete, was distributed.",2020-07-20,2020-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86371 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood Product,  for which donor eligibility was incomplete, was distributed.
",2020-09-23,2020-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86785 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood products, for which the donor's arm preparation may have lacked maximal assurance of sterility, were distributed.",2020-12-02,2020-12-02,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86790 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Irradiated Red Blood Cells, Leukoreduced, which were labeled as non-irradiated, were distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87277 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Misbranded Red Blood Cell product was distributed.
",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87131 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87297 - Class II - Biologics - American National Red Cross, Penn Jersey Region",Misbranded Leukoreduced Red Blood Cells were distributed.,2021-02-26,2021-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88356 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood product, for which donor eligibility was incomplete, was distributed.
",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88901 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood Products, in which West Nile Virus Testing was performed incorrectly, were distributed.",2021-11-18,2021-11-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89347 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Misbranded Red Blood Cell product was distributed.
",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89549 - Class III - Biologics - American National Red Cross, Penn Jersey Region","Blood products, for which donor eligibility screening was incomplete, were distributed.",2022-02-10,2022-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89732 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Leukoreduced Red Blood Cells, collected in a manner that compromises the sterility of the collection system, were distributed.",2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90034 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Misbranded Apheresis Red Blood Cell product was distributed.
",2022-05-10,2022-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90265 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood product, for which donor eligibility was incomplete, was distributed.
",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91186 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Misbranded Red Blood Cell product was distributed.
",2022-11-25,2022-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91453 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Red Blood Cell product, for which donor eligibility was incomplete, was distributed.
",2023-01-10,2023-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91459 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Leukoreduced Red Blood Cells, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-18,2023-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91460 - Class II - Biologics - American National Red Cross, Penn Jersey Region","Blood Products, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-18,2023-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42897 - Class III - Biologics - American National Red Cross, The","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63323 - Class III - Biologics - American National Red Cross, The","Blood products , in which extra amount of  red cell preservative solution  was added, were  distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #34083 - Class II - Biologics - American National Red Cross, The","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-09-04,2013-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67254 - Class III - Biologics - American National Red Cross, The","Blood product, which failed to meet the criteria for total weight during a validation study of the collection scales, was distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72981 - Class III - Biologics - American National Red Cross, The",Mislabelled RBC was distributed.,2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75088 - Class II - Biologics - American National Red Cross, The","Blood product, identified as unsuitable due to a collection deviation was distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76778 - Class II - Biologics - American National Red Cross, The","Blood product, labeled as leukoreduced but was not tested to verify White Blood Cell count, was distributed.",2017-04-24,2017-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63113 - Class III - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2012-10-10,2012-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66269 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, incorrectly determined to be negative for the Fyb antigen, was distributed.

",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66729 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, incorrectly determined to be negative for the E and c antigens, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67031 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, collected from a donor who may be at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68116 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, incorrectly identified as negative for the Jka antigen, was distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68149 - Class III - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, which were labeled with an incorrect expiration date, were distributed.",2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69733 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71120 - Class III - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-06-05,2015-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72622 - Class III - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, collected in a manner that may have compromised the sterility of the products, were distributed.",2015-12-03,2015-12-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73792 - Class III - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-04-29,2016-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73793 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-04-29,2016-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75024 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, collected in a manner with a potential for air contamination, were distributed.",2016-10-05,2016-10-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75039 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, possibly contaminated with air, were distributed.",2016-10-05,2016-10-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76792 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, in which donor suitability was not adequately determined, was distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78204 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, collected in a manner that lacked assurance of sterility, were distributed.",2017-11-17,2017-11-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79125 - Class III - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-02-21,2018-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79357 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,-,2018-03-07,2018-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80370 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products, which were labeled as antigen negative, but collected from donors who tested antigen positive, were distributed.",2018-07-12,2018-07-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80506 - Class III - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80950 - Class II - Biologics - American Natl Red Cross Mid Atlantic Region,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-09-17,2018-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72109 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, for which testing was not performed according to manufacturer's instructions, were distributed.",2015-10-15,2015-10-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72187 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Platelets Pheresis products, lacking proper quality control testing, were distributed., -",2015-10-22,2015-10-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72394 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,Misbranded red blood cells were distributed.,2015-11-06,2015-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73440 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,Misbranded Red Blood Cells were distributed.,2016-03-22,2016-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74496 - Class III - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Plasma product, for which product volume could not be verified, was distributed.",2016-07-28,2016-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75703 - Class III - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood product, collected from a donor for whom donor screening was performed incorrectly, was distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79723 - Class III - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood product, for which a unit received inadequate additive solution, was distributed.
",2018-04-13,2018-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79724 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Apheresis products, collected with excess amount of  PAS additive, were distributed.",2018-04-30,2018-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80040 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Platelet products, in which component preparation was not prepared in accordance with specifications, were distributed.",2018-05-14,2018-05-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80121 - Class III - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-05-30,2018-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80039 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-06-11,2018-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81586 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Plateletpheresis products, not meeting product specifications, were distributed.",2018-11-21,2018-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82848 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood product, labeled incorrectly based on RBC antigen testing, was distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83048 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-06-28,2019-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83640 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Plateletpheresis products in which quality control for white blood cell count testing was not performed, were distributed.
",2019-09-06,2019-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84873 - Class III - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Misbranded Red Blood Cells, Leukocytes Reduced, were distributed.",2020-02-19,2020-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85335 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, collected in a manner that lacked assurance of sterility, were distributed.",2020-04-20,2020-04-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85337 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, collected from a donor where donor eligibility was incomplete, were distributed.",2020-04-28,2020-04-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85970 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Plateletpheresis products that failed quality control for residual WBC count, were distributed.
",2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85971 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Red Blood Cell product, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87127 - Class III - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-01-29,2021-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88296 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, which did not meet acceptable product specifications, were distributed.",2021-08-13,2021-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89281 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed",2021-12-23,2021-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89264 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2022-01-18,2022-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89296 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89348 - Class III - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, for which transfusion-transmitted infection test/testing was performed, interpreted, or documented incorrectly, were distributed.",2022-01-19,2022-01-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89433 - Class III - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,Leukoreduced Apheresis Red Blood Cells were distributed without a final visual check.,2022-01-31,2022-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91014 - Class II - Biologics - American Natl. Red Cross-Greater Chesapeake & Potomac Region,"Blood products, for which donor eligibility was incomplete, were distributed.

",2022-10-24,2022-10-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77465 - Class II - Drugs - American Pharmaceutical Ingredients LLC,cGMP Deviations; lack of quality assurance.,2017-06-15,2017-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77525 - Class II - Drugs - American Pharmaceutical Ingredients LLC,Labeling: Not Elsewhere Classified. Manufacturer and product were discovered to be on FDA Import Alert 66-66 for misbranding of active pharmaceutical ingredient.,2017-06-29,2017-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77392 - Class II - Drugs - American Pharmaceutical Ingredients LLC,CGMP Deviations:  Lack of quality assurance at the API manufacturer.,2017-07-02,2017-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79149 - Class II - Drugs - American Pharmaceutical Ingredients LLC,CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.,2018-02-22,2018-02-22,66,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79420 - Class II - Drugs - American Pharmaceutical Ingredients LLC,Stability Data Does Not Support Expiry: Stability data from manufacturer does not support expiration dates listed.,2018-03-12,2018-03-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79122 - Class III - Biologics - American Red Cross Biomedical Services,"Blood product, that was not quarantined after receiving information concerning post-donation illness, was distributed.",2018-03-06,2018-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82701 - Class II - Biologics - American Red Cross Biomedical Services,"Plateletpheresis product, stored with a platelet count higher than is acceptable, was distributed.",2019-05-24,2019-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89249 - Class II - Biologics - American Red Cross Biomedical Services,"Blood Products, not tested for pH, were distributed.",2022-01-18,2022-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89432 - Class II - Biologics - American Red Cross Biomedical Services Northern New England Region,"Plateletpheresis products, for which quality control procedures were not performed, were distributed.
",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40833 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor in which donor suitability were not adequately determined, were distributed.",2012-07-13,2012-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40849 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46547 - Class II - Biologics - American Red Cross Blood Services,"Blood products, in which testing for Jka antigen was interpreted, or incorrectly documented were distributed",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45121 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45720 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49625 - Class III - Biologics - American Red Cross Blood Services,"Blood products, which may have reached an unacceptable temperature during storage, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62286 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40459 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44691 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-08-01,2012-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46549 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-08-01,2012-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49306 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-08-01,2012-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62376 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47121 - Class III - Biologics - American Red Cross Blood Services,"Blood products, for which storage conditions and shipment information were undocumented, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47991 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48859 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48861 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-16,2012-08-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41780 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-08-27,2012-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48860 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-08-27,2012-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40008 - Class III - Biologics - American Red Cross Blood Services,"Blood products, tested using the Hematastat equipment that was missing the daily quality control records, were distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48346 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-09-17,2012-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49658 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-17,2012-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42230 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which was labeled as leukoreduced, but exceeded the White Blood Cell count limit, were distributed.",2012-09-20,2012-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63114 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2012-10-10,2012-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40170 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2012-10-12,2012-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41421 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-10-12,2012-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47045 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2012-10-12,2012-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49627 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-10-12,2012-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50432 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-12,2012-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41641 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-10-19,2012-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38917 - Class III - Biologics - American Red Cross Blood Services,"Antihemophilic Factor (Recombinant), lacking assurance of proper temperature maintenance during storage, was distributed.",2012-10-25,2012-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41383 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47621 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39765 - Class II - Biologics - American Red Cross Blood Services,"Blood product, positive for the S-antigen but labeled as S-antigen negative, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43710 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-03,2012-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44463 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-03,2012-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63701 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-12-03,2012-12-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40317 - Class II - Biologics - American Red Cross Blood Services,"Blood product, with platelet yield that exceeded the manufacturer's limit for the product to be stored in one bag, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49720 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-12-07,2012-12-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50567 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-12-07,2012-12-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39129 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39130 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-12-27,2012-12-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43785 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor who was previously deferred, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44553 - Class II - Biologics - American Red Cross Blood Services,"Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46543 - Class II - Biologics - American Red Cross Blood Services,"Blood products, manufactured from an apheresis unit with platelet yield that did not meet the criteria for a divided unit, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41943 - Class II - Biologics - American Red Cross Blood Services,"Blood product, labeled as leukoreduced without the assurance that it met the criteria for a leukoreduced product, was distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41984 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43075 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43152 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48236 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-03,2013-01-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49198 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2013-01-03,2013-01-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49874 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor who did not respond to questions regarding increased risk for vCJD, was distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41049 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was entered negative in the computer for K, Fya and Fyb antigen when tested turned out to be positive, was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41387 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor in which hematocrit and hemoglobin was not adequately determined, was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42093 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-01-04,2013-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49899 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-23,2013-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42170 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42435 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40953 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-02-11,2013-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41701 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was in transit greater than 24 hours, was distributed.",2013-02-11,2013-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42652 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor for whom the acceptance criteria for hematocrit was not met, was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39504 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-02-26,2013-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40591 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected in a manner that may have compromised the sterility of the collection system, were distributed.",2013-02-26,2013-02-26,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64350 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48541 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-03-11,2013-03-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47297 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were incompletely irradiated, were distributed.",2013-03-19,2013-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41029 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor who traveled to a malaria endemic area, were distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41440 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor who traveled to a malaria endemic area, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43691 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected in a manner that may have compromised the sterility of the collection system, were distributed.",2013-03-26,2013-03-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57227 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected using equipment that had not been validated, were distributed.",2013-03-26,2013-03-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41143 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected using an expired blood collection set, were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52246 - Class II - Biologics - American Red Cross Blood Services,"Blood products, labeled 'leukocytes reduced' which did not meet the QC requirements for leukoreduced products, were distributed.",2013-04-03,2013-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39842 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-04-29,2013-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39848 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from donors that used  the incorrect version of the BDR, were distributed.",2013-04-29,2013-04-29,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42172 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #51464 - Class II - Biologics - American Red Cross Blood Services,"Blood products, possibly contaminated with air during collection, were distributed.",2013-07-23,2013-07-23,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39134 - Class III - Biologics - American Red Cross Blood Services,"Blood products, for which a platelet count was not performed, were distributed.",2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41051 - Class II - Biologics - American Red Cross Blood Services,"Blood product, incorrectly labeled as negative for the Jka red cell antigen, was distributed.",2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39463 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46550 - Class III - Biologics - American Red Cross Blood Services,"Blood products, in which viral testing/testing performed, interpreted, or documented incorrectly, were distributed.",2013-08-09,2013-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63853 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-08-09,2013-08-09,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49248 - Class II - Biologics - American Red Cross Blood Services,"Blood products, for which the quality control testing was not performed, were distributed.",2013-09-04,2013-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66154 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67119 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67351 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67367 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39127 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2014-02-21,2014-02-21,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68139 - Class III - Biologics - American Red Cross Blood Services,"Blood products, labeled with the incorrect expiration date, were distributed.",2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68148 - Class III - Biologics - American Red Cross Blood Services,"Blood products, labeled with the incorrect expiration date, were distributed.",2014-06-05,2014-06-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68688 - Class III - Biologics - American Red Cross Blood Services,"Blood products, in which pooled cryo did not meet acceptable product specifications were distributed.",2014-07-30,2014-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68600 - Class II - Biologics - American Red Cross Blood Services,Misbranded RBCs were distributed.,2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69988 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor with a history of high risk behaviors, were distributed.",2015-01-26,2015-01-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70983 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for which donor suitability was not adequately determined, were distributed.",2015-04-29,2015-04-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71041 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-06-04,2015-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71077 - Class III - Biologics - American Red Cross Blood Services,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-06-05,2015-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71400 - Class III - Biologics - American Red Cross Blood Services,"Blood product, which was missing a portion of the required amount of additive solution, was distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71307 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-07-09,2015-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72131 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72207 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2015-10-01,2015-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72049 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-10-05,2015-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72806 - Class III - Biologics - American Red Cross Blood Services,"Blood product, for which a unit received inadequate additive solution, was distributed.

",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72895 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed",2016-01-14,2016-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73047 - Class II - Biologics - American Red Cross Blood Services,"Apheresis products, collected on an instrument undergoing equipment qualification, and for which quality control testing was not performed, were distributed.",2016-02-11,2016-02-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73133 - Class II - Biologics - American Red Cross Blood Services,"Apheresis product, lacking assurance of proper leukoreduction, was distributed.",2016-02-11,2016-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73191 - Class III - Biologics - American Red Cross Blood Services,Mislabelled RBC was distributed.,2016-02-26,2016-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74152 - Class III - Biologics - American Red Cross Blood Services,"Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2016-06-13,2016-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74217 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which did not meet the acceptable product specifications, were distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74259 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which did not meet the acceptable product specification, was distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74580 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-08-08,2016-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75104 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-10-11,2016-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75189 - Class III - Biologics - American Red Cross Blood Services,"Blood products, labeled with an extended expiration date following irradiation, were distributed.",2016-10-25,2016-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75461 - Class III - Biologics - American Red Cross Blood Services,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-11-01,2016-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75545 - Class II - Biologics - American Red Cross Blood Services,"Blood products, in which donor screening/donor record incomplete or incorrect, were distributed.",2016-11-28,2016-11-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75854 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76315 - Class II - Biologics - American Red Cross Blood Services,"Red blood cell, for which antigen testing was documented incorrectly, was distributed.",2017-02-03,2017-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76392 - Class III - Biologics - American Red Cross Blood Services,"Blood product, manufactured without the entire quantity of additive solution, was distributed.",2017-02-28,2017-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76780 - Class II - Biologics - American Red Cross Blood Services,"Blood products, in which donor suitability was not adequately determined, were distributed.",2017-04-04,2017-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77293 - Class II - Biologics - American Red Cross Blood Services,"Plateletpheresis product, lacking assurance of proper leukoreduction, was distributed.",2017-05-15,2017-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77257 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2017-06-23,2017-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77496 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-07-17,2017-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77774 - Class II - Biologics - American Red Cross Blood Services,"Platelet products, lacking assurance of proper leukocyte reduction, were distributed.",2017-08-24,2017-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78564 - Class II - Biologics - American Red Cross Blood Services,"Apheresis products, collected from an unsuitable donor due to a donor screening deviation, were distributed.
",2017-12-05,2017-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78670 - Class II - Biologics - American Red Cross Blood Services,"Plateletpheresis products, not meeting product specifications, were distributed.",2017-12-05,2017-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78671 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2017-12-07,2017-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79285 - Class II - Biologics - American Red Cross Blood Services,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-03-02,2018-03-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80007 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-06-05,2018-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80088 - Class III - Biologics - American Red Cross Blood Services,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-06-13,2018-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80351 - Class II - Biologics - American Red Cross Blood Services,"Blood product, which was labeled as antigen negative, but was collected from a donor who subsequently tested antigen positive, was distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80395 - Class III - Biologics - American Red Cross Blood Services,"Blood product, for which donor screening was inadequately performed, was distributed.",2018-07-24,2018-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80408 - Class III - Biologics - American Red Cross Blood Services,"Blood product, for which donor screening was inadequately performed, was distributed.",2018-07-24,2018-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80411 - Class III - Biologics - American Red Cross Blood Services,"Blood product, for which West Nile Virus Testing was performed incorrectly, was distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80818 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81154 - Class III - Biologics - American Red Cross Blood Services,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-11,2018-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81652 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-12-12,2018-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82723 - Class II - Biologics - American Red Cross Blood Services,"Blood product, for which donor eligibility screening was incorrectly performed, was distributed.",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83259 - Class II - Biologics - American Red Cross Blood Services,"Plateletpheresis products in which quality control for white blood cell count testing was not performed, were distributed.
",2019-08-01,2019-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83260 - Class II - Biologics - American Red Cross Blood Services,"Blood product, collected on an instrument undergoing validation, and for which quality control testing was not performed, was distributed.",2019-08-01,2019-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83641 - Class III - Biologics - American Red Cross Blood Services,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-09-06,2019-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83719 - Class III - Biologics - American Red Cross Blood Services,"Plateletpheresis product, in which platelet yield did not meet specifications, was distributed.
",2019-09-16,2019-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84090 - Class III - Biologics - American Red Cross Blood Services,"Apheresis, Leukoreduced Platelets, which were not tested for platelet yield, were distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85114 - Class III - Biologics - American Red Cross Blood Services,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84878 - Class III - Biologics - American Red Cross Blood Services,Misbranded red blood cells were distributed.,2020-03-16,2020-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85930 - Class III - Biologics - American Red Cross Blood Services,"Plateletpheresis product, not meeting product specifications, was distributed.",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85974 - Class II - Biologics - American Red Cross Blood Services,"Plasma Frozen within 24 Hours, for which donor eligibility screening was incomplete, was distributed.",2020-07-20,2020-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86305 - Class III - Biologics - American Red Cross Blood Services,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86294 - Class III - Biologics - American Red Cross Blood Services,"Blood product, collected from a donor in which donor suitability was not adequately determined, was  distributed.",2020-09-10,2020-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86295 - Class III - Biologics - American Red Cross Blood Services,"Plateletpheresis product, manufactured without the correct amount of additive solution, was distributed.",2020-09-10,2020-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87172 - Class II - Biologics - American Red Cross Blood Services,"Plateletpheresis products, for which quality control for residual white blood cell count testing was not performed, were distributed.
",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87125 - Class II - Biologics - American Red Cross Blood Services,"Leukoreduced, Apheresis Platelets, collected by automated equipment that was not validated for use, were distributed.",2021-02-05,2021-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87325 - Class II - Biologics - American Red Cross Blood Services,"Leukoreduced, Apheresis Platelets, Platelet Additive Solution Added, collected in a manner that compromises the sterility of the collection system, were distributed.",2021-02-19,2021-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87453 - Class III - Biologics - American Red Cross Blood Services,"Blood products, collected using a scale that failed quality control testing, were distributed.",2021-03-10,2021-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87932 - Class II - Biologics - American Red Cross Blood Services,"Misbranded Red Blood Cell product was distributed.
",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87933 - Class II - Biologics - American Red Cross Blood Services,"Blood Products, for which donor eligibility was incomplete, were distributed.
",2021-06-07,2021-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88300 - Class III - Biologics - American Red Cross Blood Services,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88896 - Class III - Biologics - American Red Cross Blood Services,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-11-04,2021-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89081 - Class III - Biologics - American Red Cross Blood Services,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89159 - Class II - Biologics - American Red Cross Blood Services,"Red Blood Cell, collected from a donor whose arm preparation was performed in a manner that ensures sterility, was distributed.
",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89234 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected from donors who did not have their vitals taken, were distributed.",2022-01-04,2022-01-04,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89248 - Class II - Biologics - American Red Cross Blood Services,"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89294 - Class II - Biologics - American Red Cross Blood Services,"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, not tested for pH, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89293 - Class II - Biologics - American Red Cross Blood Services,"Blood products, which did not meet quality control specifications, were distributed.",2022-01-19,2022-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89345 - Class II - Biologics - American Red Cross Blood Services,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2022-01-19,2022-01-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89430 - Class II - Biologics - American Red Cross Blood Services,"Leukoreduced Irradiated Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-01-31,2022-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89780 - Class II - Biologics - American Red Cross Blood Services,"Apheresis Red Blood Cell products, not meeting product specifications, were distributed.
",2022-03-30,2022-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90221 - Class II - Biologics - American Red Cross Blood Services,"Blood products collected from a donors who traveled to or lived in a malarial endemic area, were distributed.
",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91026 - Class II - Biologics - American Red Cross Blood Services,"Blood products, for which donor eligibility was incomplete, was distributed.
",2022-10-24,2022-10-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91397 - Class II - Biologics - American Red Cross Blood Services,"
Leukoreduced Apheresis Platelets, Pathogen Reduced, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-30,2022-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91369 - Class II - Biologics - American Red Cross Blood Services,"Apheresis Red Blood Cell products, for which donor eligibility was incomplete, were distributed.
",2023-01-04,2023-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91628 - Class II - Biologics - American Red Cross Blood Services,"Leukoreduced Apheresis Red Blood Cells, collected in a manner that compromised the sterility of the collection system, were distributed.",2023-02-13,2023-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77773 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Platelet products, for which required WBC quality control testing was not performed, were distributed.",2017-08-08,2017-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78226 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Leukoreduced apheresis platelets, not meeting product specifications, were distributed.",2017-11-17,2017-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79013 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,Misbranded platelet product was distributed.,2018-02-21,2018-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80920 - Class III - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-10-03,2018-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81539 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood products, lacking assurance of sterility, were distributed.",2018-11-13,2018-11-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81660 - Class III - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood products, where transfusion-transmitted infection testing was incorrectly performed and / or interpreted was distributed.",2018-12-03,2018-12-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81657 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Apheresis products, which was not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2018-12-12,2018-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83307 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Apheresis Platelets, which was labeled as leukoreduced but was not tested to verify white blood cell count, was distributed.",2019-08-01,2019-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84746 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2020-01-28,2020-01-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84627 - Class III - Biologics - American Red Cross Blood Services - Massachusetts Region,-,2020-02-10,2020-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86819 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Plateletpheresis product in which quality control for white blood cell count testing was not performed, was distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87141 - Class III - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87280 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.
",2021-02-22,2021-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88568 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-09-10,2021-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88574 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood Products, labeled with the incorrect or missing information, were distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88703 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood Products, not tested for pH, were distributed.",2021-09-27,2021-09-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88893 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Plateletpheresis products, not meeting product specifications, were distributed. 
",2021-11-03,2021-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89225 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Plateletpheresis products, not meeting product specifications, were distributed
",2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89343 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2022-01-19,2022-01-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90260 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Pooled Cryoprecipitated AHF, for which donor eligibility screening was incomplete, were distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91208 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Leukoreduced Apheresis Platelets, PAS, in which platelet yield did not meet specifications, were distributed.",2022-12-08,2022-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91368 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Leukoreduced Apheresis Platelets, PAS, collected in a manner that compromises the sterility of the collection system, were distributed.",2022-12-29,2022-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91370 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Plateletpheresis product, collected on an instrument undergoing equipment qualification, and for which quality control testing was not performed, was distributed.
",2023-01-04,2023-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91465 - Class II - Biologics - American Red Cross Blood Services - Massachusetts Region,"Blood Products, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-19,2023-01-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69548 - Class III - Biologics - American Red Cross Blood Services Appalachian Region,"Blood product, labelled with incorrect expiration date, was distributed.",2014-11-05,2014-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71944 - Class III - Biologics - American Red Cross Blood Services Appalachian Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75138 - Class III - Biologics - American Red Cross Blood Services Appalachian Region,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50261 - Class II - Biologics - American Red Cross Blood Services Carolinas Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2012-07-23,2012-07-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64208 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Cryoprecipitated AHF, which failed to meet the minimum potency of 80IU of AHF (Factor VIII), was distributed.",2013-02-05,2013-02-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65639 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-08-09,2013-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67824 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood product, for which the entire amount of additive solution was not added during manufacturing, was distributed.",2014-04-16,2014-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68923 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Platelet products, collected on an instrument which failed leukoreduction quality control procedures, were distributed.",2014-08-22,2014-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69952 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Blood products, in which Quality Control and Distribution of products did not meet specifications, were distributed.",2015-01-15,2015-01-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73228 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73590 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Blood product, for which quality control testing was not performed, was distributed.",2016-04-07,2016-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77334 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Plateletpheresis products, lacking assurance of proper leukoreduction, were distributed.",2017-05-22,2017-05-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78559 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Platelet product, labeled as leukoreduced, and not tested for WBC count, was distributed.",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79287 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Blood products, collected from a donor for whom screening was incorrectly performed, were distributed.",2018-03-02,2018-03-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79126 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-03-05,2018-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79719 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Blood products, collected from a donor for whom eligibility screening was incorrectly performed, were distributed.",2018-05-02,2018-05-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80052 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-05-15,2018-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80410 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood products, associated with incorrectly performed transfusion-transmitted infection testing, were distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83035 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-07-15,2019-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83047 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2019-07-15,2019-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83613 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85927 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Plateletepheresis products, for which arm prep may have been performed inappropriately, were distributed.",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86824 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Red Blood Cell product, for which donor eligibility was incomplete, was distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87113 - Class II - Biologics - American Red Cross Blood Services Heart of America Region,"Plateletpheresis products, which were incorrectly labeled as to product type, were distributed.",2021-02-05,2021-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89263 - Class III - Biologics - American Red Cross Blood Services Heart of America Region,"Blood product, for which donor eligibility was incomplete, was distributed
",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85266 - Class II - Biologics - American Red Cross Blood Services Mid Atlantic Region,"Leukoreduced Apheresis Platelets, platelet additive solution added, not tested for  pH, were distributed.",2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86821 - Class II - Biologics - American Red Cross Blood Services Mid Atlantic Region,"Plateletpheresis product in which quality control for white blood cell count testing was not performed, was distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87789 - Class II - Biologics - American Red Cross Blood Services Mid Atlantic Region,"Blood product, which did not meet the acceptable product specifications, was distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88297 - Class II - Biologics - American Red Cross Blood Services Mid Atlantic Region,"Blood product, which were incorrectly tested for red cell antigen, was distributed.",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88298 - Class II - Biologics - American Red Cross Blood Services Mid Atlantic Region,"Plateletpheresis products, with a high platelet yield, were distributed.

",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89262 - Class II - Biologics - American Red Cross Blood Services Mid Atlantic Region,"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69699 - Class III - Biologics - American Red Cross Blood Services Northern NewEngland Region,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72313 - Class II - Biologics - American Red Cross Blood Services Northern NewEngland Region,"Blood products, that did not meet QC specifications, were distributed.",2015-10-13,2015-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72759 - Class III - Biologics - American Red Cross Blood Services Northern NewEngland Region,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77690 - Class II - Biologics - American Red Cross Blood Services Northern NewEngland Region,"Platelet product, for which WBC quality control testing was not performed, was distributed.",2017-07-13,2017-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79942 - Class III - Biologics - American Red Cross Blood Services Northern NewEngland Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-06-05,2018-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80596 - Class II - Biologics - American Red Cross Blood Services Northern NewEngland Region,"Platelet products, which were labeled as leukoreduced, but where not tested to verify WBC count, were distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87237 - Class II - Biologics - American Red Cross Blood Services River Valley Region,Misbranded Irradiated Leukoreduced Red Blood Cells were distributed.,2021-02-26,2021-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79946 - Class III - Biologics - American Red Cross Blood Services Southwest Region,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-05-02,2018-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82093 - Class II - Biologics - American Red Cross Blood Services Southwest Region,"Blood product in which routine testing/testing performed, interpreted, documented, or labeled incorrectly, was distributed.
",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89222 - Class II - Biologics - American Red Cross Blood Services Southwest Region,"Red Blood Cell, collected from a donor whose arm preparation was not performed in a manner that ensures sterility, was distributed. 
",2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63983 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Bloood product, collected from an ineligible donor, was distributed.",2013-01-07,2013-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65367 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, collected using an inadequate reagent to perform the arm scrub, were distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66039 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Red Blood Cells, mislabeled as S antigen negative, was distributed.",2013-10-01,2013-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66088 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood component, prepared from Whole Blood that was centrifuged at room temperature, was distributed.",2013-12-05,2013-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67768 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood Product, prepared from an overweight unit, was distributed.",2014-04-11,2014-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68157 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood product, which was labeled with an incorrect expiration date, was distributed.",2014-06-11,2014-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69364 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, collected in a manner that may have compromised the sterility of the products, were distributed.",2014-10-23,2014-10-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73288 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood product, collected from a donor for whom eligibility was inadequately determined, was distributed.",2016-03-22,2016-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74007 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood product, collected from an ineligible donor, was distributed.",2016-05-05,2016-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75072 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, which did not meet the acceptable product specification, were distributed.",2016-10-05,2016-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75520 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, possibly contaminated with air, were distributed.",2016-12-02,2016-12-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75669 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2016-12-16,2016-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76098 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood product, collected from a donor whose eligibility to donate was inadequately determined for malarial travel, was distributed.",2017-01-23,2017-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76971 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"lood products, lacking assurance of sterility, were distributed., Blood products, lacking assurance of sterility, were distributed.",2017-05-25,2017-05-25,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79728 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2018-05-03,2018-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80145 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2018-07-02,2018-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80665 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, collected in a collection system that may have compromised the sterility of the closed system, were distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83825 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-10-02,2019-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84103 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84747 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood Products, collected in a manner that compromises the sterility of the collection system, were distributed.",2020-01-28,2020-01-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84869 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87109 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,Misbranded Leukoreduced Red Blood Cells were distributed.,2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87136 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87399 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,Misbranded Leukoreduced Red Blood Cells were distributed.,2021-03-11,2021-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89246 - Class III - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood product, for which donor eligibility was incomplete, was distributed. 
",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90375 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Blood products, for which donor eligibility was incomplete, was distributed. 
",2022-06-13,2022-06-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90441 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Red Blood Cell, collected from a donors whose arm preparation was not performed in a manner that ensures sterility, were distributed.
",2022-06-22,2022-06-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91012 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Misbranded Red Blood Cell product, was distributed.
",2022-10-24,2022-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91487 - Class II - Biologics - American Red Cross Blood Services Tennessee Valley Region,"Red Blood Cell products, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-20,2023-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84876 - Class II - Biologics - American Red Cross Blood Svcs,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-02-26,2020-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87139 - Class III - Biologics - American Red Cross Blood Svcs,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-01-29,2021-01-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89434 - Class II - Biologics - American Red Cross Blood Svcs,"Blood products, collected from a donor whose arm preparation was not performed in a manner that ensures sterility, were distributed.
",2022-01-28,2022-01-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89621 - Class II - Biologics - American Red Cross Blood Svcs,"Blood product identified as unsuitable due to a component preparation deviation, was distributed.
",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91463 - Class II - Biologics - American Red Cross Blood Svcs,"Pooled Cryoprecipitated AHF, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-19,2023-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63372 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63695 - Class II - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood products, collected using a machine for which the monthly quality control testing for platelet products failed,  were distributed.",2012-12-03,2012-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64462 - Class II - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-12,2013-04-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66938 - Class II - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood products, collected from a donor with a history of Hepatitis A exposure, were distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68101 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood products, labeled with extended expiration dates following irradiation, were distributed.	
 
",2014-06-03,2014-06-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69001 - Class II - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood product, possibly contaminated with air, was distributed.",2014-09-15,2014-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69968 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-01-05,2015-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70463 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71491 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-07-21,2015-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72983 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,Mislabelled RBC was distributed.,2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73807 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood product, for which donor suitability was inadequately determined, was distributed.",2016-05-02,2016-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74121 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75963 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76004 - Class III - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2017-01-04,2017-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77000 - Class II - Biologics - American Red Cross Blood Svs. Indiana-Ohio Region,"Blood products, lacking assurance of sterility, were distributed.",2017-05-24,2017-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61765 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2012-06-11,2012-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64525 - Class III - Biologics - American Red Cross Greater Alleghenies Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67381 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, labeled leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2014-03-07,2014-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68104 - Class III - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, labeled with extended expiration dates following irradiation, were distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72356 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2015-11-05,2015-11-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79918 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Apheresis products, that failed quality control for residual WBC count, were distributed.
",2018-05-02,2018-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80869 - Class III - Biologics - American Red Cross Greater Alleghenies Region,"Blood product, identified as unsuitable due to a component preparation deviation, was distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82559 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2019-04-15,2019-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84344 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Plateletpheresis products, not meeting product specifications, were distributed.",2019-12-05,2019-12-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85675 - Class III - Biologics - American Red Cross Greater Alleghenies Region,"Source Plasma unit, collected from a donor whose donor eligibility was incomplete, was distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87130 - Class III - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87786 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood product, not meeting product specifications, was distributed.
",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88571 - Class III - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-09-10,2021-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88573 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, not manufactured in accordance with product specifications, were distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89155 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood product, for which donor eligibility screening was incomplete, were distributed.",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89346 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2022-01-18,2022-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89525 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"PF24 Plasma, for which donor eligibility screening was incomplete, were distributed.",2022-02-10,2022-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89811 - Class III - Biologics - American Red Cross Greater Alleghenies Region,"Red Blood Cell products, tested using expired reagents, were distributed.",2022-03-30,2022-03-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89837 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood products, lacking assurance of sterility, were distributed.
",2022-04-07,2022-04-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91461 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Leukoreduced Red Blood Cells, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-18,2023-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91486 - Class II - Biologics - American Red Cross Greater Alleghenies Region,"Blood Products, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.
",2023-01-20,2023-01-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91187 - Class II - Biologics - American Red Cross Norfolk Main Site,"Plateletpheresis products, for which donor eligibility was incomplete, were distributed.
",2023-01-26,2023-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89075 - Class I - Drugs - American Screening LLC,Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.,2021-12-06,2021-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70013 - Class II - Drugs - American Specialty Pharmacy,Presence of Particulate Matter; preservative may not have dissolved completely or precipitated out of product,2015-03-26,2015-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63585 - Class II - Drugs - Ameridose LLC,"Lack of assurance of sterility, GMP deficiencies",2012-11-14,2012-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81189 - Class III - Drugs - Amerigen Pharmaceuticals Inc.,Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.,2018-11-15,2018-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81858 - Class III - Drugs - Amerigen Pharmaceuticals Inc.,Failed Dissolution Specifications,2018-12-26,2018-12-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82158 - Class III - Drugs - Amerigen Pharmaceuticals Inc.,Failed dissolution specifications,2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66316 - Class II - Drugs - AmeriSource Bergen,Temperature abuse: Certain vials of Ifosfamide IV products were not refrigerated at certain Amerisource Bergen Drug Corp distribution centers.,2013-09-27,2013-09-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72865 - Class II - Drugs - Amerisource Health Services,Presence of Particulate Matter,2016-01-08,2016-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73094 - Class II - Drugs - Amerisource Health Services,Failed Dissolution Specifications: Unexplained low out of specification results for dissolution.,2016-01-27,2016-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73166 - Class III - Drugs - Amerisource Health Services,Failed Impurities/Degradation Specifications; 9 month stability (manufacturer),2016-02-11,2016-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73715 - Class III - Drugs - Amerisource Health Services,Labeling: Incorrect or Missing Lot and/or Exp Date,2016-04-14,2016-04-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75076 - Class II - Drugs - Amerisource Health Services,Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule,2016-09-02,2016-09-02,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75030 - Class III - Drugs - Amerisource Health Services,Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.,2016-09-15,2016-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75335 - Class III - Drugs - Amerisource Health Services,Failed Impurities/Degradation Specifications: This repackaged product was recalled by its manufacturer due to failed results for impurities.,2016-10-11,2016-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75581 - Class III - Drugs - Amerisource Health Services,Failed Dissolution Specifications: The firm was notified that there was a dissolution out of specification result on the 6 month stability samples.,2016-11-16,2016-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75470 - Class III - Drugs - Amerisource Health Services,Presence of Foreign Tablets/Capsules,2016-11-18,2016-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76484 - Class II - Drugs - Amerisource Health Services,Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities,2017-02-24,2017-02-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76636 - Class II - Drugs - Amerisource Health Services,Failed dissolution specifications: Glipizide 2.5 mg ER  Tablets exceeded  dissolution specification rates for the 10 hour testing point.,2017-03-14,2017-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78118 - Class III - Drugs - Amerisource Health Services,Failed Stability Specifications,2017-11-10,2017-11-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78490 - Class II - Drugs - Amerisource Health Services,Presence of Foreign Tablets/Capsules.,2017-11-21,2017-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90677 - Class III - Drugs - Amerisource Health Services LLC,Subpotent Drug,2022-08-17,2022-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91416 - Class II - Drugs - Amerisource Health Services LLC,Failed Impurities/Degradations Specifications,2023-01-18,2023-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91528 - Class II - Drugs - Amerisource Health Services LLC,"Failed Dissolution Specifications: This recall is being initiated in support of the recall by the manufacturer 
which included lots that were packaged for BluePoint Laboratories.
",2023-02-15,2023-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91609 - Class II - Drugs - Amerisource Health Services LLC,Failed Impurities/Degradation Specifications,2023-02-16,2023-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72967 - Class II - Drugs - Amerita Specialty Infusion Services,Lack of Assurance of Sterility,2016-01-15,2016-01-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66318 - Class II - Drugs - Amgen, Inc.",Presence of Particulate Matter: Visible cellulose fibers were observed in a small number of prefilled syringes during a routine quality examination.,2013-11-04,2013-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76012 - Class II - Drugs - Amgen, Inc.",Lack of Assurance of Sterility: Potential cracks in glass vials,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77889 - Class II - Drugs - Amgen, Inc.",Presence of particulate matter: Visible glass flakes identified as lamellae in some drug product vials.,2017-08-14,2017-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78110 - Class II - Drugs - Amgen, Inc.",Presence of particulate matter: glass flakes identified as lamellae observed during a routine quality inspection.,2017-09-19,2017-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90112 - Class II - Drugs - Amgen, Inc.","Defective container: loose crimp defect, potential loss of container integrity.",2022-05-09,2022-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88772 - Class II - Drugs - AMIVAS (US), LLC",Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.,2021-10-05,2021-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79610 - Class II - Drugs - Amneal Pharmaceuticals,Presence of particulate matter,2018-03-29,2018-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76627 - Class II - Drugs - Amneal Pharmaceuticals LLC,Failed Dissolution Specifications,2017-05-02,2017-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78035 - Class II - Drugs - Amneal Pharmaceuticals LLC,Presence of Particulate Matter,2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85781 - Class II - Drugs - Amneal Pharmaceuticals of New York, LLC",CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-06-25,2020-06-25,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90680 - Class II - Drugs - Amneal Pharmaceuticals of New York, LLC",Failed dissolution specifications.,2022-08-19,2022-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77898 - Class I - Drugs - Amneal Pharmaceuticals of New York, LLC","Defective Delivery System: the dropper measurement markings may be reversed, shifted or missing.",2017-12-20,2017-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85386 - Class II - Drugs - Amneal Pharmaceuticals of New York, LLC",CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.,2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88997 - Class II - Drugs - Amneal Pharmaceuticals of New York, LLC",Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.,2021-11-16,2021-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66014 - Class II - Drugs - Amneal Pharmaceuticals of New York, LLC.",Failed dissolution specifications; 18 month CRT,2013-11-04,2013-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84353 - Class II - Drugs - Amneal Pharmaceuticals, Inc.",CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API,2019-12-09,2019-12-09,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83137 - Class III - Drugs - Amneal Pharmaceuticals, Inc.",Subpotent Drug: Out of specification assay result in Esterified Estrogen and Methyltestosterone tablets.,2019-07-01,2019-07-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83206 - Class III - Drugs - Amneal Pharmaceuticals, Inc.",Presence of Foreign Tablet/Capsule; one Promethazine tablet was found in a bottle of Methylergonovine Maleate tablets,2019-07-24,2019-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83915 - Class III - Drugs - Amneal Pharmaceuticals, Inc.",Presence of Foreign Tablet/Capsule; Promethazine HCl tablet found in the Benazepril HCl bottle,2019-10-09,2019-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84073 - Class III - Drugs - Amneal Pharmaceuticals, Inc.",Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits.,2019-11-13,2019-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77988 - Class II - Drugs - Amphastar Pharmaceuticals, Inc.",Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.,2017-08-29,2017-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89503 - Class II - Drugs - AMS Packaging Inc,Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.,2022-03-07,2022-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90152 - Class II - Drugs - AMS Packaging Inc,Subpotent Drug: FDA analysis has revealed some bottles of these products were sub potent for ethanol.,2022-06-14,2022-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70317 - Class I - Drugs - Anabolic Science Labs, LLC",Marketed without an approved NDA/ANDA  - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.,2015-05-05,2015-05-05,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70465 - Class II - Drugs - AnazaoHealth Corporation,Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.,2015-02-09,2015-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82554 - Class II - Drugs - Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy",Lack of sterility assurance.,2019-04-18,2019-04-18,68,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77664 - Class I - Drugs - Andropharm, LLC",Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.,2017-09-12,2017-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88371 - Class II - Drugs - ANHUI WELCOME FOREIGN TRADE CO.,LTD.","Labeling: Not Elsewhere Classified; The packaging states these are ophthalmic drops. However, they are manufactured as nasal drops and sterility cannot be assured.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86584 - Class III - Drugs - ANI Pharmaceuticals, Inc.",Labeling: Incorrect expiration date.  Product dated with 24-month expiration date instead of 18-months.,2020-10-21,2020-10-21,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89556 - Class II - Drugs - ANI Pharmaceuticals, Inc.",cGMP Deviations,2022-02-17,2022-02-17,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64519 - Class III - Biologics - Antigen Laboratories Inc,"Allergenic Extracts, reprocessed by an unapproved process, were distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66020 - Class III - Biologics - Antigen Laboratories Inc,"Allergenic Extracts, reprocessed by an unapproved process, were distributed.",2013-08-21,2013-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67398 - Class III - Biologics - Antigen Laboratories Inc,"One lot of Standardized Bermuda Grass Pollen Allergenic Extract, with a decreased potency, was distributed.",2014-02-07,2014-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70121 - Class III - Biologics - Antigen Laboratories Inc,"One lot of Standardized Perennial Rye Grass Pollen Allergenic Extract, with a possible decreased potency, was distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71748 - Class III - Biologics - Antigen Laboratories Inc,"Allergenic Extract, associated with an out of specification stability result for potency, was distributed.",2015-07-27,2015-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87627 - Class II - Drugs - Antoto-K,Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.,2021-05-04,2021-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63080 - Class III - Drugs - Apace KY LLC,Labeling Illegible: Some bottles labels have incomplete NDC numbers and missing strength.,2012-09-19,2012-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73326 - Class III - Drugs - Apace KY LLC,Labeling: Incorrect or Missing Lot and/or Exp Date: the individual blisters are mislabeled with an incorrect lot number of 13560 rather than the correct lot number of 13650.,2016-04-05,2016-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77601 - Class II - Drugs - Apace KY LLC,"Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg",2017-07-31,2017-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79194 - Class II - Drugs - Apace KY LLC,Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.,2018-02-23,2018-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88289 - Class II - Drugs - API Solutions Inc.,cGMP Deviations,2021-07-28,2021-07-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79331 - Class II - Drugs - Apollo Care,Stability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.,2018-03-06,2018-03-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79517 - Class II - Drugs - Apollo Care,Stability Data Does Not Support Expiry: 90-day beyond use date (BUD) for the affected product is not supported.,2018-03-29,2018-03-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89011 - Class II - Drugs - Apollo Care,Crystallization: Product appears to be turbid.,2021-12-08,2021-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87269 - Class I - Drugs - Apotex Corp.,"Labeling; Label Mixup; syringe barrels may containing markings for 150 mg/mL (corresponding to 120 mg/0.8mL strength) instead of 100 mg/mL markings (corresponding to 100 mg/mL strength), Labeling; Label Mixup; syringe barrels may contain markings for 100 mg/mL (corresponding to 100 mg/mL strength) instead of 150 mg/mL (corresponding to 120 mg/0.8mL strength)",2021-02-17,2021-02-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87648 - Class II - Drugs - Apotex Corp.,Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate,2021-04-06,2021-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90114 - Class III - Drugs - Apotex Corp.,Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.,2022-05-18,2022-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90569 - Class II - Drugs - Apotex Corp.,Failed dissolution specifications: OOS for dissolution at the 12-month stability time point.,2022-07-21,2022-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91353 - Class III - Drugs - Apotex Corp.,Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.,2022-12-28,2022-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62436 - Class II - Drugs - Apotex Corp.,Tablet Thickness: Recall was initiated due to the presence of one slightly oversized tablet in a bottle of the identified lot.,2012-08-07,2012-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38329 - Class II - Drugs - Apotex Corp.,Subpotent (Single Ingredient Drug): Distribution of product that did not meet specifications.,2012-08-27,2012-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62930 - Class III - Drugs - Apotex Corp.,CGMP Deviations: tubing used for filling may interact with the nasal formulation of this product.,2012-08-29,2012-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64657 - Class I - Drugs - Apotex Corp.,Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.,2013-07-17,2013-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65196 - Class I - Drugs - Apotex Corp.,Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.,2013-08-02,2013-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69170 - Class III - Drugs - Apotex Corp.,Failed Impurity/Degradation Specification; high out of specification for CAD II degradant,2014-09-15,2014-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69177 - Class III - Drugs - Apotex Corp.,Subpotent Drug: Out of specification (OOS) results at the 9 month temperature point.,2014-09-24,2014-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75964 - Class II - Drugs - Apotex Corp.,CGMP Deviations,2017-01-02,2017-01-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86736 - Class II - Drugs - Apotex Corp.,Failed Dissolution Specifications: Out of specification for dissolution.,2020-11-24,2020-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65882 - Class II - Drugs - Apotex Inc,"Lack of Assurance of Sterility: Failed at expiry for Preservative Effectiveness Test (PET), therefore the product may be susceptible to microbial growth before the expiry date.",2013-08-08,2013-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82288 - Class II - Drugs - Apotex Inc.,Contraceptive Tablets Out of Sequence: Missing or incorrect tablet placement.,2019-03-11,2019-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80063 - Class I - Drugs - Apotex Inc.,Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency,2018-06-05,2018-06-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84107 - Class III - Drugs - Apotex Inc.,Presence of Foreign Tablets/Capsules: a single tablet of Pravastatin 40 mg found in bottle of Atorvastatin Calcium 40 mg.,2019-10-28,2019-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83871 - Class II - Drugs - Apotex Inc.,GGMP Deviations: Possible contamination with impurity N-nitrosodimethylamine (NDMA).,2019-11-12,2019-11-12,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85772 - Class II - Drugs - Apotex Inc.,CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels,2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62574 - Class II - Drugs - Apotex Inc.,Presence of Particulate Matter:  Lots identified in this recall notification may contain small particulates.,2012-08-02,2012-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66807 - Class II - Drugs - Apotex Inc.,"Presence of Particulate Matter: Product from lot KF2199, may contain tablets with pieces of nitrile rubber glove embedded within the tablets.",2013-11-22,2013-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67985 - Class III - Drugs - Apotex Inc.,Failed Impurities/Degradation Specifications: Out of Specification for an impurity at the 18 month stability time point.,2014-05-01,2014-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68967 - Class II - Drugs - Apotex Inc.,Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.,2014-09-03,2014-09-03,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69546 - Class III - Drugs - Apotex Inc.,"Failed Impurities/Degradation Specifications: Out of specification (OOS) results were observed for CAD-II, CAD-V and Total Impurities.",2014-11-06,2014-11-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70720 - Class III - Drugs - Apotex Inc.,CGMP Deviations: Product excipient was not re-tested at the appropriate date.,2015-04-15,2015-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71046 - Class III - Drugs - Apotex Inc.,Subpotent drug,2015-05-14,2015-05-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71418 - Class II - Drugs - Apotex Inc.,Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.,2015-07-07,2015-07-07,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71999 - Class II - Drugs - Apotex Inc.,Failed Stability Specifications: product may not meet specification limit for assay test.,2015-09-15,2015-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72118 - Class III - Drugs - Apotex Inc.,Failed Dissolution Specification: One lot of product did not meet the first stage dissolution specification limits.,2015-09-30,2015-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72341 - Class II - Drugs - Apotex Inc.,Lack of Assurance of Sterility: Failed preservative effectiveness testing,2015-10-09,2015-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75984 - Class III - Drugs - Apotex Inc.,Superpotent Drug: Product may not meet specifications throughout shelf life.,2017-02-09,2017-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76402 - Class II - Drugs - Apotex Inc.,Failed Impurities/Degradations Specifications; out of specification results for Maximum Unknown Impurities and Total Impurities.,2017-02-23,2017-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80202 - Class II - Drugs - Apotex Inc.,Presence of foreign substance: glass particles,2018-06-06,2018-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73419 - Class III - Drugs - Apotex Scientific, Inc",Failed Dissolution Specification: Out of specification dissolution results when testing product stability.,2016-07-14,2016-07-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77615 - Class II - Drugs - Apothecary By Design,Lack of Processing Controls: The metal container closure adheres to the rubber stopper on some of the units of the batch which can impact the integrity of the container closure.,2017-06-28,2017-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66241 - Class II - Drugs - Apothecary Shoppe,"Lack of Assurance of Sterility: concerns of sterility assurance with the  pharmacy's independent testing laboratory., Lack of Assurance of Sterility: concerns of sterility assurance with the  pharmacy's independent testing laboratory",2013-10-03,2013-10-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64921 - Class II - Drugs - Apothecure, Inc",Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.,2014-02-04,2014-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84289 - Class III - Drugs - Apothecus Pharmaceutical Corp.,"Defective Delivery System: canister unit exhibiting propellant leakage or loss, rendering the product and canister unusable",2019-12-19,2019-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84610 - Class II - Drugs - Appco Pharma LLC,CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API,2020-01-07,2020-01-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89905 - Class III - Drugs - AptaPharma Inc.,Incorrect/Undeclared Excipient: Product contains alcohol,2022-04-25,2022-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74857 - Class I - Drugs - Arbor Pharmaceuticals Inc.,"Defective Container: Incomplete seal on blister packaging, leading to tablet swelling and enlarging due to effervescence process beginning as oxygen and moisture enter the blister packaging.",2016-10-14,2016-10-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83959 - Class III - Drugs - Arbor Pharmaceuticals Inc.,"Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose  vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml  multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials",2019-10-30,2019-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86392 - Class III - Drugs - Arbor Pharmaceuticals Inc.,Subpotent Drug,2020-09-28,2020-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62063 - Class III - Biologics - Arc Blood Services, New England Region","Blood products,  collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63330 - Class III - Biologics - Arc Blood Services, New England Region","Blood products, with incorrectly transcribed platelet counts, were distributed.",2012-11-01,2012-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64873 - Class II - Biologics - Arc Blood Services, New England Region","Blood products, collected from an ineligible donor, were distributed.",2013-05-23,2013-05-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65593 - Class II - Biologics - Arc Blood Services, New England Region","Blood products, collected from an ineligible donor, were distributed.",2013-08-01,2013-08-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65788 - Class III - Biologics - Arc Blood Services, New England Region","Blood products, collected from an ineligible donor, were distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66192 - Class II - Biologics - Arc Blood Services, New England Region","Blood products, for which the quality control testing was incomplete, were distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66599 - Class II - Biologics - Arc Blood Services, New England Region","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2013-11-14,2013-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66800 - Class III - Biologics - Arc Blood Services, New England Region","Blood products, which was collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66974 - Class II - Biologics - Arc Blood Services, New England Region","Blood product, which did not meet the platelet QC specification for pH, was distributed.",2014-01-09,2014-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67907 - Class III - Biologics - Arc Blood Services, New England Region","Pool Cryoprecipitated AHF, not meeting quality control specifications, were distributed.",2014-05-07,2014-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68829 - Class III - Biologics - Arc Blood Services, New England Region","Blood product, which was labeled with an incorrect expiration date, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70327 - Class III - Biologics - Arc Blood Services, New England Region","Blood product, labeled with an extended expiration date following irradiation, was distributed.",2015-02-05,2015-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70796 - Class II - Biologics - Arc Blood Services, New England Region","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2015-04-13,2015-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72209 - Class II - Biologics - Arc Blood Services, New England Region","Blood Products, lacking assurance of collection in an aseptic manner, were distributed.",2015-09-17,2015-09-17,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72110 - Class II - Biologics - Arc Blood Services, New England Region","Platelet products, which did not meet specifications, were distributed.",2015-10-15,2015-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72546 - Class III - Biologics - Arc Blood Services, New England Region",Misbranded Red Blood Cells were distributed.,2015-12-02,2015-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73370 - Class III - Biologics - Arc Blood Services, New England Region","Apheresis product, for which the attached label was missing required information was distributed.",2016-03-04,2016-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73372 - Class II - Biologics - Arc Blood Services, New England Region","Apheresis products, for which quality control testing for residual white blood cell count was not performed, were distributed.",2016-03-04,2016-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73519 - Class II - Biologics - Arc Blood Services, New England Region","Leukoreduced Plateletpheresis products, that failed residual WBC counts, were distributed.",2016-04-22,2016-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73892 - Class III - Biologics - Arc Blood Services, New England Region","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74738 - Class II - Biologics - Arc Blood Services, New England Region","Platelet products, labeled as leukoreduced and for which white blood cell counting was not performed, were distributed.",2016-08-26,2016-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75165 - Class II - Biologics - Arc Blood Services, New England Region","Apheresis products, for which white blood cell count testing was not performed, were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75363 - Class III - Biologics - Arc Blood Services, New England Region","Blood products, lacking assurance of sterility, were distributed.",2016-11-17,2016-11-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75706 - Class III - Biologics - Arc Blood Services, New England Region","Blood products, not tested according to specifications  for relevant transfusion transmitted disease, were distributed.",2016-12-07,2016-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76317 - Class III - Biologics - Arc Blood Services, New England Region","Blood product, for which a unit received inadequate additive solution, was distributed.",2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76932 - Class II - Biologics - Arc Blood Services, New England Region","Blood products, which were not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2017-05-09,2017-05-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47955 - Class II - Biologics - ARC Blood Services, New England Region","Blood products, collected using equipment that was not validated, were distributed.",2012-07-03,2012-07-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #38910 - Class II - Biologics - ARC Blood Services, New England Region","Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed",2012-11-26,2012-11-26,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49758 - Class II - Biologics - ARC Blood Services, New England Region","Blood products, collected from ineligible donors, were distributed.",2015-07-23,2015-07-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49966 - Class II - Biologics - ARC Blood Services, New England Region","Platelets, lacking assurance of proper leukoreduction, were distributed.",2015-07-23,2015-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88190 - Class I - Drugs - Ardil Comercial S.R.L.,Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.,2021-07-20,2021-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87363 - Class II - Drugs - Areva Pharmaceuticals Inc,"CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.",2021-02-21,2021-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64864 - Class III - Biologics - Arkansas Lions Eye Bank & Laboratory,"Human Cornea, recovered from a donor whose donor eligibility was not determined in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, was distributed.",2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89138 - Class I - Drugs - Aroma Release Technologies Inc,Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol,2021-12-28,2021-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87746 - Class II - Biologics - Arthrex, Inc.","Biological device ABS-10063 and ABS-10064, for which the sterility may have been compromised during the manufacturing process, were distributed.",2021-06-22,2021-06-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62545 - Class II - Biologics - Arup Laboratories, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66388 - Class II - Biologics - Arup Laboratories, Inc.","Blood product, collected without the performance of a WBC count during instrument re-validation, was distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66701 - Class II - Biologics - Arup Laboratories, Inc.","Blood products, labeled leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67428 - Class II - Biologics - Arup Laboratories, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70688 - Class II - Biologics - ARUP Laboratories, Inc.","Blood products, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-04-16,2015-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72022 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, collected using equipment that was not validated, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72023 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, collected using equipment that was not validated, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72677 - Class III - Biologics - ARUP Laboratories, Inc.","Platelets, with insufficient plasma volume to support the platelet yield, were distributed.",2015-12-10,2015-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72901 - Class II - Biologics - ARUP Laboratories, Inc.","Platelet Pheresis products, labled as leuko reduced, in which WBC testing was not performed, were distributed.",2016-01-14,2016-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73108 - Class III - Biologics - ARUP Laboratories, Inc.","Platelet products, labeled with the incorrect volume, were distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74236 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75001 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2016-10-04,2016-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75381 - Class II - Biologics - ARUP Laboratories, Inc.","Apheresis products, collected from a donor who traveled to a Zika endemic area were distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75721 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, in which component preparation was not prepared in accordance with specifications, was distributed.",2016-12-09,2016-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76067 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78223 - Class II - Biologics - ARUP Laboratories, Inc.","Pooled platelet products, not meeting product specifications, were distributed.",2017-10-10,2017-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79960 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, collected from a donor who gave history of residency in a malarial area,  was distributed.",2018-05-17,2018-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82609 - Class III - Biologics - ARUP Laboratories, Inc.","Blood Products, labeled with an incorrect volume, were distributed.
",2019-04-22,2019-04-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82580 - Class III - Biologics - ARUP Laboratories, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82766 - Class III - Biologics - ARUP Laboratories, Inc.","Misbranded plateletpheresis product was distributed.
",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83642 - Class II - Biologics - ARUP Laboratories, Inc.","Plateletpheresis product in which quality control procedures were not performed, was distributed.
",2019-09-13,2019-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83956 - Class II - Biologics - ARUP Laboratories, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2019-10-16,2019-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84159 - Class II - Biologics - ARUP Laboratories, Inc.","Leukoreduced Red Blood Cells, for which donor eligibility screening was incorrectly performed, were distributed.",2019-11-15,2019-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84810 - Class II - Biologics - ARUP Laboratories, Inc.","Plateletpheresis product, in which platelet yield did not meet specifications, was distributed.",2020-02-05,2020-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86622 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, collected from a donor with an incomplete eligibility determination, was distributed.",2020-10-19,2020-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86917 - Class II - Biologics - ARUP Laboratories, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, with a platelet count below the acceptable level, were distributed.",2020-12-09,2020-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87973 - Class II - Biologics - ARUP Laboratories, Inc.","Blood product, possibly contaminated with air due to an open system, was distributed.",2021-06-04,2021-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88148 - Class II - Biologics - ARUP Laboratories, Inc.","Leukoreduced Apheresis Platelets, in which the platelet yield was below the acceptable limit, were distributed.",2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88265 - Class II - Biologics - ARUP Laboratories, Inc.","Leukoreduced Apheresis Platelets, which qualified as a double unit but was not split, was distributed.",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88776 - Class II - Biologics - ARUP Laboratories, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2021-10-26,2021-10-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89709 - Class III - Biologics - ARUP Laboratories, Inc.","Misbranded platelet product was distributed.
",2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86859 - Class II - Drugs - Ascend Laboratories LLC,Failed Dissolution Specifications; Out of Specification (low) results were obtained.,2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87032 - Class II - Drugs - Ascend Laboratories LLC,Failed Impurity/Degradation Specifications,2020-12-30,2020-12-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86850 - Class II - Drugs - Ascend Laboratories LLC,Failed Impurity/Degradation Specifications: Unidentified impurities not complying with specifications were observed in various lots of Cephalexin FOS USP 125 mg/5 mL.,2021-01-04,2021-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75698 - Class II - Drugs - Ascend Laboratories LLC,Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP,2016-11-29,2016-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77948 - Class III - Drugs - Ascend Laboratories LLC,PRESENCE OF FOREIGN TABLETS/CAPSULES:  A 2.5 mg Amlodipine Besylate tablet was found co-mingled with 10 mg Amlodipine Besylate tablets in a bottle labeled as Amlodipine Besylate 10 mg.,2017-09-11,2017-09-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81568 - Class II - Drugs - Ascend Laboratories LLC,Presence of Foreign Substance; metal shard found in tablet,2018-11-28,2018-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82223 - Class II - Drugs - Ascend Laboratories LLC,Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing.,2019-03-29,2019-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83378 - Class II - Drugs - Ascend Laboratories LLC,Failed Dissolution Specifications,2019-07-24,2019-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84750 - Class III - Drugs - Ascend Laboratories LLC,Failed Dissolution Specifications: low out of specification results for dissolution testing.,2020-02-05,2020-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84818 - Class II - Drugs - Ascend Laboratories LLC,cGMP Deviations; Olmesartan Medoximil Tablets 20 mg was released in error with alternate API source prior to filing and approval of Prior Approval Supplement.,2020-02-06,2020-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87214 - Class II - Drugs - Ascend Laboratories LLC,CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.,2021-02-18,2021-02-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87817 - Class III - Drugs - Ascend Laboratories LLC,Presence of Foreign Tablet/Capsule,2021-05-24,2021-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88982 - Class II - Drugs - Ascend Laboratories LLC,Failed Impurities/Degradation Specifications,2021-11-09,2021-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89259 - Class II - Drugs - Ascend Laboratories, LLC",Failed impurities/degradation specifications,2022-01-05,2022-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89411 - Class II - Drugs - Ascend Laboratories, LLC",Failed Dissolution Specifications.,2022-01-21,2022-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91385 - Class II - Drugs - Ascend Laboratories, LLC",Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.,2023-01-16,2023-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91442 - Class II - Drugs - Ascend Laboratories, LLC",Failed Dissolution Specification,2023-01-20,2023-01-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64116 - Class III - Drugs - Ascend Therapeutics Inc,Defective Container: Pump head detaching from the canister unit upon removal of the overcap.,2013-02-04,2013-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89060 - Class II - Drugs - Ascent Pharmaceuticals, Inc.",Product Mix-up,2021-12-07,2021-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78990 - Class III - Drugs - Ascent Pharmaceuticals, Inc.",Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol,2018-02-01,2018-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86665 - Class II - Drugs - Ascent Pharmaceuticals, Inc.","Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.",2020-11-17,2020-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81741 - Class I - Drugs - Asclemed USA Inc. dba Enovachem,"Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex",2019-01-09,2019-01-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84550 - Class II - Drugs - Asclemed USA Inc. dba Enovachem Pharmaceuticals,Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.,2020-01-08,2020-01-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87548 - Class III - Drugs - Asclemed USA Inc. dba Enovachem Pharmaceuticals,Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.,2021-04-12,2021-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86546 - Class I - Drugs - ASHTEL STUDIOS, INC.","Labeling: Not Elsewhere Classified. Container packaging is made, formed or filled to be misleading, resembling food and drink pouches",2020-11-17,2020-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86327 - Class II - Drugs - Asiaticon, SA de CV",Lack of CGMPs:,2020-12-07,2020-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89076 - Class II - Drugs - ASP CARES,Lack of Assurance of Sterility,2021-11-26,2021-11-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62969 - Class III - Biologics - Associates of Cape Cod, Inc.",One lot of mislabeled Pyrotell gel clot LAL reagent was distributed.,2012-09-13,2012-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84546 - Class II - Drugs - Assurance Infusion,Lack of sterility assurance.,2020-01-13,2020-01-13,118,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65496 - Class II - Drugs - Astellas Pharma US Inc,"Lack of Assurance of Sterility; Astellas Pharma US, Inc. is performing a voluntary recall on certain lots of AmBisome because the manufacturer has notified Astellas that during a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in the media fills.",2013-07-25,2013-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69246 - Class II - Drugs - Astellas Pharma US Inc,Failed Dissolution Specifications: The product did not meet the acceptance criteria for the dissolution test during the 24 month routine stability testing.,2014-10-07,2014-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78981 - Class II - Drugs - Astellas Pharma US Inc,Labeling: Label Error on Declared Strength,2018-02-27,2018-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64041 - Class III - Drugs - AstraZeneca LP,Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.,2013-03-12,2013-03-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62439 - Class III - Drugs - AstraZeneca Pharmaceuticals LP,Adulterated Presence of Foreign Tablets/Capsules: Some bottles may contain a small number of Nexium 20 mg capsules intended for the Japanese market in addtion to Nexium 40 mg capsules.,2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65543 - Class II - Drugs - AstraZeneca Pharmaceuticals LP,Presence of Precipitate; potential for incomplete constitution upon addition of diluent.,2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71483 - Class II - Drugs - AstraZeneca Pharmaceuticals LP,Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM capsules contained 60 SEROQUEL  XR tablets.,2015-06-18,2015-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73538 - Class II - Drugs - AstraZeneca Pharmaceuticals LP,Defective Delivery System: Some units have actuation counters set to a number other than 60.,2016-03-22,2016-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79290 - Class III - Drugs - AstraZeneca Pharmaceuticals LP,Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L  (polymorph).,2018-03-09,2018-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77336 - Class I - Drugs - AstraZeneca Pharmaceuticals, LP","Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.",2017-07-11,2017-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82419 - Class I - Drugs - Ata International Inc,"Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared ingredients: Sildenafil, Tadalafil, desmethyl carbodenafil, dithiodesmethyl carbodenafil, scutellarin, and daidzein.",2019-04-09,2019-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89779 - Class II - Drugs - Athenex Pharma Solutions, LLC",Defective container,2022-03-21,2022-03-21,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77760 - Class II - Drugs - AtHome Medical, Inc.",GMP Deviations: The firm does not include an SOP for testing for out of specifications.,2017-08-09,2017-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61907 - Class II - Biologics - Atlanta Blood Services,"Blood products,  collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-06-12,2012-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41001 - Class III - Biologics - Atlanta Blood Services,"Blood products, collected from a donor whose temperature was not documented, were distributed.",2013-04-03,2013-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66115 - Class II - Biologics - Atlanta Blood Services,"Blood product, labeled as leukoreduced without the assurance that it met the criteria for a leukoreduced product, was distributed.

",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69375 - Class II - Biologics - Atlanta Blood Services,"Plateletpheresis product, for which leukoreduction specifications were not met, was distributed.",2014-10-16,2014-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69376 - Class II - Biologics - Atlanta Blood Services,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed",2014-10-28,2014-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69403 - Class III - Biologics - Atlanta Blood Services,"Blood products, in which Viral Testing/Testing performed, interpreted, or documented incorrectly, were distributed.",2014-11-05,2014-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71621 - Class II - Biologics - Atlanta Blood Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77708 - Class II - Biologics - Atlanta Blood Services,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2017-08-10,2017-08-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78881 - Class II - Biologics - Atlanta Blood Services,"Platelet product, not prepared in accordance with specifications, was distributed.",2018-02-21,2018-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80349 - Class II - Biologics - Atlanta Blood Services,"Blood product, for which the arm prep was performed with an expired swab-stick, was distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80795 - Class II - Biologics - Atlanta Blood Services,"Apheresis products collected from a donor who traveled to a malarial endemic area, were distributed.
",2018-08-22,2018-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85026 - Class II - Biologics - Atlanta Blood Services,"Plateletpheresis product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2020-03-05,2020-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88359 - Class II - Biologics - Atlanta Blood Services,"Platelets, Pathogen Reduced, with a leak detected while in the centrifuge, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88924 - Class II - Biologics - Atlanta Blood Services,"Blood product collected from a donor who was a resident of a malaria endemic area, was distributed.
",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90005 - Class II - Biologics - Atlanta Blood Services,"Platelet, Pathogen Reduced, with a platelet count below the acceptable yield, was distributed.",2022-04-20,2022-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91209 - Class II - Biologics - Atlanta Blood Services,"Platelets, Pathogen Reduced, which were labeled as leukocytes reduced without valid confirmation testing, were distributed.",2022-12-08,2022-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91271 - Class II - Biologics - Atlanta Blood Services,"Platelets, Pathogen Reduced, which were labeled as leukocytes reduced without valid confirmation testing, were distributed.",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91243 - Class II - Drugs - Atlantic Management Resources Ltd.,cGMP Deviations,2022-12-13,2022-12-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83710 - Class II - Drugs - Atlas Pharmaceuticals, LLC","Labeling: Not Elsewhere Classified; product is labeled as ""Non-Corn Source"" however the product is from a corn source.",2019-10-15,2019-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70452 - Class II - Drugs - Attix Pharmaceuticals,"Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin., Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 through 02/12/15 are being recalled because they were repackaged without data to support the printed expiry date., Penicillin Cross Contamination: All lots of all products repackaged between 01/05/12 through 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin., Stability Data Does Not Support Expiry: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged with",2015-04-20,2015-04-20,470,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74361 - Class III - Drugs - Attix Pharmaceuticals Inc,cGMP deviation; manufacturer is Not Registered with the Food and Drug Administration,2016-06-21,2016-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82483 - Class III - Drugs - Auro Pharmacies Inc. DBA Central Drugs,Failed pH Specification: product does not meet pH label claim.,2019-04-05,2019-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80890 - Class II - Drugs - Auro Pharmacies, Inc.",Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.,2018-08-29,2018-08-29,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81442 - Class II - Drugs - Aurobindo Pharma Limited (Unit I),"CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62113 - Class II - Drugs - Aurobindo Pharma LTD,Adulterated Presence of Foreign Tablets: This product is being recalled becaiuse 30 valacyclovir hydrochloride tablets USP 500 mg were discovered in a bottle labeled Zolpidem Tartrate tables USP 10 mg,2012-11-06,2012-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78847 - Class I - Drugs - Aurobindo Pharma Ltd.,"Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.",2018-02-08,2018-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79119 - Class III - Drugs - Aurobindo Pharma Ltd.,Presence of Foreign Tablet: Metformin BP 1000mg was found in bottle of Metformin HCl 1000mg,2018-02-16,2018-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65071 - Class III - Drugs - Aurobindo Pharma USA Inc,Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label,2013-05-30,2013-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69807 - Class II - Drugs - Aurobindo Pharma USA Inc,Failed Tablet/Capsule Specifications: Complaints of empty capsules received.,2015-01-06,2015-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74949 - Class II - Drugs - Aurobindo Pharma USA Inc,Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole.,2016-09-14,2016-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75997 - Class III - Drugs - Aurobindo Pharma USA Inc,Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.,2017-02-08,2017-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76325 - Class II - Drugs - Aurobindo Pharma USA Inc,"Failed Tablet/Capsule Specifications: Some bottles contain  punctured, and/or clumped/melted capsules.",2017-02-13,2017-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81887 - Class II - Drugs - Aurobindo Pharma USA Inc.,"CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.",2019-01-14,2019-01-14,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82114 - Class II - Drugs - Aurobindo Pharma USA Inc.,"GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.",2019-03-21,2019-03-21,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82496 - Class I - Drugs - Aurobindo Pharma USA Inc.,Presence of Particulate Matter: One vial was found to contain a hair.,2019-04-25,2019-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83848 - Class II - Drugs - Aurobindo Pharma USA Inc.,Superpotent Drug: Amphetamine Mixed Salts 20mg have been found to be out of specification for weight and thickness.,2019-10-15,2019-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85183 - Class II - Drugs - Aurobindo Pharma USA Inc.,CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed,2020-04-13,2020-04-13,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86190 - Class II - Drugs - Aurobindo Pharma USA Inc.,Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).,2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86567 - Class III - Drugs - Aurobindo Pharma USA Inc.,Labeling Not Elsewhere Classified: Ibuprofen Oral Suspension  is missing dosing cups.,2020-11-05,2020-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87193 - Class II - Drugs - Aurobindo Pharma USA Inc.,Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.,2021-02-26,2021-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88227 - Class II - Drugs - Aurobindo Pharma USA Inc.,Presence of Foreign Substance- Potential of metal contamination.,2021-08-10,2021-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88639 - Class II - Drugs - Aurobindo Pharma USA Inc.,Presence of Foreign Substance: Product complaints received for the presence of metal wire in one tablet.,2021-09-20,2021-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89045 - Class III - Drugs - Aurobindo Pharma USA Inc.,Failed Impurities/Degradation Specifications,2021-12-01,2021-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89323 - Class II - Drugs - Aurobindo Pharma USA Inc.,Superpotent and Failed Tablet/Capsule Specifications,2022-01-24,2022-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89423 - Class II - Drugs - Aurobindo Pharma USA Inc.,Failed impurities/degradation specifications -Out of Specification (OOS) results of 0.78% to 1.02%; Spec NMT 0.1% for  Other Single impurities,2022-02-14,2022-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89941 - Class III - Drugs - Aurobindo Pharma USA Inc.,Subpotent Drug: Out of Specification results for Assay,2022-04-12,2022-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90949 - Class II - Drugs - Aurobindo Pharma USA Inc.,CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.,2022-10-26,2022-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81703 - Class III - Drugs - Aurobindo Pharma USA Inc.,Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).,2018-12-06,2018-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83436 - Class III - Drugs - Aurobindo Pharma USA Inc.,Labeling; Incorrect or Missing Lot and/or Exp Date; some bottles labeled with lot number 05318054B instead of 05318034B,2019-08-26,2019-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85756 - Class III - Drugs - Aurobindo Pharma USA Inc.,Failed Impurities/ Degradation Specifications,2020-06-17,2020-06-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85852 - Class II - Drugs - Aurobindo Pharma USA Inc.,Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.,2020-06-30,2020-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89869 - Class II - Drugs - Aurolife Pharma, LLC",Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.,2022-03-30,2022-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91319 - Class II - Drugs - Aurolife Pharma, LLC",Failed Impurities/Degradation Specifications,2022-12-22,2022-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83581 - Class II - Drugs - Aurolife Pharma, LLC",Failed Impurities/Degradation Specifications,2019-09-17,2019-09-17,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79996 - Class I - Drugs - AuroMedics Pharma LLC,Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.,2018-06-14,2018-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79995 - Class I - Drugs - AuroMedics Pharma LLC,"Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass",2018-07-17,2018-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80390 - Class I - Drugs - AuroMedics Pharma LLC,Presence of Particulate Matter: identified as glass and silicone material,2018-08-02,2018-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83868 - Class III - Drugs - AuroMedics Pharma LLC,"CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.",2019-10-29,2019-10-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84218 - Class II - Drugs - AuroMedics Pharma LLC,"CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.",2019-11-26,2019-11-26,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84336 - Class I - Drugs - AuroMedics Pharma LLC,"Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg tablets labelled as Mirtazapine 7.5 mg tablets.",2020-01-02,2020-01-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84308 - Class II - Drugs - AuroMedics Pharma LLC,Presence of Foreign Tablets/Capsules: One  Losartan/HCTZ tablet was found in Gabapentin 1000 count bottles..,2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84927 - Class III - Drugs - AuroMedics Pharma LLC,Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples).,2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87067 - Class II - Drugs - AuroMedics Pharma LLC,Discoloration and failed pH specifications,2021-02-04,2021-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89457 - Class I - Drugs - AuroMedics Pharma LLC,Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot,2022-02-10,2022-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90897 - Class III - Drugs - AuroMedics Pharma LLC,Presence of Particulate Matter: Piece of metal found in a vial,2022-09-30,2022-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90896 - Class II - Drugs - AuroMedics Pharma LLC,"Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.",2022-10-18,2022-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90925 - Class II - Drugs - AuroMedics Pharma LLC,Subpotent Drug: Out of specification for assay,2022-10-24,2022-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78696 - Class I - Drugs - AuroMedics Pharma LLC,Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass,2018-02-08,2018-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78800 - Class I - Drugs - AuroMedics Pharma LLC,Presence of Particulate Matter; white particulate matter identified as mold was found in one bag,2018-02-08,2018-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78932 - Class I - Drugs - AuroMedics Pharma LLC,Presence of Particulate Matter; contains visible particulate matter identified as mold.,2018-03-01,2018-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79772 - Class II - Drugs - AuroMedics Pharma LLC,Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap,2018-05-03,2018-05-03,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84240 - Class III - Drugs - AuroMedics Pharma LLC,Crystallization: Presence of visible particulate matter.,2019-11-22,2019-11-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84241 - Class II - Drugs - AuroMedics Pharma LLC,Presence of Foreign Substance: Foreign material found inside the vial.,2019-12-05,2019-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84356 - Class II - Drugs - AuroMedics Pharma LLC,Discoloration: Product complaints of discoloration after reconstitution of vials.,2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84244 - Class II - Drugs - AuroMedics Pharma LLC,Discoloration; Hazy solution found in one vial instead of a clear solution.,2019-12-09,2019-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84498 - Class III - Drugs - AuroMedics Pharma LLC,Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution.,2020-01-17,2020-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84910 - Class II - Drugs - AuroMedics Pharma LLC,Presence of Foreign Substance: Customer complaint of a foreign substance identified as nylon cable tie,2020-02-19,2020-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71670 - Class II - Biologics - Aurora Area Blood Bank dba Heartland Blood Centers,"Blood product, in which documentation of Apheresis record  was incomplete, was distributed.",2015-08-10,2015-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63833 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood product, incorrectly determined to be negative for the Fyb antigen, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63831 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood products, labeled leukoreduced but which did not meet the requirements for leukoreduced products, were distributed.",2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64255 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood product, collected from a donor who was at risk for HIV Group O, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65927 - Class III - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood product, which did not have the preservative solution added but labeled with a 42 day expiration date, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66617 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-12-02,2013-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66937 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood product, which was incorrectly labeled as negative for the S red cell antigen, was distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68866 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood products, collected from an ineligible donor, were distributed.",2014-08-14,2014-08-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70912 - Class III - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Red Blood Cells, not manufactured according to cGMP regulations, were distributed.  
",2015-05-15,2015-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71794 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood product, incorrectly labeled as negative for the Jka red cell antigen, was distributed.",2015-08-06,2015-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73516 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood products, collected from an ineligible donor, were distributed.",2016-04-21,2016-04-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73878 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-05-17,2016-05-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74766 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood products, collected from an ineligible donor, were distributed.",2016-08-31,2016-08-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74913 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood products, for which the quality control testing was incomplete, were distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75505 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Platelet product, for which quality control and distribution did not meet specifications, was distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75506 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"RBC product, for which quality control and distribution of product did not meet specifications, was distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76141 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77459 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Red blood cell, for which WBC quality control testing was pending, was distributed.",2017-06-16,2017-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79721 - Class II - Biologics - Aurora Area Blood Bank Dba Heartland Blood Centers,"Blood products, collected from a donor with a history of male to male sex, were distributed.",2018-04-18,2018-04-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84188 - Class II - Drugs - Avantor Performance Materials Inc,Failed Stability Specifications: Product exceeds compendia and firm's specifications for iron content.,2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72818 - Class III - Drugs - Avantor Performance Materials Inc,Failed Impurities/Degradation Specifications: Out of specifications results for impurities.,2016-01-06,2016-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66210 - Class II - Drugs - Avella of Deer Valley, Inc.",Lack of Assurance of Sterility: Avella Specialty Pharmacy is recalling bevacizumab and vancomycin due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.,2013-09-16,2013-09-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69405 - Class II - Drugs - Avella of Deer Valley, Inc.",Crystallization: Formation of crystals observed in product.,2014-10-10,2014-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80307 - Class II - Drugs - Avella of Deer Valley, Inc. Store 38",Lack of Assurance of Sterility: Potential leakage of bags.,2018-07-19,2018-07-19,38,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81413 - Class II - Drugs - Avella of Deer Valley, Inc. Store 38",Lack of assurance of sterility,2018-11-01,2018-11-01,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81466 - Class II - Drugs - Avella of Deer Valley, Inc. Store 38",Lack of Assurance of Sterility,2018-11-07,2018-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82102 - Class II - Drugs - Avella of Deer Valley, Inc. Store 38","Labeling: Incorrect or Missing Lot and/or Exp Date:The product labels contain a Two-Dimensional ( 2D ) barcode that, when scanned, reveals information specific to the batch of the labeled product, including Expiration Date.  The expiration date included within these 2D barcodes is incorrect and does not match the correct expiration date listed on the face of the label itself.",2019-03-12,2019-03-12,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82790 - Class II - Drugs - Avella of Deer Valley, Inc. Store 38",Lack of assurance of sterility,2019-05-29,2019-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83833 - Class II - Drugs - Avella of Deer Valley, Inc. Store 38",Lack of sterility assurance.,2019-10-18,2019-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67940 - Class II - Biologics - Avera McKennan Hospital & University Health Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2014-04-24,2014-04-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69060 - Class II - Biologics - Avera McKennan Hospital & University Health Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt- Jacob Disease (vCJD), were distributed.",2014-09-12,2014-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77751 - Class III - Biologics - Avera McKennan Hospital & University Health Center,"Blood product, which may have reached unacceptable temperatures during storage, was distributed.",2017-08-23,2017-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82706 - Class II - Drugs - AVKARE Inc.,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.",2019-04-28,2019-04-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86695 - Class II - Drugs - AVKARE Inc.,Failed Dissolution Specifications,2020-11-06,2020-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86940 - Class I - Drugs - AVKARE Inc.,Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.,2020-12-16,2020-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88091 - Class III - Drugs - AVKARE Inc.,Failed Impurities Specification: Out of specification when measuring the impurity degradant D level.,2021-06-16,2021-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90637 - Class III - Drugs - AVKARE Inc.,"Labeling: Label Error on Declared Strength
",2022-08-08,2022-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70635 - Class III - Drugs - AVKARE Inc.,Subpotent Drug,2015-03-04,2015-03-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76617 - Class II - Drugs - AVKARE Inc.,Failed impurities/ degradation specifications: Product was above specification for unknown impurities.,2017-03-22,2017-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77800 - Class III - Drugs - AVKARE Inc.,Failed impurities/degradation specifications: Out of specification for a related compound C.,2017-08-15,2017-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78240 - Class II - Drugs - AVKARE Inc.,Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.,2017-10-27,2017-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78867 - Class II - Drugs - AVKARE Inc.,Failed Dissolution Specifications: Low out of specification results for dissolution during annual stability testing.,2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79680 - Class II - Drugs - AVKARE Inc.,Failed Dissolution Specifications,2018-04-17,2018-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80828 - Class II - Drugs - AVKARE Inc.,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-28,2018-08-28,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81603 - Class II - Drugs - AVKARE Inc.,Microbial Contamination of Non-Sterile Product: Presence of Pseudomonas aeruginosa in product,2018-11-28,2018-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82296 - Class III - Drugs - AVKARE Inc.,Failed Dissolution Specifications,2019-03-11,2019-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82314 - Class II - Drugs - AVKARE Inc.,"CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified",2019-03-21,2019-03-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82564 - Class III - Drugs - AVKARE Inc.,Failed Impurities/Degradation Specifications; 18 month long term stability study (manufacturer),2019-04-11,2019-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83700 - Class II - Drugs - AVKARE Inc.,Failed Stability Specifications.,2019-09-17,2019-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84081 - Class II - Drugs - AVKARE Inc.,CGMP Deviations: Impurity  N-nitrosodimethylamine (NDMA) found in API,2019-10-28,2019-10-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84287 - Class II - Drugs - AVKARE Inc.,CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API,2019-11-26,2019-11-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84677 - Class II - Drugs - AVKARE Inc.,Failed Impurities/Degradation Specifications: High out of specification results for related compounds.,2020-01-13,2020-01-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85783 - Class III - Drugs - AVKARE Inc.,Presence of Foreign Substance consistent with granules from desiccant packs used during storage,2020-06-04,2020-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85811 - Class II - Drugs - AVKARE Inc.,CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-06-12,2020-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80940 - Class II - Drugs - Avkare Incorporated,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-09-06,2018-09-06,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91390 - Class II - Drugs - AVKARE LLC,Failed impurities/degradation specifications: Out of specification for unknown impurities.,2022-12-28,2022-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88539 - Class II - Drugs - AVRIO HEALTH L.P,Subpotent Drug,2021-09-23,2021-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62628 - Class III - Drugs - Axcentria Pharmaceuticals LLC,Labeling; labeled with incorrect EXP Date; Incorrect expiration date printed on the outer packaging.  Package incorrectly states 5/2014 should correctly state 4/2014,2012-08-02,2012-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62983 - Class III - Drugs - Axcentria Pharmaceuticals LLC,Stability data does not support expiration date:  Stability data indicates the Carbamide Peroxide will degrade below acceptable levels within the 24-month expiration date printed on the packaging.,2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68481 - Class II - Drugs - Axcentria Pharmaceuticals, LLC",Marketed without an Approved NDA/ANDA; product is being manufactured and distributed without a NDC number,2014-07-15,2014-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64957 - Class II - Drugs - Axium Healthcare Pharmacy dba Balanced Solutions Compounding,"Lack of Assurance of Sterility:All sterile products compounded, repackaged, and distributed by this
compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes., Lack of Sterility Assurance",2013-04-23,2013-04-23,26,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79923 - Class I - Biologics - Aziyo Biologics,"Distribution of human tissue allografts, that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88547 - Class I - Drugs - Azurity Pharmaceuticals, Inc.",Product Mix-up: Incorrect diluent component included in the kit.,2021-10-05,2021-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85440 - Class II - Drugs - B & B Pharmaceuticals, Inc.",cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.,2020-04-16,2020-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66469 - Class I - Drugs - B @ B Trade Inc.,Marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine,2014-04-14,2014-04-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84827 - Class II - Drugs - B AND A TRADING CORPORATION,"Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine",2020-02-12,2020-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67095 - Class II - Drugs - B. Braun Medical Inc,Labeling: Wrong Bar Code; Bar code scans as 0.15% Potassium Chloride in 0.9% Sodium Chloride (20 mEq K/liter).,2014-01-10,2014-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66497 - Class I - Drugs - B. Braun Medical Inc,Presence of Particulate Matter:  The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.,2014-01-31,2014-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66913 - Class I - Drugs - B. Braun Medical Inc,Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.,2014-04-25,2014-04-25,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73626 - Class I - Drugs - B. Braun Medical Inc,Non-Sterility: fungal contamination due to leaking containers.,2016-10-12,2016-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78767 - Class II - Drugs - B. Braun Medical Inc,"Presence of Particulate Matter: identified as polyethylene, which is consistent with the material used to manufacture the contain cap",2017-12-20,2017-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79348 - Class II - Drugs - B. Braun Medical Inc,"Presence of Particulate Matter: Customer complaint of particulate matter which has been identified as polyethylene, which is consistent with the material used to manufacture the container cap was received.",2018-02-27,2018-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83089 - Class II - Drugs - B. Braun Medical Inc,Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.,2019-06-13,2019-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85507 - Class I - Drugs - B. Braun Medical Inc,Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.,2020-04-28,2020-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89665 - Class II - Drugs - B. Braun Medical, Inc.",Lack of sterility assurance: leaking bags,2022-03-17,2022-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91194 - Class II - Drugs - B. Braun Medical, Inc.",Lack of sterility assurance: Bags have the potential to leak.,2022-12-05,2022-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68170 - Class I - Drugs - Bacai Inc. Dba Ky Duyen House,"Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, lot 13165, due to undeclared sibutramine, making it an unapproved new drug.",2014-08-08,2014-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89783 - Class II - Biologics - Banco de Ojos del Leonismo Puertorrique?o, Inc.","Cornea, recovered from a donor in which donor suitability was not adequately determined, was distributed.",2022-04-07,2022-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63810 - Class II - Biologics - Banco de Ojos del Leonismo Puertorriqueno,"Human Corneas, recovered with a donor with risk factors for relevant communicable disease agents and diseases, were distributed.",2012-12-11,2012-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61566 - Class II - Biologics - Banco de Sangre Servicios Mutuos, Inc.","Blood product, collected from a  donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-23,2012-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78227 - Class II - Drugs - Banner Pharmacy Services, LLC",Lack of Assurance of Sterility.,2017-10-23,2017-10-23,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73899 - Class II - Drugs - Baptist Health Medical Towers Pharmacy and Infusion Services,"Lack of Sterility Assurance, Lack of Sterility Assurance.",2016-05-29,2016-05-29,38,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86805 - Class II - Drugs - BASF Corporation,Cross contamination: the excipient was found to be contaminated with theophylline.,2020-12-15,2020-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83997 - Class II - Drugs - Basic Reset Inc.,Marketed without an Approved NDA/ANDA,2019-11-05,2019-11-05,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76598 - Class II - Biologics - Baton Rouge Regional Eye Bank (The),"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2017-03-28,2017-03-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83093 - Class III - Drugs - Bausch & Lomb,Failed Stability Specifications: Out of specification for viscosity.,2019-06-19,2019-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61964 - Class II - Drugs - Bausch & Lomb, Inc.","Lack of Assurance of Sterility: Bausch & Lomb, Inc. is recalling 7 Lots of Murocel Methylcellulose Lubricant Opthalmic Solution 1% (15 mL).  Product was found to be OOS for Antimicrobial Effectiveness testing (AET) at the 12 month stability time point.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68348 - Class II - Drugs - Bausch & Lomb, Inc.","Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.",2014-06-25,2014-06-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71896 - Class II - Drugs - Bausch & Lomb, Inc.",Lack of Assurance of Sterility: Failed preservative effectiveness testing.,2015-08-20,2015-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73032 - Class III - Drugs - Bausch & Lomb, Inc.",Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.,2016-01-28,2016-01-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77391 - Class II - Drugs - Bausch & Lomb, Inc.",CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.,2017-06-09,2017-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63488 - Class III - Drugs - Bausch Health Companies, Inc.","Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the benzoyl peroxide active ingredient.  Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label., Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicyclic acid active ingredient., Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicylic acid ingredient.  Additionally, this product is mislabeled because the label either omits or erroneously added inactive ingredients to the label.",2012-11-06,2012-11-06,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66356 - Class III - Drugs - Bausch Health Companies, Inc.",Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being carried out due to an incorrect  expiration date assigned to a lot of physicians samples.,2013-11-26,2013-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86557 - Class II - Drugs - Bausch Health Companies, Inc.",SUBPOTENT DRUG,2020-10-26,2020-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87093 - Class III - Drugs - Bausch Health Companies, Inc.",Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D.,2021-01-25,2021-01-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88079 - Class III - Drugs - Bausch Health Companies, Inc.",Failed Impurities/Degradation Specifications,2021-06-23,2021-06-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77259 - Class III - Biologics - Baxalta (Formerly Baxter Healthcare Corp),"Vonvendi, with a package insert error, was distributed.",2017-05-16,2017-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87148 - Class II - Biologics - Baxalta US Inc.,"Von Willebrand Factor, contaminated due to a media fill challenge, was distributed.",2021-02-01,2021-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63189 - Class II - Drugs - Baxter Healthcare Corp.,Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).,2012-09-25,2012-09-25,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65061 - Class II - Drugs - Baxter Healthcare Corp.,"Labeling Wrong Barcode;  It may display wrong product code reflecting  0.9% Sodium Chloride Injection , USP 100 mL in MINI-BAG Plus container instead of 50 mL.",2013-06-27,2013-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65288 - Class II - Drugs - Baxter Healthcare Corp.,"Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port., Lack of Assurance of Sterilty: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.",2013-06-28,2013-06-28,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65784 - Class II - Drugs - Baxter Healthcare Corp.,"Defective Container: There is a potential for frangible components to be broken, resulting in a leak at the port when the closure is removed.",2013-08-01,2013-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66820 - Class II - Drugs - Baxter Healthcare Corp.,Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured,2013-12-17,2013-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66880 - Class I - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter; particulate matter in one vial identified as silicone rubber and EPDM rubber from the vial stopper.,2014-01-31,2014-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67092 - Class I - Drugs - Baxter Healthcare Corp.,"Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag, Presence of Particulate Matter: Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag",2014-03-14,2014-03-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67107 - Class I - Drugs - Baxter Healthcare Corp.,"Presence of Particulate Matter: Particulate matter includes wood, sodium citrate and dextrose.",2014-03-14,2014-03-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67608 - Class I - Drugs - Baxter Healthcare Corp.,Non-Sterility: Complaints of leaks and particulate matter identified as mold in the solution bag and the overpouch.,2014-04-25,2014-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67974 - Class II - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter: Nylon fibers found in a bottle of 0.9% sodium chloride for irrigation.,2014-04-28,2014-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68577 - Class II - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.,2014-07-01,2014-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68089 - Class I - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter; blue polyisoprene shavings found inside the bag port tubes,2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69144 - Class II - Drugs - Baxter Healthcare Corp.,Lack of Assurance of Sterility; complaints of mold in the overpouch,2014-09-05,2014-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68728 - Class I - Drugs - Baxter Healthcare Corp.,"Presence of Particulate Matter: particulate matter identified as fibers and/or plastics., Presence of Particulate Matter: particulate matter identified as fibers and/or plastics",2014-09-18,2014-09-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69011 - Class I - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter: particulate matter was found during the manufacturing process.,2014-09-26,2014-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69303 - Class II - Drugs - Baxter Healthcare Corp.,"Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the overpouch.",2014-10-02,2014-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69518 - Class II - Drugs - Baxter Healthcare Corp.,"Labeling: Label Error On Declared Strength: Bags of Potassium Chloride 10 mEq per 100 mL were incorrectly overpouched with wraps labeled as Potassium Chloride Injection, 20 mEq per 100 mL.",2014-11-21,2014-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69634 - Class II - Drugs - Baxter Healthcare Corp.,Subpotent Drug: Heparin raw material was found to have low potency,2014-11-24,2014-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68171 - Class II - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.,2014-12-10,2014-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69868 - Class II - Drugs - Baxter Healthcare Corp.,Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal,2014-12-16,2014-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70057 - Class II - Drugs - Baxter Healthcare Corp.,Lack of Assurance of Sterility: Complaints of leaks due to an incomplete seal at the bag seam.,2015-01-26,2015-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70770 - Class II - Drugs - Baxter Healthcare Corp.,Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.,2015-03-25,2015-03-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70926 - Class I - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter: Products recalled due to  presence of particulate matter (metal),2015-07-06,2015-07-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71627 - Class II - Drugs - Baxter Healthcare Corp.,"Presence of Particulate Matter and Lack of Assurance of Sterility: The firm received a complaint for customer of presence of particulate matter, leaky containers, and missing port protectors. 
",2015-08-12,2015-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71749 - Class I - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter: Customer complaint for an insect found free floating inside a single bag for each lot recalled.,2015-08-14,2015-08-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73235 - Class II - Drugs - Baxter Healthcare Corp.,PRESENCE OF PARTICULATE MATTER: Product complaint for the presence of particulate matter identified as an insect.,2016-02-26,2016-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73812 - Class II - Drugs - Baxter Healthcare Corp.,Discoloration:  presence of atypical yellow discoloration of the solution .,2016-05-12,2016-05-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73118 - Class I - Drugs - Baxter Healthcare Corp.,"Presence of Particulate Matter: identified as cardboard., Presence of Particulate Matter: identified as a cloth fiber., Presence of Particulate Matter: identified as dried skin., Lack of Assurance of Sterility: potential for leaking containers which lacks the assurance of sterility.",2016-05-23,2016-05-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72816 - Class I - Drugs - Baxter Healthcare Corp.,Presence of Particulate Matter: Confirmed customer compliants of finding an insect floating in the primary container of each product.,2016-06-06,2016-06-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86529 - Class II - Drugs - Baxter Healthcare Corporation,Presence of particulate matter in solution - black and transparent particles,2020-11-12,2020-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90699 - Class II - Drugs - Baxter Healthcare Corporation,"Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating ""Refrigerate Upon Arrival"", however product is labeled to be stored in a controlled room temperature environment.",2022-08-16,2022-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68963 - Class II - Drugs - Baxter Healthcare Corporation,"Presence of Particulate Matter: identification of particulates in a retention sample that have been identified as a mixture of the amino acid leucine and inorganic material (containing iron, silicone and chlorine).",2014-08-18,2014-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69130 - Class II - Drugs - Baxter Healthcare Corporation,Correct Labeled Product Mispack: Shipping cartons labeled as containing Potassium Chloride injection actually contained bags labeled and containing Gentamicin Sulfate injection inside.,2014-09-23,2014-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70695 - Class II - Drugs - Baxter Healthcare Corporation,Lack of Assurance of Sterility; increased complaints received for leaks,2015-03-31,2015-03-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69962 - Class I - Drugs - Baxter Healthcare Corporation,"Presence of Particulate Matter: Confirmed customer
complaints received for the presence of blue plastic,
identified as fragments of the frangible from the vial adapter.",2015-04-08,2015-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71356 - Class II - Drugs - Baxter Healthcare Corporation,Subpotent Drug; out of specification results for heparin raw material,2015-06-09,2015-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72060 - Class II - Drugs - Baxter Healthcare Corporation,Lack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.,2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75831 - Class II - Drugs - Baxter Healthcare Corporation,Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.,2016-12-19,2016-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75835 - Class II - Drugs - Baxter Healthcare Corporation,"Discoloration: there were customer reports of yellow discolored solution. The yellow coloration is the result of oxidation of the amino acid tryptophan due to a damaged overpouch.
",2017-01-09,2017-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77247 - Class II - Drugs - Baxter Healthcare Corporation,Lack of assurance of sterility: customer complaints received for the presence of leaks.,2017-05-18,2017-05-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77678 - Class II - Drugs - Baxter Healthcare Corporation,Lack of Assurance of Sterility: Customer complaints for leaking bags.,2017-07-07,2017-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77676 - Class II - Drugs - Baxter Healthcare Corporation,Lack of Assurance of Sterility: Bags have the potential to leak.,2017-07-11,2017-07-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78155 - Class I - Drugs - Baxter Healthcare Corporation,"Temperature Abuse: A portion of this product lot was exposed to subfreezing temperatures, which is outside of the acceptable storage range listed on the product labeling, during transit to a distribution facility.",2017-10-24,2017-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78531 - Class I - Drugs - Baxter Healthcare Corporation,"Presence of Particulate Matter:Particulate identified as polyethylene, the primary constituent of the film and ports used to manufacture the bag in which product is packaged",2018-03-01,2018-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80653 - Class III - Drugs - Baxter Healthcare Corporation,Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.,2018-08-03,2018-08-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80881 - Class II - Drugs - Baxter Healthcare Corporation,CGMP Deviations,2018-08-27,2018-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80976 - Class II - Drugs - Baxter Healthcare Corporation,cGMP Deviation,2018-09-15,2018-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80987 - Class III - Drugs - Baxter Healthcare Corporation,Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.,2018-09-27,2018-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81353 - Class III - Drugs - Baxter Healthcare Corporation,Failed pH Specifications: Upward shift in the pH of the solution within the shelf life of the impacted lots.,2018-11-07,2018-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81881 - Class II - Drugs - Baxter Healthcare Corporation,Lack of Assurance of Sterility: Confirmed customer complaints for leaks on the tubing.,2019-01-08,2019-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83055 - Class II - Drugs - Baxter Healthcare Corporation,Failed Stability Specifications,2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83340 - Class II - Drugs - Baxter Healthcare Corporation,Lack of Assurance of Sterility: Bags have potential to leak.,2019-07-23,2019-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84288 - Class II - Drugs - Baxter Healthcare Corporation,Lack of  Assurance of Sterility: Product has the potential to leak.,2019-11-20,2019-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91283 - Class I - Drugs - BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy",Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL,2022-12-22,2022-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88394 - Class II - Drugs - BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy",Lack of sterility assurance,2021-08-04,2021-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89599 - Class III - Drugs - BayCare Integrated Service Center, LLC /dba BayCare Central Pharmacy",Subpotent drug,2022-02-18,2022-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88677 - Class I - Drugs - Bayer Healthcare Pharmaceuticals Inc.,"Chemical Contamination: presence of benzene, cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene., cGMP Deviations: LOTRIMIN AF (Tolnaftate 1%) manufactured at the same facility where other lots were found to be contaminated with benzene.",2021-11-18,2021-11-18,19,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62651 - Class II - Drugs - Bayer HealthCare Pharmaceuticals Inc.,Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.,2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62908 - Class III - Drugs - Bayer HealthCare Pharmaceuticals Inc.,Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.,2013-02-07,2013-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65702 - Class III - Drugs - Bayer HealthCare Pharmaceuticals Inc.,Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.,2013-07-18,2013-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76585 - Class III - Drugs - Bayer HealthCare Pharmaceuticals, Inc.",Labeling: Incorrect/Undeclared Excipients: Firm is recalling A+D Diaper Rash Cream due to a labeling claim issue.,2017-03-21,2017-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77484 - Class II - Drugs - Bayer HealthCare Pharmaceuticals, Inc.",Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.,2017-08-01,2017-08-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78505 - Class III - Drugs - Bayer HealthCare Pharmaceuticals, Inc.",Failed Stability Specifications,2017-12-28,2017-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79252 - Class II - Drugs - Bayer HealthCare Pharmaceuticals, Inc.",Labeling: Label mix-up,2018-03-12,2018-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79555 - Class I - Drugs - Bayer HealthCare Pharmaceuticals, Inc.","Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo located on the lower left corner of the front of the carton, because the ingredients on the front sticker may not match the actual product in the carton.",2018-04-24,2018-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61948 - Class III - Drugs - Bayer Healthcare, LLC","Labeling: Label Mix-up: This recall was initiated after identifying that the label statement on the blister strip regarding the maximum number of capsules/caplets that should be taken within a 24-hour period, does not match the statement on the carton.",2012-07-19,2012-07-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63821 - Class III - Drugs - Bayer Healthcare, LLC",Labeling: Label lacks warning or Rx legend; Certain information was inadvertently excluded from the product carton label.,2013-02-28,2013-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76193 - Class III - Biologics - Bayer HealthCare, LLC","Kogenate FS Antihemophilic Factor (Recombinant) and Helixate FS, where routine stability testing showed potency declining faster than expected in certain lots, were distributed.",2017-01-11,2017-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85165 - Class II - Biologics - Bayer HealthCare, LLC","Some vials that were distributed from lots 27118RK & 27119CG were inadvertently  labeled as Kogenate FS actually contain the FVIII hemophilia A treatment, Jivi antihemophilic factor (recombinant) PEGylated-auci 3000 IU.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43372 - Class II - Biologics - Baylor University Medical Center - Transfusion Service Center,"Blood product, labeled with an incorrect expiration date, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86280 - Class II - Drugs - BAYSHORE PHARMACEUTICALS,CGMP Deviations,2020-08-25,2020-08-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75318 - Class II - Biologics - Baystate Medical Center, Inc.","Red blood cell that did not meet acceptable product specifications, was distributed.",2016-10-26,2016-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64632 - Class III - Biologics - BD Biosciences, Systems & Reagents","Certain lots of HLA-B27 FITC/CD3 PE reagent contained in the HLA-B27 kit, contaminated with CD4 PE, were distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65466 - Class II - Biologics - BD Biosciences, Systems & Reagents","BD Stem cells controls, not functioning as intended, were distributed.",2013-06-26,2013-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65876 - Class II - Drugs - Beacon Hill Medical Pharmacy, P.C.","Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance, Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance.",2013-09-10,2013-09-10,86,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89918 - Class II - Drugs - Beak & Skiff Cider Mill, Inc.",CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.,2022-04-14,2022-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85784 - Class II - Drugs - Beaming White Llc,Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.,2020-06-26,2020-06-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65130 - Class I - Drugs - Beamonstar Products,"Marketed Without an Approved NDA/ANDA; products have been found to contain tadalafil, the active ingredient in an FDA approved product used to treat erectile dysfunction, making this product an unapproved drug",2013-09-05,2013-09-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80963 - Class II - Drugs - Beaumont Bio-med, Inc.",CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.,2018-09-17,2018-09-17,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77616 - Class III - Biologics - Beckman Coulter Inc.,"Beckman Coulter's PK7300, associated with a defect or glitch with the dispensing monitoring board, was distributed.",2017-07-24,2017-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78124 - Class II - Drugs - Becton Dickinson & Company,"Labeling; Label Mixup; the immediate package is labeled incorrectly as Chloroprep Onestep (Clear), however, the correct label should be Chloroprep with Tint (Hi Lite Orange)",2017-10-23,2017-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72233 - Class II - Drugs - Bedford Pharmacy,Lack of assurance of sterility,2015-10-15,2015-10-15,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71187 - Class I - Drugs - Bee Extremely Amazed LLC,"Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, and phenolphthalein, an ingredient found in over-the-counter laxative products that was withdrawn from the US market due to concerns of carcinogenicity, making it an unapproved drug., Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared sibutramine, an appetite suppressant that was withdrawn from the US market for safety reasons, making it an unapproved drug., Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with undeclared fluoxetine, an FDA approved drug used to treat depression, anxiety, panic attacks, obsessive-compulsive disorder, or bulimia and phenolphthalein, an ingredient found in over-the-counter laxative p",2016-07-06,2016-07-06,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73167 - Class I - Drugs - Bee Xtreme,Marketed without an Approved NDA/ANDA; FDA analysis found them to contain sibutramine and phenolphthalein,2016-10-12,2016-10-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88770 - Class I - Drugs - Beiersdorf Inc,"Chemical contamination; presence of benzene, cGMP Deviations",2021-10-15,2021-10-15,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74138 - Class II - Drugs - Beiersdorf Manufacturing, LLC",Labeling; Product Contains Undeclared API (Oxybenzone),2016-06-09,2016-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79327 - Class I - Drugs - Bella All Natural,"Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.",2018-03-13,2018-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77959 - Class II - Drugs - Bella Pharmaceuticals, Inc.",Lack of Assurance of Sterility.,2017-09-12,2017-09-12,16,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40631 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor with a history of living in an HIV-O risk area, were distributed.",2012-07-03,2012-07-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38681 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, negative for the Fyb-antigen but typed as Fyb-antigen positive, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38689 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-07-13,2012-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42718 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-07-13,2012-07-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45130 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-07-13,2012-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47198 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-07-13,2012-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50403 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor with a history of Hepatitis A, were distributed.",2012-07-13,2012-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63013 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, which were collected from a donor who gave history which warranted deferral or follow up, were distributed.",2012-10-01,2012-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63638 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, which was collected from a donor who had lived in a malarial endemic area, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67110 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, with insufficient red cell preservative solution added, was distributed.",2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67745 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2014-04-11,2014-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68945 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, which were out of controlled storage for 30 minutes during irradiation, were distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68921 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, collected from a donor who received a tattoo within 12 months of donation, was distributed.",2014-08-22,2014-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69041 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from donors who lived in a malarial endemic area, were  distributed.",2014-09-23,2014-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69218 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, incorrectly labeled as negative for the cytomegalovirus (CMV), were distributed.",2014-10-06,2014-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69287 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, for which donor suitability was not fully determined, was distributed.",2014-10-20,2014-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69502 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, for which routine testing was not  documented, were distributed.",2014-10-28,2014-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69776 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Plateletpheresis products, with low platelet counts, were distributed.",2014-12-17,2014-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69925 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, in which expiration time was missing from final label, was distributed.",2015-01-05,2015-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71545 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71770 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2015-08-20,2015-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74200 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, collected from a donor who did not meet eligibility criteria, was distributed.",2016-06-07,2016-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74432 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, for which donor suitability was inadequately determined, was distributed.",2016-06-28,2016-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75084 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, in which labels applied to blood unit or product incorrect or missing information were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75298 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from donors who lived in  malarial endemic areas, were distributed.",2016-10-11,2016-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75325 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, collected from a donor whose donor suitability was not adequately determined, was distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75438 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed., Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed",2016-11-01,2016-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75436 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor considered to be at increased risk for Zika virus, were distributed.",2016-11-14,2016-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75815 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, manufactured without additive solution, was distributed.",2016-12-14,2016-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76759 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, tested incorrectly for relevant Transfusion-Transmitted Infections, were distributed.",2017-03-29,2017-03-29,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76776 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, associated with incorrectly performed testing for relevant Transfusion-Transmitted Infections, were distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76814 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2017-05-09,2017-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77020 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, in which quality control and distribution of product that did not meet specifications, was distributed.",2017-05-15,2017-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77885 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected from a donor who lived in a malarial endemic area, were distributed.",2017-08-24,2017-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78202 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, for which donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2017-10-19,2017-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78361 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Apheresis platelet products, collected from a donor whose donor deferral was missing or incorrectly identified, were distributed.",2017-11-01,2017-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78245 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, which was collected from a donor in which donor screening and/or record incomplete or incorrect, was distributed.",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78580 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, for which the donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78625 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected in a manner that may have  compromise sterility,  were distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78874 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood product, collected in a manner that may have compromised the sterility of the collection system, was distributed.",2018-02-07,2018-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79869 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected in defective collection bags, were distributed.
",2018-04-30,2018-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80345 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected in bags lacking assurance of sterility, were distributed.",2018-07-11,2018-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80348 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, collected in bags lacking assurance of sterility, were distributed.",2018-07-11,2018-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80988 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81422 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, not meeting product specifications, were distributed.",2018-10-26,2018-10-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82671 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, where donor testing was incorrectly performed for evidence of infection due to a relevant transfusion-transmitted infection and were distributed.",2019-04-23,2019-04-23,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82700 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Platelet product, in which platelet yield did not meet specifications, was distributed.
",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83011 - Class III - Biologics - Belle Bonfils Memorial Blood Center,"Misbranded plateletpheresis products were distributed.
",2019-07-12,2019-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83034 - Class II - Biologics - Belle Bonfils Memorial Blood Center,"Blood products, which did not meet acceptable product specifications, were distributed.",2019-07-15,2019-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83231 - Class I - Biologics - Bellus Medical,"Two lots of Bellus Medical PRP ProGen Advantage 15mL and 30mL tubes, lacking sterility, were distributed.",2019-09-23,2019-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81362 - Class III - Biologics - Belmont Instrument Corporation,"Belmont Instrument Corporation's buddy Disposable sets (Part No, 905-00010(P), not meeting release criteria, were distributed.",2018-11-16,2018-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64109 - Class III - Drugs - Belmora LLC,Defective Container: Product lacks tamper evident breakaway band on cap.,2013-01-24,2013-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61802 - Class II - Drugs - Ben Venue Laboratories Inc,Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.,2012-06-14,2012-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62422 - Class I - Drugs - Ben Venue Laboratories Inc,Presence of Particulate Matter,2012-09-26,2012-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62490 - Class II - Drugs - Ben Venue Laboratories Inc,Presence of Particulate Matter: visible crystalline particulates and the discovery of crystalline particulate in a retain sample.,2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67512 - Class I - Drugs - Ben Venue Laboratories Inc,"Presence of Particulate Matter: During a review of retain samples, the firm found a glass particulate in one lot of Acetylcysteine Solution",2014-05-19,2014-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68800 - Class II - Drugs - Ben Venue Laboratories Inc,Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.,2014-08-18,2014-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64140 - Class III - Biologics - Bergen Comm Reg Blood Center,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64067 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood product, which did not meet acceptable product specifications, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67201 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood product, collected from a donor who had previously been deferred, was distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68540 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood product, which did not meet the acceptable product specification, was distributed.",2014-07-18,2014-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72128 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72329 - Class II - Biologics - Bergen Comm Reg Blood Center,"Red Blood Cells, collected from a donor who confirmed positive for syphilis, was distributed.",2015-11-04,2015-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73322 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2016-03-31,2016-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73565 - Class III - Biologics - Bergen Comm Reg Blood Center,"Platelet product, which reached an unacceptable temperature during shipment, was distributed.",2016-04-08,2016-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75377 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood products, collected with 5% dextrose instead of 0.9% saline, were distributed.",2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76532 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood product, collected from a donor who had taken aspirin, was distributed.",2017-03-16,2017-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77680 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood product, collected from an ineligible donor, was distributed.",2017-08-11,2017-08-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78205 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood products, untested but labeled as negative for Zika virus, were distributed.",2017-10-19,2017-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78337 - Class II - Biologics - Bergen Comm Reg Blood Center,"Platelet product, in which component preparation was not prepared in accordance with specifications, was distributed.",2017-10-31,2017-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78857 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood product, collected from a donor who lived in a malarial endemic area, was distributed.
",2018-01-23,2018-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81669 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood product, not meeting product specifications, was distributed.",2018-12-17,2018-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82149 - Class III - Biologics - Bergen Comm Reg Blood Center,Misbranded red blood cells were distributed.,2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83308 - Class II - Biologics - Bergen Comm Reg Blood Center,Misbranded Leukoreduced Red Blood Cells were distributed.,2019-08-15,2019-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83717 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2019-09-13,2019-09-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84932 - Class III - Biologics - Bergen Comm Reg Blood Center,"Plateletpheresis products for which monthly quality control for platelet yield testing was not performed, were distributed.
",2020-02-18,2020-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86030 - Class II - Biologics - Bergen Comm Reg Blood Center,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2020-08-07,2020-08-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86730 - Class II - Biologics - Bergen Comm Reg Blood Center,"Platelet products, collected from donors who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89351 - Class II - Biologics - Bergen Comm Reg Blood Center,"Platelets, Pathogen Reduced, inappropriately prepared by recording the incorrect volume on label, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89802 - Class I - Drugs - Best Brands Consumer Products, Inc.","Chemical Contamination; FDA analysis found product to contain methanol, Chemical Contamination; FDA analysis found product to contain benzene",2022-05-17,2022-05-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90124 - Class III - Drugs - Bestco LLC,Subpotent drug: Low OOS for menthol content at the three month room temperature.,2022-05-18,2022-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72069 - Class III - Drugs - Bestco, Inc.",Presence of Foreign Tablets/Capsules: Presence of comingled Sugar Free Honey Lemon cough drops.,2015-09-09,2015-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77768 - Class I - Drugs - BESTHERBS COFFEE LLC,Marketed without an approved NDA/ANDA: presence of undeclared desmethyl carbodenafil and undeclared milk.,2017-09-12,2017-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67155 - Class II - Drugs - Betachem, Inc.",CGMP Deviations: The Active Pharmaceutical Ingredient was not manufactured according to current good manufacturing practices.,2014-01-10,2014-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64122 - Class II - Biologics - Beth Israel Medical Center, The Ralph Gore Blood Bank","Blood product, labeled as leukoreduced, but which had not undergone leukoreduction, was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65441 - Class I - Drugs - Bethel Nutritional Consulting, Inc","Marketed Without An Approved NDA/ANDA: FDA analysis found this product contained undeclared sibutramine and phenolphthalein, two active ingredients that were once marketed in the U.S. but removed due to safety reasons, making this product an unapproved new drug.
",2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65894 - Class I - Drugs - Bethel Nutritional Consulting, Inc","Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine, N-Desmethylsibutramine and phenolphthalein. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs., Marketed Without An Approved NDA/ANDA: FDA analyses detected the presence of phenolphthalein, N-di-Desmethylsibutramine, and trace amounts of sibutramine and N-Desmethylsibutramine. Sibutramine and phenolphthalein were previously available drug products but were removed from the U.S. market making these products unapproved new drugs.",2013-12-18,2013-12-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70096 - Class II - Drugs - Bethel Nutritional Consulting, Inc","Marketed without an Approved NDA/ANDA; found to contain Lorcaserin, a controlled substance used for weight loss",2015-03-24,2015-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70089 - Class I - Drugs - Bethel Nutritional Consulting, Inc","Marketed Without An Approved NDA/ANDA: Product was found to contain sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling and analysis.",2015-07-06,2015-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85726 - Class II - Drugs - Bingbing Pharmaceutical (Hubei) Co., Ltd","CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.",2020-05-28,2020-05-28,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75507 - Class III - Biologics - Bio-Blood Components Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-12-02,2016-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42916 - Class III - Biologics - Bio-Blood Components, Inc.","Blood product, which tested initially reactive for the hepatitis C virus, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44296 - Class III - Biologics - Bio-Blood Components, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64098 - Class III - Biologics - Bio-Blood Components, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64301 - Class III - Biologics - Bio-Blood Components, Inc.","Blood products, collected from a donor who was listed as a permanent deferral, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64414 - Class II - Biologics - Bio-Blood Components, Inc.","Blood product, collected from a donor who was suspected of receiving a piercing within 12 months of donating, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53064 - Class II - Biologics - Bio-Medics,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68847 - Class II - Drugs - Bio-pharm, Inc.","Superpotent Drug: Bio-Pharm, Inc. is initiating a recall of one lot of Acetaminophen Oral Suspension Liquid 160mg/5mL failure of the product assay at the 6 month timepoint.",2014-10-17,2014-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72819 - Class III - Drugs - Bio-pharm, Inc.",Failed Impurities/Degradation Specifications: Product recalled due to elevated impurity result detected during routine stability testing.,2016-04-01,2016-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63609 - Class III - Biologics - Bio-Rad Laboratories,"Bio-Rad Multispot HIV-1/HIV-2 Rapid Test, with reports of decreased reactivity accompanied by a faint speckling appearance on cartridge membrances when using some vials of Conjugate, were distributed.",2012-11-13,2012-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83375 - Class II - Biologics - Bio-Rad Laboratories, Inc","Bio-Rad Laboratories IH-LISS Racks (for use on automated IH-1000 analyzers) that may contain reduced LISS-solution volume in some wells resulting in RBC suspensions outside of specified ranges for testing, were distributed.",2019-08-02,2019-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74933 - Class III - Biologics - Bio-Rad Laboratories, Inc.","TANGO Infinity System, with a defect or glitch allowing an  incorrect microplate type, was distributed.",2016-09-01,2016-09-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87509 - Class II - Biologics - Bio-Rad Laboratories, Inc.","Reagent red blood cells, demonstrating unexpected false positive or false negative results were discovered to be outside of specifications, were distributed.",2021-03-29,2021-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64490 - Class II - Biologics - Bio-Rad Medical Diagnostics GmbH,"Biotest reagent A1 red blood cell, with higher than expected cell concentration, was distributed.",2013-03-14,2013-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65124 - Class III - Biologics - Bio-Rad Medical Diagnostics GmbH,"Seraclone Anti-S, with a decreased reactivity in two lots numbers, was distributed.",2013-05-16,2013-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66022 - Class III - Biologics - Bio-Rad Medical Diagnostics GmbH,"Seraclone Anti-S with a reactivity decrease after approximately 12 months, was distributed.",2013-10-01,2013-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68716 - Class III - Biologics - Bio-Rad Medical Diagnostics GmbH,Misbranded reagent red blood cells were distributed.,2014-07-16,2014-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71747 - Class III - Biologics - Bio-Rad Medical Diagnostics GmbH,"Anti-D Blend Solidscreen II, containg a weak reacting contaminating anitbody, was distributed.",2015-07-27,2015-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86301 - Class III - Biologics - Bio-Rad Medical Diagnostics GmbH,"Reagent Red Blood Cells Instructions for Use (IFU) containing a typographical error in the ""Interpretation of Results"" table, was distributed.",2020-08-24,2020-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68059 - Class III - Biologics - Bio-Save Resources Of Albuquerque LLC,"Blood products, collected from a donor with no arm inspection, were distributed.",2014-06-02,2014-06-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79384 - Class III - Biologics - BioArray Solutions, Ltd.","PreciseType HEA BeadChip Kits, associated with a defect or glitch in the software, were distributed.",2018-03-15,2018-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81501 - Class III - Biologics - BioArray Solutions, Ltd.","HEA Precise Type BeadChip Kit (IVD) which may be impacted by sporadic, decreased activity of the Clean-up Reagent contained within the kits, was distributed.",2018-11-14,2018-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89693 - Class II - Biologics - BioArray Solutions, Ltd.","PreciseType Human Erythrocytes Antigen Molecular BeadChip Tests, demonstrating increased occurrence of false negative results, were distributed.",2022-03-24,2022-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71576 - Class III - Drugs - BioComp Pharma, Inc.",Subpotent Drug: menthol and methyl salicylate below specification,2015-07-09,2015-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75253 - Class III - Drugs - Biocompatibles U.K., Ltd.",Defective Delivery System: Incorrect type of syringe found in commercially distributed administration pack,2016-10-03,2016-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73699 - Class III - Drugs - Biocon Inc,Subpotent Drug,2016-04-08,2016-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91577 - Class II - Drugs - BIOCON PHARMA INC,Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.,2023-02-14,2023-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80277 - Class II - Drugs - BioDiagnostic International,CGMP Deviations: Products not manufactured under current good manufacturing practices.,2018-06-14,2018-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85906 - Class III - Drugs - Biogen MA Inc.,cGMP deviations: one lot of the product was distributed to US Markets despite being rejected during in-process control.,2020-07-09,2020-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86945 - Class II - Drugs - Biogen MA Inc.,Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.,2020-12-14,2020-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90190 - Class II - Biologics - BioLab Sciences, Inc.","Amniotic Fluid, processed in a manner that could cause contamination or cross-contamination during processing, was distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49222 - Class II - Biologics - BioLife Plasma Service, LP","Blood products which tested negative for all viral markers, were collected from a donor who subsequently tested positive for hepatitis C (HCV) by NAT.",2013-07-09,2013-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71579 - Class II - Biologics - Biolife Plasma Services,"Blood product, collected from a donor with a history of incarceration, was distributed.",2015-08-05,2015-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72624 - Class II - Biologics - Biolife Plasma Services,"Blood products, collected from a donor considered to be at risk for variant Creutzfeldt- Jacob Disease (vCJD), were distributed.",2015-12-03,2015-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81372 - Class III - Biologics - BioLife Plasma Services,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.

",2018-10-30,2018-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83080 - Class II - Biologics - BioLife Plasma Services,"Source Plasma, collected from a donor who received a tattoo within one year of donation, was distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72694 - Class II - Biologics - BioLife Plasma Services L. P.,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81335 - Class III - Biologics - BioLife Plasma Services L. P.,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
.",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79941 - Class III - Biologics - Biolife Plasma Services L.P.,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-06-05,2018-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81498 - Class III - Biologics - Biolife Plasma Services L.P.,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56083 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49692 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39452 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who was subsequently deferred after testing positive for anti-HCV, were distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40080 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, which was not quarantined subsequent to receiving post donation information, was distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40644 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who received body piercing within 12 months of donation, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48841 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-10-10,2012-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48843 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-10,2012-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42632 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who had been incarcerated, were distributed.",2012-10-12,2012-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44635 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, collected from a donor who received a mumps, measles , rubella (MMR) vaccination, was distributed",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47971 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were collected from a donor in which donor suitability were not adequately determined, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48247 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, which were collected from a donor in which donor suitability were not adequately determined, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49304 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40495 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48840 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49612 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, for which the sterility may have been compromised during collection, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50285 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45721 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, identified as unsuitable due to a donor screening deviation, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50434 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, collected from a donor who did not have a  required  physical examination, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39138 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were collected from a donor with a history of high risk behaviors, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41343 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who received body piercing's, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44158 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43350 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were collected from a donor with a history of multiple high risk behaviors, were distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50588 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were collected from a donor with a history of multiple high risk behaviors, were distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38822 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59131 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from  donors  with incomplete physical examination, were distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61380 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43051 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from donors whose donor suitability was not adequately determined, were distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40646 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who received a piercing within 12 months of the donation, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48914 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who was not asked vCJD travel questions, was distributed.",2013-02-26,2013-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42204 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40977 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were not quarantined after receiving post donation information concerning prior incarceration, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52267 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor whose record was incomplete, were distributed.",2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39660 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who was permanently deferred after testing reactive for Hepatitis B surface antigen (HbSAg), were distributed.",2013-04-03,2013-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55584 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57060 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who received tattoos within 12 months of donation, were distributed",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58781 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor with a history of brain surgery, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41619 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, collected from a donor who was previously HIV-1/2 reactive, was distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43768 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, which tested negative for viral markers, but was collected from a donor who subsequently tested positive for hepatitis B surface antigen (HBsAg), was distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39199 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were not quarantined subsequent to receiving information regarding a post donation information related to vCJD risk, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41626 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, which was not quarantined after receiving information regarding the donor's contact with a person who tested reactive for HBsAg, was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42701 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were not quarantined after receiving information regarding a risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39200 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, collected from a donor who reported post donation information regarding IV drug use, was distributed.",2013-06-17,2013-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48525 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation information, was distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48723 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, which were not quarantined subsequent to receiving information regarding  post donation information, were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65313 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, collected from a donor who was allowed to donate without a current physical, was distributed.     
 
",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47332 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, which were collected from a donor with a history of high risk behaviors, were distributed.",2013-07-23,2013-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45180 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who was previously HIV-1/2 reactive, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48373 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor with a history of hepatitis and fatty liver disease, were distributed.",2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59253 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from donors who may not have had a complete physical examination, were distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55743 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from donors who did not have a complete physical examination, were distributed.",2013-09-16,2013-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40686 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, which were not quarantined after receiving information regarding the suitability of the donors, were distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40717 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood product, which was not quarantined after receiving information regarding the donor's history of incarceration, was distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41939 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who received a MMR vaccine prior to donation, were distributed.",2013-11-14,2013-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68478 - Class II - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from ineligible donors, were distributed.",2014-09-18,2014-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70588 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor who had been incarcerated, were distributed.",2015-04-09,2015-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #51463 - Class II - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from donors who did not receive a complete physical examination, were distributed.",2015-05-27,2015-05-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81255 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from an ineligible donor, were distributed.",2018-10-22,2018-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81231 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.
",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81360 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from an ineligible donor, was distributed.",2018-10-26,2018-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81358 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-10-30,2018-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81204 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81469 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from an ineligible donor, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81470 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from an ineligible donor, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81423 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-11-13,2018-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81424 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-11-13,2018-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81496 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81497 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81584 - Class II - Biologics - BioLife Plasma Services L.P.,"Source Plasma, collected from an ineligible donor, was distributed.",2018-11-21,2018-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81792 - Class III - Biologics - BioLife Plasma Services L.P.,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-02-01,2019-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82340 - Class II - Biologics - BioLife Plasma Services L.P.,"Source Plasma units, not meeting product specifications, were distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82381 - Class III - Biologics - BioLife Plasma Services L.P.,"Source plasma products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82689 - Class III - Biologics - BioLife Plasma Services L.P.,"Source plasma products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83079 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma units, for which donor eligibility screening was incorrectly performed, were distributed.",2019-07-30,2019-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86142 - Class III - Biologics - BioLife Plasma Services L.P.,"Source Plasma, for which donor eligibility was incomplete, were distributed.
",2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83140 - Class III - Biologics - BioLife Plasma Services L.PL,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-25,2019-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42262 - Class II - Biologics - BioLife Plasma Services LP,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-09-20,2012-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49181 - Class III - Biologics - BioLife Plasma Services LP,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49760 - Class III - Biologics - BioLife Plasma Services LP,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39738 - Class II - Biologics - BioLife Plasma Services LP,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52245 - Class II - Biologics - BioLife Plasma Services LP,"Blood products, collected from a donor with a history of Hepatitis A, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50675 - Class II - Biologics - BioLife Plasma Services LP,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53640 - Class II - Biologics - BioLife Plasma Services LP,"Blood products, which were collected from a donor who had received a ear piercing within 12 months of the donation, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69882 - Class III - Biologics - BioLife Plasma Services LP,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-12-23,2014-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80338 - Class II - Biologics - BioLife Plasma Services LP,"Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed
",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81359 - Class III - Biologics - BioLife Plasma Services LP,"Source Plasma, collected from an ineligible donor, was distributed.",2018-10-26,2018-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81373 - Class III - Biologics - BioLife Plasma Services LP,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.

",2018-10-30,2018-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81253 - Class III - Biologics - BioLife Plasma Services LP,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81254 - Class III - Biologics - BioLife Plasma Services LP,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81275 - Class III - Biologics - BioLife Plasma Services LP,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81329 - Class III - Biologics - BioLife Plasma Services LP,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
.",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81435 - Class III - Biologics - BioLife Plasma Services LP,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-11-13,2018-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83770 - Class II - Biologics - BioLife Plasma Services LP,"Source Plasma, collected from an ineligible donor, was distributed.",2019-09-11,2019-09-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85027 - Class III - Biologics - BioLife Plasma Services LP,"Source Plasma units, collected from a donor for whom donor eligibility was incomplete, were distributed.

",2020-03-05,2020-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75346 - Class III - Biologics - BioLife Plasma Services, L.P","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76267 - Class II - Biologics - Biolife Plasma Services, L.P.","Source Plasma, collected from an ineligible donor, was distributed.",2017-01-26,2017-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63565 - Class II - Biologics - BioLife Plasma Services, L.P.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63568 - Class II - Biologics - BioLife Plasma Services, L.P.","Blood product, collected from a donor who did not have a complete physical examination, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65939 - Class II - Biologics - BioLife Plasma Services, L.P.","Blood product, which was not quarantined subsequent to receiving post donation information, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69475 - Class III - Biologics - BioLife Plasma Services, L.P.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69991 - Class II - Biologics - BioLife Plasma Services, L.P.","Blood product, collected from a donor with a history of incarceration, was distributed.",2015-01-26,2015-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78916 - Class III - Biologics - BioLife Plasma Services, L.P.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-01-24,2018-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80825 - Class III - Biologics - BioLife Plasma Services, L.P.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-08-22,2018-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81336 - Class III - Biologics - BioLife Plasma Services, L.P.","Blood products, collected from an ineligible donor, were distributed.",2018-10-22,2018-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81252 - Class III - Biologics - BioLife Plasma Services, L.P.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81263 - Class III - Biologics - BioLife Plasma Services, L.P.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81327 - Class III - Biologics - BioLife Plasma Services, L.P.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
.",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81494 - Class III - Biologics - BioLife Plasma Services, L.P.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83627 - Class III - Biologics - BioLife Plasma Services, L.P.","Blood product, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84036 - Class III - Biologics - BioLife Plasma Services, L.P.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-10-25,2019-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85437 - Class III - Biologics - BioLife Plasma Services, L.P.","Blood products, for which donor eligibility screening was incomplete, were distributed.",2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62668 - Class II - Biologics - BioLife Plasma Services, LP","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68087 - Class II - Biologics - BioLife Plasma Services, LP","Blood products, collected from a donor whose physical examination was incomplete, were distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77326 - Class II - Biologics - Biological Specialty Corp,"Blood products, collected from ineligible donors, were distributed.",2017-05-25,2017-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81011 - Class II - Drugs - BioLyte Laboratories, LLC","CGMP Deviations: finished product produced with active ingredients recalled by the manufacturer, King Bio Inc., due to water contamination issues that could potentially affect the quality of this product.",2018-10-01,2018-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67554 - Class III - Biologics - Biomat USA Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73893 - Class III - Biologics - Biomat USA Inc,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64362 - Class II - Biologics - Biomat USA, Inc","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53764 - Class II - Biologics - Biomat USA, Inc",Donor Screening/Donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked,2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67338 - Class II - Biologics - Biomat USA, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69210 - Class II - Biologics - Biomat USA, Inc","Blood products, collected from a donor who was previously deferred by another donor center, were distributed.",2014-10-20,2014-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40880 - Class III - Biologics - Biomat USA, Inc.","Blood products collected from a donor who was permanently deferred for unsuitable test results, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61887 - Class III - Biologics - Biomat USA, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40693 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41043 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39858 - Class III - Biologics - Biomat USA, Inc.","Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63376 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63377 - Class II - Biologics - Biomat USA, Inc.","Blood product, collected from a deferred donor due to risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53059 - Class II - Biologics - Biomat USA, Inc.","Blood products, which were not quarantined subsequent to receiving information regarding high risk behavior, were distributed.",2012-11-06,2012-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41848 - Class III - Biologics - Biomat USA, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41850 - Class III - Biologics - Biomat USA, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41852 - Class III - Biologics - Biomat USA, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41854 - Class III - Biologics - Biomat USA, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42599 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who received a piercing within one year of donation, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42601 - Class II - Biologics - Biomat USA, Inc.","Blood product, collected from a donor who received a piercing within one year of donation, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42750 - Class II - Biologics - Biomat USA, Inc.","Blood product, collected from a donor who received a piercing within one year of donation, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49158 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50250 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53065 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor with a history of incarceration, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48953 - Class III - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #57284 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #51366 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53422 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who had been incarcerated, were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #58204 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who was in close contact with an individual diagnosed with viral hepatitis, were distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50246 - Class II - Biologics - Biomat USA, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40040 - Class III - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40045 - Class III - Biologics - Biomat USA, Inc.","Blood products, which were collected from a donor with a history of living with someone who is HIV positive, were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65312 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40401 - Class III - Biologics - Biomat USA, Inc.","Blood products, collected from a donor whose suitability to donate were not adequately determined, were distributed.",2013-07-12,2013-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41493 - Class III - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who were previously deferred, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39546 - Class III - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who was deferred for unknown reasons, were distributed.
",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42482 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed.",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65789 - Class II - Biologics - Biomat USA, Inc.","Blood product, collected from a donor who received a tattoo within 12 months of donation, was distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53423 - Class II - Biologics - Biomat USA, Inc.","Blood products, collected from a donor who reported receiving a body piercing within 12 months of donating, were distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71801 - Class II - Biologics - Biomat USA, Inc.","Source Plasma, collected from an inelgible donor, was distributed.",2015-08-21,2015-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73805 - Class II - Biologics - Biomat USA, Inc.","Blood product, collected from a donor who was previously deferred, was distributed.",2016-04-28,2016-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73963 - Class III - Biologics - Biomat USA, Inc.",Misbranded Source Plasma was distributed.,2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73932 - Class III - Biologics - Biomat USA, Inc.","Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2016-06-02,2016-06-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81250 - Class II - Biologics - Biomat USA, Inc.","Blood product, collected from a donor who was incarcerated within twelve months of donation, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83356 - Class II - Drugs - Bionpharma Inc.,Microbial Contamination of Non-Sterile Products: Out-of-specification results for Microbial Enumeration Tests USP <61> was observed.,2019-07-25,2019-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85706 - Class II - Drugs - BIOTA Biosciences LLC,Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin,2020-06-19,2020-06-19,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86057 - Class III - Biologics - Biotest Biopharmaceuticals Corp.,"Source Plasma,  for which donor eligibility was incomplete, was distributed.
",2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86059 - Class III - Biologics - Biotest Biopharmaceuticals Corp.,"Source Plasma,  for which donor eligibility was incomplete, was distributed.
",2020-08-03,2020-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86093 - Class III - Biologics - Biotest Biopharmaceuticals Corp.,"Source Plasma, for which donor eligibility screening was incomplete, were distributed.",2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73300 - Class II - Biologics - Biotest Pharmaceuticals,"Source plasma product, in quarantine pending post donation investigation regarding prior incarceration, was distributed.",2016-03-24,2016-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75135 - Class II - Biologics - Biotest Pharmaceuticals,"Blood product,s collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75299 - Class II - Biologics - Biotest Pharmaceuticals,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-10-11,2016-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86058 - Class III - Biologics - Biotest Pharmaceuticals,"Source Plasma, for which donor eligibility was incomplete, was distributed.",2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69216 - Class II - Biologics - Biotest Pharmaceuticals Corp.,"Blood products, collected from a donor who was previously deferred, were distributed.",2014-10-20,2014-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70420 - Class II - Biologics - Biotest Pharmaceuticals Corp.,"Various lots of BIVIGAM (Immune Globulin Intravenous (Human), 10% Liquid), 100 mL vial, with a potential for a very small percentage of the vials to exhibit a vial integrity defect, were distributed.",2015-03-09,2015-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76711 - Class III - Biologics - Biotest Pharmaceuticals Corp.,"Misbranded BIVIGAM [Immune Globulin Intravenous (Human), 10% Liquid)] lacking required safety information, was distributed.",2017-04-18,2017-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59336 - Class II - Biologics - Biotest Pharmaceuticals Corporation,"Blood products, which were not quarantined subsequent to receiving disqualifying post donation information, were distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58782 - Class II - Biologics - Biotest Pharmaceuticals Corporation,"Blood products, collected from a donor who did not have a physical examination, were distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65076 - Class II - Biologics - Biotest Pharmaceuticals Corporation,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84802 - Class II - Biologics - Biotest Pharmaceuticals Corporation,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed",2020-02-28,2020-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86148 - Class III - Biologics - Biotest Pharmaceuticals Corporation,"Source Plasma, for which donor eligibility was incomplete, was distributed.
",2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86092 - Class III - Biologics - Biotest Pharmaceuticals Corporation,"Source Plasma, for which donor eligibility screening was incomplete, were distributed.",2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86221 - Class III - Biologics - Biotest Pharmaceuticals Corporation,"Source Plasma,  for which donor eligibility was incomplete, was distributed.
",2020-08-24,2020-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86222 - Class III - Biologics - Biotest Pharmaceuticals Corporation,"Source Plasma,  for which donor eligibility was incomplete, was distributed.
",2020-08-24,2020-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86133 - Class III - Biologics - Biotest Pharmaceuticals Corporation,"Source Plasma, for which donor eligibility screening was incomplete, were distributed.",2020-08-26,2020-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87630 - Class II - Drugs - Bit & Bet LLC,Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.,2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89481 - Class I - Drugs - Blaine Labs Inc,Microbial Contamination of Non-sterile Product; FDA analysis found the product to be contaminated with Bacillus cereus.,2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71331 - Class II - Drugs - Blenheim Pharmacal, Inc.","cGMP Deviations; products being recalled in response to a recall notice from the manufacturer, Wockhardt Limited, following a FDA inspection which noted inadequate investigation of market complaints, resulting in unsuccessful identification of root causes, and the investigation not being expanded to prevent repeat failure",2015-05-28,2015-05-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53061 - Class III - Biologics - Blood and Plasma Research, Inc.","Quality Control and Distribution/Testing not performed, incompletely performed, or not documented for:",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61905 - Class II - Biologics - Blood Assurance Inc,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2012-06-12,2012-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61904 - Class II - Biologics - Blood Assurance Inc,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-06-22,2012-06-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61992 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-06-28,2012-06-28,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61993 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61994 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-06-28,2012-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62354 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-07-25,2012-07-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62584 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 

",2012-07-25,2012-07-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62507 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-08-14,2012-08-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62544 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-08-14,2012-08-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62740 - Class II - Biologics - Blood Assurance Inc,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-27,2012-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62741 - Class II - Biologics - Blood Assurance Inc,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-27,2012-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62743 - Class II - Biologics - Blood Assurance Inc,"Blood products, which were collected from  a donor in which donor suitability was not adequately determined, were distributed, -",2012-08-27,2012-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62933 - Class III - Biologics - Blood Assurance Inc,"Blood product, collected using expired cryo blood collection bag was distributed.",2012-09-20,2012-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63567 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-11-26,2012-11-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63570 - Class II - Biologics - Blood Assurance Inc,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-26,2012-11-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63740 - Class II - Biologics - Blood Assurance Inc,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-21,2012-12-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63741 - Class II - Biologics - Blood Assurance Inc,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-21,2012-12-21,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63742 - Class II - Biologics - Blood Assurance Inc,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-21,2012-12-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64022 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-30,2013-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64093 - Class II - Biologics - Blood Assurance Inc,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64095 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64171 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-02-25,2013-02-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64025 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-03-19,2013-03-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64484 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-12,2013-04-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64612 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-04-22,2013-04-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65658 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-08-22,2013-08-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65815 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-08-29,2013-08-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66748 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor considered to be at increased risk for Creutzfeldt-Jakob Disease (CJD), were distributed. 

",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68203 - Class II - Biologics - Blood Assurance Inc,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68084 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-06-03,2014-06-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68366 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68827 - Class II - Biologics - Blood Assurance Inc,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69016 - Class II - Biologics - Blood Assurance Inc,"Plateletpheresis product, lacking product quality control, was distributed.",2014-09-10,2014-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69209 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-10-09,2014-10-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69695 - Class II - Biologics - Blood Assurance Inc,"Platelet product, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70076 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70405 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor who disclosed history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2015-02-19,2015-02-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70228 - Class II - Biologics - Blood Assurance Inc,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-02-25,2015-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70620 - Class II - Biologics - Blood Assurance Inc,"Blood product, which did not meet acceptable product specifications, was distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71223 - Class II - Biologics - Blood Assurance Inc,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71224 - Class II - Biologics - Blood Assurance Inc,"Blood product, collected from a donor with an unacceptable hemoglobin, was distributed.",2015-06-10,2015-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71772 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-08-27,2015-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71900 - Class II - Biologics - Blood Assurance Inc,"Blood product, in which donor gave history which warranted deferral or follow up and was not deferred or follow up questions was not asked, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71901 - Class II - Biologics - Blood Assurance Inc,"Blood product, in which donor gave history which warranted deferral or follow up and was not deferred or follow up questions was not asked, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72124 - Class II - Biologics - Blood Assurance Inc,"Blood product, which did not meet the acceptable product specifications, was distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72193 - Class II - Biologics - Blood Assurance Inc,"Blood product, collected from a donor who disclosed travel history to a malarial endemic area, was distributed.",2015-10-16,2015-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72194 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor who disclosed travel history to a malarial endemic area, were distributed.",2015-10-16,2015-10-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72333 - Class II - Biologics - Blood Assurance Inc,"Blood products, in which quality control for residual WBC count was not performed, was distributed. 

",2015-10-23,2015-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72791 - Class III - Biologics - Blood Assurance Inc,"Apheresis products, for which quality control testing for residual white blood cell count was not performed, were distributed.",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73048 - Class II - Biologics - Blood Assurance Inc,"Blood product collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-02-04,2016-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73517 - Class II - Biologics - Blood Assurance Inc,"Blood products, which did not meet the acceptable product specifications, were distributed.",2016-04-11,2016-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74291 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected in a manner with a potential for air contamination, were distributed.",2016-06-14,2016-06-14,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74175 - Class III - Biologics - Blood Assurance Inc,"Blood products, collected in blood bags that had exceeded the manufacturer's instructions for use, were distributed.",2016-06-22,2016-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74382 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74769 - Class II - Biologics - Blood Assurance Inc,Blood product mislabeled with incorrect Rh antigen type was distributed.,2016-08-05,2016-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74673 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-08-24,2016-08-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75183 - Class III - Biologics - Blood Assurance Inc,"Blood product, collected from a donor whose arm inspection was not adequately documented, was distributed.",2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75803 - Class II - Biologics - Blood Assurance Inc,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2017-01-05,2017-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76139 - Class II - Biologics - Blood Assurance Inc,"Blood product, with a low pH, was distributed.",2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77718 - Class II - Biologics - Blood Assurance Inc,"Blood product, in which quality control and distribution of product did not meet specifications, was distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78294 - Class II - Biologics - Blood Assurance Inc,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78484 - Class II - Biologics - Blood Assurance Inc,"Platelet product, labeled as leukoreduced but failed the WBC quality control testing, was distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78992 - Class II - Biologics - Blood Assurance Inc,"Platelet products, which failed quality control testing for pH, were distributed.",2018-02-22,2018-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79760 - Class II - Biologics - Blood Assurance Inc,"Platelet product, for which labeling contained incorrect  information, was distributed.",2018-04-30,2018-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80216 - Class II - Biologics - Blood Assurance Inc,"Blood products, collected from an ineligible donor, were distributed.",2018-07-12,2018-07-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80777 - Class II - Biologics - Blood Assurance Inc,"Apheresis Products, collected on an apheresis machine with instructions to discard product, were distributed.",2018-08-29,2018-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81714 - Class II - Biologics - Blood Assurance Inc,"Apheresis products, in which platelet yield did not meet specifications, were distributed.",2019-02-07,2019-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82768 - Class III - Biologics - Blood Assurance Inc,"Misbranded plateletpheresis product was distributed.
",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83320 - Class II - Biologics - Blood Assurance Inc,"Plateletpheresis product in which routine testing/testing performed, interpreted, or documented incorrectly, was distributed.
",2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83214 - Class II - Biologics - Blood Assurance Inc,"Plateletpheresis product, not meeting product specifications, was distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86231 - Class III - Biologics - Blood Assurance Inc,"Plateletpheresis products, manufactured using expired blood collection bags, were distributed.",2020-08-24,2020-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86485 - Class II - Biologics - Blood Assurance Inc,"Plateletpheresis product, not meeting product specifications, was distributed.",2020-09-24,2020-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87388 - Class II - Biologics - Blood Assurance Inc,Misbranded Leukoreduced Red Blood Cells were distributed.,2021-03-11,2021-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91683 - Class III - Biologics - Blood Assurance Inc,"Platelets, Pathogen Reduced,  which were not manufactured within the acceptable time frame from collection, were distributed.",2023-02-16,2023-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63796 - Class III - Biologics - Blood Bank Computer Systems, Inc","Blood Bank software, with a defect or glitch, was distributed.",2013-01-09,2013-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63797 - Class II - Biologics - Blood Bank Computer Systems, Inc","Blood Bank software, with a defect or glitch possibly causing mislabeling blood products with a donor's CMV status, was distributed.",2013-01-09,2013-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64560 - Class II - Biologics - Blood Bank Computer Systems, Inc","Blood Bank Software, with a defect or glitch, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64561 - Class II - Biologics - Blood Bank Computer Systems, Inc","Blood Bank Software, with a defect or glitch, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64562 - Class II - Biologics - Blood Bank Computer Systems, Inc","Blood Bank Software with a defect or glitch, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64563 - Class II - Biologics - Blood Bank Computer Systems, Inc","Blood Bank Software, with a defect or glitch, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65463 - Class II - Biologics - Blood Bank Computer Systems, Inc","Blood Bank software Primary Application (Model Numbers 5.4.0.2 and 5.4.1), with a defect or glitch, was distributed.",2013-07-01,2013-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76137 - Class II - Biologics - Blood Bank Computer Systems, Inc","Blood Bank Control System (BBCS) with Primary Application (software version BBCS Primary Application 5.4.3, 5.5; ABO Express 1.0.0, 1.1.0, 1.2.0), with a defect or glitch, was distributed.",2017-01-23,2017-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82736 - Class III - Biologics - Blood Bank Computer Systems, Inc","Blood Bank software, with a defect or glitch, was distributed.",2019-06-07,2019-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86470 - Class II - Biologics - Blood Bank Computer Systems, Inc","Blood Bank software, with a defect or glitch, was distributed.",2020-09-28,2020-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75364 - Class II - Biologics - Blood Bank of Alaska,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-11-14,2016-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82670 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2019-04-29,2019-04-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54939 - Class III - Biologics - Blood Bank of Alaska, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed..",2013-02-12,2013-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64024 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood product, collected from a donor who received a tattoo, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67222 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70004 - Class III - Biologics - Blood Bank of Alaska, Inc.","Blood products, labeled with an incorrect expiration date, were distributed.",2015-01-15,2015-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72143 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-10-26,2015-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72337 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood products, which were not filtered according to specifications, were distributed.",2015-10-28,2015-10-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72621 - Class III - Biologics - Blood Bank of Alaska, Inc.","Blood products, leukodepleted greater than three days after collection, were distributed.",2015-12-07,2015-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72792 - Class III - Biologics - Blood Bank of Alaska, Inc.","Apheresis products, stored at the incorrect temperature, were distributed.",2015-12-17,2015-12-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73758 - Class II - Biologics - Blood Bank of Alaska, Inc.","Misbranded Red Blood Cells were distributed.
",2016-04-25,2016-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73727 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2016-05-02,2016-05-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74292 - Class II - Biologics - Blood Bank of Alaska, Inc.",Low platelet yield pheresis product was distributed.,2016-06-21,2016-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75842 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood products, labeled with an incorrect expiration date, were distributed.",2017-01-05,2017-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77864 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood product, in which donor deferral/donor missing or incorrectly identified on deferral list, was distributed.",2017-08-28,2017-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78061 - Class II - Biologics - Blood Bank of Alaska, Inc.",-,2017-10-13,2017-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78355 - Class III - Biologics - Blood Bank of Alaska, Inc.","Blood product, collected from a donor which warranted deferral or follow up was not deferred or follow up questions were not asked regarding vaccinations, was distributed.",2017-10-31,2017-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78354 - Class III - Biologics - Blood Bank of Alaska, Inc.","Red cell product, for which the donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83013 - Class II - Biologics - Blood Bank of Alaska, Inc.","Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84419 - Class II - Biologics - Blood Bank of Alaska, Inc.",Misbranded Leukoreduced Red Blood Cells were distributed.,2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85791 - Class III - Biologics - Blood Bank of Alaska, Inc.","Red Blood Cell product, not meeting product specifications, was distributed.
",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89215 - Class II - Biologics - Blood Bank of Alaska, Inc.","Misbranded Red Blood Cell product was distributed. 
",2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89475 - Class II - Biologics - Blood Bank of Alaska, Inc.",Misbranded Leukoreduced Red Blood Cells were distributed.,2022-02-04,2022-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89498 - Class II - Biologics - Blood Bank Of Delmarva, a Division of New York Blood Center, Inc.","Plateletpheresis product, for which for pH testing was not performed, was distributed.
",2022-02-09,2022-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63463 - Class II - Biologics - Blood Bank Of Delmarva, Inc","Blood product, labeled with an incorrect expiration date, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63730 - Class II - Biologics - Blood Bank Of Delmarva, Inc","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-31,2012-12-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65526 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood products, which were labeled with incorrect expiration dates, were distributed.",2013-07-23,2013-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68251 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Whole blood, collected in misbranded collection sets, were distributed.",2014-06-23,2014-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68772 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood products, labeled with incorrect expiration dates, were distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74662 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood product, which failed to meet the minimum specifications for red blood cell percent recovery, was distributed.",2016-07-17,2016-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74482 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood product, manufactured without additive solution, was distributed.",2016-08-08,2016-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79545 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood product, manufactured without the entire quantity of additive solution, was distributed.",2018-04-27,2018-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80335 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood products, in which Transfusion-Transmitted Infection testing was performed, interpreted, and/or documented incorrectly, were distributed.",2018-07-17,2018-07-17,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80439 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood product, for which a unit received inadequate additive solution, was distributed.
",2018-07-24,2018-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80381 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood product, manufactured with insufficient additive solution, was distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81803 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Blood product, manufactured without the entire quantity of additive solution, was distributed.",2019-02-01,2019-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82083 - Class II - Biologics - Blood Bank Of Delmarva, Inc","Blood product, which did not meet the acceptable product specifications, was distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82908 - Class III - Biologics - Blood Bank Of Delmarva, Inc","Irradiated platelet product, labeled with a volume significantly lower than the product's actual volume, was distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61906 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor taking the medication Finasteride, were distributed.",2012-06-12,2012-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63563 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64552 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66851 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66799 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-12-20,2013-12-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67449 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67651 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-03-27,2014-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68212 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor who was taking the medication Proscar, were distributed.",2014-06-17,2014-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68365 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68409 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor whose health history was not adequately performed, was distributed.",2014-06-26,2014-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68436 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-07-16,2014-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68629 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69530 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor whose travel history was not complete, was distributed.",2014-11-14,2014-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70189 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-02-09,2015-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70192 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2015-02-09,2015-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70745 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-04-02,2015-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70797 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, in which donor gave history which warranted deferral or follow up questions were not asked, were distributed.",2015-04-13,2015-04-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70654 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-04-16,2015-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70689 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-04-16,2015-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70900 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70901 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70944 - Class III - Biologics - Blood Bank Of Hawaii,"Blood product, in which quality control and distribution/failure to quarantine unit due to medical history, was distributed.",2015-05-06,2015-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72061 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2015-10-07,2015-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72545 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2015-11-13,2015-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75623 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, untested for communicable disease agents, were distributed.",2016-11-17,2016-11-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76066 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, collected from a donor who travelled to a malarial endemic area within one year of donation, was distributed.",2017-01-09,2017-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76613 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor who was previously deferred due to history, were distributed.",2017-03-15,2017-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76708 - Class II - Biologics - Blood Bank Of Hawaii,"Platelet components, not prepared in accordance with specifications, were distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76849 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, which was collected from a donor who lived in a malarial endemic area, was distributed.",2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76996 - Class II - Biologics - Blood Bank Of Hawaii,"Platelet products, for which unit sterility was compromised during collection, were distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77097 - Class II - Biologics - Blood Bank Of Hawaii,Blood product collected from a donor who traveled to a malarial endemic area was distributed.,2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77294 - Class III - Biologics - Blood Bank Of Hawaii,"Red Blood Cells, not meeting product quality control specifications, were distributed.",2017-06-05,2017-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77577 - Class III - Biologics - Blood Bank Of Hawaii,"Red blood cell, for which product quality control testing did not meet specifications, was distributed.",2017-07-12,2017-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77692 - Class II - Biologics - Blood Bank Of Hawaii,"Platelet products, for which WBC quality control testing was not performed, were distributed.",2017-07-13,2017-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77825 - Class II - Biologics - Blood Bank Of Hawaii,"Platelet products, for which required WBC quality control testing was not performed, were distributed.",2017-08-08,2017-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78201 - Class III - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-11-08,2017-11-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79417 - Class II - Biologics - Blood Bank Of Hawaii,-,2018-04-09,2018-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81101 - Class II - Biologics - Blood Bank Of Hawaii,"A blood product, which did not meet the acceptable product specifications for release, was distributed.",2018-10-12,2018-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82339 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82765 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2019-05-16,2019-05-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83241 - Class II - Biologics - Blood Bank Of Hawaii,"Blood products collected from a donor who traveled to a malarial endemic area, were distributed.
",2019-07-12,2019-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84014 - Class II - Biologics - Blood Bank Of Hawaii,"Plateletpheresis products, not meeting product specifications, were distributed.",2019-10-10,2019-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84853 - Class II - Biologics - Blood Bank Of Hawaii,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85251 - Class II - Biologics - Blood Bank Of Hawaii,"Red Blood Cell products, lacking assurance of sterility, were distributed.
",2020-03-19,2020-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86727 - Class III - Biologics - Blood Bank Of Hawaii,"Red Blood Cell products, collected from an unsuitable donor due to a donor screening deviation, were distributed.
",2020-12-02,2020-12-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87120 - Class II - Biologics - Blood Bank Of Hawaii,"Plateletpheresis products, in which quality control for  WBC count was not performed, were distributed.
",2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91245 - Class II - Biologics - Blood Bank Of Hawaii,"Leukoreduced Red Blood Cells, collected from a donor who emigrated from a malarial endemic area, were distributed.",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46563 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40191 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, collected from a donor taking the medication Purinethol, were distributed.",2013-05-13,2013-05-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47073 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-05-13,2013-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49698 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood product, collected from a donor with a history of Hepatitis A, was distributed.",2013-05-13,2013-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44355 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-06-07,2013-06-07,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39177 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood product, possibly contaminated with air, was distributed.",2013-06-12,2013-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46128 - Class III - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, not prepared in accordance with specifications, were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44064 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-07-11,2013-07-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43197 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood product, which was not quarantined after the donor provided information of a possible blood exposure, was distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48521 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, collected from donors whose suitability to donate was not adequately determined, were distributed.",2013-08-09,2013-08-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49155 - Class III - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, which exceeded time limits taken out of storage for labeling, were distributed.",2013-09-03,2013-09-03,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44292 - Class III - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood product, manufactured without additive solution, was distributed.",2013-09-04,2013-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44379 - Class III - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, which may have reached an unacceptable temperature during shipment, were distributed.",2013-09-04,2013-09-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42764 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood product, collected in a manner that may have compromised the sterility of the unit, was distributed.",2014-01-02,2014-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45360 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45726 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-01-23,2014-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49824 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67982 - Class II - Biologics - Blood Bank of San Bernardino and Riverside Counties,"Blood products, for which the samples for bacterial testing were collected in a manner that may have compromised the sterility of the units, were distributed.",2014-12-10,2014-12-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41487 - Class II - Biologics - Blood Bank Of San Bernardino and Riverside Counties,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-06-07,2013-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43967 - Class III - Biologics - Blood Bank Of San Bernardino and Riverside Counties,"Blood products, for which storage condition was outside the acceptable range, were distributed.",2013-06-18,2013-06-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #37111 - Class II - Biologics - Blood Bank Of San Bernardino and Riverside Counties,"Blood product, collected from a donor who reported post donation illness, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #34085 - Class II - Biologics - Blood Bank Of San Bernardino and Riverside Counties,"Blood product, which was labeled as leukoreduced, but was not tested to verify white blood cell count, was distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63830 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64639 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, collected from a donor with a history of Hepatitis A, were distributed.",2013-04-11,2013-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43624 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, collected from a donor who warranted deferral due to travel to a malaria endemic area, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #34086 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product, with insufficient plasma to support the platelet yield, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66616 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2013-11-14,2013-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74990 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, lacking assurance of proper leukoreduction, were distributed.",2016-08-25,2016-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74992 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product, which did not meet the acceptable product specifications, was distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75057 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, collected using equipment that required requalification/validation before returning to service, were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76389 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Apheresis Platelets, labeled with an incorrect volume, were distributed.",2017-02-07,2017-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76529 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, incorrectly labeled as having an extended expiration date, were distributed.",2017-03-02,2017-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76449 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product, which may have been exposed to unacceptable temperatures during storage, was distributed.",2017-03-16,2017-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77563 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Misbranded red blood cells, were distributed.",2017-06-16,2017-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77544 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2017-07-21,2017-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78263 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-10-19,2017-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78188 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product, which did not meet the acceptable product specifications, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78812 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2018-01-23,2018-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79503 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, which was not quarantined after receiving post donation information concerning an illness following donation, were distributed.
",2018-03-22,2018-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79369 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2018-04-09,2018-04-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79390 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, which were not quarantined after receiving information regarding a post donation illness, were distributed.",2018-04-09,2018-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80707 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Plasma product, collected from a donor who traveled to an area considered at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87527 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white cell count, were distributed.",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87776 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, for which donor eligibility was incomplete, were distributed.
",2021-05-18,2021-05-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87967 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2021-06-04,2021-06-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88068 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Apheresis Red Blood Cell products, for which residual white blood cell count testing was not performed, were distributed.
",2021-06-22,2021-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88128 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Red Blood Cell products, not meeting product specifications, were distributed.
",2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88169 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-07-06,2021-07-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88232 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Pooled Cryoprecipitated AHF, which were not manufactured in accordance to acceptable product specifications, were distributed.",2021-07-12,2021-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88532 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Leukoreduced Red Blood Cells, which did not meet the minimum requirement for Red Blood Cell recovery following leukoreduction, were distributed.",2021-09-02,2021-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88715 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-09-27,2021-09-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88904 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-11-04,2021-11-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88967 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"PF24 Plasma, collected from a donor in which donor suitability was not adequately determined, was distributed.",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89131 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed",2021-12-14,2021-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89232 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2022-01-04,2022-01-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89350 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, for which donor eligibility was incomplete, were distributed.
",2022-01-18,2022-01-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89398 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,Misbranded Leukoreduced Red Blood Cells were distributed.,2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89473 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, for which donor eligibility was incomplete, were distributed.
",2022-02-09,2022-02-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89564 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood Products, for which donor eligibility was incomplete, were distributed. 
",2022-02-22,2022-02-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89636 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Leukoreduced Red Blood Cells, collected in a manner that compromises the sterility of the collection system, were distributed.",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90081 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Apheresis Red Blood Cell products, for which donor eligibility was incomplete, were distributed. 
",2022-05-10,2022-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90309 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Irradiated Red Blood Cells, labeled with the incorrect expiration date, were distributed.",2022-09-02,2022-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90369 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Leukoreduced Red Blood Cells, Irradiated, labeled with the incorrect expiration date, were distributed.",2022-09-21,2022-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90489 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Blood products, for which donor eligibility was incomplete, were distributed.
",2022-10-06,2022-10-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91372 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties,"Plateletpheresis product, for which quality control for residual WBC count was not performed, was distributed.
",2023-01-04,2023-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81271 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties dba LifeStream,"Blood products, not meeting product specifications, were distributed.",2018-10-25,2018-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81566 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties dba LifeStream,"Blood products, collected from an ineligible donor, were distributed.",2018-11-15,2018-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82269 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties dba LifeStream,"Blood products, collected from an ineligible donor, were distributed.",2019-03-05,2019-03-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82883 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties dba LifeStream,"Blood products, collected from a duplicate donor who was previously deferred due to testing human immunodeficiency virus (HIV) reactive, were distributed.",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83476 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties dba LifeStream,"Plateletpheresis units, not prepared in accordance with specifications, were distributed.",2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84114 - Class II - Biologics - Blood Bank Of San Bernardino And Riverside Counties dba LifeStream,"Apheresis Plasma, not meeting product specifications, was distributed.",2019-10-30,2019-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85596 - Class III - Biologics - Blood Bank Of San Bernardino And Riverside Counties dba LifeStream,"Plateletpheresis product, in which quality control for residual WBC count was not performed, was distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63903 - Class II - Biologics - Blood Center Hammond Laboratory (the),"Blood products, collected from a donor whose suitability was not adequately determined, were distributed.",2013-01-25,2013-01-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64296 - Class II - Biologics - Blood Center Hammond Laboratory (the),"Blood products, which were incompletely irradiated, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65612 - Class III - Biologics - Blood Center Hammond Laboratory (the),"Blood product,  labeled with an incorrect expiration date and product code, was distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67311 - Class II - Biologics - Blood Center Hammond Laboratory (the),"Blood products, in which donor testing was not performed or incomplete, were distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67767 - Class III - Biologics - Blood Center Hammond Laboratory (the),"Blood product, labeled with the incorrect anticoagulant, was distributed.",2014-04-11,2014-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38566 - Class II - Biologics - Blood Center of Central Iowa (The),"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38567 - Class III - Biologics - Blood Center of Central Iowa (The),"Blood product, collected from a donor with a history of surgery within 12 months, was distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38568 - Class II - Biologics - Blood Center of Central Iowa (The),"Blood products, collected from a donor who was taking Prednisone, were distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39098 - Class II - Biologics - Blood Center of Central Iowa (The),"Blood products, collected from a donor taking the Prednisone, were distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39099 - Class II - Biologics - Blood Center of Central Iowa (The),"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38565 - Class II - Biologics - Blood Center of Central Iowa (The),"Blood products, which were collected from a donor who had traveled to a malarial endemic area, were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39097 - Class III - Biologics - Blood Center of Central Iowa (The),"Blood product, which was labeled with an incorrect expiration date, was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39101 - Class III - Biologics - Blood Center of Central Iowa (The),"Blood product, which may have been exposed to unacceptable temperatures during storage, was distributed.",2013-02-01,2013-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39102 - Class II - Biologics - Blood Center of Central Iowa (The),"Blood product, which were collected from a donor who traveled to malarial endemic areas, was distributed.",2013-02-07,2013-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45715 - Class II - Biologics - Blood Center of Iowa (The),"Blood products, collected from a donor possibly at increased risk for Creutzfeldt-Jakob Disease (CJD), were distributed.",2013-02-06,2013-02-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46535 - Class II - Biologics - Blood Center of Iowa (The),"Blood products, collected from a donor who reported a post donation illness, were distributed.",2013-02-06,2013-02-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63067 - Class II - Biologics - Blood Center of New Jersey, The","Blood products, with an unacceptable total hemoglobin level, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50669 - Class II - Biologics - Blood Center of Northcentral Wisconsin, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-07-19,2012-07-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62296 - Class II - Biologics - Blood Center of Northcentral Wisconsin, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-07-19,2012-07-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66571 - Class III - Biologics - Blood Center of Northcentral Wisconsin, Inc.","Blood products, labeled with incorrect or missing information, were distributed.",2013-11-14,2013-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67310 - Class II - Biologics - Blood Center of Northcentral Wisconsin, Inc.","Blood product, with a low platelet yield, was distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88791 - Class III - Biologics - Blood Center of Northcentral Wisconsin, Inc.","Blood products, in which donor testing was not performed or incomplete, were distributed.",2021-10-27,2021-10-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49164 - Class III - Biologics - Blood Centers of the Pacific,"Blood products, which were exposed to unacceptable temperature during transport, were distributed.",2012-07-20,2012-07-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49249 - Class II - Biologics - Blood Centers of the Pacific,"Blood product, collected from a donor who received a mumps, measles , rubella (MMR) vaccination, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59696 - Class III - Biologics - Blood Centers of the Pacific,"Blood products, collected using scales that did not meet the acceptable quality control specifications, were distributed.",2012-11-01,2012-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62139 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, collected from a donor who gave history which warranted deferral or follow up were distributed.",2012-07-13,2012-07-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62064 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, collected from a donor with a history reactive results for HCV, were distributed.",2012-07-18,2012-07-18,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62667 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-08-08,2012-08-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63371 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product,, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63474 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,-,2012-11-14,2012-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64120 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64121 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, with an unacceptably low red cell recovery rate, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64300 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, failed to meet the minimum specification for deglycerolized components, were distributed.",2013-03-19,2013-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64976 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, which did not meet the minimum requirement for Red Blood Cell recovery, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64978 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, for which the quality control testing was not performed, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65344 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.

",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65623 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-08-09,2013-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67072 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, failed to meet the minimum specification for percent red blood cell recovery, was distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67120 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, which was not prepared according to specifications, was distributed.",2014-01-31,2014-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67269 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, collected from a donor whose arm inspection was not documented, were distributed.",2014-02-05,2014-02-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68213 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-06-11,2014-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68248 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed.",2014-06-24,2014-06-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71087 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, which was not labeled with the correct  information, was distributed.",2015-05-19,2015-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71086 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, in which quality control and/or distribution of product  did not meet specifications, was distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71504 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, which did not meet the minimum requirement for Red Blood Cell recovery, was distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71386 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, in which labeling was incorrect and/ or missing information, were distributed.",2015-07-09,2015-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71544 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, in which quality control and distribution of product did not meet specifications, was distributed.",2015-07-21,2015-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72186 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, which were collected from a donor who traveled in a malarial endemic area, were distributed.",2015-10-13,2015-10-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72492 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Apheresis blood products, incorrectly labeled as having an extended expiration date, were distributed.

",2015-11-06,2015-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72355 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Platelet Pheresis product, in which the platelet product yield was below  the 3.0 x 10^11 requirement, was distributed.
",2015-11-16,2015-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72672 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-12-10,2015-12-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74184 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, collected from a donor who lived with an individual who had Hepatitis B, was distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74358 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,Misbranded blood product was distributed.,2016-06-21,2016-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75022 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, not meeting product specifications, was distributed.",2016-09-01,2016-09-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75002 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, for which the residual white blood cell count testing was not performed, was distributed.",2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75054 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, labeled with an incorrect expiration date, were distributed",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75137 - Class II - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product,s collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-10-05,2016-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76302 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood product, collected from a donor for whom eligibility was incorrectly determined, was distributed.",2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76171 - Class III - Biologics - Blood Centers of the Pacific - Irwin Center,"Blood products, which tested positive for unexpected antibodies,were labeled without statement of antibodies, were distributed.",2017-02-21,2017-02-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81063 - Class III - Biologics - Blood Connection, Inc. (The)","Blood product identified as unsuitable due to shipping, was distributed.
",2018-10-05,2018-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82558 - Class II - Biologics - Blood Connection, Inc. (The)","Blood products, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-04-12,2019-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85708 - Class II - Biologics - Blood Connection, Inc. (The)","Blood products, collected from a donor who was a resident of a malarial endemic area, were distributed.",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87171 - Class III - Biologics - Blood Connection, Inc. (The)","Plateletpheresis product, for which storage temperature was not documented, was distribtuted.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89812 - Class II - Biologics - Blood Connection, Inc. (The)","Leukoreduced, Washed, Red Blood Cells, labeled with an incorrect expiration date/time, were distributed.",2022-03-30,2022-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62658 - Class II - Biologics - Blood Systems Inc,"Blood product, collected from a donor who was previously deferred, was distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62876 - Class II - Biologics - Blood Systems Inc,"Blood product, positive for the S-antigen but labeled as S-antigen negative, was distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63237 - Class II - Biologics - Blood Systems Inc,"Blood products, which were not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48554 - Class II - Biologics - Blood Systems Inc,"Blood products, collected from a donor who reported testing positive for hepatitis, were distributed.",2013-03-04,2013-03-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64524 - Class II - Biologics - Blood Systems Inc,"Blood product, with a low platelet concentration, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64977 - Class II - Biologics - Blood Systems Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65265 - Class III - Biologics - Blood Systems Inc,"Blood products, collected using an expired blood collection set, were distributed.",2013-07-02,2013-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66213 - Class III - Biologics - Blood Systems Inc,"Blood products, which were incorrectly tested for West Nile Virus, were distributed.",2013-10-21,2013-10-21,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66214 - Class III - Biologics - Blood Systems Inc,"Blood products, which were out of controlled storage for greater than 30 minutes during irradiation, were distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66215 - Class II - Biologics - Blood Systems Inc,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66540 - Class II - Biologics - Blood Systems Inc,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66667 - Class II - Biologics - Blood Systems Inc,"Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2013-12-11,2013-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66668 - Class II - Biologics - Blood Systems Inc,"Blood products, with insufficient plasma to support the platelet concentrations, were distributed.",2014-01-09,2014-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67121 - Class II - Biologics - Blood Systems Inc,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 

",2014-01-31,2014-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67791 - Class II - Biologics - Blood Systems Inc,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-04-24,2014-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64523 - Class II - Biologics - Blood Systems Inc,"Blood Products, collected from an ineligible donor, were distributed.",2015-07-24,2015-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88386 - Class III - Biologics - Blood Systems Inc,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89474 - Class II - Biologics - Blood Systems Inc,"Leukoreduced Apheresis Platelets, in which platelet yield did not meet specifications, were distributed.",2022-02-04,2022-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91433 - Class II - Biologics - Blood Systems Inc,"Pooled Cryoprecipitated AHF, for which donor eligibility screening was incomplete, were distributed.",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62430 - Class II - Biologics - Blood Systems Inc/dba United Blood Services,"Blood products, collected using equipment that had not been validated, were distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62810 - Class II - Biologics - Blood Systems Inc/dba United Blood Services,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-06,2012-09-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63461 - Class II - Biologics - Blood Systems Inc/dba United Blood Services,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-11-14,2012-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62300 - Class II - Biologics - Blood Systems, Inc","Blood products, collected from a donor with a history of malaria, were distributed.",2012-07-27,2012-07-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63261 - Class II - Biologics - Blood Systems, Inc","Blood product, left in shipping container and was exposed to unacceptable temperatures, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54946 - Class II - Biologics - Blood Systems, Inc","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed., Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed..",2013-01-28,2013-01-28,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64603 - Class II - Biologics - Blood Systems, Inc","Blood product, which did not meet the acceptable product specifications, was distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64685 - Class II - Biologics - Blood Systems, Inc","Blood product, which was incorrectly labeled as negative for the Jk(a) red cell antigen, was distributed",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65100 - Class II - Biologics - Blood Systems, Inc","Blood products, which were not manufactured in accordance to acceptable product specifications, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66158 - Class II - Biologics - Blood Systems, Inc","Blood products, collected from an ineligible donor, were distributed.",2013-10-17,2013-10-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66572 - Class III - Biologics - Blood Systems, Inc","Blood product, labeled with incorrect or missing information, was distributed.",2013-11-14,2013-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66644 - Class II - Biologics - Blood Systems, Inc","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-12-02,2013-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66924 - Class II - Biologics - Blood Systems, Inc","Blood products, which tested negative for West Nile Virus (WNV) using pooled testing, but were not tested for WNV by individual donor testing, were distributed.",2013-12-27,2013-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66940 - Class II - Biologics - Blood Systems, Inc","Blood products, which tested negative for West Nile Virus (WNV) using pooled testing, but were not tested for WNV by individual donor testing, were distributed.",2013-12-27,2013-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66941 - Class III - Biologics - Blood Systems, Inc","Blood product, which did not meet the minimum requirement for Red Blood Cell recovery following leukoreduction, was distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67943 - Class II - Biologics - Blood Systems, Inc","Blood products, with unacceptable cell recovery rates, were distributed.",2014-04-24,2014-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68288 - Class II - Biologics - Blood Systems, Inc","Blood products, collected from an ineligible donor, were distributed.",2014-06-13,2014-06-13,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68250 - Class II - Biologics - Blood Systems, Inc","Platelets, with a low platelet count, were distributed.",2014-06-23,2014-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69099 - Class III - Biologics - Blood Systems, Inc","Red Blood Cells, lacking antibody identification labeling, were distributed.",2014-10-03,2014-10-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69108 - Class II - Biologics - Blood Systems, Inc","Blood products, which did not meet acceptable product specifications, were distributed.",2014-10-06,2014-10-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69096 - Class III - Biologics - Blood Systems, Inc","Blood products, leukoreduced using a Fenwal filter greater than 72 hours of draw, were distributed.",2014-10-07,2014-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69351 - Class II - Biologics - Blood Systems, Inc","Blood products, for which donor screening testing may not have been performed according to manufacturer's specifications, were distributed.",2014-10-22,2014-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69306 - Class II - Biologics - Blood Systems, Inc","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-10-30,2014-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69350 - Class II - Biologics - Blood Systems, Inc","Blood products, which was not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2014-11-12,2014-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70460 - Class II - Biologics - Blood Systems, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-03-20,2015-03-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70587 - Class II - Biologics - Blood Systems, Inc","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-04-09,2015-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71065 - Class II - Biologics - Blood Systems, Inc","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2015-05-07,2015-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71392 - Class II - Biologics - Blood Systems, Inc","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-06-19,2015-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71487 - Class III - Biologics - Blood Systems, Inc","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-07-22,2015-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72125 - Class III - Biologics - Blood Systems, Inc","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72081 - Class III - Biologics - Blood Systems, Inc","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-10-15,2015-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72757 - Class II - Biologics - Blood Systems, Inc","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73015 - Class II - Biologics - Blood Systems, Inc","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2016-02-18,2016-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74767 - Class II - Biologics - Blood Systems, Inc","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-08-24,2016-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74904 - Class II - Biologics - Blood Systems, Inc","Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2016-09-12,2016-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61996 - Class II - Biologics - Blood Systems, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62809 - Class II - Biologics - Blood Systems, Inc.","Blood products, with insufficient plasma volume to support the platelet yield, were distributed.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63173 - Class II - Biologics - Blood Systems, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48264 - Class III - Biologics - Blood Systems, Inc.","Blood products, which were possibly contaminated, were distributed.",2012-11-16,2012-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48835 - Class II - Biologics - Blood Systems, Inc.","Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47598 - Class III - Biologics - Blood Systems, Inc.","Blood products, where the blood collection of the products may have been compromised, were distributed.

",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48263 - Class II - Biologics - Blood Systems, Inc.","Blood Products, which were contaminated with Corynebacterium species, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #38834 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59012 - Class II - Biologics - Blood Systems, Inc.","Blood products, which did not meet the minimum requirement for volume, were distributed.",2013-03-11,2013-03-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65014 - Class II - Biologics - Blood Systems, Inc.","Blood products, which did not meet acceptable product specifications, were distributed.",2013-05-24,2013-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39149 - Class II - Biologics - Blood Systems, Inc.","Blood product, with positive bacterial detection testing, was distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39150 - Class II - Biologics - Blood Systems, Inc.","Blood product, with positive bacterial detection testing, was distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39151 - Class II - Biologics - Blood Systems, Inc.","Blood Products, which were contaminated with Corynebacterium species, were distributed.
",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39155 - Class II - Biologics - Blood Systems, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39156 - Class II - Biologics - Blood Systems, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46553 - Class III - Biologics - Blood Systems, Inc.","Blood product, possibly contaminated with P.acne, was distributed.",2013-07-09,2013-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47085 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor taking the drug Avodart, were distributed.",2013-07-09,2013-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46554 - Class II - Biologics - Blood Systems, Inc.","Blood products, which were possibly contaminated with Propionibacterium species, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47124 - Class III - Biologics - Blood Systems, Inc.","Blood product, prepared without the appropriate amount of RBC additive, was distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39152 - Class III - Biologics - Blood Systems, Inc.","Blood products, which failed to meet the minimum specification for percent red blood cell recovery, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44674 - Class III - Biologics - Blood Systems, Inc.","Blood products, for which storage conditions and shipment information were undocumented, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45700 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-08-09,2013-08-09,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41615 - Class II - Biologics - Blood Systems, Inc.","Blood products, failed to meet specifications for product volume, were distributed.",2013-08-14,2013-08-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47147 - Class III - Biologics - Blood Systems, Inc.","Red Cell product, lacking a proper visual inspection for clots, was distributed.",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48508 - Class II - Biologics - Blood Systems, Inc.","Blood product, labeled as leukoreduced was not tested to verify the White Blood Cell count, was distributed.",2013-09-05,2013-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41078 - Class II - Biologics - Blood Systems, Inc.","Blood product, inappropriately stored in one platelet bag instead of two, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66259 - Class II - Biologics - Blood Systems, Inc.","Blood products, with insufficient platelet yield to have been split into triple apheresis units, were distributed.",2013-10-18,2013-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66212 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor who was previously deferred for testing positive for the human immunodeficiency virus, were distributed.",2013-10-21,2013-10-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40763 - Class II - Biologics - Blood Systems, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41145 - Class III - Biologics - Blood Systems, Inc.","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66922 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected in a way that may have compromised their sterility, were distributed.
",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43366 - Class III - Biologics - Blood Systems, Inc.","Blood products, which may have been exposed to unacceptable storage temperatures, were distributed.",2014-01-02,2014-01-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44122 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor who was taking the medication Avodart, were distributed.",2014-01-02,2014-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42188 - Class II - Biologics - Blood Systems, Inc.","Blood products, which did not meet the minimum requirement for volume, were distributed.",2014-01-08,2014-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42941 - Class III - Biologics - Blood Systems, Inc.","Blood product, for which the entire amount of additive solution was not added during manufacturing, was distributed.",2014-01-08,2014-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45163 - Class II - Biologics - Blood Systems, Inc.","Blood products, labeled leukoreduced which did not meet the requirements for leukoreduced products, were distributed.",2014-01-23,2014-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45723 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor who was taking the drug Methotrexate, were distributed.",2014-01-23,2014-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46126 - Class III - Biologics - Blood Systems, Inc.","Blood products, which were out of controlled storage temperatures, were distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47088 - Class II - Biologics - Blood Systems, Inc.","Blood product, with positive bacterial detection testing, was distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45164 - Class II - Biologics - Blood Systems, Inc.","Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42077 - Class II - Biologics - Blood Systems, Inc.","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-02-20,2014-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45415 - Class III - Biologics - Blood Systems, Inc.","Blood components, processed from Whole Blood and refrigerated more than eight hours after collection, were distributed.",2014-02-20,2014-02-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40738 - Class III - Biologics - Blood Systems, Inc.","Blood product, not prepared in accordance with specifications was distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41965 - Class II - Biologics - Blood Systems, Inc.","Blood products, which were stored under unacceptable storage conditions, were distributed.",2014-02-21,2014-02-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42034 - Class II - Biologics - Blood Systems, Inc.","Blood products, which did not meet acceptable product specifications, were distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45158 - Class III - Biologics - Blood Systems, Inc.","Blood product, collected from an ineligible donor, was distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45159 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50560 - Class III - Biologics - Blood Systems, Inc.","Blood products, exposed to unacceptable temperature during storage, were distributed.",2014-02-21,2014-02-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41330 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor who was taking a medication containing aspirin at the time of donation, were distributed.",2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45160 - Class II - Biologics - Blood Systems, Inc.","Blood products, which were not appropriately tested for West Nile Virus (WNV), were distributed.",2014-03-05,2014-03-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49192 - Class II - Biologics - Blood Systems, Inc.","Blood products, for which the irradiation was performed incorrectly, were distributed.",2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47002 - Class II - Biologics - Blood Systems, Inc.","Blood product, which was possibly contaminated with Propionibacterium acnes, was distributed.",2014-03-10,2014-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44629 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-05-12,2014-05-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47995 - Class II - Biologics - Blood Systems, Inc.","Blood product, which was not tested for pH and platelet count, was distributed.",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68172 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2014-06-11,2014-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68249 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2014-06-24,2014-06-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42685 - Class II - Biologics - Blood Systems, Inc.","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-07-22,2014-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50437 - Class II - Biologics - Blood Systems, Inc.","Blood products, collected from a donor who was taking Avodart, were distributed.",2014-12-04,2014-12-04,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47994 - Class II - Biologics - Blood Systems, Inc.","Blood products, which may have reached unacceptable temperatures during shipment, were distributed.",2015-01-23,2015-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70391 - Class III - Biologics - Blood Systems, Inc.","Blood product, in which component preparation/component not prepared in accordance with specifications, was distributed.",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76709 - Class III - Biologics - Blood Systems, Inc.","Blood product, for which the donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77269 - Class II - Biologics - Blood Systems, Inc.","Blood products, for which donor eligibility  screening was incorrectly performed, were distributed.",2017-05-25,2017-05-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78053 - Class III - Biologics - Blood Systems, Inc.","Blood product, collected from an unsuitable donor due to a donor screening deviation, was distributed.",2017-09-05,2017-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78893 - Class III - Biologics - Blood Systems, Inc.","Blood products, for which the donor screening was performed incorrectly, were released.",2018-01-29,2018-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78872 - Class III - Biologics - Blood Systems, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-02-15,2018-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79522 - Class II - Biologics - Blood Systems, Inc.","Platelet product for which platelet count QC did not meet specification, was distributed.",2018-04-03,2018-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80907 - Class III - Biologics - Blood Systems, Inc.","Blood product, which failed to meet  product specifications, was distributed.",2018-10-03,2018-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82120 - Class II - Biologics - Blood Systems, Inc.","Blood product, for which donor eligibility screening was incorrectly performed, was distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82493 - Class III - Biologics - Blood Systems, Inc.","Blood products, where donor testing was incorrectly performed for evidence of infection due to a relevant transfusion-transmitted infection and were distributed.",2019-04-23,2019-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84404 - Class III - Biologics - Blood Systems, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84429 - Class II - Biologics - Blood Systems, Inc.",Misbranded Leukoreduced Red Blood Cells were distributed.,2020-01-14,2020-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84852 - Class II - Biologics - Blood Systems, Inc.","Blood product, for which the quality control testing was incomplete, was distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84937 - Class II - Biologics - Blood Systems, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2020-03-24,2020-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85922 - Class III - Biologics - Blood Systems, Inc.","Red Blood Cell products for which a visual inspection was not performed or documented were distributed.
",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85895 - Class III - Biologics - Blood Systems, Inc.",Leukoreduced Red Blood Cells were distributed without a final visual check.,2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85968 - Class III - Biologics - Blood Systems, Inc.","Red Blood Cell product for which a visual inspection was not performed or documented, was distributed.
",2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86056 - Class III - Biologics - Blood Systems, Inc.","Misbranded Apheresis Red Blood Cell product was distributed.
",2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73564 - Class II - Biologics - Blood Systems, Inc.  dba UBS - California","Blood products, possibly collected from a donor who traveled to a malarial endemic area, were distributed.",2016-04-25,2016-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73905 - Class II - Biologics - Blood Systems, Inc.  dba UBS - California",Apheresis products collected from donors taking Propecia and Accutane were distributed.,2016-05-02,2016-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74347 - Class II - Biologics - Blood Systems, Inc.  dba UBS - California","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2016-07-18,2016-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75040 - Class II - Biologics - Blood Systems, Inc.  dba UBS - California","Apheresis products, in which quality control for WBC testing was not performed, were distributed.",2016-09-19,2016-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75204 - Class II - Biologics - Blood Systems, Inc.  dba UBS - California","Platelet products, which did not meet quality control specifications, were distributed.",2016-11-01,2016-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71825 - Class III - Biologics - Blood Systems, Inc.  dba UBS -Coast","Blood product, collected using a shaker device for which the quality control results were not documented, was distributed.",2015-08-21,2015-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72513 - Class III - Biologics - Blood Systems, Inc.  dba UBS -Coast","Apheresis blood products, incorrectly labeled as having an extended expiration date, were distributed.",2015-12-02,2015-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72623 - Class III - Biologics - Blood Systems, Inc.  dba UBS -Coast","Apheresis blood products, possibly incorrectly labeled as having an extended expiration date, were distributed.",2015-12-04,2015-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72980 - Class II - Biologics - Blood Systems, Inc.  dba UBS -Coast","Blood product, in which quality control and distribution of product did not meet specifications, was distributed.",2016-01-21,2016-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73439 - Class II - Biologics - Blood Systems, Inc.  dba UBS -Coast","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2016-04-11,2016-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80776 - Class III - Biologics - Blood Systems, Inc. DBA Blood Centers of the Pacific - Irwin Center","Apheresis product, identified as unsuitable due to a collection deviation, was distributed.
",2018-08-20,2018-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78112 - Class II - Biologics - Blood Systems, Inc. dba Lifeblood","Plateletpheresis products, that failed residual WBC counts, were distributed.",2017-09-20,2017-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78684 - Class II - Biologics - Blood Systems, Inc. dba Lifeblood","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-01-03,2018-01-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78723 - Class II - Biologics - Blood Systems, Inc. dba Lifeblood","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-01-05,2018-01-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79917 - Class III - Biologics - Blood Systems, Inc. dba Lifeblood","Apheresis product, which was irradiated labeled with an incorrect expiration date, was distributed.",2018-05-04,2018-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80259 - Class III - Biologics - Blood Systems, Inc. dba Lifeblood","Blood product, labeled with a combination of incorrect or missing information was distributed.",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80344 - Class II - Biologics - Blood Systems, Inc. dba Lifeblood","Blood products, collected from a donor whose eligibility to donate was inadequately determined for malarial travel, were distributed.",2018-06-28,2018-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62026 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62475 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62482 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services","Blood products, which did not meet the acceptable product specifications, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62483 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services","Blood products, which did not meet the acceptable product specifications, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62814 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-09-19,2012-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64033 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services","Blood products, which were incorrectly labeled as negative anti-K, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64119 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services","Blood product, collected from a donor whose medical history screening  was not adequately performed, was distributed.",2013-03-01,2013-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64521 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services","Blood products, collected from donors whose body temperatures were determined incorrectly, were distributed.",2013-04-15,2013-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80505 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services","Blood product identified as unsuitable due to shipping, was distributed.",2018-07-26,2018-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66942 - Class III - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood product, for which the quality control testing for the Hemoflow shaker was not documented, was distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67169 - Class III - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-02-27,2014-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67771 - Class II - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood product, manufactured from an overweight whole blood unit, was distributed.",2014-04-11,2014-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68867 - Class II - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood product, labeled with an incorrect expiration date, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69860 - Class III - Biologics - Blood Systems, Inc. DBA United Blood Services","Platelets, with misbranded product volumes, were distributed.",2014-12-17,2014-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72030 - Class II - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73135 - Class II - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2016-02-08,2016-02-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73787 - Class II - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood product, for which donor eligibility was inadequately determined, was distributed.",2016-05-02,2016-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74047 - Class II - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood product, for which donor suitability was not adequately determined, was distributed.",2016-05-19,2016-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80493 - Class III - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood products, which failed to meet product specifications,  were distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80780 - Class III - Biologics - Blood Systems, Inc. DBA United Blood Services","Blood products, in which the documented  temperature at the time of receipt exceeded the acceptable range, were distributed.",2018-09-06,2018-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65538 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, collected from an ineligible donor, were distributed.",2013-07-30,2013-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65528 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, collected from a donor who traveled to a malaria endemic area, were distributed.",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65709 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, incorrectly determined to be negative for the Fya antigen, was distributed.",2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65710 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, labeled with the incorrect platelet count and product volume, was distributed.

",2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66923 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66925 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, for which the additive solution was not added during manufacturing, was distributed.",2014-01-08,2014-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68713 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, labeled leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2014-08-14,2014-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70616 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, which did not meet acceptable product specifications, were distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70617 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70618 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71389 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71824 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, collected from a donor who resided in an area considered endemic for malaria, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71959 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-09-18,2015-09-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72126 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72145 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, in which quality control and distribution of product did not meet specifications, was distributed.",2015-10-26,2015-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72303 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, collected from donors who resided in or traveled to an area considered endemic for malaria, were distributed.",2015-10-28,2015-10-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73049 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed",2016-02-04,2016-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73107 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Apheresis product, in which the platelet yield was below 3.0x10^11, was distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73563 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, collected from a donor who possibly traveled to a malarial endemic area, was distributed.",2016-04-25,2016-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73788 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas",Mislabeled RBC products were distributed.,2016-05-02,2016-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74246 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-06-03,2016-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74957 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, which did not meet the acceptable product specifications, was distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75134 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Apheresis products for which white blood cell count testing was not performed, were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76582 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products whose relevant Transfusion-Transmitted Infection Testing was performed, incorrectly, were distributed.",2017-03-29,2017-03-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76597 - Class III - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, whose relevant Transfusion-Transmitted Infection testing was performed incorrectly, were distributed.",2017-03-29,2017-03-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77012 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, in which donor screening warranted deferral or follow up and was not deferred or follow up questions was not asked.",2017-05-15,2017-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78317 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Red cell product, for which donor suitability was inadequately determined, was distributed.",2017-11-15,2017-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78873 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-02-07,2018-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79704 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood product, which did not meet acceptable product specifications, was distributed.",2018-05-03,2018-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80347 - Class II - Biologics - Blood Systems, Inc. dba United Blood Services Texas","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-06-28,2018-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62506 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63248 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Blood products, not prepared according to specifications, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63401 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, which was incorrectly labeled as negative for the C red cell antigen, was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64027 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64183 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, which were collected from a donor who lived in a malarial endemic area, were distributed.",2013-02-25,2013-02-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64415 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor who was taking Plavix, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64780 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor with risk factors for vCJD, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66387 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected in expired collection bags, were distributed.",2013-10-21,2013-10-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67697 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, not prepared in accordance with specifications, were distributed.",2014-03-27,2014-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67937 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, which was labeled as leukoreduced, but failed the post filtration acceptance criteria for white blood cell count, was distributed.",2014-05-20,2014-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68662 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected using equipment that had not been validated, were distributed.",2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69816 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Plasma product, that was not quarantined after receiving information concerning post donation illness, was distributed.",2014-12-05,2014-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70227 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, for which donor suitability was not adequately determined, was distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70636 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-03-20,2015-03-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70943 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-05-13,2015-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71778 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, which quality control and distribution of product  did not meet specifications, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72065 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-10-05,2015-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72514 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2015-11-12,2015-11-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72612 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-12-07,2015-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73190 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-03-09,2016-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73529 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-04-11,2016-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73530 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-04-11,2016-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73531 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-04-11,2016-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73532 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-04-11,2016-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73842 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from an ineligible donor, were distributed.",2016-04-21,2016-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74360 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom eligibility was inadequately determined, were distributed.",2016-06-14,2016-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74711 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, in which donor suitability was inadequately determined, were distributed.",2016-07-28,2016-07-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74739 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from an ineligible donor, were distributed.",2016-08-15,2016-08-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75217 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-10-18,2016-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75218 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-10-18,2016-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75463 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-11-01,2016-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75464 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75625 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from an ineligible donor, were distributed.",2016-11-28,2016-11-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75705 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom screening was incorrectly performed, were distributed.",2016-12-07,2016-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75733 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-12-07,2016-12-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75841 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-01-05,2017-01-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76092 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-01-31,2017-01-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76093 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products,  in which donor suitability was not adequately determined, were distributed.",2017-01-31,2017-01-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76399 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2017-02-28,2017-02-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76658 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Blood product, in which donor suitability was not adequately determined, was distributed.",2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76355 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from an ineligible donor, were distributed.",2017-04-06,2017-04-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76892 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, collected from a donor for whom donor eligibility screening was performed incorrectly, was distributed.",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77237 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, in which donor suitability was not adequately determined, was distributed.",2017-05-16,2017-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77238 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, in which donor suitability was not adequately determined, were distributed.",2017-05-16,2017-05-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77046 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-05-23,2017-05-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77047 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-05-23,2017-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77561 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor who was previously deferred due to testing history for HBV, were distributed.",2017-07-12,2017-07-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77461 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-07-19,2017-07-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77644 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2017-07-21,2017-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77645 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-07-21,2017-07-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77854 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, for which donor screening was incorrectly performed, were distributed.",2017-08-10,2017-08-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77853 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Blood product, manufactured without the entire quantity of additive solution, was distributed.",2017-08-22,2017-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78701 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-01-05,2018-01-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78797 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, for which donor suitability was inadequately determined, were distributed.",2018-01-16,2018-01-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78921 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood product, which did not meet the acceptable product specifications, was distributed.",2018-02-07,2018-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79202 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Apheresis products for which quality control procedures were not performed, were distributed.
",2018-02-22,2018-02-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79127 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-03-05,2018-03-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79326 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor for whom  screening was incorrectly performed, were distributed.",2018-03-07,2018-03-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79746 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-05-16,2018-05-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80336 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-07-12,2018-07-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80412 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Blood products, not prepared in accordance with specifications for temperature during component preparation, were distributed.",2018-07-24,2018-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80796 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Apheresis product, which may have been exposed to unacceptable temperatures during shipment, was distributed.
",2018-08-22,2018-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81032 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected in a manner that lacked assurance of sterility, were distributed.",2018-09-18,2018-09-18,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81201 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Apheresis products tested using a flow cytometer for WBC that had not been properly calibrated, were distributed.",2018-10-24,2018-10-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81817 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, which did not meet acceptable product specifications for release, were distributed.",2019-02-01,2019-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82043 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products, collected from an ineligible donor, were distributed.",2019-02-08,2019-02-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82465 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Apheresis product, for which the pH did not meet specifications, was distributed.",2019-04-05,2019-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84258 - Class II - Biologics - BloodCenter of Wisconsin, Inc","Blood products where transfusion-transmitted infection testing was incorrectly interpreted, were distributed.",2019-11-26,2019-11-26,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84670 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Blood product, which was exposed to unacceptable temperature during storage, was distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85042 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Leukoreduced Red Blood Cells, missing some of the additive solution, were distributed.",2020-03-05,2020-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87001 - Class III - Biologics - BloodCenter of Wisconsin, Inc","Leukoreduced, Red Blood Cells, not meeting product specifications, were distributed.",2020-12-23,2020-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69920 - Class II - Biologics - BloodCenter of Wisconsin, Inc.","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2015-06-17,2015-06-17,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43312 - Class III - Biologics - BloodNetUSA, Inc.","Blood product, collected from a donor whose arm inspection was not performed, was distributed.",2013-03-11,2013-03-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42335 - Class II - Biologics - BloodNetUSA, Inc.","Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59883 - Class II - Biologics - BloodSource, Inc.","Blood products, which were collected in a manner that may have compromised the sterility of the collection system, were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62954 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2012-10-01,2012-10-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64844 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor who was previously deferred for a positive HIV test result, were distributed.",2013-05-08,2013-05-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65249 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from an ineligible donor, were distributed",2013-07-02,2013-07-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67853 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor without documentation of a body temperature, was distributed.",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69341 - Class II - Biologics - BloodSource, Inc.","Plateletpheresis products, collected in a manner that may have compromised sterility of the units, were distributed.",2014-10-03,2014-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69707 - Class III - Biologics - BloodSource, Inc.","Blood products, in which Viral Testing/Testing performed, interpreted, or documented incorrectly were distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73111 - Class III - Biologics - BloodSource, Inc.",Misbranded apheresis product was distributed.,2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73367 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-03-04,2016-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73726 - Class II - Biologics - BloodSource, Inc.","Platelet products, not prepared according to specifications, were distributed.",2016-04-15,2016-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73789 - Class II - Biologics - BloodSource, Inc.","Blood product, collected from a donor who did not have a complete physical examination, was distributed.",2016-04-28,2016-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73791 - Class II - Biologics - BloodSource, Inc.","Blood product, collected from a donor who was allowed to donate without a current physical, was distributed.",2016-04-29,2016-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74768 - Class II - Biologics - BloodSource, Inc.","Apheresis product, collected from a donor who had not had an annual physical exam performed, was distributed.",2016-08-05,2016-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74852 - Class II - Biologics - BloodSource, Inc.","Blood product, collected from a donor who was allowed to donate without a current physical, was distributed.",2016-08-10,2016-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75021 - Class III - Biologics - BloodSource, Inc.","Misbranded apheresis products were distributed.
",2016-09-01,2016-09-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75216 - Class II - Biologics - BloodSource, Inc.","Platelet products, not prepared in accordance with specifications, were distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75317 - Class III - Biologics - BloodSource, Inc.",Mislabeled plasma product was distributed.,2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75687 - Class II - Biologics - BloodSource, Inc.","Apheresis products, collected from a donor who was allowed to donate without a current physical, were distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76084 - Class II - Biologics - BloodSource, Inc.","Apheresis product, collected from a donor who was allowed to donate without a current physical, was distributed.",2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76140 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76240 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-02-02,2017-02-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76477 - Class II - Biologics - BloodSource, Inc.","Apheresis products for which quality control procedures were not performed, were distributed.",2017-02-21,2017-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76557 - Class II - Biologics - BloodSource, Inc.","Blood product, in which donor deferral and/or donor incorrectly deleted from deferral list, was distributed.",2017-03-06,2017-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76691 - Class II - Biologics - BloodSource, Inc.","Blood product, in which donor suitability was not adequately determined, was distributed.",2017-03-16,2017-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76416 - Class II - Biologics - BloodSource, Inc.","Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2017-03-27,2017-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76867 - Class II - Biologics - BloodSource, Inc.","Blood product, in which donor suitability was not adequately determined, was distributed.",2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76878 - Class III - Biologics - BloodSource, Inc.","Blood product, in which donor suitability was not adequately determined, was distributed.",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76995 - Class II - Biologics - BloodSource, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2017-04-20,2017-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76735 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77162 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-05-30,2017-05-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77253 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2017-06-23,2017-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77254 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2017-06-23,2017-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77562 - Class III - Biologics - BloodSource, Inc.","Blood products, lacking assurance of proper storage temperatures, were distributed.",2017-06-27,2017-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77707 - Class III - Biologics - BloodSource, Inc.","Plasma product, for which donor screening was performed incorrectly, was distributed.",2017-07-26,2017-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77919 - Class II - Biologics - BloodSource, Inc.","Apheresis products, in which platelet yield and component preparation did not meet specifications, were distributed.",2017-08-22,2017-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77924 - Class II - Biologics - BloodSource, Inc.","Blood product, which failed to meet specification for red blood cell percent recovery, was distributed.",2017-09-21,2017-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78203 - Class III - Biologics - BloodSource, Inc.","Blood products, for which donor suitability was  incorrectly performed, were distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78615 - Class II - Biologics - BloodSource, Inc.","Apheresis product, collected from a donor who was allowed to donate without a current physical, was distributed.
",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78616 - Class II - Biologics - BloodSource, Inc.","Blood product, collected from a donor who was allowed to donate without a current physical, was distributed.",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78617 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor who was allowed to donate without a current physical, were distributed.",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78618 - Class II - Biologics - BloodSource, Inc.","Blood product, collected from a donor who was allowed to donate without a current physical, was distributed.
",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78358 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2017-12-04,2017-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78626 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-12-21,2017-12-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78627 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78853 - Class III - Biologics - BloodSource, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-01-29,2018-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78906 - Class III - Biologics - BloodSource, Inc.","Blood product, for which donor suitability  was not adequately  determined, was distributed.",2018-02-12,2018-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79761 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.
",2018-04-18,2018-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79945 - Class III - Biologics - BloodSource, Inc.","Blood product, which failed to meet the minimum specification, was distributed.",2018-06-05,2018-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80214 - Class III - Biologics - BloodSource, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80479 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-08-09,2018-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81105 - Class III - Biologics - BloodSource, Inc.","Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-05,2018-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81139 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-11,2018-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81141 - Class III - Biologics - BloodSource, Inc.","Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-11,2018-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81272 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81304 - Class III - Biologics - BloodSource, Inc.","Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81412 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-11-13,2018-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82052 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from an ineligible donor, was distributed.",2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82054 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from an ineligible donor, was distributed.",2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82055 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from an ineligible donor, were distributed.",2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82203 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-02-28,2019-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82547 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82859 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82647 - Class III - Biologics - BloodSource, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82929 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-06-24,2019-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83389 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83223 - Class II - Biologics - BloodSource, Inc.","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2019-08-05,2019-08-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83393 - Class II - Biologics - BloodSource, Inc.","Blood products collected from donors who traveled to a malarial endemic area, were distributed.
",2019-08-13,2019-08-13,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83614 - Class III - Biologics - BloodSource, Inc.","Plateletpheresis product, collected by apheresis using a machine that failed quality control testing, was distributed.",2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84502 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84717 - Class II - Biologics - BloodSource, Inc.","Plateletpheresis product, in which platelet yield did not meet specifications, was distributed.",2020-01-28,2020-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84783 - Class III - Biologics - BloodSource, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84905 - Class III - Biologics - BloodSource, Inc.","Red Blood Cell products, not labeled with a tag indicating that it contained antibodies, were distributed.",2020-02-18,2020-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84904 - Class III - Biologics - BloodSource, Inc.","Leukoreduced, Irradiated Red Blood Cells were distributed without a final visual check.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84774 - Class III - Biologics - BloodSource, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2020-02-28,2020-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85248 - Class II - Biologics - BloodSource, Inc.","Red Blood Cell product, identified as unsuitable due to a collection deviation, was distributed.




",2020-03-19,2020-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85303 - Class II - Biologics - BloodSource, Inc.","Blood products, for which donor eligibility was incomplete, were distributed.
",2020-03-31,2020-03-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85568 - Class II - Biologics - BloodSource, Inc.","Leukoreduced Apheresis Platelets, in which platelet yield did not meet specifications, were distributed.",2020-05-01,2020-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85657 - Class II - Biologics - BloodSource, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86460 - Class III - Biologics - BloodSource, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2020-09-23,2020-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86613 - Class III - Biologics - BloodSource, Inc.",Misbranded red blood cells were distributed.,2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86914 - Class III - Biologics - BloodSource, Inc.","Blood product, for which donor eligibility was incomplete, was distributed.
",2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87374 - Class II - Biologics - BloodSource, Inc.","Plateletpheresis products, in which platelet yield did not meet specifications, were distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87480 - Class II - Biologics - BloodSource, Inc.","Blood products, that lacked documented assurance of visual inspection and proper storage temperatures, were distributed.",2021-03-12,2021-03-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87116 - Class III - Biologics - BloodSource, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2021-03-15,2021-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87646 - Class II - Biologics - BloodSource, Inc.",Pooled Cryoprecipitated AHF that failed to meet QC specifications was distributed.,2021-04-14,2021-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87777 - Class II - Biologics - BloodSource, Inc.","Irradiated Apheresis Platelets, Leukocytes Reduced, stored with a platelet count higher than is acceptable, were distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89708 - Class II - Biologics - BloodSource, Inc.","Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2022-03-17,2022-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90138 - Class II - Biologics - BloodSource, Inc.","Irradiated, Leukoreduced Apheresis Platelets, labeled with an expiration date and time that was incorrect, were distributed.",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91678 - Class II - Biologics - BloodSource, Inc.","Leukoreduced Apheresis Platelets, where associated blood sample collection tubes were mislabeled, were distributed.",2023-02-16,2023-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85569 - Class III - Biologics - Bloodworks,Leukoreduced Red Blood Cells were distributed without a final visual check.,2020-05-01,2020-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78187 - Class II - Biologics - Bloodworks,"Blood product, with a low platelet count, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78941 - Class II - Biologics - Bloodworks,"Blood product, which did not meet the acceptable product specifications, was distributed.",2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81585 - Class III - Biologics - Bloodworks,"Platelet product, not meeting product specification requirements, was distributed.",2018-11-21,2018-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81688 - Class III - Biologics - Bloodworks,"Blood products, not meeting product specifications, were distributed.",2018-12-18,2018-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82155 - Class II - Biologics - Bloodworks,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-02-26,2019-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82526 - Class III - Biologics - Bloodworks,Unlicensed blood products were distributed in interstate commerce.,2019-05-13,2019-05-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83033 - Class III - Biologics - Bloodworks,Unlicensed blood products were distributed in interstate commerce.,2019-06-27,2019-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83205 - Class III - Biologics - Bloodworks,"Leukoreduced Pooled Platelets, in which WBC count was performed using a sample that exceeded the time frame requirements for analysis, were distributed.",2019-07-12,2019-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83321 - Class III - Biologics - Bloodworks,"Blood products, which tested positive for unexpected antibodies, were distributed.",2019-07-31,2019-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83612 - Class III - Biologics - Bloodworks,Unlicensed blood products were distributed in interstate commerce.,2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83616 - Class III - Biologics - Bloodworks,"Leukoreduced Pooled Platelets, which were expired, were distributed.",2019-09-06,2019-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84158 - Class II - Biologics - Bloodworks,"Plateletpheresis product, incorrectly labeled as irradiated, was distributed.
",2019-11-01,2019-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85570 - Class II - Biologics - Bloodworks,"Leukoreduced Red Blood Cells, for which donor eligibility screening was incomplete, were distributed.",2020-05-01,2020-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85769 - Class II - Biologics - Bloodworks,"Leukoreduced Red Blood Cells, for which donor eligibility screening was incomplete, were distributed.",2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86511 - Class III - Biologics - Bloodworks,"Red Blood Cells, not meeting product specifications, were distributed.",2020-09-29,2020-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86984 - Class III - Biologics - Bloodworks,"Leukoreduced, Red Blood Cells were distributed without a final visual check.",2020-12-23,2020-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87394 - Class II - Biologics - Bloodworks,"Blood products, collected in a manner that may have compromised sterility, were distributed.",2021-03-10,2021-03-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87466 - Class II - Biologics - Bloodworks,"Blood products, shipped without documenting visual inspection and shipping requirements, were distributed.",2021-03-12,2021-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87779 - Class III - Biologics - Bloodworks,Leukoreduced Red Blood Cells were distributed without a final visual check.,2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87807 - Class II - Biologics - Bloodworks,"Misbranded Red Blood Cell products were distributed.
",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88385 - Class III - Biologics - Bloodworks,"Apheresis Red Blood Cells, which did not meet product specifications, were distributed. 
",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88527 - Class III - Biologics - Bloodworks,"Red Blood Cell product, for which a visual inspection was not performed or documented, was distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91184 - Class III - Biologics - Bloodworks,"Red Blood Cell products, for which a visual inspection was not performed or documented, were distributed.
",2022-11-25,2022-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86842 - Class III - Biologics - Bloodworks Northwest,"Leukoreduced, Apheresis Red Blood Cells were distributed without a final visual check.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88777 - Class III - Biologics - Bloodworks Northwest,Leukoreduced Red Blood Cells were distributed without a final visual check.,2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89083 - Class III - Biologics - Bloodworks Northwest,"Red Blood Cell products, for which a visual inspection was not performed or documented, were distributed.
",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67739 - Class II - Drugs - Blu Pharmaceuticals Inc,Defective container: Product distributed without inner seal on bottles.,2014-05-05,2014-05-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78634 - Class I - Drugs - Blue Fusion Natural,"Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared  sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.",2018-02-01,2018-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71912 - Class I - Drugs - Blue Square Market, Inc.","Marketed Without An Approved NDA/ANDA: presence of undeclared Sibutramine and Phenolphthalein., Marketed Without An Approved NDA/ANDA: presence of undeclared Sulfoaildenafil.",2015-11-17,2015-11-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62836 - Class I - Drugs - Body Basics Inc,"Marketed without an Approved NDA/ANDA; product contains sildenafil, an active ingredient in a FDA approved product for the treatment of Erectile Dysfunction",2013-04-18,2013-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81340 - Class II - Drugs - Boehringer Ingelheim Pharmaceuticals, Inc.",Failed Dissolution Specifications: OOS resultsduring routine stability testing,2018-11-01,2018-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75374 - Class II - Drugs - Boehringer Ingelheim Pharmaceuticals, Inc.",Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and  50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.,2016-10-24,2016-10-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78172 - Class III - Drugs - Boehringer Ingelheim Pharmaceuticals, Inc.",Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.,2017-10-06,2017-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78775 - Class II - Drugs - Boehringer Ingelheim Pharmaceuticals, Inc.",Failed Stability Specifications,2018-01-26,2018-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80961 - Class II - Drugs - Boehringer Ingelheim Pharmaceuticals, Inc.",Cross Contamination With Other Products:,2018-09-27,2018-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82310 - Class III - Drugs - Boehringer Ingelheim Pharmaceuticals, Inc.",Failed Tablet/Capsule Specifications: identification of low weight tablets during routine stability testing.,2019-03-11,2019-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86527 - Class II - Drugs - Boehringer Ingelheim Pharmaceuticals, Inc.",An extraneous peak was observed for dissolution testing.,2020-10-26,2020-10-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87856 - Class II - Drugs - Boehringer Ingelheim Pharmaceuticals, Inc.",Subpotent Drug,2021-05-28,2021-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70990 - Class II - Drugs - Boehringer Ingelheim Roxane Inc,Subpotent Drug: The firm received an out of specification result for Assay (potency was below specification) at the 9 month stability time point.,2015-05-27,2015-05-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63630 - Class II - Drugs - Boehringer Ingelheim Roxane Inc,Defective container; damaged bottles could allow moisture to get into the bottle and thus may impair the quality of the product,2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63952 - Class III - Drugs - Boehringer Ingelheim Roxane Inc,"Impurities/Degradation Products: Out of Specification results found for impurity B, identified as the drug's metabolite.",2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65467 - Class III - Drugs - Boehringer Ingelheim Roxane Inc,Labeling: Missing Label; missing label on blister card,2013-08-12,2013-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65428 - Class III - Drugs - Boehringer Ingelheim Roxane Inc,Presence of Foreign Substance: This recall is being conducted due to the potential for extrinsic foreign particles in the API used to manufacture SPIRIVA Handihaler,2013-09-16,2013-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66289 - Class II - Drugs - Boehringer Ingelheim Roxane Inc,Resuspension Problems: Recalled lot did not meet resuspendability requirements.,2013-11-20,2013-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66288 - Class III - Drugs - Boehringer Ingelheim Roxane Inc,SubPotent Drug: The firm discovered out of specification results for assay and the extended investigation revealed the potential for lower weight tablets.,2013-12-11,2013-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67796 - Class III - Drugs - Boehringer Ingelheim Roxane Inc,Defective Delivery System: Potential for dose delivery out of specification due to interation of the drug product powder with the lubricant on the interior of the capsule shell.,2014-04-10,2014-04-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67928 - Class III - Drugs - Boehringer Ingelheim Roxane Inc,Labeling: Incorrect or Missing Lot and/or Exp Date: This recall is being conducted because the product was given 36 month expiration dates instead of the filed 24 months.,2014-05-06,2014-05-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68389 - Class II - Drugs - Boehringer Ingelheim Roxane Inc,Failed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time point,2014-07-09,2014-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68879 - Class III - Drugs - Boehringer Ingelheim Roxane Inc,Failed Stability Specifications: Out of specification result for preservative sodium benzoate.,2014-07-28,2014-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71760 - Class II - Drugs - Boehringer Ingelheim Roxane Inc,"Defective Delivery System: Inhalers do not spray properly, emitting either no spray or a short transient spray.",2015-07-27,2015-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72234 - Class III - Drugs - Boehringer Ingelheim Roxane Inc,CGMP Deviations: The active pharmaceutical ingredient (API) intended for use in furosemide oral solution USP was inadvertently used to manufacture the recalled furosemide tablets USP.,2015-10-09,2015-10-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79846 - Class III - Drugs - Boiron Inc.,Labeling: Labeling Error on Declared Strength; The outer carton (secondary packaging) statement of ingredients misstates the concentration of active ingredient at 7%.  The primary packaging (tube) correctly states the active ingredient at 10%.,2018-05-11,2018-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72420 - Class II - Biologics - Bone Bank Allografts,"Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2015-10-22,2015-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85595 - Class II - Biologics - Bone Bank Allografts,"ViaCell allografts, lacking in-process controls and testing so that HCT/Ps are processed in a way that does not cause contamination or cross-contamination during processing, and that prevents the introduction, transmission, or spread of communicable disease through the use of the HCT/P.",2020-05-07,2020-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73174 - Class II - Drugs - Bonita Pharmaceuticals, LLC",Marketed without an approved NDA/ANDA,2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78720 - Class I - Drugs - BotanicalNow,Marketed without an approved NDA/ANDA: FDA analysis found the product to contain undeclared sibutramine.,2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81504 - Class II - Drugs - Bound Tree Medical, LLC","Labeling: Incorrect or Missing Lot and/or Exp date:  vials of epinephrine within kit 8600-01100 expired on December 2018, but the outer kit label has an expiration date of January 2020.  In addition, device component (syringe) may lack 510(k) clearance.",2019-01-14,2019-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81487 - Class III - Drugs - Bound Tree Medical, LLC","Labeling: Incorrect or missing Lot and/or Exp Date:The Kit is incorrectly labeled as expiring May 2018 however the correct expiration date is May 2019.   In addition, device component (syringe) lacks 510(k) clearance.",2019-01-16,2019-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81344 - Class II - Drugs - Bound Tree Medical, LLC","Labeling Incorrect Instructions:  This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the Safety Lok Syringe in Model 8600-01120) recommend a midpoint dosage of epinephrine for children between 0 lbs. and 66 lbs. of 0.15mL that has not been approved by FDA for children. Reliance on the current IFU and/or use of the Epi-Safe Syringe as instructed may result in the administration of an inappropriate dosage of epinephrine to young children experiencing anaphylaxis, especially those under 33 lbs. Additionally the Epi Safe syringe does not have the correct markings to allow a health care provider to draw up the correct dosage for children under 33 kg.",2019-01-18,2019-01-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86224 - Class III - Biologics - BPC Plasma Inc,"Source Plasma, for which donor eligibility was incomplete, was distributed.
",2020-08-24,2020-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72483 - Class II - Biologics - BPL Plasma,"Blood product, collected from a donor who received a piercing within one year of donation, was distributed.",2015-11-16,2015-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73085 - Class III - Biologics - BPL Plasma,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74165 - Class III - Biologics - BPL Plasma,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-06-13,2016-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74279 - Class III - Biologics - BPL Plasma,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74460 - Class III - Biologics - BPL Plasma,"Blood product, in which donor screening/donor record incomplete or incorrect, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78528 - Class III - Biologics - BPL Plasma,"Source Plasma unit, not meeting product specifications, was distributed.",2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83127 - Class III - Biologics - BPL Plasma,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86710 - Class III - Biologics - BPL Plasma,"Source Plasma units, collected from donors with incomplete donor eligibility determinations, were distributed.",2020-12-21,2020-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78530 - Class III - Biologics - BPL Plasma Inc,"Source Plasma units, not meeting product specifications, were distributed.",2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78536 - Class III - Biologics - BPL Plasma Inc,"Source Plasma unit, not meeting product specifications, was distributed.",2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82809 - Class III - Biologics - BPL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83125 - Class III - Biologics - BPL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83141 - Class III - Biologics - BPL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86012 - Class III - Biologics - BPL Plasma Inc,"Source Plasma, not meeting product specifications, was distributed.",2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70449 - Class III - Biologics - BPL Plasma Inc.,"Blood product, collected from a donor for whom there was no documentation of an arm inspection, was distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77183 - Class III - Biologics - BPL Plasma Inc.,"Plasma product, for which donor eligibility screening was performed incorrectly, was distributed.",2017-05-09,2017-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77448 - Class III - Biologics - BPL Plasma Inc.,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-07-17,2017-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78452 - Class III - Biologics - BPL Plasma Inc.,"Source Plasma units, not meeting product specifications, were distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78525 - Class III - Biologics - BPL Plasma Inc.,"Source Plasma unit, not meeting product specifications, was distributed.",2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82772 - Class III - Biologics - BPL Plasma Inc.,"Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85877 - Class III - Biologics - BPL Plasma Inc.,"Source Plasma products, which may have been exposed to unacceptable temperatures, were distributed.",2020-07-22,2020-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71792 - Class II - Biologics - BPL Plasma, Inc","Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2015-08-14,2015-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72185 - Class III - Biologics - BPL Plasma, Inc","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-11-12,2015-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73161 - Class III - Biologics - BPL Plasma, Inc","Blood product, in which quality control and failure to quarantine unit due to medical history, was distributed.",2016-03-14,2016-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73774 - Class III - Biologics - BPL Plasma, Inc","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74463 - Class III - Biologics - BPL Plasma, Inc","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-06-28,2016-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74462 - Class III - Biologics - BPL Plasma, Inc","Blood product, collected from a donor for whom there was no documentation on the donor record of an arm inspection, was distributed.",2016-07-29,2016-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75906 - Class III - Biologics - BPL Plasma, Inc","Blood product, collected from a donor for whom there was no documentation on the donor record of an arm inspection or general appearance of the donor, was distributed.",2017-01-04,2017-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76303 - Class III - Biologics - BPL Plasma, Inc","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76833 - Class III - Biologics - BPL Plasma, Inc","Plasma product, for which donor eligibility screening was incorrectly performed, was distributed.",2017-04-20,2017-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77258 - Class III - Biologics - BPL Plasma, Inc","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-06-23,2017-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78029 - Class III - Biologics - BPL Plasma, Inc","Source Plasma, collected from an ineligible donors, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78077 - Class II - Biologics - BPL Plasma, Inc","Source Plasma, collected from ineligible donors, were distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78278 - Class III - Biologics - BPL Plasma, Inc","Source Plasma unit, not meeting product specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78282 - Class III - Biologics - BPL Plasma, Inc","Source Plasma unit, not meeting product specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78285 - Class III - Biologics - BPL Plasma, Inc","Source Plasma unit, not meeting product specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78454 - Class III - Biologics - BPL Plasma, Inc","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78498 - Class III - Biologics - BPL Plasma, Inc","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78524 - Class III - Biologics - BPL Plasma, Inc","Source Plasma units, not meeting product specifications, were distributed.",2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78529 - Class III - Biologics - BPL Plasma, Inc","Source Plasma units, not meeting product specifications, were distributed.",2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78551 - Class III - Biologics - BPL Plasma, Inc","Source Plasma units, not meeting product specifications, were distributed.",2017-11-14,2017-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80726 - Class III - Biologics - BPL Plasma, Inc","Blood product, collected from a donor identified as unsuitable due to a donor screening deviation, was distributed.",2018-08-29,2018-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80902 - Class III - Biologics - BPL Plasma, Inc","Source Plasma, exposed to unacceptable storage temperatures and not re-labeled as Source Plasma, Salvaged was distributed.",2018-09-26,2018-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82805 - Class III - Biologics - BPL Plasma, Inc","Source plasma product, exposed to unacceptable storage temperatures and not re-labeled as Source Plasma, Salvaged, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83126 - Class III - Biologics - BPL Plasma, Inc","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83134 - Class III - Biologics - BPL Plasma, Inc","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83225 - Class III - Biologics - BPL Plasma, Inc","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-27,2019-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82808 - Class III - Biologics - BPL Plasma, Inc","Source Plasma, collected from a donor in which donor eligibility was not adequately determined, was distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83720 - Class II - Biologics - BPL Plasma, Inc","Source Plasma, collected from a donor who received a tattoo within 12 months of donating, were distributed.
",2019-09-13,2019-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83668 - Class II - Biologics - BPL Plasma, Inc","Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2019-10-11,2019-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84276 - Class II - Biologics - BPL Plasma, Inc","Source Plasma, collected from an ineligible donor, was distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84278 - Class II - Biologics - BPL Plasma, Inc","Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2019-12-20,2019-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85418 - Class II - Biologics - BPL Plasma, Inc",Source Plasma units were distributed after a failure to quarantine related to the donor's medical history.,2020-04-08,2020-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85481 - Class III - Biologics - BPL Plasma, Inc","Source Plasma, not meeting product specifications, was distributed.",2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85419 - Class II - Biologics - BPL Plasma, Inc","Source Plasma, collected from a donor who received a piercing within one year of donation, were distributed.
",2020-04-25,2020-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73725 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2016-04-07,2016-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70161 - Class II - Biologics - BPL Plasma, Inc.","Blood product, for which the donor did not meet acceptance criteria, was distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70769 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor who had been incarcerated, were distributed.",2015-04-24,2015-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71012 - Class III - Biologics - BPL Plasma, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71463 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed",2015-07-21,2015-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71513 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor whose suitability was not adequately determined, was distributed.",2015-07-24,2015-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71661 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor whose arm inspection was not documented, was distributed.",2015-08-05,2015-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71685 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2015-08-14,2015-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71638 - Class III - Biologics - BPL Plasma, Inc.","Blood products, in which quality control and distribution/failure to quarantine units due to medical history, were distributed.",2015-08-20,2015-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72062 - Class II - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor who did not have a complete physical examination, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72063 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor in which there was no documentation of an arm or mouth inspection, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72064 - Class III - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor for whom there was no documentation of  checking the arm, mouth, or general appearance on the day of donation, were distributed.",2015-10-05,2015-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72277 - Class II - Biologics - BPL Plasma, Inc.","Blood products, which were not quarantined after receiving post donation information concerning receipt of a tattoo, were distributed.",2015-10-22,2015-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72334 - Class III - Biologics - BPL Plasma, Inc.","Blood product, in which donor suitability was not adequately determined, was distributed.",2015-10-22,2015-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72291 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor who received a tattoo and involved in high risk activity, were distributed.",2015-10-23,2015-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72267 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor who was at risk for Creutzfeldt-Jakob Disease (CJD), were distributed.",2015-11-03,2015-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72263 - Class II - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor who had previously tested reactive for Hepatitis C (HCV), was distributed.",2015-11-04,2015-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72584 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor who received body piercings within one year of donation, were distributed.",2015-12-04,2015-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72769 - Class III - Biologics - BPL Plasma, Inc.",Untested Source plasma for further manufacture was distributed.,2015-12-11,2015-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72691 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from an unsuitable donor, were distributed.",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72881 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor who subsequently tested HIV reactive, were distributed.

",2016-01-14,2016-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72835 - Class II - Biologics - BPL Plasma, Inc.","Blood products, for which donor suitability was inadequately determined, were distributed.",2016-01-21,2016-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73109 - Class II - Biologics - BPL Plasma, Inc.","Plasma products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73270 - Class II - Biologics - BPL Plasma, Inc.","Blood products, which were not quarantined due to medical history, were distributed.",2016-03-25,2016-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73271 - Class II - Biologics - BPL Plasma, Inc.","Blood products, which were not quarantined subsequent to receiving information regarding a post donation information, were distributed.",2016-03-25,2016-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73524 - Class III - Biologics - BPL Plasma, Inc.","Blood product for which donor screener failed to ask donor Pre-Donation Health History questions, was distributed.",2016-03-25,2016-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73723 - Class II - Biologics - BPL Plasma, Inc.",Source Plasma was inappropriately distributed.,2016-04-07,2016-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73406 - Class II - Biologics - BPL Plasma, Inc.","Blood product, in which quality control and distribution/testing not performed, incompletely performed, or not documented, was distributed.",2016-04-14,2016-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73904 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-05-02,2016-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73724 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor whose physical examination was not documented, were distributed.",2016-05-04,2016-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73731 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73732 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73771 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor with no documentation of general appearance or arm inspection, was distributed.",2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73772 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed",2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73775 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor whose suitability was not adequately determined, was distributed.",2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73927 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from an ineligible donor, were distributed.",2016-05-17,2016-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73902 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor for whom no documentation of an arm inspection and/or screening questions, was distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73928 - Class II - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor who had been incarcerated, was distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73972 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from an ineligible donor, was distributed.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74167 - Class II - Biologics - BPL Plasma, Inc.","Plasma products, for which donor eligibility determinations were inadequately performed, were distributed.",2016-05-31,2016-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74168 - Class II - Biologics - BPL Plasma, Inc.","Plasma products, collected from a donor who received a tattoo within a year of donating, were distributed.",2016-06-10,2016-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74261 - Class II - Biologics - BPL Plasma, Inc.","Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74266 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74268 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74459 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74461 - Class III - Biologics - BPL Plasma, Inc.","Blood product, in which donor screening/donor record incomplete or incorrect, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74644 - Class III - Biologics - BPL Plasma, Inc.","Blood product, in which donor screening/donor record incomplete or incorrect, was distributed.",2016-08-08,2016-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75232 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75259 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-10-26,2016-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75320 - Class III - Biologics - BPL Plasma, Inc.","Plasma product, for which the donor suitability was inadequately determined, was distributed.",2016-10-26,2016-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72428 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma, collected from ineligible donors, were distributed.",2016-11-17,2016-11-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75544 - Class III - Biologics - BPL Plasma, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75624 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75686 - Class III - Biologics - BPL Plasma, Inc.","Blood product, in which donor suitability was not adequately determined, was distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75704 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor for whom screening was incomplete, was distributed.",2016-12-08,2016-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75524 - Class III - Biologics - BPL Plasma, Inc.","Blood products, collected from ineligible donors, were distributed.",2016-12-14,2016-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75960 - Class II - Biologics - BPL Plasma, Inc.","Plasma products, for which a failure to quarantine units due to medical history occurred, were distributed.",2017-01-09,2017-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76305 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-02-21,2017-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76526 - Class II - Biologics - BPL Plasma, Inc.","Plasma products, for which donor screening was incorrectly performed, were distributed.",2017-03-01,2017-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76671 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76692 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76949 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76959 - Class III - Biologics - BPL Plasma, Inc.","Plasma product, for which the donor screening was performed incorrectly, was distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76999 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-05-15,2017-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77098 - Class III - Biologics - BPL Plasma, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-05-15,2017-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77067 - Class III - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2017-05-23,2017-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77462 - Class III - Biologics - BPL Plasma, Inc.","Blood products, in which quality control and distribution/testing not performed, incompletely performed, or not documented, were distributed.",2017-07-05,2017-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78025 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78026 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78027 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78028 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78030 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donors, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78045 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donors, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78046 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78076 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma, collected from ineligible donors, were distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78272 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78274 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78275 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78276 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78279 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78280 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78281 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78283 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78284 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78438 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78439 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78440 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78451 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78453 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78455 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78456 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78457 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78458 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78459 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78499 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78514 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78515 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78526 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78527 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2017-11-13,2017-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78550 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.
",2017-11-14,2017-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78882 - Class III - Biologics - BPL Plasma, Inc.","Plasma product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-01-23,2018-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79461 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2018-03-19,2018-03-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81772 - Class II - Biologics - BPL Plasma, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2019-02-01,2019-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81992 - Class II - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor who received a tattoo within 12 months of donation, was distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82776 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82778 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82779 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82804 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82810 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82812 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82811 - Class III - Biologics - BPL Plasma, Inc.","Source plasma blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-05-24,2019-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82813 - Class III - Biologics - BPL Plasma, Inc.","Source plasma blood products, collected from a donor who was illiterate, were distributed.",2019-05-24,2019-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83123 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83124 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83128 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83131 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83132 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83133 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83226 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-27,2019-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83227 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-27,2019-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82815 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who received a tattoo within one year of donation, was distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83186 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma units, collected from a donor who had an undocumented tattoo within the last 12 months, were distributed.

",2019-07-12,2019-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83390 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who failed arm inspection and/or general appearance, were distributed.

",2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83677 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who received a tattoo within one year of donation, was distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83694 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who received a tattoo within one year of donation, was distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83695 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who received a tattoo within one year of donation, was distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83217 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, collected from ineligible donors, were distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84906 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85319 - Class II - Biologics - BPL Plasma, Inc.","Blood product, collected from a donor who received a tattoo within 12 months of donation, was distributed.",2020-04-28,2020-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85713 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.",2020-06-09,2020-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85813 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, were distributed.
",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85913 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, collected from a donor whose donor screening record was incomplete or incorrect, were distributed.",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85851 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma, collected from a donor who received a tattoo within one year of donation, was distributed.",2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86444 - Class II - Biologics - BPL Plasma, Inc.","Source Plasma, not meeting product specifications, was distributed.",2020-09-18,2020-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86918 - Class III - Biologics - BPL Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71225 - Class II - Biologics - BPL PLasma, Inc.","Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2015-06-10,2015-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71226 - Class III - Biologics - BPL PLasma, Inc.","Source plasma product collected from a donor for which suitability was inadequately determined, was distributed.",2015-06-10,2015-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71323 - Class III - Biologics - BPL PLasma, Inc.","Blood product, which was not quarantined subsequent to receiving information due to a donor vCJD risk, was distributed.",2015-06-23,2015-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72033 - Class II - Biologics - BPL PLasma, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69949 - Class III - Biologics - BPL Plasma, Inc. (Hot Springs)","Blood products, which were not quarantined subsequent to receiving information regarding unexplained weight loss, were distributed.",2015-01-15,2015-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71781 - Class II - Biologics - BPL Plasma, Inc. (Hot Springs)","Blood product, for which the donor was found not suitable for donation and product was not quarantined, was distributed.",2015-08-28,2015-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72029 - Class II - Biologics - BPL Plasma, Inc. (Hot Springs)","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75276 - Class III - Biologics - BPL Plasma, Inc. (Hot Springs)","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78273 - Class III - Biologics - BPL Plasma, Inc. (Hot Springs)","Source Plasma unit, not meeting product specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83216 - Class II - Biologics - BPL Plasma, Inc. (Hot Springs)","Source Plasma units, not meeting product specifications, were distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76452 - Class III - Biologics - BPL Plasma, Inc. (Texarkana)","Blood product, in which donor suitability was not adequately determined, was distributed.",2017-02-21,2017-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78277 - Class III - Biologics - BPL Plasma, Inc. (Texarkana)","Source Plasma unit, not meeting product specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78513 - Class III - Biologics - BPL Plasma, Inc. (Texarkana)","Source Plasma unit, not meeting product specifications, was distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82807 - Class III - Biologics - BPL Plasma, Inc. (Texarkana)","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63535 - Class III - Drugs - Bracco Diagnostic Inc,Presence of Particulate Matter; potential for charcoal particulates,2012-12-19,2012-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63765 - Class I - Drugs - Bracco Diagnostic Inc,Presence of Particulate Matter; fibers identified as cellulose and polyvinyl,2013-02-07,2013-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68812 - Class III - Drugs - Bracco Diagnostic Inc,Subpotent Drug: Low out of specification results for both pH and assay obtained during routine stability testing after 36 months.,2014-08-12,2014-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69389 - Class III - Drugs - Bracco Diagnostic Inc,Subpotent Drug: Out of Specification (OOS) result during routine stability testing at 24 months.,2014-10-09,2014-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71442 - Class III - Drugs - Bracco Diagnostic Inc,Failed stability specifications:This recall has been initiated due to out of specification results for viscosity.,2015-06-22,2015-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62636 - Class III - Drugs - Bracco Diagnostics Inc,Short Fill:  The product is being recalled due to a potential underfill of the affected vials.,2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62735 - Class II - Drugs - Bracco Diagnostics Inc,Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.,2012-08-28,2012-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62866 - Class II - Drugs - Bracco Diagnostics Inc,GMP deviation; Sr-82 levels exceeded alert limit specification,2012-09-21,2012-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65878 - Class II - Drugs - Bracco Diagnostics Inc,Presence of foreign substance: One lot of the product may contain black foreign particles,2013-08-12,2013-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66032 - Class III - Drugs - Bracco Diagnostics Inc,Failed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.,2013-08-22,2013-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67262 - Class III - Drugs - Bracco Diagnostics Inc,Failed Stability Testing: This product is below specification for preservative content.,2014-02-07,2014-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79481 - Class II - Drugs - Bracco Diagnostics Inc.,Failed stability specifications: Out-of-specification (OOS) result for a preservative assay - methylparaben - during stability testing of one lot.,2018-03-29,2018-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65676 - Class III - Drugs - Braintree Laboratories Inc.,Defective Container; Small micro fracture observed in the 2-Liter bottle at the fill line resulting in a small leak when patient reconstitutes the bulk powder,2013-08-20,2013-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72563 - Class III - Drugs - Breckenridge Pharmaceutical, Inc",Presence of Foreign Tablets/Capsules: one foreign capsule identified as omeprazole 10 mg was found in the bottle,2015-11-10,2015-11-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85186 - Class II - Drugs - Breckenridge Pharmaceutical, Inc",CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.,2020-03-23,2020-03-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85054 - Class III - Drugs - Breckenridge Pharmaceutical, Inc",Failed Impurities/Degradation Specifications: Out-of-specification results obtained for impurities during stability testing.,2020-03-25,2020-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87498 - Class II - Drugs - Breckenridge Pharmaceutical, Inc",Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.,2021-03-18,2021-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81523 - Class III - Drugs - Breckenridge Pharmaceutical, Inc.",Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.,2018-11-20,2018-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77375 - Class I - Drugs - Brian P. Richardson,"Marketed without an Approved NDA/ANDA; FDA analysis result found product to contain sildenafil, tadalafil and undeclared milk",2017-08-22,2017-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82584 - Class I - Drugs - Brian P. Richardson,"Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared sildenafil and tadalafil, two FDA approved drugs for the treatment of male erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.",2019-04-22,2019-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68276 - Class I - Drugs - Bristol-Meyers Squibb,Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials,2014-09-18,2014-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62898 - Class II - Drugs - Bristol-myers Squibb Company,"Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly labeled as Kombiglyze XR 2.5mg/1000mg on the external package carton, whereas the contents were Kombiglyze XR 5 mg/500 mg blister packaged tablets.  The individual blister units are labeled correctly.",2012-10-24,2012-10-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63043 - Class I - Drugs - Bristol-myers Squibb Company,Superpotent (Single Ingredient) Drug: All BiCNU lots within expiration which contain carmustine vial lots manufactured by BenVenue Laboratories (BVL) are being recalled because of an overfilled vial discovered during stability testing for a single carmustine lot.,2012-10-24,2012-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77414 - Class I - Drugs - Bristol-myers Squibb Company,Labeling: Label Mix-up: One bottle of Eliquis 5 mg tablet was found to contain lower-strength Eliquis 2.5 mg tablets only instead of the labeled 5 mg tablets.,2017-07-11,2017-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63706 - Class II - Drugs - Bristol Myers Squibb Manufacturing Company,"CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86127 - Class I - Drugs - Broncolin, S.A. de C.V.","Chemical Contamination: HERBACIL, Antiseptic Hand Sanitizer, 70% Alcohol,  was found to be below the label claim for ethanol content and contained methanol., CGMP Deviations: products were recalled because they were manufactured in the same facility as the product found to contain methanol.",2020-09-11,2020-09-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67026 - Class I - Drugs - Brookfield Prescription Center Inc,Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.,2014-04-21,2014-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68616 - Class II - Drugs - Brookfield Prescription Center Inc. dba MD Custom Rx,Incorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.,2014-07-03,2014-07-03,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63867 - Class I - Drugs - Brower Enterprises Inc,"Marketed without an Approved NDA/ANDA: Brower  Enterprises Inc., is recalling its WOW Health Enterprises Dietary Supplement, because it contains undeclared drug ingredients making it an unapproved drug.  FDA sample analysis has found the product to contain methocarbamol, dexamethasone, and diclofenac.",2013-04-23,2013-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73683 - Class III - Drugs - Bryant Ranch Prepack Inc.,"Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation.",2016-05-04,2016-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80634 - Class II - Drugs - Bryant Ranch Prepack Inc.,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-02,2018-08-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90481 - Class I - Drugs - Bryant Ranch Prepack, Inc.","Labeling: Label Mix-up:  bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.   
",2022-07-08,2022-07-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87283 - Class I - Drugs - Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals","Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets., Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.",2021-03-16,2021-03-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88861 - Class I - Drugs - Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals",Labeling: Label Error on Declared Strength; Bottles labeled as Methocarbamol 500 mg Tablets actually contain Methocarbamol 750 mg Tablets,2021-11-02,2021-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88847 - Class III - Drugs - Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals","Labeling: Not Elsewhere Classified: the controlled substance classification ""CIII"" is missing on the label",2021-11-23,2021-11-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69649 - Class III - Biologics - BTG International Inc.,"Digoxin Immune Fab (Ovine), with incorrect prescribing information, was distributed.",2014-11-06,2014-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75566 - Class II - Drugs - Burel Pharmaceuticals Inc,CGMP Deviations; deficiencies at the manufacturer  may result in assay or content uniformity failures,2016-11-29,2016-11-29,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90382 - Class I - Drugs - Buzzagogo, LLC","Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain elevated levels of yeast and mold as well as the presence of Bacillus cereus.
",2022-06-24,2022-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78666 - Class III - Drugs - BYL Solutions Inc.,Marketed without an Approved NDA/ANDA; product found to be tainted with sildenafil,2018-02-12,2018-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72304 - Class II - Drugs - C. O. Truxton,Labeling: Wrong Bar Code,2015-11-10,2015-11-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77082 - Class I - Drugs - C. O. Truxton,"Labeling: Labeled Error on Declared Strength; report of a 1000 ct bottle labeled as Phenobarbital 15 mg tablets actually contained 30 mg tablets, Labeling: Label Mixup; potentially mislabeled",2017-08-22,2017-08-22,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62643 - Class II - Drugs - Cadence Pharmaceuticals,Presence of Particulate Matter: The firm initiated the recall due to visible presence of particulate matter.,2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75278 - Class II - Drugs - Cadila Pharmaceuticals Limited,Microbial Contamination of Non-Sterile Product,2016-12-01,2016-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86123 - Class II - Drugs - Calvin Scott & Company, Inc.",CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.,2020-08-20,2020-08-20,19,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86442 - Class II - Drugs - Calvin Scott & Company, Inc.",cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.,2020-10-02,2020-10-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90183 - Class I - Drugs - Calvin Scott & Company, Inc.",Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.,2022-06-09,2022-06-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82281 - Class II - Drugs - Camber Pharmaceuticals Inc,CGMP Deviations; trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) detected in the active pharmaceutical ingredient,2019-03-21,2019-03-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91239 - Class III - Drugs - Camber Pharmaceuticals, Inc",Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content,2022-12-28,2022-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76166 - Class II - Drugs - Cambrex Charles City Inc,Presence of Particulate Matter: Stainless steel in a chemical reactor dissolved into the API solution and was detected in the finished product.,2017-01-26,2017-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45449 - Class II - Biologics - Cangene Corporation - Rh Plasma Center,"Blood product, quality control and distribution/required testing not performed for HIV/HCV Nucleic Acid Test (NAT), was distributed.",2013-02-26,2013-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68367 - Class III - Biologics - Cangene Plasma Resources, Inc.","Blood products, collected from a donor who did not have a complete medical history interview, were distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68370 - Class III - Biologics - Cangene Plasma Resources, Inc.","Blood products, collected from a donor who did not have a complete medical history interview, were distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68883 - Class III - Biologics - Cangene Plasma Resources, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72028 - Class I - Drugs - Cantrell Drug Company,"Subpotent Drug, Stability Data Does Not Support Expiry",2016-07-06,2016-07-06,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75745 - Class II - Drugs - Cantrell Drug Company,Lack of Assurance of Sterility - the firm is recalling select sterile drug products.,2016-12-13,2016-12-13,21,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77780 - Class II - Drugs - Cantrell Drug Company,Lack of Sterility Assurance.,2017-08-09,2017-08-09,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81556 - Class II - Drugs - CAO Group, Inc.",cGMP violations noted during the firm's most recent inspection.,2018-12-11,2018-12-11,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62756 - Class II - Drugs - Capco Custom Packaging Inc,Microbial Contamination of Non-Sterile Products; Product was found to be contaminated with Sphingomonas paucimobilis bacteria.,2012-08-28,2012-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83745 - Class III - Biologics - Captain James Lovell Federal Health Care Center,"Blood product, in which donor testing was not performed or incomplete, was distributed.",2019-10-18,2019-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85867 - Class III - Biologics - Captain James Lovell Federal Health Care Center,"Blood product, from a previously deferred donor, was distributed.",2020-06-22,2020-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86134 - Class III - Biologics - Captain James Lovell Federal Health Care Center,"Red Blood Cells, collected from a donor whos donor suitability was incomplete, were distributed
",2020-08-26,2020-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86135 - Class III - Biologics - Captain James Lovell Federal Health Care Center,"Whole Blood CPDA-1, collected from a donor whose body temperature was not recorded, was distributed.",2020-08-26,2020-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86136 - Class II - Biologics - Captain James Lovell Federal Health Care Center,"Whole Blood  CPDA-1, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2020-08-26,2020-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86137 - Class II - Biologics - Captain James Lovell Federal Health Care Center,"Whole Blood CPDA-1, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2020-08-26,2020-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87874 - Class II - Biologics - Captain James Lovell Federal Health Care Center,"Blood products, for which donor eligibility was incomplete, were distributed.
",2021-06-07,2021-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88328 - Class II - Biologics - Captain James Lovell Federal Health Care Center,"Blood products, collected from donors with incomplete donor eligibility determinations, were distributed.
",2021-08-09,2021-08-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63031 - Class II - Drugs - Caraco Pharmaceutical Laboratories Ltd.,Crystallization: Presence of crystals of Nimodipine within the capsule solution.,2012-10-03,2012-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67426 - Class II - Drugs - Caraco Pharmaceutical Laboratories Ltd.,Failed Tablet Specifications: Broken Tablets Present.,2014-02-10,2014-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70334 - Class III - Drugs - Cardinal Health,Labeling: Incorrect or Missing Package Insert: the package insert for the potassium chloride 8 mEq and 10 mEq strength instead of the potassium chloride 10 mEq and 20 mEq strength was packaged with the product.,2015-04-15,2015-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83731 - Class II - Drugs - Cardinal Health dba Specialty Pharmaceutical Services,Temperature Abuse; Product stored and shipped outside of labeled storage requirements.,2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89976 - Class I - Drugs - Cardinal Health Inc.,"TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions due to inclement weather. 
, TEMPERATURE ABUSE: Products were exposed to temperatures outside of the products labeled storage conditions 
",2022-05-19,2022-05-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87512 - Class II - Drugs - Cardinal Health Inc.,CGMP Deviations: Intermittent exposure to temperature excursion during storage.,2021-05-24,2021-05-24,198,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87489 - Class III - Drugs - Cardinal Health Inc.,Temperature Abuse,2021-03-29,2021-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75535 - Class III - Drugs - Care-Tech Laboratories, Inc.","Labeling: Incorrect or Missing Lot and/or Exp Date - Product is missing or has illegible lot and expiry codes, as well as defective or cracked caps.",2016-12-23,2016-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62971 - Class II - Drugs - Carefusion 213, Llc",Lack of Assurance of Sterility: A customer complaint reported some units had incomplete seals (open seals) on the Individual unit packaging.,2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62900 - Class II - Drugs - Carefusion 213, Llc","Lack of Assurance of Sterility: Firm mistakenly released quarantined, non conforming material that failed sterility testing.",2012-10-03,2012-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87715 - Class I - Drugs - CareFusion 213, LLC",Defective Delivery System: An increase in complaints identified endcap being loose or falling off upon activation releasing glass shards containing the solution.,2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64583 - Class II - Drugs - CareFusion 213, LLC",Labeling: Not Elsewhere Classified: This product is misbranded because the product is not sterile and the labeling is misleading in relation to sterility claims.,2013-03-28,2013-03-28,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68566 - Class II - Drugs - CareFusion 213, LLC",Lack of Assurance of Sterility; Immediate product pouches may not be properly sealed.,2014-07-17,2014-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69605 - Class III - Drugs - CareFusion 213, LLC",Does Not Meet Monograph: Chlorhexidine Gluconate  Surgical Scrub Brush is being recalled due to higher concentrations of available chlorhexidine gluconate.,2014-12-10,2014-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85903 - Class I - Drugs - CareFusion 213, LLC",Non-Sterility: Product is being recalled due to presence of Aspergillus Penicilloides,2020-08-19,2020-08-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86998 - Class I - Drugs - CareFusion 213, LLC","Non-sterility: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity., Microbial Contamination of Non-Sterile Products:Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity., Microbial Contamination of Non-Sterile Product: Product is being recalled to climatic Zone IV regions of the world where at the labeled storage conditions of 30*C/75% Relative Humidity for more than 6 months, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.",2021-02-19,2021-02-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87592 - Class I - Drugs - CareFusion 213, LLC","Non-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity., Microbial Contamination of Non-Sterile Product.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity., Microbial Contamination of Non-Sterile Product:.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity., Lack of Assurance of Sterility:  Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity., CGMP Deviations:  Product is being",2021-04-26,2021-04-26,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68176 - Class II - Drugs - Carefusion 2200 Inc,Subpotent Drug: CareFusion is recalling the CareFusion Scrub Care Surgical Scrub Brush-Sponge/Nail Cleaner. The available iodine in the product is less than as stated on the product label.,2014-06-05,2014-06-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64634 - Class II - Drugs - Carib Import & Export, Inc.",CGMP Deviations: this product is being recalled because an FDA inspection revealed that it was not manufactured under current good manufacturing practices.,2013-05-01,2013-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63190 - Class II - Biologics - CaridianBCT, Inc.","TerumoBCT Vista version 3.2 software, with a defect or glitch causing donors to be incorrectly deemed eligible, was distributed.",2012-11-15,2012-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90798 - Class II - Drugs - Carolina Infusion,Lack of Assurance of Sterility,2022-09-15,2022-09-15,20,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61864 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor in which donor screening/donor records were incomplete or incorrect.",2012-07-17,2012-07-17,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62931 - Class II - Biologics - Carter BloodCare,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-20,2012-09-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63626 - Class II - Biologics - Carter BloodCare,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-03,2012-12-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63757 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor who was previously deferred, were distributed",2012-12-27,2012-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65329 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-07-08,2013-07-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67143 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-01-31,2014-01-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67395 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2014-03-07,2014-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67694 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-03-27,2014-03-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67692 - Class III - Biologics - Carter BloodCare,"Blood Product, collected from a donor whose health history screening was not    adequately performed, was distributed.",2014-03-28,2014-03-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67744 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-04-11,2014-04-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68103 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68323 - Class II - Biologics - Carter BloodCare,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68602 - Class II - Biologics - Carter BloodCare,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-08-04,2014-08-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68661 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-08-13,2014-08-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68691 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-08-13,2014-08-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68823 - Class II - Biologics - Carter BloodCare,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-08-19,2014-08-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69153 - Class II - Biologics - Carter BloodCare,"Blood products, which were labeled as leukoreduced, but exceeded the acceptable limit for white blood cell count, were distributed.",2014-09-10,2014-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69176 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-10-09,2014-10-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69401 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-10-28,2014-10-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69620 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-12-01,2014-12-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70660 - Class II - Biologics - Carter BloodCare,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-04-16,2015-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70887 - Class II - Biologics - Carter BloodCare,"Blood products, in which donor screening/donor record incomplete or incorrect, were distributed.",2015-04-24,2015-04-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70953 - Class III - Biologics - Carter BloodCare,"Blood product, in which labeling/crossmatch tag, or missing information, was distributed.",2015-05-19,2015-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68105 - Class III - Biologics - Carter BloodCare,"Blood products, which may have reached unacceptable temperatures during storage, were distributed.",2015-06-10,2015-06-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72765 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2016-01-07,2016-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73039 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-02-04,2016-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74659 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-07-17,2016-07-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75087 - Class II - Biologics - Carter BloodCare,"Pooled platelets, which did not meet acceptable product specifications was distributed.",2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75431 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-10-13,2016-10-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75690 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donors who had taken Feldene,  Clopidogrel, and Plavix medication were distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75822 - Class II - Biologics - Carter BloodCare,"Apheresis products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-12-14,2016-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75981 - Class II - Biologics - Carter BloodCare,"Blood products, collected from ineligible donors, were distributed.",2017-01-26,2017-01-26,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76398 - Class III - Biologics - Carter BloodCare,"Blood products, collected from ineligible donors based on testing for relevant transfusion transmitted infection testing, were distributed.",2017-02-10,2017-02-10,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76940 - Class II - Biologics - Carter BloodCare,Blood products collected from a donor who traveled to a malarial endemic area were distributed.,2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76817 - Class II - Biologics - Carter BloodCare,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2017-05-09,2017-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76881 - Class III - Biologics - Carter BloodCare,"Platelet pool, lacking assurance regarding bacterial contamination risk, was distributed.",2017-05-12,2017-05-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77863 - Class II - Biologics - Carter BloodCare,"Blood products, for which the donor's screening record was incomplete, were distributed.",2017-08-10,2017-08-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78222 - Class III - Biologics - Carter BloodCare,"Blood products, stored in conditions that lacked assurance of proper temperature monitoring, were distributed.",2017-10-10,2017-10-10,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80350 - Class II - Biologics - Carter BloodCare,"Blood products, for which donor suitability was inadequately determined, were distributed.",2018-07-12,2018-07-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80870 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81370 - Class II - Biologics - Carter BloodCare,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2018-10-30,2018-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81696 - Class II - Biologics - Carter BloodCare,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-12-20,2018-12-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82132 - Class II - Biologics - Carter BloodCare,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82529 - Class III - Biologics - Carter BloodCare,"Blood product, for which donor eligibility screening was incorrectly performed, was distributed.",2019-04-12,2019-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85075 - Class III - Biologics - Carter BloodCare,"Red Blood Cell product, which was not prepared within the appropriate time frame after collection, was distributed.
",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86551 - Class II - Biologics - Carter BloodCare,"Red Blood Cell product that failed quality control for residual WBC count, was distributed.
",2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88167 - Class III - Biologics - Carter BloodCare,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2021-07-13,2021-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88709 - Class III - Biologics - Carter BloodCare,"Blood Products, collected from a donor who did not fully read educational materials, was distributed.",2021-09-27,2021-09-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88943 - Class III - Biologics - Carter BloodCare,"Platelet product, for which donor eligibility was incomplete, was distributed.
",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89476 - Class III - Biologics - Carter BloodCare,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.
",2022-02-09,2022-02-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89891 - Class II - Biologics - Carter BloodCare,"Apheresis Red Blood Cell product, possibly contaminated with air, was distributed. 
",2022-04-07,2022-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76918 - Class II - Biologics - Carter BloodCare - Tyler,"Blood product, which did not meet the acceptable product specifications, was distributed.",2017-05-09,2017-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78002 - Class III - Biologics - Carter BloodCare - Tyler,"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2017-09-07,2017-09-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78137 - Class II - Biologics - Carter BloodCare - Tyler,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2017-10-13,2017-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79187 - Class II - Biologics - Carter BloodCare - Tyler,"Blood products, in which quality control for Factor VIII testing did not meet specifications, were distributed.
",2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86090 - Class III - Biologics - Carter BloodCare - Tyler,"Blood products, not manufactured according to product specifications, were distributed.",2020-08-03,2020-08-03,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68689 - Class II - Biologics - Carter BloodCare, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-08-05,2014-08-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69004 - Class III - Biologics - Carter BloodCare, Inc.","Blood products, shipped using coolers that had not been validated and possibly reached unacceptable temperatures, were distributed.",2014-09-16,2014-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69815 - Class II - Biologics - Carter BloodCare, Inc.","Blood products, collected from a donor in which suitability was not adequately determined, were distributed.",2014-12-05,2014-12-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73567 - Class II - Biologics - Carter BloodCare, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-04-25,2016-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65199 - Class II - Biologics - Carter BloodCare/ WE & Lela I Stewart Blood Center, Inc","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67621 - Class II - Biologics - Carter BloodCare/ WE & Lela I Stewart Blood Center, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-03-10,2014-03-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68086 - Class III - Biologics - Carter BloodCare/ WE & Lela I Stewart Blood Center, Inc","Blood components, incorrectly labeled as units of Fresh Frozen Plasma, were distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68575 - Class II - Biologics - Carter BloodCare/ WE & Lela I Stewart Blood Center, Inc","Blood products, collected from a donor whose health history was inadequately determined, were distributed.",2014-07-30,2014-07-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88222 - Class II - Drugs - Cascade Kelly Holdings LLC,CGMP Deviations: Does not meet monograph for denaturant.,2021-07-30,2021-07-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81775 - Class III - Drugs - CBI Laboratories, Inc.",Subpotent Drug:Out of specification for percentage of active pharmaceutical ingredients.,2018-12-20,2018-12-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43378 - Class II - Biologics - Cedars-Sinai Medical Center,"Blood products, collected from a donor who was previously deferred, were distributed.",2013-08-15,2013-08-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89563 - Class I - Drugs - Celebrate Today,"Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.",2022-02-28,2022-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68687 - Class III - Biologics - Celera Corporation,"ViroSeq HIV-1 Genotyping System v2.0, not meeting labeling claim, was distributed.",2014-09-19,2014-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76861 - Class II - Drugs - Cell Distributors Inc,"Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.",2017-05-24,2017-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68532 - Class I - Drugs - Central Admixture Pharmacy Services, Inc.",Non Sterility; microbial contamination identified as Aspergillus species,2014-08-25,2014-08-25,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70148 - Class I - Drugs - Central Admixture Pharmacy Services, Inc.",Non-Sterility: Out of specification results for the sterility test for microbial contamination.,2015-04-08,2015-04-08,34,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62531 - Class II - Biologics - Central Blood Bank,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-08-24,2012-08-24,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63987 - Class III - Biologics - Central Blood Bank,"Blood products, collected from a paid donor but incorrectly labeled with the ""volunteer donor"" classification, were distributed.",2013-01-30,2013-01-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64745 - Class III - Biologics - Central Blood Bank,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65053 - Class II - Biologics - Central Blood Bank,"Blood products, which did not undergo the required quality control testing, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65054 - Class II - Biologics - Central Blood Bank,"Blood products, quarantined pending discard, were distributed",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65536 - Class II - Biologics - Central Blood Bank,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66309 - Class II - Biologics - Central Blood Bank,"Blood product, which was labeled as leukoreduced, but was not tested to verify white blood cell count, was distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68461 - Class II - Biologics - Central Blood Bank,"Blood product, which failed the residual white blood cell count and labeled as leukoreduced, was distributed.",2014-06-27,2014-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70447 - Class II - Biologics - Central Blood Bank,"Blood product, which did not meet the acceptable product specifications, was distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70653 - Class II - Biologics - Central Blood Bank,"Platelet products, which did not meet specifications, were distributed.",2015-04-16,2015-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71512 - Class II - Biologics - Central Blood Bank,"Blood product, which was labeled as leukoreduced, but was not tested to verify white blood cell count, was distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61997 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2012-06-28,2012-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62517 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-07-25,2012-07-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64564 - Class II - Biologics - Central California Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64946 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 

",2013-05-24,2013-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66555 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-10-31,2013-10-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66556 - Class III - Biologics - Central California Blood Center,"Blood products, collected using a machine for which daily quality control testing was not performed, were distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66684 - Class III - Biologics - Central California Blood Center,"Blood products, collected using a trip scale for which daily QC was not properly recorded, were distributed.",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67772 - Class II - Biologics - Central California Blood Center,"Blood product, which was collected from a donor who  traveled to a malarial endemic area, was distributed.",2014-04-11,2014-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68182 - Class II - Biologics - Central California Blood Center,"Blood product, in which Quality Control and Distribution of product did not meet specifications, was distributed.",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68183 - Class II - Biologics - Central California Blood Center,"Blood products, in which platelet units failed residual white blood cell counts, were distributed.",2014-05-21,2014-05-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68102 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-06-03,2014-06-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68473 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-06-27,2014-06-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68325 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-07-01,2014-07-01,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69040 - Class II - Biologics - Central California Blood Center,"Blood product, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions was not asked, was distributed.",2014-09-09,2014-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69709 - Class II - Biologics - Central California Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70329 - Class II - Biologics - Central California Blood Center,"Blood product, collected from a donor who disclosed travel history that warranted deferral, was distributed.",2015-02-05,2015-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69202 - Class II - Biologics - Central California Blood Center,"Blood products, collected from donors who traveled to a malarial endemic area, were distributed.",2015-03-24,2015-03-24,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70782 - Class II - Biologics - Central California Blood Center,"Blood products, in which donor was incorrectly deleted from deferral list and/or prior deferral due to history, were distributed.",2015-04-13,2015-04-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71662 - Class III - Biologics - Central California Blood Center,"Blood products, collected using a Hemoflow device for which the quality control results were not documented, were distributed.",2015-08-07,2015-08-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71864 - Class III - Biologics - Central California Blood Center,"Blood products, collected using a mixer/scale device which failed quality control testing, were distributed.",2015-09-08,2015-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73075 - Class II - Biologics - Central California Blood Center,"Apheresis products, in which leuko reduced units did not meet WBC count specification, were distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73154 - Class II - Biologics - Central California Blood Center,"Blood products, which were collected in a manner that may have compromised the sterility of the collection system, were distributed.",2016-03-09,2016-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75380 - Class II - Biologics - Central California Blood Center,"Red Blood Cells, collected from a donor who was allowed to donate without documentation regarding history of travel to a Zika endemic risk area, were distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75382 - Class II - Biologics - Central California Blood Center,"Red Blood Cells, collected from a donor who was allowed to donate without documentation regarding history of travel to a Zika endemic risk area, were distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76558 - Class II - Biologics - Central California Blood Center,"Blood products collected from a donor who travelled to a malarial endemic area within a year of donation, were distributed.",2017-03-06,2017-03-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78374 - Class III - Biologics - Central California Blood Center,"Blood product, which was collected from a donor whose temperature was not documented, was distributed.",2017-11-02,2017-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79521 - Class II - Biologics - Central California Blood Center,"Blood products, for which donor screening was  incorrectly performed, were distributed.",2018-03-22,2018-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80123 - Class III - Biologics - Central California Blood Center,"Blood product, collected from a donor in which the donor's temperature was not documented, was distributed.",2018-06-08,2018-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80237 - Class II - Biologics - Central California Blood Center,"Blood product, which were collected from a donor who traveled to a malarial endemic area, was distributed.",2018-07-05,2018-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81138 - Class II - Biologics - Central California Blood Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81557 - Class II - Biologics - Central California Blood Center,"Blood product, collected from an ineligible donor, was distributed.",2018-11-15,2018-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81844 - Class II - Biologics - Central California Blood Center,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-02-07,2019-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82546 - Class III - Biologics - Central California Blood Center,"Blood product, for which the donor did not give history of receiving vaccines which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed..",2019-04-09,2019-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86141 - Class II - Biologics - Central California Blood Center,"Red Blood Cell product, collected from a donor who lived in a malarial endemic area, was distributed.
",2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86306 - Class II - Biologics - Central California Blood Center,"Platelets, Pathogen Reduced, for which donor eligibility screening was incomplete, were distributed.",2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86308 - Class II - Biologics - Central California Blood Center,"Platelets, Pathogen Reduced, for which donor eligibility screening was incomplete, were distributed.",2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86492 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor whose donor eligibility was incomplete, were distributed.",2020-09-25,2020-09-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86493 - Class III - Biologics - Central California Blood Center,"Blood products, collected from a donor whose donor eligibility was incomplete, were distributed.",2020-09-25,2020-09-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86552 - Class III - Biologics - Central California Blood Center,"Plateletpheresis products, for which donor eligibility was incomplete, were distributed.
",2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86893 - Class II - Biologics - Central California Blood Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86913 - Class II - Biologics - Central California Blood Center,"Blood Products, for which donor eligibility was incomplete, were distributed.
",2020-12-16,2020-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86943 - Class III - Biologics - Central California Blood Center,"Blood products, collected from a donor not meeting re-entry criteria from a prior deferral, were distributed.",2020-12-22,2020-12-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87106 - Class III - Biologics - Central California Blood Center,"Apheresis Platelets, Leukoreduced,for which donor eligibility screening was incomplete, were distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87347 - Class II - Biologics - Central California Blood Center,"Platelet product, for which donor eligibility was incomplete, was distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87522 - Class III - Biologics - Central California Blood Center,"Platelet product, for which donor eligibility was incomplete, was distributed.
",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88743 - Class II - Biologics - Central California Blood Center,"Blood product, which were collected from a donor who lived in a malarial endemic area, was distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89187 - Class II - Biologics - Central California Blood Center,"Platelets, Pathogen Reduced, for which donor eligibility screening was incomplete, were distributed.",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89188 - Class II - Biologics - Central California Blood Center,"Blood products, collected from a donor for whom donor suitability was incomplete, were distributed.
",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89265 - Class III - Biologics - Central California Blood Center,"Red Blood Cell, collected from a donor whose body temperature was not documented, was distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89360 - Class III - Biologics - Central California Blood Center,"Blood product, collected from a donor whose body temperature was not documented during the donor screening process, was distributed.",2022-01-19,2022-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89405 - Class III - Biologics - Central California Blood Center,"Red Blood Cell product, for which the donor's body temperature was not documented, was distributed.",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89497 - Class II - Biologics - Central California Blood Center,"Leukoreduced Red Blood Cell, for which donor eligibility screening was incomplete, was distributed.",2022-02-04,2022-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89734 - Class II - Biologics - Central California Blood Center,"Platelets, Pathogen Reduced, for which donor eligibility screening was incomplete, were distributed.",2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89988 - Class III - Biologics - Central California Blood Center,"Leukoreduced Red Blood Cell, collected from a donor whose temperature was not documented, was distributed.",2022-04-20,2022-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90440 - Class II - Biologics - Central California Blood Center,"Blood product, collected from a donor who tested positive for Hepatitis C antibody, was distributed",2022-06-22,2022-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91210 - Class III - Biologics - Central California Blood Center,"Leukoreduced Red Blood Cells, collected with too much anticoagulant, were distributed.",2022-12-08,2022-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91256 - Class III - Biologics - Central California Blood Center,"Red Blood Cell product, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62821 - Class II - Biologics - Central Jersey Blood Center, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63679 - Class II - Biologics - Central Jersey Blood Center, Inc.","Blood product, mislabeled as to antigen phenotype, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67333 - Class III - Biologics - Central Jersey Blood Center, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68372 - Class II - Biologics - Central Jersey Blood Center, Inc.","Blood product, collected from a donor who emigrated from a malarial endemic area, was distributed.",2014-06-26,2014-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76956 - Class II - Biologics - Central Jersey Blood Center, Inc.","Apheresis product, with unacceptably high platelet concentrations, was distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78044 - Class II - Biologics - Central Jersey Blood Center, Inc.","Platelet products, for which the WBC count quality control was not performed and labeled as leukoreduced,  were distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43553 - Class II - Biologics - Central Kentucky Blood Center Inc,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42178 - Class III - Biologics - Central Kentucky Blood Center, Inc.","Blood products, which may have reached an unacceptable temperature during shipment, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39760 - Class II - Biologics - Central Kentucky Blood Center, Inc.","Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed",2013-06-17,2013-06-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50716 - Class II - Biologics - Central Kentucky Blood Center, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75562 - Class III - Biologics - Central Maine Medical Center/BB,"Blood products, labeled with an incorrect expiration date, were distributed.",2016-12-02,2016-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86935 - Class II - Biologics - Central Ohio Lions Eye Bank Inc,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2020-12-08,2020-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64192 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64743 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, which was not quarantined after the donor provided information concerning a post-donation illness, was distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66006 - Class III - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor who previously tested positive for NAT, were distributed.",2013-09-13,2013-09-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66367 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66405 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor who received a body piercing within 12 months of donating, was distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67212 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67822 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor who lived in an area considered endemic for malaria, was distributed.",2014-04-16,2014-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67823 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor who lived in an area considered endemic for malaria, were distributed.",2014-04-16,2014-04-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68510 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor who reported travel to an area possibly endemic for malaria, was distributed.",2014-07-23,2014-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68919 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor considered to be at increased risk for Creutzfeldt-Jacob Disease (CJD), were distributed., Blood products, collected from a donor considered to be at increased risk for Creutzfeldt-Jacob Disease (CJD), were distributed",2014-08-22,2014-08-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69030 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, in which donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed",2014-09-09,2014-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72206 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from an ineligible donor, were distributed.",2015-09-17,2015-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72188 - Class III - Biologics - Central Pennsylvania Blood Bank,"Blood product, which was stored at an unacceptable temperature, was distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72766 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-01-07,2016-01-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72783 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-01-07,2016-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72955 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2016-01-21,2016-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73105 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-02-18,2016-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73368 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-03-04,2016-03-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73819 - Class II - Biologics - Central Pennsylvania Blood Bank,Blood Products collected from a donor who traveled to a malaria endemic area were distributed.,2016-04-29,2016-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73920 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-05-03,2016-05-03,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74257 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-06-23,2016-06-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77809 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2017-08-18,2017-08-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78948 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor who took medication that may affect platelet function, was distributed.",2018-01-24,2018-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81624 - Class III - Biologics - Central Pennsylvania Blood Bank,Blood product for which a visual inspection was not performed or documented was distributed.,2018-11-30,2018-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81625 - Class III - Biologics - Central Pennsylvania Blood Bank,Blood product for which a visual inspection was not performed or documented was distributed.,2018-11-30,2018-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84360 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2019-12-20,2019-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85280 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood product, collected from a donor whose donor eligibility was incomplete, was distributed.",2020-03-20,2020-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87755 - Class II - Biologics - Central Pennsylvania Blood Bank,"Blood products, collected in a manner that may have compromised the sterility of the closed system, were distributed.",2021-05-10,2021-05-10,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89410 - Class II - Biologics - Central Pennsylvania Blood Bank,"Red Blood Cell product, collected from a donor whose eligibility to donate was inadequately determined for malarial travel, was distributed.

",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66313 - Class II - Drugs - Central Shared Services dba Parallon,CGMP Deviation: Discoloration; Product fails specification for appearance/color.  A complaint was received regarding an abnormal appearance of children's ibuprofen suspension.,2014-02-04,2014-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67990 - Class II - Biologics - Central Shared Services, LLC.","Blood product, with a low platelet concentration, was distributed.",2014-05-23,2014-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68743 - Class II - Biologics - Central Shared Services, LLC.","Blood products, possibly air contaminated but not  labeled with a 24-hour expiration date, were distributed.

",2014-08-19,2014-08-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68825 - Class III - Biologics - Central Shared Services, LLC.","Blood product, collected from a donor that was missing or incorrectly identified on deferral list who should have been deferred due to history, was distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68858 - Class III - Biologics - Central Shared Services, LLC.","Blood product, prepared without the appropriate amount of additive (ADSOL), was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69608 - Class II - Biologics - Central Shared Services, LLC.","Blood product, with platelet concentration below the specified minimum requirement, was distributed.",2014-11-24,2014-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69609 - Class II - Biologics - Central Shared Services, LLC.","Blood product, in which donor screening did not meet acceptance criteria for hematocrit, was distributed.",2014-11-24,2014-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64066 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Blood product, collected that did not have WBC QC testing for contamination,  was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65659 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Blood products, labeled leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2013-08-22,2013-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66716 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Blood products, collected from a donor who had taken aspirin prior to donating, were distributed.

",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66903 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68852 - Class III - Biologics - Central Texas Regional Blood & Tissue Center,"Blood products, in which labels applied to blood units or products were incorrect or missing information, were distributed.",2014-09-09,2014-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72388 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2015-10-23,2015-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73841 - Class III - Biologics - Central Texas Regional Blood & Tissue Center,"Apheresis red cells, not meeting product specifications, were distributed.",2016-04-21,2016-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73906 - Class III - Biologics - Central Texas Regional Blood & Tissue Center,"Apheresis red cells, not meeting product specifications, were distributed.",2016-05-02,2016-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73901 - Class III - Biologics - Central Texas Regional Blood & Tissue Center,"Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74120 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Apheresis products, for which quality control testing for residual white blood cell count was not performed, were distributed.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74199 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Platelet products, labeled as leukoreduced, which did not meet leukoreduction criteria, were distributed.",2016-06-07,2016-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74077 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2016-06-13,2016-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76555 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Apheresis product for which white blood cell count testing was not performed, was distributed.",2017-03-06,2017-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76612 - Class III - Biologics - Central Texas Regional Blood & Tissue Center,"Blood products, whose relevant Transfusion-Transmitted Infection testing was performed incorrectly, were distributed.",2017-03-29,2017-03-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77056 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Apheresis products, in which quality control for residual WBC count was not performed, were distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78628 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Blood product, labeled as leukoreduced but failed quality control testing for WBC count, was distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80122 - Class II - Biologics - Central Texas Regional Blood & Tissue Center,"Apheresis products, not meeting product specifications, were distributed.
",2018-05-30,2018-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80625 - Class III - Biologics - Central Texas Regional Blood & Tissue Center,"Platelet products,labeled with the incorrect volume, were distributed.",2018-08-16,2018-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71401 - Class I - Drugs - Centro Naturista,"Marketed without an approved NDA/ANDA - Product contains undeclared sibutramine, desmethylsibutramine and phenolphthalein.",2016-05-26,2016-05-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77990 - Class II - Drugs - Centurion Labs, LLC",Microbial contamination of Non-sterile Products; potential B. cepacia contamination,2017-09-12,2017-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66012 - Class II - Drugs - Cetylite Industries, Inc.","Subpotent Drug: Cetacaine Topical Anesthetic Liquid is being recalled because one of the three active ingredients, tetracaine, is below the specification limit  at the 21 month stability test point.",2013-11-26,2013-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49085 - Class I - Drugs - Chang Kwung Products,"Marketed Without An Approved NDA/ANDA: Lightning Rod capsules are being recalled because FDA analysis found it to contain an undeclared analogue of sildenafil.  Sildenafil is the active ingredient in an FDA-approved product indicated for the treatment of male erectile dysfunction (ED), making this product an unapproved new drug.",2013-08-02,2013-08-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69779 - Class II - Drugs - Chaotic Labz,Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.,2014-12-22,2014-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88552 - Class II - Drugs - Charles Paint Research Inc,"CGMP Deviations: Product manufactured in same facility where product was found to contain acetaldehyde and acetal above the allowable limits., CGMP Deviations: Product contains acetaldehyde and acetal above the allowable limits.",2021-09-08,2021-09-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91123 - Class III - Biologics - Charles River Laboratories, Inc. DBA Charles River, Endosafe",Charles River identified distributed Product Code R130 (Single-Test product lot M3221S) involving a gel-clot potency test that did not meet product specifications during stability testing.,2023-01-27,2023-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72402 - Class II - Drugs - Chen Shwezin, Inc. dba Park Compounding Pharmacy",Lack of Assurance of Sterility: all sterile compounded products within expiry,2015-10-28,2015-10-28,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76407 - Class II - Drugs - Cherry Hill Sales Co.,CGMP Deviations,2017-02-18,2017-02-18,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77812 - Class I - Drugs - Chiavna Saffron LLC,Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil,2017-09-12,2017-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82993 - Class II - Drugs - Chiesi USA, Inc.",Failed Dissolution Specifications: Out of specification result for dissolution.,2019-06-13,2019-06-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39188 - Class II - Biologics - Children's Hospital of Orange County:  Blood & Donor Services,"Blood products, which were collected from a donor who had taken aspirin prior to the donation, were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68853 - Class III - Biologics - Childrens Hospital Colorado Transfusion Medical Services,"Blood product, in which the donor screening/donor record was incomplete or incorrect, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48862 - Class III - Biologics - Childrens Hospital Los Angeles,"Blood products, collected from a donor who was previously deferred, were distributed.",2013-07-10,2013-07-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41570 - Class III - Biologics - Childrens Hospital Los Angeles,"Blood product, in which an extended collection time for FFP, was distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87496 - Class II - Drugs - China Gel Inc,CGMP deviations: Product being recalled as it was made in the same facility where contamination with B. cepacia was found in other products.,2021-09-02,2021-09-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69076 - Class III - Drugs - ChiroNutraceutical LLC,Marketed without an Approved NDA/ANDA; Product contains unapproved hHCG.,2014-09-09,2014-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62461 - Class II - Drugs - Church & Dwight Inc,"CGMP Deviations: Product was made with an incorrect ingredient, Laureth-9 was mistakenly substituted for PEG.",2012-11-21,2012-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65642 - Class II - Drugs - Church & Dwight Inc,Presence of Foreign Substance: raw material recalled due to stainless steel and other contamination.,2013-07-12,2013-07-12,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76011 - Class III - Drugs - Cipher Pharmaceuticals US LLC,"Subpotent Drug: Product label claim is 4% Benzoyl Peroxide, Initial Stability testing showed variation within the lot outside of product specifications.",2016-12-28,2016-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88090 - Class II - Drugs - CIPLA,CGMP Deviations,2021-07-15,2021-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90608 - Class II - Drugs - CIPLA,Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.,2022-07-20,2022-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90702 - Class II - Drugs - CIPLA,Lack of Assurance of Sterility: Complaints received of defective container closure.,2022-08-05,2022-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90796 - Class II - Drugs - CIPLA,Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.,2022-09-07,2022-09-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90864 - Class II - Drugs - CIPLA,Lack of Assurance of Sterility,2022-09-27,2022-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90920 - Class II - Drugs - CIPLA,Lack of Assurance of Sterility: environmental monitoring failure.,2022-09-30,2022-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86969 - Class II - Drugs - CIPLA,cGMP deviations: Vials may not be sealed correctly affecting sterility.,2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87038 - Class II - Drugs - CIPLA,"Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline",2020-12-30,2020-12-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71133 - Class III - Drugs - Cipla Limited,Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.,2015-05-14,2015-05-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81795 - Class II - Drugs - Cipla Limited,Failed Dissolution Specifications.,2019-01-16,2019-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68210 - Class II - Biologics - Citra Labs LLC.,"Rejuvesol Red Blood Cell Processing Solution, with a potentially compromised container closure seal, was distributed.",2014-07-31,2014-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68649 - Class III - Biologics - Citra Labs LLC.,"ACD-A (Anticoagulant Citrate Dextrose Solution, Solution A, USP 50mL) contaminated with silicone particles, was distributed.",2014-09-18,2014-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74528 - Class II - Biologics - Citra Labs LLC.,"Citra Lab's ACD-A and tri-Citrasol anticoagulants, both manufactured in glass containers which may contain a defect and compromise sterility of the products, were distributed.",2016-08-29,2016-08-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76738 - Class III - Drugs - Citron Pharma Llc,Presence of Foreign Tablet/Capsule; Amoxicillin 500 mg was found in bottles of Penicillin V potassium 500 mg,2017-04-07,2017-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76733 - Class II - Drugs - Claris Lifesciences Inc,Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.,2017-03-24,2017-03-24,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78446 - Class III - Drugs - Claris Lifesciences Inc,Superpotent,2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64661 - Class II - Drugs - Clinical Specialties Compounding Pharmacy,"Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes, Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.",2013-07-03,2013-07-03,49,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65253 - Class II - Drugs - Clinical Specialties Compounding Pharmacy,Lack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye infections and FDA inspection findings resulted in concerns regarding quality control processes,2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74746 - Class III - Drugs - Clinique International,"Subpotent Drug: Two of the active sunscreen ingredients, octinoxate and octisalate, are below the specifications for assay.",2016-08-26,2016-08-26,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82620 - Class II - Drugs - CMC Enterprise Pharmacy,Lack of sterility assurance.,2019-04-23,2019-04-23,32,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80005 - Class II - Drugs - Coast Quality Pharmacy LLC,Lack of Assurance of Sterility,2018-05-10,2018-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83996 - Class II - Drugs - Coast Quality Pharmacy, LLC dba Anazao Health","Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.",2019-12-06,2019-12-06,31,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64375 - Class II - Biologics - Coastal Bend Blood Center,"Blood products, which were not quarantined subsequent to receiving information regarding donor's deferral status, were distributed.",2013-03-07,2013-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64866 - Class II - Biologics - Coastal Bend Blood Center,"Blood products, labeled leukoreduced without the assurance they met the criteria for leukoreduced products, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68511 - Class II - Biologics - Coastal Bend Blood Center,"Blood product, which was collected from a donor who had traveled to a malarial endemic area, was distributed.",2014-07-18,2014-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73229 - Class II - Biologics - Coastal Bend Blood Center,"Platelet product, collected from a duplicate donor who was previously deferred due to CJD travel risk, was distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76064 - Class II - Biologics - Coastal Bend Blood Center,"Blood products, collected from a donor at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76335 - Class II - Biologics - Coastal Bend Blood Center,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2017-02-03,2017-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76646 - Class III - Biologics - Coastal Bend Blood Center,"Blood components, not manufactured according to specifications, were distributed.",2017-03-16,2017-03-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77646 - Class II - Biologics - Coastal Bend Blood Center,"Blood product, in which donor deferral/donor incorrectly deleted from deferral list or donor not reentered properly, was distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85628 - Class II - Biologics - Coastal Bend Blood Center,"Blood products, collected from a donor who was a resident of a malarial endemic area, were distributed.",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86949 - Class II - Biologics - Coastal Bend Blood Center,"Blood products, collected from donors previously deferred for testing reactive for syphilis and who were not properly tested for re-entry, were distributed.",2020-12-16,2020-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87126 - Class II - Biologics - Coastal Bend Blood Center,"Platelet product, collected from a donor previously deferred for testing reactive for syphilis and was not properly tested for re-entry, was distributed.   
",2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87245 - Class III - Biologics - Coastal Bend Blood Center,Misbranded Blood Products were distributed.,2021-03-02,2021-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88375 - Class II - Biologics - Coastal Bend Blood Center,"Blood products, collected from a donor who lived in a malarial endemic area, were distributed.
",2021-08-20,2021-08-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88717 - Class III - Biologics - Coastal Bend Blood Center,"Pooled Cryoprecipitated AHF, which did not have cryo QC performed, was distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91011 - Class III - Biologics - Coastal Bend Blood Center,"Red Blood Cell product, which were processed with expired reagents, was distributed.
",2022-10-25,2022-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79671 - Class II - Drugs - Coastal Meds, LLC.",Presence of Particulate matter. Recall due to presence of unknown particulate matter.,2018-05-09,2018-05-09,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70921 - Class II - Drugs - Cody Laboratories, Inc.",Labeling: Label mix-up; bottles were incorrectly labeled as 10 mL instead of correctly labeled as 4 mL,2015-05-05,2015-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64143 - Class II - Biologics - Coffee Memorial Blood Center,"Blood product, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65549 - Class III - Biologics - Coffee Memorial Blood Center,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-08-14,2013-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66256 - Class II - Biologics - Coffee Memorial Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-10-18,2013-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66855 - Class II - Biologics - Coffee Memorial Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-12-19,2013-12-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #58605 - Class II - Biologics - Coffee Memorial Blood Center, Inc.","Blood products, for which the sterility may have been compromised, were distributed.",2012-12-03,2012-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76516 - Class III - Drugs - Colgate Palmolive Co,Label Mix up; rear panel is incorrectly labeled with the PreviDent 5000 Enamel Protect rear panel.,2017-03-15,2017-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74286 - Class II - Drugs - Colonia Care Pharmacy,Lack of Assurance of Sterility; sterility concerns with all injectable drug products that were made with sterilized filtered stock solutions.,2016-12-22,2016-12-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83427 - Class II - Drugs - Colonia Care Pharmacy,Lack of Assurance of Sterility: product sterility cannot be guaranteed.,2019-10-01,2019-10-01,32,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66839 - Class I - Drugs - Command Global LLC,Marketed Without an Approved NDA/ANDA: FDA sampling found undeclared  vardenafil and tadalafil in vitaliKOR capsules,2014-06-11,2014-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61938 - Class II - Biologics - Community Blood Bank of Erie County,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-06-11,2012-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62467 - Class II - Biologics - Community Blood Bank of Erie County,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64430 - Class III - Biologics - Community Blood Bank of Erie County,"Blood products, collected from donors whose hematocrits were determined using an analyzer with an invalid QC control, were distributed.

",2013-04-11,2013-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65638 - Class II - Biologics - Community Blood Bank of Erie County,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66366 - Class II - Biologics - Community Blood Bank of Erie County,"Blood product, labeled leukoreduced which did not meet the requirements for a leukoreduced product, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75133 - Class II - Biologics - Community Blood Bank of Erie County,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75275 - Class II - Biologics - Community Blood Bank of Erie County,"Blood products, which did not meet the acceptable product specifications, were distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77826 - Class II - Biologics - Community Blood Bank of Erie County,"Blood products, in which quality control and distribution/testing not performed, incompletely performed, or not documented, were distributed.",2017-08-18,2017-08-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87236 - Class II - Biologics - Community Blood Bank of Erie County,"Blood products, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2021-02-19,2021-02-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88417 - Class III - Biologics - Community Blood Bank of Erie County,"Leukoreduced Red Blood Cells, in which the donor temperature was not documented, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88708 - Class III - Biologics - Community Blood Bank of Erie County,"Blood product, which failed to meet volume specifications, was distributed.
",2021-09-24,2021-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89733 - Class II - Biologics - Community Blood Bank of Erie County,"Red Blood Cell product, for which residual WBC count did not meet specifications, was distributed.
",2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90931 - Class III - Biologics - Community Blood Bank of Erie County,"Platelets, Pathogen Reduced, not manufactured within the acceptable time frame from collection, were distributed.",2022-10-17,2022-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39117 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, which were collected from a donor with a history of multiple high risk behaviors, were distributed.",2012-07-16,2012-07-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39118 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, which were collected from a donor with a history of high risk behaviors, were distributed.",2012-07-16,2012-07-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39119 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from donors whose suitability to donate was not adequately determined, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42885 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor taking the medication Propecia, were distributed.",2012-07-16,2012-07-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43895 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-07-16,2012-07-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46537 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor with a history of Hepatitis A, were distributed",2012-07-16,2012-07-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49145 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, which were collected from a donor who had lived in a malarial endemic area, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50293 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products,  which did not meet the acceptable product specifications for release, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42875 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44403 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood product, which was collected from a donor who lived in a malarial endemic area, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45110 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collection bag with pin size hole under the label were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46539 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-08-01,2012-08-01,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47614 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-08-01,2012-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39899 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected using expired control materials, were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46538 - Class III - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, which Viral Testing performed, interpreted, or documented incorrectly, were distributed.",2012-08-08,2012-08-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62601 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood product, collected from a donor with a history of Hepatitis A, was distributed.",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47981 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor with a history of Hepatitis A, were distributed.",2012-08-16,2012-08-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40195 - Class III - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood product, viral testing performed, interpreted, or documented incorrectly, were distributed.",2012-08-27,2012-08-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48854 - Class III - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood product, labels applied to blood unit or product  with incorrect or missing information, was distributed.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47179 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, which was collected from a donor who  traveled to a malarial endemic area, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39116 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42883 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43239 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40232 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, which did not meet the acceptable product specifications, were distributed.",2012-12-03,2012-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63669 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-12-03,2012-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47980 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64629 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.",2013-04-11,2013-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65518 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-07-22,2013-07-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65962 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66850 - Class II - Biologics - Community Blood Bank of Lancaster County Medical Society,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39174 - Class III - Biologics - Community Blood Bank, Inc.","Blood products, prepared without additive (Optisol), were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41746 - Class II - Biologics - Community Blood Bank, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43063 - Class II - Biologics - Community Blood Bank, Inc.","Blood products, collected from a donor with a history of Hepatitis, were distributed.",2013-08-09,2013-08-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44641 - Class II - Biologics - Community Blood Bank, Inc.","Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48870 - Class II - Biologics - Community Blood Bank, Inc.","Blood products, which were collected from a donor who traveled to malarial endemic areas, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42437 - Class II - Biologics - Community Blood Bank, Inc.","Blood products, collected from a donor who immigrated from a malarial endemic country, were distributed.",2013-08-14,2013-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50715 - Class II - Biologics - Community Blood Bank, Inc.","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-09-04,2013-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41438 - Class II - Biologics - Community Blood Bank, Inc.","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-09-13,2013-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42160 - Class II - Biologics - Community Blood Bank, Inc.","Blood product, collected from a donor who traveled to potential malaria endemic areas, was distributed",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61930 - Class II - Biologics - Community Blood Center,"Blood product, which did not meet the acceptable product specifications, was distributed.",2012-06-12,2012-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42943 - Class II - Biologics - Community Blood Center,"Blood product, which was collected from a donor who had traveled to a malarial endemic area, was distributed.",2012-07-09,2012-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62570 - Class III - Biologics - Community Blood Center,"Blood products, labeled with extended expiration dates, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38787 - Class II - Biologics - Community Blood Center,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2012-07-31,2012-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38788 - Class II - Biologics - Community Blood Center,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38789 - Class II - Biologics - Community Blood Center,"Blood products, collected from a donor with a history of living with an individual diagnosed with Hepatitis B, were distributed.",2012-08-01,2012-08-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38790 - Class II - Biologics - Community Blood Center,"Blood product, with a low platelet count, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38791 - Class II - Biologics - Community Blood Center,"Blood product, with a low platelet count, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62635 - Class III - Biologics - Community Blood Center,"Blood product, labeled with an extended expiration date following irradiation, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63221 - Class II - Biologics - Community Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-19,2012-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63571 - Class II - Biologics - Community Blood Center,"Blood product, collected from a donor who had a previous history of travel to a malarial endemic area, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63763 - Class III - Biologics - Community Blood Center,"Blood products, leukodepleted greater than three days after collection, were distributed.",2012-12-27,2012-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63939 - Class II - Biologics - Community Blood Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65231 - Class III - Biologics - Community Blood Center,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65310 - Class III - Biologics - Community Blood Center,"Blood product, not labeled with a tag indicating that it contained anti-D, was distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66804 - Class II - Biologics - Community Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70231 - Class III - Biologics - Community Blood Center,"Skin grafts, that did not meet release criteria, were distributed.",2015-02-20,2015-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70347 - Class II - Biologics - Community Blood Center,"Blood products, which were incorrectly tested for CMV, were distributed.",2015-09-10,2015-09-10,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72452 - Class II - Biologics - Community Blood Center,"Blood product, for which the donor was previously deferred due to malarial history, was distributed.",2015-11-10,2015-11-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74381 - Class II - Biologics - Community Blood Center,"Blood product, in which labeling applied to blood unit or product incorrect or missing information, was distributed.",2016-07-29,2016-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76524 - Class III - Biologics - Community Blood Center,Bone allografts were inappropriately distributed.,2017-03-07,2017-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84403 - Class III - Biologics - Community Blood Center,"Plateletpheresis product, labeled with an incorrect expiration date, was distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85371 - Class II - Biologics - Community Blood Center,"Human skin allografts, where in-process controls were not followed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2020-04-02,2020-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86196 - Class II - Biologics - Community Blood Center,"Blood product, collected from a donor with risk factors for vCJD, was distributed.",2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88525 - Class III - Biologics - Community Blood Center,"Blood product, Labeled with incorrect or missing information, was distributed.",2021-08-24,2021-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89206 - Class II - Biologics - Community Blood Center,"Skin, processed in a manner that could cause contamination or cross-contamination, was distributed.",2021-12-23,2021-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91304 - Class II - Biologics - Community Blood Center,"Pooled Cryoprecipitated AHF, that was frozen over an hour after removal from centrifuge, was distributed.",2022-12-19,2022-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62742 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58498 - Class III - Biologics - Community Blood Center of Carolinas,"Blood products, which were not manufactured in accordance to acceptable product specifications, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63564 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, which was not tested to verify the pH and White Blood Cell count, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63812 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected from a donor whose eligibility to donate was not adequately determined, were distributed. 
 
",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64658 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-04-11,2013-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64659 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-04-22,2013-04-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64863 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-05-08,2013-05-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65105 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65267 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-07-02,2013-07-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65547 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-08-14,2013-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65548 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed.",2013-08-14,2013-08-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65835 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, collected in a manner that may have compromised the sterility of the collection system, was distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66283 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, collected from a donor who reported travel to an area possibly endemic for malaria, was distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66753 - Class III - Biologics - Community Blood Center of Carolinas,"Blood product, which may have been exposed to unacceptable temperatures during storage, was distributed",2013-12-11,2013-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66890 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67253 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, with no assurance that platelet counts met the specified minimum requirement, were distributed.
",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67699 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2014-04-09,2014-04-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68411 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, labeled as leukoreduced which did not meet the requirements for a leukoreduced product, was distributed.",2014-06-26,2014-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68541 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, in which quality control on a platelet apheresis product was found to be unacceptable, was distributed.",2014-07-18,2014-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68759 - Class III - Biologics - Community Blood Center of Carolinas,"Blood products, collected from a donor for whom there was no record of an arm inspection, were distributed.",2014-08-20,2014-08-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68760 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-08-20,2014-08-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69219 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2014-10-24,2014-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70253 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, with a low platelet count, were distributed..",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71153 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, which did not meet acceptable product specifications, was distributed.",2015-06-04,2015-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71321 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, which did not meet acceptable product specifications, were distributed.",2015-06-23,2015-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71620 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, with a low platelet count, was distributed.",2015-08-13,2015-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72007 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, in which component preparations were not prepared in accordance with specifications, were distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72219 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, with a low platelet yield, were distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72421 - Class II - Biologics - Community Blood Center of Carolinas,"Platelet Pheresis products, in which the platelet yield was below 3.0x10^11, were distributed.


",2015-10-23,2015-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72532 - Class II - Biologics - Community Blood Center of Carolinas,"Plateletphersis products, with a low platelet yield, were distributed.",2015-12-02,2015-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72693 - Class II - Biologics - Community Blood Center of Carolinas,"Apheresis products, in which the platelet yield was below 3.0x10^11, were distributed.",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72790 - Class II - Biologics - Community Blood Center of Carolinas,"Apheresis products, in which platelet yield did not meet specifications, were distributed.",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73414 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, which did not meet the acceptable product specifications, was distributed.",2016-04-14,2016-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76528 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected in a manner with a potential for air contamination, were distributed.",2017-03-01,2017-03-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77904 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2017-08-28,2017-08-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78414 - Class II - Biologics - Community Blood Center of Carolinas,"Plasma product for which the donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79260 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected from an ineligible donor, were distributed.",2018-04-03,2018-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79261 - Class II - Biologics - Community Blood Center of Carolinas,"Blood products, collected from an ineligible donor, were distributed.",2018-04-03,2018-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79574 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2018-04-27,2018-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80787 - Class III - Biologics - Community Blood Center of Carolinas,"Blood product, which was labeled with an incorrect product and anticoagulant volume, was distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82053 - Class II - Biologics - Community Blood Center of Carolinas,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2019-03-04,2019-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83029 - Class III - Biologics - Community Blood Center of Carolinas,"Blood products, which failed to meet the minimum specification for percent red blood cell recovery, were distributed.",2019-07-15,2019-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83392 - Class II - Biologics - Community Blood Center of Carolinas,"Plateletpheresis products, in which residual WBC count was not performed, were distributed.
",2019-08-13,2019-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83703 - Class II - Biologics - Community Blood Center of Carolinas,"Leukoreduced Apheresis Red Blood Cells, which were labeled as antigen negative, but were collected from a donor who subsequently tested antigen positive, were distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84390 - Class II - Biologics - Community Blood Center of Carolinas,"Irradiated Apheresis Washed Platelets, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85013 - Class II - Biologics - Community Blood Center of Carolinas,"Plateletpheresis product, not meeting product specifications, was distributed.",2020-02-19,2020-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87197 - Class II - Biologics - Community Blood Center of Carolinas,"Plateletpheresis products, which did not meet acceptable product specifications, were distributed.
",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46541 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood products, possibly contaminated with Propionibacterium species, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39122 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, which did not meet the acceptable product specifications, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41165 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41481 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46540 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40124 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40154 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40477 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood products, which may have been exposed to unacceptable storage temperatures, were distributed. 
",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40560 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood product, which did not have the preservative solution added but labeled with a 42 day expiration date, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40721 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood product, which did not have the preservative solution added but labeled with a 42 day expiration date, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40771 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40997 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41015 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41141 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41550 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39625 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood products, stored under improper conditions, were distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40066 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood product, stored at unacceptable temperatures, was distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39682 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40063 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39124 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood product, for which viral marker testing was incomplete, were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40097 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood Products, possible exposed to unacceptable temperatures, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41467 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood product, manufactured without additive solution, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41764 - Class II - Biologics - Community Blood Center of Greater Kansas City,Blood product which did not meet Quality Control  specifications was distributed.,2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39813 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood products, with invalid HIV/HCV nucleic acid testing (NAT) results, were distributed.",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50295 - Class II - Biologics - Community Blood Center of Greater Kansas City,"Blood products, collected from a donor with a history of living with an individual diagnosed with Hepatitis B, were distributed.",2012-11-16,2012-11-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68835 - Class III - Biologics - Community Blood Center of Greater Kansas City,"Blood products, which were mislabeled according to testing results, were distributed.",2015-01-09,2015-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91241 - Class II - Biologics - Community Blood Center Of Gtr Kansas City, An Operating Division of New York Blood Center, Inc.","Platelets Extended Dating, collected in a manner that compromises the sterility of the collection system, were distributed.",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91452 - Class III - Biologics - Community Blood Center Of Gtr Kansas City, An Operating Division of New York Blood Center, Inc.","Deglycerolyzed Red Blood Cell product, not tested for product specifications, was distributed.",2023-01-10,2023-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43405 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, which did not meet acceptable product specifications, were distributed.
",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39126 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor for whom the arm  appearance was not acceptable was distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42120 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor whose donor suitability was not   adequately determined, were distributed.",2012-07-16,2012-07-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62547 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39908 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, stored at unacceptable temperatures, were distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42623 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, with an unacceptable low red cell recovery rate, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45358 - Class III - Biologics - Community Blood Center Of Gtr KC,"In this situation, blood product was stored where the temperature was not continuously monitored, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43018 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was exposed to unacceptable temperature during storage, was distributed.",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47984 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, which did not meet the acceptable product specifications for release, was distributed.",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42336 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47615 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, with positive bacterial detection testing, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47616 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood Products, which were contaminated with Aspergillus versicolor, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47618 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, for which storage condition was outside the acceptable range, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49294 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who was illiterate, were distributed.",2012-09-17,2012-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49353 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor whose health history screening was inadequately performed, was distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49809 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, manufactured without additive solution, was distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50642 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, manufactured without additive solution, was distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47617 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood Products, which were contaminated with Aspergillus versicolor, were distributed.",2012-09-19,2012-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47619 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, which were possibly contaminated with Propionibacterium species, were distributed.",2012-09-19,2012-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48855 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-10-10,2012-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48857 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, for which the additive solution was not added during manufacturing, was distributed.",2012-10-12,2012-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48537 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48856 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49169 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63476 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47620 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-11-16,2012-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47982 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48282 - Class II - Biologics - Community Blood Center Of Gtr KC,Donor Screening/Donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked.,2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47050 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was possibly contaminated with Propionibacterium species, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47138 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, which were possibly contaminated with Propionibacterium species, were distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47987 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, which failed to meet the minimum specification for product volume, were distributed",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47139 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, with positive bacterial detection testing, were distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47985 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who was in close contact with an individual diagnosed with viral hepatitis, were distributed.",2012-12-03,2012-12-03,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47983 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who was in close contact with an individual diagnosed with viral hepatitis, were distributed.",2012-12-27,2012-12-27,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63930 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-01-25,2013-01-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50294 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, labeled as an AS product but with no red cell preservative solution added, was distributed.",2013-02-06,2013-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64144 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64090 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, with an unacceptably low red cell recovery rate, was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54045 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who was in close contact with an individual diagnosed with viral hepatitis, were distributed.",2013-02-28,2013-02-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64241 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who was at risk for Leishmaniasis, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64522 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42261 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, stored without continuous monitoring and possibly exposed to unacceptable temperatures, were distributed.",2013-05-08,2013-05-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53621 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.

",2013-05-24,2013-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56197 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2013-05-29,2013-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66181 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, for which the quality control testing was incomplete, were distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66350 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was not tested for pH and residual White Blood Cell count, was distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67000 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who may have traveled to a malarial endemic area, was distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67001 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who may have traveled to a malarial endemic area, were distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67202 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor with Porphyria Cutanea Tarda, were distributed.",2014-02-12,2014-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68690 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, whose integrity was compromised during component preparation (e.g., leaking at sterile connection site), was distributed.",2014-07-23,2014-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66590 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood products, tested for CMV using expired reagents, were distributed.",2014-12-04,2014-12-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69832 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70173 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-01-23,2015-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71151 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71320 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2015-06-23,2015-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71822 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, for which some quality control procedures were not performed, were distributed.",2015-08-25,2015-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73620 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-04-08,2016-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73866 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected within one year from a donor who travelled to a malarial endemic country, was distributed.",2016-05-17,2016-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74202 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who disclosed travel history to a malarial endemic area, were distributed.",2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75086 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2016-09-19,2016-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75101 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, not meeting product specifications, was distributed.",2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77126 - Class III - Biologics - Community Blood Center Of Gtr KC,Blood products were released for distribution based on incorrectly performed relevant Transfusion-Transmitted Infection testing.,2017-04-27,2017-04-27,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77382 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2017-06-27,2017-06-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77752 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2017-08-16,2017-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77807 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2017-08-18,2017-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78270 - Class III - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor taking the medication Propecia, was distributed.",2017-10-25,2017-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78478 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2017-12-11,2017-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78892 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from an ineligible donor, were distributed.",2018-02-12,2018-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79460 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2018-04-20,2018-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80337 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80663 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from donors for whom donor screening was performed incorrectly, were distributed.",2018-08-09,2018-08-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82121 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82122 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84322 - Class II - Biologics - Community Blood Center Of Gtr KC,"Red Blood Cell product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-12-03,2019-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84809 - Class II - Biologics - Community Blood Center Of Gtr KC,"Red Blood Cell product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2020-02-05,2020-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84692 - Class II - Biologics - Community Blood Center Of Gtr KC,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2020-02-21,2020-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87375 - Class II - Biologics - Community Blood Center Of Gtr KC,"Apheresis Red Blood Cell products, collected from an ineligible donor, were distributed.",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90100 - Class II - Biologics - Community Blood Center Of Gtr KC,"Red Blood Cell product collected from a donor who was a resident of a malaria endemic area, was distributed. 
",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90111 - Class II - Biologics - Community Blood Center Of Gtr KC,"Plateletpheresis product that failed quality control for residual WBC count, was distributed.
",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48916 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42877 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39982 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, which did not meet the acceptable product specifications, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41571 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-11-16,2012-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47322 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, was not quarantined subsequent to receiving post donation illness information, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40629 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42501 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, which tested positive for viral testing but incorrectly entered as negative, were distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63566 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor who was in close contact with an individual diagnosed with Hepatitis B, were distributed.",2012-12-06,2012-12-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43331 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43945 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor taking the medication Accutane, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41905 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46133 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-01-04,2013-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39143 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2013-02-01,2013-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39836 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed., Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed",2013-02-01,2013-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40625 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-02-01,2013-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41059 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-02-01,2013-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42729 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, which may have been unacceptable, was distributed.",2013-02-01,2013-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45793 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, collected from a donor who reported post donation illness, was distributed.",2013-02-06,2013-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48915 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor who was previously  deferred, were distributed.
	
",2013-02-06,2013-02-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41200 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, collected from a donor who traveled to malarial endemic areas, was distributed.",2013-02-07,2013-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39139 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-02-12,2013-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46647 - Class III - Biologics - Community Blood Center of the Ozarks,"Blood product, that was irradiated twice, was distributed",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48509 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor who was previously deferred for positive HIV test results, were distributed.",2013-03-07,2013-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41692 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2013-03-27,2013-03-27,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39140 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.",2013-04-05,2013-04-05,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40694 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood Collection/Sterility compromised., Blood products, possibly contaminated with air, were distributed.",2013-04-29,2013-04-29,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42697 - Class III - Biologics - Community Blood Center of the Ozarks,"Blood products, manufactured from Whole Blood units with extended collection times, were distributed.",2013-05-03,2013-05-03,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64867 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor whose sexual partner had a history of hepatitis B, were distributed.",2013-05-03,2013-05-03,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64862 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor who lived with a hepatitis positive individual, were distributed., Blood products, collected from a donor who lived  with a hepatitis positive individual, were distributed.",2013-05-08,2013-05-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48494 - Class III - Biologics - Community Blood Center of the Ozarks,"Blood products, stored at unacceptable storage temperatures, were distributed.",2013-05-21,2013-05-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59132 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2013-06-17,2013-06-17,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65294 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from an ineligible donor, were distributed.",2013-07-10,2013-07-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66669 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor who resided with a person who has hepatitis B, were distributed., Blood products, collected from a donor who resided with a person who has  hepatitis B, were distributed.",2013-12-16,2013-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70651 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, collected from a donor who lived in an area considered endemic for malaria, was distributed.",2015-04-16,2015-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72764 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, possibly contaminated with air, were distributed.",2016-01-07,2016-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75598 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product collected from a donor who traveled to a malaria endemic area, was distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76886 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood product, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76887 - Class III - Biologics - Community Blood Center of the Ozarks,"Blood products, for which the donor  gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2017-04-19,2017-04-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78993 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-01-29,2018-01-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79345 - Class III - Biologics - Community Blood Center of the Ozarks,Mislabeled blood product was distributed.,2018-03-16,2018-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80368 - Class III - Biologics - Community Blood Center of the Ozarks,"Blood products, for which the labeling was missing information, were distributed.",2018-07-24,2018-07-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80711 - Class III - Biologics - Community Blood Center of the Ozarks,"Blood products, with unacceptable quality control results, were distributed.",2018-10-05,2018-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81396 - Class II - Biologics - Community Blood Center of the Ozarks,"Platelet product, not manufactured according to product specifications, was distributed.",2018-10-26,2018-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82321 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from an ineligible donor, were distributed.",2019-03-15,2019-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83590 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed., Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-10-07,2019-10-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84539 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, lacking assurance of sterility, were distributed.",2020-01-08,2020-01-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84557 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, lacking assurance of sterility, were distributed.",2020-02-03,2020-02-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85045 - Class III - Biologics - Community Blood Center of the Ozarks,"Leukoreduced Red Blood Cells, that were not quarantined after receiving information concerning post-donation illness, were distributed.",2020-03-05,2020-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86155 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, collected from a donor for whom donor suitability was incomplete, were distributed.",2020-08-07,2020-08-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87031 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, associated with a blood bank software glitch, were distributed.",2021-02-01,2021-02-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87377 - Class II - Biologics - Community Blood Center of the Ozarks,"Red Blood Cell product, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87756 - Class II - Biologics - Community Blood Center of the Ozarks,"Blood products, which were not tested for Chagas, were distributed.",2021-05-10,2021-05-10,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91028 - Class III - Biologics - Community Blood Center of the Ozarks,"Misbranded Red Blood Cell product was distributed.
",2022-10-24,2022-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65987 - Class II - Biologics - Community Blood Center, Inc.","Blood product, collected from a donor who was previously deferred, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66642 - Class II - Biologics - Community Blood Center, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-12-02,2013-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69525 - Class III - Biologics - Community Blood Center, Inc.","Blood product, collected from a donor with an invalid result for body temperature, was distributed, Blood product, collected from a donor with an invalid result for body temperature, was distributed.",2014-11-17,2014-11-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70756 - Class II - Biologics - Community Blood Center, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-04-24,2015-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71076 - Class III - Biologics - Community Blood Center, Inc.","Blood products, which were labeled with an incorrect expiration date, were distributed.",2015-06-04,2015-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81233 - Class III - Biologics - Community Blood Center, Inc.","Blood product, manufactured without the entire quantity of additive solution, was distributed.",2018-11-14,2018-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83473 - Class III - Biologics - Community Blood Center, Inc.","Apheresis Platelets, Leukoreduced and Irradiated, returned without documenting the shipping temperature, was distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62297 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which was collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-07-25,2012-07-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62299 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed., Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed",2012-07-25,2012-07-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62819 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-06,2012-09-06,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62820 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-06,2012-09-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62822 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62841 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-06,2012-09-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62859 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-09-12,2012-09-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62815 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed., Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2012-09-19,2012-09-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62818 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-09-19,2012-09-19,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62862 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-19,2012-09-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62957 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-20,2012-09-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63171 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed",2012-10-10,2012-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63301 - Class III - Biologics - Community Blood Centers of Florida, Inc.","Blood product, collected from a donor whose arm inspection prior to collection was not performed, was distributed.",2012-10-16,2012-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63325 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-26,2012-10-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63326 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-06,2012-11-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63327 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-11-06,2012-11-06,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63507 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-11-14,2012-11-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63561 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-26,2012-11-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63593 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63637 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63590 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-06,2012-12-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63715 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-21,2012-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63718 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-21,2012-12-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63790 - Class III - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-16,2013-01-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64034 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64037 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-02-12,2013-02-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64074 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64050 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-02-14,2013-02-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64167 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64170 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-02-25,2013-02-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64515 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-04-15,2013-04-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64766 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-04-29,2013-04-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65206 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-07-02,2013-07-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65305 - Class II - Biologics - Community Blood Centers of Florida, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64432 - Class II - Biologics - Community Blood Centers of South FL, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64979 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor who lived in an area considered endemic for malaria and had a piercing within 12 months of donation, were distributed.",2013-06-05,2013-06-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62660 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2012-08-08,2012-08-08,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62510 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62858 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-09-12,2012-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62860 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-09-17,2012-09-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62816 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-09-19,2012-09-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62817 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-09-19,2012-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62955 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-20,2012-09-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62956 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-20,2012-09-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62958 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-09-20,2012-09-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63037 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-01,2012-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63038 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-01,2012-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63172 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-10,2012-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63324 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-24,2012-10-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63560 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63592 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-06,2012-12-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63716 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-12-21,2012-12-21,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63901 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-18,2013-01-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63940 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-30,2013-01-30,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63986 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-30,2013-01-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64035 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-02-12,2013-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64036 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-02-12,2013-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64168 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.
",2013-02-25,2013-02-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64169 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-02-25,2013-02-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39704 - Class III - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, with an unacceptable hematocrit, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39864 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, labeled with an incorrect expiration date, was distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40204 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, labeled with the incorrect expiration date, were distributed.",2013-03-04,2013-03-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42325 - Class III - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, stored at the incorrect temperature, was distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46461 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, with an unacceptable platelet yield, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64299 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which was collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-03-11,2013-03-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39075 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, labeled leukoreduced which did not meet the requirements for leukoreduced products, were distributed.",2013-04-03,2013-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39077 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which did not meet the specified pH for platelets, were distributed.",2013-04-03,2013-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64429 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-11,2013-04-11,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64628 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-04-11,2013-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64474 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-12,2013-04-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64627 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from an inelgible donor, were distributed.",2013-04-12,2013-04-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39536 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Platelet, with an unacceptable pH, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42768 - Class III - Biologics - Community Blood Centers of South Florida, Inc.","Blood  product was not frozen in required time, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43953 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47052 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which was identified as being contaminated by the BacT/ALERT system, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47054 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were identified as being contaminated by the BacT/ALERT system, were distributed.",2013-04-15,2013-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47055 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which were identified as being contaminated by the BacT/ALERT system, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47268 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, whose integrity was compromised during component preparation (e.g., leaking at sterile connection site), was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47270 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, which gave a positive result by the BacT system, were distributed.",2013-04-15,2013-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47271 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, with positive bacterial detection testing, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47272 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, with positive bacterial detection testing, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64514 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-04-15,2013-04-15,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46459 - Class III - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, possibly contaminated with bacteria, were distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45024 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products,  collected from a donor who was previously deferred,  due to testing Anti-HTLV reactive, were distributed.., Blood products,  collected from a donor who was previously deferred,  due to testing Anti-HTLV reactive, were distributed.",2013-04-29,2013-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47269 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, labels applied to blood unit or product with incorrect and/or missing information, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47944 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, possibly contaminated with bacteria, were distributed.

",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48802 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product,  labeled with  incorrect or missing information, expiration date, was distributed. 
",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64817 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed",2013-04-29,2013-04-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46086 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, possibly contaminated with bacteria, was distributed.

",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47109 - Class III - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, possibly contaminated with bacteria, were distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48483 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, identified unsuitable due to a donor screening deviation, was distributed.",2013-05-10,2013-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47732 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-05-24,2013-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65025 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-05-24,2013-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65114 - Class III - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65277 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from an ineligible donor, was distributed.",2013-05-30,2013-05-30,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39071 - Class III - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, for which RBC volume QC. failed, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41111 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products,  that were possibly contaminated with Enterococcus Faecalis, were distributed.",2013-06-04,2013-06-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65026 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-06-06,2013-06-06,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47946 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood product, manufactured from a unit of whole blood with incorrect volume was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65220 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-07-02,2013-07-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65222 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-07-02,2013-07-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65250 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-07-02,2013-07-02,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65251 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from an ineligible donor, were distributed.",2013-07-02,2013-07-02,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65276 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-07-02,2013-07-02,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65278 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from an ineligible donor, were distributed.",2013-07-03,2013-07-03,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65306 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-07-08,2013-07-08,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65307 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from an ineligible donor, were distributed.",2013-07-09,2013-07-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65308 - Class II - Biologics - Community Blood Centers of South Florida, Inc.","Blood products, collected from an ineligible donor, were distributed.",2013-07-12,2013-07-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68147 - Class III - Biologics - Community Blood Council of New Jersey, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-06-17,2014-06-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76678 - Class I - Drugs - Complete Pharmacy and Medical Solutions LLC,Non-sterility: presence of mold confirmed by outside laboratory at the 14 day culture.,2017-06-13,2017-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76681 - Class I - Drugs - Complete Pharmacy and Medical Solutions LLC,Non-sterility - presence of bacteria confirmed by outside laboratory after day 14.,2017-06-13,2017-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87076 - Class II - Drugs - Complete Pharmacy and Medical Solutions, LLC.",CGMP deviations: Lack of potency testing.,2021-01-19,2021-01-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83722 - Class II - Drugs - Compounded Solutions in Pharmacy,Lack of Processing Controls:,2019-09-12,2019-09-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66568 - Class II - Drugs - Compounding Centre At Blue Ridge,Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.,2014-01-09,2014-01-09,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91521 - Class II - Drugs - Consolidated Chemical, Inc",CGMP Deviations: initiated due to violations of CGMP manufacturing practices,2023-02-15,2023-02-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64838 - Class I - Drugs - Consumer Concepts, Inc.","Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain hydroxythiohomosildenafil, an analogue of sildenafil which is an ingredient in an FDA-approved drug for the treatment of male erectile dysfunction, making this an unapproved new drug.",2013-05-16,2013-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53056 - Class II - Biologics - Continental Services Group, Inc.","Blood product, which was labeled as negative for hepatitis B surface antigen (HBsAg), but tested positive for HBsAg, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53175 - Class II - Biologics - Continental Services Group, Inc.","Blood product, which tested positive for the human immunodeficiency virus (HIV), but was labeled as negative for HIV, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69554 - Class II - Drugs - Contract Packaging Resources Inc.,"Correct Labeled Product Mispacked; correct labeled bottles of Assured Ibuprofen softgels were packaged into cartons of Assured Naproxen Sodium Tablets, USP",2014-11-13,2014-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84857 - Class II - Drugs - Contract Pharmacal Corporation,Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle.,2020-02-27,2020-02-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89462 - Class I - Drugs - CooperSurgical, Inc",Non-sterility,2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62543 - Class I - Drugs - Coral Rock Man, Inc.",Marketed Without an Approved NDA/ANDA: Products tested positive for Sildenafil and analogs of Sildenafil.,2012-11-01,2012-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67291 - Class II - Drugs - Corepharma LLC,Failed Dissolution Specification: Corepharma Inc. is recalling Pyridostigmine Bromide Tablets USP 60 mg due to an out of specification dissolution test generated at the 30 month stability time point.,2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65889 - Class II - Drugs - CorePharma, LLC","Failed Stability Specifications: Pyridostigmine Bromide tablets, is being recalled due to an out of specification test result during stablity testing.",2013-09-20,2013-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86390 - Class I - Drugs - CORGIOMED LLC,Marketed without an Approved NDA/ANDA; product labeled as Edible Alcohol rendering the product an unapproved new drug and misbranded.,2020-09-18,2020-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90008 - Class I - Biologics - CorneaGen,"Sclera, recovered from a donor in which donor suitability was not adequately determined, was distributed.",2022-05-19,2022-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90007 - Class II - Biologics - CorneaGen,"Tissues, recovered from donors in which donor suitability was not adequately determined, were distributed. Donors tested reactive for antibody to Hepatitis B core antigen.",2022-05-24,2022-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90006 - Class I - Biologics - CorneaGen,"Corneas, recovered from a donor in which donor suitability was not adequately determined, were distributed.  The donor tested reactive for antibodies to HIV, non-reactive for HIV NAT.",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90371 - Class II - Biologics - CorneaGen,"Sclera, recovered from a donor in which donor suitability was not adequately determined, were distributed.",2022-09-16,2022-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90374 - Class II - Biologics - CorneaGen,"Sclera, recovered from a donor in which donor suitability was not adequately determined, were distributed.",2022-09-16,2022-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91023 - Class II - Biologics - CorneaGen - Boston,"Cornea, in which donor testing was conducted with an unacceptable sample, was distributed.",2023-02-14,2023-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91593 - Class II - Biologics - CorneaGen - Boston,"Corneas, in which donor testing was conducted with an unacceptable sample, were distributed.
",2023-02-15,2023-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87608 - Class II - Drugs - Cosette Pharmaceuticals, Inc.",CGMP Deviaitons,2021-04-07,2021-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66084 - Class II - Drugs - Creative Compounds,Glutathione 100 mg/mL injectable human drug is recalled due to Out Of Specification results or potential bacterial contamination and it was reported as passing by a contract laboratory.,2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42731 - Class II - Biologics - Creative Testing Solutions,"Blood product, in which routine testing was performed, interpreted and/or documented incorrectly, was distributed.
",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85833 - Class II - Drugs - Crown Laboratories,"Subpotent Drug: Out of specification for assay at the 9-month interval for Nystatin Cream, USP.",2020-06-24,2020-06-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74740 - Class III - Biologics - Crown Peak Industries, LLC",Amniotic Membranes were not made available for distribution in accordance with current Good Tissue Practice.,2016-08-03,2016-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64210 - Class II - Biologics - CryoLife, Inc.","Human Tissues, recovered from a donor whose donor eligibility determination did not identify if the donor was free from risk factors for and clinical evidence of, infection due to relevant communicable disease agents, were distributed.",2013-01-31,2013-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64660 - Class III - Biologics - CryoLife, Inc.","Human tissue allograft, recovered from a donor whose donor eligibility determination did not confirm the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseeases, was distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65232 - Class III - Biologics - CryoLife, Inc.","Vascular grafts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65233 - Class III - Biologics - CryoLife, Inc.","Cardiac grafts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65234 - Class III - Biologics - CryoLife, Inc.","Vascular graft, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed., Cardiac graft, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-06-04,2013-06-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65235 - Class III - Biologics - CryoLife, Inc.","Vascular grafts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65236 - Class III - Biologics - CryoLife, Inc.","Human tissue allograft, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-06-04,2013-06-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65238 - Class III - Biologics - CryoLife, Inc.","Human tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-04,2013-06-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65239 - Class III - Biologics - CryoLife, Inc.","Human vascular allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65241 - Class III - Biologics - CryoLife, Inc.","Heart Valves, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65242 - Class III - Biologics - CryoLife, Inc.","Cardiac tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86910 - Class III - Biologics - CryoLife, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2020-12-07,2020-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74238 - Class III - Biologics - CSL Behring GmbH,"Two batches of Prothrombin Complex Concentrate (Human), not meeting incoming material specifications, were distributed.",2016-06-03,2016-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81332 - Class II - Biologics - CSL Behring GmbH,"Prothrombin Complex Concentrate (Human) Kcentra 1000 U, with a potential risk of breakage of the glass vials, was distributed. 
",2018-10-29,2018-10-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81371 - Class II - Biologics - CSL Behring GmbH,"Three lots of Prothrombin Complex Concentrate (Human) Kcentra 1000 U, with a potential risk of breakage of the glass vials, were distributed. 
",2018-10-29,2018-10-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82976 - Class III - Biologics - CSL Behring GmbH,Misbranded Kcentra lot was distributed.,2019-06-05,2019-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84254 - Class III - Biologics - CSL Behring GmbH,"Lots of Humate-P with misaligned labeling on the folding box, was distributed.",2019-11-25,2019-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83495 - Class II - Biologics - CSL Behring LLC,"Batches of Alpha1-Proteinase Inhibitor (Human) and Coagulation Factor IX (Human), with the potential for inadequate aseptic technique during the filling process, were distributed.",2019-08-20,2019-08-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88360 - Class III - Biologics - CSL Behring LLC,"Zemaira and Mononine, manufactured in a manner that could affect product sterility, were distributed.",2021-08-19,2021-08-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45792 - Class II - Biologics - Csl Bioplasma Inc,"Blood products, which were collected from a donor with a history of high risk behaviors, were distributed.",2012-07-23,2012-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38781 - Class II - Biologics - Csl Plasma,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38780 - Class II - Biologics - Csl Plasma,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-06-12,2013-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52869 - Class II - Biologics - Csl Plasma,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66687 - Class II - Biologics - Csl Plasma,"Blood products, collected from a donor whose annual physical examination was incomplete, were distributed. 

",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42282 - Class III - Biologics - CSL Plasma,"Blood products, which may have reached unacceptable temperatures during storage, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49905 - Class II - Biologics - CSL Plasma,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-11-01,2013-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66612 - Class II - Biologics - CSL Plasma,"Blood products, in which donor testing was not performed or incomplete, were distributed.",2013-11-14,2013-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40514 - Class II - Biologics - CSL Plasma,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-02-20,2014-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42958 - Class III - Biologics - CSL Plasma,"Blood products, collected from a donor who was previously deferred for unsuitable test results, were distributed.",2014-12-05,2014-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69817 - Class III - Biologics - CSL Plasma,"Plasma products, collected from donors whose suitability to donate was not adequately determined, were distributed.",2014-12-05,2014-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76672 - Class III - Biologics - CSL Plasma,"Blood product, in which donor suitability was not adequately determined, was distributed.",2017-03-16,2017-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77865 - Class II - Biologics - CSL Plasma,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2017-08-28,2017-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78537 - Class III - Biologics - CSL Plasma,"Blood products, in which donor suitability was not adequately determined, were distributed.
",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79203 - Class III - Biologics - CSL Plasma,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-02-22,2018-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80108 - Class III - Biologics - CSL Plasma,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-05-17,2018-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82369 - Class III - Biologics - CSL Plasma,"Source Plasma products, collected from a donor who was illiterate, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82576 - Class III - Biologics - CSL Plasma,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-04-12,2019-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83065 - Class III - Biologics - CSL Plasma,"Source Plasma, collected from a donor who was illiterate, was distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83754 - Class III - Biologics - CSL Plasma,"Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2019-10-08,2019-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83751 - Class III - Biologics - CSL Plasma,"Blood products, which was collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-10-18,2019-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84476 - Class III - Biologics - CSL Plasma,"Source Plasma, collected from a donor who was illiterate, was distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84484 - Class III - Biologics - CSL Plasma,"Source Plasma, collected from a donor who was illiterate, was distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84471 - Class III - Biologics - CSL Plasma,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84489 - Class III - Biologics - CSL Plasma,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84967 - Class III - Biologics - CSL Plasma,"Source Plasma, where donor eligibility was incomplete, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83747 - Class III - Biologics - CSL PLASMA,Further Manufacturing,2019-10-18,2019-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85727 - Class II - Biologics - CSL PLASMA,"Source Plasma, collected in a manner that resulted in the test sample possibly being diluted with saline, was distributed.",2020-05-26,2020-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49940 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor whose physical was rescheduled as a sample only, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49993 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54966 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor who was previously deferred, were distributed",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55395 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor who was permanently deferred, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48850 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor whose physical examination was incomplete, were distributed.",2012-07-23,2012-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54066 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor who received a piercing within one year of donation, were distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54208 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54209 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53629 - Class III - Biologics - Csl Plasma Inc,Donor Screening/Donor did not meet acceptance criteria,2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54951 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from deferred donors, were distributed.",2012-10-12,2012-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56582 - Class III - Biologics - Csl Plasma Inc,"Blood products, which were collected from a donor with a history of high risk behaviors, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47999 - Class III - Biologics - Csl Plasma Inc,"Blood products, collected from a donor, whose suitability to donate were not adequately determined, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48000 - Class III - Biologics - Csl Plasma Inc,"Blood products, collected from a donor, whose suitability to donate were not adequately determined, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50444 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44254 - Class II - Biologics - Csl Plasma Inc,"Blood product, collected from a donor whose physical exam was incomplete, was distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48299 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor whose annual physical examination was inadequately documented, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55593 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 
",2013-07-12,2013-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48412 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60297 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67007 - Class II - Biologics - Csl Plasma Inc,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71066 - Class II - Biologics - Csl Plasma Inc,"Blood product, which did not meet the acceptable product specifications, was distributed.",2015-06-04,2015-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83059 - Class III - Biologics - Csl Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54945 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who was previously deferred, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41400 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43045 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who did not have a complete physical examination, were distributed",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42835 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who did not have a physical examination, were distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53839 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who did not have a physical examination, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56006 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59257 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from donor's who did not have a complete physical examination, were distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50630 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from donors whose scheduled physical examinations were  incomplete, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #51360 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor whose routine physical examination was inadequately documented, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41587 - Class III - Biologics - CSL Plasma Inc,"Blood products collected from a donor who was previously permanently, were distributed.",2013-06-05,2013-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41639 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55733 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor, whose suitability to donate were not adequately determined, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74186 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who received a piercing within one year of donation, were distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75287 - Class II - Biologics - CSL Plasma Inc,"Blood products, collected from a donor with a history of intravenous drug use, were distributed.",2016-10-13,2016-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76668 - Class II - Biologics - CSL Plasma Inc,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-04-21,2017-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77681 - Class III - Biologics - CSL Plasma Inc,"Blood products, in which donor suitability was not adequately determined, were distributed.",2017-07-13,2017-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77684 - Class III - Biologics - CSL Plasma Inc,"Blood products, in which donor suitability was not adequately determined, were distributed.",2017-07-13,2017-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78539 - Class III - Biologics - CSL Plasma Inc,"Plasma products, for which the donor screening was   incorrectly performed, were distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78804 - Class III - Biologics - CSL Plasma Inc,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.
",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79743 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80109 - Class III - Biologics - CSL Plasma Inc,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-05-17,2018-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80102 - Class III - Biologics - CSL Plasma Inc,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-06-13,2018-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80824 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-08-22,2018-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80822 - Class III - Biologics - CSL Plasma Inc,"Plasma products, for which the donor screening  was incorrectly performed, were distributed.",2018-09-07,2018-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80883 - Class III - Biologics - CSL Plasma Inc,"Plasma products, collected from a donor for whom donor suitability was inadequately determined, were distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80884 - Class III - Biologics - CSL Plasma Inc,"Plasma products, collected from a donor for whom donor suitability was inadequately determined, were distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80885 - Class III - Biologics - CSL Plasma Inc,"Plasma products, collected from a donor for whom donor suitability was inadequately determined, were distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80886 - Class III - Biologics - CSL Plasma Inc,"Plasma products, collected from a donor for whom donor suitability was inadequately determined, were distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80819 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80821 - Class III - Biologics - CSL Plasma Inc,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81260 - Class II - Biologics - CSL Plasma Inc,"Source plasma, associated with a deviation in the collection process, was distributed.",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81256 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81236 - Class III - Biologics - CSL Plasma Inc,"Blood products collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81542 - Class III - Biologics - CSL Plasma Inc,"Source Plasma units, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81671 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81827 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-02-07,2019-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81997 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, were distributed.",2019-02-07,2019-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81829 - Class III - Biologics - CSL Plasma Inc,"Source plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81830 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81835 - Class III - Biologics - CSL Plasma Inc,"Source plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82260 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, were distributed.",2019-02-28,2019-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82287 - Class III - Biologics - CSL Plasma Inc,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-04,2019-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82233 - Class III - Biologics - CSL Plasma Inc,"Source Plasma products, collected from a donor who was illiterate, were distributed.",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82234 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82235 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82231 - Class III - Biologics - CSL Plasma Inc,"Source Plasma products, collected from a donor who was illiterate, were distributed.",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82255 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who could not understand the donation materials, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82373 - Class III - Biologics - CSL Plasma Inc,"Source Plasma products, collected from a donor who was illiterate, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82259 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who could not understand the donation materials, were distributed.",2019-04-03,2019-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82608 - Class II - Biologics - CSL Plasma Inc,"Blood product, which did not meet the acceptable product specifications, was distributed.
",2019-04-22,2019-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82774 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82775 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82777 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82872 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82873 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83061 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83062 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83063 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83064 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82843 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor who could not understand the donation materials/questions, were distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82956 - Class II - Biologics - CSL Plasma Inc,"Source Plasma, which may have been contaminated with saline during collection, was distributed.",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82961 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83454 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83447 - Class II - Biologics - CSL Plasma Inc,"Blood product, manufactured without the entire quantity of additive solution, was distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83749 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-10-18,2019-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84095 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, for which donor eligibility screening was incorrectly performed, were distributed.",2019-11-05,2019-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84092 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, was distributed.",2019-11-07,2019-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84467 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84470 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, were distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84473 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84485 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84486 - Class III - Biologics - CSL Plasma Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84974 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84975 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84952 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84997 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who was illiterate, were distributed.
",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84999 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85000 - Class III - Biologics - CSL Plasma Inc,"Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2020-03-05,2020-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85665 - Class III - Biologics - CSL Plasma Inc,"Source Plasma units, collected from a donor whose donor screening record was either incomplete or incorrect, were distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85666 - Class III - Biologics - CSL Plasma Inc,"Source Plasma units, collected from a donor whose donor eligibility was incomplete, were distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85668 - Class III - Biologics - CSL Plasma Inc,"Source Plasma unit, collected from a donor whose donor screening record was either incomplete or incorrect, was distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85674 - Class III - Biologics - CSL Plasma Inc,"Source Plasma unit, collected from a donor whose donor eligibility was incomplete, was distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85676 - Class II - Biologics - CSL Plasma Inc,"Source Plasma, collected from a donor who received a tattoo within 12 months of donating, were distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83066 - Class III - Biologics - CSL Plasma INC,"Source Plasma units, collected from a donor who was illiterate, were distributed.",2019-07-01,2019-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85669 - Class III - Biologics - CSL Plasma INC,"Source Plasma units, collected from a donor whose donor screening record was either incomplete or incorrect, were distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70530 - Class II - Biologics - Csl Plasma Inc.,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-03-24,2015-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81230 - Class III - Biologics - CSL Plasma Inc.,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81259 - Class II - Biologics - CSL Plasma Inc.,"Source plasma, associated with a deviation in the collection process, was distributed.",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81676 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82261 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82577 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-04-12,2019-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82960 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83453 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor who was illiterate, were distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83752 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor who was illiterate, was distributed.",2019-10-08,2019-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84102 - Class III - Biologics - CSL Plasma Inc.,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85046 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor whose donor eligibility was incomplete, was distributed.",2020-02-27,2020-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84953 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor for whose donor eligibility was incomplete, was distributed.",2020-03-24,2020-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85001 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor for whom donor eligibility was incomplete, was distributed.",2020-03-24,2020-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85678 - Class II - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor who received a tattoo within 12 months of donation, were distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85661 - Class II - Biologics - CSL Plasma Inc.,"Source Plasma, collected in a manner that resulted in the test sample possibly being diluted with saline, was distributed.",2020-05-26,2020-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85662 - Class II - Biologics - CSL Plasma Inc.,"Source Plasma, collected in a manner that resulted in the test sample possibly being diluted with saline, was distributed.",2020-05-26,2020-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85663 - Class II - Biologics - CSL Plasma Inc.,"Source Plasma, collected in a manner that resulted in the test sample possibly being diluted with saline, was distributed.",2020-05-26,2020-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85664 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor whose donor screening record was either incomplete or incorrect, was distributed.",2020-05-26,2020-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85758 - Class III - Biologics - CSL Plasma Inc.,"Source Plasma, collected from a donor who was illiterate, were distributed.
",2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80823 - Class III - Biologics - CSL Plasma Services, Inc.","Plasma product, for which donor screening was incorrectly performed, was distributed.",2018-09-07,2018-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81828 - Class III - Biologics - CSL Plasma Services, Inc.","Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84472 - Class III - Biologics - CSL Plasma Services, Inc.","Source Plasma, collected from a donor who was illiterate, were distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41664 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from donors whose physical examination documentation was incomplete, were distributed.",2012-07-23,2012-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47258 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose physical examination was incomplete, were distributed.",2012-07-23,2012-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49237 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose physical examination was incomplete, were distributed.",2012-07-23,2012-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49260 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose physical examination was incomplete, were distributed.",2012-07-23,2012-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47550 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor who had not had an annual physical performed, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47551 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose routine physical examination was inadequately documented, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48766 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose physical examination was incomplete, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49669 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose physical examination was incomplete, were distributed. 

",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50634 - Class III - Biologics - CSL Plasma, Inc","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #51349 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose routine physical examination was inadequately documented, were distributed.

",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #51350 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose routine physical examination was inadequately documented, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49676 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor who had not had an annual physical performed, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49950 - Class II - Biologics - CSL Plasma, Inc","Blood product, collected from a donor whose physical examination was incomplete, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48349 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor who was previously deferred, were distributed.",2012-10-12,2012-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54972 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor with a  permanent deferral history, were distributed",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71437 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2015-06-23,2015-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71438 - Class II - Biologics - CSL Plasma, Inc","Blood product, collected from a donor who did not have a complete physical examination, was distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71439 - Class II - Biologics - CSL Plasma, Inc","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77868 - Class II - Biologics - CSL Plasma, Inc","Blood product, which did not meet the acceptable product specifications, was distributed.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79707 - Class III - Biologics - CSL Plasma, Inc","Plasma products, collected from a donor for whom donor suitability was inadequately determined, were distributed.",2018-04-13,2018-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80107 - Class III - Biologics - CSL Plasma, Inc","Plasma products, for which donor screening was incorrectly performed, were distributed.",2018-06-01,2018-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80154 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-06-08,2018-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80156 - Class III - Biologics - CSL Plasma, Inc","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2018-06-08,2018-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80597 - Class III - Biologics - CSL Plasma, Inc","Plasma products, for which donor screening was incorrectly performed, were distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81257 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from an ineligible donor, were distributed.",2018-10-22,2018-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81261 - Class II - Biologics - CSL Plasma, Inc","Source plasma, associated with a deviation in the collection process, was distributed.",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81235 - Class III - Biologics - CSL Plasma, Inc","Blood products collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81434 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2018-11-13,2018-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81677 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81689 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-02-01,2019-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81834 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-02-07,2019-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82232 - Class III - Biologics - CSL Plasma, Inc","Source plasma products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82253 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82258 - Class III - Biologics - CSL Plasma, Inc","Blood product, collected from a donor who could not understand the donation materials, was distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82368 - Class III - Biologics - CSL Plasma, Inc","Source plasma products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82836 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-06-03,2019-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82833 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82834 - Class III - Biologics - CSL Plasma, Inc","Source plasma blood products, collected from a donor who was illiterate, were distributed.",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82835 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82837 - Class III - Biologics - CSL Plasma, Inc","Blood product, collected from a donor who could not understand the donation materials/questions, was distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82838 - Class III - Biologics - CSL Plasma, Inc","Blood product, collected from a donor who could not understand the donation materials/questions, was distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82840 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor who could not understand the donation materials/questions, were distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82841 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor who could not understand the donation materials/questions, were distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82842 - Class III - Biologics - CSL Plasma, Inc","Blood product, collected from a donor who could not understand the donation materials/questions, was distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82844 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor who could not understand the donation materials/questions, were distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82959 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82891 - Class II - Biologics - CSL Plasma, Inc","Blood product, collected in a manner that may have compromised product potency, was distributed.",2019-06-27,2019-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83067 - Class III - Biologics - CSL Plasma, Inc","Source Plasma units, collected from a donor who was illiterate, were distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83451 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, for which donor eligibility screening was incorrectly performed, were distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83455 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83743 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83753 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-10-08,2019-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84100 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84388 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84394 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84392 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-12-31,2019-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84393 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-12-31,2019-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84475 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, was distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84478 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, was distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84480 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, was distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84468 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, were distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84469 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who was illiterate, were distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84474 - Class III - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-01-09,2020-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84487 - Class III - Biologics - CSL Plasma, Inc","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84691 - Class III - Biologics - CSL Plasma, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2020-02-21,2020-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85670 - Class III - Biologics - CSL Plasma, Inc","Source Plasma units, collected from a donor whose donor screening record was either incomplete or incorrect, were distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85677 - Class II - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who received a tattoo within 12 months of donation, were distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85679 - Class II - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who received a tattoo within 12 months of donation, was distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85760 - Class II - Biologics - CSL Plasma, Inc","Source Plasma, collected from a donor who received a tattoo within 12 months of donating, were distributed.
",2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82575 - Class III - Biologics - CSL PLASMA, INC","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-04-12,2019-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83746 - Class III - Biologics - CSL PLASMA, INC","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-10-18,2019-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66805 - Class II - Biologics - Csl Plasma, Inc.",-,2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67071 - Class II - Biologics - Csl Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-01-09,2014-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67551 - Class II - Biologics - Csl Plasma, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75527 - Class II - Biologics - Csl Plasma, Inc.","Plasma product collected from a donor who received a piercing within 12 months of donation, was distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83662 - Class III - Biologics - Csl Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-10-16,2019-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84389 - Class III - Biologics - Csl Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85850 - Class III - Biologics - Csl Plasma, Inc.","Source Plasma unit, collected from a donor whose donor eligibility determination, was distributed.",2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54059 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54970 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54974 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #55390 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54896 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor regarding multiple high-risk behaviors, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54948 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a previously deferred donor,  were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54950 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from donors who were previously deferred for high risk behavior, were distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53630 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56469 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53632 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56468 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose physical examination findings were not documented, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #55396 - Class II - Biologics - CSL Plasma, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #55397 - Class II - Biologics - CSL Plasma, Inc.","Blood products, which were collected from a donor in which donor suitability were not adequately determined, were distributed",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54050 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed..",2012-10-24,2012-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54962 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from  donors who were previously deferred, were distributed.",2012-10-24,2012-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54971 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-10-24,2012-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53202 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54210 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56198 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose suitability was not adequately determined, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54960 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from donors who were previously deferred for high risk behavior, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #55399 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor with an incomplete health assessment, were distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54963 - Class III - Biologics - CSL Plasma, Inc.","Blood products, which were collected from a donor with a history of high risk behaviors, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #57168 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-01-08,2013-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54967 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54953 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from  donors who were previously deferred, were distributed.",2013-02-28,2013-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64938 - Class II - Biologics - CSL Plasma, Inc.","Blood product, tested for viral markers using a sample that was diluted with saline, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54959 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from donors who were permanently deferred, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53631 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-06-12,2013-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54954 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from  donors who were permanently deferred, were distributed.",2013-07-12,2013-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54961 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from donors who were permanently deferred, were distributed.",2013-07-12,2013-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54061 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-07-23,2013-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54968 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who was deferred for specific high risk behavior, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #57167 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor, whose suitability to donate were not adequately determined, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52874 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54054 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63118 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54958 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-12-02,2013-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59256 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from donors whose physical exams  were not adequately performed, were distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69231 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who had not had an annual physical performed, were distributed.",2014-10-06,2014-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68061 - Class II - Biologics - CSL Plasma, Inc.","Source Plasma units, collected from ineligible donors, were distributed.",2014-10-30,2014-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69429 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69477 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71612 - Class II - Biologics - CSL Plasma, Inc.","Source Plasma, collected from inelgible donors, was distributed.",2015-08-12,2015-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73220 - Class II - Biologics - CSL Plasma, Inc.","Plasma products collected from a donor who did not meet acceptance criteria, were distributed.",2016-02-25,2016-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75734 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who did not have a complete health assessment, were distributed.",2016-12-07,2016-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77032 - Class II - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2017-05-15,2017-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78538 - Class III - Biologics - CSL Plasma, Inc.",-,2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78540 - Class III - Biologics - CSL Plasma, Inc.","Plasma products, for which the donor screening was incorrectly performed, were distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78535 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79201 - Class III - Biologics - CSL Plasma, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-02-26,2018-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79922 - Class III - Biologics - CSL Plasma, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-05-02,2018-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79741 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79745 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79919 - Class III - Biologics - CSL Plasma, Inc.","Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-06-01,2018-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80155 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-06-08,2018-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80820 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81265 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from an ineligible donor, were distributed.",2018-10-22,2018-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81229 - Class III - Biologics - CSL Plasma, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81232 - Class III - Biologics - CSL Plasma, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81262 - Class II - Biologics - CSL Plasma, Inc.","Source plasma, associated with a deviation in the collection process, was distributed.",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81264 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81234 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81672 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81826 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-01-29,2019-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81690 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor for whom donor suitability was incomplete/incorrect, were distributed.",2019-01-30,2019-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82236 - Class III - Biologics - CSL Plasma, Inc.","Source plasma products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82237 - Class III - Biologics - CSL Plasma, Inc.","Source plasma products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82252 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82256 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who could not understand the donation materials, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82257 - Class III - Biologics - CSL Plasma, Inc.","Blood product, collected from a donor who could not understand the donation materials, was distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82370 - Class III - Biologics - CSL Plasma, Inc.","Source plasma products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82372 - Class III - Biologics - CSL Plasma, Inc.","Source plasma products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82578 - Class III - Biologics - CSL Plasma, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82579 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82672 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-04-29,2019-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82773 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82780 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.
",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82875 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82685 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-06-03,2019-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82686 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-06-03,2019-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83057 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83058 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83060 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-10,2019-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82839 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82955 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82958 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, were distributed.
",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83242 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma units, collected from a donor who was illiterate, were distributed.",2019-07-12,2019-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83450 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83452 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, were distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83444 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who could not read/understand the donor materials, were distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83446 - Class II - Biologics - CSL Plasma, Inc.","Blood product, prepared without the appropriate amount of additive solution, was distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83449 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who could not read/understand the donor materials, were distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83658 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83659 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83660 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-10-11,2019-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83661 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-10-11,2019-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83748 - Class III - Biologics - CSL Plasma, Inc.","Blood product, collected from a donor who was illiterate, was distributed.",2019-10-18,2019-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83750 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor who was illiterate, were distributed.",2019-10-18,2019-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84093 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2019-11-05,2019-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84091 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.",2019-11-07,2019-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84089 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, for which donor eligibility screening was incorrectly performed, were distributed.",2019-11-14,2019-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84099 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84101 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84137 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2019-11-26,2019-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84477 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, for which donor eligibility screening was incorrectly performed, were distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84481 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, for which donor eligibility screening was incorrectly performed, were distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84482 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, for which donor eligibility screening was incorrectly performed, were distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84483 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who was illiterate, was distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84488 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84966 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84969 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84970 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, where donor eligibility was incomplete, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84971 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84972 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84973 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2020-02-20,2020-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84951 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, for which donor eligibility screening was incorrectly performed, was distributed.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84998 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85002 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor for whose donor eligibility was incomplete, was distributed.",2020-03-24,2020-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85061 - Class III - Biologics - CSL Plasma, Inc.","Blood products, collected from an ineligible donor. were distributed.",2020-04-01,2020-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85587 - Class II - Biologics - CSL Plasma, Inc.","Source Plasma, associated with a device collection unexpected event, was distributed.",2020-05-01,2020-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85667 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma units, collected from a donor whose donor screening record was either incomplete or incorrect, were distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85671 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma units, collected from a donor whose donor screening record was either incomplete or incorrect, were distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85672 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma units, collected from a donor whose donor screening record was either incomplete or incorrect, were distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85673 - Class III - Biologics - CSL Plasma, Inc.","Source Plasma unit, collected from a donor whose donor screening record was either incomplete or incorrect, was distributed.",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85761 - Class II - Biologics - CSL Plasma, Inc.","Source Plasma, collected from a donor who received a tattoo within 12 months of donating, was distributed.
",2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81673 - Class III - Biologics - CSL Plasma, Inc. (CSL)","Source Plasma, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65900 - Class I - Drugs - CTV Best Group,"Marketed without an Approved NDA/ANDA: Product contains an undeclared drug, sibutramine, making it an unapproved new drug.",2014-03-12,2014-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66041 - Class I - Drugs - Cubist Pharmaceuticals, Inc.",Presence of Particulate Matter; Glass particulates observed in vials,2014-01-17,2014-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68025 - Class I - Drugs - Cubist Pharmaceuticals, Inc.",Presence of Particulate Matter: Customer complaint stating that one vial contained a glass shard.,2014-06-12,2014-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68969 - Class I - Drugs - Cubist Pharmaceuticals, Inc.",Presence of Particulate Matter: Potential presence of glass particulate matter in the vials.,2014-10-01,2014-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67180 - Class I - Drugs - Cubist Pharmaceuticals, Inc.",Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.,2014-10-30,2014-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62775 - Class II - Drugs - Custom Medical Specialties, Inc.","Lack of Assurance of Sterility; the firm's medical trays contain Hospira's 0.9% Sodium Chloride bags which were subject to recall due to leaking bags, Lack of Assurance of Sterility; the firm's medical trays contain Hospira's 0.9% Sodium Chloride bags which were subject to recall due to leaking bags.",2012-08-17,2012-08-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82615 - Class II - Drugs - Customceutical Compounding,Lack of assurance of sterility for injectables and solutions intended to be sterile.,2019-04-30,2019-04-30,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88489 - Class II - Drugs - Custopharm, Inc.",Lack of Assurance of Sterility: the manufacturing firm had microbial recoveries during environmental monitoring in aseptic areas of manufacturing.,2021-08-23,2021-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75490 - Class III - Drugs - CutisPharma, Inc.",Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL,2016-11-16,2016-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82758 - Class I - Drugs - D B P Distribution,Marketed without an approved NDA/ANDA: undeclared  sildenafil and tadalafil.,2019-05-22,2019-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64190 - Class I - Drugs - D& S Herbals, LLC","Marketed Without An Approved NDA/ANDA: This dietary supplement has been found to contain sildenafil, an FDA approved drug for the treatment of male erectile dysfunction making this an unapproved new drug.",2013-05-16,2013-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61619 - Class III - Biologics - D. D. Eisenhower Army Med. Ctr. -  Blood Bank,"Blood products, labeled with an incorrect expiration date, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63591 - Class II - Biologics - D. D. Eisenhower Army Med. Ctr. -  Blood Bank,"-, Blood products, collected from a donor considered to be at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-12-06,2012-12-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71807 - Class II - Biologics - D. D. Eisenhower Army Med. Ctr. -  Blood Bank,"Blood product, collected from a donor who received a tattoo within 12 months of donating, was distributed.",2015-08-25,2015-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79986 - Class III - Biologics - D. D. Eisenhower Army Med. Ctr. -  Blood Bank,"Blood product, where transfusion-transmitted infection testing was performed and/or interpreted incorrectly, was distributed.",2018-05-02,2018-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82906 - Class III - Biologics - D. D. Eisenhower Army Med. Ctr. -  Blood Bank,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68793 - Class II - Drugs - Daiichi Sankyo Pharma Development,"Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping, Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping.",2014-07-31,2014-07-31,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86704 - Class II - Biologics - Dakota Lions Sight & Health,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2020-11-03,2020-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83734 - Class I - Drugs - Darmerica, LLC","Label Mix-Up: Product labeled as Quinacrine Dihydrochloride; however, after testing, identified as Artemisinin.",2019-10-03,2019-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89814 - Class II - Drugs - DASH Pharmaceuticals LLC,Labeling: Label Mix-Up,2022-04-06,2022-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87923 - Class II - Drugs - DASH XCLUSIVE,Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sibutramine and Fluoxetine,2021-06-11,2021-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65336 - Class II - Biologics - Data Innovations, Inc.","Laboratory software, with a defect or glitch, was distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65340 - Class II - Biologics - Data Innovations, Inc.","Laboratory software, with a defect or glitch, was distributed.",2013-07-31,2013-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49996 - Class II - Biologics - DCI Biologicals Bryan LLC,"Blood products, which were not quarantined after receiving post donation information regarding an undocumented piercing, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64574 - Class II - Biologics - DCI Biologicals Carbondale, LLC","Blood products, collected from a donor who had been incarcerated, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69967 - Class III - Biologics - DCI Biologicals Carbondale, LLC","Blood products, which Donor Screening/Deferral screening not done or incorrectly performed, including incorrect ID used during search,prior deferral due to history, was distributed.",2015-01-05,2015-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71251 - Class II - Biologics - DCI Biologicals Carbondale, LLC","Plasma product, collected from a donor whose suitability to donate was not documented, was distributed.",2015-06-10,2015-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71746 - Class II - Biologics - DCI Biologicals Greenville, Inc","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2015-08-20,2015-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73132 - Class II - Biologics - DCI Biologicals Greenville, Inc","Blood products, collected from a donor who had been incarcerated, were distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73518 - Class III - Biologics - DCI Biologicals Greenville, Inc","Blood products, exposed to unacceptable temperatures during storage, were distributed.",2016-03-25,2016-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74645 - Class III - Biologics - DCI Biologicals Greenville, Inc","Blood product, in which quality control and distribution of product did not meet specifications, was distributed.",2016-08-08,2016-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75154 - Class III - Biologics - DCI Biologicals Greenville, Inc","Blood product, in which donor suitability was not adequately determined, was distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75233 - Class III - Biologics - DCI Biologicals Greenville, Inc","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75258 - Class III - Biologics - DCI Biologicals Greenville, Inc","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75493 - Class II - Biologics - DCI Biologicals Greenville, Inc","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75657 - Class III - Biologics - DCI Biologicals Greenville, Inc","Source Plasma, collected from an ineligible donor, was distributed.",2016-11-11,2016-11-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75823 - Class III - Biologics - DCI Biologicals Greenville, Inc","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-12-14,2016-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66781 - Class III - Biologics - DCI Biologicals Hot Springs, Inc","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-12-11,2013-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50455 - Class II - Biologics - DCI Biologicals Little Rock LLC,"Blood products, which were not quarantined subsequent to receiving information regarding  post donation information, were distributed.",2013-02-28,2013-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48241 - Class II - Biologics - DCI Biologicals Little Rock LLC,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62485 - Class II - Biologics - Dci Biologicals Llc,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67097 - Class II - Biologics - Dci Biologicals Llc,"Blood products, collected from a donor who engaged in high risk behavior, were distributed.",2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69458 - Class III - Biologics - Dci Biologicals Llc,"Blood product, collected from donors, whose suitability to donate was not adequately determined, was distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63195 - Class II - Biologics - DCI Biologicals LLC,"Blood products, which were not quarantined subsequent to receiving post- donations information, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60488 - Class II - Biologics - DCI Biologicals LLC,"Blood products, collected from a donor with a history of high-risk behavior, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40892 - Class II - Biologics - DCI Biologicals LLC,"Blood products, which tested reactive to HIV 1/2 and staff failed to quarantine units due to medical history, were distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59676 - Class II - Biologics - DCI Biologicals LLC,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64475 - Class II - Biologics - DCI Biologicals LLC,"Blood products, collected from a donor who had not had an annual physical performed, were distributed.",2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66193 - Class II - Biologics - DCI Biologicals LLC,"Blood products, which were not quarantined subsequent to receiving information regarding a post donation information, were distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68475 - Class III - Biologics - DCI Biologicals LLC,"Blood product, collected from a donor who had no responses to medical history questions documented, was distributed.",2014-07-18,2014-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69187 - Class III - Biologics - DCI Biologicals LLC,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-10-17,2014-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69459 - Class II - Biologics - DCI Biologicals LLC,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70160 - Class II - Biologics - DCI Biologicals LLC,"Blood product, for which the donor did not meet acceptance criteria, was distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71590 - Class III - Biologics - DCI Biologicals LLC,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64566 - Class II - Biologics - DCI Biologicals Lubbock, LLC","Blood products, which were not quarantined subsequent to receiving information regarding  post donation information, were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47924 - Class II - Biologics - DCI Biologicals Orlando LLC,"Blood products, collected from a donor who admitted to high risk behavior, were distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48058 - Class III - Biologics - DCI Biologicals Orlando LLC,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40010 - Class II - Biologics - DCI Biologicals Orlando LLC,"Blood products, collected from a donor who subsequently reported a tattoo, were distributed",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49870 - Class II - Biologics - DCI Biologicals Orlando LLC,"Blood products, collected from a donor who had been incarcerated, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66194 - Class II - Biologics - DCI Biologicals Orlando LLC,"Blood products, which were not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68140 - Class III - Biologics - DCI Biologicals Orlando LLC,"Blood product, collected from a donor for whom there was no documentation of an arm inspection or general donor appearance, was distributed.",2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68184 - Class III - Biologics - DCI Biologicals Orlando LLC,"Blood product, collected from a donor taking the medication Accutane, was distributed.",2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69042 - Class II - Biologics - DCI Biologicals Orlando LLC,"Source plasma product, for which donor eligibility was not complete, was distributed.",2014-09-12,2014-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69009 - Class II - Biologics - DCI Biologicals Orlando LLC,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-09-15,2014-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69501 - Class II - Biologics - DCI Biologicals Orlando LLC,"Blood product, for which donor eligibility was not complete, was distributed.",2014-10-28,2014-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69456 - Class III - Biologics - DCI Biologicals Orlando LLC,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63900 - Class III - Biologics - DCI Biologicals Temple Terrace, LLC","Blood products, collected from a donor whose donor suitability was not adequately determined, were distributed.",2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65266 - Class II - Biologics - DCI Biologicals Temple Terrace, LLC","Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-07-02,2013-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67096 - Class II - Biologics - DCI Biologicals Temple Terrace, LLC","Blood products, collected from a donor whose physical examination was incomplete, were distributed.",2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67309 - Class II - Biologics - DCI Biologicals Temple Terrace, LLC","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2014-02-20,2014-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67541 - Class II - Biologics - DCI Biologicals Temple Terrace, LLC","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67542 - Class II - Biologics - DCI Biologicals Temple Terrace, LLC","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67544 - Class II - Biologics - DCI Biologicals Temple Terrace, LLC","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67540 - Class II - Biologics - DCI Biologicals Temple Terrace, LLC","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2014-03-12,2014-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67770 - Class II - Biologics - DCI Biologicals Temple Terrace, LLC","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-04-11,2014-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46650 - Class II - Biologics - DCI Biologicals Wilmington, Inc.","Blood products, which were collected from a donor with a history of high risk behavior, were distributed.",2012-10-12,2012-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69008 - Class III - Biologics - DCI Biologicals Wilmington, Inc.","Blood product, collected from a donor with no documentation of an arm inspection or general appearance, was distributed.",2014-09-15,2014-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70518 - Class III - Biologics - DCI Biologicals Wilmington, Inc.","Blood products, which were not quarantined subsequent to receiving information regarding medical history, were distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72047 - Class III - Biologics - DCI Biologicals Wilmington, Inc.","Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed.",2015-10-05,2015-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72843 - Class III - Biologics - DCI Biologicals Wilmington, Inc.","Blood product, in which donor screening/donor record incomplete or incorrect, was distributed.",2016-01-21,2016-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65598 - Class II - Biologics - DCI Biologicals,  LLC","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed",2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63963 - Class II - Biologics - DCI Biologicals, LLC","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-02-04,2013-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67008 - Class II - Biologics - DCI Biologicals, LLC","Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67543 - Class III - Biologics - DCI Biologicals, LLC","Blood products, collected from a donor who was previously deferred, were distributed.",2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67538 - Class III - Biologics - DCI Biologicals, LLC","Blood products, which tested negative for viral markers, but were collected from a donor who was previously deferred for positive testing, were distributed.",2014-03-10,2014-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68476 - Class II - Biologics - DCI Biologicals, LLC","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2014-07-16,2014-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69007 - Class III - Biologics - DCI Biologicals, LLC","Blood product, in which donor testing was not performed or incomplete, was distributed.",2014-09-16,2014-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69457 - Class II - Biologics - DCI Biologicals, LLC","Blood product, collected from a donor who had been incarcerated, was distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70450 - Class II - Biologics - DCI Biologicals, LLC","Blood products, collected from a donor who subsequently reported a tattoo/piercing, were distributed.",2015-03-24,2015-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70980 - Class II - Biologics - DCI Biologicals, LLC","Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2015-04-22,2015-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71024 - Class III - Biologics - DCI Biologicals, LLC","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71026 - Class II - Biologics - DCI Biologicals, LLC","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41489 - Class II - Biologics - DCI Biologicals, Orlando LLC","Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68186 - Class II - Biologics - DCI Biologicals, Orlando LLC","Blood products, which were not quarantined after receiving post donation information concerning receipt of a tattoo, were distributed.",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65280 - Class II - Biologics - DCI Donor Services dba Sierra Donor Services,"Corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-14,2013-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67938 - Class III - Biologics - DCI Donor Services dba Sierra Donor Services,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-05-06,2014-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63238 - Class II - Biologics - DCI Donor Services Tissue Services Division,"Skin allografts, lacking assurance of proper temperature maintenance during transportation, were distributed.",2012-10-09,2012-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73005 - Class II - Biologics - DCI Donor Services Tissue Services Division,"Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed.",2016-01-14,2016-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73371 - Class II - Biologics - DCI Plasma Center Of Duluth, LLC","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed",2016-03-04,2016-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74289 - Class III - Biologics - DCI Plasma Center Of Duluth, LLC","Source Plasma, collected from an ineligible donor, was distributed.",2016-06-21,2016-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74369 - Class III - Biologics - DCI Plasma Center Of Duluth, LLC","Blood product, collected from a donor for whom suitability to donate was inadequately determined, was distributed.",2016-06-22,2016-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78034 - Class II - Drugs - Degasa Sa De Cv,"Labeling: Label mix-up. Finished product Povidone iodine 7.5% was labeled as Povidone iodine 10% , the outer box had the correct label.",2017-09-07,2017-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57375 - Class III - Biologics - Delta Blood Bank,"Blood products, collected from a donor whose arm inspection was not documented, were distributed.",2012-07-03,2012-07-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57770 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46988 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled  to a malaria endemic area, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57771 - Class II - Biologics - Delta Blood Bank,"Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60914 - Class III - Biologics - Delta Blood Bank,"Blood products, collected from a donor for whom there was no documentation on the donor record of an arm inspection, were distributed.",2012-07-19,2012-07-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60915 - Class III - Biologics - Delta Blood Bank,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47662 - Class II - Biologics - Delta Blood Bank,"Blood products, collected from a donor taking the drug methotrexate, were distributed.",2012-07-20,2012-07-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57772 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58339 - Class II - Biologics - Delta Blood Bank,"Blood products, collected from a donor who may be at increased risk for Creutzfeldt-Jakob Disease (CJD), were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58340 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58499 - Class II - Biologics - Delta Blood Bank,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59133 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59337 - Class II - Biologics - Delta Blood Bank,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59338 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60014 - Class II - Biologics - Delta Blood Bank,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60015 - Class III - Biologics - Delta Blood Bank,"Blood product, collected from a donor whose arm preparation was not documented, was distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60439 - Class II - Biologics - Delta Blood Bank,"Blood product, which was collected from a donor who had traveled to a malarial endemic area, was distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61706 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-09-19,2012-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61707 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45833 - Class II - Biologics - Delta Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45834 - Class II - Biologics - Delta Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57222 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor based on travel to an area considered endemic for malaria, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62882 - Class II - Biologics - Delta Blood Bank,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64554 - Class II - Biologics - Delta Blood Bank,"Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65684 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who reported travel through a malarial endemic area, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68175 - Class II - Biologics - Delta Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67979 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2014-10-16,2014-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69921 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-02-27,2015-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69922 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-02-27,2015-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70337 - Class III - Biologics - Delta Blood Bank,"Blood product, collected from a donor who tested reactive for the antibody to hepatitis B core antigen (anti-HBc) on two occasions, was distributed.",2015-03-23,2015-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70336 - Class II - Biologics - Delta Blood Bank,"Blood products, collected from a donor who tested reactive for anti-HBc on two separate occasions, were distributed.",2015-05-05,2015-05-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70606 - Class II - Biologics - Delta Blood Bank,"Blood product, which tested repeatedly reactive for the antibody to Hepatitis B core antigen (anti-HBc), was distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69200 - Class II - Biologics - Delta Blood Bank,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-07-13,2015-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71183 - Class III - Biologics - Delta Blood Bank,"Irradiated Red Blood Cells, not manufactured according to specifications, were distributed.",2015-09-04,2015-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73840 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from an ineligible donor, was distributed.",2016-04-14,2016-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74235 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74661 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-07-17,2016-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75085 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who had been incarcerated, was distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75136 - Class II - Biologics - Delta Blood Bank,"Blood product, in which quality control for WBC count was not performed, was distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75465 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-11-14,2016-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76354 - Class II - Biologics - Delta Blood Bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2017-02-28,2017-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76578 - Class II - Biologics - Delta Blood Bank,"Blood products, tested with expired reagents, were distributed.",2017-03-30,2017-03-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67335 - Class II - Biologics - Dendreon Corp,"PROVENGE, which did not meet the release spec for CD54 upregulation, or which had the potential to not meet the potency release specification for CD54 upregulation, was distributed.",2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61340 - Class III - Biologics - Dendreon Corporation,"Provenge (sipuleucel-T), with an out-of-specification (OOS) assay result, was distributed.",2012-11-15,2012-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89152 - Class III - Drugs - Dental Alliance Holdings LLC,Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.,2022-01-26,2022-01-26,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84657 - Class II - Drugs - Denton Pharma, Inc.",CGMP Deviations: Presence of NDMA impurity detected in product.,2020-01-20,2020-01-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86593 - Class II - Drugs - Denton Pharma, Inc.",CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer),2020-11-02,2020-11-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89136 - Class II - Drugs - Denver Solutions, LLC DBA Leiters Health",Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL,2021-12-17,2021-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75132 - Class II - Biologics - Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank,Blood product collected from a donor who traveled to a malarial endemic area was distributed.,2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89782 - Class II - Biologics - Department AF 81st Med. Group/SGQC Keesler AFB MC Blood Bank,"Red Blood Cell products, leuko-reduced by filtration at an unacceptable temperature, were distributed.",2022-03-30,2022-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64999 - Class II - Biologics - Department of Air Force - BB/HT,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89005 - Class II - Biologics - Department of Air Force 88th Medical Group SGQC WPAFB,"Blood products, not tested according to specifications, were distributed.",2021-11-23,2021-11-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90110 - Class II - Biologics - Department of Air Force 88th Medical Group SGQC WPAFB,"Leukoreduced Red Blood Cells, collected from a donor who had recently traveled to a malarial endemic area, were distributed.",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77710 - Class II - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Blood product, labeled 'leukoreduced', but which had not undergone leukoreduction, was distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77787 - Class II - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2017-08-23,2017-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79309 - Class II - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Leukoreduced Blood product, in which residual WBC count did not meet specifications, was distributed.",2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79308 - Class III - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Blood product, which failed to meet the minimum specification for red blood cell percent recovery, was distributed.",2018-03-15,2018-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83150 - Class III - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Blood product, for which the quality control testing was incorrect, was distributed.",2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84098 - Class III - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Plateletpheresis products, not tested completely for  transfusion-transmitted infection, were distributed.",2019-10-30,2019-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85349 - Class II - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Misbranded plateletpheresis products were distributed.
",2020-04-25,2020-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86072 - Class III - Biologics - Department of Air Force, 59th Medical Wing/SGVLB",Misbranded Plasma blood product was distributed.,2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86299 - Class II - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Blood products, which did not meet the acceptable product specifications, were distributed.",2020-09-10,2020-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86640 - Class III - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Blood product, which failed to meet product specifications, was distributed.",2020-11-12,2020-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86958 - Class II - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Blood product, collected from a donor whose arm preparation was performed in a manner that did not provide maximal assurance of sterility, was distributed.
",2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87733 - Class III - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Blood products, held at incorrect temperature during component preparation, were distributed.",2021-04-27,2021-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90139 - Class II - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Plateletpheresis product, possibly contaminated with air, was distributed. 
",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90236 - Class II - Biologics - Department of Air Force, 59th Medical Wing/SGVLB","Leukoreduced Red Blood Cells, filtered 72 hours after collection, were distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65024 - Class II - Biologics - Department of Army US Army Blood Bank Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73312 - Class II - Biologics - Department of Army US Army Blood Bank Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-03-31,2016-03-31,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74288 - Class II - Biologics - Department of Army William Beaumont Army Medical Center,"Blood products, collected from ineligible donors, were distributed.",2016-06-21,2016-06-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75038 - Class II - Biologics - Department of Army William Beaumont Army Medical Center,"Apheresis product, collected from a donor who previously tested repeat reactive for anti-HTLV on two separate occasions, was distributed.

",2016-09-07,2016-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74958 - Class II - Biologics - Department of Army William Beaumont Army Medical Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77204 - Class III - Biologics - Department of Army William Beaumont Army Medical Center,"Blood products, collected from ineligible donors, were distributed.",2017-05-11,2017-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86049 - Class III - Biologics - Department of Army William Beaumont Army Medical Center - Blood Donation Center,"Blood product, collected using expired blood collection sets, was distributed.",2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42446 - Class II - Biologics - Department of the Air Force,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50952 - Class II - Biologics - Department of the Air Force,"Blood products, which were incorrectly tested for HIV/HCV NAT using expired reagents, were distributed.",2015-04-29,2015-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71339 - Class II - Biologics - Department of the Air Force, 779th Medical Group","Blood products, which were stored at unacceptable temperatures, were distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71340 - Class II - Biologics - Department of the Air Force, 779th Medical Group","Blood products, which were stored at unacceptable temperatures, were distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71578 - Class II - Biologics - Department of the Army,"Blood product, collected from a donor who received a piercing within one year of donation, was distributed.",2015-08-05,2015-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78905 - Class II - Biologics - Department of the Army,"Blood product, collected from an ineligible donor, was distributed.",2018-02-21,2018-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82957 - Class II - Biologics - Department of the Army,"Red Blood Cell product, incorrectly labeled as Leukocytes Reduced was distributed.",2019-06-26,2019-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63294 - Class II - Biologics - Department Of The Army,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2012-10-24,2012-10-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75071 - Class III - Biologics - Department of the Army, Tripler Army Medical Center","Blood products, collected using expired blood collection bags, were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #51430 - Class II - Biologics - Department of the Navy,"Blood product, for which the Viral testing was not performed, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52144 - Class III - Biologics - Department of the Navy,"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2013-05-13,2013-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49926 - Class II - Biologics - Department of the Navy,"Blood products, collected from a donor whose suitability to donate were not adequately determined, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44528 - Class III - Biologics - Department of the Navy,"Blood product, which did not meet the minimum requirement for Red Blood Cell recovery, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58500 - Class II - Biologics - Department of the Navy,"Blood products, for which CMV testing was performed incorrectly, were distributed.",2014-11-18,2014-11-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77327 - Class III - Biologics - Department of the Navy,"Blood product, mislabeled as leukoreduced, was distributed.",2017-05-25,2017-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86543 - Class III - Biologics - Department of the Navy,"Plateletpheresis products, manufactured using expired blood collection bags, were distributed.
",2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91514 - Class II - Biologics - Dept of Defense - Army,"Leukorduced Red Blood Cells, collected from a donor who had recently traveled to a malarial endemic area, were distributed.",2023-01-20,2023-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64488 - Class II - Biologics - Dept Of The Navy, Naval Medical Center","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64489 - Class II - Biologics - Dept Of The Navy, Naval Medical Center","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64492 - Class II - Biologics - Dept Of The Navy, Naval Medical Center","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66488 - Class II - Biologics - Dept Of The Navy, Naval Medical Center","Blood product which was collected from a donor who was a resident of a malarial endemic area, was distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63751 - Class II - Biologics - Dept Of Veterans Affairs Office Of Information & Technology,"Software, with a defect or glitch, was distributed.",2012-12-21,2012-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83928 - Class III - Biologics - Dept. of the Army - Armed Services Blood Bank Ctr. - Europe,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2019-10-29,2019-10-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72724 - Class II - Biologics - Dept. of the Navy - U.S. Naval Hospital,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79572 - Class III - Biologics - Dept. of the Navy - U.S. Naval Hospital,"Blood products, not properly tested for relevant transfusion transmitted infections, were distributed.",2018-03-22,2018-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85866 - Class II - Biologics - Dept. of the Navy - U.S. Naval Hospital,"Blood products where Transfusion-Transmitted Infection Testing/Testing was performed incorrectly, were distributed.",2020-06-22,2020-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83399 - Class II - Drugs - Dercher Enterprises, Inc., DBA Gordon Laboratories",Microbial Contamination of Non-Sterile Products and Superpotent Drug: FDA analysis revealed microbial contamination in addition to high out of specification results for iron content.,2019-07-25,2019-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63378 - Class II - Drugs - DermaCare, Inc.",Microbial Contamination of Non-Sterile Products: Laboratory findings of high total plate count above specification.,2012-11-01,2012-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67247 - Class II - Drugs - Dermamedics, L.L.C.","Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded. 
",2014-07-29,2014-07-29,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66817 - Class I - Drugs - Deseo Rebajar,Marketed Without an Approved NDA/ANDA: FDA lab results found undeclared API Fluoxetine in this dietary supplement.,2014-04-25,2014-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67162 - Class I - Drugs - Deseo Rebajar,Marketed Without an Approved NDA/ANDA: Undeclared sibutramine and phenolphthalein  in Burn 7 dietary supplement,2014-05-27,2014-05-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78174 - Class II - Drugs - Deserving Health International Corp,Lack of Assurance of Sterility,2017-10-18,2017-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70444 - Class I - Drugs - Detox Transforms,"Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein and fluoxetine, making EDGE an unapproved drug., Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein, making iNDiGO an unapproved drug., Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, making AMPD GOLD an unapproved drug., Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein, making BtRiM Max an unapproved drug., Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared phenolphthalein and fluoxetine, making iNSANE an unapproved drug.",2015-05-04,2015-05-04,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83327 - Class II - Drugs - Deva Holding AS - Cerkezkoy Subesi,CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.,2019-07-23,2019-07-23,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72271 - Class II - Drugs - Diabetes Corporation of America dba DCA Pharmacy,Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.,2015-10-05,2015-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79758 - Class II - Drugs - Diamond Wipes International, Inc.",CGMP Deviations: finished products were manufactured with poor quality water.,2018-04-16,2018-04-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87917 - Class I - Drugs - Dibar Nutricional S. de R.L. de C.V.,"Chemical Contamination: FDA analysis found 3 lots of DiBAR hand Sanitizer to be below the label claim for ethanol content and to contain methanol., CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.
",2021-06-29,2021-06-29,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89642 - Class II - Drugs - Direct Rx,Failed impurities/degradation specifications,2022-02-25,2022-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89807 - Class II - Drugs - Direct Rx,Defective Container: Leaking containers.,2022-03-22,2022-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90215 - Class II - Drugs - Direct Rx,CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.,2022-05-20,2022-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90161 - Class II - Drugs - Direct Rx,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,2022-05-27,2022-05-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90869 - Class II - Drugs - Direct Rx,CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.,2022-09-15,2022-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91114 - Class II - Drugs - Direct Rx,cGMP deviation: discontinue of stability support for product.,2023-01-11,2023-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86498 - Class II - Drugs - Direct Rx,CGMP Deviations: Presence of NDMA impurity detected in product.,2020-10-05,2020-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86499 - Class II - Drugs - Direct Rx,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level per manufacturer",2020-10-05,2020-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86487 - Class II - Drugs - Direct Rx,CGMP deviation: Trace amounts of impurity detected to be N-Methylnitrosobutyric acid (NMBA) in the API.,2020-10-12,2020-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86601 - Class II - Drugs - Direct Rx,CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer),2020-11-02,2020-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87458 - Class II - Drugs - Direct Rx,cGMP deviations: The quantity of active ingredient used for the product lot was inadvertently taken from an ingredient lot from an alternate supplier before that specific lot was formally qualified for use by the manufacturing site.,2021-03-12,2021-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88749 - Class II - Drugs - Direct Rx,CGMP deviations: Gaps in the quality system in the Quality Control microbiology laboratory.,2021-09-23,2021-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89749 - Class II - Drugs - Direct Rx,CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.),2022-03-10,2022-03-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90200 - Class II - Drugs - Direct Rx,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .,2022-05-24,2022-05-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91559 - Class II - Drugs - DISCOVERY PHARMA LLC,CGMP deviations,2023-02-01,2023-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63095 - Class II - Drugs - Dispensing Solutions, Inc",Label Mix up; side panel of sticker label applied by Dispensing Solutions Inc. incorrectly indicates product name as Ventolin HFA 90 mcg instead of correctly as Atrovent HFA 12.9 grams Inhalation Aerosol,2012-09-25,2012-09-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90675 - Class I - Drugs - Distributor RFR, LLC.",Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.,2022-08-09,2022-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78841 - Class II - Drugs - DLC Laboratories, Inc",Microbial Contamination of Non-Sterile Products.,2018-01-25,2018-01-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87257 - Class II - Drugs - DLC Laboratories, Inc",Labeling: Label Mix-Up. THe English label with Drug Facts panel for Camphor was incorrectly placed on product.,2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79868 - Class II - Biologics - DLP Marquette General Hospital, LLC - Marquette","Blood product, collected from a donor who received a piercing within one year of donation, was distributed.
",2018-04-30,2018-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68638 - Class II - Drugs - Doctor's Best Vitamins,"Marketed Without an Approved NDA/ANDA: FDA analysis discovered undeclared lovastatin, making this an unapproved new drug.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89657 - Class II - Drugs - Dollar Tree Distribution, Inc.",CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center.,2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65383 - Class I - Drugs - Dolphin Intertrade Corporation,"Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.",2014-04-18,2014-04-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65936 - Class II - Biologics - Donor Network of Arizona,"Human Cornea, recovered from a donor who was not properly assess for hemodilution, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68558 - Class III - Biologics - Donor Network of Arizona,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-07-14,2014-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76314 - Class II - Biologics - Donor Network of Arizona,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2017-01-26,2017-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89548 - Class II - Biologics - Donor Network of Arizona,"Corneas, recovered from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2022-02-08,2022-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89704 - Class II - Biologics - Dorotea, LLC dba Alamo Tissue Service","Tendon and bone, recovered from a donor whose donor eligibility determination failed to ensure the donor was free from risk factors and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2022-03-30,2022-03-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72455 - Class II - Drugs - Downing Labs, LLC",Lack of Assurance of Sterility,2015-11-18,2015-11-18,48,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64405 - Class II - Drugs - Dr Reddys Laboratories Tennessee LLC,Microbial Contamination of Non-Sterile Products: Suspensions made from these lots of Amoxicillin 125 mg/5 mL showed yeast and mold growth at the 14 day time point.,2013-04-02,2013-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64733 - Class III - Drugs - Dr. Reddy'S Laboratories,Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.,2013-04-01,2013-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81441 - Class I - Drugs - Dr. Reddy's Laboratories, Inc.","Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the NDC incorrectly identifies the product as Levetiracetam in 0.75% Sodium Chloride (1000 mg/100 mL) however, the external foil pouch correctly identifies the product as Levetiracetam in 0.54% Sodium Chloride Injection (1,500/100 mL).",2019-02-11,2019-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82085 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications: Out of specification results observed for high dissolution.,2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87365 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.","Failed Impurities/Degradation Specifications:presence of ATV cyclo IP and FP, Dihydroxy epoxy and Dieto epoxy impurities",2021-03-01,2021-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83908 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",CGMP Deviations: Presence of NDMA impurity detected in product.,2019-11-05,2019-11-05,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89042 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed dissolution specifications,2021-12-07,2021-12-07,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89364 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications,2022-01-18,2022-01-18,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89388 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Subpotent drug,2022-01-19,2022-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89626 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Subpotent Drug: Out-of-specification results observed in Assay in sapropterin dihydrochloride powder 100mg.,2022-02-28,2022-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89833 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities/Degradation Specifications: Out of Specification results for related substance.,2022-03-29,2022-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89871 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications; during long term stability testing.,2022-03-31,2022-03-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90021 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications,2022-05-05,2022-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90601 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",FAILED DISSOLUTION SPECIFICATIONS,2022-07-22,2022-07-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90868 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.,2022-10-06,2022-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91190 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed dissolution specifications,2022-11-30,2022-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62591 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.","Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets., Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets",2012-07-31,2012-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63524 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.","Failed USP Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
",2012-11-20,2012-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63285 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.,2013-02-28,2013-02-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65885 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Microbial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp.,2013-08-12,2013-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66117 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.,2013-09-13,2013-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67293 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specification; 12-Month stability interval.,2014-02-06,2014-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67303 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Microbial Contamination of Non-Sterile Products: Out-of-specification results for microbial count were observed at the initial stability interval for Lansoprazole Delayed Release Capsules.,2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68513 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications: Failure of dissolution test observed at the 18 month time point.,2014-06-12,2014-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71374 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications; exceeded specification at the 9 hour time point,2015-06-12,2015-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71375 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Subpotent drug,2015-06-18,2015-06-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71906 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications,2015-08-11,2015-08-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71984 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Subpotent Drug: Subpotent atorvastatin.,2015-08-27,2015-08-27,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72648 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Tablet/Capsule Specifications:  Product recalled due to reports of breakage and leakage of Paricalcitol capsules.,2016-02-18,2016-02-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73527 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Lack of Assurance of Sterility; defective seals where the metal silver ring was not attached tightly to the vial,2016-03-28,2016-03-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73822 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities/Degradation Specifications; 12 month stability time point,2016-05-09,2016-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74220 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.","Failed impurities/degradation specification: An out of specification results has been determined for an individual related substance during stability testing at the 18th month interval for the Famotidine 10 mg Tablet, USP.",2016-06-30,2016-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74325 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed impurities/degradation: out of specification result for impurity secorapamycin.,2016-07-05,2016-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75162 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications,2016-10-13,2016-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76122 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications; 18 month stability time point,2017-01-30,2017-01-30,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75442 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.,2017-02-03,2017-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76539 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed dissolution specifications - low dissolution  results at S3 stage.,2017-03-02,2017-03-02,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76699 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.","Cross-contamination with other products -Related Substances test for Rivastigmine Tartrate Capsules USP, 1.5 mg showed a peak for Ranitidine.",2017-04-06,2017-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77353 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications: out of specification results observed for low dissolution.,2017-06-02,2017-06-02,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77734 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.,2017-07-31,2017-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78220 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine stability testing of a batch for related substances -impurity 8 at 24 month stability interval.,2017-10-11,2017-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78404 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Labeling: Incorrect or Missing Lot and/or Exp Date; lot number on the secondary packaging doesnt match the lot number printed on the bottle,2017-11-07,2017-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78842 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.,2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79065 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities/Degradations Specifications; out-of-specification results observed for Total Degradation Impurities during stability,2018-02-13,2018-02-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79472 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Stability Specifications:Out-of-specification results observed for viscosity during stability testing.,2018-03-14,2018-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79980 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Presence of Foreign Tablets/Capsules: One foreign tablet identified as Clopidogrel 75 mg was found in a 100 count bottle of Metoprolol Succiante Extended-Release Tablets.,2018-05-09,2018-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80208 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Presence of Foreign Substance: A product complaint was received for a defective tablet with an embedded foreign object observed in a bottle.,2018-06-18,2018-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80275 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities/Degradation Specifications,2018-06-21,2018-06-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80675 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities/Degradation Specifications - OOS was observed for ATV Cyclo FP Impurity and Total Degradation Impurities tested at the 18 month stability time point in Atorvastatin Calcium Tablets 40 mg 500 tablets.,2018-08-14,2018-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80953 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .,2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81083 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed stability specifications - An out of specification result was observed for the test parameter : composition of Nystatin during stability testing.,2018-10-04,2018-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81012 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities/Degradation Specifications: OOS for unknown impurities.,2018-10-26,2018-10-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81530 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specification: Out-of-Specification results were observed for dissolution at 18th month stability testing.,2018-11-27,2018-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81748 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.,2018-12-11,2018-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81936 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Presence of Foreign Substance: Product complaint of black speckles observed on tablets.,2019-01-22,2019-01-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82065 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Discoloration: Esomeprazole Magnesium DR Capsules (40mg)  may contain brown pellets.,2019-03-12,2019-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82323 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Defective Container: complaint for seal and cap vial issues that could lead to a lack of sterility assurance.,2019-03-12,2019-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82617 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.,2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85231 - Class I - Drugs - Dr. Reddy's Laboratories, Inc.",Defective Container: Recall is due to breaking and shattering of ampules upon opening,2020-04-06,2020-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85557 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Discoloration: product contains brown pellets,2020-04-28,2020-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87339 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications,2021-02-24,2021-02-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87411 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Dissolution Specifications: Out-of-specification results observed for dissolution during stability testing.,2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87879 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities -Degradation Specifications:due to presence of ATV cyclo IP and FP impurities,2021-05-27,2021-05-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88041 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Impurities/Degradation Specifications: due to presence of ATV cyclo IP and FP impurities,2021-06-11,2021-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88309 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",Failed Tablet/Capsule Specification: Some tablets are shaved,2021-08-18,2021-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88809 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.",CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.,2021-10-22,2021-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88798 - Class II - Drugs - Dr. Reddy's Laboratories, Inc.","Failed Excipient Specifications; product manufactured using an excipient found to be OOS for conductivity, Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle",2021-10-29,2021-10-29,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89447 - Class III - Drugs - Dr. Reddy's Laboratories, Inc.",Failed stability specifications,2022-02-22,2022-02-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74588 - Class II - Drugs - Dream Body Weight Loss,Marketed without an approved NDA/ANDA: Undeclared sibutramine.,2016-10-19,2016-10-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89808 - Class II - Drugs - Drug Depot, Inc., dba APS Pharmacy",Lack of sterility assurance.,2022-03-29,2022-03-29,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78648 - Class III - Biologics - DSM Biomedical, Inc.",Misbranded Genius PRP System and B/M/C Systems were distributed.,2017-12-07,2017-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62320 - Class II - Drugs - Dukal Corp.,Microbial contamination of Non Sterile Product; contamination with Burkholderia cepacia (manufacturer),2012-09-17,2012-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88428 - Class III - Drugs - DuPont Nutrition USA, Inc",Out of specification results for conductivity.,2021-08-16,2021-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88617 - Class I - Drugs - DuPont Nutrition USA, Inc",Microbial Contamination of Non-Sterile Product: Out-of-specification results obtained for total aerobic microbial count (TAMC).,2021-09-23,2021-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81811 - Class II - Drugs - Duren Health Mart Pharmacy,Lack of Processing Controls.,2019-01-28,2019-01-28,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77333 - Class I - Drugs - DYNAMIC TECHNICAL FORMULATIONS,Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: Product was tested by FDA and found to contain andarine and ostarine.,2017-08-14,2017-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61108 - Class I - Drugs - Eagle Pharmaceuticals Inc.,A complaint was received from a hospital pharmacy on 11/10/11 for crystalline particulates in a single vial from Lot V10194. Additional small visible particles consisting of fibers were identified.,2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72101 - Class II - Drugs - Eagle Pharmacy, Inc.",Subpotent Drug: trace amounts of methylcobalamin in compounded drug.,2015-09-29,2015-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78595 - Class II - Drugs - EAI-JR286, Inc.",CGMP Deviations: products manufactured in a manner that may impact product quality that includes but is not limited to failed viscosity.,2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63406 - Class II - Drugs - Earthborn Products, Inc.",Marketed Without An Approved NDA/ANDA: This product is being recalled because FDA issued a final rule establishing that all over-the-counter (OTC) drug products containing colloidal silver ingredients or silver salts for internal or external use are not generally recognized as safe and effective and are misbranded.,2012-10-18,2012-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65606 - Class II - Drugs - Earthlabs, Inc. DBA Wise Woman Herbals",Lack of Assurance of Sterility; Lack of Assurance of Sterility; product not manufactured under sterile conditions as required for ophthalmic drug products,2013-08-20,2013-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63678 - Class III - Biologics - East Tennessee Lions Eye Bank,"Human corneas, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-11-15,2012-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80238 - Class II - Biologics - East Tennessee Lions Eye Bank,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2018-06-05,2018-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80359 - Class II - Drugs - Eb5 Corporation,"Failed Stability Specifications: Out-of-specification for viscosity, pH and specific gravity",2018-07-03,2018-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88467 - Class I - Drugs - Ebay Seller - John Nguyen,Marketed without an approved NDA/ ANDA - presence of undeclared sibutramine,2021-09-14,2021-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85774 - Class II - Drugs - Eco Lips Inc,"Superpotent Drug: The active ingredient, avobenzone, is used at 5% which is higher than the allowable 3% in the sunscreen formula per FDA sunscreen regulations.",2020-06-15,2020-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90560 - Class III - Drugs - Eco Lips, Inc",Failed Dissolution Specifications,2022-07-27,2022-07-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90197 - Class III - Drugs - Eco Lips, Inc","Mislabeling: The active ingredient list on the label does not match the product's actual ingredients Specifically, the label states Octinoxate 7.5% and Oxybenzone 3%, while the product therein is made with Octinoxate 7.5%, Octisalate 5%, Octocrylene 5%, and Avobenzone 3%.",2022-05-23,2022-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86246 - Class II - Drugs - Ecolab Inc,Discoloration and Presence of Foreign Substance,2020-08-24,2020-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73264 - Class III - Drugs - Ecolab Inc,Subpotent drug,2016-03-08,2016-03-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81510 - Class II - Drugs - Ecolab Inc,Labeling: Label mix-up -  the label on the product may not match the formula in the bottle.,2018-11-20,2018-11-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82344 - Class II - Drugs - Ecolab Inc,Chemical Contamination: low levels of various substituted benzene (aromatic) compounds identified in the product after complaints of  malodor.,2019-03-27,2019-03-27,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83114 - Class III - Drugs - Ecolab Inc,Incorrect/undeclared excipients: Hand sanitizer was made using the wrong alcohol raw material.,2019-06-18,2019-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76177 - Class III - Drugs - Ecolab, Inc.",Subpotent Drug,2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87115 - Class II - Drugs - Edge Pharma, LLC",Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.,2021-01-12,2021-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87135 - Class II - Drugs - Edge Pharma, LLC",Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.,2021-01-19,2021-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86324 - Class II - Drugs - Edge Pharma, LLC",Labeling: Label Error on Declared Strength,2020-09-07,2020-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89172 - Class II - Drugs - Edge Pharma, LLC","Lack of Assurance of Sterility, Lack of Assurance of Sterility., CGMP Deviations",2022-01-24,2022-01-24,56,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86652 - Class II - Biologics - Edge Pharma, LLC","Edge Pharma's allergy stock vial of Feather Mix, mislabeled as Dog Epithelia, and subsequently used in the preparation of allergy treatment sets, one of which was distributed.",2020-11-18,2020-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85512 - Class II - Biologics - Edge Pharma, LLC","Edge Pharma's Custom Patient Prescriptions and Low Dose Antigen products, prepared within the cleanroom with multiple environmental monitoring excursions on the day of processing, were distributed.",2020-12-08,2020-12-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87348 - Class III - Drugs - Edge Pharma, LLC",Temperature Abuse; labeled with the incorrect room temperature (15-25 C) storage conditions rather than the correct refrigerated (2 - 8 C) storage conditions,2021-03-18,2021-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87514 - Class III - Drugs - Edge Pharma, LLC",Labeling: Incorrect or Missing Lot and/or Exp Date,2021-03-18,2021-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87710 - Class II - Drugs - Edge Pharma, LLC",Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility,2021-04-19,2021-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84864 - Class II - Drugs - Efficient Laboratories, Inc.",Microbial Contamination of Non-Sterile Products,2020-02-14,2020-02-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89205 - Class II - Drugs - Efficient Laboratories, Inc.",Microbial Contamination of Non-Sterile Products,2021-12-22,2021-12-22,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69959 - Class III - Drugs - Eisai Inc,"Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.",2014-12-16,2014-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88193 - Class II - Drugs - Eli Lilly & Company,"cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.",2021-08-11,2021-08-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88505 - Class II - Drugs - Eli Lilly & Company,Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.,2021-08-26,2021-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88764 - Class I - Drugs - Eli Lilly & Company,"SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance.  There was also a lack of full drug effect upon administration.",2021-10-14,2021-10-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81511 - Class III - Drugs - Eli Lilly and Company,Labeling: Missing label; potential for missing primary container label on the vial.,2018-11-15,2018-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78502 - Class III - Drugs - Elite Laboratories Inc.,Failed Impurities/Degradation Specifications,2017-12-05,2017-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79606 - Class II - Drugs - Elroselabs Inc.,cGMP Deviations,2018-04-06,2018-04-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72172 - Class III - Drugs - EMD Serono, Inc.",Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.,2015-09-15,2015-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85938 - Class II - Drugs - EMD Serono, Inc.",Defective Container: Market complaints of missing rubber stoppers from drug vial. Missing rubber stoppers could lead to lack of sterility assurance.,2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61791 - Class III - Drugs - Endo Pharmaceuticals, Inc.",Adulterated Presence of Foreign Tablets: Customer complaint that some Endocet 10 mg/325 mg tablets were found mixed in a bottle with Endocet 10 mg/650 mg tablets.,2012-06-14,2012-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76542 - Class II - Drugs - Endo Pharmaceuticals, Inc.","Lack of Assurance of Sterility: Defective container resulting in the lack of sterility assurance.
ok thanks",2017-03-03,2017-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81034 - Class I - Drugs - Endo Pharmaceuticals, Inc.","Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states ""Two to four tablets four times daily."" rather than the correct dosage of ""Two tablets three times daily.""",2018-10-09,2018-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90372 - Class II - Biologics - Envision Sight, Inc","Cornea, processed in a manner that could cause contamination or cross-contamination, was distributed",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76858 - Class I - Drugs - Envy Me,Marketed without an approved NDA/ANDA: Product contains undeclared Sibutramine.,2017-05-25,2017-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86171 - Class II - Drugs - Eosera, Inc.",cGMP Deviations.,2020-08-13,2020-08-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83809 - Class III - Drugs - EPI Health, LLC",Failed Dissolution Specifications:,2019-10-02,2019-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83849 - Class II - Drugs - Epic Pharma, LLC",Presence of Foreign Tablets/Capsules: Estradiol 1 mg was found in a 100 count bottle of Estradiol 0.5 mg Tablets.,2019-10-09,2019-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81729 - Class II - Drugs - Epic Pharma, LLC",Presence of foreign tablet/capsule: A single foreign tablet was found in pharmacy dispensed bottle of 30 Estradiol 2 mg tablets.,2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79842 - Class I - Drugs - Epic Products, LLC","Marketed Without An Approved NDA/ANDA: product contains undeclared sildenafil, tadalafil, and oxytetracycline, FDA approved drug products making Euphoric an unapproved drug.",2018-11-30,2018-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89726 - Class I - Biologics - Estar Technologies Ltd.,"TropoCells Autologous Platelet Preparation Kit PRP- Platelet preparation tube (PPT-1) 22 ml tubes, with higher than normal endotoxin levels, were distributed..",2022-03-20,2022-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82452 - Class III - Drugs - Estee Lauder Inc,Defective container: Ineffective seal between the cap and jar of the affected product.,2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63510 - Class III - Drugs - Estee Lauder Inc,"Failed Stability Specifications: The active sunscreen ingredient, avobenzone 3%, may not be stable over the shelf life, the sunscreen effectiveness may be less than labeled.",2013-02-05,2013-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68449 - Class III - Drugs - Estee Lauder Inc,Stability Data Does Not Support Expiry,2014-07-24,2014-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89501 - Class I - Drugs - Esupplementsales, LLC","Marketed Without an Approved NDA/ANDA: Firm was informed by Amazon that analytical testing showed the presence of tadalafil. Tadalafil is a FDA approved drug, making this product an unapproved drug.",2022-02-15,2022-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63282 - Class III - Biologics - Ethicon, Inc.","Evicel and Evithrom, manufactured with a processing deviation that potentially led to decreased potency, were distributed.",2013-02-19,2013-02-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68218 - Class I - Drugs - Eugene Oregon, Inc.",Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.,2014-09-29,2014-09-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91406 - Class II - Drugs - Eugia US LLC,Presence of Particulate Matter: Customer complaint of dark particles found inside the vial,2023-01-03,2023-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86568 - Class III - Drugs - eVenus Pharmaceutical Laboratories,DEFECTIVE CONTAINER: Desflurane Liquid for Inhalation 240 mL may be leaking.,2020-10-20,2020-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82858 - Class II - Biologics - Eversight,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87110 - Class II - Biologics - Eversight,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2021-01-29,2021-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76226 - Class II - Biologics - Eversight Illinois (Chicago),"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2017-01-17,2017-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78781 - Class II - Biologics - Eversight Illinois (Chicago),"Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2017-12-19,2017-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83262 - Class II - Biologics - Eversight Illinois (Chicago),"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2019-07-03,2019-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84201 - Class II - Biologics - Eversight Illinois (Chicago),"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2019-11-05,2019-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91592 - Class II - Biologics - Eversight Illinois (Chicago),"Corneas, in which donor testing was conducted with an unacceptable sample, were distributed.",2023-02-14,2023-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91594 - Class II - Biologics - Eversight Illinois (Chicago),"Corneas, in which donor testing was conducted with an unacceptable sample, were distributed.
",2023-02-15,2023-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74201 - Class II - Biologics - Eversight Illinois, Bloomington","Human Corneas, recovered from a donor who was not properly evaluated for hemo-dilution, were distributed.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75286 - Class II - Biologics - Eversight Michigan,"Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63232 - Class I - Drugs - Evol Nutrition,"Marketed Without an Approved NDA/ANDA:  The products were found to contain FDA approved ingredients and analogues of FDA approved ingredients used to treat male erectile dysfunction, making them unapproved new drugs.",2013-05-16,2013-05-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74744 - Class III - Drugs - Exact-Rx Inc,Crystallization; complaints received by the manufacturer of crystals forming in product,2016-08-23,2016-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90956 - Class I - Drugs - Exela Pharma Sciences LLC,"Defective Container: Complaints received of vial breakage and glass flying when
pressurized while preparing the product for administration",2022-10-27,2022-10-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91197 - Class I - Drugs - Exela Pharma Sciences LLC,Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.,2022-12-13,2022-12-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79969 - Class II - Drugs - Exela Pharma Sciences LLC,Labeling: Label Mix-Up: bottle labeled as Diclofenac Sodium and Misoprostol 75 mg/0.2 mg contained Diclofenac Sodium and Misoprostol 50 mg/0.2 mg tablets.,2018-05-22,2018-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86288 - Class III - Drugs - Exela Pharma Sciences LLC,Short Fill,2020-09-14,2020-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89402 - Class II - Drugs - Exela Pharma Sciences LLC,Lack of Assurance of Sterility,2022-01-13,2022-01-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73037 - Class II - Biologics - Exempla Saint Joseph Hospital,"Blood product, labeled RBC antigen negative tested RBC antigen positive, was distributed.",2016-02-04,2016-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77371 - Class III - Biologics - Exempla Saint Joseph Hospital,"Blood product, labeled with an incorrect expiration date, was distributed.",2017-06-27,2017-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66584 - Class II - Biologics - Eye Bank For Sight Restoration,"Human allograft, recovered from a donor who may have participated in high risk behavior, was distributed.",2013-11-05,2013-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69492 - Class II - Biologics - Eye Bank For Sight Restoration,"Human Cornea, recovered from an ineligible donor, was distributed.",2014-12-03,2014-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71885 - Class III - Biologics - Eye Bank For Sight Restoration,"Human cornea, that did not meet release criteria, was distributed.",2015-08-07,2015-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84600 - Class II - Biologics - Eye Bank For Sight Restoration Inc.,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2019-12-31,2019-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85438 - Class III - Biologics - Eye Bank For Sight Restoration Inc.,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2020-04-09,2020-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65121 - Class III - Biologics - Eye Bank Of Wisconsin, Inc.","Human Corneas, recovered from a donor whose donor eligibility determination was incomplete related to evaluating  the donor's clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-05-15,2013-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65517 - Class III - Biologics - Eye Bank Of Wisconsin, Inc.","Human Corneas, recovered from a donor whose plasma dilution was not properly evaluated, were distributed.",2013-07-26,2013-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65972 - Class III - Biologics - Eye Bank Of Wisconsin, Inc.","Human corneas, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65973 - Class III - Biologics - Eye Bank Of Wisconsin, Inc.","Human Corneas, recovered from a donor who was improperly assessed for hemodilution, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72082 - Class III - Biologics - Eye Bank Of Wisconsin, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2015-09-08,2015-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73269 - Class II - Biologics - Eye Bank Of Wisconsin, Inc.","Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2016-02-18,2016-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86740 - Class II - Drugs - EYWA PHARMA INC,Presence of foreign tablet/capsule: A 1000 mg Levetiracetam Tablet was found in 500 gram bottle of Levetiracetam Tablets.,2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77817 - Class I - Drugs - EZWeightLossTX LLC,Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.,2017-12-20,2017-12-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63656 - Class II - Drugs - F. Hoffmann-LaRoche Ltd.,Lack of Assurance of Sterility; container closure issues with the bulk batch.,2012-12-21,2012-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66043 - Class I - Drugs - Fabscout Entertainment, Inc","Marketed without an Approved NDA/ANDA: product found to contain undeclared sildenafil, Marketed without an Approved NDA/ANDA: products were found to contain undeclared sildenafil, Marketed without an Approved NDA/ANDA: product found to contain undeclared sildenafil and tadalafil",2013-12-18,2013-12-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65892 - Class I - Drugs - Fabscout Entertainment, Inc","Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that the products was found to contain sildenafil, an undeclared active pharmaceutical ingredient.",2014-03-20,2014-03-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77584 - Class II - Drugs - Fagron Compounding Services LLC dba Fagron Sterile Services,Lack Of Assurance Of Sterility: voluntary recall initiated by the commercial supplier,2017-07-06,2017-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80383 - Class I - Drugs - Fagron Compounding Services LLC dba Fagron Sterile Services,"Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.",2018-07-06,2018-07-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89805 - Class I - Drugs - Fagron, Inc",Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.,2022-05-09,2022-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89797 - Class III - Drugs - Fagron, Inc",Subpotent Drug,2022-05-11,2022-05-11,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68896 - Class II - Drugs - Fagron, Inc",Microbial Contamination of Non-Sterile Products: Fagron is recalling six lots due to the presence of mold.,2014-07-30,2014-07-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72797 - Class III - Drugs - Fagron, Inc",Subpotent Drug,2016-01-06,2016-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72795 - Class II - Drugs - Fagron, Inc",Penicillin Cross Contamination: Potential for products to be cross-contaminated with penicillin.,2016-01-12,2016-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72854 - Class II - Drugs - Fagron, Inc",Presence of Foreign Substance,2016-01-19,2016-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72886 - Class II - Drugs - Fagron, Inc",Microbial Contamination of Non-Sterile Products: Syrspend SF and Syrspend SF Grape Flavor are being recalled due to the presence of yeast.,2016-02-05,2016-02-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77018 - Class III - Drugs - Fagron, Inc",Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.,2017-05-03,2017-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77060 - Class II - Drugs - Fagron, Inc",cGMP Deviations: lack of quality assurance at the API manufacturer.,2017-05-19,2017-05-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78402 - Class II - Drugs - Fagron, Inc",cGMP Deviations: lack of quality assurance at the API manufacturer.,2017-11-14,2017-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79253 - Class II - Drugs - Fagron, Inc",Microbial contamination of Non-Sterile Product;  product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).,2018-02-27,2018-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84179 - Class II - Drugs - Fagron, Inc",Microbial contamination of non-sterile product.,2019-11-29,2019-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66200 - Class II - Drugs - Fallon Wellness Pharmacy Llc,"Lack of Assurance of Sterility: Fallon Pharmacy recalled Bevacizumab 25mg/mL due to sterility assurance concerns based on testing of this lot by a third party lab, indicating that test results reported as passing sterility may have been inaccurate.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70807 - Class II - Drugs - Fallon Wellness Pharmacy, L.L.C.",Lack of assurance of sterility,2015-05-12,2015-05-12,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75695 - Class II - Drugs - Fallon Wellness Pharmacy, L.L.C.",Lack of Assurance of Sterility: product produced on a day there was an excursion in environmental monitoring data.,2016-12-08,2016-12-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90270 - Class II - Drugs - Family Dollar Stores, Llc.",cGMP deviations: product stored outside of labeled temperature requirements.,2022-05-31,2022-05-31,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90566 - Class II - Drugs - Family Dollar Stores, Llc.",CGMP Deviations: product held outside appropriate storage temperature conditions.,2022-08-22,2022-08-22,100,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90774 - Class II - Drugs - Family Dollar Stores, Llc.",cGMP deviation: Product held outside of appropriate temperature storage conditions.,2022-08-29,2022-08-29,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89773 - Class II - Drugs - Family Pharmacy of Statesville,Lack of Assurance of Sterility,2022-03-17,2022-03-17,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65349 - Class III - Drugs - Faria Limited LLC dba Sheffield Pharmaceuticals,Failed Stability Specifications: Unable to meet shelf life expiry.,2013-06-14,2013-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66962 - Class II - Drugs - Faria Limited LLC dba Sheffield Pharmaceuticals,Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing,2014-02-05,2014-02-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65044 - Class III - Biologics - Fenwal Inc,"BLOOD-PACK Units in which the platelet container is incorrectly labeled as ""AS-1 Red Blood Cell Adenine-Saline added"", were distributed.",2013-04-30,2013-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65149 - Class III - Biologics - Fenwal Inc,"Blood-Pack Units, with missing labeling on the satellite bags, were distributed.",2013-05-16,2013-05-16,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66240 - Class III - Biologics - Fenwal Inc,Mislabeled Blood-Pack Units were distributed.,2013-10-17,2013-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66993 - Class II - Biologics - Fenwal Inc,"PLASMACELL-C Disposable Set for Use with SPIKESMART System, with a defect in the base of the blue vent cap on the reservoir assembly that may result in a leak of the reservoir assembly, was distributed.",2014-01-27,2014-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79780 - Class III - Biologics - Fenwal Inc,"Fresenius Kabi's DXT Relay 2.X Software, with a defect or glitch, was distributed.",2018-05-31,2018-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86066 - Class I - Drugs - Ferring Pharmaceuticals Inc,Superpotent Drug,2020-08-17,2020-08-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87455 - Class II - Drugs - Ferring Pharmaceuticals Inc,Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.,2021-03-30,2021-03-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63538 - Class III - Drugs - Ferring Pharmaceuticals Inc,Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.,2012-11-30,2012-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64339 - Class III - Drugs - Ferring Pharmaceuticals Inc,"Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A",2013-04-02,2013-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68407 - Class II - Drugs - Ferring Pharmaceuticals Inc,Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying process.,2014-06-17,2014-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66604 - Class III - Drugs - Ferring Pharmaceuticals Inc,Discoloration; due to prolonged heat exposure.,2014-07-09,2014-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72181 - Class III - Drugs - Ferring Pharmaceuticals Inc,Subpotent Drug,2015-10-14,2015-10-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87382 - Class III - Drugs - Ferring Pharmaceuticals Inc,"Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP",2021-03-11,2021-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85274 - Class II - Drugs - Filltech USA, LLC",Microbial contamination of non-sterile products: positive test for yeast and bacteria.,2020-04-16,2020-04-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67846 - Class II - Drugs - First Aid Only Inc,"First Aid Only, Inc is recalling Smart Tab First Aid ezRefill System Ibuprofen boxes  and First Aid Cabinets containing these Ibuprofen boxes.  Ibuprofen boxes (FAE 7014) were accidentally used to package  aspirin packs  (10 packs of 2 / 235mg tablets).",2014-05-15,2014-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83253 - Class II - Drugs - First Pharma Associates LLC dba Riverpoint Pharmacy,Lack of Assurance of Sterility.,2019-07-11,2019-07-11,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83669 - Class II - Drugs - First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy",Lack of Assurance of Sterility,2019-11-05,2019-11-05,100,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88693 - Class II - Drugs - First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy",Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns,2021-10-26,2021-10-26,40,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91427 - Class II - Drugs - Fisher Scientific Co., LLC","CGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced under temporary approval, into the market after March 31, 2022.",2023-01-18,2023-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72874 - Class I - Drugs - Fit Firm and Fabulous,"Marketed Without An Approved NDA/ANDA: product marketed as a dietary supplement was found to be tainted with undeclared sibutramine, a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons, in this tainted product renders it an unapproved drug.",2016-02-18,2016-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83812 - Class I - Drugs - FITOTERAPIA USA, INC",Marketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil.,2019-11-12,2019-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68158 - Class II - Drugs - Flawless Beauty and Skin,"Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling includes drug claims to act as an antidote., Marketed Without An Approved NDA/ANDA: Parenteral product is labeled for use as an antidote., Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used parenterally for drug claims., Marketed Without An Approved NDA/ANDA: Parenteral product is sold over the counter whose labeling indicates it is to be used for the treatment of disease., Marketed Without An Approved NDA/ANDA: Product is sold over the counter whose labeling indicates it is to be used for parenteral injection.",2014-05-13,2014-05-13,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78991 - Class II - Drugs - Flawless Beauty and Skin,"Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.",2018-02-05,2018-02-05,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85742 - Class III - Drugs - Flexion Therapeutics, Inc.",Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded,2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #36297 - Class II - Biologics - Florida,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-10-18,2013-10-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63779 - Class II - Biologics - Florida's Blood Centers - Lake Park,"Blood products, leukoreduced more than three days after collection, were distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65066 - Class II - Biologics - Florida's Blood Centers - Lake Park,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65323 - Class II - Biologics - Florida's Blood Centers - Lake Park,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62355 - Class III - Biologics - Florida's Blood Centers, Inc.","Blood product, collected from a therapeutic donor with a history of polycythemia vera, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62029 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62028 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62484 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62488 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, which was collected from a donor who lived in a malarial endemic area, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62523 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62861 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, labeled 'leukoreduced', but which had not undergone leukoreduction, was distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63179 - Class III - Biologics - Florida's Blood Centers, Inc.","Blood product, which may have been exposed to unacceptable temperature during storage, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63625 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63780 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, leukoreduced more than three days after collection, were distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63985 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64123 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64124 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64125 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50275 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products,  which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-02-19,2013-02-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50299 - Class III - Biologics - Florida's Blood Centers, Inc.","Blood products, which reached an unacceptable temperature during shipment, were distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50302 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who lived in an area considered endemic for malaria, were distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50674 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48527 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, platelet pheresis leukocytes reduced with an unacceptable pH, were distributed.",2013-02-26,2013-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49633 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, which were collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-02-26,2013-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50028 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-02-26,2013-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64352 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2013-03-07,2013-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48271 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, labeled with incorrect expiration date and product code, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64630 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, which were collected from a donor who traveled to malarial endemic areas, were distributed.",2013-04-11,2013-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64526 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who deferred for receiving a piercing, were distributed.",2013-04-15,2013-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64567 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2013-04-15,2013-04-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41567 - Class II - Biologics - Florida's Blood Centers, Inc.","Blood product, collected from a donor who reported travel to an area that was endemic for malaria, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62937 - Class III - Biologics - Florida Blood Services, Inc.","Blood product, which was washed with an incorrect wash solution, was distributed.",2012-10-01,2012-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42952 - Class III - Biologics - Florida Blood Services, Inc.","Blood products, which may have been exposed to unacceptable temperature during storage, were distributed.",2013-02-12,2013-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50629 - Class II - Biologics - Florida Blood Services, Inc.","Blood products, for which the quality control testing was not performed, were distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63293 - Class II - Biologics - Florida Blood Services, Inc.","Blood product, collected from a therapeutic donor with polycythemia vera, was distributed",2013-02-28,2013-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48774 - Class II - Biologics - Florida Blood Services, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48776 - Class II - Biologics - Florida Blood Services, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49253 - Class II - Biologics - Florida Blood Services, Inc.","Blood products, collected from a donor who provided a different last name,  were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48336 - Class II - Biologics - Florida Blood Services, Inc.","Blood product, possibly contaminated with air, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39044 - Class II - Biologics - Florida Blood Services, Inc.","Blood product, incorrectly labeled as negative for the Jka red cell antigen, was distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42466 - Class II - Biologics - Florida Blood Services, Inc.","Blood product,  which was positive for E antigen was distributed to a recipient who was identified  with an E antibody.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49911 - Class III - Biologics - Florida Blood Services, Inc.","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42781 - Class II - Biologics - Florida Georgia Blood Alliance, Inc.","Blood product, which was collected from a donor who traveled to malarial endemic area, was distributed",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39053 - Class II - Biologics - Florida Georgia Blood Alliance, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44985 - Class II - Biologics - Florida Georgia Blood Alliance, Inc.","Blood products, collected from a donor whose close contact with partner who emigrated from an area at risk for HIV-Group O, were distributed.",2013-03-26,2013-03-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43942 - Class II - Biologics - Florida Georgia Blood Alliance, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-04-29,2013-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44986 - Class III - Biologics - Florida Georgia Blood Alliance, Inc.","Blood products, for which there was no documentation for the time period out of controlled storage, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63332 - Class III - Biologics - Florida Lions Eye Bank, Inc.","Human Corneas, recovered from donors whose donor eligibility was not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.",2012-11-12,2012-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64073 - Class II - Biologics - Florida Lions Eye Bank, Inc.","Human Corneal tissues, recovered from donors and not tested using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.",2013-01-24,2013-01-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64206 - Class III - Biologics - Florida Lions Eye Bank, Inc.","Human Corneas, recovered from donors whose donor eligibility was not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.",2013-02-08,2013-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79843 - Class II - Biologics - Florida Lions Eye Bank, Inc.","Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2018-04-16,2018-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81653 - Class II - Biologics - Florida Lions Eye Bank, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2018-11-30,2018-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82094 - Class II - Biologics - Florida Lions Eye Bank, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2019-02-13,2019-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82874 - Class II - Biologics - Florida Lions Eye Bank, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77315 - Class II - Drugs - Forest Laboratories, LLC",Labeling; Label Mixup; blister lidding foil and shell-pack labeled as 10 mg but package actually contains 5 mg tablets,2017-05-31,2017-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66838 - Class III - Drugs - Forest Pharmaceuticals Inc,Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.,2014-02-04,2014-02-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68246 - Class II - Drugs - Forest Pharmaceuticals Inc,Failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.,2014-05-22,2014-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68548 - Class II - Drugs - Forest Pharmaceuticals Inc,Failed Dissolution Specifications: Drug failed stage III dissolution testing.,2014-06-30,2014-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69298 - Class II - Drugs - Forest Pharmaceuticals Inc,Failed Dissolution Specification; at the 6-month stability time point,2014-10-17,2014-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66878 - Class I - Drugs - Fossil Fuel Products, LLC","Marketed Without an Approved NDA/ANDA: Fossil Fuel Products, is recalling  RezzRX due to undeclared  hydroxylthiohomosildenafil and aminotadalafil.",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62625 - Class III - Drugs - Fougera Pharmaceuticals  Inc.,Failed Impurities/Degradation Specifications: Ketoconazole Cream 2% is the subject of a voluntary drug recall by Fougera due to an Out Of Specification result for an unknown degradant product,2013-04-02,2013-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66881 - Class III - Drugs - Fougera Pharmaceuticals  Inc.,Failed Impurities/Degradation Specifications: Out-of-Specification degradant results.,2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67329 - Class III - Drugs - Fougera Pharmaceuticals  Inc.,Labeling: Label Error on Declared Strength: There is a misprint on the end flap which read 01% rather than 0.1%.,2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68683 - Class III - Drugs - Fougera Pharmaceuticals  Inc.,"Failed PH Specifications: It has been determined that the pH of the lots recalled, may not meet specification at expiry.",2014-07-17,2014-07-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68839 - Class II - Drugs - Fougera Pharmaceuticals  Inc.,"Failed Stability Specifications: The lots of Fluocinonide Gel USP, 0.05% recalled, may not meet the requirements for residual solvents as outlined in USP <467>.",2014-11-12,2014-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76611 - Class II - Drugs - Fougera Pharmaceuticals  Inc.,Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream,2017-03-23,2017-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62136 - Class III - Drugs - Fougera Pharmaceuticals, Inc.",Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.,2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68497 - Class II - Drugs - Franck's Lab Inc dba Trinity Care Solutions,Lack of Assurance of Sterility; All lots of sterile products compounded by the pharmacy within expiry are subject to this recall. This recall is initiated due to concerns associated with quality control procedures observed during a recent FDA inspection.,2014-07-24,2014-07-24,30,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62416 - Class II - Drugs - Franck's Lab Inc., d.b.a. Franck's Compounding Lab",Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.,2012-08-10,2012-08-10,100,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62443 - Class II - Drugs - Franck's Lab Inc., d.b.a. Franck's Compounding Lab",Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012. FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.,2012-08-10,2012-08-10,98,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91325 - Class II - Drugs - Frenda Corporation,cGMP Deviations,2023-01-30,2023-01-30,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88698 - Class II - Drugs - Fresenius Kabi USA LLC,Defective container: Cracked vials leading to lack of sterility assurance,2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68019 - Class III - Drugs - Fresenius Kabi USA LLC,Failed Impurities/Degradation Specifications: Fresenius Kabi is recalling three lots of Haloperidol Decanoate Injection due to an out-of-specification result.,2014-11-13,2014-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88194 - Class II - Drugs - Fresenius Kabi USA LLC,Low out of specification results for epinephrine assay.,2021-07-07,2021-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64266 - Class III - Drugs - Fresenius Kabi USA LLC (FK USA),Labeling: Missing label,2013-03-13,2013-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64102 - Class II - Drugs - Fresenius Kabi USA LLC (FK USA),Crystallization: Active pharmaceutical ingredient is precipitating in product solution.,2013-08-21,2013-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81570 - Class I - Drugs - Fresenius Kabi USA, LLC",Labeling Not Elsewhere Classified: Fresenius Kabi is taking this action due to an incorrect statement on the product insert for product codes 918610 and 918620 indicating that the stoppers do not contain natural rubber latex.  The tray label for these two product codes and the vial label for product code 918620 also incorrectly state that the stoppers do not contain latex.  The above listed product codes and batches being recalled have stoppers containing natural rubber latex.,2018-12-14,2018-12-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85504 - Class I - Drugs - Fresenius Kabi USA, LLC",Presence of Particulate Matter - found in reserve sample vials at the firm.,2020-06-08,2020-06-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87005 - Class II - Drugs - Fresenius Kabi USA, LLC",Presence of Particulate Matter - found in reserve sample vials at the firm.,2020-12-31,2020-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87082 - Class I - Drugs - Fresenius Kabi USA, LLC",Presence of Particulate Matter - found in reserve sample vials at the firm.,2021-01-27,2021-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89725 - Class I - Drugs - Fresenius Kabi USA, LLC","Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.",2022-04-06,2022-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91198 - Class II - Drugs - Fresenius Kabi USA, LLC",Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.,2023-01-13,2023-01-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65588 - Class II - Drugs - Fresenius Kabi USA, LLC",Presence of particulate matter:  characterized as thin colorless flakes that are visually and chemically consistent with glass delamination observed in reserve sample vials,2013-07-05,2013-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65213 - Class III - Drugs - Fresenius Kabi USA, LLC",Failed Impurities/Degradation Specification,2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65512 - Class II - Drugs - Fresenius Kabi USA, LLC",Subpotent Drug; 15-month stability test station,2013-07-17,2013-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65218 - Class I - Drugs - Fresenius Kabi USA, LLC",Presence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.,2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66810 - Class III - Drugs - Fresenius Kabi USA, LLC","Labeling: Incorrect or Missing Package Insert- Missing text on the product insert in the ""Clinical Studies"" and ""Specific Adverse Events"" sections.",2013-11-22,2013-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67054 - Class III - Drugs - Fresenius Kabi USA, LLC",Failed Impurities/Degradation specifications: out-of-specification results 14 & 15 month time point,2013-12-18,2013-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66678 - Class II - Drugs - Fresenius Kabi USA, LLC",Presence of Particulate Matter: Particulate matter consistent with delamination of the glass vial container.,2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67330 - Class II - Drugs - Fresenius Kabi USA, LLC",Subpotent; 18 month time point,2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68152 - Class II - Drugs - Fresenius Kabi USA, LLC",Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.,2014-07-09,2014-07-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68910 - Class II - Drugs - Fresenius Kabi USA, LLC",CGMP Deviations: Citations given to API supplier by the Italian Health Agency AIFA for several critical deficiencies which caused a recall of the API lot used to manufacture Propanolo HCl Injection.,2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69810 - Class II - Drugs - Fresenius Kabi USA, LLC",Defective Container: Vials may be missing stoppers.,2014-12-08,2014-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63451 - Class II - Drugs - Fresenius Kabi USA, LLC",Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.,2014-12-10,2014-12-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71222 - Class II - Drugs - Fresenius Kabi USA, LLC",Labeling: Label Error on Declared Strength: Labeled 3.1% Amino Acids but contains 3.3% Amino Acids,2015-06-03,2015-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71409 - Class II - Drugs - Fresenius Kabi USA, LLC","Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradation",2015-07-14,2015-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71827 - Class III - Drugs - Fresenius Kabi USA, LLC","Incorrect Expiration Date: The ""11/06"" expiration date printed on the tray (secondary packaging) is incorrect (it should be 11/2016)",2015-08-12,2015-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73652 - Class III - Drugs - Fresenius Kabi USA, LLC",Failed Impurities/Degradation Specifications: Firm is recalling product due to an impurity out-of-specification result.,2016-04-11,2016-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73751 - Class II - Drugs - Fresenius Kabi USA, LLC",Incorrect/ Undeclared Excipient: Firm is recalling product due to an incorrect statement of Preservative free on the individual carton label.  The vial label and outer carton label contain the correct statement of 0.9% benzyl alcohol added as a preservative.,2016-04-12,2016-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73811 - Class II - Drugs - Fresenius Kabi USA, LLC",Failed Impuities/Degradation Specifications,2016-05-24,2016-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73935 - Class II - Drugs - Fresenius Kabi USA, LLC",Presence of Particulate Matter: Glass particulate found in sterile injectable product,2016-06-16,2016-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76001 - Class II - Drugs - Fresenius Kabi USA, LLC",Failed Impurities/Degradation Specifications,2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76728 - Class III - Drugs - Fresenius Kabi USA, LLC",Subpotent Drug,2017-04-05,2017-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78396 - Class I - Drugs - Fresenius Kabi USA, LLC","Labeling: Label MIX-UP.  Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL",2018-01-04,2018-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78949 - Class III - Drugs - Fresenius Kabi USA, LLC",Failed impurities/ degradation specifications: Out-of-specification (OOS) result for USP related compound F at the 12 month stability test station.,2018-02-15,2018-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82915 - Class III - Drugs - Fresenius Kabi USA, LLC",Failed Impurities/Degradation Specifications.,2019-06-14,2019-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83234 - Class I - Drugs - Fresenius Kabi USA, LLC",Presence of Particulate Matter; glass particulates,2019-07-17,2019-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86018 - Class III - Drugs - Fresenius Kabi USA, LLC","Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.",2020-07-16,2020-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86095 - Class I - Drugs - Fresenius Kabi USA, LLC",Cross Contamination with other products: trace amounts of lidocaine,2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86765 - Class III - Drugs - Fresenius Kabi USA, LLC",Cross Contamination with Other Products: trace amounts of octreotide found during testing,2020-11-24,2020-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86766 - Class I - Drugs - Fresenius Kabi USA, LLC",Cross Contamination with other products: trace amounts of lidocaine,2020-12-08,2020-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86964 - Class II - Drugs - Fresenius Kabi USA, LLC",Subpotent Drug: Low out-of-specification assay results for the epinephrine component.,2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90997 - Class II - Drugs - Fresenius Medical Care Holdings, Inc.","Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.",2022-10-20,2022-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91226 - Class II - Drugs - Fresenius Medical Care Holdings, Inc.","Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.",2022-12-02,2022-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67995 - Class II - Drugs - Fresenius Medical Care Holdings, Inc.",Cross Contamination with Other Products: Potential for contaminant on the cotton packaging inside the bottle.  Chemical analysis of the contaminant found on the cotton was identified as a formulation of 4% Trimipramine methanesulfonate - a tricyclic antidepressant..,2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85228 - Class II - Drugs - Fresenius Medical Care Holdings, Inc.",CGMP Deviation: Chemical indicators were not positioned properly during sterilization process.,2020-03-26,2020-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87907 - Class II - Drugs - Fresenius Medical Care Holdings, Inc.",Temperature Abuse: Product exposed to temperature outside specified limits.,2021-06-09,2021-06-09,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79403 - Class II - Drugs - Fresenius Medical Care Renal Therapies Group, LLC",Lack of Assurance of Sterility: Leakage of the peritoneal dialysis (PD) solution bag.,2018-03-20,2018-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79501 - Class II - Drugs - Fresenius Medical Care Renal Therapies Group, LLC",Lack of Assurance of Sterility,2018-05-22,2018-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87809 - Class II - Drugs - Fresenius Medical Care, North America",Labeling; Label Mix-up; 4.25% DEXTROSE bag was found inside a 1.5% DEXTROSE box.,2021-05-19,2021-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86834 - Class II - Drugs - Fusion Health and Vitality LLC,Marketed without an Approved NDA/ANDA: Product marketed with drug claims.,2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84978 - Class II - Drugs - Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical",Lack of Assurance of Sterility,2020-03-05,2020-03-05,63,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77757 - Class II - Drugs - Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical",CGMP Deviations,2017-07-31,2017-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66139 - Class II - Drugs - Fusion Pharmaceuticals, LLC",Microbial Contamination of Non-Sterile Products: Fusion Pharmaceuticals is recalling the Dicopanol FusePaq Kit due to Total Yeasts and Molds Count above USP limits.,2014-01-31,2014-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70682 - Class II - Drugs - Fusion Pharmaceuticals, LLC",Microbial Contamination of a Non-Sterile Product: Kit component is contaminated with Burkholderia multivorans.,2015-03-12,2015-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64879 - Class II - Drugs - FVS Holdings, Inc. dba. Green Valley Drugs","Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes., Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes..",2013-05-16,2013-05-16,78,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66454 - Class III - Drugs - G & W  Laboratories Inc,Failed Content Uniformity Specifications; at the 18 month time point.,2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76430 - Class II - Drugs - G & W  Laboratories, Inc.",Failed  Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing.,2017-03-01,2017-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76641 - Class III - Drugs - G & W  Laboratories, Inc.",CGMP Deviations: an expired active ingredient was used in the manufacture of these recalled lots.,2017-03-14,2017-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76767 - Class III - Drugs - G & W  Laboratories, Inc.",Labeling: Incorrect or Missing Package Insert: product lots packaged with an out-of-date insert.,2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77401 - Class III - Drugs - G & W  Laboratories, Inc.","Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.",2017-07-06,2017-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78974 - Class III - Drugs - G & W  Laboratories, Inc.",Discoloration: Product is supposed to be a white to off white homogenous cream and may have intermittent yellow discoloration.,2018-02-02,2018-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78151 - Class I - Drugs - Gadget Island, Inc","Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.",2017-12-04,2017-12-04,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80343 - Class I - Drugs - Gaia Ethnobotanical LLC,Microbal Contamination of Non-Sterile Product; FDA analysis found  salmonella contamination,2018-07-26,2018-07-26,24,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62803 - Class III - Drugs - Galderma Laboratories, L.P.",Subpotent; fluocinolone acetonide.,2012-08-24,2012-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74209 - Class III - Drugs - Galderma Laboratories, L.P.",Labeling: Incorrect Or Missing Lot and/or Exp Date: Some expiries and lot numbers are missing.,2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76680 - Class II - Drugs - Gary Wood,"Marketed without an Approved NDA/ANDA; FDA analysis has found the product to be tainted with human chorionic gonadotropin, rendering it an unapproved drug",2017-04-21,2017-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86898 - Class II - Drugs - GAZA PROVEEDORA DE SERVICIOS DE HOSPEDAJE Y ALIMENTACION,cGMP deviations: Product made at the same facility where product tested was sub-potent.,2021-01-14,2021-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71480 - Class I - Drugs - GC Natural Nutrition, Inc.","Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared diclofenac, a prescription non-steroidal anti-inflammatory drug, and chlorpheniramine, an over-the-counter antihistimine, making this an unapproved drug.",2015-08-14,2015-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75531 - Class III - Biologics - GCAM Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2016-11-01,2016-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75530 - Class II - Biologics - GCAM Inc,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82098 - Class II - Biologics - GCAM Inc,"Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.
",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83835 - Class II - Drugs - GCP Laboratories Inc,Microbial Contamination of Non-Sterile Product.,2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81691 - Class II - Drugs - GE Healthcare Inc. - Life Sciences,Defective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.,2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67944 - Class III - Biologics - Gen-Probe Inc,"In-vitro diagnostics, with mixed master lots, were distributed.",2014-05-13,2014-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90959 - Class III - Drugs - Genentech Inc,"Defective Delivery System: Commercial implants do not meet the filed specification for the intended use, a few patients have experienced an issue with the implants that renders it non-functioning.",2022-11-01,2022-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63243 - Class II - Drugs - Genentech Inc,Miscalibrated and/or Defective Delivery System: Genentech has received complaints  for Nutropin AQ NuSpin 10 & 20  reporting that the dose knob spun slowly and the injection took longer than usual (slow dose delivery).,2012-12-04,2012-12-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63258 - Class I - Drugs - Genentech Inc,"Presence of Particulate Matter: One lot of Bacteriostatic Water for Injection, USP diluent vials that were packed with Trastuzumab Kits for investigational use has the potential to contain glass particulates.",2013-01-22,2013-01-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87724 - Class III - Drugs - Genentech Inc,"Defective Container: complaints received regarding some incorrect press-in-bottle-adapters (PIBA), the incorrect PIBAs have a female instead of male fit so they cannot be used in combination with co-packed syringes.",2021-04-29,2021-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88100 - Class II - Drugs - Genentech Inc,Failed Stability Specifications: Out of Specification results of Polysorbate 20 (PS20) content were detected at the 12 month testing time point.,2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76726 - Class II - Drugs - Genentech Inc.,Superpotent Drug: An oversized tablet was found in a bottle.,2017-04-05,2017-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63874 - Class III - Drugs - Genentech, Inc.",Short Fill: some bottles contained less than 120-count per labeled claim.,2012-12-20,2012-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78088 - Class I - Drugs - Genentech, Inc.","Non-Sterility:presence of cracked or chipped glass at the neck of Sterile Water for Injection vials.  
",2017-12-01,2017-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79175 - Class III - Drugs - Genentech, Inc.","Labeling: Not Elsewhere Classified: Schedule IV controlled substance indicator of CIV being omitted
from the product carton, primary label is correct.

",2018-02-13,2018-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68865 - Class III - Biologics - Genesis BPS, LLC.","Genesis BPS Pedi-Pak Pediatric Transfer Packs, lacking pre-market notification, were distributed.",2014-09-18,2014-09-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86427 - Class II - Drugs - Genesis Partnership Company SA,"CGMP Deviations: hand sanitizers were recalled because they were manufactured in the same facility as another hand sanitizer product with sub-potent ethanol levels., Sub-Potent Drug; Killz GERMz was recalled due to sub-potent results. Testing revealed ethanol levels as low as 62% while labelled claim is 70%.",2020-10-19,2020-10-19,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68098 - Class III - Drugs - Genesis Pharmaceutical, Inc.",Failed Stability Specifications: Out of specification results for viscosity in one lot of Glytone Acne Treatment Facial Cleanser.,2014-04-29,2014-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77208 - Class I - Drugs - Genetic Edge Compounds LLC,Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: FDA analysis found the product to tainted with undeclared anabolic steroids and steroid like substances.,2017-08-15,2017-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75982 - Class II - Drugs - Gentell, Inc",CGMP Deviations,2017-01-02,2017-01-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77196 - Class II - Drugs - Gentell, Inc",GMP Deviations; product may not meet cGMP requirements,2017-05-24,2017-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87044 - Class III - Drugs - Genus Lifesciences Inc.,Presence of Foreign Substance: Particulate matter was found in multiple lots of product.,2021-01-15,2021-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62670 - Class II - Biologics - Genzyme Corporation,"Anti-Thymocyte Globulin (Rabbit) 25 mg, with an OOS assay result on the molecular size distribution stability test, was distributed.",2013-02-04,2013-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73301 - Class II - Drugs - Genzyme Corporation,Presence of Particulate Matter: Glass particles found in the product after reconstitution.,2016-02-26,2016-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72929 - Class III - Drugs - Genzyme Corporation,Labeling: Incorrect or Missing Lot and/or Exp Date,2016-03-31,2016-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78286 - Class III - Drugs - Genzyme Corporation,Labeling: Incorrect or Missing Package Insert.,2017-11-10,2017-11-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74046 - Class III - Drugs - Genzyme Corporation / Genzyme Biosurgery,Labeling: Wrong barcode. An incorrect bar code was noted on the vial label of Hectorol 2 mcg/1mL vial.,2016-06-10,2016-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74968 - Class III - Drugs - Genzyme Corporation / Genzyme Biosurgery,Labeling: Incorrect or Missing Lot and/or Exp. Date,2016-09-22,2016-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68133 - Class III - Biologics - Genzyme, A Sanofi Company","Anti-Thymocyte Globulin (Rabbit) 25 mg, with a trend approaching the upper limit on the molecular size distribution tests for polymers, aggregates and fragments, was distributed.",2014-09-19,2014-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71441 - Class III - Drugs - Geritrex Corp,CGMP Deviation: Poor container closure of the bulk storage container,2015-07-14,2015-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72509 - Class II - Drugs - Geritrex Corp,Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.,2015-11-27,2015-11-27,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82947 - Class II - Drugs - Geritrex, LLC",Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported,2019-06-28,2019-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83200 - Class II - Drugs - Geritrex, LLC",cGMP Deviations: Products may have microbial contamination.,2019-07-25,2019-07-25,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91410 - Class I - Drugs - GFA Production Xiamen Co. Ltd.,Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.,2023-01-27,2023-01-27,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64267 - Class I - Drugs - Gilead Sciences, Inc.",Presence of Particulate Matter: Particulate matter was found in some vials of Vistide (cidofovir injection).,2013-05-16,2013-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65555 - Class II - Drugs - Gilead Sciences, Inc.","Lack of Sterility Assurance; During a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in some media fill units. No contaminated batches have actually been identified in the finished product, but there is a possibility of contamination.",2013-07-25,2013-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67557 - Class III - Drugs - Gilead Sciences, Inc.",Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.,2014-02-27,2014-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69414 - Class III - Drugs - Gilead Sciences, Inc.",Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.,2014-10-09,2014-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69411 - Class II - Drugs - Gilead Sciences, Inc.",Defective Container; leaking around the cap,2014-10-24,2014-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89153 - Class I - Drugs - Gilead Sciences, Inc.",Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.,2021-12-28,2021-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84105 - Class I - Drugs - GL Holdings,"Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.",2019-11-15,2019-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72737 - Class I - Drugs - Glades Drugs Inc.,Superpotent Drug: The vitamin supplement contains an extremely high level of vitamin D3 (Cholecalciferol).,2016-02-16,2016-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80612 - Class III - Biologics - GlaxoSmithKline Biologicals SA,"MENVEO [Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM(197) Conjugate Vaccine] Solution for intramuscular injection, associated with a mechanical intervention that is not supported by validation data, was distributed.",2018-07-30,2018-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89632 - Class II - Biologics - GlaxoSmithKline Biologicals SA,"Vaccine, placed in glass vials found to have morphology defects, was distributed.",2022-03-10,2022-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71717 - Class III - Drugs - GlaxoSmithkline Consmer Healthcare,Failed Dissolution Specifications,2015-08-05,2015-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71750 - Class II - Drugs - GlaxoSmithkline Consmer Healthcare,Presence of Foreign Substance: Fragments of wood found when the product was extruded onto a toothbrush.,2015-08-11,2015-08-11,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85224 - Class II - Drugs - Glaxosmithkline Consumer Healthcare Holdings,Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.,2020-03-26,2020-03-26,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85500 - Class III - Drugs - Glaxosmithkline Consumer Healthcare Holdings,Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card,2020-05-13,2020-05-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85755 - Class II - Drugs - Glaxosmithkline Consumer Healthcare Holdings,Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.,2020-06-18,2020-06-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85848 - Class II - Drugs - Glaxosmithkline Consumer Healthcare Holdings,Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.,2020-06-26,2020-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91259 - Class I - Drugs - Glaxosmithkline Consumer Healthcare Holdings DBA Haleon,"Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back",2023-01-25,2023-01-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67800 - Class III - Drugs - GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline,"Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.",2014-04-18,2014-04-18,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62392 - Class II - Drugs - GlaxoSmithKline Inc,"Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.",2012-07-12,2012-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62799 - Class II - Drugs - GlaxoSmithKline Inc,Does Not Deliver Proper Metered Dose: Potential content of albuterol per dose is below specification.,2012-08-28,2012-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90166 - Class III - Drugs - GlaxoSmithKline LLC,"Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76839 - Class II - Drugs - GlaxoSmithKline, LLC",Defective Delivery System: Elevated number of units with out of specification results for leak rate.,2017-03-31,2017-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77329 - Class II - Drugs - GlaxoSmithKline, LLC",Defective Delivery System: Elevated number of units with out of specification results for leak rate,2017-05-22,2017-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72800 - Class II - Drugs - GlaxoSmithKline, LLC",Defective Delivery System: Some canisters may not contain sufficient propellant to deliver the labeled claim of 200 actuations through the end of shelf life.,2015-12-09,2015-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74742 - Class II - Drugs - GlaxoSmithKline, LLC",Penicillin Cross Contamination,2016-07-20,2016-07-20,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63707 - Class III - Drugs - GlaxoSmithKline, LLC.",Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.,2012-11-23,2012-11-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63691 - Class II - Drugs - GlaxoSmithKline, LLC.",Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.,2012-11-27,2012-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65856 - Class III - Drugs - GlaxoSmithKline, LLC.","Presence of Foreign Tablets/Capsules: Product labeled TUMS Ultra Assorted Berries 1000mg Chewable tables, may contain EX TUMS Assorted Berries 750mg tablets",2013-08-07,2013-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66988 - Class II - Drugs - GlaxoSmithKline, LLC.",Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.,2013-12-24,2013-12-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71920 - Class II - Drugs - GlaxoSmithKline, LLC.",Penicillin Cross Contamination and Presence of Foreign Substance.  Product was contaminated with penicillin and foreign substances during manufacturing process.,2015-08-25,2015-08-25,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63264 - Class II - Drugs - Glenmark Generics Inc., USA","Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.",2012-09-27,2012-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64338 - Class III - Drugs - Glenmark Generics Inc., USA","Chemical Contamination: The recall has been initiated based on multiple complaints received from pharmacists and consumers reporting that they detected an off-odor, described as moldy, musty or fishy in nature which has been identified as trace levels of Tribromoanisole (TBA) and Trichloroanisole (TCA).",2013-03-05,2013-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64995 - Class III - Drugs - Glenmark Generics Inc., USA","Chemical Contamination: Gabapentin Sodium tablets is recalled due to complaints related to an off - odor described as moldy, musty or fishy in nature., Chemical Contamination: Pravastatin Sodium Tablets isbeing recalled due to complaints related to an off-odor described as moldy, musty or fishy in nature., Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.",2013-05-16,2013-05-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67776 - Class II - Drugs - Glenmark Generics Inc., USA","Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a ""foreign material"", identified as Metoprolol Tartrate Tablet USP 50 mg, found co-mingled in a bottle of Ranitidine Tablets USP 150 mg.",2014-04-09,2014-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84282 - Class III - Drugs - Glenmark Pharmaceuticals Inc., USA",Defective delivery system; product is not foaming or is coming out as liquid.,2019-12-10,2019-12-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84516 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",CGMP Deviations: Presence of NDMA impurity detected in product.,2020-01-05,2020-01-05,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88591 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA","Lack of Assurance of Sterility, CGMP Deviations",2021-09-21,2021-09-21,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90029 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",cGMP deviations,2022-04-27,2022-04-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90431 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",CGMP Deviations,2022-06-30,2022-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90473 - Class III - Drugs - Glenmark Pharmaceuticals Inc., USA",Defective Container,2022-07-01,2022-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90543 - Class III - Drugs - Glenmark Pharmaceuticals Inc., USA",Failed Tablet/Capsule Specification : Capsule breakage,2022-07-18,2022-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90550 - Class III - Drugs - Glenmark Pharmaceuticals Inc., USA",Defective Container: Tube split from side seam,2022-08-04,2022-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90541 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",Packaging : Blister package issues.,2022-08-05,2022-08-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78605 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA","CGMP Deviations: Market complaints related to ""gritty texture"".",2018-02-07,2018-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79570 - Class III - Drugs - Glenmark Pharmaceuticals Inc., USA","Labeling: Incorrect Instructions: bottles incorrectly labeled with the usual adult dosage of ""One or two capsules 2 or 3 times a day."" rather than the correct usual adult dosage of ""One capsule 2 or 3 times a day.",2018-03-26,2018-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81639 - Class III - Drugs - Glenmark Pharmaceuticals Inc., USA",Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.,2019-01-07,2019-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81876 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",Defective Delivery System: Customer complaints of malfunctioning plunger of the applicator,2019-01-08,2019-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82461 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",Presence Of  Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg.,2019-04-11,2019-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83019 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",Defective Delivery System: Estradiol Vaginal Inserts USP plunger is not functioning properly.,2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83413 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.,2019-08-02,2019-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83526 - Class III - Drugs - Glenmark Pharmaceuticals Inc., USA",Temperature Abuse: Complaints received of liquidy texture.,2019-08-15,2019-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84071 - Class II - Drugs - Glenmark Pharmaceuticals Inc., USA",Defective Delivery System: complaints for difficulty in pushing the plunger of the applicator.,2019-10-28,2019-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77357 - Class II - Drugs - Global Marketing Enterprises, Inc.","Marketed without an Approved NDA/ANDA:  The product consists of pure, powdered caffeine and is an unapproved drug due to stimulant claims.  The product is also misbranded as it fails to bear adequate directions for its intended use.",2017-08-17,2017-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87941 - Class I - Drugs - Global Sanitizers LLC,"Chemical Contamination: FDA analysis found 1 lot of MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA (ethyl alcohol 70%) to be below the label claim for ethanol content and to contain methanol., CGMP Deviations: lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol., CGMP Deviations:  lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.",2021-08-30,2021-08-30,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63048 - Class I - Drugs - Globe All Wellness, LLC","Marketed Without an Approved NDA/ANDA: Product tested positive for Sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, making this product an unapproved new drug.",2013-02-05,2013-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85008 - Class III - Drugs - Golden State Medical Supply Inc.,Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.,2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89863 - Class II - Drugs - Golden State Medical Supply Inc.,CGMP Deviations,2022-07-07,2022-07-07,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90992 - Class II - Drugs - Golden State Medical Supply Inc.,Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopoperazine (MNP).,2022-10-17,2022-10-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90909 - Class I - Drugs - Golden State Medical Supply Inc.,Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets,2022-10-21,2022-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64695 - Class II - Drugs - Golden State Medical Supply Inc.,Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets by the manufacturer,2013-04-07,2013-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68009 - Class II - Drugs - Golden State Medical Supply Inc.,Presence of Foreign Substance; some bottles may contain debris that was swept up during cleaning,2014-06-02,2014-06-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71921 - Class III - Drugs - Golden State Medical Supply Inc.,Presence of Foreign Substance: Presence of hair.,2015-09-09,2015-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72733 - Class III - Drugs - Golden State Medical Supply Inc.,Failed Impurities/Degradation Specifications: Out of specification for impurities.,2015-12-04,2015-12-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73152 - Class III - Drugs - Golden State Medical Supply Inc.,Failed Impurities/Degradation Specifications,2016-03-09,2016-03-09,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74558 - Class III - Drugs - Golden State Medical Supply Inc.,"Labeling; Incorrect or Missing Lot and/or Exp Date; incorrect expiration date on container label is 02/2019, correct expiration date should be 02/2018",2016-07-11,2016-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74847 - Class II - Drugs - Golden State Medical Supply Inc.,Failed Dissolution Specifications: Out-of-specification results in retained sample.,2016-08-16,2016-08-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81500 - Class II - Drugs - Golden State Medical Supply Inc.,"CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine (NDEA) in product.",2018-11-20,2018-11-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82832 - Class II - Drugs - Golden State Medical Supply Inc.,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer",2019-05-19,2019-05-19,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83161 - Class II - Drugs - Golden State Medical Supply Inc.,CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.,2019-07-09,2019-07-09,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84233 - Class II - Drugs - Golden State Medical Supply Inc.,CGMP Deviations: Presence of NDMA impurity detected in product.,2019-11-10,2019-11-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85401 - Class II - Drugs - Golden State Medical Supply Inc.,CGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA) detected in active ingredient (API) used to manufacture finished products.,2020-04-13,2020-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86129 - Class III - Drugs - Golden State Medical Supply Inc.,Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.,2020-08-13,2020-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86786 - Class II - Drugs - Golden State Medical Supply Inc.,FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets,2020-11-30,2020-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87566 - Class II - Drugs - Golden State Medical Supply Inc.,Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer,2021-03-24,2021-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88866 - Class II - Drugs - Golden State Medical Supply Inc.,"Failed Excipient Specifications and Presence of Foreign Tablets/Capsules; product manufactured using an excipient found to be OOS for conductivity and some Ezetimibe and Simvastatin Tablets, 10 mg/10 mg were found in the bottle, Failed Excipient Specification; product manufactured using an excipient found to be OOS for conductivity",2021-11-09,2021-11-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89712 - Class II - Drugs - Golden State Medical Supply Inc.,CGMP Deviation: Potential cross-contamination with other drug substance during the manufacturing process.,2022-03-15,2022-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82246 - Class I - Drugs - Golean Detox US,"Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain undeclared sibutramine and phenolphthalein. Sibutramine is an appetite suppressant that was withdrawn from the US market due to safety concerns. Phenolphthalein was once an ingredient used in over-the-counter laxatives, but because of concerns of carcinogenicity is not currently approved for marketing in the US. The presence of sibutramine and phenolphthalein in this product renders it an unapproved drug for which the safety and efficacy has not been established and, therefore, subject to recall.",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81661 - Class II - Biologics - Good Samaritan Hospital Laboratory & Blood Donor Center,The","Red Blood Cells, not prepared in accordance with product specifications, were distributed.",2018-12-03,2018-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71036 - Class II - Biologics - Good Samaritan Regional Medical Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81719 - Class II - Drugs - Gordon Laboratories,Superpotent Drug: contains higher levels of Iron than labeled.,2018-12-17,2018-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87742 - Class II - Drugs - Grace Healthcare Medical, Inc",cGMP deviations,2021-04-26,2021-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61838 - Class II - Drugs - Grandpa Brands Co,Superpotent; benzocaine,2012-07-24,2012-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84522 - Class II - Drugs - Granules India Limited,CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API,2019-12-29,2019-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85986 - Class II - Drugs - Granules Pharmaceuticals Inc,CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-07-14,2020-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88475 - Class II - Drugs - Granules USA, Inc.",CGMP Deviations,2021-08-27,2021-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90297 - Class II - Drugs - Grato Holdings, Inc.",Microbial contamination of non-sterile product.,2022-06-08,2022-06-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72891 - Class II - Drugs - Grato Holdings, Inc.",Microbial Contamination of Non Sterile Products; testing revealed out of specification results for total aerobic microbiological count,2016-01-20,2016-01-20,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85072 - Class III - Drugs - Grato Holdings, Inc.",Labeling mix-up - Indications on product label are incorrect.,2020-03-20,2020-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86233 - Class II - Drugs - Grato Holdings, Inc.",Labeling: Error on Declared Strength,2020-08-29,2020-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86690 - Class III - Drugs - Grato Holdings, Inc.",Labeling: Product Contains Undeclared API; Incorrect formulation,2020-11-19,2020-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88182 - Class III - Drugs - Grato Holdings, Inc.",Superpotent,2021-07-12,2021-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84814 - Class II - Drugs - Graviti Pharmaceuticals Private Limited,"Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.",2020-02-07,2020-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77735 - Class II - Biologics - Greater Delaware Valley Society of Transplant Surgeons,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2017-07-11,2017-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90384 - Class I - Drugs - Green Pharmaceuticals, Inc.","Microbial contamination of non-sterile product: FDA laboratory analysis found product to contain microbial contamination identified as Providencia rettgeri.


",2022-06-27,2022-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64571 - Class I - Drugs - Green Planet Inc,Marketed Without an Approved NDA/ANDA; product contains analogues of sildenafil and tadalafil which are active pharmaceutical ingredients in FDA-approved drugs used to treat erectile dysfunction (ED) making this product an unapproved new drug.,2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63953 - Class I - Drugs - Green Valley Drugs,"Non-Sterility: Green Valley Drugs received positive sterility results from their testing lab on two lots of Methylprednisolone Preservative Free 40 mg/mL injectable suspension and  one lot of Cyanocobalamin 1000 mcg/mL injection, 30 mL MDV.",2013-05-15,2013-05-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66822 - Class II - Drugs - Greenstone Llc,Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.,2013-11-20,2013-11-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66760 - Class II - Drugs - Greenstone Llc,Labeling: Incorrect or Missing Lot and/or Exp Date: Greenstone LLC is recalling  Nifedipine Extended Release tablets (90mg). The expiration date on the package is 48 months instead of 36 months.,2014-01-16,2014-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66814 - Class III - Drugs - Greenstone Llc,"Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval",2014-02-03,2014-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67637 - Class I - Drugs - Greenstone Llc,Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot,2014-06-09,2014-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66696 - Class II - Drugs - Greenstone LLC,"Labeling: Incorrect or Missing Lot No. and/or Exp Date: Expiration date incorrectly reflects a 36 month shelf life, instead of the 24 month shelf life",2014-01-17,2014-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62921 - Class II - Biologics - Greer Laboratories Inc,Mislabeled vials of Allergenic Extract were distributed.,2012-08-28,2012-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67084 - Class III - Biologics - Greer Laboratories Inc,"Sterile Diluent for Allergenic Extracts, with lack of assurance of sterility, was distributed.",2014-01-27,2014-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75430 - Class II - Biologics - Greer Laboratories Inc,"Allergenic Extract, associated with an error in the assignment of bulk lots for filling, was distributed.",2016-10-13,2016-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75433 - Class III - Biologics - Greer Laboratories Inc,"Allergenic Extracts, labeled with an incorrect PNU measurement, were distributed.",2016-10-13,2016-10-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79121 - Class III - Biologics - Greer Laboratories Inc,"Licensed Allergenic Extracts, with a lack of assurance of sterility, were distributed.",2018-02-14,2018-02-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83012 - Class III - Biologics - Grifols Biologicals Inc.,"Profilnine, packaged with a vial of 5mL diluent instead of a vial of 10mL diluent, was distributed.",2019-06-05,2019-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68692 - Class II - Biologics - Grifols PlasmaCare, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68693 - Class II - Biologics - Grifols PlasmaCare, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68694 - Class III - Biologics - Grifols PlasmaCare, Inc.","Blood products, collected from a donor who disclosed history that warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68630 - Class II - Biologics - Grifols PlasmaCare, Inc.","Blood product, collected from a donor who had been incarcerated, was distributed.",2014-08-13,2014-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86266 - Class I - Drugs - Grupo Asimex de Mexico SA de CV,"Chemical Contamination: FDA analysis found the product contains methanol, additionally it is sub-potent for ethanol content., CGMP Deviations: All other lots are being recalled because they were manufactured under the same conditions as the product lots found to contain methanol.",2021-09-13,2021-09-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86271 - Class II - Drugs - GRUPO YACANA MEXICO SAS DE CV,cGMP Deviations,2020-09-22,2020-09-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84931 - Class II - Drugs - GSK Consumer Health, Inc","Labeling: Label Lacks Warning: Product recalled due to absence of a warning statement on the product label,  Ask a doctor before use if you have a sodium-restricted diet.",2020-03-07,2020-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81041 - Class II - Drugs - GSK Consumer Health, Inc",CGMP deviations,2018-10-23,2018-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75482 - Class III - Drugs - GSK Consumer Healthcare,"Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating ""use for the cure of most jock itch"" rather than ""use for the cure of most athlete's foot"".",2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76662 - Class II - Drugs - GSK Consumer Healthcare,"Presence of Foreign Substance; low concentration of an additional flavoring ingredient, Patchouli oil resulting in complaints of off flavor/scent",2017-03-30,2017-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77651 - Class II - Drugs - GSK Consumer Healthcare,Presence of Foreign Substance: possibility of the presence of metal in the product.,2017-07-06,2017-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75268 - Class I - Drugs - Guardian Pharmacy Services,Non-Sterility: failed sterility test result.,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80118 - Class II - Drugs - Guardian Pharmacy Services,Lack of sterility assurance.,2018-08-08,2018-08-08,23,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83798 - Class II - Drugs - GUERBET LLC,Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.,2019-10-09,2019-10-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61886 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor who was previously deferred, were distributed.",2012-06-25,2012-06-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68254 - Class III - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor with a history of polycythemia, were distributed.",2014-06-13,2014-06-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70532 - Class III - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-04-10,2015-04-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66066 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from ineligible donors, were distributed.",2015-06-22,2015-06-22,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71435 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-06-23,2015-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71184 - Class II - Biologics - Gulf Coast Regional Blood Center,"Platelets, lacking proper quality control testing, were distributed.",2015-08-12,2015-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71903 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood product, for which the quality control testing was incomplete, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72464 - Class II - Biologics - Gulf Coast Regional Blood Center,"Apheresis product, in which quailty control was not performed on a  leukocyte reduced unit, was distributed.

",2015-11-04,2015-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73952 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-06-06,2016-06-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74960 - Class III - Biologics - Gulf Coast Regional Blood Center,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76420 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor whose deferral was missing or incorrectly identified on the deferral list, were distributed.",2017-03-16,2017-03-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76419 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, in which donor screening was not done or incorrectly performed, including incorrect ID used during search,prior deferral due to history, were distributed.",2017-03-27,2017-03-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76917 - Class III - Biologics - Gulf Coast Regional Blood Center,"Blood product, prepared without the appropriate amount of additive, was distributed.",2017-05-11,2017-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77886 - Class III - Biologics - Gulf Coast Regional Blood Center,"Blood products, lacking assurance of proper temperature monitoring, were distributed.",2017-08-22,2017-08-22,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78164 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected using instruments that had not been validated following repair, were distributed.",2017-10-23,2017-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78788 - Class II - Biologics - Gulf Coast Regional Blood Center,"Apheresis products for which quality control procedures were not performed, were distributed.
",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79985 - Class II - Biologics - Gulf Coast Regional Blood Center,"Apheresis products for which quality control procedures were not performed, were distributed.
",2018-05-02,2018-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82275 - Class III - Biologics - Gulf Coast Regional Blood Center,"Platelets, lacking assurance of proper temperature maintenance, were distributed.",2019-03-05,2019-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82221 - Class III - Biologics - Gulf Coast Regional Blood Center,"Platelet blood product, for which donor eligibility screening was incorrectly performed, was distributed prior to receiving test results for RTTIs.",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85548 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor who was previously deferred for high risk behavior, were distributed.",2020-05-05,2020-05-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85627 - Class III - Biologics - Gulf Coast Regional Blood Center,"Blood product, manufactured without additive solution, was distributed.",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86648 - Class III - Biologics - Gulf Coast Regional Blood Center,"Blood product, missing the required shipment information, was distributed.",2020-11-12,2020-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86957 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from donors previously deferred for testing reactive for HIV and who were not properly tested for re-entry, were distributed.",2020-12-16,2020-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86956 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2021-01-29,2021-01-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87599 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor who previously tested positive for the antibody to hepatitis B core antigen (anti-HBc) on two separate occasions, were distributed.",2021-04-10,2021-04-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88707 - Class II - Biologics - Gulf Coast Regional Blood Center,"Plasma frozen within 24 hours after phlebotomy, collected from a therapeutic donor and not labeled properly, was distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88966 - Class II - Biologics - Gulf Coast Regional Blood Center,"Blood products, collected from a donor which previously tested positive for viral testing marker(s), were distributed.",2021-11-18,2021-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89813 - Class III - Biologics - Gulf Coast Regional Blood Center,"Apheresis Red Blood Cell product, for which a visual inspection was not performed or documented, was distributed.
",2022-03-30,2022-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90409 - Class II - Biologics - Gulf Coast Regional Blood Center,"Red Blood Cell product from a donor with a history of hepatitis, was distributed.",2022-09-26,2022-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91563 - Class II - Biologics - Gulf Coast Regional Blood Center,"Red Blood Cell product from a donor with a history of hepatitis, was distributed.
",2023-01-31,2023-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91684 - Class II - Biologics - Gulf Coast Regional Blood Center,"Leukoreduced Red Blood Cells, collected from a donor who tested positive for HCV and was deferred but was allowed to donate later, was distributed.",2023-02-16,2023-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72089 - Class III - Drugs - Guthy-Renker LLC,Subpotent Drug: Salicylic acid is subpotent.,2015-10-01,2015-10-01,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69243 - Class II - Drugs - Gyma Laboratories Of Amer,Inc",cGMP Deviations: GYMA laboratories Inc. has recalled multiple Active Pharmaceutical Ingredients manufactured in Italy upon receipt of a Rapid Alert Notification issued by The Italian Medicines Agency due to lack of good manufacturing practices.,2014-10-10,2014-10-10,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86712 - Class II - Drugs - H & H Remedies, LLC",CGMP Deviations,2020-11-09,2020-11-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84637 - Class II - Drugs - H J Harkins Company Inc dba Pharma Pac,CGMP Deviations: Presence of NDMA impurity detected in product.,2020-01-20,2020-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82574 - Class II - Drugs - H J Harkins Company Inc dba Pharma Pac,CGMP Deviations:Traces amounts of N-Nitroso N-Methyl 4- amino butyric acid (NMBA) impurity found in Active Pharmaceutical Ingredient (API).,2019-04-07,2019-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83195 - Class II - Drugs - H J Harkins Company Inc dba Pharma Pac,Microbial Contamination of Non-sterile Products: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).,2019-06-27,2019-06-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83339 - Class II - Drugs - H J Harkins Company Inc dba Pharma Pac,CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.,2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85158 - Class II - Drugs - H J Harkins Company Inc dba Pharma Pac,Presence of Foreign Tablets/Capsules: Complaint involving one Women's Prenatal dietary supplement tablet commingled in a bottle of Extra Strength Acetaminophen 500 mg contents 1000 count bottle,2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85482 - Class II - Drugs - H J Harkins Company Inc dba Pharma Pac,cGMP Deviations,2020-04-16,2020-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80674 - Class II - Drugs - H J Harkins Company Inc dba Pharma Pac,Carcinogen impurity detected in API used to manufacture drug product.,2018-08-01,2018-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81343 - Class II - Drugs - H J Harkins Company Inc dba Pharma Pac,Presence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 month clarity testing.,2019-01-28,2019-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61150 - Class III - Biologics - Haemonetics Corporation,"Apheresis Collection Devices, with a possible pump encoder failure, were distributed.",2012-07-10,2012-07-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63911 - Class II - Biologics - Haemonetics Corporation,"Whole Blood Collection Sets, with a potential for a leak to occur in the flexible Y connector of the donor line, were distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72815 - Class III - Biologics - Haemonetics Corporation,Haemonetics' Rotor Cleaning Updated User Manual Addendum was distributed.,2016-03-02,2016-03-02,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74379 - Class II - Biologics - Haemonetics Corporation,"All lots of Haemonetics Corporation Leukotrap RC System with RC2D Filter (Re-Order Numbers 129-62 & 129-63) with reports of higher than expected residual white blood cells, were distributed.",2016-08-25,2016-08-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75913 - Class II - Biologics - Haemonetics Corporation,"Blood bank software, with a defect or glitch, was distributed.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79447 - Class III - Biologics - Haemonetics Corporation,"Surround Laboratory Management Software, with a defect or glitch, was distributed.",2018-03-20,2018-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79639 - Class II - Biologics - Haemonetics Corporation,"Specific lots of Haemonetics Acrodose PLus and PL Systems, associated with low pH readings in the CLX HP bag, and in some instances accompanied by a yellow discoloration of the storage bag, were distributed.",2018-05-31,2018-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80903 - Class II - Biologics - Haemonetics Corporation,"Multiple lots of Haemonetics Leukotrap RC System with RC2D Filter, associated with reports of higher than expected residual WBC, were distributed.",2018-09-26,2018-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87207 - Class II - Biologics - Haemonetics Corporation,"Blood bank software, with a defect or glitch, was distributed.",2021-01-27,2021-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88645 - Class II - Biologics - Haemonetics Corporation,"SQ40SK Microaggregate Blood Transfusion Filter, not manufactured in accordance with acceptable specifications, were distributed.",2021-10-22,2021-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90696 - Class II - Biologics - Haemonetics Corporation,Haemonetics Corporation is recalling distributed devices of NexSys PCS software version 1.4.2 and earlier due to a defect affecting the software when the instrument is configured to run Smart Last Cycle and Red Blood Cell (RBC) Loss estimator.,2023-01-24,2023-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90697 - Class II - Biologics - Haemonetics Corporation,"Haemonetics Corporation has identified a defect affecting the distributed PCS2 (110V) software versions K.2, K.1, K, J and H (non-Express), when the instrument is configured to run Smart Last Cycle.",2023-01-27,2023-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66244 - Class II - Biologics - Haemonetics Software Solutions,"Blood Bank Software, with a defect or glitch, was distributed.",2013-10-17,2013-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89947 - Class II - Drugs - Hand Sanitizer LLC,CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.,2022-06-14,2022-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81913 - Class I - Drugs - Happy Together, Inc.",Marketed without an Approved NDA/ANDA; FDA analysis found product to be tainted with undeclared sildenafil and tadalafil,2019-01-22,2019-01-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77660 - Class I - Drugs - HARDCORE FORMULATIONS,Marketed Without An Approved NDA/ANDA: Product contains Methylstenbolone or Dymethazine.,2017-08-14,2017-08-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71990 - Class I - Drugs - Hartley Medical Center Pharmacy, Incorporated","Non-Sterility: Hartley Medical Center Pharmacy, Inc. is recalling Prolotherapy with Phenol due to non-sterility concerns.",2015-09-25,2015-09-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73304 - Class II - Drugs - Hartley Medical Center Pharmacy, Incorporated",Lack of Assurance of Sterility,2016-03-04,2016-03-04,30,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66406 - Class I - Drugs - Haute Health, LLC","Marketed without an Approved NDA/ANDA: Dietary supplement may contain amounts of an active ingredient found in some FDA-approved drugs for erectile dysfunction (ED) making the dietary supplement an unapproved drug., Marketed without an Approved NDA/ANDA: Dietary supplement may contain amounts of  active ingredients found in some FDA-approved drugs for erectile dysfunction (ED) making the dietary supplement an unapproved drug.",2014-04-15,2014-04-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90056 - Class II - Biologics - Hawaii Lions Eye Bank and Makana Foundation,"Cornea, recovered from a donor in which donor suitability was not adequately determined, was distributed.",2022-04-28,2022-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62361 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2012-07-25,2012-07-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62362 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2012-08-01,2012-08-01,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62620 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor whose medical history screening was incomplete, were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63752 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed",2012-12-27,2012-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63836 - Class III - Biologics - HCSC-Blood Center,"Blood Products, washed with 1.6% sodium chloride during deglycerolization, were distributed.",2012-12-31,2012-12-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64752 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2013-04-29,2013-04-29,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65055 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2013-05-24,2013-05-24,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65221 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2013-07-02,2013-07-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66818 - Class III - Biologics - HCSC-Blood Center,Unlicensed blood products were distributed in interstate commerce.,2013-11-19,2013-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67019 - Class II - Biologics - HCSC-Blood Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-12-27,2013-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67244 - Class II - Biologics - HCSC-Blood Center,"Blood products, for which QC testing for platelet pH was not performed, were distributed.",2014-02-05,2014-02-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67668 - Class II - Biologics - HCSC-Blood Center,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2014-04-16,2014-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68205 - Class II - Biologics - HCSC-Blood Center,"Blood products, which were not tested for pH and platelet count, were distributed.",2014-05-21,2014-05-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68060 - Class II - Biologics - HCSC-Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-06-02,2014-06-02,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58609 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2014-07-31,2014-07-31,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68715 - Class II - Biologics - HCSC-Blood Center,"Blood products,that did not undergo quality control testing for pH or platelet count, were distributed.",2014-08-13,2014-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68714 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from  donors whose health history screening was not adequately performed, were distributed.",2014-08-21,2014-08-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58606 - Class II - Biologics - HCSC-Blood Center,"Blood products, incorrectly tested for cytomegalovirus (CMV), were distributed.",2014-09-12,2014-09-12,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68561 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-09-12,2014-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69212 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2014-09-12,2014-09-12,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69552 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from ineligible donors, were distributed.",2014-12-05,2014-12-05,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69885 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-12-10,2014-12-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69883 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from an ineligible donor, were distributed.",2014-12-17,2014-12-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69886 - Class III - Biologics - HCSC-Blood Center,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69884 - Class II - Biologics - HCSC-Blood Center,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-12-23,2014-12-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70119 - Class II - Biologics - HCSC-Blood Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-02-06,2015-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70623 - Class III - Biologics - HCSC-Blood Center,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71200 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-05-21,2015-05-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71324 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor whose suitability to donate was not fully documented, were distributed.",2015-06-19,2015-06-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71322 - Class II - Biologics - HCSC-Blood Center,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-06-23,2015-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68601 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from ineligible donors, were distributed.",2015-07-27,2015-07-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71467 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-07-30,2015-07-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71668 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-08-10,2015-08-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71671 - Class III - Biologics - HCSC-Blood Center,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-08-14,2015-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71672 - Class II - Biologics - HCSC-Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-08-27,2015-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72009 - Class II - Biologics - HCSC-Blood Center,"Blood product, which tested positive for CMV, but was labeled as CMV-negative, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72151 - Class III - Biologics - HCSC-Blood Center,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72149 - Class II - Biologics - HCSC-Blood Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-10-26,2015-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72153 - Class III - Biologics - HCSC-Blood Center,"Blood products, which were not manufactured in accordance to acceptable product specifications, were distributed.",2015-10-26,2015-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72558 - Class II - Biologics - HCSC-Blood Center,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-11-27,2015-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72559 - Class II - Biologics - HCSC-Blood Center,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-11-27,2015-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72560 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2015-11-27,2015-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72561 - Class III - Biologics - HCSC-Blood Center,"Blood products, collected from a donor who may have received or had close contact with a smallpox vaccination, were distributed.",2015-11-27,2015-11-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72562 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor who was previously deferred, were distributed.",2015-12-15,2015-12-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72985 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-01-14,2016-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72984 - Class II - Biologics - HCSC-Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-01-21,2016-01-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72986 - Class II - Biologics - HCSC-Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed., Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed",2016-01-21,2016-01-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73006 - Class II - Biologics - HCSC-Blood Center,"Blood products, which did not meet acceptable product specifications, were distributed.",2016-02-04,2016-02-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73146 - Class III - Biologics - HCSC-Blood Center,"Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2016-02-08,2016-02-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73147 - Class II - Biologics - HCSC-Blood Center,"Blood product, in which donor screening/donor record incomplete or incorrect, was distributed.",2016-03-09,2016-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73148 - Class II - Biologics - HCSC-Blood Center,"Blood products, in which donor screening/donor record incomplete or incorrect, were distributed.",2016-03-09,2016-03-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73272 - Class II - Biologics - HCSC-Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-03-17,2016-03-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84803 - Class III - Biologics - HCSC-Blood Center,"Leukoreduced Red Blood Cells, while under investigation for a discrepancy, were distributed.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85767 - Class II - Biologics - HCSC-Blood Center,"Leukoreduced Red Blood Cells, collected from a donor who had recently traveled to a malaria endemic area.",2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85887 - Class II - Biologics - HCSC-Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2020-07-22,2020-07-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86587 - Class II - Biologics - HCSC-Blood Center,"Misbranded Red Blood Cell product, was distributed.
",2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86589 - Class II - Biologics - HCSC-Blood Center,"Blood products, collected from a donor for whom donor suitability was incomplete, were distributed.
",2020-10-15,2020-10-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86711 - Class II - Biologics - HCSC-Blood Center,"Blood products, for which arm prep may have been performed inappropriately, were distributed.
",2020-11-13,2020-11-13,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87239 - Class III - Biologics - HCSC-Blood Center,"Leukoreduced Whole Blood, which did not meet the minimum requirement for Red Blood Cell recovery following leukoreduction, were distributed.",2021-02-19,2021-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87701 - Class II - Biologics - HCSC-Blood Center,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-04-27,2021-04-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88705 - Class II - Biologics - HCSC-Blood Center,"Blood product, which did not meet acceptable product specifications, was distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88945 - Class III - Biologics - HCSC-Blood Center,"Blood products, with questionable donor sample integrity for Babesia testing, were distributed.",2021-10-29,2021-10-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89933 - Class II - Biologics - HCSC-Blood Center,"Blood products, for which donor eligibility was incomplete, were distributed. 
",2022-04-19,2022-04-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89934 - Class II - Biologics - HCSC-Blood Center,"Leukoreduced Red Blood Cell, collected from a donor who traveled outside the United States, was distributed.",2022-04-20,2022-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90035 - Class II - Biologics - HCSC-Blood Center,"Blood Products, mislabeled as having been tested by NAT for HIV/HCV/HBV, were distributed.",2022-05-09,2022-05-09,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90038 - Class II - Biologics - HCSC-Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2022-05-10,2022-05-10,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91059 - Class II - Biologics - HCSC-Blood Center,"Leukoreduced Apheresis Platelets, labeled as a single donor platelet but should have been labeled with a reduced platelet count, were distributed.",2022-11-16,2022-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91546 - Class II - Biologics - HCSC-Blood Center,"Red Blood Cells, collected from a donor who had previously donated under a different last name and was permanently deferred due to a repeat reactive test result, was distributed.",2023-02-01,2023-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73821 - Class III - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood product, collected from donors for whom donor suitability was not adequately determined, was distributed.",2016-04-26,2016-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73820 - Class II - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-05-05,2016-05-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74185 - Class III - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,Mislabeled blood products were distributed.,2016-05-26,2016-05-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74551 - Class II - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Apheresis products, for which Quality Control was not performed, were distributed.",2016-07-17,2016-07-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75329 - Class III - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood product, in which donor testing was not performed or incomplete, was distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77038 - Class II - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2017-05-22,2017-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77746 - Class II - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2017-07-27,2017-07-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77747 - Class II - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood products, for which donor screening was performed incorrectly, were distributed.",2017-08-02,2017-08-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77748 - Class II - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-08-23,2017-08-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78798 - Class III - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood products, lacking assurance of proper temperature storage, were distributed.",2017-12-21,2017-12-21,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79049 - Class II - Biologics - HCSC-Blood Center dba as Miller-Keystone Blood Center,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79844 - Class II - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-05-16,2018-05-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79845 - Class II - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood product, which was not quarantined subsequent to receiving disqualifying information, was distributed.",2018-05-24,2018-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80083 - Class III - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood product, which lacked proper shipping documentation, was distributed.",2018-06-13,2018-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80226 - Class III - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Platelet component, not prepared in accordance with specifications, was distributed,",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80339 - Class II - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-06-26,2018-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81205 - Class II - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood products, collected from an ineligible donor, were distributed.",2018-11-15,2018-11-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81753 - Class III - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood product, where transfusion-transmitted infection testing was not performed, was distributed.",2018-12-17,2018-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81752 - Class II - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-02-14,2019-02-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82473 - Class II - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood product, which did not meet acceptability criteria, was distributed.",2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82876 - Class II - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Blood product, which did not meet the acceptable product specifications, was distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83955 - Class II - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Plateletpheresis product, with a low platelet count, was distributed.",2019-10-10,2019-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84807 - Class III - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Red Blood Cell product, collected from a donor whose eligibility to donate was inadequately determined for malarial travel, was distributed.",2020-02-05,2020-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84808 - Class III - Biologics - HCSC Blood Center dba as Miller-Keystone Blood Center,"Red Blood Cell product, collected from a donor whose eligibility to donate was inadequately determined for malarial travel, was distributed.
",2020-02-05,2020-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68304 - Class II - Drugs - Healix Infusion Therapy, Inc.",Presence of Particulate Matter:  The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by the supplier due to a customer complaint of visible particles embedded in the glass vial.,2014-07-07,2014-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69056 - Class II - Drugs - Healix Infusion Therapy, Inc.",Lack of Assurance of Sterility: Firm received fentanyl from a supplier who recalled it  because fliptop vial crimps were loose or missing.,2014-08-21,2014-08-21,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65273 - Class II - Drugs - Health & Beyond,Marketed Without an Approved NDA/ANDA; product found to contain Doxepin (an antidepressant) and Chlorpromazine (an antipsychotic),2014-02-04,2014-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70656 - Class II - Drugs - Health Innovations Pharmacy, Inc",Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.,2015-05-08,2015-05-08,65,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62442 - Class III - Drugs - Health Plus Incorporated,Labeling: Label Mix-up:  The product is being recalled because active ingredient in the Drug Facts box incorrectly states &quot;Active Ingredients per dose&quot; Senna Leaf powder 140 mg.  It should correctly be stated as &quot;Active ingredient (in each capsule)&quot; Senna Leaf Powder 140 mg.It should correctly be stated as Active ingredient (in each capsule)  Senna Leaf Powder 140 mg.,2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82278 - Class II - Drugs - Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy,Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.,2019-04-09,2019-04-09,25,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72039 - Class II - Drugs - Healthpoint, Ltd","Chemical Contamination: Naphthalene compound identified in the product after complaints of a petroleum odor.
",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65842 - Class I - Drugs - Healthy Life Chemistry Inc dba Purity First,"Marketed Without An Approved NDA/ANDA: FDA analysis of this product found it to contain undeclared steroids and steroid-like substances making this an unapproved new drug., Marketed Without An Approved NDA/ANDA: New York State Department of Health analysis of this product found it to contain undeclared steroid-like substances making it an unapproved new drug.",2013-12-18,2013-12-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53172 - Class II - Biologics - Heartland Lions Eye Bank,"Human Corneas, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-07-09,2012-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64217 - Class II - Biologics - Heartland Lions Eye Bank,"Human Corneas, recovered in a manner that increased the risk of the introduction, transmission, or spread of communicable disease, were distributed.",2013-01-31,2013-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80893 - Class I - Drugs - Hello Life, Inc","Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia",2018-09-17,2018-09-17,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64193 - Class III - Biologics - Hemacare Corporation,"Blood product, collected from a donor with an initially positive test for syphilis, was distributed.",2013-01-31,2013-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64089 - Class II - Biologics - Hemacare Corporation,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #34089 - Class II - Biologics - Hemacare Corporation,"Blood product, collected from a donor who tested reactive for the antibody to hepatitis B core antigen on two separate occasions, was distributed.",2013-09-13,2013-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40790 - Class II - Biologics - Hemacare Corporation,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-09-13,2013-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40489 - Class II - Biologics - HemaCare Corporation,"Blood products, labeled with an incorrect ABO type, were distributed.",2013-05-13,2013-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44539 - Class II - Biologics - HemaCare Corporation,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-05-13,2013-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45179 - Class II - Biologics - HemaCare Corporation,"Blood product, collected from a donor during a one year period of deferral for travel to a malarial endemic area.",2013-06-17,2013-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40787 - Class II - Biologics - HemaCare Corporation,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39198 - Class II - Biologics - HemaCare Corporation,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-07-23,2013-07-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43821 - Class II - Biologics - HemaCare Corporation,"Blood products, collected from a donor who was previously deferred, were distributed..
",2013-07-23,2013-07-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46664 - Class II - Biologics - HemaCare Corporation,"Blood products, collected from a donor during a deferral period for travel to a malarial endemic area, were distributed.",2013-07-23,2013-07-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59134 - Class II - Biologics - HemaCare Corporation,"Blood products, collected from donors who reported travel to malarial endemic areas, were distributed.",2013-07-23,2013-07-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57059 - Class II - Biologics - HemaCare Corporation,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed. 
",2013-07-29,2013-07-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45178 - Class II - Biologics - HemaCare Corporation,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39192 - Class III - Biologics - HemaCare Corporation,"Blood product, prepared from a whole blood unit that had an extended bleed time documented, was distributed.",2013-09-19,2013-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83437 - Class II - Drugs - Herbal Doctor Remedies,CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.,2019-08-02,2019-08-02,43,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85341 - Class II - Drugs - Herbal Doctor Remedies,"CGMP Deviations: These products have been found to be misbranded as unapproved new drugs, CGMP Deviations: These products have been found to be misbranded as
unapproved new drugs",2020-04-07,2020-04-07,70,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65774 - Class I - Drugs - Herbal Give Care Llc,"Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di-
Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.",2014-05-20,2014-05-20,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91171 - Class II - Drugs - Heritage Pharmaceuticals Inc,Subpotent Drug,2022-11-29,2022-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86659 - Class III - Drugs - Heritage Pharmaceuticals Inc,Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A,2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87762 - Class III - Drugs - Heritage Pharmaceuticals Inc,Labeling: Incorrect or Missing Lot and/or Exp Date,2021-05-06,2021-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81276 - Class II - Drugs - HERITAGE PHARMACEUTICALS INC,Lack of Assurance of Sterility: complaints received about dried powder on the outside of the bottle,2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70592 - Class II - Drugs - HERITAGE PHARMACEUTICALS INC,Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.,2015-03-17,2015-03-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70845 - Class II - Drugs - HERITAGE PHARMACEUTICALS INC,Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.,2015-04-07,2015-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81896 - Class II - Drugs - HERITAGE PHARMACEUTICALS INC,Lack of Assurance of Sterility: complaints received about dried powder on the outside of bottle,2019-01-08,2019-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82198 - Class II - Drugs - HERITAGE PHARMACEUTICALS INC,Subpotent Drug.,2019-03-27,2019-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82782 - Class II - Drugs - HERITAGE PHARMACEUTICALS INC,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer",2019-05-21,2019-05-21,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82918 - Class I - Drugs - HERITAGE PHARMACEUTICALS INC,"Non-Sterility:Microbial growth detected in
sub lot of  Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .",2019-06-19,2019-06-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85283 - Class II - Drugs - HERITAGE PHARMACEUTICALS INC,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level",2020-04-07,2020-04-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85307 - Class I - Drugs - HERITAGE PHARMACEUTICALS INC,Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.,2020-04-27,2020-04-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90712 - Class III - Drugs - HERON THERAPEUTICS, INC.",Defective Delivery System: An incorrect 10 mL (12 mL) Luer (slip) syringe packaged in one lot of Zynrelef 400 mg/12 mg kit,2022-08-12,2022-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76120 - Class III - Drugs - Hetero Drugs Ltd. - Unit 1,Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.,2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86191 - Class II - Drugs - Hetero Labs Limited (Unit V),Failed Tablet/Capsule Specification; complaint of bulging tablet,2020-08-26,2020-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80773 - Class II - Drugs - Hetero Labs Limited Unit V,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-23,2018-08-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80803 - Class I - Drugs - Hetero Labs Limited Unit V,Labeling: Label Mix-Up - One lot labeled Montelukast Sodium Tablets 10 mg tablets may contain 90 tablets of Losartan Potassium 50 mg.,2018-10-17,2018-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78811 - Class II - Drugs - Hetero Labs Limited Unit V,Temperature Abuse: Complaints of tablets being wet and stuck together with tablet coating peeled and disintegrated as a result of prolonged exposure to high temp during distribution.,2018-02-15,2018-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79142 - Class II - Drugs - Hetero Labs Limited Unit V,Temperature Abuse: Valganciclovir Tablets USP 450 mg and  Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).,2018-03-16,2018-03-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81029 - Class II - Drugs - Hetero Labs Limited Unit V,Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.,2018-09-26,2018-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78287 - Class II - Drugs - Hetero Labs, Ltd. - Unit III",Presence of foreign substance (screw),2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78821 - Class III - Drugs - Hetero Labs, Ltd. - Unit III",Presence of foreign substance: metallic razor blade was found in one bottle.,2018-01-16,2018-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78809 - Class II - Drugs - Hetero Labs, Ltd. - Unit III",CGMP Deviations: lot made with active pharmaceutical ingredient that did not meet all its intended specifications.,2018-03-13,2018-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80589 - Class II - Drugs - Hetero Labs, Ltd. - Unit III","Failed Tablet/Capsule Specifications: customer complaints of deformed, clumped, misshaped, melted or stuck together capsules.",2018-07-27,2018-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81017 - Class III - Drugs - Hetero Labs, Ltd. - Unit III","Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.",2018-09-25,2018-09-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76412 - Class III - Drugs - Hetero USA Inc,Discoloration: the firm received a complaint of a sealed bottle in which tablets inside had blue spots and a blue powder inside the bottle.,2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77122 - Class III - Drugs - Hetero USA Inc,Presence of Foreign Substance:  human hair melded into tablet.,2017-06-07,2017-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77846 - Class II - Drugs - Hetero USA Inc,Failed Impurities/Degradation Specification: single unknown impurity OOS 0.33% (Limit:NMT 0.20%W/W) at the three month stability point.,2017-08-16,2017-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85916 - Class III - Drugs - HF Acquisition Co. LLC,TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.,2020-07-21,2020-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65017 - Class III - Drugs - Hi-Tech Pharmacal Co., Inc.",Subpotent Drug: The product/lot is out-of-specification (OOS) for the assay of acetic acid at the 18-month test station.,2013-04-30,2013-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64857 - Class III - Drugs - Hi-Tech Pharmacal Co., Inc.",Subpotent; Cetylpyridinum Chloride,2013-05-16,2013-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65047 - Class III - Drugs - Hi-Tech Pharmacal Co., Inc.",Subpotent; 24 month stability test station,2013-06-14,2013-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65803 - Class III - Drugs - Hi-Tech Pharmacal Co., Inc.",Labeling: Label Mix-up; some cartons labeled as Clobetasol Propionate Cream USP contain tubes labeled as Clobetasol Propionate Gel USP.  The actual product in the tube is Clobetasol Propionate Cream USP,2013-08-13,2013-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66207 - Class III - Drugs - Hi-Tech Pharmacal Co., Inc.",Subpotent; phenylephrine HCl,2013-10-22,2013-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66675 - Class III - Drugs - Hi-Tech Pharmacal Co., Inc.",Failed Stability Specification; product viscosity and or pH are below specification.,2013-12-24,2013-12-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67894 - Class II - Drugs - Hi-Tech Pharmacal Co., Inc.",Failed Impurity/Degradation Specification; out-of-specification result for one individual unknown impurity at the 24-month room temperature stability test station.,2014-10-27,2014-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81883 - Class II - Drugs - Hiers Enterprises, LLC dba Northwest Compounding Pharmacy",Lack of sterility assurance.,2019-01-27,2019-01-27,17,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88310 - Class II - Drugs - High Performance Formulas, L.L.C. (HPF, L.L.C.)",Marketed Without an Approved NDA/ANDA,2021-08-15,2021-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86948 - Class II - Drugs - Hikma Pharmaceuticals USA Inc.,Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2ml vial.,2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88402 - Class III - Drugs - Hikma Pharmaceuticals USA Inc.,Labeling: Not elsewhere classified: Mislabeling,2021-08-26,2021-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90583 - Class II - Drugs - Hikma Pharmaceuticals USA Inc.,Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.,2022-08-05,2022-08-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91333 - Class II - Drugs - Hikma Pharmaceuticals USA Inc.,Labeling: Label mix-up - one vial was mislabeled as Cladribine Injection 10mg/mL inside a 10-count carton of Ganciclovir 500 mg.,2022-12-27,2022-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84676 - Class III - Drugs - Hikma Pharmaceuticals USA Inc.,Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to reconstitute product with 16 mL rather than the correct volume of 8 mL of Bacteriostatic Water for Injection with Benzyl Alcohol.,2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84534 - Class I - Drugs - Hikma Pharmaceuticals USA Inc.,Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS),2020-03-02,2020-03-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85831 - Class II - Drugs - Hikma Pharmaceuticals USA Inc.,Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.,2020-06-12,2020-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86243 - Class II - Drugs - Hikma Pharmaceuticals USA Inc.,Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.,2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86685 - Class II - Drugs - Hikma Pharmaceuticals USA Inc.,Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2 mL vial.,2020-11-20,2020-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62607 - Class III - Drugs - Hill Dermaceuticals, Inc.",Subpotent; fluocinolone acetonide,2012-08-14,2012-08-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64455 - Class III - Drugs - Hill Dermaceuticals, Inc.","Subpotent; 12 month stability timepoint, Subpotent; 22 month stability timepoint",2013-03-22,2013-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65434 - Class III - Drugs - Hill Dermaceuticals, Inc.","Subpotent Drug: the active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.",2013-06-21,2013-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66371 - Class III - Drugs - Hill Dermaceuticals, Inc.","Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.",2013-11-20,2013-11-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67420 - Class III - Drugs - Hill Dermaceuticals, Inc.","Subpotent Drug: The active ingredient, fluocinolone acetonide, was found to be subpotent during the firm's routine testing.",2014-03-24,2014-03-24,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87990 - Class II - Drugs - Hill Dermaceuticals, Inc.",Presence of Foreign Substance: Potential for broken glass within the glass pipette of the dropper.,2021-06-23,2021-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64020 - Class II - Drugs - Hillyard GMP,Microbial Contamination of Non-Sterile Products: The product may be contaminated with bacteria.,2013-01-31,2013-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88303 - Class II - Drugs - HIS ENTERPRISE INC,Marketed without ANDA/NDA approval,2021-08-26,2021-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68950 - Class II - Drugs - HLI dba Humphreyline Inc,Microbial Contamination of Non-Sterile Product,2014-08-06,2014-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77533 - Class II - Drugs - Hospira a Pfizer Company,Lack of Sterility Assurance,2017-08-01,2017-08-01,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77836 - Class II - Drugs - Hospira Inc,Presence of Particulate Matter: Silicone oil,2017-08-09,2017-08-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80167 - Class I - Drugs - Hospira Inc,Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.,2018-07-02,2018-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80399 - Class II - Drugs - Hospira Inc,Microbial Contamination of Sterile Products: Product associated with reports of adverse events indicative of infusion reactions related to microbiological contamination.,2018-08-02,2018-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71681 - Class II - Drugs - Hospira Inc.,Crystallization; identified as calcium salt of Ketorolac,2015-07-15,2015-07-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77111 - Class I - Drugs - Hospira Inc.,Presence of Particulate Matter: human hair found within an internal sample syringe.,2017-05-24,2017-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62999 - Class II - Drugs - Hospira Inc.,Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.,2012-08-30,2012-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67045 - Class II - Drugs - Hospira Inc.,Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.,2014-01-02,2014-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67354 - Class I - Drugs - Hospira Inc.,"Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.",2014-08-18,2014-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69971 - Class II - Drugs - Hospira Inc.,Lack of Assurance of Sterility; improperly crimped fliptop vials,2014-12-10,2014-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70174 - Class II - Drugs - Hospira Inc.,Lack of Assurance of Sterility: The product has the potential for solution to leak at the administrative port.,2015-01-07,2015-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70179 - Class II - Drugs - Hospira Inc.,Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.,2015-01-27,2015-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69327 - Class I - Drugs - Hospira Inc.,"Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70642 - Class II - Drugs - Hospira Inc.,Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.,2015-03-17,2015-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70515 - Class II - Drugs - Hospira Inc.,Crystallization,2015-04-08,2015-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70925 - Class II - Drugs - Hospira Inc.,Lack of Sterility Assurance: The product has the potential to leak at the administrative port.,2015-04-17,2015-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71002 - Class II - Drugs - Hospira Inc.,Crystallization,2015-04-28,2015-04-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70818 - Class I - Drugs - Hospira Inc.,Presence of Particulate Matter: Confirmed finding of human hair floating in IV solution.,2015-05-04,2015-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70643 - Class I - Drugs - Hospira Inc.,Labeling: Wrong Bar Code: There is a potential for some units to be mislabeled with an incorrect barcode on the immediate container that scans as heparin sodium 2000 USP units/1000 mL in 0.9%  in sodium chloride injection.,2015-05-13,2015-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70700 - Class I - Drugs - Hospira Inc.,"Non-Sterility: Confirmed customer report of dark, fibrous particulates floating within the solution of the primary container, which were subsequently identified as mold",2015-05-28,2015-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71377 - Class I - Drugs - Hospira Inc.,"Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.
",2015-07-08,2015-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71382 - Class III - Drugs - Hospira Inc.,Failed pH Specifications: 12 month stability testing,2015-07-08,2015-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75619 - Class II - Drugs - Hospira Inc.,Lack of Assurance of Sterility: Complaints of broken tips on the ampules.,2016-11-23,2016-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79238 - Class II - Drugs - Hospira Inc. A Pfizer Company,"Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.",2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64083 - Class II - Drugs - Hospira, Inc.",Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial,2013-02-26,2013-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65523 - Class III - Biologics - Houchin Blood Services,"Blood products, which did not meet acceptable product specifications, were distributed.",2013-07-23,2013-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66680 - Class III - Biologics - Houchin Community Blood bank,"Blood product, frozen more than 8 hours after collection, was distributed.",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67652 - Class II - Biologics - Houchin Community Blood bank,"Blood product, collected from a donor who lived with an individual who had Hepatitis B, was distributed.",2014-03-27,2014-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68850 - Class III - Biologics - Houchin Community Blood bank,"Blood product, collected from a donor with a  reported post donation illness, was distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73226 - Class II - Biologics - Houchin Community Blood bank,"Blood product, collected from a donor who received a tattoo within one year of donation, was distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73756 - Class II - Biologics - Houchin Community Blood bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-04-25,2016-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74906 - Class II - Biologics - Houchin Community Blood bank,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-09-12,2016-09-12,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76721 - Class II - Biologics - Houchin Community Blood bank,"Blood products, in which routine testing performed, interpreted or documented incorrectly,  were distributed.",2017-03-21,2017-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84936 - Class II - Biologics - Houchin Community Blood bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2020-03-24,2020-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86839 - Class II - Biologics - Houchin Community Blood bank,"Leukoreduced Red Blood Cells, collected from a donor who emigrated from a malarial endemic area, was distributed.",2020-12-02,2020-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87170 - Class II - Biologics - Houchin Community Blood bank,"Red Blood Cell product, collected from a donor with a history of using injectable steroids, was distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87687 - Class II - Biologics - Houchin Community Blood bank,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2021-04-10,2021-04-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87730 - Class II - Biologics - Houchin Community Blood bank,"Red Blood Cell product, for which donor eligibility was incomplete, was distributed.
",2021-04-27,2021-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89107 - Class II - Biologics - Houchin Community Blood bank,"Plateletpheresis products, in which platelet yield did not meet specifications, were distributed.
",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91429 - Class II - Biologics - Houchin Community Blood bank,"Leukoreduced Red Blood Cells, collected from a donor who had recently traveled to a malarial endemic area, were distributed.",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66482 - Class II - Biologics - Hoxworth Blood Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66490 - Class II - Biologics - Hoxworth Blood Center,"Blood products, which were collected from a donor who was a resident of  a malarial endemic area, were distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66491 - Class III - Biologics - Hoxworth Blood Center,"Blood products, collected from a donor whose arm inspection was not documented, were distributed.",2013-11-22,2013-11-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66492 - Class II - Biologics - Hoxworth Blood Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-11-22,2013-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67289 - Class II - Biologics - Hoxworth Blood Center,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-02-20,2014-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67286 - Class II - Biologics - Hoxworth Blood Center,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67653 - Class II - Biologics - Hoxworth Blood Center,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2014-03-27,2014-03-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67704 - Class II - Biologics - Hoxworth Blood Center,"Blood products, collected from a donor who lived in an area considered endemic for malaria, were distributed.",2014-04-09,2014-04-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69005 - Class II - Biologics - Hoxworth Blood Center,"Blood products, collected from a donor with a history of Hepatitis A, were distributed.",2014-09-16,2014-09-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69254 - Class II - Biologics - Hoxworth Blood Center,"Blood product, collected from a donor who lived in a malarial endemic area, was distributed.",2014-10-03,2014-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69266 - Class III - Biologics - Hoxworth Blood Center,"Blood products, collected from a donor who was at risk for leishmaniasis, were distributed.",2014-10-23,2014-10-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69438 - Class II - Biologics - Hoxworth Blood Center,"Blood product, collected from a donor who disclosed travel history that warranted deferral, was distributed.",2014-10-23,2014-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69440 - Class III - Biologics - Hoxworth Blood Center,"Blood products, that were not quarantined after receiving information concerning post-donation illness, were distributed.",2014-10-23,2014-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70215 - Class II - Biologics - Hoxworth Blood Center,"Blood products, that were not quarantined after receiving information concerning post-donation illness, were distributed.",2015-01-30,2015-01-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70999 - Class III - Biologics - Hoxworth Blood Center,"Blood product, collected from a donor who was at risk for leishmaniasis, was distributed.",2015-05-07,2015-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71173 - Class II - Biologics - Hoxworth Blood Center,"Blood products, for which the donors gave history which warranted deferral or follow up and were not deferred or follow up questions were not asked, were distributed.",2015-05-27,2015-05-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71000 - Class II - Biologics - Hoxworth Blood Center,"Blood product, which was positive for K antigen, but was labeled as negative for K antigen, was distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73299 - Class II - Biologics - Hoxworth Blood Center,"Blood product, collected from a donor whose suitability to donate were not adequately determined, were distributed.",2016-03-17,2016-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74290 - Class III - Biologics - Hoxworth Blood Center,"Red Blood Cells, lacking proper labeling, were distributed.",2016-06-21,2016-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75341 - Class II - Biologics - Hoxworth Blood Center,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75521 - Class III - Biologics - Hoxworth Blood Center,"Blood product, in which quality control and distribution of product did not meet specifications, was distributed.",2016-11-14,2016-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76205 - Class II - Biologics - Hoxworth Blood Center,"Apheresis unit, incorrectly labeled as irradiated, was distributed.",2017-02-03,2017-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77366 - Class II - Biologics - Hoxworth Blood Center,"Plasma product, for which a donor screening deviation occurred, was distributed.",2017-06-07,2017-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81658 - Class II - Biologics - Hoxworth Blood Center,"Blood product, that failed quality control for residual WBC count, was distributed.",2018-12-12,2018-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83521 - Class III - Biologics - Hoxworth Blood Center,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61950 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, collected from a donor who reported post donation illness, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62656 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62657 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-08-08,2012-08-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62659 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62823 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63349 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood products, which were collected from a donor who traveled to malarial endemic areas, were distributed.",2012-10-19,2012-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63351 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63352 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, which was labeled as leukoreduced, but was not tested to verify white blood cell count, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63363 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63925 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, collected from a donor whose health history was not adequately performed, was distributed.",2013-01-25,2013-01-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63992 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64023 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64174 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-02-25,2013-02-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64575 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64602 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64686 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64687 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64688 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65065 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65123 - Class II - Biologics - Hoxworth Blood Center  UC Medical Center,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44338 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, collected from a donor who lived in a Country at risk for HIV Group O, were distributed.",2012-07-20,2012-07-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44222 - Class III - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood product, for which the quality control testing was incomplete, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44443 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood product, collected from a donor who was taking the drug Prednisone, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53762 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, which were collected from a donor who traveled to malarial endemic areas, were distributed.",2013-02-26,2013-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42352 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed. 
, Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed. 

",2013-03-27,2013-03-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44541 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46484 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, which were not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2013-04-29,2013-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52180 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-05-13,2013-05-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41951 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, collected from a donor taking the medication Azathioprine, were distributed.",2013-06-07,2013-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50556 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-06-07,2013-06-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50557 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-06-07,2013-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50558 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, collected from a donor taking the medication Proscar, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43981 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, with a low volume, were distributed.",2013-06-19,2013-06-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55634 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41949 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-08-09,2013-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84923 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Leukoreduced Red Blood Cells, collected from a donor who traveled to a malarial endemic area, were distributed.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85966 - Class III - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Red Blood Cell products for which a visual inspection was not performed or documented were distributed.
",2020-07-08,2020-07-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86542 - Class III - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products for which a visual inspection was not performed or documented were distributed.
",2020-10-15,2020-10-15,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87188 - Class III - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, for which a visual inspection was not performed or documented, were distributed.
",2021-01-26,2021-01-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87693 - Class III - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,Blood products distributed without a final visual check.,2021-04-27,2021-04-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88418 - Class III - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Red Blood Cell product, not meeting product specifications, was distributed. 
",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89472 - Class III - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,Leukoreduced Red Blood Cells were distributed without a final visual check.,2022-02-04,2022-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89477 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, collected from a donor who had recently traveled to a malarial endemic area, were distributed.",2022-02-04,2022-02-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89572 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Blood products, collected from a donor who previously tested positive for Hepatitis C, were distributed.",2022-03-02,2022-03-02,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91216 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Red Blood Cell product, for which routine testing/testing performed was labeled incorrectly, was distributed. 
",2022-12-02,2022-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91428 - Class III - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,Leukoreduced Apheresis Red Blood Cells were distributed without a final visual check.,2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91475 - Class II - Biologics - Hoxworth Blood Center University of Cincinnati Medical Center,"Red Blood Cell product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88140 - Class II - Drugs - HOYU(US) LOGISTICS INC,Subpotent,2021-06-29,2021-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91694 - Class II - Drugs - HTO Nevada, Inc.","cGMP Deviation: Raw material recalled by repackager, due to discoloration of the epinephrine API.",2023-02-15,2023-02-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80753 - Class III - Drugs - Huijing (Shanghai) Bio-tech Co., Ltd.",Subpotent drug: The product active ingredient level not matching the exact levels indicated on the packaging label.,2018-08-10,2018-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67265 - Class I - Drugs - HUMAN SCIENCE FOUNDATION,"Marketed without an Approved NDA/ANDA; FDA analysis found the product to contain Chlorzoxazone, Nefopam, Diclofenac, Ibuprofen, Naproxen, and Indomethacin",2014-05-19,2014-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64416 - Class II - Drugs - Humco Holding Group, Inc",Microbial Contamination of Non-Sterile Product(s): The product has the potential to be contaminated with Bulkholderia gladioli.,2013-03-12,2013-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66927 - Class II - Drugs - Humco Holding Group, Inc",Microbial Contamination of Non-Sterile Product(s): The product was found to be contaminated with Bulkholderia sp.,2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81061 - Class II - Drugs - Humco Holding Group, Inc",CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.,2018-10-12,2018-10-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87711 - Class II - Drugs - Hyobin LLC,Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil.,2021-05-14,2021-05-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63548 - Class I - Drugs - ICU Medical Inc,Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.,2013-02-06,2013-02-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72072 - Class II - Drugs - ICU Medical Inc,"Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72432 - Class III - Drugs - ICU Medical Inc,Failed Impurities/Degradation Specifications: Out of Specification(OOS) results for degradation product of etomidate was confirmed during stability testing.,2015-10-21,2015-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73313 - Class III - Drugs - ICU Medical Inc,"Labeling: Incorrect or Missing Lot and/or Exp Date: Confirmed customer report of an incorrect expiration date printed on the primary container labeled ""01AUG1017"" rather than ""01AUG2017"".",2016-02-24,2016-02-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73647 - Class III - Drugs - ICU Medical Inc,Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.,2016-05-04,2016-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73681 - Class III - Drugs - ICU Medical Inc,Failed pH Specifications: Confirmed high out of specification (OOS) results for pH.,2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73653 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter:  particulate matter identified as an insect in one vial.,2016-05-23,2016-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73855 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter.,2016-07-06,2016-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74925 - Class I - Drugs - ICU Medical Inc,Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88620 - Class I - Drugs - ICU Medical Inc,"Presence of Particulate Matter: Particulate matter identified as fibers, hair, and proteinaceous material along with other particles, found in retain smples.",2021-09-17,2021-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91113 - Class II - Drugs - ICU Medical Inc,Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.,2022-11-16,2022-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62009 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: A single visible particulate was observed in a retention sample bottles identified as stainless steel,2012-06-14,2012-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62053 - Class III - Drugs - ICU Medical Inc,Superpotent (Single Ingredient) Drug: Above specification assay results for percentage of magnesium sulfate.,2012-06-20,2012-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61624 - Class I - Drugs - ICU Medical Inc,Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL,2012-07-15,2012-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61847 - Class I - Drugs - ICU Medical Inc,Superpotent (Single Ingredient) Drug: Some of the prefilled cartridge units have been found to be overfilled and contain more than the 1 mL labeled fill volume.,2012-08-07,2012-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62463 - Class III - Drugs - ICU Medical Inc,Failed PH specification:  The lots of Carboplatin Injection were manufactured from Carboplatin API lots which trended out of specification low pH.,2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62459 - Class II - Drugs - ICU Medical Inc,"The affected lots of Carboplatin Injection, Cytarabine
Injection, Methotrexate Injection, USP, and Paclitaxel Injection are beig recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution., The affected lots of Carboplatin Injection, Cytarabine
Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.",2012-09-19,2012-09-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63198 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: A single visible particulate was observed and confirmed in sample bottles of the recalled lots during retain inspection.,2012-09-21,2012-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62854 - Class I - Drugs - ICU Medical Inc,Superpotent (Single Ingredient) Drug: The prefilled cartridge unit has been found to be overfilled and contain more than the 1 mL labeled fill volume.,2012-10-24,2012-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63884 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.,2012-12-20,2012-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63913 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.,2012-12-20,2012-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63589 - Class II - Drugs - ICU Medical Inc,Presence of Particulates; may contain glass particles,2012-12-28,2012-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64062 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Visible particulate and particulate embedded in vials were observed during retain inspection.,2013-02-08,2013-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64441 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: There is a potential for the solution to leak from the administration port of the primary container.,2013-02-28,2013-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63522 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: There is the potential for the solution to leak from the seal of the fill tube to the bag.,2013-03-05,2013-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64001 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.,2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64482 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.,2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63242 - Class III - Drugs - ICU Medical Inc,CGMP Deviations: Shipment of product not approved for release.,2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64719 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Visible particulate embedded in vials was observed and confirmed in a sample bottle during retain inspection.,2013-03-28,2013-03-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64481 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal.,2013-04-04,2013-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63432 - Class I - Drugs - ICU Medical Inc,"Non-Sterility: One confirmed customer report that product contained spore-like particulates, consistent with mold.",2013-04-17,2013-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64197 - Class I - Drugs - ICU Medical Inc,Non-Sterility: Confirmed customer complaint of product contaminated with mold.,2013-04-17,2013-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64990 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: A single visible particulate was identified during a retain sample inspection.,2013-04-24,2013-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64720 - Class II - Drugs - ICU Medical Inc,"Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial, Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.",2013-05-01,2013-05-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65077 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.,2013-05-06,2013-05-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65315 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.,2013-05-31,2013-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65225 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Confirmed report of leaking in the primary container.,2013-06-03,2013-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65400 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: The product has the potential for solution to leak at or near the administrative port of the primary container.,2013-06-20,2013-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61918 - Class II - Drugs - ICU Medical Inc,"Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.",2013-06-21,2013-06-21,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65226 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: visible particles were identified floating in the primary container.,2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65731 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or rust colored ring embedded in between the plastic layers of the plastic vial.,2013-07-22,2013-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64792 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: reports of small grey/brown particles found in the primary container identified as brass particulates,2013-08-02,2013-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65300 - Class II - Drugs - ICU Medical Inc,Presence of Particulate; lot being recalled as a precaution due to the discovery of 2 particles found in a lot which preceded the recalled lot,2013-08-07,2013-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65616 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter; single visible particulate was identified during a retain sample inspection identified as stainless steel,2013-08-13,2013-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63364 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter; product may contain fibrous material,2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66050 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.,2013-08-28,2013-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66104 - Class II - Drugs - ICU Medical Inc,Lack of assurance of sterility: ineffective crimp on fliptop vials that may result in leaking at the neck of the vials.,2013-08-28,2013-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66134 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Visible particulate embedded in the glass vial was observed and confirmed in a sample bottle during retain sample inspection.,2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66201 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter; report of visible particulates in the glass ampule,2013-10-02,2013-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66295 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility; potential for vial breakage,2013-10-07,2013-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66637 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Visible particles embedded in the glass identified during a retain sample inspection.,2013-11-04,2013-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66422 - Class II - Drugs - ICU Medical Inc,"Presence of Particulate Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials., Presence of Particular Matter: Potential vendor glass issue - glass spiticules (glass strands) were identified during site inspection of the vials.",2013-11-20,2013-11-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66435 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Confirmed customer report of leakage of vial contents due to the breaking of the vial neck.,2013-12-02,2013-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66260 - Class I - Drugs - ICU Medical Inc,Presence of particulate matter: visible free floating and partially embedded particulate matter in the glass vials.,2013-12-18,2013-12-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66147 - Class I - Drugs - ICU Medical Inc,"Presence of Particulate Matter: Confirmed customer complaint of particulate matter, identified as a human hair, visible in the injection port and primary container.",2014-01-13,2014-01-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67322 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.,2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67317 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility; potential leakage from administrative port.,2014-01-24,2014-01-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67605 - Class II - Drugs - ICU Medical Inc,"Lack of Assurance of Sterility:Solution leaking through the port cover of the primary container, which was identified during a retain sample visual inspection.",2014-03-03,2014-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67601 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the glass vial.,2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66503 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: Units of this lot may have visible metal particles embedded in the vial and in the solution causing the product to be discolored.,2014-03-14,2014-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67750 - Class III - Drugs - ICU Medical Inc,Labeling; Missing label; ampoules are missing the immediate container label,2014-04-08,2014-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66441 - Class I - Drugs - ICU Medical Inc,"Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.",2014-04-14,2014-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67935 - Class II - Drugs - ICU Medical Inc,Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide,2014-04-24,2014-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67140 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter- Confimed customer complaint of  particulates embedded in glass container and in contact with product solution.,2014-04-27,2014-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68048 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.,2014-06-05,2014-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68296 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solution,2014-07-08,2014-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68631 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.,2014-07-09,2014-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68751 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Fliptop vial crimps are loose or missing.,2014-07-14,2014-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67936 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.,2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69247 - Class II - Drugs - ICU Medical Inc,"Presence of Particulate Matter:  A confirmed customer complaint reported the presence of a brown, rust-colored particle embedded at the bottom of the glass vial.",2014-09-17,2014-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69163 - Class II - Drugs - ICU Medical Inc,Failed Impurities/Degradation Specification: Out of Specification results for pseudobuprenorphine impurity at the 9-month stability time point.,2014-09-19,2014-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68579 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.,2014-10-01,2014-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68901 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.,2014-10-10,2014-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69314 - Class II - Drugs - ICU Medical Inc,Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked.,2014-10-23,2014-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69659 - Class III - Drugs - ICU Medical Inc,Correct Labeled Product Mispack: Product tray containing vials was mislabeled to contain another product.,2014-11-19,2014-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69494 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.,2014-11-25,2014-11-25,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69798 - Class II - Drugs - ICU Medical Inc,Defective Container: Glass vials may crack due to low (thin) out of specification vial wall thickness which may lead to contamination and lack of assurance of sterility.,2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69900 - Class III - Drugs - ICU Medical Inc,Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.,2014-12-22,2014-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69214 - Class I - Drugs - ICU Medical Inc,"Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused administrative port of the container.",2014-12-23,2014-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69567 - Class I - Drugs - ICU Medical Inc,Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.,2015-02-13,2015-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69573 - Class I - Drugs - ICU Medical Inc,Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.,2015-02-13,2015-02-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68764 - Class I - Drugs - ICU Medical Inc,"Non-Sterility: Confirmed customer complaint of particulate matter floating within the solution of the primary container, consistent with mold.",2015-02-17,2015-02-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70064 - Class I - Drugs - ICU Medical Inc,Failed Stability Specifications: Product is subpotent and has out of specification known and unknown impurities.,2015-04-06,2015-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70303 - Class I - Drugs - ICU Medical Inc,"Presence of Particulate Matter; Hospira has identified the particulate as a human hair, sealed in the bag at the additive port area.",2015-04-23,2015-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71629 - Class II - Drugs - ICU Medical Inc,Lack of assurance of sterility: Potential channel leaks near the threaded vial port.,2015-07-15,2015-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71939 - Class II - Drugs - ICU Medical Inc,Defective Container: There were customer complaints of cracked and leaking glass vials.,2015-09-15,2015-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72996 - Class I - Drugs - ICU Medical Inc,Labeling: Incorrect Barcode: Primary bag labeling may be mislabeled with the wrong barcode which scans in as heparin sodium.,2016-02-16,2016-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73472 - Class II - Drugs - ICU Medical Inc,Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.,2016-04-21,2016-04-21,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73572 - Class III - Biologics - ICU Medical Inc,"Hetastarch products, with potential contact of products with an aromatic hydrocarbon resin during manufacturing, were distributed.",2016-04-29,2016-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73992 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter: Cardboard,2016-06-15,2016-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74399 - Class II - Drugs - ICU Medical Inc,Crystallization: Product contains particulate identified to be crystallized active ingredient.,2016-07-12,2016-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74707 - Class II - Drugs - ICU Medical Inc,Discoloration: Firm received complaints of product discoloration and particulates.,2016-09-14,2016-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75156 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.,2016-10-13,2016-10-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74720 - Class III - Drugs - ICU Medical Inc,Failed Stability Specifications: The recalled lots did not meet the specification for color and pH throughout shelf life.,2016-12-06,2016-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76460 - Class II - Drugs - ICU Medical Inc,Lack of Sterility Assurance: customer report of leaking bag,2017-02-17,2017-02-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76284 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: A hair was found stuck to the stopper of inside a single vial. The hair came in contact with the reconstituted drug product.,2017-04-05,2017-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77288 - Class II - Drugs - ICU Medical Inc,GMP Deviation; A foreign stopper was observed during packaging of a lot of product.,2017-06-09,2017-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77687 - Class III - Drugs - ICU Medical Inc,Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point,2017-07-14,2017-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77824 - Class II - Drugs - ICU Medical Inc,Presence of Particulate Matter; stainless steel,2017-08-14,2017-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80213 - Class II - Drugs - ICU Medical Inc,Lack of assurance of sterility: Bags have potential to leak.,2018-06-20,2018-06-20,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81199 - Class II - Drugs - ICU Medical Inc,Lack of Assurance of Sterility; bags have the potential to leak,2018-11-02,2018-11-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82048 - Class II - Drugs - ICU Medical Inc,CGMP Deviations,2019-02-19,2019-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84144 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter.,2019-11-15,2019-11-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85625 - Class I - Drugs - ICU Medical Inc,Presence of Particulate Matter: confirmed customer complaint for the presence of particulate matter identified as iron oxide.,2020-05-19,2020-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87484 - Class II - Drugs - ICU Medical Inc,"Presence of particulate matter.one confirmed
customer report of particulate matter within two semi-rigid bottles identified prior to use",2021-03-25,2021-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72602 - Class III - Biologics - ID Biomedical Corp., a subsidary of GSK Biologicals","Certain lots of FLULAVAL QUADRIVALENT, with observed loss of potency below the minimum specification prior to product expiry, were distributed.",2015-11-18,2015-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89270 - Class II - Drugs - Ideal Specialty Apothecary, Inc. dba Ideal Pharmacy",Lack of Assurance of Sterility,2022-01-31,2022-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79967 - Class II - Drugs - Ideaz Llc,CGMP Deviations: Products manufactured with an ingredient that exceed the benzene levels allowed in drug products.,2018-05-24,2018-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84620 - Class III - Drugs - Idelle Labs,Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.,2020-01-16,2020-01-16,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69936 - Class III - Biologics - Illinois Eye-Bank (MEBTC),"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-12-17,2014-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78152 - Class II - Biologics - Immucor GTI Diagnostics, Inc","LIFECODES ThromboType 1 Kit, with the potential to generate a failed assay or sample mistype, was distributed.",2017-10-03,2017-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79102 - Class III - Biologics - Immucor GTI Diagnostics, Inc","Immucor GTI Diagnostics' LIFECODES HLA-A SSO Typing Kits and LIFECODES HLA-A eRES SSO Typing Kits that utilize MATCH IT! DNA Software v1.2, were distributed.",2018-02-08,2018-02-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80446 - Class III - Biologics - Immucor GTI Diagnostics, Inc","Immucor GTI Diagnostics ThromboType kit,  with the potential for poor amplification for the HPA-1a and HPA-3a reactions, was distributed.",2018-07-25,2018-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61882 - Class III - Biologics - Immucor Inc,"Capture-R Ready Indicator Cells, with a rate of reported events for equivocal and unexpected positive reactions significantly higher than other lots, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63072 - Class II - Biologics - Immucor Inc,"Single lot of Capture-R Ready Indicator Red Cells, which may result in higher rates for equivocal and unexpected positive reactions compared to other in-date or previously released lots, was distributed.",2012-09-14,2012-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63760 - Class III - Biologics - Immucor Inc,"Capture-P Indicator Red Cells, with confirmed weaker than expected reactivity with the weak positive control, were distributed.",2012-12-20,2012-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64387 - Class III - Biologics - Immucor Inc,"Immucor WB corQC, associated with complaints of hemolysis, was distributed.",2013-02-21,2013-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64849 - Class III - Biologics - Immucor Inc,"Capture-P and Capture-P Ready Screen assays, with confirmed reduced reactivity with the weak positive control, were distributed.",2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65527 - Class III - Biologics - Immucor Inc,"Capture-R Ready plates, with higher rates of equivocal and unexpected positive reactions, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70621 - Class III - Biologics - Immucor Inc,Misbranded reagent red blood cells were distributed.,2015-03-03,2015-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73951 - Class III - Biologics - Immucor Inc,"Galileo Echo automated blood bank analyzer, with potentially incorrect Color Level settings, were identified and corrected.",2016-05-10,2016-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77530 - Class II - Biologics - Immucor Inc,"Immucor's TPHA Screen Test Cells, with a decrease in sensitivity for detection of antibodies to Treponema pallidum over the shelf life, were distributed.",2017-07-24,2017-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82060 - Class III - Biologics - Immucor Inc,Misbranded reagent red blood cells were distributed.,2019-02-13,2019-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85972 - Class II - Biologics - Immucor Inc,"Blood Grouping Reagent (In-Vitro Diagnostic), not meeting product specifications, was distributed.",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86968 - Class III - Biologics - Immucor Inc,Misbranded reagent red blood cells were distributed.,2020-12-11,2020-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74676 - Class II - Biologics - Immunotek Bio Centers, LLC","Blood products, collected from a donor who gave history which warranted deferral and was not deferred, were distributed.",2016-08-15,2016-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74677 - Class II - Biologics - Immunotek Bio Centers, LLC","Blood products, collected from a donor who gave history which warranted deferral and was not deferred, were distributed.",2016-08-15,2016-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74678 - Class II - Biologics - Immunotek Bio Centers, LLC","Blood products, collected from an ineligible donor, were distributed.",2016-08-18,2016-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90350 - Class III - Biologics - ImpactLife,"Red Blood Cell products, labeled with incorrect volumes, were distributed. 
",2022-06-12,2022-06-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91246 - Class III - Biologics - ImpactLife,"Leukoreduced Apheresis Platelets Washed, Irradiated, labeled with a volume significantly higher than the product's actual volume, were distributed.",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91513 - Class III - Biologics - ImpactLife,"Leukoreduced Apheresis Platelets, collected from a donor who had taken aspirin within 48 hours of donating, were distributed.",2023-01-20,2023-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73551 - Class III - Drugs - Impax Laboratories, Inc.",Labeling: Incorrect or Missing Lot and/or Exp. Date,2016-04-14,2016-04-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73679 - Class II - Drugs - Impax Laboratories, Inc.",Failed Impurities/Degradation Specifications,2016-04-21,2016-04-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74953 - Class I - Drugs - Impax Laboratories, Inc.",Labeling; Label Mixup; box labeled to contain 200 mg blister packs but actually contain 100 mg blister packs,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87029 - Class II - Drugs - Imprimis NJOF, LLC",Lack of assurance of sterility: 13 vials were discovered to have faulty crimps.,2020-12-30,2020-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77647 - Class II - Drugs - ImprimisRx CA, Inc., dba ImprimisRx",Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier,2017-09-07,2017-09-07,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91140 - Class II - Drugs - ImprimisRx NJ,Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.,2022-11-14,2022-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83353 - Class II - Drugs - ImprimisRx NJ,Subpotent Drug,2019-07-31,2019-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72614 - Class I - Drugs - Inaffit, LLC",Marketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine.,2016-02-17,2016-02-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86199 - Class I - Drugs - Incredible Products, SA de CV",Chemical Contamination: Product contains methanol as an active ingredient and is sub-potent for ethanol.,2020-09-18,2020-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65284 - Class II - Drugs - Indelicare LLC,"Marketed without an approved NDA/ANDA: INK-EEZE Tattoo Numbing Spray contains 5% Lidocaine and is being marketed without an approved NDA/ANDA. Lidocaine 5% is an ingredient in many FDA approved products, making Ink-Eeze an unapproved new drug.",2013-06-27,2013-06-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68199 - Class II - Drugs - Independent Nutrition Center, Inc.",Marketed Without An Approved NDA/ANDA: Product is being recalled due to excessive levels of lovastatin. Lovastatin is an FDA approved drug making this dietary supplement an unapproved new drug.,2014-05-22,2014-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62466 - Class II - Biologics - Indiana Blood Center,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63922 - Class II - Biologics - Indiana Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63962 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who reported a post donation illness, were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65725 - Class II - Biologics - Indiana Blood Center,"Blood products, with disparate weights between the two units collected during the apheresis procedure, were distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65974 - Class II - Biologics - Indiana Blood Center,"Blood product, collected from a donor who provided history that warranted a deferral, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66686 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who reported high risk behavior, were distributed.",2013-12-16,2013-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68416 - Class III - Biologics - Indiana Blood Center,"Blood products, collected from a donor with an invalid result for body temperature, were distributed.",2014-06-27,2014-06-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68822 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69208 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2014-10-09,2014-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69574 - Class II - Biologics - Indiana Blood Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2014-11-24,2014-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70326 - Class III - Biologics - Indiana Blood Center,"Blood product, for which donor suitability was not adequately determined, was distributed.",2015-02-04,2015-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70188 - Class II - Biologics - Indiana Blood Center,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2015-02-19,2015-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70249 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2015-02-23,2015-02-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70585 - Class II - Biologics - Indiana Blood Center,"Blood product, which did not meet the acceptable product specifications, was distributed.",2015-03-23,2015-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70955 - Class III - Biologics - Indiana Blood Center,"Blood products, for which quality control and distribution of products did not meet specifications, were distributed.",2015-05-06,2015-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70967 - Class II - Biologics - Indiana Blood Center,"Blood products, possibly contaminated with air, were distributed.",2015-05-13,2015-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70968 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2015-05-13,2015-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71347 - Class II - Biologics - Indiana Blood Center,"Blood product, collected from a donor who received a tattoo in a non-regulated state, was distributed.",2015-06-23,2015-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71823 - Class II - Biologics - Indiana Blood Center,"Blood product, collected from a donor for which the hemoglobin determination was not recorded, was distributed.",2015-08-25,2015-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72805 - Class II - Biologics - Indiana Blood Center,"Apheresis products, in which viral testing sample was exposed to unacceptable temperatures during storage, were distributed. 

",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73720 - Class II - Biologics - Indiana Blood Center,"Blood products, in which donor screening/deferral screening not done or incorrectly performed were distributed.",2016-05-04,2016-05-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74570 - Class III - Biologics - Indiana Blood Center,"Blood products, collected from two donors who tested positive for the antibody to Hepatitis B core Antigen on more than one occasion, were distributed.",2016-07-12,2016-07-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74979 - Class II - Biologics - Indiana Blood Center,"Blood product, collected form a donor who previously tested positive for the antibody to Hepatitis B core Antigen on more than one occasion, was distributed.",2016-08-26,2016-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74993 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who were previously deferred, were distributed.",2016-09-12,2016-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74994 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who was previously deferred, were distributed.",2016-09-12,2016-09-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74995 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who were previously deferred, were distributed.",2016-09-12,2016-09-12,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74996 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who were previously deferred, were distributed.",2016-09-12,2016-09-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74997 - Class III - Biologics - Indiana Blood Center,"Blood products, collected from a donor for whom donor eligibility was inadequately determined, were distributed.",2016-09-19,2016-09-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75174 - Class II - Biologics - Indiana Blood Center,"Blood product, collected from an ineligible donor, was distributed.",2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75429 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-10-13,2016-10-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75437 - Class II - Biologics - Indiana Blood Center,"Blood products, in which donor screening/deferral screening not done or incorrectly performed, including incorrect ID used during search,prior deferral due to testing were distributed.",2016-11-01,2016-11-01,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75434 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who was previously deferred, were distributed.",2016-11-17,2016-11-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75435 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who was previously deferred, were distributed.",2016-11-17,2016-11-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75722 - Class II - Biologics - Indiana Blood Center,"Blood product, in which donor gave history which warranted deferral or follow up questions were not asked, was distributed.",2016-12-09,2016-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76369 - Class II - Biologics - Indiana Blood Center,"Blood products, which were collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2017-02-28,2017-02-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76479 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor who travelled to a malaria endemic area within one year of donation, were distributed.",2017-03-01,2017-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78003 - Class II - Biologics - Indiana Blood Center,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2017-09-05,2017-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79389 - Class II - Biologics - Indiana Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-04-09,2018-04-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80851 - Class II - Biologics - Indiana Blood Center,"Apheresis product, in which quality control for WBC count was not performed, was distributed.
",2018-08-29,2018-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82732 - Class II - Biologics - Indiana Blood Center,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71426 - Class III - Drugs - Indiana Botanic Gardens, Inc",Superpotent Drug: Product may not be uniformly blended resulting in non-uniform distribution of the active ingredient menthol.,2015-06-25,2015-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64002 - Class II - Biologics - Indiana Lions Eye and Tissue Transplant Bank,"Human Cornea, recovered in a manner that increased the risk of the introduction, transmission, or spread of communicable disease, was distributed.",2013-01-07,2013-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64268 - Class II - Biologics - Indiana Lions Eye and Tissue Transplant Bank,"Human Corneas, recovered from a donor whose donor screening was performed in a manner that did not determine the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-02-05,2013-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83136 - Class II - Drugs - Infusion Options, Inc.",Lack of Assurance of Sterility,2019-08-15,2019-08-15,76,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89393 - Class II - Drugs - Ingenus Pharmaceuticals Llc,CGMP Deviations,2022-01-14,2022-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90934 - Class II - Drugs - Ingenus Pharmaceuticals Llc,Out of specification for related substances (impurities).,2022-10-17,2022-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80254 - Class II - Drugs - Ingenus Pharmaceuticals Llc,Superpotent Drug: High out of specification assay value results for potency.,2018-06-29,2018-06-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82401 - Class III - Drugs - Ingenus Pharmaceuticals Llc,Defective Container: firm discovered samples stored horizontally as well as product quality complaints from customers for bottles leaking.,2019-03-25,2019-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84011 - Class II - Drugs - Ingenus Pharmaceuticals Llc,Crystallization: Presence of particulate matter identified as API crystallization,2019-10-17,2019-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61928 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-06-12,2012-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62721 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, collected from a donor who reported travel through a malarial endemic area, was distributed.",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63331 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2012-11-08,2012-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64032 - Class II - Biologics - Inland Northwest Blood Center,"Blood products, collected from a donor who had taken aspirin, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64279 - Class III - Biologics - Inland Northwest Blood Center,"Blood products, manufactured from Whole Blood units that were stored at an incorrect temperature, were distributed.",2013-03-11,2013-03-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64880 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65013 - Class II - Biologics - Inland Northwest Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed., Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2013-05-24,2013-05-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66141 - Class II - Biologics - Inland Northwest Blood Center,"Blood products, collected from a donor considered to be at increased risk for Creutzfeldt-Jakob Disease (CJD), were distributed.",2013-09-17,2013-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67063 - Class II - Biologics - Inland Northwest Blood Center,"Blood products, collected from a donor with a history of Hepatitis after age 11, were distributed.",2014-01-23,2014-01-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67240 - Class II - Biologics - Inland Northwest Blood Center,"Blood products labeled as leukoreduced which did not meet the requirements for leukoreduced products, were distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69000 - Class II - Biologics - Inland Northwest Blood Center,"Blood products, possibly contaminated with air, were distributed.",2014-09-15,2014-09-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69708 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, collected from a donor who warranted deferral due to travel to a malaria endemic area, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70379 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, in which quality control and distribution/failure to quarantine unit due to medical history, was distributed.",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71660 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, labeled as leukoreduced, but exceeded the acceptable White Blood Cell count (WBC), was distributed.",2015-08-04,2015-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74494 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, collected from a donor for whom eligibility was incorrectly determined, was distributed.",2016-07-28,2016-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75102 - Class II - Biologics - Inland Northwest Blood Center,"Apheresis products, in which quality control for residual WBC count was not performed, were distributed.",2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75231 - Class III - Biologics - Inland Northwest Blood Center,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75504 - Class II - Biologics - Inland Northwest Blood Center,"Apheresis product, in which quality control for residual WBC count was not performed, was distributed.",2016-11-01,2016-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75578 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, collected from an ineligible donor, was distributed.",2016-11-11,2016-11-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76388 - Class III - Biologics - Inland Northwest Blood Center,"Blood products, inappropriately released from quarantine, were distributed.",2017-03-07,2017-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76530 - Class II - Biologics - Inland Northwest Blood Center,"Blood product, collected from an ineligible donor, was distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76933 - Class III - Drugs - InnovaGel,Subpotent,2017-04-19,2017-04-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68508 - Class III - Biologics - Innovasis, Inc",Human tissue allografts were distributed with expired packaging.,2014-07-14,2014-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65695 - Class II - Biologics - Innovative Blood Resources,"Blood products, exposed to unacceptable shipping temperatures, were distributed.",2013-08-23,2013-08-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65696 - Class III - Biologics - Innovative Blood Resources,"Blood products, collected from donors who were at risk for Leishmaniasis, were distributed.",2013-08-23,2013-08-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65836 - Class III - Biologics - Innovative Blood Resources,"Blood products, which may have reached an unacceptable temperature during storage, were distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66007 - Class II - Biologics - Innovative Blood Resources,"Platelet, with insufficient plasma volume to support the platelet yield, was distributed.",2013-09-05,2013-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66479 - Class II - Biologics - Innovative Blood Resources,"Platelet, with insufficient plasma volume to support the platelet yield, was distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66951 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected on an apheresis machine undergoing validation and which did not have the required quality control testing performed, were distributed.",2014-01-09,2014-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67854 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68053 - Class II - Biologics - Innovative Blood Resources,"Blood product, labeled as leukoreduced were not tested to verify the White Blood Cell count, was distributed",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68428 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-06-26,2014-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69010 - Class II - Biologics - Innovative Blood Resources,"Platelets, with insufficient plasma volume to support the platelet yield, were distributed.",2014-09-16,2014-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69529 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who travelled to an area considered endemic for malaria, was distributed.",2014-10-30,2014-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69523 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69524 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69528 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69652 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2014-12-04,2014-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69653 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2014-12-04,2014-12-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69654 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2014-12-04,2014-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69655 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2014-12-04,2014-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69651 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69756 - Class II - Biologics - Innovative Blood Resources,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69757 - Class II - Biologics - Innovative Blood Resources,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2014-12-11,2014-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69889 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who disclosed travel information to an area considered endemic for malaria, were distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69890 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who disclosed travel information to an area considered endemic for malaria, were distributed.",2014-12-11,2014-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69892 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who disclosed travel information to an area considered endemic for malaria, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69888 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from an inelgible donor, were distributed.",2014-12-17,2014-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69891 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who disclosed travel information to an area considered endemic for malaria, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69893 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who disclosed travel information to an area considered endemic for malaria, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69894 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who disclosed travel information to an area considered endemic for malaria, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69895 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who disclosed travel information to an area considered endemic for malaria, were distributed.",2014-12-18,2014-12-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69896 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who disclosed travel information to an area considered endemic for malaria, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69887 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2015-01-05,2015-01-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70037 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70038 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70039 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-01-30,2015-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70040 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70356 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who disclosed travel history that warranted deferral, was distributed.",2015-02-05,2015-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70357 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who disclosed travel history that warranted deferral, was distributed.",2015-02-05,2015-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70254 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from an ineligible donor, were distributed.",2015-02-26,2015-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70255 - Class II - Biologics - Innovative Blood Resources,"Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2015-02-26,2015-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70256 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from an ineligible donor, was distributed.",2015-02-26,2015-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70481 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who visited a malarial endemic area, was distributed.",2015-03-12,2015-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70479 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who visited a malarial endemic area, were distributed.",2015-03-17,2015-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70483 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who visited a malarial endemic area, were distributed.",2015-03-17,2015-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70480 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who visited a malarial endemic area, were distributed.",2015-03-19,2015-03-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70482 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who visited a malarial endemic area, was distributed.",2015-03-19,2015-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70484 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who visited a malarial endemic area, were distributed.",2015-03-19,2015-03-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70485 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who visited a malarial endemic area, were distributed.",2015-03-19,2015-03-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70746 - Class II - Biologics - Innovative Blood Resources,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-04-02,2015-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70957 - Class II - Biologics - Innovative Blood Resources,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70971 - Class II - Biologics - Innovative Blood Resources,"Blood product, manufactured in a manner that may have compromised the sterility of the unit, was distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70867 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2015-05-06,2015-05-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70956 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2015-05-13,2015-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70969 - Class III - Biologics - Innovative Blood Resources,"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2015-05-19,2015-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70972 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who had traveled to a malarial endemic region within 12 months of donation, was distributed.",2015-05-21,2015-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71284 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2015-06-10,2015-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71282 - Class II - Biologics - Innovative Blood Resources,"Blood product, with a low platelet count, was distributed.",2015-06-17,2015-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71759 - Class III - Biologics - Innovative Blood Resources,"Blood product, component preparation/component not prepared in accordance with specifications, was distributed.",2015-08-20,2015-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71982 - Class II - Biologics - Innovative Blood Resources,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72939 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2016-01-14,2016-01-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73289 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor for whom eligibility was inadequately determined, was distributed.",2016-03-22,2016-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73591 - Class II - Biologics - Innovative Blood Resources,"Blood products, lacking product quality control testing, were distributed.",2016-04-07,2016-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72429 - Class II - Biologics - Innovative Blood Resources,"Blood products, lacking assurance of sterility, were distributed.",2016-04-22,2016-04-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73755 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled within one year to a malarial endemic area, was distributed.",2016-04-25,2016-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73760 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74203 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-05-26,2016-05-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73942 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-06-02,2016-06-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74770 - Class III - Biologics - Innovative Blood Resources,"Blood product, collected from a paid donor but incorrectly labeled with the ""volunteer donor"" classification, was distributed.",2016-08-05,2016-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75839 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-12-14,2016-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76225 - Class II - Biologics - Innovative Blood Resources,"Platelet products, for which WBC quality control was not performed, were distributed.",2017-01-31,2017-01-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76227 - Class III - Biologics - Innovative Blood Resources,"Blood product, in which labeling applied to blood unit or product incorrect or missing information, was distributed.",2017-03-02,2017-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76941 - Class III - Biologics - Innovative Blood Resources,"Apheresis Platelet, labeled with an incorrect volume, was distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77586 - Class II - Biologics - Innovative Blood Resources,"Apheresis products for which white blood cell count testing was not performed, were distributed.",2017-07-12,2017-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77905 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-09-18,2017-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77971 - Class II - Biologics - Innovative Blood Resources,"Blood products, which did not meet the acceptable product specifications, were distributed.",2017-09-18,2017-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80146 - Class II - Biologics - Innovative Blood Resources,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-07-02,2018-07-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80480 - Class II - Biologics - Innovative Blood Resources,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81995 - Class II - Biologics - Innovative Blood Resources,"Blood product in which routine testing/testing performed, interpreted, or documented incorrectly, was distributed.
",2019-02-07,2019-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82303 - Class II - Biologics - Innovative Blood Resources,"Apheresis products in which quality control for residual WBC count was not performed, were distributed.",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82407 - Class III - Biologics - Innovative Blood Resources,"Red Blood Cells, not meeting product specifications, were distributed.",2019-04-01,2019-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83602 - Class II - Biologics - Innovative Blood Resources,"Plateletpheresis product with a high white blood cell count, was distributed.
",2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84872 - Class III - Biologics - Innovative Blood Resources d.b.a. Nebraska Community Blood Bank,"Plateletpheresis products, lacking assurance of proper storage and shipment temperatures, were distributed.",2020-02-18,2020-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84745 - Class III - Biologics - Innovative Blood Resources d.b.a. Nebraska Community Blood Bank,"Blood product, which was labeled with an incorrect volume, was distributed.",2020-02-21,2020-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86813 - Class II - Biologics - Innovative Blood Resources d.b.a. Nebraska Community Blood Bank,"Blood products, collected from a donor who previously tested positive for the antibody to Hepatitis B core Antigen on more than one occasion and not properly re-entered, were distributed.
",2020-12-02,2020-12-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89892 - Class II - Biologics - Innovative Blood Resources d.b.a. Nebraska Community Blood Bank,"Leukoreduced Apheresis Platelets, collected in a manner that compromises the sterility of the collection system, were distributed.",2022-04-08,2022-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85351 - Class II - Drugs - Innovative Intrathecal Solutions, Inc. dba Innovative Compounding Pharmacy",Lack of Assurance of Sterility,2020-04-06,2020-04-06,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83939 - Class II - Biologics - Innovative Transfusion Medicine, Inc.","Leukoreduced Red Blood Cells, collected from a donor who emigrated from a malarial endemic area, were distributed",2019-10-25,2019-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89838 - Class II - Biologics - Innovative Transfusion Medicine, Inc.","Leukoreduced Red Blood Cells, with NAT testing not done, were distributed.",2022-04-08,2022-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88159 - Class II - Drugs - Innoveix Pharmaceuticals Inc,Lack of Assurance of Sterility,2021-07-20,2021-07-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84006 - Class II - Drugs - Innoveix Pharmaceuticals Inc,Lack of Sterility Assurance.,2019-10-28,2019-10-28,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82645 - Class II - Drugs - Inopak Ltd,CGMP Deviations: hand sanitizers and soaps were not produced under current good manufacturing practices.,2019-05-29,2019-05-29,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78098 - Class II - Drugs - Inopak Ltd,"GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump

, GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump.

",2017-10-04,2017-10-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80196 - Class II - Drugs - Inopak Ltd,Microbial contamination of NonSterile Product; FDA analysis returned out of specification results for total aerobic microbial counts,2018-06-13,2018-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73074 - Class II - Biologics - Inova Health Care Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-02-08,2016-02-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73919 - Class II - Biologics - Inova Health Care Services,Red Blood Cell product collected from a donor who traveled to a malarial endemic area was distributed.,2016-05-02,2016-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74480 - Class II - Biologics - Inova Health Care Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2016-08-08,2016-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75843 - Class III - Biologics - Inova Health Care Services,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-01-11,2017-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80036 - Class II - Biologics - Inova Health Care Services,"Platelet products, for which quality control of product did not meet specifications, were distributed.",2018-05-17,2018-05-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82243 - Class II - Biologics - Inova Health Care Services,"Blood product, collected from an ineligible donor, was distributed.",2019-02-28,2019-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83077 - Class II - Biologics - Inova Health Care Services,"Leukoreduced Red Blood Cell products, collected from a donor who traveled to a malarial endemic area, were distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83076 - Class II - Biologics - Inova Health Care Services,"Blood products, collected from an ineligible donor, were distributed.",2019-07-11,2019-07-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84668 - Class II - Biologics - Inova Health Care Services,"Red Blood Cell product, collected from a donor who lived in a malarial endemic area, was distributed.
",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86459 - Class II - Biologics - Inova Health Care Services,"Blood product, collected from an ineligible donor, was distributed.",2020-09-21,2020-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86612 - Class II - Biologics - Inova Health Care Services,"Blood product, not meeting product specifications, was distributed.",2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87334 - Class II - Biologics - Inova Health Care Services,"Blood products, labeled with an incorrect expiration date, were distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88251 - Class II - Biologics - Inova Health Care Services,"Leukoreduced Red Blood Cells, Irradiated, collected from a donor who tested repeat reactive for Hepatitis, was distributed.",2021-07-21,2021-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63704 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood product, collected from a donor whose health history screening was inadequately performed, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63813 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63834 - Class III - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood product, collected from a donor whose hemoglobin was not recorded during donor screening, was distributed.",2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63921 - Class III - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood product, collected from a donor for whom there was no documentation on the donor record of an arm inspection, general appearance of the donor or hemoglobin screening, was distributed.",2013-01-18,2013-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64520 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-03-22,2013-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67074 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-01-23,2014-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68628 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-08-05,2014-08-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69415 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2014-10-28,2014-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69460 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69858 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood products, which did not meet the acceptable product specifications, were distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69881 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood product, which did not meet the acceptable product specifications, was distributed.",2014-12-23,2014-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70707 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood products, collected from an ineligible donor due to improper HIV re-entry, were distributed.",2015-04-13,2015-04-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70866 - Class II - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood products, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2015-05-06,2015-05-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71172 - Class III - Biologics - Inova Health Care Services, Inova Blood Donor Services","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-06-16,2015-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65107 - Class II - Drugs - Insight Instruments, Inc.",Marketed without an Approved NDA/ANDA.,2014-01-31,2014-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61900 - Class I - Drugs - InSo-Independent Contractor for West Coast Nutritionals,LTD","Marketed Without an Approved NDA/ANDA: These products found to contain undeclared tadalafil. Tadalafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making these products unapproved new drugs.",2013-05-16,2013-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88731 - Class II - Drugs - IntegraDose Compounding Services LLC,Lack of sterility assurance.,2021-09-30,2021-09-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84284 - Class II - Drugs - Integrated Health Concepts Inc. dba Conversio Health,Lack of Processing Controls,2019-11-19,2019-11-19,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43037 - Class II - Biologics - International BioResources, LLC","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43318 - Class III - Biologics - International BioResources, LLC","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47084 - Class III - Biologics - International BioResources, LLC","Blood product, collected from a donor whose donor suitability was not adequately determined, was distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42577 - Class II - Biologics - International BioResources, LLC","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42579 - Class II - Biologics - International BioResources, LLC","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43057 - Class III - Biologics - International BioResources, LLC","Blood product, collected from a donor whose arm check and general appearance inspection were not documented, was distributed.",2013-07-09,2013-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77899 - Class I - Drugs - International Laboratories, Inc.","Labeling: Label mix-up, the product labeled as Pravastatin sodium tablets 40 mg was filled with Bupropion hydrochloride XL Tablets 300 mg.",2017-12-01,2017-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78939 - Class II - Drugs - International Laboratories, Inc.",Presence of Foreign Tablets/Capsules: bottles could contain both pravastatin sodium 10 mg and 20 mg tablets in the same bottle.,2018-01-24,2018-01-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78913 - Class I - Drugs - International Laboratories, LLC","LABELING: LABEL MIX-UP. Simvastatin tablets, USP 10 mg were found in bottles labeled as Clopidogrel tablets, USP 75 mg.",2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61324 - Class II - Biologics - International Sight Restoration, Inc.","Human corneas, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-07-09,2012-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65386 - Class III - Biologics - International Sight Restoration, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-11,2013-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65521 - Class II - Biologics - International Sight Restoration, Inc.","Human corneas, recovered from donors whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-07-26,2013-07-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65525 - Class III - Biologics - International Sight Restoration, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68241 - Class III - Biologics - International Sight Restoration, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-05-13,2014-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71561 - Class II - Biologics - International Sight Restoration, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2015-07-06,2015-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91348 - Class III - Drugs - Intersect ENT, Inc.",Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.,2023-01-19,2023-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53642 - Class II - Biologics - Interstate Blood Bank Inc,"Blood products, collected from a donor who was previously deferred, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85320 - Class II - Biologics - Interstate Blood Bank Inc,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2020-05-07,2020-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49930 - Class II - Biologics - Interstate Blood Bank Inc Mo,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44584 - Class III - Biologics - Interstate Blood Bank Inc Mo,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62682 - Class III - Biologics - Interstate Blood Bank Inc of Chicago,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84854 - Class II - Biologics - Interstate Blood Bank Inc of Missouri,"Blood products, collected from a donor who was previously deferred, were distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62532 - Class II - Biologics - Interstate Blood Bank Inc. of Wisconsin,"Blood products, collected from a donor who had been permanently deferred, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65928 - Class II - Biologics - Interstate Blood Bank, Inc of Wisconsin","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62906 - Class II - Biologics - Interstate Blood Bank, Inc. of Wisconsin","Blood products, collected from a donor who was permanently deferred, were distributed.",2012-09-20,2012-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62907 - Class II - Biologics - Interstate Blood Bank, Inc. of Wisconsin","Blood products, collected from a donor who was permanently deferred, were distributed.",2012-09-20,2012-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63753 - Class II - Biologics - Interstate Blood Bank, Inc. of Wisconsin","Blood products, collected from a donor who was previously deferred, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64744 - Class II - Biologics - Interstate Blood Bank, Inc. of Wisconsin","Blood product, collected from a donor whose scheduled physical examination was incomplete, was distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65574 - Class III - Biologics - Interstate Blood Bank, Inc. of Wisconsin","Blood products, collected from an ineligible donor, were distributed.
",2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69578 - Class II - Biologics - Interstate Blood Bank, Inc. of Wisconsin","Blood product, in which donor did not meet donor suitability due to an incomplete physical examination, was distributed.",2014-12-01,2014-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80598 - Class II - Biologics - Interstate Blood Bank, Inc. of Wisconsin","Plasma products, collected from an ineligible donor, were distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62266 - Class III - Biologics - Interstate Blood Bank, Inc. WI","Blood products, collected from a donor who was previously deferred, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70267 - Class II - Biologics - Interstate Blood Bank, Inc. WI","Blood products, collected from a deferred donor, were distributed.",2015-02-26,2015-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78669 - Class II - Drugs - Intrathecal Compounding Specialist, LLC",Lack of sterility assurance.,2018-02-04,2018-02-04,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79446 - Class III - Drugs - InvaGen Pharmaceuticals, Inc.",Failed Dissolution Specifications; during stability testing,2018-04-04,2018-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79729 - Class III - Drugs - InvaGen Pharmaceuticals, Inc.",Failed impurities/degradation specifications: Failure to water content and impurity,2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80973 - Class III - Drugs - InvaGen Pharmaceuticals, Inc.",Failed impurities/ degradation specifications: Out-of-specification results were observed in the meta-chlorobenzoic acid impurity in batches 18 months or older from date of manufacture in the 90 count bottle size.,2018-09-25,2018-09-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81099 - Class III - Drugs - InvaGen Pharmaceuticals, Inc.","Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month
long term stability condition.
",2018-10-11,2018-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82463 - Class II - Drugs - InvaGen Pharmaceuticals, Inc.",Presence of Particulate Matter.,2019-04-15,2019-04-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83117 - Class III - Drugs - InvaGen Pharmaceuticals, Inc.",Defective Container; actuator may improperly function and affect dose delivery.,2019-07-03,2019-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85646 - Class III - Drugs - InvaGen Pharmaceuticals, Inc.",Failed Impurities/Degradation Specifications; failure of Impurity A test at the 12-month long-term stability testing.,2020-05-21,2020-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86708 - Class III - Drugs - InvaTech Pharma Solutions, LLC",Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count  failed stability testing.,2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75642 - Class II - Drugs - Inventia Healthcare Private Limited,"Failed Tablet/Capsule Specifications: Capsule shell (s) opening inside the bottle

The Initial reports stated one or two capsules in a bottle count of 30s opening.  First report came in June 14, 2016. Till date about 22 reports have come in from pharmacies which report two batches 130/16/001 and 130/16/002. Third batch 130/16/003 is not distributed yet, will be recalled from warehouse.
",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73698 - Class II - Drugs - Invisiblu International LLC,"Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033",2016-05-27,2016-05-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83304 - Class II - Biologics - Invitrx Therapeutics, Inc","Cord Blood Stem Cells, recovered from a  donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2019-08-15,2019-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78295 - Class III - Biologics - Iowa Lions Eye Bank,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2017-10-19,2017-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66965 - Class I - Drugs - IQ Formulations, LLC","Marketed Without an Approved NDA/ANDA; this product is being recalled for containing an undeclared diuretic called Triamterene, an FDA approved prescription only medication used to treat edema, making it an unapproved new drug",2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62779 - Class II - Drugs - Island Kinetics dba Covalence,Microbial Contamination of Non Sterile Product; mold,2012-08-29,2012-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84561 - Class III - Drugs - Island Kinetics, Inc. d.b.a. CoValence Laboratories",Superpotent Drug: Salicylic acid content is above the firm's specification.,2019-12-31,2019-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82397 - Class II - Drugs - Iso-Tex Diagnostics, Inc","Lack of Assurance of Sterility: preliminary environmental monitoring report exceeds limits, therefore sterility cannot be assured.",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82652 - Class II - Drugs - Iso-Tex Diagnostics, Inc","Lack of Assurance of Sterility: environmental monitoring report exceeds limits, therefore sterility cannot be assured.",2019-04-18,2019-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73207 - Class III - Drugs - Isomeric Pharmacy Solution, LLC","Labeling: Incorrect or Missing Lot and/or Exp Date: some vials may be mislabeled with an incorrect ""Compounded"" date, lot number, and ""Do Not Use Beyond"" date or BUD (Before Use Date) that may be longer than intended.",2016-02-25,2016-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74832 - Class II - Drugs - Isomeric Pharmacy Solution, LLC","Lack of processing controls: Isomeric Pharmacy Solution, LLC is recalling Betamethasone Acetate / Betamethasone Sodium Phosphate 7 mg/mL INJ SUSP because of the potential of drug clumps in the vial of the sterile drug product and larger particle sizes.",2016-08-04,2016-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74603 - Class II - Drugs - Isomeric Pharmacy Solution, LLC","Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles.",2016-09-02,2016-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76676 - Class II - Drugs - Isomeric Pharmacy Solution, LLC",CGMP Deviations,2017-03-13,2017-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76951 - Class II - Drugs - Isomeric Pharmacy Solution, LLC",Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.,2017-04-26,2017-04-26,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85987 - Class I - Drugs - Itech 361 LLC,Chemical Contamination: Product contains undeclared methanol.,2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63428 - Class III - Drugs - ITW Dymon,CGMP Deviations: The products were manufactured with raw material which contain unknown particles believed to be water and dirt.,2012-11-15,2012-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87403 - Class II - Biologics - ITxM Clinical Services,"Misbranded Red Blood Cell product was distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88237 - Class II - Biologics - ITxM Clinical Services,"Blood product, mislabeled as to antigen phenotype, was distributed.",2021-07-13,2021-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62953 - Class III - Biologics - ITXM Clinical Services,"Blood products, leukoreduced greater than five days after collection, were distributed.",2012-09-20,2012-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64209 - Class III - Biologics - ITXM Clinical Services,"Blood products, leukodepleted greater than five days after collection, were distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81637 - Class II - Biologics - ITXM Clinical Services,"Blood products, not meeting product specifications, were distributed.",2018-11-28,2018-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69977 - Class III - Drugs - J. Strickland and Co,Failed pH specification: Product pH test value of 5.72 failed to meet its product specification of 6.0 to 7.5.,2014-12-23,2014-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73332 - Class III - Drugs - J. Strickland and Co,Subpotent Drug: failed at the 3 and 6 month stability time points.,2016-03-02,2016-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65895 - Class I - Drugs - Jack Rabbit, Inc",Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined that J.R.  Jack Rabbit Male Enhancement product was found to contain two undeclared  active pharmaceutical ingredients: sildenafil and tadalafil.,2013-11-27,2013-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88647 - Class I - Drugs - Jacobus Pharmaceutical Company Inc.,"Microbial contamination of non-sterile products: Firm's testing found lots to exceed specification for aerobic bacteria, yeast, and mold counts.",2021-10-08,2021-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62237 - Class II - Drugs - James G. Cole, Inc.","Lack of Assurance of Sterility: The product is being recalled because the product label does not state sterile in accordance with 21 CFR Part 200.50(a)(1), Ophthalmic Preparations and Dispensers, and it is not in compliance with 21 CFR Part 349, Ophthalmic Drug Products for Over-The-Counter Use.",2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69302 - Class II - Drugs - Janssen Ortho L.L.C.,Microbial Contamination of Non-Sterile Products:  Consumer complaint confirmed microbial contamination in sales sample.,2014-10-03,2014-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75449 - Class III - Drugs - Janssen Ortho L.L.C.,Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.,2016-10-25,2016-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66261 - Class II - Drugs - Janssen Pharmaceuticals, Inc.",Non-Sterility: Janssen  is recalling  one lot of Risperdal CONSTA (risperiDONE)   due to a sterility failure in a  stability sample,2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71064 - Class II - Drugs - Janssen Pharmaceuticals, Inc.",Subpotent Drug,2015-05-11,2015-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81289 - Class II - Drugs - Janssen Pharmaceuticals, Inc.",Labeling: Incorrect Instructions; Instructions included  for use with the Veridate dispenser contained instructions for the Dialpak dispenser.,2018-11-06,2018-11-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86617 - Class II - Drugs - Jarrow Formulas Inc,"Mislabeling of SUS (N-A-C Sustain 600 mg 100 tab) with N-A-C N-Acetyl-L-Cysteine 500 mg, 100 cap.",2020-10-29,2020-10-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72782 - Class I - Drugs - JAT Natural Products Corp.,"Marketed Without An Approved NDA/ANDA: Tainted product marketed as a dietary supplement. Product found to be tainted with sibutramine, an appetite suppressant that was withdrawn from the U.S. market in October 2010 for safety reasons, and diclofenac, a prescription non-steroidal anti-inflammatory drug, making this an unapproved drug.",2016-05-23,2016-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70085 - Class II - Drugs - Jaymac Pharmaceuticals L.L.C.,"Labeling: Not Elsewhere Classified: Product is labeled ""Dye Free"" on front panel but contains Red Dye 40.",2014-12-29,2014-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78962 - Class III - Drugs - JCB Laboratories LLC,Subpotent Drug: The product is sub-potent prior to its 90-day beyond use date.,2018-01-30,2018-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66099 - Class II - Drugs - JCB Labs LLC,Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.,2013-09-13,2013-09-13,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71806 - Class II - Drugs - JD & SN Inc., dba Moses Lake Professional Pharmacy",Lack of Assurance of Sterility; all sterile human compounded drugs within expiry,2015-10-27,2015-10-27,101,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88409 - Class I - Drugs - Je Dois Lavoir LLC,"Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.",2022-02-23,2022-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75741 - Class I - Drugs - Jeffreys Drug Store,Marketed without an approved NDA/ANDA for which safety and efficacy has not been established.,2017-02-27,2017-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75929 - Class I - Drugs - Jersey Shore Supplements, LLC",Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.,2017-02-13,2017-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62013 - Class III - Drugs - JHP Pharmaceuticals, LLC","Labeling: Label Mix-up: Pitocin storage conditions should be labeled, ""Store between 20 to 25C (68 to 77F)"". Pitocin lot 225867 and part of Pitocin lot 231423 were labeled, ""Store between 20 to 25C (28 to 77F)"".",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79476 - Class I - Drugs - Jimmy Weber,"Marketed without an Approved NDA/ANDA; FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction.",2018-04-11,2018-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67812 - Class II - Drugs - John W Hollis Inc,"Labeling: Incorrect Expiration Date; Expiration date is earlier than listed on vial., Presence of Particulate Matter",2014-04-25,2014-04-25,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68557 - Class II - Drugs - John W Hollis Inc,Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.,2014-06-18,2014-06-18,19,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88288 - Class I - Drugs - Johnson & Johnson Consumer, Inc.","Chemical Contamination: presence of benzene, cGMP Deviations",2021-09-24,2021-09-24,20,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63787 - Class III - Drugs - Johnson & Johnson Consumer, Inc.",Superpotent (Single Ingredient Drug): salicylic acid,2012-12-20,2012-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78610 - Class II - Drugs - Johnson & Johnson Consumer, Inc.","Defective Container: products showed leakage (bubbles, foaming) of propellant and product from the container valve cup area.",2018-01-29,2018-01-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82298 - Class II - Drugs - Johnson Matthey Inc.,Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.,2019-04-03,2019-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82618 - Class III - Drugs - Johnson Matthey Inc.,Failed Impurities/Degradation Specifications: Unknown impurity above specification limits.,2019-04-30,2019-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83457 - Class II - Drugs - Johnson Matthey Inc.,cGMP Deviations: Potential glass contamination,2019-09-25,2019-09-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66782 - Class III - Biologics - Joliet Blood Plasma LLC dba Plasma Care, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed",2013-12-11,2013-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64869 - Class II - Drugs - Jubilant Cadista Pharmaceuticals Inc.,cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.,2013-04-26,2013-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68776 - Class II - Drugs - Jubilant Cadista Pharmaceuticals Inc.,Presence of Foreign Substance: Tablets may contain dark blemishes identified as stainless steel.,2014-07-31,2014-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89923 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Subpotent,2022-04-06,2022-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91412 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.,2023-01-05,2023-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75954 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Labeling: Incorrect or Missing Lot and/or Exp Date: incorrect expiration date of 02/0218 is printed on the container label instead of the correct expiration date of 02/2018.,2016-12-15,2016-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76982 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.","Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation products, m-chlorobenzoic acid.",2017-04-13,2017-04-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78461 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.,2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80133 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Incorrect/Undeclared excipient: Product batches were released into commercial distribution with a larger size grade of excipient (Crospovidone).,2018-06-15,2018-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80836 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.,2018-08-17,2018-08-17,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80951 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Failed Stability Specifications: An out-of-specification result was obtained during 18-month stability testing for assay.,2018-09-21,2018-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81162 - Class II - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.,2018-10-09,2018-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82280 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Failed Dissolution Specifications; 9-monthstability timepoint,2019-03-06,2019-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82523 - Class II - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.,2019-04-01,2019-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83408 - Class I - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Failed dissolution specifications : failed results at the 3-month stability time point.,2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83705 - Class II - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",CGMP Deviation: Presence of dark brown discoloration on edges of tablets.,2019-10-17,2019-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84396 - Class II - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Presence of Foreign Substance: Presence of a foreign object in a single tablet.,2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85181 - Class II - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",CGMP Deviations: Presence of dark brown discoloration on edges of tablets,2020-03-24,2020-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85752 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Presence of Foreign Substance visually consistent with the silica granules present in the desiccant packs utilized during storage of the product.,2020-05-29,2020-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86658 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Subpotent,2020-11-05,2020-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86698 - Class II - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Failed Tablet/Capsule Specification,2020-11-24,2020-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87342 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.,2021-03-04,2021-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87667 - Class II - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Failed Dissolution Specifications,2021-04-12,2021-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88523 - Class III - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Subpotent,2021-08-31,2021-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89854 - Class I - Drugs - Jubilant Cadista Pharmaceuticals, Inc.",Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride,2022-04-12,2022-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90610 - Class II - Drugs - Jubilant Cadista Pharmaceuticals, Inc.","Failed dissolution specifications., Failed Dissolution Specifications",2022-07-26,2022-07-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90455 - Class II - Drugs - Jubilant Draximage Inc,Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.,2022-07-08,2022-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73586 - Class III - Drugs - Jubilant Draximage Inc,Labeling: Label Error on Declared Strength,2016-04-06,2016-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85226 - Class II - Drugs - Jubilant Draximage Inc,Failed Stability Specifications,2020-03-25,2020-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63929 - Class III - Biologics - Jubilant HollisterStier, LLC",-,2012-12-21,2012-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64097 - Class III - Biologics - Jubilant HollisterStier, LLC","Allergenic Extracts, with confirmed OOS potency results at 15 month stability time point, were distributed.",2013-02-27,2013-02-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66061 - Class II - Biologics - Jubilant HollisterStier, LLC","Diluent containing phenol failed an apperance test on stability.  The Diluent is included in the JHS licensed venomil kits that were distributed.
",2013-08-30,2013-08-30,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66849 - Class III - Biologics - Jubilant HollisterStier, LLC",Misbranded Mixed Vespid Venomil Maintenance Kits were distributed.,2013-12-06,2013-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75673 - Class III - Biologics - Jubilant HollisterStier, LLC",Misbranded allergenic extract was distributed.,2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89543 - Class I - Drugs - Junp Hydration LLC,"Marketed Without An Approved NDA/ANDA: product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.",2022-02-11,2022-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90828 - Class II - Drugs - Justified Laboratories,Marketed Without An Approved NDA/ANDA; Unapproved new drug,2022-10-07,2022-10-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55714 - Class II - Drugs - K C Pharmaceuticals Inc,"Labeling: Label Mix-Up: Incorrect back labeling of the immediate container of eye drops (unit carton and front label are correct) which do not list three active ingredients: Dextran 70, PEG 400, and povidone.",2013-03-08,2013-03-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69945 - Class III - Drugs - K C Pharmaceuticals Inc,"CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.",2014-12-23,2014-12-23,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81512 - Class I - Drugs - Kadesh International,Non-Sterility: Product manufactured under non-sterile production conditions.,2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66019 - Class II - Biologics - Kaiser Foundation Hospital,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-09-10,2013-09-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66480 - Class II - Biologics - Kaiser Foundation Hospital,"Blood products, collected from a donor who received a MMR vaccine, were distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69317 - Class II - Biologics - Kaiser Foundation Hospital,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2014-10-30,2014-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79304 - Class II - Drugs - Kalchem International, Inc.",cGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.,2018-03-07,2018-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72241 - Class II - Drugs - Kalman Health & Wellness, Inc. dba Essential Wellness Pharma",Lack of Assurance of Sterility:  A recall of all compounded sterile preparations within expiry is being initiated due to observations associated with poor sterile production practices resulting in a lack of sterility assurance for their finished drugs.,2015-11-17,2015-11-17,39,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76835 - Class III - Biologics - Kamada Ltd,"Misbranded GLASSIA [Alpha1 - Proteinase Inhibitor (Human)] for GLASSIA Self-Administration, was distributed.",2017-04-18,2017-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64038 - Class III - Biologics - Kapiolani Medical Center for Women and Children,"Blood product, which label was applied to blood unit with incorrect or missing information, was distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #53558 - Class II - Drugs - Kareway Product Inc,Labeling: Not Elsewhere Classified; foil label on immediate blister pack indicates active ingredient as Chlorpheniramine rather than Diphenhydramine,2013-06-26,2013-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78541 - Class I - Drugs - Kareway Product Inc,Non-sterility: confirmed microbial contamination with Achromobacter xylosoxidans,2018-02-28,2018-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64677 - Class III - Biologics - KDNA Life Sciences LLC,"Human tissue allografts were processed in a manner that could cause contamination or cross-contamination during processing, and well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P.",2013-04-08,2013-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66583 - Class II - Biologics - KDNA Life Sciences LLC,"Human tissue allograft, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, was distributed.",2013-11-05,2013-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73514 - Class III - Biologics - KED Plasma LLC,"Source Plasma, collected from an ineligible donor, was distributed.",2016-04-14,2016-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70393 - Class II - Biologics - KEDPlasma LLC,"Blood products, collected from a donor considered to be at increased risk for Creutzfeldt-Jacob Disease (CJD), were distributed.",2015-03-12,2015-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80908 - Class II - Biologics - KEDPlasma LLC,"Blood products, which were not quarantined after receiving post donation information concerning receipt of a tattoo, were distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80909 - Class II - Biologics - KEDPlasma LLC,"Blood products, which were not quarantined after receiving post donation information concerning receipt of a tattoo, were distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83139 - Class II - Biologics - KEDPlasma LLC,"Blood product, collected from a donor who received a piercing within 12 months of donation, was distributed.",2019-07-26,2019-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77816 - Class II - Biologics - KEDPLASMA LLC,"Plasma products, that were not quarantined for a donor suitability failure, were distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78108 - Class II - Biologics - KEDPlasma USA, LLC","Source Plasma, collected from a donor with unreported tattoos, was distributed.",2017-09-26,2017-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78497 - Class II - Biologics - KEDPlasma USA, LLC","Plasma products, which where not quarantined after receiving information that warranted donor deferral, were distributed.",2017-12-12,2017-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80882 - Class II - Biologics - KEDPlasma USA, LLC","Plasma products, collected from a donor who  received a tattoo within 12 months of donation, were distributed.",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76349 - Class II - Biologics - KEDPlasma, LLC","Plasma products, for which a failure to quarantine units due to medical history occured, were distributed.",2017-02-14,2017-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73268 - Class III - Biologics - Kedrion Melville Inc.,Misbranded Rho(D) Immune Globulin (Human) was distributed.,2016-02-11,2016-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68287 - Class II - Biologics - Kentucky Blood Center Inc,"Blood product, possibly contaminated with air during collection, was distributed.",2014-06-26,2014-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68927 - Class III - Biologics - Kentucky Blood Center Inc,"Blood products, in which CMV testing was performed with an expired reagent, were distributed, Blood products, in which CMV testing was performed with an expired reagent, were distributed.",2014-08-21,2014-08-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70910 - Class II - Biologics - Kentucky Blood Center Inc,"Blood product, collected on an instrument undergoing validation, and for which quality control testing was not performed, was distributed.",2015-05-06,2015-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70908 - Class III - Biologics - Kentucky Blood Center Inc,"Platelet product, for which unit labeling contained incorrect product information, was distributed.",2015-05-15,2015-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71532 - Class III - Biologics - Kentucky Blood Center Inc,"Blood products, which were labeled with an incorrect volume and incorrect platelet yield, were distributed.",2015-07-28,2015-07-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71969 - Class II - Biologics - Kentucky Blood Center Inc,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76418 - Class III - Biologics - Kentucky Blood Center Inc,"Blood product, manufactured without the entire quantity of additive solution, was distributed.",2017-03-27,2017-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77045 - Class II - Biologics - Kentucky Blood Center Inc,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-05-23,2017-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82131 - Class III - Biologics - Kentucky Blood Center Inc,"Red Blood Cells, not prepared according to product specifications, were distributed.",2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84052 - Class III - Biologics - Kentucky Blood Center Inc,"Misbranded plateletpheresis products were distributed.
",2019-11-04,2019-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84684 - Class III - Biologics - Kentucky Blood Center Inc,"Leukocyte reduced Red Blood Cells, manufactured with less additive solution than required, were distributed.",2020-01-28,2020-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88052 - Class II - Biologics - Kentucky Blood Center Inc,"Apheresis Red Blood Cell,  incorrectly labeled as irradiated, was distributed.",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90004 - Class II - Biologics - Kentucky Blood Center Inc,"Leukoreduced Red Blood Cell, collected from a donor who tested positive for the Cytomegalovirus (CMV) virus but were mislabeled as CMV antibody negative, was distributed.",2022-04-20,2022-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78773 - Class III - Drugs - Keryx Biopharmaceuticals, Inc.",Presence of Foreign Substance: Reports have been received of damaged StripPax packets containing silica gel desiccant potentially allowing the silica gel granules to make contact with Auryxia tablets in the bottle.,2017-12-26,2017-12-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86008 - Class II - Drugs - Keryx Biopharmaceuticals, Inc.",cGMP deviations: Lots recalled were not manufactured in conformance with the FDA-approved manufacturing process for Auryxia.,2020-07-15,2020-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76912 - Class II - Drugs - Key Pharmacy and Compounding Center,Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.,2017-05-17,2017-05-17,79,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73284 - Class II - Drugs - Keystone Laboratories Inc,"Microbial Contamination of a Non-Sterile Products: 
The product had a positive Staphylococcus aureus test result.
",2016-02-22,2016-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73895 - Class II - Drugs - Keystone Laboratories Inc,Microbial Contamination of Non-Sterile Products: Failed S.aureus test.,2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62418 - Class II - Drugs - Kimberly-Clark Corporation,"Microbial Contamination of Non-Sterile Products; The affected lots were found to be contaminated with bacterium, Burkholderia cepacia complex.",2012-07-12,2012-07-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87304 - Class II - Drugs - Kimberly-Clark Corporation,Labeling; Label Mix-up; some bottles containing Foam Skin Cleanser soap are incorrectly labeled as Moisturizing Foam Hand Sanitizer,2021-04-02,2021-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80601 - Class I - Drugs - King Bio Inc.,Microbial contamination,2019-03-08,2019-03-08,465,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65172 - Class II - Drugs - King Legacy, a wholly owned subsidiary of Pfizer",Subpotent Drug: The products were below specification for potency at the expiry stability point.,2013-05-20,2013-05-20,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78235 - Class II - Drugs - Kiriko, LLC.","Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared  sibutramine, phenolphthalein, and n-desmethyl sibutramine, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.",2017-11-01,2017-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63435 - Class III - Biologics - Knoxville Plasma Corporation,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63702 - Class II - Biologics - Knoxville Plasma Corporation,"Blood product, collected from a donor with a history of incarceration, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65636 - Class II - Biologics - Knoxville Plasma Corporation,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68052 - Class III - Drugs - Konsyl Pharmaceuticals Inc,Labeling: Label Error on Declared Strength; Listed active ingredient strength is inaccurate.,2014-05-13,2014-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66218 - Class II - Drugs - Kremers Urban Pharmaceuticals, Inc.",Failed Tablet/Capsule Specification: some capsules over time do not meet or are suspected to not meet the specification for acid resistance.,2013-11-20,2013-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71656 - Class II - Drugs - Kremers Urban Pharmaceuticals, Inc.","Failed Impurities/Degradation Specifications: failed specification for unknown impurity at the 24 month stability testing., Failed Impurities/Degradation Specifications: Two lots failed specification for unknown impurity at the 24 month stability testing.",2015-07-14,2015-07-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79748 - Class II - Drugs - Kroger Specialty Pharmacy, Inc.",Lack of Processing Controls.,2018-05-10,2018-05-10,67,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78553 - Class II - Drugs - KRS Global Biotechnology, Inc",Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.,2018-01-08,2018-01-08,47,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82509 - Class II - Drugs - KRS Global Biotechnology, Inc",Labeling: Label mix-up,2019-04-04,2019-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83789 - Class II - Drugs - KRS Global Biotechnology, Inc",Lack of Assurance of Sterility,2019-10-01,2019-10-01,80,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61960 - Class II - Drugs - Kutol Products Co Inc,"Labeling: Presence of Undeclared Additive: Medicated lotion soap produced and distributed by the recalling firm contains the unapproved ingredient, Red Dye #15.  This dye is not approved for use in food, drugs or cosmetics.",2012-06-18,2012-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67103 - Class II - Drugs - KVK-Tech, Inc.",Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.,2014-01-22,2014-01-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71726 - Class III - Drugs - KVK-Tech, Inc.",Failed Impurities/Degradation Specifications: out-of-specification results for individual unknown and total impurity at the 12th month room temperature stability test station,2015-08-25,2015-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74086 - Class III - Drugs - KVK-Tech, Inc.",Discoloration: presence of scuffing marks on tablets.,2016-06-28,2016-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77878 - Class III - Drugs - KVK-Tech, Inc.",Failed Impurities/Degradation Specifications: out-of-specification results obtained for individual unknown impurities found at 30 month Room Temperature Retained Sample stability test.,2017-08-11,2017-08-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81804 - Class II - Drugs - KVK-Tech, Inc.",Labeling: Wrong bar code,2018-12-19,2018-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83851 - Class III - Drugs - KVK-Tech, Inc.",Presence of Foreign Substance; Fiber particles.,2019-10-15,2019-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84184 - Class II - Drugs - KVK-Tech, Inc.",Presence of Foreign Substance: Black particles were found in the lots during retain sample inspection,2019-11-29,2019-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87020 - Class III - Drugs - KVK-Tech, Inc.",Failed Impurities/Degradation Specifications; out of specification results obtained for N-Oxide impurity during the 12-month long term stability testing for Batch# 15892A,2021-01-11,2021-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87810 - Class III - Drugs - KVK-Tech, Inc.",Failed Impurities/Degradation Specifications,2021-05-17,2021-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88220 - Class I - Drugs - KVK-Tech, Inc.",Temperature abuse: the firm received customer complaints of unusual grittiness in the product.,2021-08-26,2021-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63966 - Class II - Drugs - L. Perrigo Co.,"Presence of Foreign Substance(s); Perrigo has been notified of a recall by the manufacturer of this product, West-Ward Pharmaceuticals. This is a sub-recall due to tablets contaminated with trace amounts of food-grade lubricant, as well as stainless steel inclusions",2013-01-14,2013-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64388 - Class III - Drugs - L. Perrigo Co.,Subpotent; 12 month time point for the active ingredient Phenylephrine HCl.,2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64729 - Class III - Drugs - L. Perrigo Co.,"Failed Impurities/Degradation Specifications: 3 month stability testing.
",2013-05-09,2013-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66711 - Class II - Drugs - L. Perrigo Co.,Defective Delivery System: There is a remote potential that cartons of product could be co-packaged with an oral dosing syringe without dose markings.,2013-11-20,2013-11-20,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76061 - Class II - Drugs - L. Perrigo Company,Microbial Contamination of Non-Sterile Product; small number of tubes may include the presence of mold on the cap,2017-01-17,2017-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76443 - Class III - Drugs - L. Perrigo Company,Failed Impurities/Degradation Specifications: The API for these products had an out of specification result for an organic impurity.,2017-03-01,2017-03-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77397 - Class II - Drugs - L. Perrigo Company,Defective Container: Carton is missing the tablet blister strip  and tablet.,2017-06-06,2017-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77450 - Class III - Drugs - L. Perrigo Company,Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. The incorrect product sleeve is for Day-Night Cold and Flu whereas the batch contains Day-Night Cough Liquid.,2017-06-28,2017-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78520 - Class II - Drugs - L. Perrigo Company,Microbial Contamination of Non-Sterile Products,2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80041 - Class II - Drugs - L. Perrigo Company,Defective delivery system,2018-05-15,2018-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81473 - Class II - Drugs - L. Perrigo Company,Presence of foreign substance: Product found to contain metal particles.,2018-11-20,2018-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82857 - Class II - Drugs - La Fresh Group, Inc.",Marketed without an Approved NDA/ANDA: The product may be construed a sunscreen due to labeling of the product and comments about the product found on e-commerce websites.,2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80416 - Class II - Drugs - La Vita Compounding Pharmacy, LLC",Lack of Processing Controls: products produced in a manner that calls into question the sterility of the drug product intended to be sterile.,2018-07-13,2018-07-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86167 - Class II - Drugs - Laboratorios Jaloma S.A. de C.V.,cGMP deviations,2020-08-28,2020-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79640 - Class III - Drugs - Lake Erie Medical & Surgical Supply Inc,Labeling: Incorrect or Missing Lot and/or Exp Date,2018-04-11,2018-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63527 - Class II - Biologics - Lane Memorial Blood Bank,"Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63579 - Class II - Biologics - Lane Memorial Blood Bank,"Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2012-12-06,2012-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50673 - Class II - Biologics - Lane Memorial Blood Bank,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64094 - Class II - Biologics - Lane Memorial Blood Bank,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47321 - Class II - Biologics - Lane Memorial Blood Bank,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47150 - Class III - Biologics - Lane Memorial Blood Bank,"Blood product, collected from a donor with an elevated body temperature, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44013 - Class II - Biologics - Lane Memorial Blood Bank,"Blood products, collected from a donor who emigrated from an area considered at risk for human immunodeficiency virus (HIV) Group O, were distributed.",2013-03-26,2013-03-26,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46057 - Class II - Biologics - Lane Memorial Blood Bank,"Blood product, which were collected from a donor who traveled to a malarial endemic area, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67290 - Class II - Biologics - Lane Memorial Blood Bank,"Blood product, collected from a donor who was taking the medication Avodart, was distributed.",2014-02-20,2014-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69549 - Class II - Biologics - Lane Memorial Blood Bank,"Blood product, collected from an unsuitable donor, was distributed.",2014-11-13,2014-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71388 - Class II - Biologics - Lane Memorial Blood Bank,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71623 - Class II - Biologics - Lane Memorial Blood Bank,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71622 - Class II - Biologics - Lane Memorial Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-08-13,2015-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71791 - Class III - Biologics - Lane Memorial Blood Bank,"Blood product, collected from a donor whose arm inspection was not documented, was distributed.",2015-08-14,2015-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71744 - Class II - Biologics - Lane Memorial Blood Bank,"Blood product, which was labeled with an incorrect expiration date, was distributed.",2015-08-20,2015-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72841 - Class II - Biologics - Lane Memorial Blood Bank,"Blood product, which was collected from a donor who lived in a malarial endemic area, was distributed.",2016-01-07,2016-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91142 - Class III - Drugs - Lannett Company Inc.,Failed Impurity/Degradation Specifications,2023-01-16,2023-01-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82144 - Class III - Drugs - Lannett Company Inc.,Failed Dissolution Specifications,2019-03-12,2019-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89551 - Class II - Drugs - Lannett Company, Inc.",Failed Impurities/Degradation Specifications: Out of specification results for related substances.,2022-02-14,2022-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81225 - Class II - Drugs - Lannett Company, Inc.",CGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.,2018-10-19,2018-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84149 - Class II - Drugs - Lannett Company, Inc.",CGMP Deviations: Presence of NDMA impurity detected in product.,2019-11-10,2019-11-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84427 - Class I - Drugs - Lannett Company, Inc.",Microbial Contamination of Non-sterile Products: Out-of-specification results obtained for Total Aerobic Microbial Count.,2019-12-27,2019-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86130 - Class II - Drugs - Lannett Company, Inc.","Labeling: Label Mix Up: bottle labeled to contain  Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg",2020-08-17,2020-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77433 - Class III - Drugs - Lantheus MI Radipharmaceuticals Inc.,"Failed Impurities/Degradation 
Specifications; out of specification result for Acetonitrile residual solvent",2017-07-05,2017-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67196 - Class II - Biologics - Las Cruces Biologicals LLC,"Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90427 - Class I - Drugs - Latin Foods Market,Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and dexamethasone.,2022-07-21,2022-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79240 - Class III - Drugs - LEADIANT BIOSCIENCES, INC",Subpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.,2018-02-28,2018-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79849 - Class III - Drugs - LEADIANT BIOSCIENCES, INC",Subpotent drug: Out of specification for an active ingredient cysteamine hydrochloride.,2018-04-17,2018-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91643 - Class II - Drugs - Leadiant Biosciences, Inc.",Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.,2023-02-15,2023-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86525 - Class III - Drugs - Leadiant Biosciences, Inc.","Subpotent Drug: Product testing identified a decreased level of the active ingredient, Cysteamine HCl.",2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90853 - Class III - Drugs - Leading Pharma, LLC",Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules,2022-09-28,2022-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78471 - Class II - Drugs - Leading Pharma, LLC",Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam,2017-11-20,2017-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64180 - Class II - Drugs - Lee Pharmaceuticals, Inc",Microbial Contamination of a Non-Sterile Products: 12-Hour Sinus Nasal Spray under various labeling are being recalled due to microbial contamination identified during testing.,2013-02-11,2013-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82326 - Class II - Drugs - Legacy Pharmaceutical Packaging LLC,"CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected",2019-03-21,2019-03-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82490 - Class II - Drugs - Legacy Pharmaceutical Packaging LLC,"CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected.",2019-04-01,2019-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82710 - Class II - Drugs - Legacy Pharmaceutical Packaging LLC,CGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API),2019-05-01,2019-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64974 - Class II - Drugs - Legacy Pharmaceutical Packaging LLC,"Labeling: Label Error on Declared Strength-The recalled product has a misprint on the Amoldipine 10 mg label, 5 mg is listed in the USP description.  Tablet strength is 10 mg.",2013-05-16,2013-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64794 - Class III - Drugs - Legacy Pharmaceutical Packaging LLC,Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009,2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67526 - Class II - Drugs - Legacy Pharmaceutical Packaging LLC,Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.,2014-04-28,2014-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67978 - Class II - Drugs - Legacy Pharmaceutical Packaging LLC,Correct Labeled Product Miscart/Mispack: some cartons labeled as Pantoprazole Sodium Delayed-Release may contain correctly labeled blister cards of Lorazepam tablets,2014-06-10,2014-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76666 - Class II - Drugs - Legacy Pharmaceutical Packaging LLC,Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.,2017-03-21,2017-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86471 - Class III - Drugs - Legacy Pharmaceutical Packaging LLC,Presence of Foreign Tablets/Capsules: Metformin 1000mg with different imprint was found in bottles.,2020-09-30,2020-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86182 - Class II - Drugs - Leiper's Fork Distillery,Labeling Not Elsewhere Classified: Product labeled to contain methanol.,2020-09-03,2020-09-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75230 - Class II - Drugs - Leiter's Compounding,Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters,2016-10-12,2016-10-12,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82229 - Class II - Drugs - Leiter's Enterprises, Inc.",Incorrect Product Formulation; compounded sterile drug reconstituted using sterile water instead of sterile 0.9% Sodium Chloride.,2019-03-06,2019-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66103 - Class II - Drugs - Leiter's Pharmacy,"Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS results were reported to customers as passing.  Hence the sterility of these products cannot be assured. 
 
, Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS/failed results were reported to customers as passing.  Hence the sterility of the products cannot be assured., Lack of Assurance of Sterility: Leiter Pharmacy is recalling due bacterial contamination found after investigation at contract testing laboratory discovered that OOS/failed results were reported to customers as passing.  Hence the sterility of these products cannot be assured. 
 
",2013-09-13,2013-09-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76370 - Class III - Drugs - LEO PHARMA INC,Labeling: Incorrect or missing package insert:  the affected product was packaged with an out-of-date package insert (PI) dated February 2014.,2017-02-15,2017-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76467 - Class II - Drugs - LEO PHARMA INC,Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the brand product labeling not being incorporated into the Authorized Generic labeling.,2017-03-03,2017-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75791 - Class III - Drugs - Les Emballages Knowlton Inc.,Labeling: Label Mix Up- Incorrect back label applied to the product.,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74605 - Class II - Drugs - Let's Talk Health, Inc.",Marketed Without An Approved NDA/ANDA: product is an unapproved drug due to nasal decongestant claims as well as not complying with the nasal decongestant final monograph.,2016-07-29,2016-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84686 - Class II - Drugs - Letco Medical LLC,Subpotent,2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81606 - Class II - Drugs - LGM Pharma LLC,CGMP Deviations: Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.,2018-12-12,2018-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81790 - Class II - Drugs - LGM Pharma LLC,CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.,2019-02-11,2019-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71591 - Class II - Drugs - Liberty Drug & Surgical,Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.,2015-08-27,2015-08-27,25,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71733 - Class I - Drugs - Life and More LLC,"Marketed Without An Approved NDA/ANDA: Dietary supplements contains undeclared sibutramine, desmethylsibutramine and phenolphthalein based on FDA sampling.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71494 - Class II - Drugs - Life Science Pharmacy Inc,Penicillin Cross Contamination: potentially contaminated with penicillin,2015-12-02,2015-12-02,23,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39434 - Class II - Biologics - Life Sera, Inc.","Blood products, which tested negative for the human immunodeficiency virus (HIV) but were collected from a donor who previously tested positive for HIV, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67028 - Class II - Biologics - Life Technologies Corporation,"HLA typing assay, associated with false negative results, were distributed.",2014-02-11,2014-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67048 - Class II - Biologics - Life Technologies Corporation,"HLA typing assay, associated with false negative results, were distributed.",2014-02-11,2014-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67068 - Class II - Biologics - Life Technologies Corporation,"HLA typing assay, associated with false negative results, were distributed.",2014-02-11,2014-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67783 - Class II - Biologics - Life Technologies Corporation,"HLA typing assay, associated with false typing assignments, was distributed.",2014-04-25,2014-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68036 - Class II - Biologics - Life Technologies Corporation,"HLA typing assay, associated with false typing assignments, was distributed.",2014-04-25,2014-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69238 - Class III - Biologics - Life Technologies Corporation,"HLA typing assay, associated with false negative results, were distributed.",2014-10-29,2014-10-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65507 - Class III - Biologics - Life Technologies Holdings Pte Ltd,"Injection solvent for use with genetic analyzers, stored in warehouse at improper temperatures, was distributed.",2013-07-03,2013-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61526 - Class II - Biologics - Life Technologies, Inc.","HLA typing assay, associated with false negative results, were distributed.",2012-08-03,2012-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62468 - Class II - Biologics - Life Technologies, Inc.","HLA typing assay, associated with false negative results, was distributed.",2012-08-03,2012-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85607 - Class II - Biologics - LifeCell Corporation,"Human bone allografts associated with a failure to prevent distribution of allografts that do not meet release criteria designed to prevent communicable disease transmission, were distributed.",2020-05-14,2020-05-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88080 - Class II - Biologics - LifeLink Foundation, Inc. dba Lifelink Tissue Bank","Bone, with incomplete processing control testing, was distributed.",2021-06-28,2021-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62610 - Class II - Biologics - LifeNet Health,"Human tissue allografts, recovered from a donor with a medical history that indicated risk factors for communicable disease agents and diseases, were distributed.",2012-11-15,2012-11-15,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63427 - Class II - Biologics - LifeNet Health,"Cardiac Tissue Allograft, processed in a manner that did not prevent the introduction, transmission, or spread of communicable disease, was distributed.",2012-11-15,2012-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65437 - Class II - Biologics - LifeNet Health,"Cardiac pulmonary patch, recovered from a donor and not tested using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, was distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65453 - Class III - Biologics - Lifepoint, Inc.","Corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-06-13,2013-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62011 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-06-28,2012-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62726 - Class III - Biologics - LifeServe Blood Center,"Blood products, collected from a donor's arm that was documented as unacceptable, were distributed.",2012-09-07,2012-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63170 - Class III - Biologics - LifeServe Blood Center,"Blood products, which were collected in a manner that may have compromised the sterility of the collection system, were distributed.",2012-10-10,2012-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42448 - Class III - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who disclosed taking Dapsone, were distributed.",2012-11-01,2012-11-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63462 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63194 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63636 - Class II - Biologics - LifeServe Blood Center,"Blood product, which tested negative for viral markers, but was collected from a donor that subsequently reported a previous history of positive test hepatitis, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39579 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-12-07,2012-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39636 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41296 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39637 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-12-27,2012-12-27,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47102 - Class III - Biologics - LifeServe Blood Center,"Blood product, exposed to unacceptable shipping temperatures, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47295 - Class III - Biologics - LifeServe Blood Center,"Blood products, for which the quality control testing was incomplete, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47978 - Class II - Biologics - LifeServe Blood Center,"Blood component, processed from Whole Blood stored at room temperature for more than 8 hours after collection, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40148 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39583 - Class II - Biologics - LifeServe Blood Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40989 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who was in close contact with an individual diagnosed with viral hepatitis, were distributed.",2013-01-04,2013-01-04,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41155 - Class III - Biologics - LifeServe Blood Center,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43004 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44371 - Class II - Biologics - LifeServe Blood Center,"Blood product, positive for the E-antigen but labeled as E-antigen negative, was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45357 - Class II - Biologics - LifeServe Blood Center,"Blood product, positive for the c-antigen but labeled as c-antigen negative, was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43835 - Class II - Biologics - LifeServe Blood Center,"Blood product, positive for the JKb-antigen but labeled as JKb-antigen negative, was distributed.",2013-01-08,2013-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45105 - Class II - Biologics - LifeServe Blood Center,"Blood products, for which the required quality control testing was not performed, were distributed.",2013-01-08,2013-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49202 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was labeled as leukoreduced, but was not tested to verify the White Blood Cell count, was distributed.",2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63920 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50562 - Class III - Biologics - LifeServe Blood Center,"Blood products, which were labeled with an incorrect expiration date, were distributed..",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50720 - Class III - Biologics - LifeServe Blood Center,"Blood products, collected from a donor taking the medication Enbrel, were distributed.",2013-01-28,2013-01-28,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47116 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39520 - Class III - Biologics - LifeServe Blood Center,"Blood product, which failed to meet the minimum specification for 85% red blood cell recovery, was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39521 - Class III - Biologics - LifeServe Blood Center,"Blood product, which failed to meet the minimum specification for 85% red blood cell recovery, was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41163 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-01-30,2013-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47114 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-01-30,2013-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45103 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected in a manner that may have compromised the sterility of the units, were distributed.

",2013-02-06,2013-02-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48852 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-02-06,2013-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49167 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed",2013-02-06,2013-02-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42667 - Class III - Biologics - LifeServe Blood Center,"Blood products, collected from a donor with a history of surgery within the previous 12 months, were distributed.",2013-02-08,2013-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44645 - Class III - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who had previously tested reactive for hepatitis, were distributed.",2013-02-08,2013-02-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47612 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor possibly at increased risk for Creutzfeldt-Jakob Disease (CJD), was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48309 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48851 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor taking the drug Finasteride, were distributed.",2013-02-12,2013-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48853 - Class II - Biologics - LifeServe Blood Center,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2013-02-13,2013-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44611 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor who was considered at risk for human immunodeficiency virus (HIV) Group O, was distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64252 - Class III - Biologics - LifeServe Blood Center,"Blood products, which was collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64277 - Class III - Biologics - LifeServe Blood Center,"Blood product, collected from a donor with no documentation on the donor record of an arm inspection or general appearance, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64278 - Class III - Biologics - LifeServe Blood Center,"Blood product, collected from a donor with no documentation on the donor record of an arm inspection or general appearance, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50723 - Class III - Biologics - LifeServe Blood Center,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64517 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was  distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64518 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64779 - Class III - Biologics - LifeServe Blood Center,"Blood product, which was not quarantined subsequent to receiving post donation medical information, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65001 - Class II - Biologics - LifeServe Blood Center,"Blood product, which did not meet the acceptable product specifications for release, was distributed",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65144 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65198 - Class II - Biologics - LifeServe Blood Center,"Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66245 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66848 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor with a history of Hepatitis A, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66802 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66847 - Class II - Biologics - LifeServe Blood Center,"Blood products,collected from donors who did not meet the re-entry criteria following invalid NAT testing, were distributed.",2014-01-08,2014-01-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66997 - Class II - Biologics - LifeServe Blood Center,"Blood products, tested using a pH meter that had not been calibrated, were distributed.",2014-01-10,2014-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67190 - Class II - Biologics - LifeServe Blood Center,"Blood products, which may not have met the criteria for leukoreduced products because the WBC count was performed incorrectly, were distributed.",2014-02-05,2014-02-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67409 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67906 - Class III - Biologics - LifeServe Blood Center,"Blood product, collected from a donor whose arm inspection was not documented, was distributed.",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67888 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-05-06,2014-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67826 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-05-07,2014-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68869 - Class II - Biologics - LifeServe Blood Center,"Blood product for which some quality control procedures were not performed, was distributed.",2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69697 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2014-12-01,2014-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69755 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69754 - Class III - Biologics - LifeServe Blood Center,"Platelets, with lack of assurance of proper storage temperatures, were distributed.",2014-12-17,2014-12-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68063 - Class II - Biologics - LifeServe Blood Center,"Blood products, which were labeled as leukoreduced, but were tested incorrectly for residual White Blood Cell count, were distributed.",2014-12-18,2014-12-18,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70162 - Class II - Biologics - LifeServe Blood Center,"Blood product, collected from a donor considered to be at risk for variant Creutzfeldt-Jacob Disease (vCJD), were distributed.",2015-01-23,2015-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70205 - Class II - Biologics - LifeServe Blood Center,"Blood product, positive for the K-antigen but labeled as K-antigen negative, was distributed.",2015-02-11,2015-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70468 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70417 - Class III - Biologics - LifeServe Blood Center,"Blood product, in which quality control and distribution/distribution of product did not meet specifications, was distributed.",2015-02-25,2015-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70531 - Class II - Biologics - LifeServe Blood Center,"Blood products, possibly contaminated with air, were distributed.",2015-03-24,2015-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71465 - Class II - Biologics - LifeServe Blood Center,"Blood products, in which donor testing was not performed or  performed incorrectly, were distributed.",2015-07-21,2015-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71580 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was tested for residual White Blood Cells using a sample that exceeded acceptable time limits, was distributed.",2015-08-07,2015-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73839 - Class II - Biologics - LifeServe Blood Center,"Apheresis Platelets, lacking proper quality control testing, were distributed.",2016-04-14,2016-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73926 - Class III - Biologics - LifeServe Blood Center,"Blood product, which did not meet acceptable product specifications, was distributed.",2016-06-02,2016-06-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74267 - Class III - Biologics - LifeServe Blood Center,"Platelet, labeled with an incorrect volume, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75059 - Class III - Biologics - LifeServe Blood Center,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75400 - Class II - Biologics - LifeServe Blood Center,"In this situation, quality control and distribution of product did not meet specifications, was distributed.",2016-10-26,2016-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75659 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2016-12-16,2016-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75961 - Class II - Biologics - LifeServe Blood Center,"RBC unit, incorrectly labeled as irradiated, was distributed.",2017-01-09,2017-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76630 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was not quarantined after receiving post donation information concerning an illness following donation, was distributed.",2017-03-15,2017-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76722 - Class III - Biologics - LifeServe Blood Center,"Red blood cells, for which quality control testing did not meet specifications, were distributed.",2017-03-29,2017-03-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76734 - Class II - Biologics - LifeServe Blood Center,"Blood products, for which donor screening was performed incorrectly, were distributed.",2017-03-29,2017-03-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78336 - Class III - Biologics - LifeServe Blood Center,"Pooled Platelet products, not manufactured according to specifications, were distributed.",2017-11-29,2017-11-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78347 - Class III - Biologics - LifeServe Blood Center,"Blood product, collected from a donor whose suitability was not adequately determined, was distributed.",2017-12-04,2017-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78875 - Class II - Biologics - LifeServe Blood Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2018-02-07,2018-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79027 - Class II - Biologics - LifeServe Blood Center,"Apheresis product, in which quality control for residual WBC count was not performed, was distributed.
",2018-02-07,2018-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79120 - Class II - Biologics - LifeServe Blood Center,"Blood products collected from a donor in which the donor screening was performed incorrectly, were distributed.",2018-02-22,2018-02-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79391 - Class II - Biologics - LifeServe Blood Center,"Platelet products, with a failure to meet product specifications, were distributed., Mislabeled platelet products were distributed.",2018-03-16,2018-03-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79370 - Class II - Biologics - LifeServe Blood Center,-,2018-04-09,2018-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79742 - Class II - Biologics - LifeServe Blood Center,"Blood products, labeled as leukoreduced did not receive leukoreduced quality control testing, were distributed.",2018-05-17,2018-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80225 - Class II - Biologics - LifeServe Blood Center,"Platelet product, for which donor screening was incorrectly performed, was distributed.",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80592 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-08-24,2018-08-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80936 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-10-12,2018-10-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81258 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected form an ineligible donor, were distributed.",2018-10-22,2018-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81140 - Class II - Biologics - LifeServe Blood Center,"Apheresis products, in which residual WBC count were not performed, were distributed.
",2018-10-24,2018-10-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81541 - Class II - Biologics - LifeServe Blood Center,"Apheresis products, in which donor suitability was not adequately determined, were distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81993 - Class II - Biologics - LifeServe Blood Center,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2019-02-20,2019-02-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83952 - Class II - Biologics - LifeServe Blood Center,"Plateletpheresis products, collected from a donor who received a tattoo within 12 months of donating, were distributed.
",2019-10-10,2019-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84131 - Class II - Biologics - LifeServe Blood Center,"Blood product, which was not quarantined subsequent to receiving post donation illness information, was distributed.",2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84395 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-12-12,2019-12-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84555 - Class II - Biologics - LifeServe Blood Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2020-01-15,2020-01-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84683 - Class III - Biologics - LifeServe Blood Center,"Apheresis Red Blood Cell product for which quality control procedures were not performed, was distributed.
",2020-01-21,2020-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86329 - Class II - Biologics - LifeServe Blood Center,"Platelepheresis unit, not manufactured according to product specifications, was distributed.",2020-08-26,2020-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86468 - Class II - Biologics - LifeServe Blood Center,"Pooled platelet product, not meeting product specifications, was distributed.",2020-09-22,2020-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86908 - Class II - Biologics - LifeServe Blood Center,"Blood products, which were exposed to unacceptable storage/shipping conditions, were distributed.",2020-12-03,2020-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88284 - Class III - Biologics - LifeServe Blood Center,"Leukoreduced Red Blood Cell, which did not meet Red Blood Cell recovery requirements, was distributed.",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88507 - Class II - Biologics - LifeServe Blood Center,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-08-27,2021-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88508 - Class II - Biologics - LifeServe Blood Center,"Blood products, for which donor eligibility was incomplete, were distributed.
",2021-09-16,2021-09-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88790 - Class II - Biologics - LifeServe Blood Center,"Leukoreduced, Irradiated Apheresis Platelets, for which documentation of irradiation was incomplete, were distributed.",2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89189 - Class II - Biologics - LifeServe Blood Center,"Blood products, in which West Nile Virus testing was performed incorrectly, were distributed.",2021-12-14,2021-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89828 - Class III - Biologics - LifeServe Blood Center,"Blood Products, collected from a donor who did not understand English, were distributed.",2022-03-30,2022-03-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91056 - Class II - Biologics - LifeServe Blood Center,"Leukoreduced Apheresis Platelets, Irradiated, which did not have documentation of being irradiated, were distributed.",2022-11-16,2022-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91472 - Class II - Biologics - LifeServe Blood Center,"Blood products, for which donor eligibility was incomplete, were distributed.
",2023-01-12,2023-01-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91476 - Class II - Biologics - LifeServe Blood Center,"Blood products, for which donor eligibility was incomplete, were distributed.
",2023-01-12,2023-01-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62428 - Class II - Biologics - LifeShare Blood Centers,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62585 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who received a tattoo within 12 months of donating, was distributed.",2012-08-31,2012-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62811 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a therapeutic donor and not labeled to indicate the type of donation, were distributed.",2012-09-19,2012-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62812 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a therapeutic donor and not labeled to indicate the type of donation, was distributed",2012-09-19,2012-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62952 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-09-20,2012-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62959 - Class III - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-10-01,2012-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #56901 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63414 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63415 - Class III - Biologics - LifeShare Blood Centers,"Blood product, which reached an unacceptable temperature during storage, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63416 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-11-14,2012-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63417 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who emigrated from an area considered endemic for malaria, was distributed.",2012-11-19,2012-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63689 - Class III - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor for whom there was no documentation on the donor record of an arm inspection, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63688 - Class III - Biologics - LifeShare Blood Centers,"Blood product, which was collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62974 - Class III - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor whose donor records failed answers to follow-up questions regarding vaccinations, was distributed",2013-01-10,2013-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64031 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2013-02-12,2013-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64240 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64379 - Class II - Biologics - LifeShare Blood Centers,"Blood products, labeled with an incorrect expiration dates, were distributed.",2013-03-21,2013-03-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64565 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64742 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who visited a malarial endemic region, was distributed.",2013-05-07,2013-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65011 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who had recently visited a malarial endemic region, were distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65012 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who had recently visited a malarial endemic region, was distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65455 - Class II - Biologics - LifeShare Blood Centers,"Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2013-07-22,2013-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65454 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from an ineligible donor, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65625 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-08-09,2013-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66182 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who visited a malarial endemic area, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67221 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67731 - Class III - Biologics - LifeShare Blood Centers,"Blood product, which did not meet the minimum requirement for Red Blood Cell recovery, was distributed.",2014-04-16,2014-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67707 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67887 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-05-06,2014-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68187 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-05-20,2014-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68188 - Class II - Biologics - LifeShare Blood Centers,"Blood product, for which documentation of the donor history was incomplete, was distributed., Blood product, for which the documentation of the donor history was incomplete, was distributed.",2014-05-20,2014-05-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68180 - Class II - Biologics - LifeShare Blood Centers,"Blood product, in which Quality Control Distribution/Distribution of product did not meet specifications, was distributed.",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68796 - Class III - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who had unsuitable test results, was distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68797 - Class II - Biologics - LifeShare Blood Centers,"Blood products, which was collected from a donor who traveled to a malarial endemic area, were distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68855 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor considered to be at risk for variant Creutzfeldt- Jakob Disease (vCJD), was distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68856 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected using automated equipment that lacked validation, were distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69077 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.",2014-09-10,2014-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69526 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69527 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69698 - Class II - Biologics - LifeShare Blood Centers,"Blood products, which were not quarantined after the donor provided information concerning medical history, were distributed.",2014-12-11,2014-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71001 - Class III - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2015-05-13,2015-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71769 - Class II - Biologics - LifeShare Blood Centers,"Blood product, in which donor gave history which warranted deferral or follow up and was not deferred or follow up questions was not asked, was distributed.",2015-08-20,2015-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71798 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from an ineligible donor, were distributed.",2015-08-25,2015-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71796 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-08-27,2015-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71797 - Class III - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who was at risk for leishmaniasis, was distributed.",2015-08-27,2015-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72281 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-10-13,2015-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72184 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2015-10-19,2015-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72608 - Class II - Biologics - LifeShare Blood Centers,"Plateletpheresis product, which monthly product QC test for pH was not performed, was distributed.",2015-12-04,2015-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72609 - Class II - Biologics - LifeShare Blood Centers,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-12-07,2015-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72675 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73903 - Class II - Biologics - LifeShare Blood Centers,Blood Product collected from a donor who traveled to a malarial endemic area was distributed.,2016-04-26,2016-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74076 - Class II - Biologics - LifeShare Blood Centers,"Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.",2016-06-13,2016-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74150 - Class II - Biologics - LifeShare Blood Centers,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2016-06-13,2016-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74075 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75058 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75060 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who gave a history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75319 - Class II - Biologics - LifeShare Blood Centers,"Red blood cell, for which donor suitability was inadequately determined, was distributed.",2016-10-26,2016-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75724 - Class III - Biologics - LifeShare Blood Centers,"Blood Product, collected from a donor who disclosed receiving a vaccine within eight weeks of donating, was distributed.",2016-12-16,2016-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75725 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-12-16,2016-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76390 - Class III - Biologics - LifeShare Blood Centers,"Apheresis red cells, not meeting product specifications, were distributed.",2017-02-07,2017-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76720 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2017-03-21,2017-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77446 - Class II - Biologics - LifeShare Blood Centers,"Blood product collected from donors who lived in malarial endemic areas, was distributed.",2017-06-14,2017-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77851 - Class III - Biologics - LifeShare Blood Centers,"Blood product, mislabeled as crossmatch compatible, was distributed.",2017-08-29,2017-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77968 - Class III - Biologics - LifeShare Blood Centers,"Platelet products, stored at an unacceptable temperature, were distributed.",2017-09-12,2017-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78128 - Class III - Biologics - LifeShare Blood Centers,Misbranded red blood cell product was distributed.,2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78770 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2018-01-19,2018-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79249 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2018-03-05,2018-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79392 - Class II - Biologics - LifeShare Blood Centers,"Blood products collected from a donor who traveled to a malarial endemic area, were distributed.
",2018-03-07,2018-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79234 - Class II - Biologics - LifeShare Blood Centers,"Platelet, with an unacceptable pH, was distributed.",2018-03-15,2018-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79233 - Class III - Biologics - LifeShare Blood Centers,"Blood products, collected from ineligible donors, were distributed.",2018-03-22,2018-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79359 - Class III - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-04-12,2018-04-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79431 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed.",2018-04-20,2018-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79744 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80124 - Class II - Biologics - LifeShare Blood Centers,"Blood product, which was not quarantined subsequent to receiving information regarding a post donation illness, was distributed.",2018-06-13,2018-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80215 - Class III - Biologics - LifeShare Blood Centers,"Blood product, collected from a donor who was taking antibiotics, was distributed.",2018-06-27,2018-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80898 - Class III - Biologics - LifeShare Blood Centers,"Blood products, labeled with an incorrect expiration date, were distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80899 - Class II - Biologics - LifeShare Blood Centers,"Blood product, mislabeled as to CMV testing, was distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80900 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from an ineligible donor, were distributed.",2018-10-05,2018-10-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80901 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from an ineligible donor, were distributed.",2018-10-05,2018-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82154 - Class II - Biologics - LifeShare Blood Centers,"Blood product, collected from an ineligible donor, was distributed.",2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82148 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who reported testing positive for Hepatitis, were distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82156 - Class III - Biologics - LifeShare Blood Centers,"Misbranded red blood cells product was distributed.
",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82849 - Class II - Biologics - LifeShare Blood Centers,"Blood products, which did not meet acceptable product specifications, were distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82806 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2019-06-28,2019-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83044 - Class II - Biologics - LifeShare Blood Centers,"Blood product, which did not meet acceptable product specifications, was distributed.",2019-07-17,2019-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83263 - Class II - Biologics - LifeShare Blood Centers,"Blood products, which did not meet acceptable product specifications for release, were distributed.",2019-08-05,2019-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83531 - Class III - Biologics - LifeShare Blood Centers,"Red Blood Cell product in which Donor Screening/Donor record was incomplete, was distributed.",2019-09-06,2019-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83941 - Class II - Biologics - LifeShare Blood Centers,"Blood products, collected from an ineligible donor, were distributed.",2019-11-15,2019-11-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84087 - Class III - Biologics - LifeShare Blood Centers,"Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84416 - Class III - Biologics - LifeShare Blood Centers,"Plateletpheresis products, not meeting product specifications, were distributed.
",2019-12-17,2019-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87598 - Class II - Biologics - LifeShare Blood Centers,"Plateletphresis products, for which quality control for pH testing was not performed, was distributed.
",2021-04-14,2021-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89221 - Class II - Biologics - LifeShare Blood Centers,"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which was labeled with the incorrect platelet yield, were distributed.",2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89223 - Class II - Biologics - LifeShare Blood Centers,"Red Blood Cell product, collected from a donor for whom donor suitability was incomplete, was distributed. 
",2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89226 - Class II - Biologics - LifeShare Blood Centers,"Apheresis Platelets, Leukoreduced and Irradiated, not tested for pH, were distributed.",2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90033 - Class III - Biologics - LifeShare Blood Centers,"Leukoreduced Red Blood Cells, with a positive initial screen for Syphilis and a negative confirmation test, were distributed.",2022-05-09,2022-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91404 - Class II - Biologics - LifeShare Blood Centers,"Red Blood Cells products, which tested reactive for syphilis, were distributed.
",2023-01-04,2023-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55585 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61965 - Class II - Biologics - LifeShare Community Blood Services,"Blood product, collected from a donor with unacceptably low hemoglobin, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63984 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed",2013-01-30,2013-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64829 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, which were collected from a donor who had traveled to an area considered endemic for malaria, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65389 - Class III - Biologics - LifeShare Community Blood Services,"Blood products, collected in an expired triple transfer pack, were distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41755 - Class III - Biologics - LifeShare Community Blood Services,"Blood products, which were not manufactured in accordance with required specifications, were distributed.",2013-07-12,2013-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65977 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67830 - Class III - Biologics - LifeShare Community Blood Services,"Blood products, in which quality control testing was performed, interpreted, or documented incorrectly,  were distributed.",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38779 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, in which quality control and distribution of products  did not meet specifications, were distributed.",2014-09-09,2014-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69329 - Class III - Biologics - LifeShare Community Blood Services,"Blood product, labeled with incorrect expiration date, was distributed.",2014-10-16,2014-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73522 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, collected from an ineligible donor, were distributed.",2016-04-22,2016-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76192 - Class III - Biologics - LifeShare Community Blood Services,"Blood product, for which the quality control testing was incomplete, was distributed.",2017-02-21,2017-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76710 - Class II - Biologics - LifeShare Community Blood Services,"Platelet products, for which quality control testing for pH was not documented, were distributed",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76876 - Class II - Biologics - LifeShare Community Blood Services,"Apheresis product, in which quality control for WBC count was not performed within 48 hour of collection, was distributed.
",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76879 - Class II - Biologics - LifeShare Community Blood Services,"Apheresis products, with unacceptably high platelet concentrations, were distributed.",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79726 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80130 - Class III - Biologics - LifeShare Community Blood Services,"Apheresis product, not meeting product specifications, was distributed.
",2018-06-01,2018-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83184 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83391 - Class III - Biologics - LifeShare Community Blood Services,"Irradiated Apheresis Red Blood Cell product, which was labeled with an incorrect expiration date, was distributed.
",2019-08-13,2019-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83862 - Class II - Biologics - LifeShare Community Blood Services,"Blood products, which may have been stored in unacceptable temperatures, were distributed.",2019-10-29,2019-10-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76667 - Class II - Biologics - Lifeshare Of The Carolinas,"Human Sclera, mislabeled with an extended expiration date, was distributed.",2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90065 - Class II - Biologics - Lifeshare Of The Carolinas,"Corneas, recovered from a donor in which donor suitability was not adequately determined, were distributed.",2022-04-28,2022-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61971 - Class II - Biologics - LifeSource,"Blood products, labeled leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62546 - Class II - Biologics - LifeSource,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-08-24,2012-08-24,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64237 - Class II - Biologics - LifeSource,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64746 - Class II - Biologics - LifeSource,"Blood product, collected from a donor who was previously deferred, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65611 - Class II - Biologics - LifeSource,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65976 - Class II - Biologics - LifeSource,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-09-09,2013-09-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67732 - Class II - Biologics - LifeSource,"Blood products, which were incorrectly stored in a single storage bag, were distributed.",2014-04-16,2014-04-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68275 - Class III - Biologics - LifeSource,"Blood product, collected from a donor with polycythemia vera, was distributed.",2014-06-26,2014-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64616 - Class II - Biologics - LifeSource,"Blood products, collected from unsuitable donors, were distributed.",2014-10-03,2014-10-03,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70781 - Class II - Biologics - LifeSource,"Blood products, collected from unsuitable donors, were distributed.",2015-04-02,2015-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70652 - Class II - Biologics - LifeSource,"Blood products, which lacked assurance of proper storage temperatures, were distributed.",2015-04-16,2015-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70768 - Class II - Biologics - LifeSource,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-04-24,2015-04-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71929 - Class II - Biologics - LifeSource,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-09-10,2015-09-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73721 - Class III - Biologics - LifeSource,"Blood products,  in which labeling/labels applied to blood unit or product incorrect or missing information, were distributed.",2016-04-28,2016-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75139 - Class II - Biologics - LifeSource,"Blood products, for which the sterility may have been compromised, were distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75378 - Class III - Biologics - LifeSource,"Blood products, collected using recalled blood collection bags, were distributed.",2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76834 - Class II - Biologics - LifeSource,"Blood products, for which quality control testing was not performed, were distributed.",2017-04-21,2017-04-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77236 - Class II - Biologics - LifeSource,"Blood products, which were not quarantined for a donor eligibility screening deviation, were distributed.",2017-05-25,2017-05-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77724 - Class II - Biologics - LifeSource,"Blood product, labeled with an incorrect expiration date, was distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78083 - Class III - Biologics - LifeSource,"Blood product, collected from an ineligible donor,  was distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81369 - Class II - Biologics - LifeSource,"Blood products, collected from a donor who traveled and lived in a malarial endemic area, were distributed.
",2018-10-30,2018-10-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82548 - Class II - Biologics - LifeSource,"Blood products, which did not meet the acceptable product specifications, were distributed.",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83530 - Class II - Biologics - LifeSource,"Plateletpheresis product in which quality control for residual WBC count was not performed, was distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85132 - Class II - Biologics - LifeSource,"Blood products, collected from a donor who emigrated from an area considered endemic for malaria, were distributed.",2020-04-08,2020-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85616 - Class II - Biologics - LifeSource,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85656 - Class III - Biologics - LifeSource,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87112 - Class III - Biologics - LifeSource,"Red Blood Cell product, for which a visual inspection was not performed or documented, was distributed.
",2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87754 - Class II - Biologics - LifeSource,"Blood product, which did not meet the acceptable product specifications, was distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88517 - Class II - Biologics - LifeSource,"Leukoreduced Red Blood Cells, collected from a donor who had recently traveled to a malaria endemic area, were distributed.",2021-09-02,2021-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89004 - Class III - Biologics - LifeSource,"Red Blood Cell products, for which irradiation was not performed in accordance with specifications, were distributed.",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90264 - Class II - Biologics - LifeSource,"Plateletpheresis products, with a high platelet yield, were distributed.
",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90420 - Class II - Biologics - LifeSource,"Plateletpheresis products, with a low platelet count, were distributed.
",2022-09-26,2022-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91434 - Class II - Biologics - LifeSource,"Blood product, for which donor eligibility was incomplete, was distributed.
",2023-01-09,2023-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91435 - Class II - Biologics - LifeSource,"Blood product, for which donor eligibility was incomplete, was distributed.
",2023-01-09,2023-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91509 - Class II - Biologics - LifeSource,"Blood products, where transfusion-transmitted infection testing was performed and/or interpreted incorrectly, were distributed.",2023-01-20,2023-01-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91679 - Class III - Biologics - LifeSource,"Leukoreduced Red Blood Cells Washed, Irradiated, with the incorrect expiration time on the label, were distributed.",2023-02-16,2023-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87597 - Class II - Biologics - LifeSource d.b.a Vitalant,"Leukoreduced Apheresis Platelets, collected using apheresis kits that had exceeded the acceptable time period for use, were distributed.",2021-04-14,2021-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72130 - Class II - Biologics - LifeSource dba Central Blood Bank,"Platelet products, which were labeled as leukoreduced, but did not meet leukoreduction criteria, were distributed.",2015-10-07,2015-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73722 - Class III - Biologics - LifeSource dba Central Blood Bank,"Blood products, in which labeling/labels applied to blood units or products incorrect or missing information, were distributed.",2016-04-28,2016-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75379 - Class II - Biologics - LifeSource dba Central Blood Bank,"Blood product, which did not meet the acceptable product specifications, was distributed.",2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76919 - Class III - Biologics - LifeSource dba Central Blood Bank,"Blood products, lacking assurance regarding bacterial contamination risk, were distributed.",2017-05-15,2017-05-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78194 - Class II - Biologics - LifeSource dba Central Blood Bank,"In this situation, donor gave history which warranted deferral or follow up and was not deferred or follow up questions was not asked, was distributed.",2017-10-16,2017-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79598 - Class II - Biologics - LifeSource dba Central Blood Bank,"Platelet products that  did not meet specification, were distributed.",2018-04-04,2018-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79795 - Class III - Biologics - LifeSource dba Central Blood Bank,"Blood products, labeling/crossmatch tag incorrect or missing information were distributed.",2018-04-18,2018-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80082 - Class II - Biologics - LifeSource dba Central Blood Bank,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2018-05-30,2018-05-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81291 - Class II - Biologics - LifeSource dba Central Blood Bank,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-11-08,2018-11-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81686 - Class III - Biologics - LifeSource dba Central Blood Bank,"Apheresis products, which were incorrectly tested for CMV were distributed.",2018-12-20,2018-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82096 - Class II - Biologics - LifeSource dba Central Blood Bank,"Blood product in which routine testing/testing performed, interpreted, documented, or labeled incorrectly, was distributed.
",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83718 - Class II - Biologics - LifeSource dba Central Blood Bank,"Plateletpheresis product, in which platelet yield did not meet specifications, was distributed.
",2019-09-13,2019-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85087 - Class III - Biologics - LifeSource dba Central Blood Bank - Parkway Center,"Red Blood Cell product, not meeting product specifications, was distributed.
",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84935 - Class II - Biologics - LifeSource dba Central Blood Bank - Parkway Center,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2020-03-24,2020-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86094 - Class III - Biologics - LifeSource dba Central Blood Bank - Parkway Center,"Leukoreduced Red Blood Cells, which did not meet the minimum requirement for Red Blood Cell recovery following leukoreduction, were distributed.",2020-08-20,2020-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87927 - Class II - Biologics - LifeSource dba Central Blood Bank - Parkway Center,"Plateletpheresis products, not meeting product specifications, were distributed.
",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49268 - Class II - Biologics - LifeSouth Community Blood Center, Inc","Blood product, which did not meet acceptable product specifications, was distributed",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49806 - Class II - Biologics - LifeSouth Community Blood Centers,"Blood product, with a low platelet count, was distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64769 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, which did not meet required specifications, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65143 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, with platelet counts below the specified minimum requirement, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65385 - Class III - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, labeled with an extended expiration date, was distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65714 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, with platelet counts below the specified minimum requirement, were distributed.",2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65715 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, with platelet counts below the specified minimum requirement, were distributed.",2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65716 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66768 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, with a low platelet count, were distributed.",2013-12-05,2013-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67695 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low pH, was distributed.",2014-04-09,2014-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68322 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, for which the monthly product quality control was outside the acceptable range, were distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69349 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, associated with a unit of platelets with an unacceptable pH, was distributed",2014-11-12,2014-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69362 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, associated with a unit of platelets with an unacceptable pH, were distributed.",2014-11-12,2014-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69490 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low platelet count, was distributed.",2014-11-17,2014-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69731 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with an unacceptable pH, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69935 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, in which Quality Control and Distribution of product did not meet specifications, were distributed.",2015-01-05,2015-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70252 - Class III - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, collected from a donor who was previously deferred for testing reactive for anti-HCV, was distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70328 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product, which failed acceptability testing for platelet count, was distributed.",2015-02-05,2015-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70325 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low platelet count, was distributed.",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70378 - Class III - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, in which labeling/labels applied to blood unit or product was incorrect or missing information.",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70885 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, in which Quality Control and Distribution of product did not meet specifications, were distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71767 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, which did not meet the criteria for leukoreduced products, were distributed.",2015-08-27,2015-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71960 - Class III - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, labeled with an incorrect volume, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72218 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low platelet yield, was distributed.
",2015-10-13,2015-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73050 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low pH, was distributed.",2016-02-04,2016-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74006 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product, not meeting firm specifications, were distributed.",2016-05-05,2016-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74495 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product, for which the quality control testing for pH did not meet specifications, was distributed.",2016-07-28,2016-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75023 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product, for which the quality control testing for pH did not meet specifications, was distributed.",2016-09-01,2016-09-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74956 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, with unacceptable pH levels, were distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75432 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis products, for which the quality control testing for pH did not meet specifications, were distributed.",2016-10-13,2016-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75340 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75316 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet product, that did not meet acceptable product specifications, was distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75868 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet component, for which product QC was unacceptable, was distributed.",2016-12-20,2016-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76005 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2017-01-04,2017-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76216 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76218 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76220 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76221 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76222 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76241 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76242 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76244 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76245 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletphersis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76353 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product that did not meet specifications, was distributed.",2017-02-01,2017-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76150 - Class III - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2017-02-06,2017-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76574 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet product, for which quality control and distribution of product did not meet specifications, was distributed.",2017-03-15,2017-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76791 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product, for which the quality control testing for pH did not meet specifications, was distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76795 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet product, for which quality control testing did not meet specifications, was distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77135 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2017-05-30,2017-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77343 - Class III - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, which was labeled with an incorrect volume, was distributed.",2017-06-23,2017-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77345 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, with a low platelet count, were distributed.",2017-06-27,2017-06-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77539 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product, which failed acceptability testing for platelet count, was distributed.",2017-07-12,2017-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77929 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet product, for which quality control testing did not meet specifications, was distributed.",2017-08-22,2017-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77736 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low platelet count, was distributed.",2017-08-23,2017-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78010 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, collected from a donor whose arm scrub procedure was not performed, was distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78011 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low platelet count, was distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78214 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Apheresis product, for which the quality control testing for pH did not meet specifications, was distributed.
",2017-10-04,2017-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78258 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet product, for which quality control testing for platelet count did not meet specifications, was distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78259 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet product, for which quality control testing for platelet count did not meet specifications, was distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78382 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet product, for which quality control testing for platelet count did not meet specifications, was distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78384 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Platelet product, for which quality control testing for platelet count did not meet specifications, was distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80141 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2018-06-01,2018-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83591 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low platelet count, was distributed.",2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84503 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, prepared without the appropriate amount of additive solution, were distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86894 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86980 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Leukoreduced, Apheresis Platelets, in which platelet count did not meet product specifications, were distributed.",2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87449 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2021-03-10,2021-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87465 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2021-03-10,2021-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87651 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-04-20,2021-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87668 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood product, with a low platelet count, was distributed.",2021-04-20,2021-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88914 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2021-11-05,2021-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89340 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89341 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Plateletpheresis, for which platelet yield did not meet product specifications, was distributed.
",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90927 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Leukoreduced Apheresis Platelets, in which platelet yield did not meet specifications, were distributed.",2022-10-17,2022-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91061 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Blood Products, collected in a manner that compromises the sterility of the collection system, was distributed.",2022-11-16,2022-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91244 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91431 - Class II - Biologics - Lifesouth Community Blood Centers - Montgomery Region,"Leukoreduced Apheresis Platelets, PAS, with a pH lower than the expected value, were distributed.",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61903 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, which were collected from a donor in which donor suitability were not adequately determined, were distributed.",2012-06-22,2012-06-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62619 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products collected from a therapeutic donor with polycythemia, were distributed.",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62975 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, which did not meet the acceptable product specifications, was distributed.",2012-10-01,2012-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63572 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, which were not quarantined subsequent to receiving post donation illness information, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63888 - Class III - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, collected from a donor who reported post donation illness, was distributed.

",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64765 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, for which the quality control testing was incomplete and not documented , was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66767 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, not prepared in accordance with specifications, were distributed.",2013-12-05,2013-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67304 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, for which the testing for pH was invalid, were distributed.",2014-02-20,2014-02-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68849 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69679 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with an unacceptable pH, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71503 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2015-07-21,2015-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72441 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis product, in which a leuko reduced unit did not meet WBC count specifications, was distributed.

",2015-10-30,2015-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74817 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet products that did not meet specifications for leukoreduction, were distributed.",2016-08-26,2016-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75339 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2016-10-27,2016-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75865 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, which did not meet acceptable product specifications, was distributed.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76219 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76243 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76304 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76796 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet products, for which quality control testing did not meet specifications, were distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77034 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2017-05-22,2017-05-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77344 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Plateletpheresis unit, not meeting product specifications, was distributed.",2017-05-23,2017-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77738 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet product, for which platelet count quality control testing did not meet specifications, was distributed.",2017-07-13,2017-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77542 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2017-07-21,2017-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77709 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77737 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, with a low platelet count, were distributed.",2017-08-16,2017-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77927 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, which did not meet acceptable product specifications, were distributed.",2017-09-18,2017-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78212 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2017-10-04,2017-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78213 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2017-10-04,2017-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78115 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet product, for which quality control testing did not meet specifications, was distributed.",2017-10-17,2017-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78381 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2017-11-02,2017-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78260 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet product, for which quality control testing for platelet count did not meet specifications, was distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78473 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78357 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet product, for which quality control testing for platelet count did not meet specifications, was distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78602 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet products, for which the quality control for pH testing was performed incorrectly, were distributed.",2017-12-07,2017-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78721 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet products, not prepared in accordance with specifications, were distributed.",2017-12-19,2017-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78494 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2018-01-08,2018-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79281 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2018-03-15,2018-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79459 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2018-04-20,2018-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80051 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis product, in which platelet yield did not meet specifications, was distributed.",2018-05-15,2018-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79880 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet product, which failed platelet count quality control testing, was distributed.",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79866 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2018-05-24,2018-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80028 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2018-06-11,2018-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80103 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2018-06-13,2018-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80245 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet product that did not meet specifications for platelet count, was distributed.",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80246 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet product that did not meet specifications for platelet count, was distributed.",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80786 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, with a low platelet count, was distributed.",2018-09-06,2018-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81643 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis unit, incorrectly labeled as Leukocytes Reduced was distributed.
",2018-12-12,2018-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82059 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82134 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82084 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Platelet, with a low platelet count, was distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82309 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-04-15,2019-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87311 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Leukoreduced, Apheresis Platelets, in which platelet yield did not meet specifications, were distributed.",2021-02-19,2021-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87312 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Leukoreduced, Apheresis Platelets, in which platelet yield did not meet specifications, were distributed.",2021-02-19,2021-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87358 - Class III - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, exposed to unacceptable temperatures during storage, were distributed.
",2021-03-03,2021-03-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87461 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2021-03-09,2021-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87423 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood product, which did not meet acceptable product specifications, was distributed.",2021-03-10,2021-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87448 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood products, which did not meet the acceptable product specifications, were distributed.",2021-03-10,2021-03-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88373 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88374 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Leukoreduced Apheresis Platelets, in which platelet yield did not meet specifications, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89158 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Blood Products, which were not transported at the correct temperature, were distributed.",2021-12-16,2021-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89342 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89637 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count, were distributed.",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90109 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91029 - Class II - Biologics - LifeSouth Community Blood Centers Inc,"Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2022-10-24,2022-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61962 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61963 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62425 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62426 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62445 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62474 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62489 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62632 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62633 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62634 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62631 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62837 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62839 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62973 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-10-01,2012-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63402 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63403 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63404 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63575 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63886 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63889 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65390 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with platelet count below the specified minimum requirement, was distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65711 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with no documentation of monthly QC testing for pH, was distributed. 

",2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76573 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood products, collected from a donor for whom donor screening was incorrectly performed, were distributed.",2017-03-15,2017-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76577 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood products, with a low platelet count, were distributed.",2017-03-30,2017-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76797 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Platelet products, for which quality control testing did not meet specifications, were distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77035 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2017-05-22,2017-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77134 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2017-05-30,2017-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77346 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood products, with a low platelet count, were distributed.",2017-06-27,2017-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77538 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.",2017-06-27,2017-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77541 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2017-07-21,2017-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77721 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77920 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.",2017-08-22,2017-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77921 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.",2017-08-22,2017-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77925 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2017-09-18,2017-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77926 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood products, which did not meet acceptable product specifications, were distributed.",2017-09-18,2017-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78113 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.",2017-09-20,2017-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78012 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78013 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78014 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, which did not meet acceptable product specifications, was distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78145 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78114 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Platelet product, for which quality control testing did not meet specifications, was distributed.",2017-10-04,2017-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78262 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2017-10-19,2017-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78356 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2017-12-04,2017-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78386 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2017-12-04,2017-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78512 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78600 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Blood product, with a low platelet count, was distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80205 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80989 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2018-09-17,2018-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81816 - Class III - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis Platelet, labeled with an incorrect volume, was distributed.
",2019-01-29,2019-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85115 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Apheresis, Leukoreduced Platelets, with a platelet count below the acceptable yield, were distributed",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85118 - Class II - Biologics - LifeSouth Community Blood Centers Inc - Birmingham Region,"Plateltpheresis  product, with a low platelet count, was distributed.",2020-04-08,2020-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83504 - Class II - Biologics - LifeSouth Community Blood Centers Jacksonville Depot,"Blood product, with a low platelet count, was distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91242 - Class II - Biologics - LifeSouth Community Blood Centers, Inc","Leukoreduced Red Blood Cells, which were not crossmatched for the patient, were distributed.",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91306 - Class III - Biologics - LifeSouth Community Blood Centers, Inc","Leukoreduced Apheresis Red Blood Cells, which did not meet the minimum requirement for Red Blood Cell recovery following leukoreduction, were distributed.",2022-12-19,2022-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61902 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62427 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62630 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, labeled leukoreduced without assurance that they met the criteria for leukoreduced products, were distributed

",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62808 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62838 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63399 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63668 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which was labeled as leukoreduced, but was not tested to verify the White Blood Cell count, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63576 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2012-12-06,2012-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63578 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Platelet, with a low platelet count, was distributed.",2012-12-06,2012-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63573 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, labeled leukoreduced but was not tested to verify the White Blood Cell count, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63885 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, labeled as leukoreduced without the assurance that they met the criteria for leukoreduced products, were distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63887 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with platelet count below the specified minimum requirement, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42671 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50590 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50591 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #48801 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Quality Control and Distribution/Distribution of product that did not meet specifications. Product in which instrument QC or validation was unacceptable, incomplete, not performed, or not documented.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49948 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #38561 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64378 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39432 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, for which the quality control testing was incomplete, was distributed.",2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64451 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, labeled leukoreduced without the assurance that it met the criteria for a leukoreduced product, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64893 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65384 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65387 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, labeled leukoreduced which had not undergone leukoreduction, were distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65712 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, which did not meet QC specifications for platelet pH, were distributed.",2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66286 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, tested for pH using a malfunctioning pH meter, were distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50265 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66751 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2013-12-05,2013-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66752 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, with a low platelet counts, were distributed.",2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66769 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood Product, which did not meet specifications, were distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66939 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67626 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which was incorrectly labeled with an extended expiration date, was distributed.",2014-03-10,2014-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67941 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which had a low pH value, was distributed.",2014-05-12,2014-05-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68082 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, labeled as leukoreduced which did not meet the requirements for a leukoreduced product, was distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69328 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2014-11-12,2014-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69678 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with an unacceptable pH, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69947 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, for which the monthly quality control testing for pH was unacceptable, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71213 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2015-06-16,2015-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40285 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72129 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2015-10-05,2015-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72440 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis products, in which leuko reduced units did not meet WBC count specifications, were distributed.

",2015-10-30,2015-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72279 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, associated with an unacceptable pH, was distributed.",2015-11-04,2015-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72439 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Red Blood Cell products, manufactured with lack of assurance of sterility, were distributed.",2015-11-04,2015-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72566 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72917 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, with a low platelet yield, was distributed.
",2016-01-07,2016-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73026 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, in which NAT testing was performed incorrectly, were distributed.",2016-02-04,2016-02-04,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73143 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis products for which pH testing was not documented, were distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73321 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low pH, was distributed.",2016-03-31,2016-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74303 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with an unacceptable pH, was distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74660 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.",Mislabeled blood product was distributed.,2016-07-17,2016-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74784 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which was collected in a manner that may have compromised the sterility of the collection system, was distributed.",2016-08-24,2016-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75314 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.",2016-10-11,2016-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75315 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.",2016-10-11,2016-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75821 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.",2016-12-14,2016-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75867 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Platelet product, for which quality control testing did not meet specifications, was distributed.",2016-12-20,2016-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75866 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product,s which did not meet acceptable product specifications, were distributed.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76217 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product that did not meet specifications, was distributed.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76579 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis products, lacking proper quality control testing, were distributed.",2017-03-28,2017-03-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76575 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, which failed to meet quality control specifications for platelet pH testing, were distributed.",2017-03-30,2017-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76757 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with an unacceptable pH, was distributed.",2017-04-24,2017-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76758 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.",Transfusion,2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77136 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Platelet product, for which pH quality control testing did not meet specifications, was distributed.",2017-05-03,2017-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76893 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Co-component blood product, lacking assurance regarding bacterial contamination risk, was distributed.",2017-05-12,2017-05-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76894 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Co-component blood products, lacking assurance regarding bacterial contamination risk, were distributed.",2017-05-12,2017-05-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77033 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2017-05-15,2017-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77404 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.",Misbranded plasma product was distributed.,2017-06-16,2017-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77540 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Platelet pheresis product,  which failed acceptability testing for platelet count, was distributed.",2017-07-12,2017-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77403 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, labeled RBC antigen negative tested RBC antigen positive, was distributed.",2017-07-17,2017-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77720 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77722 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77928 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Platelet product, for which quality control testing did not meet specifications, was distributed.",2017-08-22,2017-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77922 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2017-09-18,2017-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78215 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, collected from a donor who tested positive for the antibody to Hepatitis B core Antigen on more than one occasion, was distributed.
",2017-10-10,2017-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78261 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Platelet product, for which quality control testing for platelet count did not meet specifications, was distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78383 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Platelet product, for which quality control testing for platelet count did not meet specifications, was distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78385 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2017-12-04,2017-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78601 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, for which a donor screening deviation occurred, was distributed.",2017-12-19,2017-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78511 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78796 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Platelet products, in which platelet yield did not meet specifications, were distributed.
",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80029 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products collected from a donor whose arm cleansing procedures were performed using an expired cleanser, were distributed.",2018-05-09,2018-05-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79786 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2018-05-24,2018-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80104 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2018-06-13,2018-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80331 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81104 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.",2018-10-05,2018-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81136 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81515 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81642 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.",2018-12-12,2018-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81687 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2018-12-14,2018-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82308 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product in which quality control for residual WBC count was not performed, was distributed.",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82320 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82597 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.",2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82598 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.",2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82428 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptability criteria, was distributed.",2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82635 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82688 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet the acceptable product specifications for release, was distributed.",2019-06-03,2019-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82884 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet the acceptable product specifications for release, was distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83243 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Platelets, not meeting product specifications, were distributed.",2019-07-01,2019-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83032 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, which did not meet acceptable product specifications, were distributed.",2019-07-15,2019-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83306 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, collected from a donor with an increased risk factor for vCJD, were distributed.",2019-08-15,2019-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83494 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Red Blood Cells, which was not tested for Chagas disease, was distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83440 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, manufactured without the entire quantity of additive solution, was distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83441 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83442 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83443 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83505 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83846 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, in which platelet yield did not meet specifications, was distributed.
",2019-10-02,2019-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84015 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2019-10-10,2019-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84192 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood component, not manufactured according to product specifications, was distributed.",2019-11-07,2019-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84086 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, with incompatible crossmatch testing, were distributed.",2019-11-19,2019-11-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84448 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2019-12-31,2019-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84581 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Red Blood Cells, labeled with a volume significantly lower than the product's actual volume, were distributed.",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84804 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis products, in which quality control for residual WBC count  was not performed, were distributed.
",2020-02-05,2020-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84624 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2020-02-10,2020-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84625 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, which did not meet the acceptable product specifications, was distributed.",2020-02-10,2020-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84892 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, in which platelet yield did not meet specifications, was distributed.
",2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84761 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2020-02-28,2020-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84762 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2020-02-28,2020-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85116 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, platelet additive solution added, with a low pH value, were distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85117 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, platelet additive solution added, with a low pH value, were distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85213 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, with incomplete testing for relevant transfusion transmitted infections, were distributed.",2020-03-16,2020-03-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85192 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Platelets, leukoreduced and irradiated, in which the platelet yield did not meet specifications, were distributed.",2020-03-20,2020-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85285 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Red Blood Cell product, which tested positive for an unexpected antibody, was distributed.",2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85471 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, in which platelet yield did not meet specifications, was distributed.
",2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85824 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.",-,2020-06-12,2020-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85825 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletepheresis product, with an unacceptably high platelet concentration, was distributed.
",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85768 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Leukoreduced Platelets with Platelet Additive Solution Added, in which platelet yield did not meet specifications, were distributed.",2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85777 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2020-06-26,2020-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85896 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Leukoreduced Platelets, Platelet Additive Solution Added, not tested for pH, were distributed.",2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86032 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed",2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86033 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, prepared without the appropriate amount of additive solution, were distributed.",2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86389 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, not meeting minimum product specifications, was distributed.",2020-09-04,2020-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86445 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2020-09-18,2020-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86446 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2020-09-18,2020-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86703 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.",Mislabeled plateletpheresis product was distributed.,2020-11-03,2020-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86770 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, in which platelet yield did not meet specifications, were distributed.",2020-11-23,2020-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86771 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, in which the pH quality control testing did not meet acceptability criteria, were distributed.",2020-11-23,2020-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86772 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.",Misbranded Leukoreduced Red Blood Cells were distributed.,2020-11-23,2020-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86780 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, Irradiated, in which the platelet yield did not meet specifications, were distributed.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86782 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86783 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, Irradiated, in which the platelet yield did not meet specifications, were distributed.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86891 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86916 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Fresh Frozen Plasma, labeled with a volume significantly lower than the product's actual volume, was distributed.",2020-12-09,2020-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86921 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, with a  pH value below the expected value, were distributed.",2020-12-09,2020-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86911 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.",Red Blood Cell product was inappropriately distributed prior to resolution of discrepancy.,2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86912 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood Products, for which donor eligibility was incomplete, were distributed.
",2020-12-16,2020-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86915 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletepheresis product, for which the quality control testing for pH did not meet specifications, was distributed.
",2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86974 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, in which platelet count did not meet product specifications, were distributed.",2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86975 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, in which platelet count did not meet product specifications, were distributed.",2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86976 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, in which platelet count did not meet product specifications, were distributed.",2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86977 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, in which platelet count did not meet product specifications, were distributed.",2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86978 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, in which platelet count did not meet product specifications, were distributed.",2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86979 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, Platelet Additive Solution Added, in which platelet count did not meet product specifications, were distributed.",2020-12-22,2020-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87121 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, in which platelet yield did not meet specifications, were distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87198 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, in which platelet yield did not meet specifications, was distributed.
",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87220 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, Platelet Additive Solution Added, in which platelet yield did not meet specifications, were distributed.",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87310 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, Platelet Additive Solution Added, in which platelet yield did not meet specifications, were distributed.",2021-02-19,2021-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87376 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.",Red Blood Cell product was inappropriately distributed prior to resolution of discrepancy.,2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87459 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2021-03-09,2021-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87463 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2021-03-10,2021-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87564 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, collected from a donor taking aspirin, were distributed.",2021-03-29,2021-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87612 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, with a low platelet count, was distributed.",2021-03-29,2021-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87524 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced, Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87526 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which was labeled as Leukoreduced but failed monthly QC residual white cell count, was distributed.",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87700 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, in which platelet yield did not meet specifications, were distributed.",2021-04-27,2021-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87909 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2021-05-21,2021-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87912 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, in which platelet yield did not meet specifications, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87929 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Red Blood Cells ,collected from a donor who had not read the educational material, was distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88110 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-06-22,2021-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88042 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, in which donor testing was not performed or incomplete, was distributed.",2021-06-28,2021-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88188 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88256 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which failed to meet product specifications, was distributed.",2021-07-13,2021-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88255 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletepheresis product, for which the quality control testing for pH did not meet specifications, was distributed.
",2021-07-14,2021-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88318 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88319 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, in which platelet yield did not meet specifications, were distributed.",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88321 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood Products, exposed to unacceptable storage temperatures, were distributed.",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88406 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Red Blood Cell, collected from a donor for whom donor suitability was incomplete, was distributed.
",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88706 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Red Blood Cell product, not meeting product specifications, was distributed. 
",2021-09-24,2021-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88710 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletepheresis product, not meeting WBC quality control testing, was distributed.
",2021-09-24,2021-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88742 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89094 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Platelets, Leukocytes Reduced, not stored at a controlled temperature, was distributed.",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89154 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Red Blood Cell product, not stored at a controlled temperature, was distributed.",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89156 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Red Blood Cell product, for which quality control for residual white blood cell count testing was not performed, was distributed.
",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89352 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, for which transfusion-transmitted infection test/testing was performed, interpreted, or documented incorrectly, were distributed.",2022-01-19,2022-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89353 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2022-01-19,2022-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89355 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood product, for which transfusion-transmitted infection test/testing was performed, interpreted, or documented incorrectly, was distributed.",2022-01-19,2022-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89448 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Red Blood Cell products, for which unit sterility was compromised during collection, were distributed.
",2022-02-09,2022-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89620 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, collected from donors considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2022-03-01,2022-03-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89849 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2022-04-07,2022-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89850 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, Irradiated, in which the platelet yield did not meet specifications, were distributed.",2022-04-08,2022-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90082 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis Platelet, for which platelet yield did not meet specifications, was distributed.
",2022-05-10,2022-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90155 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, with a pH value that did not meet specifications, were distributed.",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90394 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.","Blood products, for which donor eligibility was incomplete, were distributed.
",2022-10-06,2022-10-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91062 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Red Blood Cells, collected in a manner that compromises the sterility of the collection system, was distributed.",2022-11-16,2022-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91367 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2022-12-29,2022-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91436 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Plateletepheresis products, for which arm prep may have been performed inappropriately, were distributed.
",2023-01-09,2023-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91596 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Apheresis product, in which platelet yield did not meet specifications, was distributed.
",2023-02-01,2023-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91586 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2023-02-10,2023-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91630 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, which had a lower pH value than was acceptable, were distributed.",2023-02-13,2023-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91631 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, not tested for pH, were distributed.",2023-02-13,2023-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91680 - Class II - Biologics - LifeSouth Community Blood Centers, Inc.","Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2023-02-16,2023-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91681 - Class III - Biologics - LifeSouth Community Blood Centers, Inc.",Misbranded Fresh Frozen Plasma was distributed.,2023-02-16,2023-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64377 - Class II - Biologics - Lifesouth Community Blood Centers, Inc. - Mobile Region","Blood product, which did not meet acceptable product specifications, was distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65388 - Class II - Biologics - Lifesouth Community Blood Centers, Inc. - Mobile Region","Blood products, collected without the performance of a WBC count during instrument re-validation, were distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73073 - Class II - Biologics - Lifesouth Community Blood Centers, Inc. - Mobile Region","Apheresis Platelet product, for which pH testing was invalid, was distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76379 - Class II - Biologics - Lifesouth Community Blood Centers, Inc. - Mobile Region","Blood product, which did not meet the acceptable product specifications for release, was distributed.",2017-02-28,2017-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86781 - Class II - Biologics - LifeSouth Community Blood Centers, Inc. - Mobile Region","Leukoreduced, Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87108 - Class II - Biologics - LifeSouth Community Blood Centers, Inc. - Mobile Region","Leukoreduced, Apheresis Red Blood Cells, which failed Quality Control due to low volume, were distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88320 - Class II - Biologics - LifeSouth Community Blood Centers, Inc. - Mobile Region","Red Blood Cell product, collected from a donor who had previously tested reactive for Hepatitis C (HCV), was distributed.
",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71415 - Class II - Drugs - Lincare, Inc.","Lack of Assurance of Sterility: Sterility of product is not assured., Lack of Assurance of Sterility: Sterility of product is not assured.
, Lack of Assurance of Sterility: Sterility of product is not assured, Lack of Assurance of Sterility: Sterility of product is not assure",2015-07-01,2015-07-01,54,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77840 - Class III - Drugs - Linde Eckstein Gmbh + Co KG,"Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.",2017-08-17,2017-08-17,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61917 - Class II - Drugs - Linde Gas LLC,"CGMP Deviations: The pressure gages, vacuum gages, and thermometer had surpassed the calibration expiry period, which may have resulted in overfill/underfill of oxygen cylinders.",2012-06-15,2012-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65816 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-08-30,2013-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65817 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-08-30,2013-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65818 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-08-30,2013-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65932 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65933 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65934 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65935 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65937 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65940 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65941 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65942 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65943 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65944 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65945 - Class II - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65946 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65947 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65963 - Class II - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65964 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65965 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65966 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65989 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65990 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65991 - Class III - Biologics - Lions Eye Bank For Long Island,"Human tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66078 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66079 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66096 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66072 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-12,2013-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66073 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-12,2013-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66074 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-12,2013-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66075 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-12,2013-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66076 - Class II - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-12,2013-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66077 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-12,2013-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66090 - Class II - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66091 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66093 - Class II - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66094 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66095 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66159 - Class III - Biologics - Lions Eye Bank For Long Island,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66164 - Class II - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66160 - Class III - Biologics - Lions Eye Bank For Long Island,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-19,2013-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78894 - Class II - Biologics - Lions Eye Bank of Delaware Valley, Inc.","Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2018-01-09,2018-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79809 - Class II - Biologics - Lions Eye Bank of Delaware Valley, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2018-06-05,2018-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63023 - Class II - Biologics - Lions Eye Bank of Texas,Expired human cornea was distributed.,2012-08-31,2012-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71886 - Class II - Biologics - Lions Eye Bank of West Central Ohio,"Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2015-08-06,2015-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79358 - Class II - Biologics - Lions Eye Bank of West Central Ohio,Mislabeled human corneas were distributed.,2018-06-05,2018-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89195 - Class II - Biologics - Lions Eye Bank of West Central Ohio,"Cornea, recovered from an ineligible donor, was distributed.",2022-02-01,2022-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63052 - Class II - Biologics - Lions Eye Institute for Transplant & Research, Inc.","Human corneas, recovered from a donor whose donor eligibility may have been been determined with inaccurate and/or incomplete donor records, were distributed.",2012-08-31,2012-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64205 - Class II - Biologics - Lions Eye Institute for Transplant & Research, Inc.","Human Corneas, recovered from a donor whose donor screening may have been performed in a manner that did not determine the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-02-05,2013-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77487 - Class II - Biologics - Lions Eye Institute for Transplant & Research, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2017-07-11,2017-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86232 - Class II - Biologics - Lions Gift of Sight,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2020-08-12,2020-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90306 - Class II - Biologics - Lions Gift of Sight,"Tissues, processed without conducting the proper antibiotic soak, were distributed., Corneas, processed without conducting the proper antibiotic soak, were distributed.",2022-06-07,2022-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65708 - Class III - Biologics - Lions Medical Eye Bank & Research Center of Eastern VA,Mislabeled human cornea was distributed.,2013-08-22,2013-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88066 - Class II - Biologics - Lions Medical Eye Bank & Research Center of Eastern VA,"Corneas, with processing records containing discrepant or missing information, were distributed.",2021-06-28,2021-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65938 - Class III - Biologics - Lions VisionGift,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-09-17,2013-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69577 - Class III - Biologics - Lions VisionGift,Corneal tissue donor screening performed incorrectly (incomplete or inaccurate) were distributed.,2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91591 - Class II - Biologics - Lions VisionGift,"Cornea, in which donor testing was conducted with an unacceptable sample, was distributed.",2023-02-14,2023-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86078 - Class I - Drugs - Liq-E S.A. De C.V.,Chemical Contamination: Products contain methanol and were below the label claim for ethanol content,2021-02-12,2021-02-12,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84016 - Class II - Biologics - Liveyon LLC.,"Human tissue allografts, where in-process controls were not followed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2019-11-05,2019-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80814 - Class I - Drugs - Living Well Remedies, LLC",Microbial Contamination of Non-Sterile Products: Weight Away Remedy is being recall due to out of specification microbial results.,2018-10-01,2018-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78074 - Class II - Drugs - Llorens Pharmaceutical Corp.,Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.,2017-11-15,2017-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61094 - Class II - Drugs - Lloyd Inc,Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.,2012-06-22,2012-06-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61252 - Class II - Drugs - Lloyd Inc,Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.,2012-06-22,2012-06-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62511 - Class II - Drugs - Lloyd Inc. of Iowa,cGMP Deviations; does not meet in process specification requirements,2012-12-03,2012-12-03,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62664 - Class II - Drugs - Lloyd Inc. of Iowa,Subpotent; 9-month stability interval,2012-12-21,2012-12-21,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65154 - Class II - Drugs - Lloyd Inc. of Iowa,"cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.",2013-05-21,2013-05-21,20,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88244 - Class III - Drugs - LNK International, Inc.","Labeling: Not Elsewhere Classified The primary label contains the words ""enteric coated"" but the tablet is not enteric coated and should only say 'coated tablet'",2021-07-16,2021-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83315 - Class II - Drugs - LNK International, Inc.",Microbial contamination of non-sterile product,2019-08-06,2019-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90708 - Class III - Drugs - LNK International, Inc.","Labeling: Not Elsewhere Classified: Carton incorrectly identifies product as doxylamine succinate HCl, however the product is doxylamine succinate.",2022-08-30,2022-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90983 - Class III - Drugs - LNK International, Inc.","Boxes mislabeled to read ""Decongestant Free"", but the product contains Phenylephrine HCI 5mg",2022-10-18,2022-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62613 - Class II - Drugs - LNK International, Inc.","Incorrect/Undeclared Excipients: The firm recalled specific lots of Walgreens brand Aspirin Free Tension Headache Caplets due to the presence of sucralose, which was not declared on the label.",2014-12-23,2014-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82538 - Class II - Drugs - Lohxa LLC,Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.,2019-04-15,2019-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86717 - Class I - Drugs - Lohxa LLC,Microbial contamination of non-sterile products: Repackaged product was recalled by manufacturer because it was contaminated with the bacteria Burkholderia lata.,2020-11-30,2020-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89272 - Class I - Drugs - Lohxa, LLC",Microbial Contamination of Non-Sterile Product,2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80614 - Class II - Drugs - Longbow First Aid Products Manufactory,CGMP Deviations,2018-08-08,2018-08-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90551 - Class I - Drugs - Loud Muscle Science,"Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug., Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.",2022-08-15,2022-08-15,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75537 - Class I - Drugs - Love My Tru Body,"Marketed without an approved NDA/ANDA: presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and phenolphthalein.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65360 - Class II - Drugs - Lowlite Investments, Inc. D/B/A Olympia Pharmacy",Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes,2013-07-11,2013-07-11,105,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77427 - Class II - Drugs - Lucid Pharma LLC,Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.,2017-06-16,2017-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78051 - Class I - Drugs - Lucky Mart Inc.,Incorrect Product Formulation: product contains dexamethasone instead of hydrocortisone.,2017-10-24,2017-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72269 - Class I - Drugs - Lucy's Weight Loss (dba. Waisted With Lucy),Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.,2016-05-26,2016-05-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72820 - Class I - Drugs - Lucy's Weight Loss (dba. Waisted With Lucy),"Marketed without an approved NDA/ANDA: Product contains undeclared Sibutramine, Phenolphthalein and/or Diclofenac.",2016-05-26,2016-05-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #58410 - Class II - Drugs - Luitpold Pharmaceuticals, Inc.",Presence of Particulate Matter:  In the course of inspecting retention samples visual particles were observed.,2012-06-14,2012-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61714 - Class II - Drugs - Luitpold Pharmaceuticals, Inc.",Presence of Particulate Matter,2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90167 - Class II - Drugs - Lula Holdings L.L.C.,CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.,2022-05-11,2022-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74964 - Class III - Drugs - Lupin Limited,CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.,2016-09-06,2016-09-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74944 - Class III - Drugs - Lupin Limited,Labeling: Incorrect or Missing Lot and/or Expiration Date,2016-09-21,2016-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78566 - Class II - Drugs - Lupin Limited,"Presence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a Pravastatin Sodium Tablets USP, 40mg bottle.",2017-11-21,2017-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77323 - Class I - Drugs - Lupin Limited (Unit 1),"Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package.",2017-08-15,2017-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88838 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Out of specification result observed in a dissolution test at the 9-month long term stability time point.,2021-10-22,2021-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89916 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,2022-05-03,2022-05-03,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90094 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Stability Specification,2022-05-16,2022-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90616 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.,2022-08-16,2022-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90859 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.,2022-09-15,2022-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91279 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.,2022-12-23,2022-12-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91295 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.,2023-01-09,2023-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91532 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Subpotent Drug: Low assay result observed during long-term stability testing.,2023-01-23,2023-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64325 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Discoloration; Product may not meet specifications for color description once reconstituted.,2013-04-18,2013-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66065 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: This product is being recalled due to an out of specification result for an impurity.,2013-12-12,2013-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66345 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: During stability testing an unknown impurity was found to be above the specification limit at 36 month test interval,2014-01-10,2014-01-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67462 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Product did not meet specification in total impurities at the 9-month stability station.,2014-04-02,2014-04-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73830 - Class III - Drugs - Lupin Pharmaceuticals Inc.,"CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications., CGMP Deviations: active pharmaceutical ingredient intermediates failed specifications.",2016-06-02,2016-06-02,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73848 - Class III - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.,2016-06-24,2016-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74945 - Class III - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose intermediates failed specifications.,2016-09-16,2016-09-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76924 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications; Impurity A,2017-04-06,2017-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77606 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Dissolution Specifications:  out of specification observed in dissolution testing at 3 month long term stability study.,2017-07-12,2017-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78032 - Class III - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations,2017-09-01,2017-09-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78596 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Dissolution Specification,2017-11-28,2017-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79612 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Superpotent Drug,2018-04-17,2018-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80097 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Marketed Without an Approved NDA/ANDA: 2-pack configuration did not receive appropriate regulatory approval prior to release.,2018-05-31,2018-05-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80668 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study.,2018-08-08,2018-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80789 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.,2018-08-13,2018-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81213 - Class III - Drugs - Lupin Pharmaceuticals Inc.,"Defective Container: Repetitive complaints received indicating pump not working.

",2018-10-23,2018-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81796 - Class I - Drugs - Lupin Pharmaceuticals Inc.,"Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.",2019-01-14,2019-01-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81888 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to be thick.,2019-01-15,2019-01-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81898 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviation; manufacturing batch record could not be located,2019-01-16,2019-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81908 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations; presence of extraneous material in the  was observed in area that is between the primary package that is heat sealed and secondary packaging (poly-woven bag) of sucrose (an excipient) used in the finished product.,2019-01-31,2019-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82022 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.,2019-02-05,2019-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82037 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Out of specification test results in related substance at three-month long term stability study was obtained.,2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82126 - Class III - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: Finished product made with lovastatin drug substance that was out of specification for individual impurity results.,2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82249 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Expansion of July 2018 and February 2019 recall due to high out-of-specification for impurities.,2019-02-28,2019-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82392 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Defective Container: Repetitive complaints received indicating pump not working.,2019-03-19,2019-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82356 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Out-of-specification results observed in related substance test (Any Other Individual Impurity and Total impurities) in Ethinyl Estradiol Tablets USP 0.01mg at 12 month long term stability study.,2019-03-25,2019-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82528 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications; 18 month long term stability study.,2019-04-11,2019-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82939 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Complaint received of metal piece identified in the product bottle prior to the reconstitution.,2019-05-30,2019-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83333 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Labeling: Missing label; Product complaints reported missing bottle label.,2019-07-17,2019-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83350 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.,2019-07-25,2019-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83284 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Kaitlib Fe Tablets has an out of specification result observed in long term stability study.,2019-07-30,2019-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83363 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg observed in 500 s count product bottle.,2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83354 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Presence of Foreign Substance; Product complaints received related to brownish/blackish stains on the tablets and brownish/blackish powder observed inside the bottles.,2019-08-09,2019-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84196 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Presence of Foreign substance: identified as a dead ant.,2019-11-07,2019-11-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84463 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Dissolution Specifications: High out of specification result observed at stability studies.,2019-12-23,2019-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84495 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.,2020-01-02,2020-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84571 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack.,2020-01-03,2020-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84674 - Class III - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: Out of specification test result observed during retrospective review of blend uniformity test data.,2020-01-17,2020-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84948 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.,2020-02-24,2020-02-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85015 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specification; high out of specification results observed,2020-03-03,2020-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85169 - Class II - Drugs - Lupin Pharmaceuticals Inc.,"Failed Content Uniformity Specifications: Out Of Specification test results observed for content uniformity., Failed Content Uniformity Specifications: Out Of Specification test results observed for content and blend uniformity.",2020-03-24,2020-03-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85355 - Class II - Drugs - Lupin Pharmaceuticals Inc.,"Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets. 
",2020-04-02,2020-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85511 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Product Mix-Up: a complaint received indicating mix-up of 10 mg Lisinopril tablets inside of 2 sealed bottles of 20 mg/1000 count bottles.,2020-04-21,2020-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85487 - Class II - Drugs - Lupin Pharmaceuticals Inc.,"Subpotent Drug: low out of specification (OOS) test result observed in long term stability study.

",2020-04-23,2020-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85770 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Product Mix Up: Lisinopril 10 mg tablets were found in Lisinopril 5 mg 1000-count bottle.,2020-06-08,2020-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85840 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-06-20,2020-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85998 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-07-14,2020-07-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85960 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.,2020-07-23,2020-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86053 - Class II - Drugs - Lupin Pharmaceuticals Inc.,"Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg",2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86108 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Out of specification result observed in related substance test.,2020-08-13,2020-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87195 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.,2021-02-03,2021-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87602 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Superpotent Drug,2021-04-12,2021-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87871 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Subpotent Drug,2021-05-19,2021-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88856 - Class II - Drugs - Lupin Pharmaceuticals Inc.,CGMP Deviations: impurity N-nitrosoirbesartan detected in API,2021-11-01,2021-11-01,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88885 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.,2021-11-02,2021-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89085 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Subpotent Drug,2021-12-01,2021-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89268 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Failed Stability Specifications: Out-of-specification results observed in a water loss test that might affect the assay content and alter drug concentration.,2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89324 - Class III - Drugs - Lupin Pharmaceuticals Inc.,Out-of-specification impurity test result observed at 18-month long term stability time point.,2022-01-05,2022-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90415 - Class II - Drugs - Lupin Pharmaceuticals Inc.,Failed Dissolution Specifications: Out of specification test results observed in dissolution testing during long term stability study.,2022-06-15,2022-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73896 - Class II - Drugs - Lymol Medical Corporation,Defective Delivery System: Defective stem valve causes leakage of the propellant in the spray canister delivering no drug or an inadequate amount of the drug to be delivered.,2016-05-20,2016-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74319 - Class III - Drugs - Lyne Laboratories, Inc.",Subpotency: product assayed and found OOS for cyproheptadine,2016-07-05,2016-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79860 - Class II - Drugs - Lyne Laboratories, Inc.",Subpotent Drug,2018-05-04,2018-05-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89607 - Class II - Drugs - Macleods Pharma Usa Inc,cGmp Deviations,2022-02-28,2022-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89766 - Class III - Drugs - Macleods Pharma Usa Inc,FAILED CONTENT UNIFORMITY SPECIFICATIONS,2022-04-07,2022-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90037 - Class II - Drugs - Macleods Pharma Usa Inc,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,2022-05-03,2022-05-03,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90426 - Class II - Drugs - Macleods Pharma Usa Inc,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,2022-06-27,2022-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90444 - Class II - Drugs - Macleods Pharma Usa Inc,Shortfill: customer complaints of one to three tablets were reported missing from 30 count bottles.,2022-07-05,2022-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73017 - Class II - Drugs - Macleods Pharma Usa Inc,Presence of Foreign Tablets/Capsules:  Presence of a comingled Carbimazole 5 mg tablet.,2016-02-05,2016-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82196 - Class II - Drugs - Macleods Pharma Usa Inc,Failed Content Uniformity Specifications: The product is out of specification for blend uniformity.,2019-03-14,2019-03-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82147 - Class II - Drugs - Macleods Pharma Usa Inc,"CGMP Deviation: Presence of NDEA (N-Nitrosodimethylamine), a carcinogen impurity, detected in the active ingredient.",2019-03-21,2019-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83151 - Class II - Drugs - Macleods Pharma Usa Inc,CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.,2019-07-09,2019-07-09,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83414 - Class II - Drugs - Macleods Pharma Usa Inc,Failed Dissolution Specifications,2019-08-28,2019-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83597 - Class III - Drugs - Macleods Pharma Usa Inc,Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg,2019-09-11,2019-09-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83960 - Class II - Drugs - Macleods Pharma Usa Inc,Superpotent,2019-10-11,2019-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84749 - Class III - Drugs - Macleods Pharma Usa Inc,Failed Dissolution Specifications:  testing revealed low out of specification result in one lot of product,2020-01-31,2020-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84754 - Class III - Drugs - Macleods Pharma Usa Inc,"Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitazone And Metformin Hydrochloride Tablets.",2020-02-11,2020-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87607 - Class III - Drugs - Macleods Pharma Usa Inc,Failed Impurities/Degradation Specifications,2021-04-12,2021-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88391 - Class II - Drugs - Macleods Pharma Usa Inc,Presence of foreign matter,2021-08-31,2021-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89600 - Class II - Drugs - Macleods Pharma Usa Inc,cGMP deviations,2022-02-25,2022-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88872 - Class III - Drugs - MACLEODS PHARMA USA, INC",Out-of-specification test results obtained in Organic Impurities test during analysis of controlled samples.,2021-10-28,2021-10-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91441 - Class III - Drugs - MACLEODS PHARMA USA, INC",Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.,2023-01-17,2023-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78952 - Class I - Drugs - Magno Humphries Laboratories, Inc",Labeling: Label Mix-Up: Customer complaint received that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg.,2018-02-09,2018-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65479 - Class I - Drugs - Main Street Family Pharmacy, LLC","The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials., Lack of Assurance of Sterility",2013-12-03,2013-12-03,299,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86268 - Class I - Drugs - Maison Terre, LLC","Microbial Contamination of Non-Sterile Products: FDA laboratory analysis found product to be contaminated with various microorganisms including Enterobacter cloacae, Cronobacter sakazakii, Cronobacter dublinensis, among others.",2020-09-13,2020-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73973 - Class I - Drugs - Making It a Lifestyle,"Marketed without an approved NDA/ANDA - presence of undeclared sildenafil., Marketed without an approved NDA/ANDA - presence of undeclared sibutramine.",2016-12-22,2016-12-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62696 - Class III - Drugs - Mallinckrodt Hospital Products Inc.,Labeling: Correct Labeled Product Miscart/Mispack: labels on outer containers do not match labels on vials (the correct label),2012-09-25,2012-09-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71220 - Class II - Drugs - Mallinckrodt Hospital Products Inc.,Labeling: incorrect or missing lot number and/or expiration date,2015-06-10,2015-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61967 - Class II - Drugs - Mallinckrodt Inc.,"CGMP Deviations: This product is being recalled because expired flavoring was used in the manufacturing of these lots., Subpotent (Multiple Ingredient) Drug: Low out of specification assay results for the hydrocodone bitartrate ingredient was found.",2012-07-31,2012-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78751 - Class III - Biologics - MALLINCKRODT PHARMACEUTICALS IRE,"Raplixa Delivery Kit, not meeting labeling claims, were distributed.",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82830 - Class II - Drugs - Mallinckrodt, LLC.","Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.",2019-05-23,2019-05-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68136 - Class II - Drugs - Mangiacotti, Inc.","Microbial Contamination of Non-Sterile Products:  Elevated counts of bacteria was found, Serratia liquefaciens.",2014-05-06,2014-05-06,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86063 - Class II - Drugs - Maquiladora Miniara Sa De Cv,CGMP Deviations: Products manufactured at the same site were FDA testing found below the label claim for ethanol content and the presence of undeclared methanol.,2020-09-10,2020-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79689 - Class II - Drugs - Marcas Usa Llc,Microbial Contamination of Non-Sterile Products,2018-04-15,2018-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82112 - Class II - Drugs - Mariposa Labs LLC,Microbial Contamination of Non-Sterile Products: Consumer complaint and subsequent testing found lot to be out of specification for mold.,2019-02-19,2019-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67088 - Class II - Drugs - Mariposa Labs, LLC",Microbial Contamination of Non-Sterile Products: Arthritis Relief Cream failed microbiological specifications.,2014-01-14,2014-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78822 - Class II - Drugs - Marksans Pharma Inc.,CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.,2018-01-24,2018-01-24,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85818 - Class II - Drugs - Marksans Pharma Limited,CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-06-25,2020-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86530 - Class II - Drugs - Marksans Pharma Limited,CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-11-02,2020-11-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65967 - Class II - Drugs - Marlex Pharmaceuticals, Inc.",CGMP Deviations: The recalled acetaminophen tablet lot was not manufactured under current good manufacturing practices as noted by a recent inspection of the manufacturing firm.,2013-09-27,2013-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64845 - Class II - Biologics - Marquette General Hospital, Inc, UP Reg Bl Ctr Marquette","Blood product, with an unacceptable low volume which was not labeled as a low volume unit, was distributed.

",2013-05-17,2013-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69152 - Class II - Drugs - Martin Avenue Pharmacy, Inc.","Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.",2014-10-29,2014-10-29,118,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40178 - Class II - Biologics - Mary Greeley Medical Center,"Blood products, collected from a donor who previously tested positive for Hepatitis B surface antigen (HBsAg), were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40583 - Class II - Biologics - Mary Greeley Medical Center,"Blood products, collected from a donor who received a tatoo within 12 months of donation, were distributed.",2012-08-08,2012-08-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73102 - Class I - Drugs - Master Herbs, Inc./Li",Marketed Without An Approved NDA/ANDA: presence of undeclared morphine.,2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85619 - Class I - Drugs - MasterPharm LLC,Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.,2020-05-19,2020-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85839 - Class I - Drugs - MasterPharm LLC,Super-potent Drug: This recall has been initiated due to the elevated presence of minoxidil and biotin.,2020-06-26,2020-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85992 - Class II - Drugs - MasterPharm LLC,Lack of Processing Controls (lack of assurance of conformity to specifications).,2020-07-29,2020-07-29,26,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70713 - Class III - Drugs - Matheson, Inc.",Failed Impurities/Degradation Specification; out of specification results for carbon dioxide,2015-03-23,2015-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63917 - Class I - Drugs - Matrixx Initiatives, Inc.",Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.,2013-02-07,2013-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85207 - Class II - Drugs - Matthew 7:25 Inc dba Thrive Pharmacy,Subpotent Drug,2020-03-23,2020-03-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65629 - Class III - Drugs - Max Huber Research Labs, Inc.","Subpotent Drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled, Subpotent drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeled",2013-07-22,2013-07-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89397 - Class II - Drugs - Mayne Pharma Inc,CGMP Deviation: Difficulty dispensing/does not dispense or dispensing liquid instead of foam.,2022-01-19,2022-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90406 - Class II - Drugs - Mayne Pharma Inc,Defective Delivery System:  Out of specification for release liner removal force results at the 3-month CRT stability timepoint.,2022-06-21,2022-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73072 - Class II - Drugs - Mayne Pharma Inc,Lack of Assurance of Sterility: Failed preservative effectiveness test,2016-01-20,2016-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78544 - Class II - Drugs - Mayne Pharma Inc,Failed Dissolution Specifications.,2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79604 - Class III - Drugs - Mayne Pharma Inc,Superpotent Drug: High out of specification results for tazarotene assay at the 9-month stability time point.,2018-03-30,2018-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80833 - Class III - Drugs - Mayne Pharma Inc,"Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.",2018-08-28,2018-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85125 - Class II - Drugs - Mayne Pharma Inc,Product Mix-Up: A foreign tablet was found in bottle.,2020-03-09,2020-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77994 - Class III - Biologics - Mayo Clinic Rochester Division of Transfusion Medicine,"Blood products, collected from an ineligible donor, were distributed.",2017-08-29,2017-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80119 - Class II - Drugs - MBi Distributing Inc. dba MBi Nutraceuticals,"Lack of Processing Controls: Firm is voluntarily recalling all lots of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir, within expiry, due to lack of adequate controls during manufacturing.",2018-06-14,2018-06-14,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82106 - Class II - Drugs - McDaniel Life-Line LLC,Unapproved new drug,2019-04-09,2019-04-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91498 - Class II - Drugs - McGuff Compounding Pharmacy Services, Inc.",Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.,2023-02-10,2023-02-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84618 - Class II - Drugs - McGuff Pharmaceuticals, Inc.",Presence of Particulate Matter: filmy/cloudy particulate observed in vial.,2020-01-29,2020-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84622 - Class II - Drugs - McGuff Pharmaceuticals, Inc.",Presence of Particulate Matter: Particulates observed in vials release for dispensing.,2020-01-29,2020-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80830 - Class II - Drugs - Mckesson Corporation,Supterpotent Drug,2018-09-05,2018-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89986 - Class II - Drugs - McKesson Corporation dba McKesson Drug Company,"CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.",2022-05-05,2022-05-05,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88008 - Class III - Drugs - McKesson Corporation dba McKesson Drug Company,Labeling; Wrong Barcode; error in the machine-readable barcode which could result in some units being read as Naproxen Tablets 500 mg. Product is labeled correctly as Levetiracetam,2021-06-15,2021-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78081 - Class III - Biologics - MCKESSON MEDICAL,"Bexsero Meningitis Vaccine, lacking assurance of proper temperature maintenance during storage, was distributed.",2017-09-19,2017-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82376 - Class III - Biologics - MCKESSON MEDICAL,"Multiple vaccines, lacking assurance of proper storage temperatures, were distributed.",2019-05-13,2019-05-13,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89646 - Class II - Drugs - Mckesson Medical-Surgical Inc. Corporate Office,cGMP deviations: Temperature abuse,2022-06-09,2022-06-09,130,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90553 - Class II - Drugs - Mckesson Medical-Surgical Inc. Corporate Office,CGMP Deviations: products were stored outside the drug label specifications.,2022-08-05,2022-08-05,17,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90935 - Class III - Biologics - Mckesson Medical-Surgical Inc. Corporate Office,McKesson Medical is recalling HEPLISAV-B because it has experienced temperature excursions and was stored at temperatures lower than those specified on the labeling prior to distribution.,2022-11-16,2022-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76863 - Class II - Drugs - Mckesson Medical Surgical,Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.,2017-04-12,2017-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63895 - Class III - Biologics - McKesson Medical Surgical Supply Chain Services, LLC","Meningococcal Oligosaccharide Diphtheria Conjugate Vaccine, with lack of assurance of proper temperature maintenance during shipment, was distributed.",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69346 - Class II - Drugs - McKesson Medical Surgical Supply Chain Services, LLC","Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing wholesalers.",2014-10-03,2014-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76631 - Class II - Drugs - Mckesson Packaging Services,Presence of Foreign Substance: foreign material found in the bulk inventory.,2017-03-07,2017-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68652 - Class III - Drugs - Mckesson Packaging Services,Failed Dissolution Specification; at the 12 month time interval.,2014-07-28,2014-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68946 - Class II - Drugs - Mckesson Packaging Services,Presence of Foreign Substance; tablets may contain stainless steel metal particulates,2014-08-06,2014-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73874 - Class III - Drugs - Mckesson Packaging Services,Labeling: Label mix-up -outer carton incorrectly labeled as aspirin chewable tablets.,2016-04-28,2016-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75215 - Class III - Drugs - Mckesson Packaging Services,"Labeling: Missing Label-Primary packaging label (i.e. blister card) is blank and contains no product information (e.g. product name, strength, lot number, expiry).",2016-09-27,2016-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75141 - Class III - Drugs - Mckesson Packaging Services,"Labeling: Label mix-up. The inner packaging was properly labeled Omeprazole DR 40mg Capsules, but the outer secondary packaging was mislabeled Lansoprazole Delayed-Release 30mg Capsules.",2016-09-28,2016-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77110 - Class III - Drugs - Mckesson Packaging Services,Supotent: Out of Specification result for assay test during routine stability testing.,2017-04-25,2017-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77411 - Class III - Drugs - Mckesson Packaging Services,Failed Moisture Limits: Product tested out-of-specification for moisture content.,2017-06-29,2017-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78020 - Class III - Drugs - Mckesson Packaging Services,Failed moisture limits: Out of specification for moisture content.,2017-09-06,2017-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79060 - Class III - Drugs - Mckesson Packaging Services,Subpotent Drug: Out of specification for assay (stability testing),2018-02-08,2018-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79936 - Class III - Drugs - Mckesson Packaging Services,Failed Dissolution Specifications. High dissolution results were obtained during stability testing.,2018-05-07,2018-05-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79367 - Class II - Drugs - Mckesson Packaging Services,Failed Stability Specifications,2018-07-09,2018-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63127 - Class III - Drugs - McKesson Packaging Services,Failed USP Dissolution Test Requirements: Possible out-of-specification dissolution results at the 8 hour stability testing point.,2012-10-01,2012-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67747 - Class III - Drugs - McKesson Packaging Services,Failed Dissolution Specification: Out of Specification dissolution results at 12 month interval.,2014-03-18,2014-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61872 - Class III - Drugs - Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.",Defective Container; damaged blister units,2012-07-02,2012-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66272 - Class II - Drugs - Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.",Presence of Foreign Substance: process-related particulates which may be associated with the raw materials were observed,2013-10-17,2013-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84265 - Class I - Drugs - Med Man Distribution, Inc.",Marketed without an Approved NDA/ANDA: Product contains undeclared sildenafil which was discovered through FDA analysis.,2020-03-19,2020-03-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64640 - Class I - Drugs - Med Prep Consulting, Inc.","Non-Sterility; mold contamination, Lack of Assurance of Sterility; potential for mold contamination",2013-07-19,2013-07-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88291 - Class I - Drugs - Med Shop Total Care Inc.,Non-Sterility,2021-08-09,2021-08-09,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61683 - Class II - Drugs - Meda Pharmaceuticals Inc.,"Labeling: Presence of Undeclared Color Additive; The product is being recalled because several inactive ingredients were not included in the labeling for this product: Undeclared D&C Red #33, FD&C Blue #1, Titanium Dioxide Suspension, Purified Water USP.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66172 - Class II - Drugs - Medaus, Inc.",Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.,2013-09-13,2013-09-13,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74466 - Class II - Drugs - Medaus, Inc.",Lack of Assurance of Sterility,2016-07-08,2016-07-08,88,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86414 - Class I - Drugs - MEDEK LLC,Chemical Contamination and Subpotent Drug: FDA analysis found product to contain methanol and below label claim for ethanol.,2022-08-15,2022-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78369 - Class II - Drugs - Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company",Lack of sterility assurance:  leaking containers which could lead to exposure to infectious agents.,2018-01-05,2018-01-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80309 - Class II - Drugs - Medgyn Products, Inc.",CGMP Deviations: The manufacturer of this product recalled because they were not manufactured under current good manufacturing practices.,2018-07-11,2018-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80453 - Class II - Drugs - Medi-Fare Drug and Home Health Center,CGMP Deviations: Syringes were filled with 19mL of potassium chloride when the labels displayed a fill of 20mL.,2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82567 - Class III - Drugs - Medi-Physics Inc. dba GE Healthcare,Chemical Contamination: Trace amounts of an impurity was detected in the reagent used to manufacture finished product.,2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74338 - Class III - Biologics - Medic Inc,"Blood product, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2016-06-22,2016-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64207 - Class II - Biologics - Medic Inc,"Blood products, collected from a donor who was in close contact with an individual diagnosed with viral hepatitis, were distributed.",2013-02-25,2013-02-25,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64819 - Class II - Biologics - Medic Inc,"Blood product, which was collected from a donor who had traveled to an area considered endemic for malaria, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64882 - Class II - Biologics - Medic Inc,"Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65000 - Class III - Biologics - Medic Inc,"Blood product, which did not meet the acceptable product specifications, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66246 - Class II - Biologics - Medic Inc,"Blood product, manufactured from a unit of Whole Blood designated as a low volume collection, was distributed.",2013-12-05,2013-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66904 - Class II - Biologics - Medic Inc,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66999 - Class III - Biologics - Medic Inc,"Blood products, labeled with extended expiration dates, were distributed.

",2014-01-09,2014-01-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67144 - Class II - Biologics - Medic Inc,"Blood product, with insufficient plasma volume to support the platelet yield, was distributed.",2014-01-31,2014-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68321 - Class III - Biologics - Medic Inc,"Blood product, which failed to meet the minimum specification for red blood cell percent recovery, was distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68603 - Class II - Biologics - Medic Inc,"Blood products, possibly contaminated with air, were distributed.",2014-08-04,2014-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68604 - Class II - Biologics - Medic Inc,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2014-08-04,2014-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68606 - Class II - Biologics - Medic Inc,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2014-08-04,2014-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68663 - Class II - Biologics - Medic Inc,"Blood product, possibly contaminated with air, was distributed.",2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69330 - Class II - Biologics - Medic Inc,"Blood products, collected from donors with unsuitable health histories, were distributed.",2014-10-22,2014-10-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69220 - Class II - Biologics - Medic Inc,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-10-23,2014-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69342 - Class III - Biologics - Medic Inc,"Blood products, which did not meet the acceptable product specifications, were distributed.",2014-11-12,2014-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70077 - Class II - Biologics - Medic Inc,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70513 - Class II - Biologics - Medic Inc,"Blood products, which did not meet acceptable product specifications, were distributed.",2015-03-24,2015-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71464 - Class II - Biologics - Medic Inc,"Blood products, collected from a donor with close contact to a Hepatitis C exposure, were distributed., Blood products, collected from a donor with close contact to a Hepatitis C exposure, were distributed",2015-07-21,2015-07-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71626 - Class II - Biologics - Medic Inc,"Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2015-08-10,2015-08-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71902 - Class II - Biologics - Medic Inc,"Blood product, in which quality control and distribution of product  did not meet specifications, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72314 - Class II - Biologics - Medic Inc,"Blood products, for which the quality control testing for residual white blood cell count was not performed, were distributed.",2015-10-09,2015-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72784 - Class III - Biologics - Medic Inc,"Apheresis products, for which quality control testing for pH as part of a process validation was not performed, were distributed.",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72902 - Class II - Biologics - Medic Inc,"Apheresis products for which pH testing was not performed, were distributed.",2016-01-07,2016-01-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72870 - Class III - Biologics - Medic Inc,"Platelet products, for which a quality control procedure was not performed, were distributed.",2016-01-27,2016-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73515 - Class II - Biologics - Medic Inc,"Apheresis products, for which quality control testing for residual white blood cell count was not performed, were distributed.",2016-03-22,2016-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74051 - Class II - Biologics - Medic Inc,"Platelet product, not prepared in accordance with specifications, was distributed.",2016-05-19,2016-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73891 - Class II - Biologics - Medic Inc,"Blood products, which did not meet the acceptable product specifications, were distributed.",2016-05-24,2016-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74335 - Class II - Biologics - Medic Inc,"Apheresis Platelet products for which pH testing was invalid, were distributed.",2016-06-10,2016-06-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74052 - Class III - Biologics - Medic Inc,"Blood products, in which labels applied to blood units or products incorrect or missing information, were distributed.",2016-06-13,2016-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74434 - Class III - Biologics - Medic Inc,"Pooled Cryoprecipitated AHF products, identified as unsuitable due to a component preparation deviation, were distributed.",2016-06-28,2016-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74914 - Class III - Biologics - Medic Inc,"Blood product, manufactured with insufficient Adsol added to product, was distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75840 - Class II - Biologics - Medic Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-01-05,2017-01-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76118 - Class II - Biologics - Medic Inc,"Blood products, which did not meet acceptable product specifications, were distributed.",2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76268 - Class II - Biologics - Medic Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2017-02-02,2017-02-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76334 - Class II - Biologics - Medic Inc,"Blood product, collected from a donor which warranted deferral or follow up after travel to a malarial endemic area, was distributed.",2017-02-28,2017-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76614 - Class III - Biologics - Medic Inc,"Blood products, whose testing was conducted with expired reagents/testing kits, were distributed.",2017-04-06,2017-04-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77348 - Class II - Biologics - Medic Inc,"Blood product, in which residual WBC count was not performed, was distributed.",2017-06-05,2017-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77972 - Class III - Biologics - Medic Inc,"Blood products, in which component preparation were not prepared in accordance with specifications, were distributed.",2017-09-25,2017-09-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78078 - Class II - Biologics - Medic Inc,"Blood products, for which donor screening was performed incorrectly, were distributed.",2017-09-29,2017-09-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78138 - Class II - Biologics - Medic Inc,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2017-10-13,2017-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78972 - Class II - Biologics - Medic Inc,"Blood products, collected from ineligible donors, were distributed.",2018-01-29,2018-01-29,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79014 - Class II - Biologics - Medic Inc,"Blood products, collected from donors who lived in malarial endemic areas, were distributed.
",2018-02-01,2018-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79504 - Class III - Biologics - Medic Inc,"Blood product, for which a unit received inadequate or  no additive solution, was distributed.
",2018-03-22,2018-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80105 - Class II - Biologics - Medic Inc,"Platelet products, which failed quality control testing for platelet count, were distributed.",2018-05-30,2018-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80106 - Class II - Biologics - Medic Inc,"Platelet products, which failed quality control testing for platelet yield were distributed.",2018-06-01,2018-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80385 - Class II - Biologics - Medic Inc,"Blood products, with a low platelet counts, were distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80854 - Class III - Biologics - Medic Inc,"Blood products, which were labeled with incorrect or missing information, were distributed.",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81309 - Class II - Biologics - Medic Inc,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81482 - Class II - Biologics - Medic Inc,"Plateletpheresis product, not prepared in accordance with specifications, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81833 - Class II - Biologics - Medic Inc,"Blood product, missing quality control testing, was distributed.",2019-02-01,2019-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82027 - Class II - Biologics - Medic Inc,"Apheresis products, in which residual WBC count was not performed, were distributed.
",2019-02-07,2019-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82062 - Class II - Biologics - Medic Inc,"Blood product, which was labeled without product volume, was distributed.",2019-03-04,2019-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82179 - Class II - Biologics - Medic Inc,"Blood product, collected from an ineligible donor, was distributed.
",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82549 - Class II - Biologics - Medic Inc,"Blood products, which did not meet acceptable product specifications, were distributed.",2019-05-17,2019-05-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83615 - Class II - Biologics - Medic Inc,"Plateletpheresis products, in which platelet yield did not meet specifications, were distributed.",2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85534 - Class II - Biologics - Medic Inc,"Leukoreduced Red Blood Cells, for which donor eligibility screening was incomplete, were distributed.",2020-05-01,2020-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85875 - Class II - Biologics - Medic Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2020-07-22,2020-07-22,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86823 - Class II - Biologics - Medic Inc,"Red Blood Cell product, collected from a donor who lived in a malarial endemic area, was distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87785 - Class II - Biologics - Medic Inc,"Blood product, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89349 - Class II - Biologics - Medic Inc,"Leukoreduced Red Blood Cells, for which donor eligibility screening was incomplete, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91543 - Class III - Biologics - Medic Inc,Misbranded Apheresis Red Blood Cell products were distributed.,2023-01-31,2023-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85217 - Class II - Drugs - Medical Center Pharmacy, Inc.",Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.,2020-04-01,2020-04-01,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70225 - Class III - Biologics - Medical Eye Bank of West Virginia, Inc.","Human corneas, recovered from an ineligible donor, were distributed.",2015-02-20,2015-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62797 - Class II - Biologics - Medical Information Technology, Inc.","Blood Bank Software, with a defect or glitch, was distributed.",2012-10-16,2012-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63162 - Class II - Biologics - Medical Information Technology, Inc.","Blood Bank Software, with a defect or glitch, was distributed.",2012-10-16,2012-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73342 - Class III - Drugs - Medical Park Homecare, Inc",CGMP Deviations: Cylinders filled using out of date gauges.,2016-03-15,2016-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68626 - Class II - Drugs - Medical Supply Liquidators Llc,Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer,2014-08-06,2014-08-06,15,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74725 - Class II - Drugs - Medicap Pharmacy,"Lack of Assurance of Sterility: Sterile products were not produced in a controlled, sterile environment.",2016-07-22,2016-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85869 - Class I - Drugs - Medichem S.A.,"Microbial contamination of Non-Sterile Product; detection
of the gram-negative bacillus Serratia marcescens in certain API batches",2020-08-21,2020-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86540 - Class II - Drugs - Medichem S.A.,Discoloration.,2020-11-02,2020-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65559 - Class II - Drugs - Medicis Pharmaceutical Corp,"cGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore Therapy",2013-08-22,2013-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61565 - Class III - Biologics - MedImmune, LLC","FluMist, Influenza Virus Vaccine, Live Intranasal, lacking assurance of proper temperature manintenance during shipment, was distributed.",2012-09-14,2012-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89356 - Class II - Drugs - Medique Products,CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.,2022-01-20,2022-01-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67531 - Class I - Drugs - Medisca Inc,"Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found instead.",2016-02-17,2016-02-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67114 - Class I - Drugs - Medisca Inc.,Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.,2014-04-25,2014-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76873 - Class II - Drugs - Medisca, Inc.",cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection,2017-04-12,2017-04-12,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78123 - Class II - Drugs - Medisca, Inc.",CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.,2017-09-20,2017-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84357 - Class II - Drugs - Medisca, Inc.",Failed Impurities/Degradation Specifications,2019-12-16,2019-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72163 - Class II - Drugs - Medistat RX L.L.C.,Lack of Assurance of Sterility,2015-09-29,2015-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79059 - Class II - Biologics - Meditech,"Blood bank software, with a defect or glitch, was distributed.",2018-02-06,2018-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73537 - Class II - Drugs - Meditech Laboratories, Inc","Superpotent Drug: one ingredient was found to be above assay specification., Lack of Assurance of Sterility: incomplete or missing data regarding production., Stability Does Not Support Expiry: manufactured with an active ingredient that expired before the labeled Beyond Use Date.",2016-04-01,2016-04-01,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78575 - Class II - Drugs - Medline Industries Inc,Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads  is below label claim of 0.85%.,2018-02-04,2018-02-04,68,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88005 - Class III - Drugs - Medline Industries Inc,"Superpotent Drug: Product is above specification for active ingredient, 2% Chlorhexidine Gluconate.",2021-06-10,2021-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89036 - Class II - Drugs - Medline Industries Inc,Defective Container: Customer complaints for leaking bottles and dispensing issues.,2021-12-17,2021-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72323 - Class I - Drugs - Medline Industries Inc,Labeling: Label Error on Declared Strength- Bottles containing 500 mg acetaminophen tablets mislabeled to contain 325 mg tablets.,2016-02-12,2016-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77936 - Class II - Drugs - Medline Industries Inc,Labeling Mixup; the individual A&D ointment foil packets are incorrectly labeled as petroleum jelly. The boxes and outer case are correctly labeled as A&D ointment.,2017-09-12,2017-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79267 - Class II - Drugs - Medline Industries Inc,Subpotent Drug: product not meeting the iodine assay level requirements through the labeled expiry.,2018-02-26,2018-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81381 - Class II - Drugs - Medline Industries Inc,Microbial Contamination of Non-Sterile Product,2018-11-15,2018-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86806 - Class II - Biologics - Medline Industries Inc,"A single lot of Influenza Vaccine, Fluzone, High Dose, Quadrivalent, 0.7 ml, single dose, pre-filled syringe, was shipped outside of the specified storage temperature range.",2020-11-27,2020-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88484 - Class III - Biologics - Medline Industries Inc,"Vaccines, in transit greater than allotted timeframe and potentially exceeding the required shipping temperature range, were distributed.",2021-12-22,2021-12-22,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80192 - Class II - Drugs - Medline Industries Inc (Northpoint Services),Microbial Contamination of a Non-Sterile Product.,2018-06-08,2018-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77428 - Class II - Drugs - MedPark Pharmacy, LLC",Lack of Assurance of Sterility,2017-06-07,2017-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62402 - Class II - Drugs - Medtech Products, Inc.",Subpotent (Single Ingredient) Drug: This product is being recalled because of sub-potency of the sennosides.,2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70932 - Class III - Drugs - Medtech Products, Inc.",Marketed without an approved NDA/ANDA: The distributed units of Monistat 1 Simple Cure include only the 1200 mg vaginal suppository; the approved NDA requires both a 1200 mg vaginal suppository and the 2% topical cream.,2015-05-13,2015-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71319 - Class II - Drugs - Medtech Products, Inc.","Labeling: Label Mix-Up: An incorrect book label for Sucrets Sore Throat, Cough & Dry Mouth Honey Lemon lozenges was applied to the underside of the Sucrets Sore Throat & Cough Vapor Cherry lozenges tin.",2015-06-01,2015-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82333 - Class II - Drugs - Medtech Products, Inc.",Incorrect/undeclared excipients: Kit carton bear incorrect labeling for two of the five items contained within the kit.,2019-03-20,2019-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83417 - Class II - Drugs - Medtech Products, Inc.",CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.,2019-08-16,2019-08-16,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62487 - Class II - Biologics - Meek Blood Center,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64142 - Class III - Biologics - Meek Blood Center,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70235 - Class III - Biologics - Meek Blood Center,"Blood product, collected from a donor with Polycythemia, was distributed.",2015-01-30,2015-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87224 - Class I - Drugs - Meitheal Pharmaceuticals Inc,"Labeling: Label mix-up: Carton of Cisatracurium Besylate Injection, USP was observed to contain ten vials mislabeled as Phenylephrine Hydrochloride Injection, USP, but confirmed to contain Cisatracurium",2021-02-22,2021-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88619 - Class III - Drugs - Meitheal Pharmaceuticals Inc,Failed Impurities/Degradation Specifications,2021-09-15,2021-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59504 - Class II - Biologics - Memorial Blood Centers,"Blood products, for which testing for hepatitis B surface antigen was invalid, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60492 - Class II - Biologics - Memorial Blood Centers,"Blood products, collected from donors whose arm preparation was inadequate, were distributed.",2012-07-13,2012-07-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62357 - Class III - Biologics - Memorial Blood Centers,"Blood product, labeled with an extended expiration date, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62359 - Class II - Biologics - Memorial Blood Centers,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62358 - Class II - Biologics - Memorial Blood Centers,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62905 - Class II - Biologics - Memorial Blood Centers,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-09-17,2012-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62903 - Class II - Biologics - Memorial Blood Centers,"Blood products,  with a low pH, was distributed.",2012-09-19,2012-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62904 - Class II - Biologics - Memorial Blood Centers,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2012-09-19,2012-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63133 - Class II - Biologics - Memorial Blood Centers,"Blood products, which were labeled as leukoreduced, but exceeded the White Blood Cell count limit, were distributed.",2012-10-10,2012-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63249 - Class II - Biologics - Memorial Blood Centers,"Blood products, which did not meet the acceptable product specifications, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63835 - Class III - Biologics - Memorial Blood Centers,"Blood product, collected in an expired collection bag, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63849 - Class II - Biologics - Memorial Blood Centers,"Blood products labeled as leukoreduced which did not meet the requirements for leukoreduced products, were distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63837 - Class II - Biologics - Memorial Blood Centers,"Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-01-16,2013-01-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64334 - Class II - Biologics - Memorial Blood Centers,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64335 - Class III - Biologics - Memorial Blood Centers,"Blood products, labeled with incorrect volume, were distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64336 - Class II - Biologics - Memorial Blood Centers,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-03-07,2013-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65052 - Class II - Biologics - Memorial Blood Centers,"Blood product, labeled leukoreduced which did not meet the requirements for a leukoreduced product, was distributed.

",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87018 - Class II - Drugs - Merck Sharp & Dohme,"Lack of assurance of sterility: The results of sterility tests of seven batches of product were out of specification. Five of these batches tested positive for Ralstonia pickettii and two batches produced turbid results that could not be further identified. While all product distributed to the market has met the registered specifications for release, including for sterility, it was manufactured on the same equipment as the affected batches.",2021-01-07,2021-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67344 - Class III - Drugs - Merck Sharp & Dohme,"This recall of LIPTRUZET is being initiated due to  packaging defects. Some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product., Defective Container; some of the outer laminate foil pouches allowed in air and moisture, which could potentially decrease the effectiveness or change the characteristics of the product.",2014-05-06,2014-05-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69684 - Class III - Biologics - Merck Sharp & Dohme,"A single lot of Sterile Diluent, with the potential for the lot number and expiry to be missing from the primary label, was distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88867 - Class I - Drugs - MERCK SHARP & DOHME CORP,Presence of Particulate Matter: Identified as Glass Particles,2021-11-03,2021-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89893 - Class II - Drugs - MERCK SHARP & DOHME CORP,Presence of foreign substance: Presence of stainless steel particulates in tablets.,2022-04-05,2022-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86633 - Class II - Biologics - Merck Sharp & Dohme Corp.,"Merck's GARDASIL 9, PNEUMOVAX and RECOMBIVAX HB vaccines, stored at temperatures outside their respective temperature specifications, were subsequently distributed",2020-11-16,2020-11-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72324 - Class II - Drugs - Merck Sharp & Dohme, Wilson Facility",Presence of Foreign Tablet/Capsule: Vytorin 10 mg/40 mg tablets were found in bottles of Vytorin 10 mg/20 mg tablets.,2015-10-05,2015-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65595 - Class III - Biologics - Merck Sharpe & Dohme Corp,"M-M-R II (Measles, Mumps and Rubella Virus Vaccine Live)was inadvertently distributed.",2013-07-11,2013-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68127 - Class II - Biologics - Merck Sharpe & Dohme Corp,"Recombivax HB, one lot with the potential for a crack to have occurred in the vial, was distributed.",2014-05-01,2014-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69245 - Class II - Biologics - Merck Sharpe & Dohme Corp,"GARDASIL, one lot with the potential for small glass particles to be present in the vial, was distributed.",2014-09-22,2014-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76417 - Class III - Biologics - Mercy Health Youngstown,Misbranded red blood cells were distributed.,2017-03-07,2017-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50433 - Class III - Biologics - Mercy Hospital St Louis,"Blood product, collected from a donor whose body temperature was not documented, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64590 - Class II - Biologics - Mercy Hospital St Louis,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64591 - Class II - Biologics - Mercy Hospital St Louis,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-15,2013-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40744 - Class II - Biologics - Mercy Medical Center,"Blood product, which tested negative for HIV, but was collected from a donor who previously tested positive for anti-HIV 1//2, was distributed.",2012-08-24,2012-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41485 - Class II - Biologics - Mercy Medical Center,"Blood product, which tested negative for HIV, but was collected from a donor who previously tested positive for anti-HIV1/2, was distributed.",2012-08-24,2012-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41475 - Class II - Biologics - Mercy Medical Center Blood Bank,"Blood product, which tested negative for hepatitis, but was collected from a donor who previously tested positive for the antibody to hepatitis B core antigen (anti-HBcore) on two separate occasions, was distributed.",2012-08-21,2012-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50646 - Class III - Biologics - Mercy Medical Center Blood Bank,"Blood products, collected using a machine for which quality control testing was not performed, were distributed",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76789 - Class I - Drugs - Meridian Medical Technologies a Pfizer Company,Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication,2017-04-28,2017-04-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62015 - Class II - Drugs - Meridian Medical Technologies, Inc. dba Meridian Medical Technologies, Inc. a Pfizer Company","Impurities/Degradation Products: High Out of Specification levels for carbostyril, a known degradation product of diazepam.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #35255 - Class I - Drugs - Merit Medical Systems, Inc",Lack of Assurance of Sterility: Procedure kits contain a balanced salt solution that may be contaminated with endotoxins.,2012-11-06,2012-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76027 - Class II - Drugs - Meta Pharmacy Services,Lack of Sterility Assurance,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60941 - Class III - Biologics - Metro Blood Services,Unlicensed blood products were distributed in interstate commerce.,2012-07-09,2012-07-09,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61972 - Class II - Biologics - Michigan Blood,"Blood products, possibly contaminated with air, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61973 - Class III - Biologics - Michigan Blood,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63039 - Class II - Biologics - Michigan Blood,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-10-01,2012-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63132 - Class II - Biologics - Michigan Blood,"Blood products,  which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-10-10,2012-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63961 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64333 - Class II - Biologics - Michigan Blood,"Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65596 - Class II - Biologics - Michigan Blood,"Blood product, which did not meet the acceptable product specification for release, was distributed.
",2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65682 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor considered to be at increased risk for Creutzfeldt-Jakob Disease (CJD), was distributed.",2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66229 - Class III - Biologics - Michigan Blood,"Blood products, collected using an automated collection device that was not validated after repairs, were distributed.",2013-10-21,2013-10-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66477 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor who was previously deferred, were distributed.",2013-10-31,2013-10-31,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66702 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 

",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67220 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68173 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-06-11,2014-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68559 - Class II - Biologics - Michigan Blood,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2014-07-18,2014-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68560 - Class III - Biologics - Michigan Blood,"Blood products, collected from a donor for whom there was no documentation of an arm inspection, were distributed.",2014-07-23,2014-07-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68562 - Class III - Biologics - Michigan Blood,"Blood product, manufactured without the entire quantity of additive solution, was distributed.",2014-07-23,2014-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68928 - Class III - Biologics - Michigan Blood,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69274 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2014-10-08,2014-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69777 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69909 - Class III - Biologics - Michigan Blood,"Blood products, collected from a donor for whom there was no documentation of an arm inspection, were distributed.",2015-01-15,2015-01-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70006 - Class II - Biologics - Michigan Blood,"Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2015-01-26,2015-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68106 - Class III - Biologics - Michigan Blood,"Blood products, collected from ineligible donors, were distributed.",2015-01-29,2015-01-29,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70204 - Class II - Biologics - Michigan Blood,"Blood products, for which the WBC test procedure was not performed but labeled as leukoreduced, were distributed.",2015-02-04,2015-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70446 - Class II - Biologics - Michigan Blood,"Blood product, possibly contaminated with air, was distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70981 - Class II - Biologics - Michigan Blood,"Blood product, which was labeled as leukoreduced, but was not tested to verify white blood cell count, was distributed.",2015-04-17,2015-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71109 - Class II - Biologics - Michigan Blood,"Blood product, for which an associated plasma collection bag had a defect which may have led to sterility being compromised, was distributed.",2015-05-19,2015-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71252 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor who was taking the medication Proscar, were distributed.",2015-05-27,2015-05-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72021 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2015-09-03,2015-09-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71856 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor who was taking the medication Proscar, were distributed.",2015-09-08,2015-09-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72336 - Class II - Biologics - Michigan Blood,"Platelet Pheresis product, labled as leuko reduced, in which WBC testing was not performed, was distributed.",2015-10-23,2015-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72264 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-11-05,2015-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72954 - Class III - Biologics - Michigan Blood,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed",2016-02-18,2016-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73622 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-04-08,2016-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73804 - Class II - Biologics - Michigan Blood,"Blood products, in which donor screening/donor record incomplete or incorrect, were distributed.",2016-04-28,2016-04-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74122 - Class II - Biologics - Michigan Blood,"Blood product, altered in a manner that possibly compromised sterility, was distributed.",2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74218 - Class II - Biologics - Michigan Blood,"Blood product, possibly contaminated with air, was distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74405 - Class II - Biologics - Michigan Blood,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74978 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2016-08-26,2016-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75245 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor possibly at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-10-18,2016-10-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75542 - Class II - Biologics - Michigan Blood,"Apheresis product, associated with a unit that was found to contain a leak, was distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75543 - Class II - Biologics - Michigan Blood,"Blood product, which was labeled as leukoreduced, but was not tested to verify the White Blood Cell count, was distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75672 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-12-09,2016-12-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76747 - Class III - Biologics - Michigan Blood,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-04-27,2017-04-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77079 - Class II - Biologics - Michigan Blood,"Blood products, for which the donor gave history which warranted deferral and was not deferred, were distributed.",2017-05-03,2017-05-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77156 - Class III - Biologics - Michigan Blood,"Blood product, in which donor gave history which warranted deferral or follow up was not deferred or follow up questions was not asked, was distributed.",2017-05-30,2017-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78855 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2018-01-23,2018-01-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78856 - Class II - Biologics - Michigan Blood,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-01-23,2018-01-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78871 - Class II - Biologics - Michigan Blood,"Blood products, for which the donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2018-01-24,2018-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78915 - Class III - Biologics - Michigan Blood,"Blood products, which were not prepared within the appropriate time frame after collection, were distributed.",2018-01-25,2018-01-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78870 - Class III - Biologics - Michigan Blood,"Blood product, collected from a donor for whom there no documentation of an arm inspection, were distributed.",2018-02-15,2018-02-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79286 - Class II - Biologics - Michigan Blood,"Blood products, collected from an ineligible donor, were distributed.",2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79222 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-03-05,2018-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79747 - Class III - Biologics - Michigan Blood,"Red Blood Cells, not meeting product specifications, were distributed.",2018-05-18,2018-05-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80413 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2018-07-12,2018-07-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80794 - Class II - Biologics - Michigan Blood,"Blood products, collected from a donor with a reading impairment, were distributed.",2018-09-06,2018-09-06,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80990 - Class II - Biologics - Michigan Blood,"Blood product, which tested positive for a red cell antibody that interfered with serological testing, was distributed.",2018-10-18,2018-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81619 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-11-30,2018-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81622 - Class II - Biologics - Michigan Blood,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-11-30,2018-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81716 - Class III - Biologics - Michigan Blood,"Blood product, collected from an ineligible donor, was distributed.",2018-12-13,2018-12-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81718 - Class III - Biologics - Michigan Blood,"Blood product, collected from an ineligible donor, was distributed.",2018-12-18,2018-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81732 - Class II - Biologics - Michigan Blood,"Apheresis blood product, which failed quality control specifications for white cell count due to a lack of validation testing, was distributed.",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85854 - Class I - Drugs - MICHIGAN HERBAL REMEDIES,"Chemical Contamination: product contains elevated levels of undeclared lead., Chemical contamination: product contains elevated levels of undeclared lead.",2020-08-04,2020-08-04,36,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69133 - Class II - Drugs - Micro Labs Usa, Inc                                    S",Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.,2014-10-27,2014-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69268 - Class III - Drugs - Micro Labs Usa, Inc                                    S",Failed Impurities/Degradation Specifications: Product failed Impurity content (Butylated Hydroxy Anisole Content) against shelf life specification.,2014-11-12,2014-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69590 - Class II - Drugs - Micro Labs Usa, Inc                                    S",Failed Content Uniformity Specifications; Dry mix failed blend uniformity.,2014-11-18,2014-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69928 - Class III - Drugs - Micro Labs Usa, Inc                                    S",Failed Impurities/Degradation Specifications: Product failed a known impurity specification.,2015-03-11,2015-03-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #32594 - Class II - Biologics - Micro Typing Systems Inc.,"ORTHO ProVue, with a software glitch or defect that could lead to erroneuous results, was distributed.",2012-07-30,2012-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63902 - Class II - Biologics - Micro Typing Systems, Inc.","In-vitro diagnostic test cards, associated with complaints of an incomplete foil seal for specific lots of ID-Micro Typing System Gel Cards, were distributed.",2013-01-14,2013-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64576 - Class II - Biologics - Micro Typing Systems, Inc.","In-vitro diagnostic test cards, associated with complaints of an incomplete foil seal for specific lots of ID-Micro Typing System Gel Cards, were distributed.",2013-03-29,2013-03-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69018 - Class III - Biologics - Micro Typing Systems, Inc.","MTS A/B/D Monoclonal and Reverse Grouping Cards, with the potential for false positive reactions with some lots, were distributed.",2014-09-12,2014-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76580 - Class III - Biologics - Micro Typing Systems, Inc.","Specific lots of MTS Anti-IgG Card lots that may exhibit a varying low-level activity of anti-complement that may result in a false positive test, were distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67669 - Class II - Biologics - Mid-America Transplant Services,"Human corneas, recovered from a donor who was not properly evaluated for hemodilution, were distributed.",2014-03-06,2014-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67825 - Class II - Biologics - Mid-America Transplant Services,"Human Corneas, recovered from donors whose donor eligibility was not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.",2014-04-25,2014-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71088 - Class III - Biologics - Mid-America Transplant Services,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2015-04-30,2015-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71089 - Class II - Biologics - Mid-America Transplant Services,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2015-04-30,2015-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71090 - Class II - Biologics - Mid-America Transplant Services,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2015-04-30,2015-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72005 - Class II - Biologics - Mid-America Transplant Services,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2015-08-21,2015-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72006 - Class II - Biologics - Mid-America Transplant Services,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2015-08-21,2015-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64049 - Class II - Biologics - Mid-South Regional Blood Center,"Blood products, which were collected from a donor who traveled to malarial endemic area, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64088 - Class II - Biologics - Mid-South Regional Blood Center,"Blood products, with pH below the acceptable level, were distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65961 - Class II - Biologics - Mid-South Regional Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-09-09,2013-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66481 - Class II - Biologics - Mid-South Regional Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-10-31,2013-10-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66783 - Class II - Biologics - Mid-South Regional Blood Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67394 - Class II - Biologics - Mid-South Regional Blood Center,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67705 - Class II - Biologics - Mid-South Regional Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2014-04-18,2014-04-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72531 - Class II - Biologics - Mid-South Regional Blood Center,"Apheresis product, for which the residual white blood cell count testing did not meet specifications, was distributed.
",2015-12-02,2015-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76531 - Class III - Biologics - Mid-South Regional Blood Center,"Blood product, whose relevant Transfusion-Transmitted Infection Testing was performed incorrectly, was distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76621 - Class II - Biologics - Mid-South Regional Blood Center,"Blood products, manufactured using the wrong collection set, were distributed.",2017-03-30,2017-03-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77021 - Class II - Biologics - Mid-South Regional Blood Center,"Blood products, collected from an ineligible donor, were distributed.",2017-04-20,2017-04-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78049 - Class II - Drugs - Mid Valley Pharmaceutical,CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.,2017-09-11,2017-09-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90756 - Class II - Drugs - Midlab Incorporated,"CGMP Deviations: Product manufactured using expired active ingredient, Benzalkonium chloride.",2022-08-25,2022-08-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65633 - Class II - Biologics - Midsouth Eye Bank for Sight Restoration Inc,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-08-13,2013-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72240 - Class II - Drugs - Midway Importing, Inc",Cross Contamination With Other Products: Potential cross-contamination of cephalosporin.,2015-10-13,2015-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80042 - Class II - Drugs - Milbar Laboratories, Inc.","Microbial Contamination of Non-sterile Product, GMP Deviations",2018-05-15,2018-05-15,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80045 - Class III - Drugs - Milbar Laboratories, Inc.",Subpotent,2018-05-22,2018-05-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86579 - Class II - Drugs - Milbar Laboratories, Inc.",GMP Deviations,2020-11-17,2020-11-17,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79083 - Class II - Drugs - Millennium Pharmaceuticals Inc.,Defective Container: Confirmed reports of loose vial crimps.,2018-02-14,2018-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63864 - Class III - Biologics - Millipore (UK) Ltd.,"Single lot of Blood Grouping Reagent For Further Manufacturing Use, with a stability test point failure, was distributed.",2013-01-09,2013-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85372 - Class II - Biologics - MiMedx Group, Inc.","Human amniotic membrane allografts, recovered from donors whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2020-04-03,2020-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80868 - Class II - Biologics - Minnesota Lions Eye Bank,"Human corneas, recovered from a donor who was not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2018-08-21,2018-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82466 - Class II - Biologics - Minnesota Lions Eye Bank,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2019-03-25,2019-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68054 - Class II - Biologics - Minnesota Lions Eye Bank, Inc","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-05-13,2014-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68451 - Class III - Biologics - Minnesota Lions Eye Bank, Inc","Human Corneas, processed with a corneal preservation media that was not verified to meet specification for use, were distributed.",2014-06-13,2014-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76397 - Class II - Biologics - Minnesota Lions Eye Bank, Inc","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2017-02-07,2017-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65772 - Class I - Drugs - Mira Health Products Ltd.,"Marketed without an Approved NDA/ANDA; product found to contain methasterone and dimethazine which are steroid and/or steroid-like drug ingredients, making it an unapproved new drug, Marketed without an Approved NDA/ANDA; product contains the steroid ingredient 2, 17a-dimethyl-17b-hydroxy-5a-androst-1-en-3-one, making it an unapproved new drug, Marketed without an Approved NDA/ANDA; product found to contain dimethazine which is a steroid and/or steroid-like drug ingredient, making it an unapproved new drug",2014-03-05,2014-03-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87981 - Class I - Drugs - Miracle Joe,Marketed without an approved NDA/ANDA - Product found to be tainted with Sildenafil and Tadalafil.,2021-06-22,2021-06-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64149 - Class III - Drugs - Mission Pharmacal Co,Superpotent: Drug product active ingredients were formulated incorrectly (too high) with respect to the label strength.,2013-06-14,2013-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71072 - Class II - Drugs - Mission Pharmacal Co,Microbial Contamination of Non-Sterile Products: Product failed USP Microbial Limits Test.,2015-05-11,2015-05-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62825 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, which did not meet the acceptable product specifications, were distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63350 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63778 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64380 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, collected from a donor who reported living in a malarial endemic area within the past three years, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64843 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-05-08,2013-05-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65197 - Class III - Biologics - Mississippi Blood Services Inc.,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65402 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-07-08,2013-07-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65846 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-08-29,2013-08-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66127 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from donors whose suitability to donate was not adequately determined, were distributed.",2013-09-17,2013-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67452 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-02-21,2014-02-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67552 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-03-07,2014-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68477 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2014-07-18,2014-07-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69006 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-09-15,2014-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69217 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-10-06,2014-10-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69503 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-11-17,2014-11-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69700 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-12-11,2014-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70619 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70563 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-04-02,2015-04-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70812 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, which did not meet the acceptable product specifications, were distributed.",2015-05-06,2015-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71035 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-05-29,2015-05-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71624 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2015-08-13,2015-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72239 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2015-10-09,2015-10-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72080 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed., Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2015-10-15,2015-10-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73227 - Class II - Biologics - Mississippi Blood Services Inc.,"Apheresis products, in which leuko reduced units did not meet WBC count specification, were distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74351 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor who received a piercing within one year of donation, were distributed.",2016-06-14,2016-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74074 - Class III - Biologics - Mississippi Blood Services Inc.,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2016-06-17,2016-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74431 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-06-28,2016-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74699 - Class II - Biologics - Mississippi Blood Services Inc.,"Apheresis product, collected from a donor with a HTLV repeatedly reactive donation was distributed.",2016-08-05,2016-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74481 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-08-08,2016-08-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74754 - Class III - Biologics - Mississippi Blood Services Inc.,"Blood product, for which donor suitability was incorrectly performed, was distributed.",2016-08-26,2016-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75117 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-09-19,2016-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75541 - Class II - Biologics - Mississippi Blood Services Inc.,"Apheresis product collected from a donor who traveled to a malaria endemic area, was distributed.",2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75362 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2016-11-17,2016-11-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75668 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-12-16,2016-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75962 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from donors for whom eligibility was inadequately determined, were distributed.",2017-01-09,2017-01-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76169 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-02-21,2017-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76645 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor for whom  eligibility screening was performed incorrectly, were distributed.",2017-03-15,2017-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78413 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor whose suitability was not adequately determined, were distributed.",2017-12-04,2017-12-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78954 - Class III - Biologics - Mississippi Blood Services Inc.,"Leukoreduced Red Blood Cells, not meeting product specifications, were distributed.",2018-02-08,2018-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79143 - Class II - Biologics - Mississippi Blood Services Inc.,"Platelet product, collected from an ineligible donor, was distributed.",2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79416 - Class II - Biologics - Mississippi Blood Services Inc.,"Apheresis products for which quality control procedures were not performed, were distributed.
",2018-03-16,2018-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79971 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, that tested positive for the antibodies to human T lymphotropic virus, types I and/or II (anti-HTLV-I/II), were distributed.",2018-06-05,2018-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80258 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-06-26,2018-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81447 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from an ineligible donor, were distributed.",2018-11-01,2018-11-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82206 - Class II - Biologics - Mississippi Blood Services Inc.,"Apheresis products, not meeting product specifications, were distributed.
",2019-03-13,2019-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83256 - Class II - Biologics - Mississippi Blood Services Inc.,"Plateletpheresis products for which quality control procedures were not performed, were distributed.
",2019-08-01,2019-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83724 - Class III - Biologics - Mississippi Blood Services Inc.,"Apheresis Red Blood Cell product, not meeting product specifications, was distributed.
",2019-09-16,2019-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83874 - Class II - Biologics - Mississippi Blood Services Inc.,"Red Blood Cells, not meeting proper storage and manufacturing specifications, were distributed.",2019-10-02,2019-10-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83953 - Class II - Biologics - Mississippi Blood Services Inc.,"Plateletpheresis products, in which platelet yield did not meet specifications, were distributed.
",2019-10-10,2019-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84806 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2020-02-05,2020-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84893 - Class II - Biologics - Mississippi Blood Services Inc.,"Plateletpheresis product, for which Chagas Disease testing was not performed, was distributed.
",2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84867 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, which did not meet the acceptable product specifications, were distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85305 - Class III - Biologics - Mississippi Blood Services Inc.,"Apheresis Red Blood Cell products, not meeting product specifications, were distributed.",2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85519 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2020-04-24,2020-04-24,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86031 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2020-08-07,2020-08-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86861 - Class II - Biologics - Mississippi Blood Services Inc.,"Blood product, not meeting product specifications, was distributed.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88470 - Class II - Biologics - Mississippi Blood Services Inc.,"Leukoreduced Red Blood Cells, which were labeled as leukocytes reduced but failed monthly QC residual white cell count, were distributed.",2021-09-02,2021-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88716 - Class III - Biologics - Mississippi Blood Services Inc.,"Red Blood Cell products, exposed to unacceptable shipping temperatures, were distributed.",2021-09-24,2021-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88712 - Class II - Biologics - Mississippi Blood Services Inc.,"Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count, were distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90130 - Class II - Biologics - Mississippi Blood Services Inc.,"Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-05-25,2022-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90263 - Class III - Biologics - Mississippi Blood Services Inc.,"Red Blood Cell products, which were exposed to unacceptable storage/shipping conditions, were distributed.
",2022-06-07,2022-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91396 - Class II - Biologics - Mississippi Blood Services Inc.,"Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count, were distributed.",2022-12-30,2022-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91399 - Class II - Biologics - Mississippi Blood Services Inc.,"Platelets, Pathogen Reduced, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count, were distributed.",2022-12-30,2022-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91401 - Class II - Biologics - Mississippi Blood Services Inc.,"Platelet product, for which platelet yield did not meet specifications, was distributed.
",2023-01-04,2023-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91583 - Class II - Biologics - Mississippi Blood Services Inc.,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2023-02-10,2023-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91668 - Class II - Biologics - Mississippi Blood Services Inc.,"Leukoreduced Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2023-02-15,2023-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61991 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, mislabeled as to antigen phenotype, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49636 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, which were labeled with an incorrect volume, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42223 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, manufactured without the entire quantity of additive solution, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42583 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45109 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45717 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which was collected in a collection system that  had product integrity compromised during component preparation, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46972 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products,  which did not meet acceptable product specifications, were distributed.",2012-07-19,2012-07-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47296 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-07-31,2012-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45108 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39115 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood Products, collected from a donor who received varicella zoster vaccine less than 28 days before donating, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42410 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47112 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor with a reactive syphilis screening test (RPR), was distributed.

",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47613 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, manufactured from an apheresis unit with platelet yield that did not meet the criteria to be split unit, were distributed.",2012-08-06,2012-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62723 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who reported travel through a malarial endemic area, was distributed.",2012-09-13,2012-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45107 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, which were collected from a donor who was taking the medication Bactrim, were distributed.",2012-09-17,2012-09-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62863 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, which were collected from a donor who traveled to malarial endemic areas, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62902 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, manufactured with an undetermined quantity of additive solution, was distributed.
",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39103 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39114 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, which were collected from a donor who traveled to malarial endemic areas, were distributed.",2012-10-19,2012-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39107 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, for which the quality control testing was incomplete or not performed , were distributed.
",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39106 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, for which the quality control testing was incomplete, were distributed.",2012-11-14,2012-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39109 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, for which the quality control testing was incomplete, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39105 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products,  with incomplete documentation of the irradiation process, were distributed.",2012-11-16,2012-11-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39111 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44686 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, for which the quality control testing was incomplete, was distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63639 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39104 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-12-07,2012-12-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39108 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who disclosed taking  a daily dose of Aspirin , was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39986 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, manufactured from an overweight whole blood unit, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40385 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40843 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which did not have the correct amount of  red cell preservative solution added, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41266 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, which did not meet the acceptable product specifications, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41456 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which tested as CMV positive but labeled as CMV negative, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43300 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from donors whose arm scrubs were performed using expired cleanser, were distributed.",2012-12-07,2012-12-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44079 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected using equipment for which quality control was not performed, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50036 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50641 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product,  labeling/crossmatch tag incorrect or missing information was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50651 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which did not meet the acceptable product specifications, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40856 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor with non-confirmed repeat reactive HBsAg, was distributed..",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41055 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product,  which tested as CMV positive but labeled as CMV negative, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41270 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49706 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, manufactured without the entire quantity of additive solution, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49635 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, held in transit storage container for 24 hours and possibly exposed to unacceptable temperatures, were distributed.",2013-01-04,2013-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64280 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, expired unit returned to the firm was inappropriately re-labeled, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64400 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64768 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which did not meet acceptable product specifications, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41454 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, whose Viral Testing/Testing was performed, interpreted, or documented incorrectly, were distributed.",2013-06-06,2013-06-06,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65796 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, with outdated satellite bags attached, were distributed.",2013-08-29,2013-08-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66376 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, with insufficient red cell preservative solution added, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66853 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who reported travel to a malarial endemic area, were distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66854 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which contained anti-Fya but was not labeled as positive for an unexpected antibody, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67337 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-02-18,2014-02-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67451 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which was labeled as leukoreduced, but exceeded the acceptable limit for white blood cell count for leukoreduced products, was distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67827 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, labeled leukoreduced which did not meet the requirements for a leukoreduced product, was distributed.",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68115 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, with platelet concentration below the specified minimum requirement, was distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68117 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2014-06-09,2014-06-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68412 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2014-06-26,2014-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68711 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which was also tested as part of a clinical trial, but was not handled according to protocol, was distributed.",2014-08-13,2014-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68712 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who emigrated from a malarial endemic country, was distributed.",2014-08-13,2014-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69859 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, possibly contaminated with air, were distributed.",2014-12-18,2014-12-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69990 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, not prepared according to  specifications, was distributed.",2015-01-26,2015-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70637 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who emigrated from an area considered endemic for malaria, was distributed.",2015-03-24,2015-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70717 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor with high risk behavior(s), were distributed.",2015-04-24,2015-04-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70902 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, in which Quality Control and Distribution of product did not meet specifications, was distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71199 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-05-19,2015-05-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70947 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who had traveled to a malarial endemic region within 12 months of donation, was distributed.",2015-05-21,2015-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71554 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, for which the quality control testing was incomplete, was distributed.",2015-07-13,2015-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71568 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2015-08-05,2015-08-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72004 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, in which quality control and distribution of product  did not meet specifications, was distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72032 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-10-01,2015-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72315 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-11-09,2015-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72610 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, with incomplete documentation of the irradiation process, was distributed.",2015-12-07,2015-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72758 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which was collected from a donor who had traveled to a malarial endemic area, was distributed.",2015-12-15,2015-12-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73310 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2016-03-17,2016-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73729 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from an ineligible donor, were distributed.",2016-04-08,2016-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73523 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, exposed to unacceptable temperatures during storage, were distributed.",2016-04-11,2016-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74260 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-06-23,2016-06-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74304 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74385 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, in which routine resting and/or performed, interpreted or documented incorrectly, was distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74383 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-07-17,2016-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74688 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-07-21,2016-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75103 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-09-19,2016-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75327 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from an ineligible donor, were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75344 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75480 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, in which no documentation that products were shipped or stored at appropriate temperature, were distributed.",2016-11-14,2016-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76100 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from an ineligible donor, were distributed.",2017-02-07,2017-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76381 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, in which donor history warranted deferral or follow up questions were not asked, were distributed.",2017-03-16,2017-03-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76451 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, manufactured without the entire quantity of additive solution, was distributed.",2017-03-16,2017-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76950 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,Blood product collected from a donor who traveled to a malarial endemic area was distributed.,2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76998 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2017-05-15,2017-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77215 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, which did not meet acceptable product specifications, were distributed",2017-05-31,2017-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77537 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who had taken aspirin, was distributed.",2017-06-27,2017-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77745 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Apheresis products, which may have been exposed to unacceptable temperatures during shipment, were distributed.",2017-07-26,2017-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77821 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2017-08-02,2017-08-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78264 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Misbranded red blood cell, was distributed.",2017-10-19,2017-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78509 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product collected from a donor who traveled to a malarial endemic area, was distributed.",2017-11-15,2017-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78510 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products for which the donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2017-11-29,2017-11-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78603 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, for which the donor gave history which warranted deferral and was not deferred, were distributed.",2017-12-19,2017-12-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78895 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from an ineligible donor, was distributed.",2018-02-12,2018-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78896 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from an ineligible donor, was distributed.",2018-02-21,2018-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79307 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2018-03-15,2018-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79657 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Red Blood Cell, collected from an ineligible donor, was distributed.",2018-04-02,2018-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80396 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, for which antigen typing was not  performed, but labeled as negative, was distributed.",2018-07-24,2018-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80594 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected in a collection system that may have compromised the sterility of the closed system, was distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80935 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-10-12,2018-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81389 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from an ineligible donor, was distributed.",2018-10-26,2018-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81455 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from an ineligible donor, were distributed.",2018-11-01,2018-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81308 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81720 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who had recently traveled to a malaria endemic area, was distributed.",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82057 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82058 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products collected from a donor who traveled to a malarial endemic area, were distributed.
",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82360 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,-,2019-04-11,2019-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82358 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, incorrectly tested and labeled for a red cell antigen, were distributed.",2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82359 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who was a resident of a malarial endemic area, were distributed.",2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82569 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor who emigrated from an area considered endemic for malaria, were distributed.",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82588 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected in a manner that may compromise the sterility of the closed system, was distributed.",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82734 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, in which donor testing was not performed or incomplete, were distributed.",2019-06-03,2019-06-03,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82928 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product, collected from a donor who was a resident in a malarial endemic area, was distributed.",2019-06-24,2019-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83092 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from an ineligible donor, were distributed.",2019-06-27,2019-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83068 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Leukocyte reduced red blood cell product, manufactured with no additive solution added to the storage bag, was distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83275 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood product where transfusion-transmitted infection testing was incorrectly performed,  was distributed.",2019-07-11,2019-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83091 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected during a software error with blood mixers, were distributed.",2019-07-26,2019-07-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83277 - Class II - Biologics - Mississippi Valley Reg Bld Ctr,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2019-08-05,2019-08-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83486 - Class III - Biologics - Mississippi Valley Reg Bld Ctr,"Apheresis Red Blood Cell product, labeled with an incorrect volume, was distributed

",2019-08-13,2019-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85451 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced, Apheresis Red Blood Cells, which were labeled as leukocytes reduced but failed QC for the daily  high control result, were distributed .",2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84304 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Plateletpheresis products in which quality control for white blood cell count testing was not performed, were distributed.
",2019-11-26,2019-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85707 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85812 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Red Blood Cell product, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85785 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced Platelets, for which donor eligibility screening was incomplete, were distributed.",2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85778 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Blood products, which did not meet acceptable product specifications, were distributed.",2020-06-26,2020-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85779 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Blood product, which were collected from a donor who traveled to a malarial endemic area, was distributed.",2020-06-26,2020-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85780 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2020-06-26,2020-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85967 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Irradiated Plateletpheresis products, not prepared according to specifications, were distributed.",2020-07-14,2020-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86425 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Blood product, not meeting product specifications, was distributed.",2020-09-15,2020-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86840 - Class II - Biologics - Mississippi Valley Regional  Blood Center,Misbranded Leukoreduced Red Blood Cells were distributed.,2020-12-02,2020-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86841 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Blood Products, collected from a donor who had recently traveled to a malaria endemic area, were distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86920 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced, Apheresis Red Blood Cells, not meeting product specifications for volume, were distributed.",2020-12-09,2020-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87357 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Misbranded Apheresis Red Blood product was distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87519 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Plateletpheresis products, for which quality control for white blood cell count testing was not performed, were distributed.
",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87520 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Blood products, which were incorrectly labeled for red cell antigens, were distributed.

",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87679 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Blood product, which did not meet the acceptable product specifications, was distributed.",2021-04-10,2021-04-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87692 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced apheresis red blood cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-04-27,2021-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87718 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Blood product, manufactured using an expired blood collection bag, was distributed.",2021-04-27,2021-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87955 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Blood products,manufactured using an expired blood collection bags, were distributed.
",2021-06-03,2021-06-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88357 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Platelepheresis products, collected under conditions where sterility of the products may have been compromised, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88472 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Red Blood Cell product, not meeting product specifications, was distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88788 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Blood products, collected using a faulty mixing scale, were distributed.",2021-10-08,2021-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88779 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Blood product, which was labeled with an incorrect product code, was distributed",2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88831 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88897 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Red Blood Cell products, exposed to unacceptable shipping temperatures, were distributed.",2021-11-03,2021-11-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89026 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Blood Products, in which CMV testing was performed incorrectly, were distributed.",2021-11-18,2021-11-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88970 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced Red Blood Cells, collected from a donor who emigrated from a malarial endemic area, were distributed.",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89025 - Class III - Biologics - Mississippi Valley Regional  Blood Center,"Blood products, labeled with incorrect volumes, were distributed.
",2021-12-09,2021-12-09,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89048 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced Apheresis Platelets, with a platelet count below the acceptable level, were distributed.",2021-12-09,2021-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89194 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced Red Blood Cells, Irradiated, Washed, labeled with the incorrect product volume, were distributed.",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89197 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Apheresis Platelets, from a donor who was taking aspirin, were distributed.",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89318 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Red Blood Cell product, collected from a donor who was taking antibiotics, was distributed.
",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89622 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Plateletpheresis product, for which platelet yield did not meet specifications, was distributed.
",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89623 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced Apheresis Platelets, with a platelet count higher than is acceptable, were distributed.",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89786 - Class II - Biologics - Mississippi Valley Regional  Blood Center,"Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2022-03-30,2022-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44183 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood product, collected using apheresis kits with small detected leaks, was distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43441 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43734 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43919 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47979 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49324 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood products, which component preparation were not prepared in accordance with specifications, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44021 - Class III - Biologics - Mississippi Valley Regional Blood Center,"Blood product, which was manufactured from whole blood units in which collection extended beyond the allowable time limits, was distributed.
",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73399 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood products, incorrectly tested for antibodies to HCV (anti-HCV), were distributed.",2016-03-07,2016-03-07,20,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79821 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood products, that lacked assurance of proper storage temperatures, were distributed.",2018-05-21,2018-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81495 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Blood product, collected from an ineligible donor, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82771 - Class III - Biologics - Mississippi Valley Regional Blood Center,"Misbranded plasmapheresis product was distributed.
",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83069 - Class II - Biologics - Mississippi Valley Regional Blood Center,"Leukoreduced Red Blood Cell product, collected from a donor who lived in a malarial endemic area, was distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64018 - Class I - Drugs - Mobius Therapeutics LLC,Non-Sterility: one or more components of the kit have been found to be contaminated with yeast.,2013-07-19,2013-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88598 - Class III - Drugs - Monarch PCM, LLC",Subpotency: one product for active ingredient assay and another one for preservative assay,2021-09-20,2021-09-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88755 - Class II - Drugs - Monarch PCM, LLC",Finished product specification did not meet USP specifications.,2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90062 - Class III - Drugs - Monarch PCM, LLC",Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content,2022-05-17,2022-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71275 - Class II - Drugs - Montana Compounding Pharmacy,Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection,2015-06-09,2015-06-09,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76235 - Class II - Drugs - MOORE'S COMPOUNDING PHARMACY,Superpotent Drug and Subpotent Drug; potency failures obtained,2017-02-21,2017-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61818 - Class III - Drugs - Morton Chemi Co,"Impurities/Degradation Products: The product was found to contain a slightly out of specification level of bromides, exceeding the bromides limit for USP Sodium Chloride.",2012-08-20,2012-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88629 - Class II - Drugs - Morton Grove Pharmaceuticals, Inc.",CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.,2021-09-20,2021-09-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89624 - Class II - Drugs - Morton Grove Pharmaceuticals, Inc.",Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.,2022-03-21,2022-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72876 - Class III - Drugs - Morton Grove Pharmaceuticals, Inc.",Super-Potent Drug: Out of Specification Assay test results were reported for stability samples.,2016-01-15,2016-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77933 - Class II - Drugs - Morton Grove Pharmaceuticals, Inc.",Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.,2017-08-29,2017-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80386 - Class II - Drugs - Morton Grove Pharmaceuticals, Inc.",Defective Container:  Tamper Evident  foil seal not completely intact.,2018-08-03,2018-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83858 - Class II - Drugs - Morton Grove Pharmaceuticals, Inc.",Failed Impurities/Degradation Specifications - failed specs for Prednisolone Impurity 14,2019-10-08,2019-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86904 - Class II - Drugs - Morton Grove Pharmaceuticals, Inc.","Failed Impurities/Degradation Specification: OOS for the following - unknown degradant/impurity, 4-chorobenzophenone, and for total impurities.",2020-12-23,2020-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84526 - Class I - Drugs - Motto International Corp,Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil,2020-01-10,2020-01-10,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86767 - Class I - Drugs - MPM Medical LLC,Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.,2020-12-07,2020-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84527 - Class II - Drugs - MPRX, Inc. dba Medical Park Pharmacy",Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.,2020-01-29,2020-01-29,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75753 - Class I - Drugs - MS Bionic,Marketed without an Approved NDA/ANDA; product contains sildenafil and tadalafil which are active pharmaceutical ingredients in FDA approved drugs used to treat erectile dysfunction (ED),2017-02-13,2017-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82421 - Class II - Drugs - MSM Nutraceuticals, LLC",Lack of Assurance of Sterility: Product is not terminally sterialized and not tested per USP 71.,2019-04-15,2019-04-15,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72512 - Class I - Drugs - MSNV Inc,Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.,2016-02-16,2016-02-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74017 - Class II - Drugs - Murray International Trading Co., Inc.","Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.",2016-07-11,2016-07-11,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63228 - Class II - Biologics - Musculoskeletal Transplant Foundation,"Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed.",2012-12-20,2012-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63229 - Class I - Biologics - Musculoskeletal Transplant Foundation,".Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed., Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed.",2012-12-20,2012-12-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66045 - Class I - Biologics - Musculoskeletal Transplant Foundation,"A single lot of CASCADE Autologous Platelet System, containing a component (yellow tube) that may have higher than normal endotoxin levels, was distributed.",2014-01-14,2014-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72442 - Class II - Biologics - Musculoskeletal Transplant Foundation, Inc.","Human skin allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2015-10-27,2015-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83005 - Class II - Biologics - Musculoskeletal Transplant Foundation, Inc.","Human bone allograft, which did not meet release criteria designed to prevent communicable disease transmission, was distributed.",2019-06-05,2019-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83572 - Class II - Biologics - Musculoskeletal Transplant Foundation, Inc.","Human tissue allografts, where in-process controls were not followed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2019-10-07,2019-10-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85459 - Class I - Biologics - Musculoskeletal Transplant Foundation, Inc.","Human tissue allografts, where in-process controls were not performed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2020-05-18,2020-05-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85460 - Class I - Biologics - Musculoskeletal Transplant Foundation, Inc.","Human tissue allografts, where in-process controls were not performed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2020-05-18,2020-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89442 - Class II - Biologics - Musculoskeletal Transplant Foundation, Inc.","Bone and tendon, recovered from a donor in which donor suitability was not adequately determined, were distributed.",2022-02-02,2022-02-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90092 - Class II - Biologics - Musculoskeletal Transplant Foundation, Inc.","Skin, recovered from a donor with a history of high risk behaviors, was distributed.",2022-05-17,2022-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64727 - Class III - Drugs - Mutual Pharmaceutical Company,  Inc.","Labeling: Incorrect instructions; an error in section 5.11 of the patient insert that results in incorrect medical advice.  Specifically, the labeling should read ""If a severely depressed HDL-C level is detected, fibrate therapy should be withdrawn, and the HDL-C level monitored until it has returned to baseline, and fibrate therapy should not be re-initiated.""  The labeling for the recalled lots",2014-01-06,2014-01-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70711 - Class II - Drugs - Mutual Pharmaceutical Company,  Inc.","Failed Impurities/Degradation Specifications: during long-term stability testing.

",2015-03-16,2015-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71684 - Class II - Drugs - Mutual Pharmaceutical Company,  Inc.","cGMP Deviations; Clonidine hydrochloride drug substance used in the manufacturing of this product, was dispensed in unauthorized rooms by the drug substance manufacturer",2015-07-30,2015-07-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71836 - Class III - Drugs - Mutual Pharmaceutical Company,  Inc.",Chemical Contamination; benzophenone leached from the product label varnish,2015-09-09,2015-09-09,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72382 - Class II - Drugs - Mutual Pharmaceutical Company,  Inc.",Presence of foreign substance -This recall has been intiated due to the presence of a polyethylene piece on the finished product.,2016-01-19,2016-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70565 - Class III - Drugs - Mylan Institutional LLC,"Correct Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride Injection 2 mg/mL, 100 mL",2015-03-13,2015-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70375 - Class III - Drugs - Mylan Institutional LLC,Subpotent Drug and Failed Impurities/Degradation Specifications,2015-03-16,2015-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70564 - Class II - Drugs - Mylan Institutional LLC,Lack of Assurance of Sterility; due to leaking vials,2015-03-23,2015-03-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70936 - Class I - Drugs - Mylan Institutional LLC,Presence of Particulate Matter,2015-08-13,2015-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71079 - Class I - Drugs - Mylan Institutional LLC,Presence of Particulate Matter,2015-08-13,2015-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70991 - Class I - Drugs - Mylan Institutional LLC,Presence of Particulate Matter,2015-08-14,2015-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71004 - Class I - Drugs - Mylan Institutional LLC,Presence of Particulate Matter,2015-08-14,2015-08-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85624 - Class II - Drugs - Mylan Institutional LLC,Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.,2020-05-20,2020-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85956 - Class I - Drugs - Mylan Institutional LLC,Presence of Particulate Matter,2020-08-04,2020-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86247 - Class I - Drugs - Mylan Institutional LLC,"Labeling: Label Mix-Up; potential for cartons labeled as Tranexamic Acid Injection, USP to contain vials of Amiodarone HCl Injection, USP and cartons labeled as Amiodarone HCl Injection, USP to contain vials of Tranexamic Acid Injection, USP.",2020-09-11,2020-09-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87803 - Class III - Drugs - Mylan Institutional LLC,Labeling: Incorrect or Missing Lot and/or Exp Date: Cartons with the correct lot number 200906 contain vials labeled with the incorrect lot number 200901.,2021-06-01,2021-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82210 - Class I - Drugs - Mylan Institutional, Inc.",Presence of Particulate Matter: particulate matter identified as copper salts,2019-03-26,2019-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89930 - Class II - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.,2022-05-11,2022-05-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63899 - Class I - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.,2013-02-15,2013-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65115 - Class III - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Failed Dissolution Specifications: Routine stability testing at the 12-month interval yielded an out-of-specification (OOS) result for dissolution testing.,2013-05-22,2013-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67393 - Class III - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Failed Impurity/degradation Specification,2014-03-12,2014-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68787 - Class III - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.,2014-07-17,2014-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66607 - Class II - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices,2015-01-21,2015-01-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70857 - Class III - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)","Failed Impurities/Degradation Specifications: the manufacturer, recalled product due to slightly above specification results for a Related Compound during routine stability testing",2015-05-15,2015-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72595 - Class III - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Failed Impurities/Degradation Specifications: Out of specification for impurities.,2015-11-13,2015-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73170 - Class III - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.,2016-02-02,2016-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66393 - Class II - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.,2016-08-23,2016-08-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75295 - Class III - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)","Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 15 month timepoint., Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint.",2016-11-10,2016-11-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76463 - Class II - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled,2017-03-08,2017-03-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76802 - Class II - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.,2017-03-28,2017-03-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79977 - Class II - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",GMP Deviations: a recent FDA inspection of the manufacturing site revealed multiple cGMP violations that would place Loxapine at risk for cross contamination,2018-05-22,2018-05-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80802 - Class III - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer,2018-08-22,2018-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81946 - Class II - Drugs - Mylan Institutional, Inc. (d.b.a. UDL Laboratories)",Failed Impurities/Degradation Specifications:  Elevated levels of a known impurity detected during 6-month RT stability interval.,2019-03-20,2019-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71218 - Class II - Drugs - Mylan Laboratories Inc,Failed Dissolution Specifications: Low out of specification dissolution results.,2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83914 - Class II - Drugs - Mylan Laboratories Limited (Sterile Products Division),Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.,2019-10-10,2019-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81707 - Class II - Drugs - Mylan Laboratories Limited, (Nashik FDF)","GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.",2018-12-14,2018-12-14,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62454 - Class II - Drugs - Mylan LLC.,Failed USP Content Uniformity Requirements: OOS result reported on retained samples.,2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76020 - Class II - Drugs - Mylan LLC.,"Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.",2017-01-25,2017-01-25,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89415 - Class II - Drugs - Mylan Pharmaceuticals Inc,cGMP deficiencies,2022-01-25,2022-01-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89357 - Class I - Drugs - Mylan Pharmaceuticals Inc,Labeling: Missing Label: label missing from some Semglee prefilled pens.,2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89906 - Class II - Drugs - Mylan Pharmaceuticals Inc,Subpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related substance impurities/degradation during routine stability testing.,2022-04-06,2022-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89910 - Class II - Drugs - Mylan Pharmaceuticals Inc,Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.,2022-04-15,2022-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89970 - Class I - Drugs - Mylan Pharmaceuticals Inc,Labeling: Missing label on the vial,2022-05-04,2022-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90545 - Class I - Drugs - Mylan Pharmaceuticals Inc,"Labeling: Missing label: Label missing from some prefilled
pens.",2022-07-26,2022-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81613 - Class II - Drugs - Mylan Pharmaceuticals Inc.,"CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.",2018-12-14,2018-12-14,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62885 - Class II - Drugs - Mylan Pharmaceuticals Inc.,"Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.",2012-09-27,2012-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62911 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Impurities/Degradation Products: Out of specification results for Related Compound during routine stability testing.,2012-09-28,2012-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63284 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Cross Contamination w/Other Products: During stability testing chromatographic review revealed extraneous peaks identified as acetaminophen and codeine.,2012-10-25,2012-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64154 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Failed Tablet/Capsule Specifications: Product exceeds specification for tablet weight and tablet thickness.,2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64186 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Presence of Foreign Tablets/Capsules: Bottles of lansoprazole 30 mg delayed-release capsules may contain topiramate 100 mg tablets.,2013-02-05,2013-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64924 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted with an incorrect identifier code on the embossed tablets..,2013-04-23,2013-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65008 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..,2013-05-30,2013-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66403 - Class II - Drugs - Mylan Pharmaceuticals Inc.,CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.,2013-11-04,2013-11-04,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67399 - Class II - Drugs - Mylan Pharmaceuticals Inc.,"Subpotent Drug: Assay results obtained during stability testing for Levothyroxine Sodium Tablets, USP were below specification.",2014-02-10,2014-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68642 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications; Out of specification for lactol and total impurities.,2014-08-18,2014-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68645 - Class III - Drugs - Mylan Pharmaceuticals Inc.,"Failed Impurities/Degradation Specifications: High out-of-specification results for a related compound
obtained during routine stability testing.",2014-08-22,2014-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68783 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol,2014-10-08,2014-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70831 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: out of specification results for a related compound - a degradant of fexofenadine.,2015-04-07,2015-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71566 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were obtained at the nine-month stability point.,2015-07-08,2015-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73671 - Class II - Drugs - Mylan Pharmaceuticals Inc.,"Failed Dissolution Specifications; three month stability time point.

",2016-05-06,2016-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75634 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: OOS results for known compound.,2016-11-23,2016-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76291 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Presence of Foreign Tablets/Capsules; bottles of Glipizide 5 mg tablets may contain Glipizide 10 mg tablets,2017-02-24,2017-02-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76357 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle,2017-03-08,2017-03-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76750 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Microbial Contamination of Non-Sterile Products: potential of an elevated bioburden with identification of objectionable organisms.,2017-03-28,2017-03-28,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77065 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.,2017-05-23,2017-05-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76922 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Failed Dissolution Specifications,2017-05-24,2017-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77430 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications; out of specification results for Sulphoxide Impurity and Total Impurities,2017-06-15,2017-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78487 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Mylan Pharmaceuticals Inc. is conducting a voluntary recall due to related out of specification compound results obtained during routine stability testing.,2018-01-19,2018-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79957 - Class II - Drugs - Mylan Pharmaceuticals Inc.,"cGMP Deviations; cleaning process for equipment used to manufacture the specified batches was not followed according to procedure, cGMP Deviations; cleaning processes for equipment used to manufacture the specified batches was not followed according to procedure",2018-05-17,2018-05-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79955 - Class II - Drugs - Mylan Pharmaceuticals Inc.,CGMP Deviations,2018-05-22,2018-05-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80006 - Class II - Drugs - Mylan Pharmaceuticals Inc.,CGMP Deviations,2018-05-22,2018-05-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80261 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.,2018-06-15,2018-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80454 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Subpotent Drug,2018-07-24,2018-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77850 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Presence of foreign substance: Potential for glass in the neck area of the glass bottles.,2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80782 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.,2018-09-10,2018-09-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81221 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.,2018-10-14,2018-10-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81930 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.,2019-02-04,2019-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81980 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Defective Container: Potential for broken glass in the neck area of the glass bottles.,2019-02-04,2019-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82086 - Class III - Drugs - Mylan Pharmaceuticals Inc.,"Failed Impurities/Degradation Specifications: High out of specification results obtained during routine stability testing 

",2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83673 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Failed Impurities/Degradation Specifications:OOS for unknown impurity.,2019-09-09,2019-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84039 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Failed Dissolution Specification: Low out of specification dissolution results.,2019-10-28,2019-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84080 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Presence of Foreign Substance,2019-11-05,2019-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84607 - Class II - Drugs - Mylan Pharmaceuticals Inc.,"CGMP Deviations: Trace amounts of an impurity, N-nitrosodimethylamine (NDMA) was detected in the API Nizatidine.",2020-01-20,2020-01-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85152 - Class II - Drugs - Mylan Pharmaceuticals Inc.,Presence of particulate matter. presence of metal particles.,2020-03-18,2020-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85273 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in 5 mg bottles.,2020-03-24,2020-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86520 - Class III - Drugs - Mylan Pharmaceuticals Inc.,Out-of-specification organic impurity results obtained during routine stability testing.,2020-10-22,2020-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67471 - Class I - Drugs - MyNicNaxs, Inc.","Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: Phenolphthalein., Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared ingredient: N-di-desmethylsibutramine, an analog of sibutramine, Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: Sibutramine and Phenolphthalein ., Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredients: Phenolphthalein and N-desmethylsibutramine, Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: Phenolphthalein, Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: sibutramine and N-desmethylsibutramine, Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared active pharmaceutical ingredient: N-desmethylsibutramine",2014-06-12,2014-06-12,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65762 - Class I - Drugs - Myson Corporation, Inc.","Marketed Without An Approved NDA/ANDA: All lots of Volcano Liquid and Volcano Capsules, marketed as dietary supplements, are being recalled because they were found to contain undeclared active pharmaceutical ingredients, making them unapproved new drugs.",2013-12-12,2013-12-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87653 - Class II - Drugs - Na Na Collection,Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.,2021-04-26,2021-04-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87609 - Class II - Drugs - Namoo Enterprise LLC,Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.,2021-04-26,2021-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86333 - Class II - Drugs - Nanomateriales Sa De Cv,GMP Deviations: Potential to contain 1-propanol.,2020-09-23,2020-09-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69611 - Class III - Drugs - Nanophase Technologies Corporation,cGMP Deviation; The incorrect amount of a raw material was added during the manufacture of two lots of Z-COTE HP 1.,2014-11-06,2014-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70568 - Class III - Drugs - Nanophase Technologies Corporation,Labeling: Illegible label. Writing is rubbing off of labels.,2015-03-04,2015-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73944 - Class III - Biologics - Naples Community Hospital Blood Bank,"Blood product, collected from a donor without documentation of a hematocrit test having been performed, was distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72893 - Class III - Drugs - National Vitamin Co Inc,Labeling: Label mix-up. Docusate Sodium 100mg Softgels were mislabeled as Docusate Calcium 240mg.,2016-01-12,2016-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75655 - Class II - Drugs - Nationwide Laboratories, LLC",CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.,2016-12-01,2016-12-01,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88275 - Class II - Drugs - NATIVE PROMOTIONS, INC",Subpotent,2021-09-09,2021-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62761 - Class III - Drugs - Natural Essentials Inc,Microbial Contamination of a Non-Sterile Products: Three product lots are contaminated with Burkholderia cepacia.,2012-08-30,2012-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68455 - Class I - Drugs - Nature's Universe,Marketed Without an Approved NDA/ANDA: Product contains undeclared sibutramine.,2014-09-18,2014-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66856 - Class II - Drugs - Natures Pharmacy & Compounding Center,Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.,2014-03-04,2014-03-04,48,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81999 - Class I - Drugs - Natures Rx,Marketed without an Approved NDA/ANDA; FDA analysis found product to be tainted with undeclared sildenafil and tadalafil,2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84279 - Class I - Drugs - Natures Rx,Marketed Without an Approved NDA/ANDA; Product contains undeclared active ingredient - Sildenafil.,2019-12-31,2019-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78073 - Class I - Drugs - Natures Supplement,Marketed without an Approved NDA/ANDA; FDA analysis found product to be tainted with Sildenafil.,2018-01-04,2018-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84255 - Class II - Biologics - Naval Medical Center Portsmouth,"Red Blood Cell product in which CMV testing/testing performed, interpreted, or documented incorrectly, was distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87876 - Class III - Biologics - Naval Medical Center Portsmouth,"Red Blood Cells, not manufactured according  to specifications, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88329 - Class III - Biologics - Naval Medical Center Portsmouth,"Blood product, processed with an incorrect centrifuge setting, was distributed.",2021-08-24,2021-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70752 - Class II - Drugs - Navinta LLC,Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.,2015-04-03,2015-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62476 - Class III - Biologics - NBAH Blood Center,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-08,2012-08-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91272 - Class II - Drugs - NCH Life Sciences LLC,CGMP Deviations: Impurities of acetal and acetaldehyde were discovered in the product in excess of allowed limits.,2022-12-28,2022-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84992 - Class II - Drugs - NCS Healthcare of Kentucky Inc,Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.,2020-02-18,2020-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87101 - Class I - Drugs - NDAL Mfg Inc.,Microbial Contamination of Non-Sterile Products: Product confirmed to have yeast,2021-02-19,2021-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69985 - Class II - Drugs - Neolpharma, Inc.",Subpotent Drug,2014-12-24,2014-12-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83999 - Class II - Drugs - Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center,Lack of Assurance of Sterility; bags have potential to leak,2019-10-18,2019-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84000 - Class II - Drugs - Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center,GMP Deviations: potential glass contamination,2019-10-18,2019-10-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84106 - Class III - Drugs - Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center,Incorrect labeling: Incorrect or missing lot and/or exp date,2019-10-28,2019-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90703 - Class II - Drugs - Nephron Sc Inc,cGMP Deviations: deviations leading to potential cross-contamination.,2022-08-17,2022-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91451 - Class II - Drugs - Nephron Sc Inc,Short Fill,2023-01-23,2023-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91449 - Class II - Drugs - Nephron Sc Inc,CGMP Deviations: potential for trace amounts of product carryover.,2023-01-24,2023-01-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62604 - Class II - Drugs - Nephron SC Inc.,"Lack of Assurance of Sterility
",2012-08-09,2012-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66462 - Class II - Drugs - Nephron SC Inc.,"Lack of Assurance of Sterility: Nephron Pharmaceuticals Corporation conducted a routine periodic aseptic process simulation and discovered bacterial growth in a number of media fill vials, exceeding the allowable limit.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72099 - Class II - Drugs - Nephron SC Inc.,Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process,2015-10-09,2015-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72102 - Class II - Drugs - Nephron SC Inc.,Discoloration,2015-11-27,2015-11-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90211 - Class II - Drugs - Nephron Sterile Compounding Center LLC,Lack of Assurance of Sterility,2022-05-27,2022-05-27,20,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90512 - Class II - Drugs - Nephron Sterile Compounding Center LLC,Lack of Assurance of Sterility,2022-07-18,2022-07-18,37,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90718 - Class II - Drugs - Nephron Sterile Compounding Center LLC,CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.,2022-08-16,2022-08-16,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91132 - Class II - Drugs - Nephron Sterile Compounding Center LLC,CGMP Deviations: Potential for cross contamination due to product carry over.,2022-11-17,2022-11-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91450 - Class II - Drugs - Nephron Sterile Compounding Center LLC,"Lack of Assurance of Sterility
",2023-01-09,2023-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84602 - Class II - Biologics - Nevada Donor Network Inc,"Long term preserved corneal tissues, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84603 - Class II - Biologics - Nevada Donor Network Inc,"Long term preserved corneal tissues, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84604 - Class II - Biologics - Nevada Donor Network Inc,"Long term preserved corneal tissues, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84605 - Class II - Biologics - Nevada Donor Network Inc,"Long term preserved corneal tissues, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89989 - Class II - Biologics - Nevada Donor Network Inc,"Corneas, recovered from a donor in which donor suitability was not adequately determined, were distributed.",2022-04-19,2022-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63511 - Class II - Drugs - New England Compounding Center,"Lack of Assurance of Sterility, GMP Deviations",2012-11-14,2012-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63305 - Class I - Drugs - New England Compounding Center,"Non-Sterility, Lack of Assurance of Sterility",2012-12-31,2012-12-31,17,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67687 - Class II - Drugs - New England Home Therapies, Inc",Lack of Assurance of Sterility: All compounded products.,2014-10-01,2014-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69206 - Class II - Drugs - New GPC Inc.,"Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A.., Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A., Does Not Meet Monograph:  NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing and lack of OTC drug labeling requirements.",2014-10-17,2014-10-17,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59719 - Class II - Biologics - New Life Generation, INC.","Human allografts, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-07-27,2012-07-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #60080 - Class II - Biologics - New Life Generation, INC.","Human allografts, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67807 - Class I - Drugs - New Life Nutritional Center,"Marketed without an approved NDA/ANDA - New Life Nutritional Center is recalling SUPER FAT BURNER, MAXI GOLD WEIGHT LOSS PILL and Esmeralda products marketed as Dietary Supplements due to the presence of undeclared and unapproved drugs.",2014-12-22,2014-12-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78304 - Class II - Drugs - New Reliance Traders, Inc.",Marketed Without an Approved NDA/ANDA,2017-11-25,2017-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88608 - Class III - Drugs - New Vision Pharmaceuticals LLC,Subpotent Drug,2021-09-24,2021-09-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82754 - Class II - Drugs - New Vision Pharmaceuticals LLC,CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.,2019-05-23,2019-05-23,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83492 - Class II - Drugs - New Vision Pharmaceuticals LLC,CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.,2019-08-08,2019-08-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83881 - Class II - Drugs - New Vision Pharmaceuticals LLC,CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.,2019-10-09,2019-10-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84189 - Class II - Drugs - New Vitalis Pharmacy LLC dba New Vitalis Pharmacy,Lack of sterility assurance.,2019-11-25,2019-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88733 - Class II - Drugs - New Vitalis Pharmacy LLC dba New Vitalis Pharmacy,Lack of Assurance of Sterility,2021-09-30,2021-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87286 - Class II - Biologics - New York Blood Center Inc,"Red Cell Blood product, for which leukoreduction was not performed in accordance with specifications, was distributed.
",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87389 - Class II - Biologics - New York Blood Center Inc,Misbranded Leukoreduced Red Blood Cells were distributed.,2021-03-11,2021-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87523 - Class II - Biologics - New York Blood Center Inc,"Red Blood Cell product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91542 - Class II - Biologics - New York Blood Center Inc,Misbranded Platelepheresis product was distributed.,2023-01-31,2023-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #38935 - Class III - Biologics - New York Blood Center, Inc.","Blood products, for which donor's whole blood unit was screened for hemoglobin utilizing the hemocue was not quality controlled, was distributed.",2012-07-09,2012-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62352 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor who was previously deferred for a history of intravenous drug use, were distributed.",2012-07-13,2012-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63012 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which quality control and distribution of products did not meet specifications, were distributed.",2012-10-01,2012-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63333 - Class II - Biologics - New York Blood Center, Inc.","Blood product, collected from a donor who received a piercing within 12 months of donation, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46585 - Class III - Biologics - New York Blood Center, Inc.","Blood product, which was possibly contaminated with penicillium species, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #60141 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2012-12-27,2012-12-27,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63764 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47152 - Class III - Biologics - New York Blood Center, Inc.","Blood products, which were exposed to unacceptable temperature during storage, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52254 - Class II - Biologics - New York Blood Center, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-01-29,2013-01-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39644 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from donors in which donor suitability was not adequately determined, were distributed.",2013-02-15,2013-02-15,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42043 - Class II - Biologics - New York Blood Center, Inc.","Blood products, with unacceptable, undocumented, or incomplete product QC, were distributed.",2013-03-27,2013-03-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47306 - Class III - Biologics - New York Blood Center, Inc.","Blood products, which were possibly contaminated with Diptheroids, were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #57149 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2013-03-27,2013-03-27,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64473 - Class II - Biologics - New York Blood Center, Inc.","Blood products, labeled leukoreduced without the assurance they met the criteria for leukoreduced products, were distributed.",2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47151 - Class II - Biologics - New York Blood Center, Inc.","Blood products, which were possibly contaminated with peptostreptococcus, were distributed.",2013-04-29,2013-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65675 - Class III - Biologics - New York Blood Center, Inc.","Blood products, held in quarantine pending results of an investigation, were distributed.",2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65775 - Class II - Biologics - New York Blood Center, Inc.","Blood product, with an unacceptable pH, was distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66682 - Class II - Biologics - New York Blood Center, Inc.","Blood products, not re-frozen within the appropriate time frame, were distributed.",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66683 - Class II - Biologics - New York Blood Center, Inc.","Blood products, tested by NAT for communicable diseases using unsuitable samples, were distributed.",2013-12-16,2013-12-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68695 - Class II - Biologics - New York Blood Center, Inc.","Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.

",2014-08-13,2014-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71821 - Class II - Biologics - New York Blood Center, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-08-25,2015-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72328 - Class II - Biologics - New York Blood Center, Inc.","Blood products, exceeding the 72 hour RBC Leuko filtration limit, were distributed.

",2015-10-28,2015-10-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72557 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2015-11-27,2015-11-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73389 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from an ineligible donor, were distributed.",2016-03-02,2016-03-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73153 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2016-03-09,2016-03-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74027 - Class II - Biologics - New York Blood Center, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74349 - Class II - Biologics - New York Blood Center, Inc.","Platelet products, labeled as leukoreduced but were not tested for WBCs, were distributed.",2016-06-28,2016-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74348 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from an ineligible donor, were distributed.",2016-07-21,2016-07-21,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75009 - Class II - Biologics - New York Blood Center, Inc.","Blood products, in which quality control for residual WBC count did not meet specifications, were distributed.",2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75479 - Class II - Biologics - New York Blood Center, Inc.","Blood products, in which donor screening/donor records were incomplete or incorrect, were distributed.",2016-11-14,2016-11-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76203 - Class II - Biologics - New York Blood Center, Inc.","Blood products, identified as unsuitable due to a donor screening deviation, were distributed.",2017-01-31,2017-01-31,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76204 - Class II - Biologics - New York Blood Center, Inc.","Blood product, in which donor suitability was not adequately determined, was distributed.",2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76348 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility was incorrectly determined, were distributed.",2017-02-14,2017-02-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76301 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-02-27,2017-02-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76523 - Class III - Biologics - New York Blood Center, Inc.","Blood product, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2017-03-01,2017-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76525 - Class II - Biologics - New York Blood Center, Inc.","Blood product, collected from a donor for whom donor screening was incorrectly performed, were distributed.",2017-03-01,2017-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76527 - Class II - Biologics - New York Blood Center, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-03-01,2017-03-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76707 - Class II - Biologics - New York Blood Center, Inc.","Blood product, in which donor suitability was not adequately determined, was distributed.",2017-03-16,2017-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76576 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2017-03-30,2017-03-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77181 - Class II - Biologics - New York Blood Center, Inc.","Blood products, in which donor suitability was not adequately determined, were distributed.",2017-05-09,2017-05-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77239 - Class II - Biologics - New York Blood Center, Inc.","Blood products, in which donor suitability was not adequately determined, were distributed.",2017-05-16,2017-05-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77235 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2017-05-25,2017-05-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77224 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-05-31,2017-05-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77418 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor screening was performed incorrectly, were distributed.",2017-06-14,2017-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77419 - Class II - Biologics - New York Blood Center, Inc.","Blood products, in which donor suitability was not adequately determined, were distributed.",2017-06-14,2017-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77420 - Class II - Biologics - New York Blood Center, Inc.","Blood products, in which donor suitability was not adequately determined, were distributed.",2017-06-14,2017-06-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77447 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor screening was  incorrectly performed, were distributed.",2017-06-14,2017-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77423 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor screening was performed incorrectly, were distributed.",2017-06-27,2017-06-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77421 - Class II - Biologics - New York Blood Center, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-07-03,2017-07-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77422 - Class II - Biologics - New York Blood Center, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-07-03,2017-07-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77689 - Class II - Biologics - New York Blood Center, Inc.","Blood products, in which donor suitability was not adequately determined, were distributed.",2017-07-13,2017-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77691 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2017-07-26,2017-07-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77693 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was performed incorrectly, were distributed.",2017-07-26,2017-07-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77657 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-08-08,2017-08-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77723 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-08-10,2017-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77808 - Class II - Biologics - New York Blood Center, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-08-18,2017-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77829 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-08-28,2017-08-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77923 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-09-18,2017-09-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78022 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was performed incorrectly, were distributed.",2017-09-20,2017-09-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78023 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2017-09-20,2017-09-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77995 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-09-29,2017-09-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78024 - Class III - Biologics - New York Blood Center, Inc.","Blood products, for which donor screening was performed incorrectly, were distributed.",2017-09-29,2017-09-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78250 - Class II - Biologics - New York Blood Center, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78252 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-11-08,2017-11-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78493 - Class II - Biologics - New York Blood Center, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2017-11-09,2017-11-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78495 - Class II - Biologics - New York Blood Center, Inc.","Apheresis products, in which donor suitability was not adequately determined, were distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78449 - Class II - Biologics - New York Blood Center, Inc.","Red blood cells, for which donor screening was performed incorrectly, were distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78557 - Class II - Biologics - New York Blood Center, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2017-11-29,2017-11-29,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78397 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor whose donor suitability was not adequately determined, were distributed.",2017-12-04,2017-12-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78496 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-12-21,2017-12-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78795 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-01-19,2018-01-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78859 - Class II - Biologics - New York Blood Center, Inc.","Blood products, which was collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-02-07,2018-02-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79079 - Class II - Biologics - New York Blood Center, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-02-07,2018-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78995 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79011 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-02-20,2018-02-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79221 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2018-03-05,2018-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79587 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor screening was incorrectly performed, were distributed.",2018-04-04,2018-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79588 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-04-04,2018-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79589 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-04-04,2018-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79718 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor screening was incorrectly performed, were distributed.",2018-04-30,2018-04-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79787 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-05-24,2018-05-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80144 - Class II - Biologics - New York Blood Center, Inc.","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-06-01,2018-06-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80235 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-07-05,2018-07-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80236 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-07-05,2018-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80502 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-07-26,2018-07-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80352 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from an ineligible donor, were distributed.",2018-08-03,2018-08-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80708 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-08-16,2018-08-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80798 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-08-22,2018-08-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80710 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-09-06,2018-09-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80958 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-09-17,2018-09-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81135 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-10-31,2018-10-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81620 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-11-30,2018-11-30,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81446 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from an ineligible donor, were distributed.",2018-12-12,2018-12-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81618 - Class II - Biologics - New York Blood Center, Inc.","Blood products where transfusion-transmitted infection testing was incorrectly performed and / or interpreted, were distributed.",2018-12-12,2018-12-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81841 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2019-02-01,2019-02-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82040 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from an ineligible donor, were distributed.",2019-02-08,2019-02-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82069 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from an ineligible donor, were distributed.",2019-02-08,2019-02-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81842 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82006 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-02-20,2019-02-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82543 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-04-05,2019-04-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82544 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-04-05,2019-04-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82596 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-04-15,2019-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82479 - Class II - Biologics - New York Blood Center, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82429 - Class II - Biologics - New York Blood Center, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-04-22,2019-04-22,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82907 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-06-11,2019-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82861 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-06-28,2019-06-28,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83030 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed., Blood products, collected from a donor for which donor suitability was not adequately determined, were distributed.",2019-07-15,2019-07-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83657 - Class II - Biologics - New York Blood Center, Inc.","Apheresis Platelets, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83800 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-10-02,2019-10-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83667 - Class III - Biologics - New York Blood Center, Inc.","Blood products, which may have been exposed to unacceptable storage temperatures, were distributed.",2019-10-11,2019-10-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84001 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-10-25,2019-10-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84271 - Class II - Biologics - New York Blood Center, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-11-19,2019-11-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84199 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2019-12-06,2019-12-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85348 - Class III - Biologics - New York Blood Center, Inc.","Platelets, not meeting product specifications, were distributed.",2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85174 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor whose donor eligibility was incomplete, were distributed.",2020-04-02,2020-04-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86300 - Class III - Biologics - New York Blood Center, Inc.","Plateletpheresis products, exposed to unacceptable temperatures during storage, were distributed.",2020-09-10,2020-09-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86809 - Class III - Biologics - New York Blood Center, Inc.","Plateletpheresis products, manufactured using expired blood collection bags, were distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87030 - Class II - Biologics - New York Blood Center, Inc.","Red Blood Cell product, for which donor Screening, deferral screening not done or incorrectly performed, including incorrect ID used during search, and prior deferral due to history for risk factors associated with variant Creutzfeldt-Jakob Disease, was distributed.
",2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87149 - Class II - Biologics - New York Blood Center, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed",2021-01-29,2021-01-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87410 - Class II - Biologics - New York Blood Center, Inc.","Misbranded Red Blood Cell product was distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87457 - Class II - Biologics - New York Blood Center, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2021-03-12,2021-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88053 - Class III - Biologics - New York Blood Center, Inc.","Plateletpheresis product identified as unsuitable due to a labeling deviation, was distributed.",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88778 - Class III - Biologics - New York Blood Center, Inc.","Blood products, which were exposed to unacceptable temperatures during shipment, were distributed.",2021-09-28,2021-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89652 - Class II - Biologics - New York Blood Center, Inc.","Blood Products, collected from a donor in which the donor was not tested for Chagas, were distributed.",2022-03-18,2022-03-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91474 - Class II - Biologics - New York Blood Center, Inc.","Red Blood Cell product, collected from a donor in which the donor was not tested for Chagas, was distributed.
",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78251 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-11-08,2017-11-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78614 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2017-11-30,2017-11-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78659 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, collected from an ineligible donor, were distributed., -",2018-01-09,2018-01-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78740 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, for which donor suitability was inadequately determined, were distributed.",2018-01-16,2018-01-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78741 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, for which donor suitability was inadequately determined, were distributed.",2018-01-16,2018-01-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78742 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, for which donor suitability was inadequately determined, were distributed.",2018-01-16,2018-01-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78858 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-01-23,2018-01-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78953 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-02-20,2018-02-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79443 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-04-20,2018-04-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80478 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2018-08-09,2018-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84049 - Class II - Biologics - New York Blood Center, Inc. dba HBVS Elmsford Donor Center","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-11-04,2019-11-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65853 - Class II - Drugs - Nexus Pharmaceuticals Inc,Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.,2013-08-27,2013-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75155 - Class II - Biologics - NIH Clinical Center,Blood Products collected from a donor who traveled to a malaria endemic area were distributed.,2016-10-05,2016-10-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83018 - Class III - Drugs - NingBo Huize Commodity Co.,Ltd.",CGMP deviations: Stability testing was not conducted on manufactured sunscreen and hand sanitizer OTC products.,2019-07-27,2019-07-27,36,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87695 - Class III - Drugs - Nomax Inc,Subpotent Drug,2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70552 - Class III - Drugs - Nomax Inc,"Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of fluorescein present in the strips., Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of rose bengal present in the strips.",2015-04-21,2015-04-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65019 - Class II - Drugs - Nora Apothecary and Alternative Therapies, Inc.",Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.,2013-05-29,2013-05-29,43,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89954 - Class II - Drugs - North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding",Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.,2022-04-21,2022-04-21,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75415 - Class II - Drugs - North American Rescue LLC.,Lack of Assurance of Sterility: Concerns with product sterility by the manufacturer of the eye wash irrigating solution.,2016-12-08,2016-12-08,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64767 - Class II - Biologics - North Carolina Eye Bank, Inc. (The)","Human corneal allograft was processed in a manner that could cause contamination or cross-contamination during processing, and well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P.",2013-04-08,2013-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64865 - Class III - Biologics - North Carolina Eye Bank, Inc. (The)","Human Corneas, recovered using an expired Prep Kit, were distributed.",2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74406 - Class III - Biologics - North Carolina Eye Bank, Inc. (The)","Human cornea, recovered without verifying supplies and reagents met specifications for use, and was distributed.",2016-06-21,2016-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89254 - Class II - Biologics - North Carolina Eye Bank, Inc. dba Miracles in Sight","Corneas, in which donor testing was conducted with an unacceptable sample, were distributed.",2021-12-23,2021-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70911 - Class II - Biologics - Northeastern Pennsylvania Region of American Red Cross,"Blood product in which routine testing/testing performed, interpreted, or documented incorrectly, was distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83046 - Class II - Biologics - Northeastern Pennsylvania Region of American Red Cross,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-07-15,2019-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83448 - Class III - Biologics - Northeastern Pennsylvania Region of American Red Cross,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2019-08-30,2019-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42130 - Class II - Biologics - Northern California Community Blood Bank,"Blood products, collected from donors whose confirmatory syphilis testing was invalid, were distributed.",2012-07-13,2012-07-13,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62618 - Class II - Biologics - Northern California Community Blood Bank,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65086 - Class II - Biologics - Northern California Community Blood Bank,"Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65279 - Class II - Biologics - Northern California Community Blood Bank,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-07-02,2013-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67855 - Class II - Biologics - Northern California Community Blood Bank,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67856 - Class II - Biologics - Northern California Community Blood Bank,"Blood products, which did not meet the acceptable product specifications for release, were distributed",2014-04-29,2014-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69610 - Class III - Biologics - Northern California Community Blood Bank,"Blood products, collected from a donor who received a shingles vaccine, were distributed.",2014-12-01,2014-12-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75768 - Class II - Biologics - Northern California Community Blood Bank,"Platelet products, which failed leukoreduction quality control, were distributed.",2016-12-20,2016-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76223 - Class II - Biologics - Northern California Community Blood Bank,"Platelet product, for which QC was unacceptable, was distributed.",2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80949 - Class III - Biologics - Northern California Community Blood Bank,"Blood products for which quality control procedures were not performed, were distributed.
",2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81715 - Class II - Biologics - Northern California Community Blood Bank,"Platelets, not tested for pH, were distributed",2019-02-07,2019-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85876 - Class II - Biologics - Northern California Community Blood Bank,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2020-07-22,2020-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87204 - Class II - Biologics - Northern California Community Blood Bank,"Red Cell Blood products, for which Leukoreduction was not performed in accordance with specifications, were distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87474 - Class III - Biologics - Northern California Community Blood Bank,"Platelets, labeled with the incorrect volume, were distributed.",2021-03-12,2021-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63434 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley BC,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64816 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley BC,"Blood product, which did not meet acceptable product specifications, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65104 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley BC,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65436 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley BC,"Blood products,  collected from a donor who had traveled to a malarial endemic area, were distributed.",2013-07-22,2013-07-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68830 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley BC,"Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79490 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley Blood Ctr,"Blood product collected from a donor who traveled to a malarial endemic area was distributed.
",2018-03-22,2018-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80153 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley Blood Ctr,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2018-07-02,2018-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84062 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley Blood Ctr,"Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-11-04,2019-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86461 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley Blood Ctr,"Plateletpheresis products, not prepared in accordance with specifications, were distributed.",2020-09-25,2020-09-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87528 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley Blood Ctr,"Pathogen Reduced Platelets, not tested for pH, were distributed.",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88238 - Class III - Biologics - Northern Illinois Blood Bank dba Rock River Valley Blood Ctr,"Platelet products, lacking assurance of proper storage and shipment temperatures, were distributed.
",2021-07-14,2021-07-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88794 - Class II - Biologics - Northern Illinois Blood Bank dba Rock River Valley Blood Ctr,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2021-10-26,2021-10-26,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66198 - Class II - Drugs - Northern New England Compounding Pharmacy LLC,Lack of Assurance of Sterility: The pharmacy is recalling one lot of Hydroxocobalamin MDV 5mg/mL due to failed sterility results by a third party contract testing lab. Hence the sterility of the product cannot be assured.,2013-09-17,2013-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91443 - Class II - Drugs - Northern VA Compounders PLLC,Lack of Assurance of Sterility,2023-01-12,2023-01-12,25,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40353 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40981 - Class III - Biologics - Northwest Florida Blood Center, Inc.","Blood product, for which storage condition was outside the acceptable range, was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41085 - Class III - Biologics - Northwest Florida Blood Center, Inc.","Blood products, prepared without the appropriate amount of additive added and/or  incorrectly added, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39775 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, which were not manufactured in accordance to acceptable product specifications, were distributed.",2013-03-04,2013-03-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41304 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood product, processed in a manner that may have compromised sterility, was distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39047 - Class III - Biologics - Northwest Florida Blood Center, Inc.","Blood products, which were labeled with an incorrect volume, were distributed.",2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39441 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-03-26,2013-03-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39567 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39591 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44981 - Class III - Biologics - Northwest Florida Blood Center, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39050 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, collected from a donor who received a piercing within 12 months of donation, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39052 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, which quality control and distribution/required testing not performed were distributed.",2013-03-27,2013-03-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40349 - Class III - Biologics - Northwest Florida Blood Center, Inc.","Blood product, manufactured from Whole Blood units that may have had an extended collection time, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44651 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40755 - Class III - Biologics - Northwest Florida Blood Center, Inc.","Blood product, which was not manufactured in accordance to acceptable product specifications, was distributed.",2013-04-02,2013-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44983 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41832 - Class III - Biologics - Northwest Florida Blood Center, Inc.","Blood product, collected from a donor who was at risk for leishmaniasis, was distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47926 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood Products, in which Antibody Screen Testing was performed incorrectly, were distributed.",2013-05-08,2013-05-08,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40983 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood products, labeled as leukoreduced, but were not properly verified by White Blood Cell count, were distributed.",2013-05-13,2013-05-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41560 - Class II - Biologics - Northwest Florida Blood Center, Inc.","Blood product, collected from a donor who had taken an aspirin-like medication, was distributed.",2013-09-19,2013-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80703 - Class II - Drugs - Northwind Pharmaceuticals LLC,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-15,2018-08-15,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72647 - Class III - Drugs - Northwind Pharmaceuticals LLC,Labeling: Not elsewhere classified. NDC number is incorrect on the container.,2015-12-02,2015-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86653 - Class II - Drugs - Nostrum Laboratories Inc,CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-11-05,2020-11-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87080 - Class II - Drugs - Nostrum Laboratories Inc,CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87210 - Class II - Drugs - Nostrum Laboratories Inc,CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.,2021-02-04,2021-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79210 - Class III - Drugs - Nostrum Laboratories Inc,Presence of Foreign Tablets/Capsules,2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85235 - Class II - Drugs - Nostrum Laboratories Inc,"CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.",2020-03-25,2020-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74194 - Class II - Drugs - Nostrum Laboratories, Inc.",Failed Dissolution Specifications,2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67860 - Class I - Drugs - Nova Products, Inc.","Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling AFRICAN BLACK ANT because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to
treat erectile dysfunction., Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling Black Ant because FDA laboratory analysis determined they contain undeclared amounts of sildenafil an active ingredient of FDA-approved drugs used to treat erectile dysfunction., Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling  XZEN GOLD because FDA laboratory analysis determined they contain undeclared amounts of sildenafil and tadalafil, active ingredients of FDA-approved drugs used to
treat erectile dysfunction., Marketed Without an Approved NDA/ANDA: Nova Products, Inc. of Aston, Pennsylvania is voluntarily recalling XZEN PLATIN",2014-09-18,2014-09-18,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71989 - Class I - Drugs - Novacare, LLC",Marketed Without an Approved NDA/ANDA: FDA sampling confirmed the presence of Salicylic acid  in dietary supplements.,2016-06-06,2016-06-06,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64533 - Class III - Drugs - Novartis Consumer Health,Labeling: Incorrect or Missing Lot and/or Exp Date. The lot number and/or expiration date may be illegible.,2013-03-21,2013-03-21,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65021 - Class III - Drugs - Novartis Consumer Health,Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.,2013-05-17,2013-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64372 - Class III - Drugs - Novartis Consumer Health,"Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot., Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot..",2013-06-06,2013-06-06,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65422 - Class II - Drugs - Novartis Consumer Health,Defective container: products are packaged in pouches which may not have been fully sealed,2013-08-06,2013-08-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65840 - Class III - Drugs - Novartis Consumer Health,"Labeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging., Labeling: Incorrect or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.",2013-08-20,2013-08-20,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66232 - Class III - Drugs - Novartis Consumer Health,Failed Tablet/Capsule Specifications: The products are being recalled due to chipped and broken tablets.,2013-11-27,2013-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65181 - Class III - Drugs - Novartis Consumer Health,"Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing., Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing",2014-01-16,2014-01-16,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65490 - Class II - Drugs - Novartis Consumer Health,Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.,2014-01-17,2014-01-17,16,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82820 - Class I - Drugs - Novartis Pharmaceuticals Corp.,Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.,2019-05-29,2019-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66015 - Class II - Drugs - Novartis Pharmaceuticals Corp.,"Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves., Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photo curing agent used in inks on shrink-wrap sleeves.",2013-12-06,2013-12-06,15,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67633 - Class III - Drugs - Novartis Pharmaceuticals Corp.,"Labeling: Incorrect or Missing Package Insert; The back of the Medication Guide attached to the Package Insert for Ritalin Tablets was printed with information related to Ritalin SR (Sustained Release) Tablets.  Both products, Ritalin Tablets and Ritalin SR Tablets utilize a combined Package Insert.  The individual Medication Guides are attached to the Package Insert via a perforation.  Although t",2014-04-08,2014-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68282 - Class III - Drugs - Novartis Pharmaceuticals Corp.,Failed Stability Specification; out of specification result for particle size distribution during stability testing,2014-06-17,2014-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68815 - Class III - Drugs - Novartis Pharmaceuticals Corp.,Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.,2014-08-06,2014-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71310 - Class III - Drugs - Novartis Pharmaceuticals Corp.,Failed Stability Specification: out of specification result obtained for the Particle Size Distribution test during stability testing.,2015-06-15,2015-06-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71830 - Class III - Drugs - Novartis Pharmaceuticals Corp.,Failed Dissolution Specifications: Product is being recalled due to out of specification (above specification) result obtained at 6-hour dissolution time point during the 12-month stability testing.,2015-09-14,2015-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76756 - Class III - Drugs - Novartis Pharmaceuticals Corp.,Failed Impurities/Degradation Specifications.,2017-04-21,2017-04-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90176 - Class III - Drugs - Novartis Pharmaceuticals Corporation,Failed Impurities/Degradation Specifications.,2022-06-06,2022-06-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90862 - Class II - Drugs - Novartis Pharmaceuticals Corporation,CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.,2022-09-26,2022-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65726 - Class II - Biologics - NOVARTIS VACCINES AND DIAGNOSTICS S.r.l,"Lot of MENVEO Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM-197 Conjugate Vaccine, with higher than specified levels of residual moisture, was distributed.",2013-08-28,2013-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69857 - Class II - Biologics - NOVARTIS VACCINES AND DIAGNOSTICS S.r.l,"Lot of MENVEO Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM-197 Conjugate Vaccine, with higher than specified levels of residual moisture, was distributed.",2014-12-05,2014-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68722 - Class III - Drugs - Novel Laboratories, Inc.",Failed Impurity/Degradation Specification; 12-month stability time point,2014-08-22,2014-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76231 - Class III - Drugs - Novel Laboratories, Inc.",Chemical Contamination,2017-04-11,2017-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79298 - Class III - Drugs - Novel Laboratories, Inc.",Failed Impurities/Degradation Specifications,2018-03-14,2018-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80377 - Class II - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Subpotent Drug and Failed Content Uniformity.,2018-07-18,2018-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81865 - Class II - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Subpotent Drug: Expansion of June 2018 recall of lots S700065 and S700619 due to below specification results for assay.,2018-12-31,2018-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80187 - Class III - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Labeling: Missing Label,2018-05-31,2018-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80266 - Class III - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Labeling: Not Elsewhere Classified -  A private label distributor noted unfiled NDC numbers on EQ ClearLax Polyethylene Glycol 3350 NF Powder Solution of various sizes.,2018-07-03,2018-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80874 - Class III - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.,2018-09-27,2018-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81168 - Class II - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Failed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysis,2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81925 - Class II - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Failed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been chemically identified as oxidative degradation products of the fluocinolone active pharmaceutical ingredient.,2019-01-23,2019-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82396 - Class II - Drugs - Novel Laboratories, Inc. d.b.a LUPIN","Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list ""natural lemon flavor"" as an ingredient",2019-04-09,2019-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82581 - Class III - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Failed Impurities/Degradation Specifications,2019-04-25,2019-04-25,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88390 - Class II - Drugs - Novel Laboratories, Inc. d.b.a LUPIN",Failed Stability Specification; Out of specification for Osmolarity,2021-08-13,2021-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87373 - Class II - Drugs - Noven Pharmaceuticals Inc,Defective Delivery System: Out of specification for mechanical peel.,2021-03-03,2021-03-03,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87741 - Class II - Drugs - Noven Pharmaceuticals Inc,"Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.",2021-04-20,2021-04-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87980 - Class II - Drugs - Noven Pharmaceuticals Inc,Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.,2021-05-24,2021-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88342 - Class II - Drugs - Noven Pharmaceuticals Inc,Failed Stability Specifications; out of specification for shear.,2021-08-13,2021-08-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90162 - Class II - Drugs - Noven Pharmaceuticals Inc,Defective Delivery System: customer complaints exceeded respective action limits.,2022-05-20,2022-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90506 - Class II - Drugs - Noven Pharmaceuticals Inc,Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.,2022-06-29,2022-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91161 - Class II - Drugs - Noven Pharmaceuticals Inc,Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.,2022-11-28,2022-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62002 - Class II - Drugs - Noven Pharmaceuticals, Inc.",Miscalibrated/Defective Delivery System; exceeded the specification for both mechanical peel force (MPF) and/or the z-statistic value,2012-07-12,2012-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62530 - Class II - Drugs - Noven Pharmaceuticals, Inc.",Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.,2012-08-17,2012-08-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64710 - Class II - Drugs - Noven Pharmaceuticals, Inc.","Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.",2013-05-02,2013-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67718 - Class II - Drugs - Noven Pharmaceuticals, Inc.","Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.",2014-03-20,2014-03-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69277 - Class II - Drugs - Noven Pharmaceuticals, Inc.",Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.,2014-09-23,2014-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72174 - Class II - Drugs - Noven Pharmaceuticals, Inc.",Defective Delivery System: Out of specification for z-statistic related to mechanical peel force.,2015-10-06,2015-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73718 - Class II - Drugs - Noven Pharmaceuticals, Inc.",Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and z-statistic value which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration.,2016-07-14,2016-07-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75450 - Class II - Drugs - Noven Pharmaceuticals, Inc.",Defective Delivery System: Out of Specification (OOS) results for the mechanical peel force (MPF) and and/or the z-statistic values.,2017-01-10,2017-01-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77466 - Class III - Drugs - Noven Pharmaceuticals, Inc.",Defective Delivery System: Out of specification for peel force from the release liner specification during stability testing at 18M 25C/60%RH.,2017-06-23,2017-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78021 - Class II - Drugs - Noven Pharmaceuticals, Inc.",Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.,2017-09-18,2017-09-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79781 - Class II - Drugs - Noven Pharmaceuticals, Inc.",Defective Delivery System: Out of specification for adhesive transfer.,2018-04-13,2018-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80033 - Class II - Drugs - Noven Pharmaceuticals, Inc.","Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.",2018-06-13,2018-06-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80997 - Class II - Drugs - Noven Pharmaceuticals, Inc.","Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.",2018-09-25,2018-09-25,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85128 - Class II - Drugs - Noven Therapeutics, LLC",Defective Delivery System: Out of specification for mechanical peel and shear.,2020-03-19,2020-03-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85357 - Class II - Drugs - Noven Therapeutics, LLC",Defective Delivery System: Out of specification for mechanical peel and shear.,2020-04-17,2020-04-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61891 - Class II - Drugs - Noven Therapeutics, LLC",Miscalibrated and/or Defective Delivery System: Out of Specification results for mechanical peel force and/or the z-statistic value which relates to the patient's ability to remove the release liner from the patch adhesive prior to administration.,2012-06-14,2012-06-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70764 - Class II - Drugs - Noven Therapeutics, LLC",Temperature Abuse: Prolonged exposure to temperatures outside of labeled storage conditions.,2015-04-13,2015-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71201 - Class II - Drugs - Noven Therapeutics, LLC",Defective Delivery System: One lot exceeded the mechanical peel specification,2015-05-28,2015-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87734 - Class II - Biologics - Novex Innovations,"Tissue, processed in a manner that could cause contamination or cross-contamination, was distributed",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87853 - Class II - Biologics - Novex Innovations,"Tissue, manufactured where in-process controls were not performed to prevent contamination or cross-contamination, was distributed.",2021-05-21,2021-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90307 - Class II - Biologics - Novex Innovations,"Amniotic Membranes, recovered from donors in which donor suitability was not adequately determined, were distributed.",2022-10-12,2022-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82968 - Class I - Drugs - Novis PR, Inc.","Labeling: Incorrect Instructions; The product has been found to provide incorrect dosage information on its label due to a typographical error. The drug facts label incorrectly states children 6 to under 2 years of age, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or directed by physician. The label should state children 6 to under 12, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or as directed by physician. Additionally, the label does not advise consumers to consult a doctor for children under 2 years of age.",2019-06-19,2019-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84147 - Class II - Drugs - Novitium Pharma LLC,CGMP Deviations: Presence of NDMA impurity detected in product.,2019-11-10,2019-11-10,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74044 - Class II - Drugs - Novo Nordisk Inc,"Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called ""air shot"" step",2016-06-06,2016-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75123 - Class I - Drugs - Novo Nordisk Inc,Defective delivery system: detached needles on the syringe in the kit.,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87537 - Class I - Drugs - Novo Nordisk Inc,Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.,2021-06-10,2021-06-10,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65979 - Class II - Drugs - Novocol Pharmaceutical of Canada,"Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1:100,000 Injectable, distributed under the names: Octocaine 100, and 2% Xylocaine Dental, may be subpotent for the epinephrine component.",2013-08-26,2013-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86867 - Class III - Drugs - Novocol Pharmaceutical of Canada, Inc.",Labeling: Label mix-up,2020-12-09,2020-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76233 - Class III - Drugs - Novum Pharma, LLC",Subpotent Drug: Out of specification result for pramoxine hydrochloride,2017-01-17,2017-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87712 - Class I - Drugs - NSNY Distributor Inc,Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil,2021-06-28,2021-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80701 - Class II - Drugs - NuCare Pharmaceuticals Inc,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-03,2018-08-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87641 - Class I - Drugs - Nuri Trading LLC,"Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall., Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil, an FDA approved drug making this an unapproved drug for which the safety and efficacy has not been established and therefore subject to recall., Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil sildenafil, and vardenafil, FDA approved drugs making them an unapproved drug for which the safety and efficacy have not been established and therefore subject to recall., Marketed Without An Approved NDA/ANDA: Product found to be tainted with undeclared tadalafil and sildenafil, two FDA approved drugs making it an unapproved drug for which the safety and efficacy have not been established and therefore subjec",2021-07-19,2021-07-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64722 - Class II - Drugs - NuVision Pharmacy, Inc.",Lack of Assurance of Sterility; reports of adverse events after injection,2013-05-16,2013-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64922 - Class I - Drugs - NuVision Pharmacy, Inc.",Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.,2014-01-30,2014-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73016 - Class I - Drugs - Nuway Distributors, LLC","Marketed Without An Approved NDA/ANDA: tainted product marketed as a dietary supplement. Product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug.",2016-02-16,2016-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68299 - Class III - Drugs - Oasis Medical Inc,Labeling: Missing Label; The label on the immediate bottle is missing.,2014-05-22,2014-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71152 - Class III - Drugs - Oasis Medical, Inc.",Failed pH specification,2015-05-21,2015-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72111 - Class III - Drugs - Oasis Medical, Inc.",Falied pH specification,2015-09-09,2015-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72517 - Class III - Drugs - Oasis Medical, Inc.","Failed pH Specification: It has been determined that the pH of the lots recalled, may not meet specification at expiry.",2015-12-22,2015-12-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69569 - Class II - Drugs - Obagi Medical Products,Labeling: Label Mix-Up; Containers of the Obagi Nu-Derm Clear pre-labeled bottles were inadvertently introduced into the Obagi Exfoderm Forte packaging line. Therefore customers which ordered Clear RX actually had contents of Exfoderm forte.,2014-10-31,2014-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72920 - Class II - Biologics - Ochsner Health System  Blood Bank,"Blood product, collected from a donor with a history of reactive results for HCV, was distributed.",2016-01-14,2016-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75750 - Class III - Biologics - Ochsner Health System  Blood Bank,"Blood products, collected from an ineligible donor, were distributed.",2016-12-14,2016-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75749 - Class II - Biologics - Ochsner Health System  Blood Bank,"Blood products, in which donor deferral and/or donor incorrectly deleted from deferral list or donor not reentered properly, were distributed.",2016-12-21,2016-12-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76091 - Class II - Biologics - Ochsner Health System  Blood Bank,"Blood products, collected from an ineligible donor, were distributed.",2017-02-01,2017-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76969 - Class II - Biologics - Ochsner Health System  Blood Bank,"Blood product, collected from a donor who was previously deferred due to travel history, was distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82153 - Class III - Biologics - Ochsner Health System  Blood Bank,"Blood products, collected from a donor who was unable to understand the donor history questionnaire (DHQ), were distributed.",2019-03-15,2019-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89171 - Class III - Biologics - Octapharma AB,"Factor FVIII, labeled with the incorrect concentration, was distributed.",2021-12-14,2021-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79925 - Class II - Biologics - Octapharma plasma,"Source Plasma unit, not meeting product specifications, was distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82165 - Class III - Biologics - Octapharma Plasma Donation Center Aurora,"Source Plasma units, not meeting product specifications, were distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82170 - Class III - Biologics - Octapharma Plasma Donation Center Aurora,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #59507 - Class III - Biologics - Octapharma Plasma Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-03-19,2013-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55402 - Class II - Biologics - Octapharma Plasma Inc,"Blood products, collected from donors who did not have a complete physical examination, were distributed.",2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48227 - Class III - Biologics - Octapharma Plasma Inc,"Blood product, in which donor donated without an acceptable arm check, was distributed.
",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39187 - Class II - Biologics - Octapharma Plasma Inc,"Blood products, which tested negative for viral markers, but were collected from a donor who previously tested positive for the antibody to hepatitis C virus (anti-HCV), were distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42338 - Class III - Biologics - Octapharma Plasma Inc,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78373 - Class II - Biologics - Octapharma Plasma Inc,"Blood product, collected from a donor who received a tattoo within 12 months of donating, was distributed.",2017-11-15,2017-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79924 - Class II - Biologics - Octapharma Plasma Inc,"Source Plasma units, not meeting product specifications, were distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79926 - Class II - Biologics - Octapharma Plasma Inc,"Source Plasma unit, not meeting product specifications, was distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79928 - Class II - Biologics - Octapharma Plasma Inc,"Source Plasma unit, not meeting product specifications, was distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82160 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma unit, not meeting product specifications, was distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82164 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma units, not meeting product specifications, were distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82169 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82173 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82341 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-11,2019-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82411 - Class III - Biologics - Octapharma Plasma Inc,-,2019-03-19,2019-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82446 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma units, not meeting product specifications, were distributed.",2019-03-22,2019-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82430 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-25,2019-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82431 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-25,2019-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82438 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-26,2019-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82439 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma unit, not meeting product specifications, was distributed.",2019-03-27,2019-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82440 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma unit, not meeting product specifications, was distributed.",2019-03-27,2019-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82444 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma unit, not meeting product specifications, was distributed.",2019-03-27,2019-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82472 - Class II - Biologics - Octapharma Plasma Inc,"Blood product, collected in a manner that may compromise potency, was distributed.",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83009 - Class III - Biologics - Octapharma Plasma Inc,"Source Plasma, collected from an ineligible donor, was distributed.",2019-06-05,2019-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79930 - Class II - Biologics - Octapharma Plasma Inc.,"Source Plasma unit, not meeting product specifications, was distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82410 - Class III - Biologics - Octapharma Plasma Inc.,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-19,2019-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82412 - Class III - Biologics - Octapharma Plasma Inc.,"Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-19,2019-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82414 - Class III - Biologics - Octapharma Plasma Inc.,"Source Plasma unit, not meeting product specifications, was distributed.",2019-03-19,2019-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82448 - Class III - Biologics - Octapharma Plasma Inc.,"Source Plasma unit, not meeting product specifications, was distributed.",2019-03-22,2019-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82342 - Class III - Biologics - Octapharma Plasma, Inc","Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-11,2019-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82449 - Class III - Biologics - Octapharma Plasma, Inc","Source Plasma, not meeting product specifications, was distributed.",2019-03-22,2019-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82437 - Class III - Biologics - Octapharma Plasma, Inc","Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-26,2019-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83224 - Class II - Biologics - Octapharma Plasma, Inc","Source Plasma, which should have been quarantined after being contaminated with saline solution, was distributed.",2019-08-07,2019-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59515 - Class III - Biologics - Octapharma Plasma, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62446 - Class II - Biologics - Octapharma Plasma, Inc.","Blood products, collected from a donor whose physical examination was incomplete, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59514 - Class III - Biologics - Octapharma Plasma, Inc.","Blood products, collected from a donor, for whom donor suitability was not adequately determined, were distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62599 - Class II - Biologics - Octapharma Plasma, Inc.","Blood products, collected from a donor whose initial physical exam was not performed within a week of donating, were distributed.",2012-08-31,2012-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59516 - Class III - Biologics - Octapharma Plasma, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59720 - Class II - Biologics - Octapharma Plasma, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59509 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from donors who did not have a complete medical history interview, was distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52892 - Class III - Biologics - Octapharma Plasma, Inc.","Blood products, collected from a deferred donor, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69711 - Class III - Biologics - Octapharma Plasma, Inc.","Blood products, collected from a donor who should have been deferred due to history, were distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72770 - Class II - Biologics - Octapharma Plasma, Inc.",Untested Source Plasma for further manufacture was distributed.,2015-12-11,2015-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72692 - Class II - Biologics - Octapharma Plasma, Inc.","Blood product, collected from a donor who received a tattoo within 12 months of donating, was distributed.",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78243 - Class II - Biologics - Octapharma Plasma, Inc.","Blood product, collected from a donor who had been incarcerated, was distributed.",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79920 - Class II - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79921 - Class II - Biologics - Octapharma Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79927 - Class II - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79929 - Class II - Biologics - Octapharma Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81802 - Class III - Biologics - Octapharma Plasma, Inc.",Unlicensed Source Plasma was distributed in interstate commerce.,2018-12-17,2018-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81850 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82161 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82162 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma unit,  not meeting product specifications, was distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82163 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82166 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82168 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81845 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81846 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81847 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81848 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82171 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.
",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82172 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82174 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82175 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82176 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-25,2019-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82180 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-02-27,2019-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82181 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, not meeting product specifications, was distributed.",2019-02-27,2019-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82409 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-19,2019-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82413 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2019-03-19,2019-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82445 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2019-03-22,2019-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82447 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2019-03-22,2019-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82432 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-25,2019-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82433 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-25,2019-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82434 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-26,2019-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82435 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-26,2019-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82436 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, collected from an ineligible donor, were distributed.",2019-03-26,2019-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82441 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2019-03-27,2019-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82442 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2019-03-27,2019-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82443 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma unit, not meeting product specifications, was distributed.",2019-03-27,2019-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82931 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-28,2019-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82933 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-28,2019-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82934 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from an ineligible donor, were distributed.",2019-05-28,2019-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82935 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-28,2019-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82962 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-05-28,2019-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82932 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2019-05-29,2019-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82936 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma units, not meeting product specifications, were distributed.",2019-05-29,2019-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83006 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-05,2019-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83007 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-05,2019-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83008 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2019-06-05,2019-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82860 - Class II - Biologics - Octapharma Plasma, Inc.","Blood product, collected in a manner that may have compromised product potency, was distributed.",2019-06-27,2019-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83579 - Class II - Biologics - Octapharma Plasma, Inc.","Blood products, collected in a manner that may have compromised product potency, were distributed.",2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84257 - Class II - Biologics - Octapharma Plasma, Inc.","Source Plasma, that did not meet product specifications, was distributed.",2019-11-18,2019-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84314 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, not meeting product specifications, was distributed.",2019-11-20,2019-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85618 - Class III - Biologics - Octapharma Plasma, Inc.","Source Plasma, for which donor eligibility was incomplete, were distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83578 - Class II - Biologics - Octapharma Plasma, Inc. Portsmouth","Blood product, collected in a manner that may have compromised product potency, was distributed.",2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78887 - Class II - Drugs - Odan Laboratories Ltd,"Failed Stability Specifications:stability failure at 12 months, long term RT conditions.",2018-01-24,2018-01-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40327 - Class II - Biologics - Ogden Medical Center, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42849 - Class II - Biologics - Ogden Medical Center, Inc.","Blood products collected from a donor with incorrect ID used during deferral search, were distributed.",2012-12-27,2012-12-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64218 - Class II - Biologics - Ogden Medical Center, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65597 - Class II - Biologics - Ogden Medical Center, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed",2013-08-05,2013-08-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66699 - Class II - Biologics - Ogden Medical Center, Inc.","Blood product, labeled leukoreduced without the assurance that it met the criteria for a leukoreduced product, was distributed.",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66700 - Class II - Biologics - Ogden Medical Center, Inc.","Blood products, labeled leukoreduced without the assurance they met the criteria for leukoreduced products, were distributed.",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67631 - Class II - Drugs - Ohm Laboratories, Inc.","Defective Container: An unacceptable level of blister defects have been identified in Loratadine and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg.",2014-04-23,2014-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71334 - Class III - Drugs - Ohm Laboratories, Inc.",Superpotent Drug: Out Of Specification (OOS) result for Assay.,2015-06-18,2015-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71973 - Class III - Drugs - Ohm Laboratories, Inc.","Superpotent Drug: Out Of Specification (OOS) result for Assay.
",2015-10-15,2015-10-15,21,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67852 - Class II - Biologics - Oklahoma Blood Institute,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2015-07-02,2015-07-02,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90356 - Class II - Biologics - Oklahoma Blood Institute,"Blood products, for which donor eligibility was incomplete, were distributed. 
",2022-06-12,2022-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90373 - Class II - Biologics - Oklahoma Blood Institute,"Blood Products, which were returned at the wrong temperature, were distributed.",2023-01-03,2023-01-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91477 - Class II - Biologics - Oklahoma Blood Institute,"Blood product, for which donor eligibility was incomplete, was distributed.
",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91584 - Class III - Biologics - Oklahoma Blood Institute,"Blood Products, with the return shipping temperature not recorded, were distributed.",2023-02-10,2023-02-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65155 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, labeled leukoreduced without the assurance they met the criteria for leukoreduced products, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68055 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2014-06-02,2014-06-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68085 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected in a manner that may have  compromised the sterility of the units, were distributed.",2014-06-03,2014-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69989 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2015-01-26,2015-01-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70813 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, in which Donor Deferral/Donor missing or incorrectly identified on deferral list and/or donor should have been previously deferred due to history, were distributed.",2015-04-13,2015-04-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71052 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, which reached an unacceptable temperature during shipment, were distributed.",2015-05-27,2015-05-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71214 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, donor screening/deferral screening not done or incorrectly performed, including incorrect ID used during search, prior deferral due to testing, were distributed.",2015-06-04,2015-06-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71546 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, which lacked assurance of proper storage temperature, were distributed.",2015-07-24,2015-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72327 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product, for which the unit was not properly labeled with correct red blood cell antigen type, was distributed.

",2015-10-23,2015-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72734 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Leukoreduced blood products, not tested for residual WBC count, were distributed.",2016-01-05,2016-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73621 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-04-08,2016-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74359 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Apheresis products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75175 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product, collected from a donor for whom eligibility screening was incorrectly performed, was distributed.",2016-10-25,2016-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75767 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Platelet Pheresis products, for which white blood cell count testing was not performed, were distributed.",2016-12-07,2016-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76095 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,Misbranded red blood cells were distributed.,2017-01-12,2017-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76647 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2017-03-30,2017-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77744 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Apheresis Platelet, labeled with an incorrect volume, was distributed.",2017-07-26,2017-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78156 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Plateletpheresis products, not meeting established specifications, were distributed.",2017-09-29,2017-09-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78711 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Platelet product, for which unit sterility was compromised during collection, was distributed.",2017-12-19,2017-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79189 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Apheresis product, in which residual WBC count was not performed, was distributed.
",2018-02-22,2018-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79347 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product in which routine testing/testing performed, interpreted, or documented incorrectly, was distributed.
",2018-03-07,2018-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80090 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80038 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product, which did not meet the acceptable product specifications, was distributed.",2018-06-11,2018-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80270 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected from a donor who traveled to malarial endemic area, were distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81031 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2018-10-05,2018-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81202 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product, collected from a donor who lived in a malarial endemic area, was distributed.
",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81328 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81468 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Plateletpheresis product that did not meet product specifications, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81771 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2019-02-01,2019-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81793 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, which did not meet the acceptable product specifications,  were distributed., Blood products, which did not meet the acceptable product specifications, were distributed.",2019-02-01,2019-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82474 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-04-05,2019-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82530 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-04-15,2019-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82673 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-04-29,2019-04-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83120 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected from an ineligible donor, were distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83121 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Plateletpheresis product in which quality control for white blood cell count testing was not performed, was distributed.
",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83122 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Apheresis Red Blood Cell products, not meeting product specifications, were distributed.
",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83031 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected from an ineligible donor, were distributed.",2019-07-11,2019-07-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83769 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Leukoreduced Apheresis Red Blood Cells, which did not meet the minimum requirement for Red Blood Cell recovery following leukoreduction, were distributed.",2019-10-08,2019-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84361 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,Misbranded plateletpheresis product was distributed.,2019-12-19,2019-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84297 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-12-20,2019-12-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85190 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Irradiated Apheresis Platelets, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-03-20,2020-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85062 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product, which failed to meet quality control specifications, was distributed.",2020-04-01,2020-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86687 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Leukoreduced Apheresis Red Blood Cells,  which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-11-09,2020-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86688 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Leukoreduced Apheresis Red Blood Cells, for which donor eligibility screening was incomplete, were distributed.",2020-11-09,2020-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86689 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Leukoreduced Red Blood Cells, collected in a manner that compromises the sterility of the collection system, were distributed.",2020-11-09,2020-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87022 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Plateletpheresis product, in which the WBC count was not performed, was distributed.
",2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87921 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Apheresis Red Blood Cell products, for which quality control for residual white blood cell count testing was not performed, were distributed.
",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88239 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Plateletpheresis products, for which residual WBC count was not performed, were distributed.
",2021-07-14,2021-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88471 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Blood product, which contained clots/aggregates, was distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89431 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Leukoreduced Apheresis Red Blood Cells, which were not stored at the correct temperature, were distributed.",2022-01-31,2022-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89565 - Class II - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Apheresis Red Blood Cell products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2022-02-22,2022-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90181 - Class III - Biologics - Oklahoma Blood Institute - Sylvan N Goldman Center,"Apheresis Red Blood Cell products, not meeting product specifications, were distributed.
",2022-06-07,2022-06-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87822 - Class II - Biologics - Oklahoma Blood Institute dba Arkansas Blood Institute,"Leukoreduced Irradiated Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-05-10,2021-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63475 - Class II - Biologics - Oklahoma Lions Eye Bank,"Human Corneas, recovered from a donor who had not been properly evaluated, were distributed.",2012-10-23,2012-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78107 - Class II - Biologics - Oklahoma Lions Eye Bank,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2017-09-19,2017-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81273 - Class II - Biologics - Oklahoma Lions Eye Bank,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2018-10-17,2018-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81991 - Class II - Biologics - Oklahoma Lions Eye Bank,"Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2019-01-28,2019-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82111 - Class II - Biologics - Oklahoma Lions Eye Bank,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62698 - Class II - Drugs - Oklahoma Respiratory Care Inc,"CGMP Deviations; no identity or purity testing on incoming oxygen gas, and lack of documentation",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65621 - Class II - Drugs - Oklahoma Respiratory Care Inc,Failed impurities/degradation specifications: Purity readings for oxygen were out of specification.,2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64409 - Class I - Drugs - OLAAX International,"Marketed Without an Approved NDA/ANDA: product contains sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.",2013-06-13,2013-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71037 - Class II - Biologics - Old Dominion Eye Foundation, Inc.","Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2015-04-30,2015-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71038 - Class II - Biologics - Old Dominion Eye Foundation, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2015-04-30,2015-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71039 - Class II - Biologics - Old Dominion Eye Foundation, Inc.","Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2015-04-30,2015-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75670 - Class II - Biologics - Old Dominion Eye Foundation, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2016-11-17,2016-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68479 - Class II - Biologics - Olerup SSP AB,"HLA typing assay, associated with false negative results, were distributed.",2014-07-14,2014-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68782 - Class III - Biologics - Olerup SSP AB,"AbSorber XM-ONE Transplantation Cross Match (ABX100-03), containing a certain lot of BD Vacutainer Cell Preparation Tubes (CPT) which has the potential for poor separation resulting in a reduced number of recovered mononuclear cells, was distributed.",2014-09-10,2014-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89717 - Class II - Drugs - Olympia Compounding Pharmacy dba Olympia Pharmacy,"Sub Potent, Product found to be Sub Potent or Exceeded reconstitution time, Super Potent and Failed Reconstitution Time, Super Potent",2022-03-29,2022-03-29,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89938 - Class II - Drugs - Olympia Compounding Pharmacy dba Olympia Pharmacy,"CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated, Failed Reconstitution time",2022-04-27,2022-04-27,34,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90204 - Class II - Drugs - Olympia Compounding Pharmacy dba Olympia Pharmacy,Lack of assurance of sterility.,2022-05-25,2022-05-25,53,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75586 - Class III - Biologics - Omrix Biopharmaceuticals Ltd. (FPPF),Misbranded Fibrin Sealant Patch was distributed.,2016-11-14,2016-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83696 - Class III - Biologics - Omrix Biopharmaceuticals, Ltd.","EVICEL Fibrin Sealant 5mL Sample, (Not for Sale) and not meeting product specifications, was distributed.",2019-09-04,2019-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69836 - Class II - Drugs - One and Zen,Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.,2014-12-30,2014-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87409 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2021-03-11,2021-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87587 - Class II - Biologics - One Blood Inc,"Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.
",2021-04-14,2021-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87852 - Class II - Biologics - One Blood Inc,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2021-06-04,2021-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88021 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88176 - Class II - Biologics - One Blood Inc,"Apheresis Red Blood Cell products, for which quality control for residual WBC count  was not performed, were distributed.
",2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88177 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88179 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88211 - Class II - Biologics - One Blood Inc,"Misbranded plateletpheresis products were distributed.

",2021-07-12,2021-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89227 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89277 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89400 - Class II - Biologics - One Blood Inc,"Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed. 
",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89429 - Class II - Biologics - One Blood Inc,"Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed. 
",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89571 - Class II - Biologics - One Blood Inc,"Blood products, collected in a manner that compromises the sterility of the collection system, were distributed.",2022-02-22,2022-02-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89610 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89612 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89613 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91024 - Class II - Biologics - One Blood Inc,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-11-04,2022-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91214 - Class II - Biologics - One Blood Inc,"Blood products, mislabeled with an incorrect ABO type were distributed.
",2022-11-30,2022-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91269 - Class II - Biologics - One Blood Inc,"Apheresis Red Blood Cell product, for which quality control procedures for residual white blood cell testing was not performed, was distributed.
",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91270 - Class II - Biologics - One Blood Inc,"Apheresis Red Blood Cell products, for which quality control procedures for residual white blood cell testing was not performed, were distributed.
",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55742 - Class II - Biologics - One Lambda Inc,"HLA typing assay, associated with false negative results, was distributed.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52053 - Class II - Biologics - One Lambda Inc,"HLA typing assay, associated with false negative results, was distributed.",2012-08-28,2012-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63300 - Class III - Biologics - One Lambda Inc,"LABScreen HLA Class II Antibody Detection Test, associated with false reactions with the DP20 antigen, was distributed.",2012-10-11,2012-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63601 - Class II - Biologics - One Lambda Inc,"HLA typing assay, associated with incorrect typing results, was distributed.",2012-11-13,2012-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #32603 - Class III - Biologics - One Lambda Inc,"Micro SSP DNA Typing Trays of HLA Class I and Class II alleles, where null allele entries were not properly verified and may cause misassignment, were distributed.",2013-04-08,2013-04-08,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65358 - Class II - Biologics - One Lambda Inc,"Micro SSP Allele Specific HLA Class I DNA Typing Trays (B*38/39), manufactured with an incorrect primer, were distributed.",2013-06-11,2013-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65911 - Class II - Biologics - One Lambda Inc,"HLA Fusion Version 2.0.0-SP4.1, with a defect or glitch causing a conversion error giving incorrect test results for certain beads, was distributed.",2013-08-21,2013-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66827 - Class III - Biologics - One Lambda Inc,"HLA typing assay, in certain instances associated with incorrect typing results, was distributed.",2013-11-19,2013-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67331 - Class II - Biologics - One Lambda Inc,"One Lambda, Inc., part of Thermo Fisher Scientific, is conducting a correction of Lambda Cell Tray"", because the product insert for Lambda Cell Tray products (document identification LCT-TRAY-PI-EN-00, Rev 14),
contains a documentation error. In the product insert, line 2 in the Directions For Use section is mistakenly repeated. The
documentation error in the protocol may cause an end user to",2014-02-28,2014-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67613 - Class III - Biologics - One Lambda Inc,"HLA typing assay, associated with false positive results, was distributed.",2014-03-10,2014-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67866 - Class II - Biologics - One Lambda Inc,"HLA typing assay, associated with false typing assignments, was distributed.",2014-04-25,2014-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69913 - Class III - Biologics - One Lambda Inc,"HLA Class I DNA Typing Trays, missing allele specific lot documentation, were distributed.",2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70274 - Class III - Biologics - One Lambda Inc,"Micro SSP Generic HLA Class I/II DNA Typing Trays, missing allele specific documentation, were distributed.",2015-01-29,2015-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70364 - Class III - Biologics - One Lambda Inc,"LABType SSO HLA Typing Tests, containing misbranded lot-specific user documents, were distributed.",2015-02-11,2015-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70634 - Class II - Biologics - One Lambda Inc,"HLA Typing Assay, which may cause a mistype, was distributed.",2015-03-12,2015-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71369 - Class III - Biologics - One Lambda Inc,"Lambda Cell Trays, with potential high background causing negative reactions to appear positive, were distributed.",2015-06-17,2015-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72070 - Class III - Biologics - One Lambda Inc,Misbranded HLA Typing Assay was distributed.,2015-09-08,2015-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74211 - Class II - Biologics - One Lambda Inc,"HLA test kits, which may be associated with false negative reactions, were distributed.",2016-06-09,2016-06-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74487 - Class II - Biologics - One Lambda Inc,"HLA test kits, which may be associated with false negative reactions, were distributed.",2016-06-30,2016-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75403 - Class III - Biologics - One Lambda Inc,"HLA test kits containing lot specific user documents, misbranded with incorrect allele specificity
information, were distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77703 - Class II - Biologics - One Lambda Inc,"AllSet Gold SSP test kits, containing the incorrect allele specificity information for two primer mixes, were distributed.",2017-07-24,2017-07-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78519 - Class III - Biologics - One Lambda Inc,"HLA Sequence Analysis Software (v1.0), with a defect or glitch, was distributed.",2017-11-20,2017-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83084 - Class II - Biologics - One Lambda Inc,"The UniMatch Plus Software, containing incorrect allele specificity information, which may result in an ambiguous result or a mistyping, was distributed.",2019-06-13,2019-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83313 - Class II - Biologics - One Lambda Inc,"One Lambda's Micro SSP Allele Specific HLA Class I DNA Typing Tray - B*45, with incorrect primer sets which may cause a mistype, was distributed.",2019-08-07,2019-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83801 - Class II - Biologics - One Legacy,-,2019-09-16,2019-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64516 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-03-22,2013-03-22,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64818 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-04-29,2013-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64861 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65145 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from an ineligible donor, were distributed.",2013-05-15,2013-05-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65010 - Class II - Biologics - OneBlood / dba CBCF,"Blood product, which did not meet acceptable product specifications, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65252 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from an ineligible donor, were distributed.",2013-05-31,2013-05-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65016 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65345 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from an inelgible donor, were distributed.",2013-07-15,2013-07-15,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65424 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-07-22,2013-07-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65425 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-07-22,2013-07-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65529 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from an ineligible donor, were distributed.",2013-07-29,2013-07-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65531 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from an ineligible donor, were distributed.",2013-08-02,2013-08-02,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65533 - Class II - Biologics - OneBlood / dba CBCF,"Blood product, collected fron an ineligible donor, was distributed.",2013-08-02,2013-08-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65692 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from an ineligible donor, were distributed.",2013-08-21,2013-08-21,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65693 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-08-23,2013-08-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65776 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-08-29,2013-08-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65924 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-08-29,2013-08-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66650 - Class II - Biologics - OneBlood / dba CBCF,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-12-05,2013-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66652 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-12-05,2013-12-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66986 - Class II - Biologics - OneBlood / dba CBCF,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-01-09,2014-01-09,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63262 - Class II - Biologics - ONEBLOOD Inc DBA:  Southeastern Comm. Blood Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2012-10-24,2012-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64238 - Class III - Biologics - ONEBLOOD Inc DBA:  Southeastern Comm. Blood Center,"Blood product,  collected from a therapeutic donor,  was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90354 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell product, for which quality control for residual WBC count was not performed, was distributed. 
",2022-06-12,2022-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64166 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-02-25,2013-02-25,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65102 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-05-24,2013-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64915 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was not deferred after testing reactive for HTLV-I/II, were distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65170 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-06-06,2013-06-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65177 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65414 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-07-08,2013-07-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65346 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an inelgibile donor, were distributed.",2013-07-15,2013-07-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65403 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, were distributed.",2013-07-15,2013-07-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65415 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-07-22,2013-07-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65522 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-07-23,2013-07-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65524 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-07-23,2013-07-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65530 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-07-29,2013-07-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65534 - Class II - Biologics - OneBlood, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-07-29,2013-07-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65535 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-07-29,2013-07-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65532 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from an inelgible donor, was distributed.",2013-08-02,2013-08-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65624 - Class II - Biologics - OneBlood, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-08-09,2013-08-09,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65661 - Class II - Biologics - OneBlood, Inc.","Blood product, labeled with an extended expiration date, was distributed.",2013-08-22,2013-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65673 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-08-23,2013-08-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65926 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-08-26,2013-08-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65748 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65750 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-08-29,2013-08-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66008 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-09-05,2013-09-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65867 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-09-09,2013-09-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65929 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-09-09,2013-09-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65931 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-09-09,2013-09-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66114 - Class II - Biologics - OneBlood, Inc.","Blood products collected from a therapeutic donor with polycythemia, were distributed.

",2013-09-17,2013-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66257 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-10-18,2013-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66216 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66228 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66230 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-10-21,2013-10-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66404 - Class II - Biologics - OneBlood, Inc.","Blood product, with unacceptably high platelet count, was distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66614 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-11-14,2013-11-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66615 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-11-14,2013-11-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66487 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-11-22,2013-11-22,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66645 - Class II - Biologics - OneBlood, Inc.","Blood product, in which viral testing sample was exposed to unacceptable temperatures during storage, was distributed.",2013-12-05,2013-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66653 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed., -",2013-12-05,2013-12-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66655 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-12-05,2013-12-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66646 - Class II - Biologics - OneBlood, Inc.","Blood products, which were labeled as leukoreduced, but exceeded the acceptable limit for white blood cell count, were distributed.",2013-12-11,2013-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66647 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-12-11,2013-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66648 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-12-11,2013-12-11,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66649 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-12-11,2013-12-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66656 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2013-12-11,2013-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66728 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66797 - Class III - Biologics - OneBlood, Inc.","Blood Products, in which component preparation/component were not prepared in accordance with specifications, were distributed.",2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66936 - Class II - Biologics - OneBlood, Inc.","Blood products, for which the platelet yield was not sufficient to support the products being split into two parts, were distributed.",2014-01-08,2014-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67032 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-01-08,2014-01-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66950 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-01-09,2014-01-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66972 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-01-09,2014-01-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67061 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67109 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed., Blood products, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-01-30,2014-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67181 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-02-05,2014-02-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67334 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose donor suitability was not adequately determined, were distributed.",2014-02-05,2014-02-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67219 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-02-18,2014-02-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67336 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed., Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2014-02-18,2014-02-18,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67340 - Class II - Biologics - OneBlood, Inc.","Blood product, mislabeled as to antigen phenotype, was distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67359 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-02-18,2014-02-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67270 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-02-19,2014-02-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67285 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2014-02-21,2014-02-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67287 - Class II - Biologics - OneBlood, Inc.","Blood product, which was incorrectly labeled as leukoreduced, was distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67288 - Class II - Biologics - OneBlood, Inc.","Blood product, which was incorrectly labeled as leukoreduced, was distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67411 - Class III - Biologics - OneBlood, Inc.","Blood products, not manufactured in accordance to current Good Manufacturing Practices, were distributed.",2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67410 - Class II - Biologics - OneBlood, Inc.","Blood products, routine testing/testing performed, interpreted, or documented incorrectly, was distributed.",2014-02-27,2014-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67571 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-03-05,2014-03-05,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67596 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-03-05,2014-03-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67450 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-03-07,2014-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67489 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67553 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-03-07,2014-03-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67693 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not fully evaluated, was distributed.",2014-03-10,2014-03-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67696 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not fully evaluated, were distributed.",2014-04-10,2014-04-10,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67942 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-04-24,2014-04-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67955 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-04-24,2014-04-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67886 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-05-01,2014-05-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67889 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from a donor with Erythrocytosis, were distributed.",2014-05-12,2014-05-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67954 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-05-21,2014-05-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68156 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-06-11,2014-06-11,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68214 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-06-11,2014-06-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68364 - Class II - Biologics - OneBlood, Inc.","Blood product, contaminated with air was distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68462 - Class II - Biologics - OneBlood, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2014-06-26,2014-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68289 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an unsuitable donor, were distributed.",2014-06-27,2014-06-27,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68463 - Class II - Biologics - OneBlood, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2014-06-27,2014-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68474 - Class II - Biologics - OneBlood, Inc.","Blood product, incorrectly determined to be negative for the Jk(a) antigen, was distributed.",2014-07-16,2014-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68563 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2014-08-04,2014-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68598 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2014-08-04,2014-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68733 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68734 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from donors who emigrated from a malarial endemic area, were distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68828 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68868 - Class II - Biologics - OneBlood, Inc.","Blood product, in which routine testing/testing performed, interpreted, or documented incorrectly, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68884 - Class II - Biologics - OneBlood, Inc.",Misbranded Red Blood Cells were distributed.,2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69071 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from a donor who previously tested reactive for anti-HCV, were distributed.",2014-09-18,2014-09-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69343 - Class II - Biologics - OneBlood, Inc.",Misbranded Red Blood Cells were distributed.,2014-10-03,2014-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69307 - Class II - Biologics - OneBlood, Inc.","Blood product, that did not meet homologous criteria, was distributed.",2014-10-08,2014-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69308 - Class III - Biologics - OneBlood, Inc.","Blood product, that did not meet allogeneic criteria, was distributed.",2014-10-08,2014-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69195 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-10-09,2014-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69215 - Class III - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose donor suitability was not adequately determined, was distributed.",2014-10-16,2014-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69196 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2014-10-22,2014-10-22,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69363 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who disclosed  history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2014-10-23,2014-10-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69416 - Class II - Biologics - OneBlood, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-10-28,2014-10-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69491 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor with a risk factor associated with Creutzfeldt-Jacob Disease, was distributed.",2014-10-30,2014-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69476 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose donor suitability was not adequately determined, was distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69722 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2014-11-20,2014-11-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69730 - Class II - Biologics - OneBlood, Inc.","Platelet product, which failed leukoreduction testing, was distributed.",2014-11-21,2014-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69732 - Class II - Biologics - OneBlood, Inc.","Blood product, labeled as antigen negative but subsequently tested as antigen positive, was distributed.",2014-11-21,2014-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69575 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-11-24,2014-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69576 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.

",2014-11-24,2014-11-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69607 - Class II - Biologics - OneBlood, Inc.","Blood product, which incorrectly tested negative for FYB subsequently tested FYB positive, was distributed.",2014-11-24,2014-11-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69680 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-12-11,2014-12-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69775 - Class II - Biologics - OneBlood, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69710 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, was distributed.",2014-12-17,2014-12-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69948 - Class II - Biologics - OneBlood, Inc.","Blood product, in which Routine Testing/Testing performed, interpreted, or documented incorrectly for FYA, was distributed.",2015-01-05,2015-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69951 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, were distributed.",2015-01-14,2015-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70120 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who disclosed travel history that warranted deferral, were distributed.",2015-01-23,2015-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70226 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet acceptable product specifications, were distributed.",2015-02-09,2015-02-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70250 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70469 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-02-23,2015-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70278 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2015-02-25,2015-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70418 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-03-04,2015-03-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70755 - Class III - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2015-04-24,2015-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70802 - Class II - Biologics - OneBlood, Inc.","Blood product in which routine testing/testing performed, interpreted, or documented incorrectly, was distributed.",2015-04-24,2015-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70954 - Class II - Biologics - OneBlood, Inc.","Blood products, in which donor screening/deferral screening were not done or incorrectly performed, were distributed.",2015-04-29,2015-04-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70941 - Class II - Biologics - OneBlood, Inc.","Blood product, routine testing/testing performed, interpreted, or documented incorrectly, was distributed.",2015-05-13,2015-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70970 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2015-05-19,2015-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71051 - Class III - Biologics - OneBlood, Inc.","Blood product, which was not quarantined after receiving post donation information concerning an illness following donation, was distributed.",2015-05-21,2015-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71091 - Class II - Biologics - OneBlood, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed, Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-05-27,2015-05-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71154 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2015-06-04,2015-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71325 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who lived in a malarial endemic area, was distributed.",2015-06-10,2015-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71354 - Class III - Biologics - OneBlood, Inc.",Misbranded red blood cells were distributed.,2015-06-17,2015-06-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71348 - Class II - Biologics - OneBlood, Inc.","Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2015-07-09,2015-07-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71471 - Class III - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-07-22,2015-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71485 - Class III - Biologics - OneBlood, Inc.","Platelet product, collected from a donor for whom suitability to donate was not adequately determined, was distributed.",2015-07-22,2015-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71489 - Class II - Biologics - OneBlood, Inc.","Blood product for which some quality control procedures were not performed, was distributed.",2015-07-22,2015-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71466 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from a donor who may have had contact with someone who received the smallpox vaccine, were distributed..",2015-07-23,2015-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71652 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-08-17,2015-08-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71745 - Class II - Biologics - OneBlood, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-08-17,2015-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71808 - Class III - Biologics - OneBlood, Inc.","Blood products, which were labeled with the incorrect product type, were distributed.",2015-08-21,2015-08-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71891 - Class II - Biologics - OneBlood, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71857 - Class III - Biologics - OneBlood, Inc.","Blood products, which may have been exposed to unacceptable temperatures during shipment, were distributed.",2015-09-08,2015-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72146 - Class III - Biologics - OneBlood, Inc.","Platelet products, which were labeled with the incorrect volumes, were distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72280 - Class II - Biologics - OneBlood, Inc.","Blood products for which some quality control procedures were not performed, were distributed.",2015-10-09,2015-10-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72255 - Class III - Biologics - OneBlood, Inc.","Blood products, that were stored under incorrect temperatures, were distributed.",2015-11-04,2015-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72544 - Class II - Biologics - OneBlood, Inc.","Apheresis products, for which the quality control testing for white blood cell count was not performed, were distributed.",2015-11-13,2015-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72635 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-12-03,2015-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72601 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-12-04,2015-12-04,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72556 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2015-12-07,2015-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72735 - Class II - Biologics - OneBlood, Inc.","Blood products, in which donor screening/deferral screening not done or incorrectly performed, including incorrect ID used during search, were distributed.",2015-12-15,2015-12-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72871 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet acceptable product specifications, were distributed.",2016-01-21,2016-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72873 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2016-01-21,2016-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72872 - Class III - Biologics - OneBlood, Inc.","Misbranded red blood cells, were distributed.",2016-01-29,2016-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73144 - Class II - Biologics - OneBlood, Inc.","Blood products, for which donor suitability was inadequately determined, were distributed.",2016-02-08,2016-02-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73218 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who travelled in a malarial endemic country within 12 months of donating, was distributed.",2016-02-25,2016-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73145 - Class II - Biologics - OneBlood, Inc.","Blood products, for which donor eligibility was inadequately determined, were distributed.",2016-02-26,2016-02-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73219 - Class II - Biologics - OneBlood, Inc.","Blood product, collected within a year from a donor who lived in a malarial endemic area, was distributed.",2016-03-15,2016-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73290 - Class II - Biologics - OneBlood, Inc.","Blood product, collected within a year from a donor who lived in a malarial endemic area, was distributed.",2016-03-22,2016-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73794 - Class III - Biologics - OneBlood, Inc.",Misbranded Blood Products were distributed.,2016-04-29,2016-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73795 - Class III - Biologics - OneBlood, Inc.",Misbranded Blood Products were distributed.,2016-04-29,2016-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73881 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who was not deferred or follow up questions were not asked, was distributed.",2016-05-05,2016-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73796 - Class III - Biologics - OneBlood, Inc.",Mislabeled plasma products were distributed.,2016-05-17,2016-05-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73879 - Class II - Biologics - OneBlood, Inc.","Blood products collected within three years from a donor immigrating from a malarial endemic area, were distributed.",2016-05-17,2016-05-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73880 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, were distributed.",2016-05-17,2016-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73971 - Class III - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, not meeting product specification, were distributed.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73955 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-06-02,2016-06-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73954 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2016-06-06,2016-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74151 - Class II - Biologics - OneBlood, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2016-06-13,2016-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74166 - Class II - Biologics - OneBlood, Inc.","Blood product,s which did not meet the acceptable product specifications, were distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74278 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74337 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-07-18,2016-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74778 - Class II - Biologics - OneBlood, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2016-08-24,2016-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74756 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, were distributed.",2016-08-31,2016-08-31,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74777 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was deferred, were distributed.",2016-08-31,2016-08-31,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75010 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2016-09-01,2016-09-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75105 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom   screening was incorrectly performed, were distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75399 - Class II - Biologics - OneBlood, Inc.","Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2016-10-26,2016-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75489 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2016-11-01,2016-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75626 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who visited a malarial endemic area within 12 months of donation, was distributed.",2016-11-28,2016-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76246 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76563 - Class II - Biologics - OneBlood, Inc.","Blood products collected from a donor  for whom deferral screening was incorrectly performed, where distributed.",2017-03-15,2017-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76322 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor with a history of hepatitis, were distributed.",2017-03-16,2017-03-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76450 - Class II - Biologics - OneBlood, Inc.",Transfusion,2017-03-16,2017-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76581 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, were distributed.",2017-03-29,2017-03-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76686 - Class II - Biologics - OneBlood, Inc.","Red Blood Cells, not manufactured according to cGMP regulations, were distributed.",2017-04-04,2017-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76818 - Class II - Biologics - OneBlood, Inc.","Platelet products, for which WBC quality control testing was not performed, were distributed.",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76967 - Class II - Biologics - OneBlood, Inc.","Blood product, lacking quality control testing, was distributed.",2017-04-20,2017-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76670 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2017-04-21,2017-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76779 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-04-24,2017-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76958 - Class II - Biologics - OneBlood, Inc.","Apheresis product, in which residual WBC count was not performed, was distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76970 - Class II - Biologics - OneBlood, Inc.","Blood product, labeled as leukoreduced, and for which WBC quality control testing was not performed, was distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76997 - Class II - Biologics - OneBlood, Inc.","Blood product, for which the donor gave travel history to a malarial endemic area within one year of donation, was distributed.",2017-04-27,2017-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77080 - Class III - Biologics - OneBlood, Inc.","Blood products, for which unit labeling was incorrect, were distributed.",2017-05-03,2017-05-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77205 - Class II - Biologics - OneBlood, Inc.","Red blood cell, for which antigen testing was documented incorrectly, was distributed.",2017-05-11,2017-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77066 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor with a history of jaundice, was distributed.",2017-05-23,2017-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77155 - Class II - Biologics - OneBlood, Inc.","Blood products, in which donor screening/deferral screening not done or incorrectly performed, were distributed.",2017-05-30,2017-05-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77349 - Class II - Biologics - OneBlood, Inc.","Apheresis unit, incorrectly labeled as Leukocytes Reduced was distributed.",2017-06-05,2017-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77460 - Class II - Biologics - OneBlood, Inc.","Red blood cells, for which quality control testing was not performed, were distributed.",2017-06-16,2017-06-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77240 - Class II - Biologics - OneBlood, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2017-06-23,2017-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77682 - Class II - Biologics - OneBlood, Inc.","Apheresis products, in which quality control for white blood count testing was not performed, were distributed.",2017-07-13,2017-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77683 - Class III - Biologics - OneBlood, Inc.","Blood product, labeled with an incorrect expiration date, was distributed.",2017-07-13,2017-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77463 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from a donor possibly at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2017-07-17,2017-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77543 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2017-07-21,2017-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77763 - Class II - Biologics - OneBlood, Inc.","Blood product for which quality control procedures were not performed, was distributed.",2017-07-27,2017-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77793 - Class III - Biologics - OneBlood, Inc.","Blood product, in which labeling/crossmatch tag, tie tag or transfusion record incorrect or missing information, was distributed.",2017-08-18,2017-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77786 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2017-08-23,2017-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78008 - Class II - Biologics - OneBlood, Inc.","Blood product, in which quality control for WBC count was not performed, was distributed.",2017-09-05,2017-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78075 - Class III - Biologics - OneBlood, Inc.","Blood components, not manufactured according to specifications, were distributed.",2017-09-12,2017-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78015 - Class II - Biologics - OneBlood, Inc.","Blood products, for which WBC count quality control was not performed, and labeled as leukoreduced, were distributed.",2017-09-20,2017-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78070 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, was distributed.",2017-09-29,2017-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78069 - Class II - Biologics - OneBlood, Inc.",Transfusion,2017-10-13,2017-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78163 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2017-10-16,2017-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78271 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor whose eligibility to donate was inadequately determined for malarial travel, was distributed.",2017-10-31,2017-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78186 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2017-11-08,2017-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78244 - Class II - Biologics - OneBlood, Inc.","Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78306 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, were distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78437 - Class II - Biologics - OneBlood, Inc.","Platelet product, labeled as leukoreduced, but for which quality control testing for WBC count wasn't performed, was distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78378 - Class II - Biologics - OneBlood, Inc.","Pooled Cryoprecipitated AHF units, not prepared in accordance with specifications, were distributed.",2017-12-07,2017-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78379 - Class II - Biologics - OneBlood, Inc.","Pooled Cryoprecipitated AHF units, not prepared in accordance with specifications, were distributed.",2017-12-07,2017-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78380 - Class II - Biologics - OneBlood, Inc.","Pooled Cryoprecipitated AHF units, not prepared in accordance with specifications, were distributed.",2017-12-07,2017-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78486 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78533 - Class II - Biologics - OneBlood, Inc.","Blood products, labeled with incorrect expiration dates, were distributed.",2017-12-21,2017-12-21,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78638 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2017-12-21,2017-12-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78710 - Class II - Biologics - OneBlood, Inc.","Platelet products, labeled as leukoreduced but did not have WBC count  testing performed, were distributed.",2018-01-10,2018-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78660 - Class II - Biologics - OneBlood, Inc.","Blood products, collected in a manner that compromises the sterility of the collection system, were distributed.",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78748 - Class II - Biologics - OneBlood, Inc.","Apheresis products for which white blood cell count testing was not performed, were distributed.
",2018-01-12,2018-01-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78745 - Class II - Biologics - OneBlood, Inc.","Platelet products, labeled as leukoreduced, but  were not tested for WBC count, were distributed.",2018-01-16,2018-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78722 - Class II - Biologics - OneBlood, Inc.","Platelet products, labeled as leukoreduced but not tested for WBC count, were distributed.",2018-01-19,2018-01-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78769 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2018-01-19,2018-01-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78780 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet acceptable product specifications for release, were distributed.",2018-01-19,2018-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78782 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2018-01-19,2018-01-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78783 - Class II - Biologics - OneBlood, Inc.",Transfusion,2018-01-19,2018-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78803 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2018-01-19,2018-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78854 - Class II - Biologics - OneBlood, Inc.","Blood products, in which quality control for WBC count was not performed, were distributed.
",2018-01-23,2018-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78955 - Class II - Biologics - OneBlood, Inc.","Apheresis products, in which quality control for WBC count were not performed, were distributed.
",2018-01-24,2018-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78825 - Class II - Biologics - OneBlood, Inc.","Apheresis products, in which residual WBC count was not performed, were distributed.
",2018-02-07,2018-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78860 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2018-02-07,2018-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78869 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2018-02-07,2018-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78933 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-02-07,2018-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78971 - Class II - Biologics - OneBlood, Inc.","Blood product, possibly contaminated with air, was distributed.",2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79012 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79094 - Class II - Biologics - OneBlood, Inc.","Platelet products, labeled as leukoreduced, but for which WBC quality control was not performed, were distributed.",2018-02-22,2018-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79259 - Class II - Biologics - OneBlood, Inc.",Misbranded platelet products were distributed.,2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79306 - Class II - Biologics - OneBlood, Inc.",Misbranded platelet product was distributed.,2018-03-02,2018-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79232 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-03-05,2018-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79280 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2018-03-15,2018-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79404 - Class II - Biologics - OneBlood, Inc.","Platelet products, with a failure to meet product specifications, were distributed.",2018-03-16,2018-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79543 - Class II - Biologics - OneBlood, Inc.","Blood product, which was labeled as leukoreduced, but was not tested to verify white blood cell count, was distributed.",2018-04-04,2018-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79430 - Class II - Biologics - OneBlood, Inc.","Platelet products, labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2018-04-17,2018-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79573 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2018-04-27,2018-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79777 - Class II - Biologics - OneBlood, Inc.","Blood product, for which the donor was incorrectly deleted from deferral list for  vCJD travel history, was distributed.",2018-04-30,2018-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79984 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2018-05-03,2018-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79867 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2018-05-24,2018-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80438 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80611 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80736 - Class II - Biologics - OneBlood, Inc.","Platelet products, labeled as leukoreduced, but not tested for WBC count,  were distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80737 - Class III - Biologics - OneBlood, Inc.","Blood product, collected from a donor for whom deferral screening was incorrectly performed, was distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80738 - Class II - Biologics - OneBlood, Inc.","Blood products for which donor deferral screening was incorrectly performed, were distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80739 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor for whom deferral screening was incorrectly performed, were distributed.",2018-08-24,2018-08-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80743 - Class II - Biologics - OneBlood, Inc.","Red blood cell, labeled as leukoreduced, but for which WBC testing was not performed, was distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80799 - Class II - Biologics - OneBlood, Inc.","Platelet products, labeled as leukoreduced, but not tested for WBC count, were distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80745 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-09-12,2018-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80853 - Class II - Biologics - OneBlood, Inc.",-,2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81033 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2018-10-12,2018-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81248 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from an ineligible donor, was distributed.",2018-10-22,2018-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81397 - Class III - Biologics - OneBlood, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2018-10-26,2018-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81448 - Class II - Biologics - OneBlood, Inc.","Apheresis red cell, not meeting product specifications, was distributed.",2018-11-01,2018-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81449 - Class III - Biologics - OneBlood, Inc.","Apheresis red cells, not meeting product specifications, were distributed.",2018-11-01,2018-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81450 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2018-11-01,2018-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81481 - Class II - Biologics - OneBlood, Inc.",Misbranded red blood cells were distributed.,2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81274 - Class III - Biologics - OneBlood, Inc.","Blood product, collected from a donor taking medication containing human pituitary growth hormones, was distributed.",2018-11-14,2018-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81565 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, not meeting product specifications, were distributed.",2018-11-15,2018-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81577 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2018-11-16,2018-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81516 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81517 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81540 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2018-11-19,2018-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81583 - Class II - Biologics - OneBlood, Inc.","Blood product, not meeting product specifications, was distributed.",2018-11-21,2018-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81596 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from an ineligible donor, was distributed.",2018-11-21,2018-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81670 - Class III - Biologics - OneBlood, Inc.","Misbranded blood product, collected from a therapeutic donor with polycythemia vera, was distributed.",2018-12-20,2018-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81831 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed",2019-02-01,2019-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82028 - Class II - Biologics - OneBlood, Inc.","Apheresis products, in which quality control for WBC count was not performed, were distributed.
",2019-02-07,2019-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82137 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was previously deferred for taking growth hormone, were distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82030 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2019-03-04,2019-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82031 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2019-03-04,2019-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82082 - Class II - Biologics - OneBlood, Inc.",-,2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82095 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82109 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82150 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82151 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82152 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who previously testing positive for Hepatitis, were distributed., Blood products, collected from a donor who previously testing positive for Hepatitis, were distributed.
",2019-03-15,2019-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82157 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2019-03-18,2019-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82284 - Class II - Biologics - OneBlood, Inc.","Apheresis products in which quality control for residual WBC count was not performed, were distributed.
",2019-03-18,2019-03-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82285 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was previously deferred for a history of intravenous drug use, were distributed.",2019-03-20,2019-03-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82301 - Class III - Biologics - OneBlood, Inc.","Apheresis red cells, not meeting product specifications, were distributed.
",2019-03-20,2019-03-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82302 - Class III - Biologics - OneBlood, Inc.","Apheresis red cell product, not meeting product specifications, was distributed.
",2019-03-20,2019-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82110 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, were distributed.",2019-03-22,2019-03-22,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82408 - Class II - Biologics - OneBlood, Inc.","Blood products, with a low granulocyte yield, were distributed.
",2019-04-01,2019-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82242 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82371 - Class II - Biologics - OneBlood, Inc.","Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2019-04-02,2019-04-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82464 - Class II - Biologics - OneBlood, Inc.","Apheresis products in which quality control for residual WBC count was not performed, were distributed.
",2019-04-05,2019-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82254 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications for release, was distributed.",2019-04-11,2019-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82557 - Class II - Biologics - OneBlood, Inc.","Apheresis blood product, which was labeled as leukoreduced but was not tested to verify white blood cell count, was distributed.",2019-04-12,2019-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82505 - Class II - Biologics - OneBlood, Inc.","Apheresis blood product, which was labeled as leukoreduced but was not tested to verify white blood cell count, was distributed.",2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82624 - Class II - Biologics - OneBlood, Inc.","Apheresis products in which quality control for residual WBC count was not performed, were distributed.
",2019-04-22,2019-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82674 - Class III - Biologics - OneBlood, Inc.","Red Blood Cell products, in which donor screening was not done or incorrectly performed, including incorrect ID used during search,prior deferral due to history, were distributed.",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82556 - Class II - Biologics - OneBlood, Inc.","Blood products, collected using equipment that had not been validated, were distributed.",2019-05-17,2019-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82687 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2019-06-03,2019-06-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82814 - Class II - Biologics - OneBlood, Inc.","Apheresis platelets product, collected in a manner that compromises the sterility of the collection system, was distributed.",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82846 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2019-06-12,2019-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83107 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from an ineligible donor, were distributed.",2019-06-27,2019-06-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83078 - Class II - Biologics - OneBlood, Inc.","Apheresis Blood product, which was labeled as leukoreduced, but was not tested to verify white blood cell count, was distributed.",2019-06-28,2019-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83168 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2019-07-01,2019-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83169 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2019-07-01,2019-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83197 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Red Blood Cells unit, which was labeled as leukocytes reduced but failed the monthly QC residual white cell count, was distributed.",2019-07-12,2019-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83204 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-07-12,2019-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83148 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83258 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2019-08-01,2019-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83475 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83401 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, in which residual WBC count was not performed, were distributed.",2019-08-28,2019-08-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83553 - Class II - Biologics - OneBlood, Inc.","Apheresis Platelets, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83618 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-09-06,2019-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83619 - Class II - Biologics - OneBlood, Inc.","Apheresis Platelets with platelet additive solution, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-09-06,2019-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83741 - Class II - Biologics - OneBlood, Inc.","Blood products, for which donor screening was incorrectly performed for a prior deferral due to HTLV testing, were distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83617 - Class II - Biologics - OneBlood, Inc.","Red Cell products, not meeting product specifications, were distributed.",2019-09-23,2019-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83802 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from a donor who had previously tested reactive for Hepatitis C (HCV), were distributed.
",2019-10-02,2019-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83803 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which white blood cell count testing was not performed, were distributed.
",2019-10-02,2019-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83837 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2019-10-02,2019-10-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83759 - Class II - Biologics - OneBlood, Inc.","Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2019-10-10,2019-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83954 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products in which quality control for white blood cell count testing was not performed, were distributed.
",2019-10-10,2019-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84097 - Class III - Biologics - OneBlood, Inc.","Blood products, collected from a previously deferred donor, were distributed.",2019-10-30,2019-10-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84176 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, not meeting product specifications, were distributed.",2019-10-31,2019-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84155 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, in which quality control for residual WBC count was not performed, was distributed.

",2019-11-01,2019-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84156 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, in which quality control for residual WBC count  was not performed, was distributed.",2019-11-01,2019-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84157 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, in which quality control for residual WBC count was not performed, were distributed.",2019-11-01,2019-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84035 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2019-11-04,2019-11-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84051 - Class III - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2019-11-04,2019-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83986 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2019-11-15,2019-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84175 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, Leukoreduced, collected in a manner that compromised the sterility of the collection system, were distributed.",2019-11-15,2019-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83987 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84136 - Class II - Biologics - OneBlood, Inc.","Blood Products, collected from a donor with high risk behavior, were distributed.",2019-11-26,2019-11-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84139 - Class II - Biologics - OneBlood, Inc.","Blood product, labeled RBC antigen negative tested RBC antigen positive, was distributed.",2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84174 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84259 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Red Blood Cells, which required Quality Control testing for White Blood Cell count and absolute Red Blood Cell volume but were not tested, were distributed.",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84428 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor with a prior deferral, were distributed.",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84529 - Class II - Biologics - OneBlood, Inc.","Apheresis RBCs, Leukoreduced, not meeting product specifications, were distributed.",2019-12-17,2019-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84556 - Class II - Biologics - OneBlood, Inc.","Red Blood Cell product in which routine testing/testing performed, interpreted, documented, or labeled incorrectly, was distributed.
",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84582 - Class II - Biologics - OneBlood, Inc.","Blood products, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed",2020-01-15,2020-01-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84718 - Class II - Biologics - OneBlood, Inc.","Misbranded Red Blood Cells, were distributed.",2020-01-30,2020-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84949 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, in which quality control for residual WBC count  was not performed, was distributed.
",2020-02-18,2020-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84950 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, in which quality control for residual WBC count  was not performed, were distributed.
",2020-02-18,2020-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84782 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blod Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85043 - Class II - Biologics - OneBlood, Inc.","Leukoreduced, Apheresis Red Blood Cells, which were not tested for residual White Blood Cells per QC, were distributed.",2020-03-05,2020-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85025 - Class II - Biologics - OneBlood, Inc.","Blood products, not meeting product specifications, were distributed.",2020-03-23,2020-03-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85131 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, not meeting labeled product specifications, were distributed.",2020-03-30,2020-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85295 - Class II - Biologics - OneBlood, Inc.","Red Blood Cell, collected from a donor where donor screening/deferral was not done or incorrectly performed, was distributed.",2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85060 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2020-04-01,2020-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85385 - Class II - Biologics - OneBlood, Inc.",Misbranded red blood cells were distributed.,2020-04-03,2020-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85520 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, in which quality control for residual WBC count was not performed, were distributed.
",2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85617 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, in which quality control for residual WBC count was not performed, were distributed.
",2020-05-15,2020-05-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85728 - Class II - Biologics - OneBlood, Inc.","Misbranded Red Blood Cell product, was distributed.

",2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85766 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85933 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products,  not meeting product specifications, were distributed.",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85934 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85849 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2020-07-08,2020-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85969 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, in which quality control for residual WBC count  was not performed, were distributed.
",2020-07-08,2020-07-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85976 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-07-20,2020-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85878 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2020-07-22,2020-07-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85879 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications for release, was distributed.",2020-07-22,2020-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86011 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86055 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, in which quality control for residual WBC count  was not performed, were distributed.",2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86309 - Class II - Biologics - OneBlood, Inc.","Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86310 - Class II - Biologics - OneBlood, Inc.","Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86297 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, which did not meet the acceptable product specifications for release, were distributed.",2020-09-10,2020-09-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86481 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor with a prior deferral history, was distributed.",2020-09-24,2020-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86370 - Class II - Biologics - OneBlood, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2020-09-30,2020-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86518 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product,  not meeting product specifications, was distributed.",2020-09-30,2020-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86639 - Class III - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2020-11-12,2020-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86784 - Class III - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, in which the percent recovery was not documented, were distributed.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86789 - Class II - Biologics - OneBlood, Inc.","Leukoreduced, Apheresis Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86791 - Class II - Biologics - OneBlood, Inc.","Leukoreduced, Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86892 - Class II - Biologics - OneBlood, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2020-12-03,2020-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86933 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, not meeting product specifications, were distributed.
",2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86936 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, in which quality control for residual WBC count was not performed, was distributed.
",2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87118 - Class II - Biologics - OneBlood, Inc.","Red Blood Cell products, in which quality control for residual WBC count was not performed, were distributed.
",2021-01-14,2021-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87107 - Class II - Biologics - OneBlood, Inc.","Apheresis Platelets,  which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87164 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.
",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87165 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for white blood cell count testing was not performed, were distributed.
",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87166 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for residual WBC count was not performed, were distributed.
",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87211 - Class III - Biologics - OneBlood, Inc.","Leukoreduced, Apheresis Red Blood Cells, which did not meet the minimum requirement for Red Blood Cell recovery following leukoreduction, were distributed.",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87226 - Class II - Biologics - OneBlood, Inc.","Blood products, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2021-02-12,2021-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87234 - Class II - Biologics - OneBlood, Inc.","Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87326 - Class III - Biologics - OneBlood, Inc.","Blood products, not prepared in accordance with specifications, were distributed.",2021-02-23,2021-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87422 - Class III - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2021-03-10,2021-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87529 - Class III - Biologics - OneBlood, Inc.","Blood products, which failed to meet product specifications for red blood cell percent recovery, were distributed.",2021-03-29,2021-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87521 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control procedures were not performed, were distributed.
",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87670 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications, was distributed.",2021-04-10,2021-04-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87586 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.
",2021-04-14,2021-04-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87623 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-04-14,2021-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87783 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, for which quality control for residual WBC count was not performed, was distributed.
",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87851 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2021-05-21,2021-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87968 - Class II - Biologics - OneBlood, Inc.","Blood products, the products failed to meet the product specifications, were distributed.",2021-06-04,2021-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87972 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2021-06-04,2021-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87908 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which did not meet the minimum requirements, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87928 - Class II - Biologics - OneBlood, Inc.","Blood products, which did not meet the acceptable product specifications for release, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87963 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87964 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88022 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88023 - Class II - Biologics - OneBlood, Inc.","Platelet product, for which quality control for residual WBC count was not performed, was distributed.
",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88034 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88035 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which did not meet product specifications, were distributed.",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88036 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for residual WBC count was not performed, were distributed.
",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88037 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for residual WBC count was not performed, were distributed.
",2021-06-14,2021-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88043 - Class II - Biologics - OneBlood, Inc.","Blood Products, collected in a manner that compromises the sterility of the collection system, were distributed.",2021-06-14,2021-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88054 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.",2021-06-14,2021-06-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88067 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which residual WBC count was not performed, were distributed.
",2021-06-22,2021-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88069 - Class III - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, not meeting product specifications, were distributed.
",2021-06-22,2021-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88111 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which was labeled as leukocytes reduced but failed the monthly QC residual white cell count, were distributed.",2021-06-22,2021-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88180 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count  was not performed, were distributed.
",2021-07-01,2021-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88168 - Class II - Biologics - OneBlood, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88178 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count  was not performed, were distributed.
",2021-07-06,2021-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88226 - Class III - Biologics - OneBlood, Inc.","Apheresis PF24 Plasma, collected using a device with a non-recoverable alarm, was distributed.",2021-07-12,2021-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88231 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, not meeting product specifications, were distributed.
",2021-07-12,2021-07-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88252 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-07-14,2021-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88407 - Class III - Biologics - OneBlood, Inc.","Blood products, which failed to meet the minimum specification for red blood cell percent recovery, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88494 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-09-02,2021-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88535 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-09-02,2021-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88493 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual white blood cell count testing was not performed, were distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88496 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88810 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.
",2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88828 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.
",2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88912 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for residual WBC count was not performed, were distributed.
",2021-11-03,2021-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88913 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for WBC count was not performed, were distributed.
",2021-11-03,2021-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88903 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-11-04,2021-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88911 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-11-05,2021-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89012 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for residual WBC count was not performed, were distributed.
",2021-12-09,2021-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89082 - Class II - Biologics - OneBlood, Inc.","Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89097 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89196 - Class II - Biologics - OneBlood, Inc.","Misbranded Red Blood Cell product was distributed.
",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89373 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, for which quality control for residual white blood cell count testing was not performed, was distributed. 
",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89399 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-01-31,2022-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89407 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-01-31,2022-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89483 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-02-04,2022-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89478 - Class II - Biologics - OneBlood, Inc.","Platelet product, for which quality control for residual WBC count was not performed, was distributed. 
",2022-02-09,2022-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89496 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.
",2022-02-09,2022-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89566 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, not meeting product specifications, were distributed. 
",2022-02-22,2022-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89609 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual white blood cell count testing was not performed, were distributed. 
",2022-03-01,2022-03-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89611 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for WBC count was not performed, were distributed. 
",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89638 - Class III - Biologics - OneBlood, Inc.",Misbranded PF24RT24 Plasma was distributed.,2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89650 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for residual white blood cell count testing was not performed, were distributed. 
",2022-03-16,2022-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89695 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for WBC count was not performed, were distributed. 
",2022-03-16,2022-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89651 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89696 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89722 - Class II - Biologics - OneBlood, Inc.","Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.
",2022-03-18,2022-03-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89851 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, in which WBC count was not performed, were distributed.
",2022-04-07,2022-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89911 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual white blood cell count testing was not performed, were distributed. 
",2022-04-19,2022-04-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89973 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for residual white blood cell count testing was not performed, were distributed. 
",2022-04-19,2022-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89912 - Class III - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were not stored under continuous agitation, were distributed.",2022-04-20,2022-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89963 - Class II - Biologics - OneBlood, Inc.","Blood products, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-04-20,2022-04-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90053 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-05-09,2022-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90018 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell product, for which quality control for residual WBC count was not performed, was distributed.
",2022-05-10,2022-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90054 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed. 
",2022-05-10,2022-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90186 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control for residual WBC count was not performed, were distributed.
",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90187 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90207 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, for which quality control for residual WBC count was not performed, was distributed. 
",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90220 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90261 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90262 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90329 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed
",2022-06-12,2022-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90357 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control for residual WBC count was not performed, were distributed. 
",2022-06-12,2022-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90439 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, in which quality control for residual WBC count was not performed, were distributed.
",2022-06-22,2022-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90328 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, collected in a manner that compromises the sterility of the collection system, was distributed.",2022-09-15,2022-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90330 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-09-15,2022-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90355 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-09-20,2022-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90353 - Class II - Biologics - OneBlood, Inc.",Misbranded Pooled Cryoprecipitated AHF was distributed.,2022-09-21,2022-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90376 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, Platelet Additive Solution Added, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-09-21,2022-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90396 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, in which quality control for residual WBC count was not performed, was distributed.
",2022-09-26,2022-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90928 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-10-17,2022-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90929 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-10-17,2022-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91057 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-11-16,2022-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91060 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, PAS, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-11-16,2022-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91207 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-08,2022-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91251 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control procedures for residual white blood cell testing was not performed, were distributed.
",2022-12-08,2022-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91252 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis product, for which quality control procedures for residual white blood cell testing was not performed, was distributed.
",2022-12-08,2022-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91247 - Class II - Biologics - OneBlood, Inc.","Blood products, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-09,2022-12-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91249 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91253 - Class II - Biologics - OneBlood, Inc.","Plateletpheresis products, for which quality control procedures for residual white blood cell testing was not performed, were distributed.
",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91254 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control procedures for residual white blood cell testing was not performed, were distributed.
",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91255 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control procedures for residual white blood cell testing was not performed, were distributed.
",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91268 - Class II - Biologics - OneBlood, Inc.","Apheresis Red Blood Cell products, for which quality control procedures for residual white blood cell testing was not performed, were distributed.
",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91264 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-19,2022-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91265 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, PAS, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-19,2022-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91266 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-19,2022-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91267 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, PAS, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-19,2022-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91307 - Class II - Biologics - OneBlood, Inc.","Blood products, where transfusion-transmitted infection testing was performed and/or interpreted incorrectly, were distributed.
",2023-01-09,2023-01-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91058 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2023-01-19,2023-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91548 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2023-02-01,2023-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91590 - Class II - Biologics - OneBlood, Inc.","Blood products, possibly contaminated with air, were distributed.
",2023-02-01,2023-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91544 - Class II - Biologics - OneBlood, Inc.","Leukoreduced Red Blood Cells, where transfusion-transmitted infection testing was performed and/or interpreted incorrectly, were distributed.",2023-02-02,2023-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44361 - Class III - Biologics - ONEBLOOD, Inc.","Blood product, collected from a deferred donor who was improperly re-entered, was distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65156 - Class II - Biologics - OneBlood, Inc. dba  Southeastern Comm. Blood Center","Blood products, collected in a manner that may have compromised the sterility of the products, were distributed.",2013-06-14,2013-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71581 - Class I - Biologics - OneLegacy,"Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2015-08-07,2015-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73890 - Class II - Biologics - OneLegacy,"Human corneas, not tested appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86251 - Class II - Drugs - Open Book Extracts,Labeling Not Elsewhere Classified: Product labeled to contain methanol,2020-09-09,2020-09-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64933 - Class II - Drugs - OPMX, LLC","Labeling: Not Elsewhere Classified: Pentrexcilina Tablets and Pentrexcilina Liquid are being recalled because the product labels are misleading because they may be confused with Pentrexyl, a prescription antibiotic used to treat respiratory illnesses in Mexico.",2013-04-25,2013-04-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84437 - Class II - Drugs - OraLabs, Incorporated",Cross contamination with other products: undeclared contaminants of phenol and camphor in petroleum jelly tubes.,2019-12-19,2019-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69519 - Class II - Drugs - Oregon Compounding Centers, Inc. dba Creative Compounds","Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection., Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.., Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection",2014-10-31,2014-10-31,56,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80801 - Class III - Drugs - Orexigen Therapeutics, Inc.",Defective Container: Customer complaints of punctures in the bottle.,2018-08-16,2018-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81505 - Class III - Drugs - Orexigen Therapeutics, Inc.",Container packaging defect.,2018-11-06,2018-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76511 - Class I - Drugs - Organic Herbal Supply,Marketed without an Approved NDA/ANDA: Product contains N-desmethyl tadalafil an analogue to tadalafil which is an active pharmaceutical ingredient in a FDA approved drug used to treat erectile dysfunction (ED).,2017-04-05,2017-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77055 - Class I - Drugs - Organic Herbal Supply,"Marketed without an Approved NDA/ANDA; FDA analysis found the presence of undeclared tadalafil, sildenafil and/or their analogues and Flibanserin",2017-07-11,2017-07-11,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89231 - Class II - Drugs - Organics Corporation of America DBA Ambix Laboratories,MICROBIAL CONTAMINATION OF NON-STERILE PRODUCT: microbial contaminant identified as Pluralibacter gergoviae.,2022-02-14,2022-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70489 - Class III - Biologics - ORGENICS LTD,"Alere Determine HIV-1/2 Ag/Ab Combo Controls, with a decrease in the activity of the HIV-1 p24 Antigen Control solution, were distributed.",2015-03-03,2015-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84306 - Class II - Biologics - OriGen Biomedical, Inc.","OriGen medical devices samples, Not labeled 'Not For Human Use' as well as not meeting product release specifications, were distributed for use.",2020-01-24,2020-01-24,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74550 - Class III - Biologics - Ortho-Clinical Diagnostics,"ORTHO ProVue Analyzers,  with suboptimal reference images and/or  Brillo values outside of specification, were distributed.",2016-08-18,2016-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90019 - Class II - Biologics - ORTHO-CLINICAL DIAGNOSTICS,"Ortho Optix Reader, incorrect QC Status assigned when using multiple Quality Control (QC) kits, was distributed.",2022-04-21,2022-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90960 - Class III - Biologics - Ortho-Clinical Diagnostics, Inc.","Ortho Clinical Diagnostics is recalling the ORTHO VISION Analyzer and ORTHO VISION Max Analyzer for ID-MTS Gel Cards because the distributed devices have the potential use of mismatched camera images during routine imaging operations. Routine imaging operations include:
 
1) Inventory of cards when sleeves are loaded in the Supply Drawer or cards are loaded in the Dua-Purpose loading drawer.

2) Quality check of cards prior to assay processing.

3) Analysis of cards at the conclusion of assay processing.

4) ID-MTS column grading for result interpretation.
 
5) Inventory of card punch tools.

6) Health Checks to ensure proper functioning of the Card Imaging System.",2022-11-30,2022-11-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89667 - Class II - Biologics - Ortho-Clinical Diagnostics, Inc.","VITROS Chemistry Products VersaTips, shape deformity resulting in an improper seal which affects volume aspiration, were distributed.",2022-03-24,2022-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83403 - Class II - Biologics - Ortho Clinical Diagnostics Inc,"Ortho Clinical Diagnostics ORTHO VISION and ORTHO VISION Max Analyzers with a pipetting probe anomaly associated with software version 5.12.3 and 5.12.4, were distributed.",2019-08-02,2019-08-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83957 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"ORTHO VISION and ORTHO VISION Max Analyzers, with a software anomaly regarding handling of duplicate Sample IDS, were distributed.",2019-12-05,2019-12-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63861 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"Ortho Pipetter Volume Verification Kit, Lot 0007,  mislabeled with the incorrect expiration date, was distributed.",2012-12-21,2012-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64068 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"Blood Grouping Reagent Anti-e (Monoclonal) BioClone, with potential of false negative results, was distributed.",2013-01-24,2013-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64253 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"RhoGAM syringes, with lack of assurance of proper temperature monitoring during shipment, were distributed.",2013-02-04,2013-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64741 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"Rh Immune Globulin, lacking assurance of proper temperature maintenance during transit, was distributed.",2013-04-08,2013-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66136 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"ORTHO VERSEIA Pipetter software, with a defect or glitch that in certain circumstances during plate processing, has the potential for false negative results.",2013-09-06,2013-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66796 - Class II - Biologics - Ortho Clinical Diagnostics Inc,IVD with weakened reactivity was distributed.,2013-11-19,2013-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73470 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"""ORTHO VISION"" Analyzer with Software Version 1.2.10, with a glitch, was distributed.",2016-03-25,2016-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73511 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"Urgent Product Correction Notification for the Ortho Vision Analyzers with Software version 2.12.13 and Below, was distributed.",2016-03-25,2016-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76170 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"Ortho reagent products, not meeting product specifications, were distributed.",2017-01-17,2017-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76270 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"Ortho reagent products, not meeting product specifications, were distributed.",2017-01-23,2017-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79864 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"A single lot of 0.8% Surgiscreen, labeled with incorrect Barcode for Cell 2, was distributed.",2018-05-22,2018-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89238 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"Ortho Clinical Diagnostics (Ortho) HCV Version 3.0 (2020) ELISA Test System, Ortho HCV Version 3.0 ELISA Test System, and ORTHO HBc ELISA Test System, with a discrepancy in the Specimen Collection, Storage and Handling section of the package insert, were distributed.",2021-12-23,2021-12-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89282 - Class III - Biologics - Ortho Clinical Diagnostics Inc,"Ortho Clinical Diagnostics 0.8% Resolve Panel cell, demonstrating weak or negative reactions, was distributed.",2022-01-20,2022-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66226 - Class III - Drugs - Osmotica Pharmaceutical Corp,Failed Dissolution Specification:12 hour time point at 18 months of product shelf life.,2013-09-27,2013-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78764 - Class III - Drugs - Osmotica Pharmaceutical Corp,Subpotent Drug,2017-12-20,2017-12-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79365 - Class III - Drugs - Osmotica Pharmaceutical Corp,Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.,2018-03-06,2018-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85542 - Class II - Biologics - Osteolife Biomedical I LLC,"Human bone allografts associated with a failure to prevent distribution of allografts that are in quarantine, are contaminated, or that otherwise do not meet release criteria designed to prevent communicable disease transmission, were distributed.",2020-04-23,2020-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81020 - Class III - Drugs - Otsuka Pharmaceutical Development & Commercialization, Inc.","Labeling Not Elsewhere Classified: Physician sample kits/cartons of treatNOW Abilify are mislabeled. Product name is misspelled, storage instructions are missing and contents of kits may be incorrectly labeled on the outer packaging of the co-packaged kit.",2018-10-12,2018-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73257 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood products, in which labeling/labels applied to blood units or products with incorrect or missing information, were distributed.",2016-03-24,2016-03-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62602 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood product, collected from a donor who reported travel to an area possibly endemic for malaria, was distributed.",2012-08-06,2012-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63436 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood product, with a platelet count that exceeded the maximum specification, was distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64176 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood products, collected from a potentially  ineligible donor, were distributed., Blood products, collected from a potentially ineligible donor, were distributed.",2013-04-23,2013-04-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69015 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood product, which was collected from a donor who had traveled to a malarial endemic area, was distributed.",2014-09-16,2014-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72465 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood product, for which the deferral screening process was incorrectly performed, was distributed.",2015-11-04,2015-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74433 - Class III - Biologics - Our Lady Of The Lake Hospital Inc,"Blood product, collected from a donor who tested positive for the antibody to Hepatitis B core Antigen on more than one occasion, was distributed.",2016-06-30,2016-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79658 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood products, in which residual WBC count were not performed, were distributed.
",2018-04-05,2018-04-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82097 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82471 - Class II - Biologics - Our Lady Of The Lake Hospital Inc,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.
",2019-04-09,2019-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86899 - Class II - Biologics - Our Lady of the Lake Hospital, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2020-12-04,2020-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91185 - Class II - Biologics - Our Lady of the Lake Hospital, Inc.","Platelet product, in which platelet yield did not meet specifications as a result of a component preparation deviation, was distributed.
",2022-11-25,2022-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90932 - Class II - Biologics - Our Lady of the Lake Hospital, Inc.","Platelets, Pathogen Reduced, in which platelet yield did not meet specifications, were distributed.",2023-01-10,2023-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91229 - Class II - Drugs - OurPharma LLC,Underfilled units.,2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91520 - Class III - Drugs - OurPharma LLC,Short Fill: Underfilled units.,2023-01-23,2023-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81914 - Class III - Drugs - Oxalis Labs,Defective Container; complaints of leakage.,2019-02-14,2019-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87873 - Class II - Drugs - Oxford Pharmaceuticals, LLC",Presence of Foreign Tablets/Capsules,2021-06-02,2021-06-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79338 - Class III - Drugs - Oxygen Development Llc,Superpotent drug: failed assay throughout the stick after 6 months stability.,2018-03-09,2018-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63942 - Class I - Drugs - P & J Trading Co,"Marketed Without an Approved NDA/ANDA: All lots of the dietary supplement Slimdia Revolution are being recalled because they contain sibutramine, a previously approved FDA drug removed from the U.S. marketplace for safety reasons, making it an unapproved new drug.",2013-02-15,2013-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77007 - Class III - Drugs - P & L Development,  LLC",Subpotent:  This product is being recalled due to low out of specification assay results at the 9 month time point.,2017-05-02,2017-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83181 - Class II - Drugs - P & L Developments,  LLC","cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).",2019-06-20,2019-06-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86403 - Class III - Drugs - P & L Developments,  LLC",Labeling: Incorrect or Missing Package Insert: The package insert included in the finished product is for the Canadian market and is not part of the current approved drug labeling.,2020-10-01,2020-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68018 - Class III - Drugs - P&L Developments, LLC",Subpotent Drug: Phenylephrine component is subpotent.,2014-04-22,2014-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68037 - Class III - Drugs - P&L Developments, LLC",Presence of Precipitate: Small amounts of diphenydramine and mannitol precipitated out of solution.,2014-05-01,2014-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63909 - Class I - Biologics - Pacific Coast Tissue Bank,"Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed. 
",2013-06-06,2013-06-06,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82477 - Class II - Drugs - Pacific Compounding Pharmacy & Consultations Inc,Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a physician after use of product.. FDA analysis identified the particulate as coring of the rubber stopper,2019-04-02,2019-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72361 - Class II - Drugs - Pacific Healthcare, Inc dba B&B Pharmacy",Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility,2015-11-10,2015-11-10,16,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76109 - Class I - Drugs - Pacific Medical Solutions,Marketed without an Approved NDA/ANDA and non-sterility:  NANO PNC Water by nebulizer was sampled and found to contain variovorax paradoxus.,2017-03-01,2017-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73560 - Class I - Drugs - Pacifico National, Inc. dba AmEx Pharmacy",Non-Sterility: Product tested positive for bacterial contamination.,2016-05-25,2016-05-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82676 - Class II - Drugs - Pacifico National, Inc. dba AmEx Pharmacy",Defective Delivery System: difficult to express,2019-05-07,2019-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83702 - Class II - Drugs - Pacifico National, Inc. dba AmEx Pharmacy",Lack of assurance of sterility.,2019-09-10,2019-09-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64198 - Class II - Drugs - Pacira Pharmaceuticals, Inc.",Subpotent; bupivacaine,2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84311 - Class II - Drugs - Pacira Pharmaceuticals, Inc.",Sub Potent Drug: Out of Specification (OOS),2019-12-10,2019-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #51880 - Class III - Drugs - Pack Pharmaceuticals,Labeling Illegible: Missing Label; The voluntary recall of the aforementioned batch of product is being initiated due to two bottles missing container labels.,2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66595 - Class III - Drugs - PACK Pharmaceuticals, LLC","Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.",2014-02-04,2014-02-04,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89310 - Class II - Drugs - Padagis US LLC,Defective Delivery System,2022-01-13,2022-01-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90790 - Class II - Drugs - Padagis US LLC,CGMP Deviations: Product complaints reporting the product to have a gritty texture and lack of effectiveness.,2022-09-07,2022-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63354 - Class II - Drugs - Paddock Laboratories, LLC","Paddock Laboratories, LLC are recalling one lot 
(2012028142) of Moexipril HCl Tablets 7.5mg (expiration 1/2014) because of a  non-conformity dissolution failure result found during routine stability testing at the 6 month test interval.",2012-10-09,2012-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67735 - Class II - Drugs - Paddock Laboratories, LLC",Presence of Particulate Matter Perrigo is recalling seven lots of Clindamycin Palmitate Hydrochloride for Oral Solution 75mg/5ml.,2014-03-20,2014-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79334 - Class II - Drugs - Paddock Laboratories, LLC.",Defective Delivery System: Potential that cracks in the vial neck near the crimp may result in product evaporation and/or leaking and the inability to properly dispense product.,2018-03-28,2018-03-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85302 - Class II - Drugs - PAI Holdings, LLC. dba Pharmaceutical Associates Inc",SubPotent Drug: Low out-of-specification results for assay testing.,2020-03-25,2020-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86170 - Class II - Drugs - PAI Holdings, LLC. dba Pharmaceutical Associates Inc",Subpotent drug: Out of specification for assay at the 15-month test interval.,2020-08-12,2020-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86409 - Class III - Drugs - PAI Holdings, LLC. dba Pharmaceutical Associates Inc",Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint,2020-10-05,2020-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88392 - Class II - Drugs - PAI Holdings, LLC. dba Pharmaceutical Associates Inc",Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.,2021-08-12,2021-08-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67726 - Class I - Drugs - Pain Free By Nature,Marketed Without an Approved NDA/ANDA; Product contains undeclared diclofenac and methocarbamol.,2014-05-15,2014-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68308 - Class II - Biologics - Pall Corporation,"Sterile Cord Blood Collection Systems, with a limited number of reports of a blood leaks, were distributed.",2014-06-04,2014-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64716 - Class II - Drugs - Pallimed Solutions,Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance,2013-08-09,2013-08-09,25,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64619 - Class II - Drugs - Palmer Natural Products,Marketed Without an Approved NDA/ANDA: The products are unapproved drugs,2013-04-01,2013-04-01,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91110 - Class II - Drugs - Par Formulations Private Limited,Failed Impurities/Degradation Specifications,2022-11-15,2022-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69999 - Class II - Drugs - Par Pharmaceutical Inc.,"Presence of Foreign Substance: Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets due to the presence of small  aluminum particles.",2015-01-06,2015-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70439 - Class II - Drugs - Par Pharmaceutical Inc.,"Presence of Foreign Substance; oxidized steel, organic material and shredded polypropylene",2015-02-20,2015-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72476 - Class III - Drugs - Par Pharmaceutical Inc.,Failed Impurities/Degradation Specifications: Out of specification for impurities.,2015-11-13,2015-11-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74270 - Class III - Drugs - Par Pharmaceutical Inc.,Failed Impurities/Degradation Specifications: Par Pharmaceutical is recalling Pramipexole Dihydrochloride Extended Release tablets because it contains a known product impurity above currently approved specification levels.,2016-06-16,2016-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84912 - Class III - Drugs - Par Pharmaceutical Inc.,Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.,2020-02-13,2020-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85136 - Class III - Drugs - Par Pharmaceutical Inc.,Labeling: Incorrect or Missing Exp Date - An incorrect expiration date has been identified on Prednisone Tablets USP 5 mg,2020-03-18,2020-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85333 - Class II - Drugs - Par Pharmaceutical Inc.,Failed Impurities/Degradation Specification: Presence of unknown impurity observed.,2020-03-30,2020-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86202 - Class II - Drugs - Par Pharmaceutical Inc.,Failed Impurity /Degradation Specifications,2020-08-25,2020-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75455 - Class III - Drugs - Par Pharmaceutical, Inc.",Subpotent Drug; Ethinyl Estradiol,2016-11-01,2016-11-01,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82680 - Class I - Drugs - Par Pharmaceutical, Inc.",Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product,2019-05-22,2019-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75471 - Class II - Drugs - Par Pharmaceutical, Inc.",Lack of Assurance of Sterility; damage to the internal portion of the dropper tip portion of the container,2016-11-25,2016-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80969 - Class III - Drugs - Par Pharmaceutical, Inc.",Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.,2018-09-10,2018-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77169 - Class II - Drugs - PAR Sterile Products LLC,"Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose and the buprenorphine active component.",2017-05-09,2017-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79619 - Class II - Drugs - Partell Specialty Pharmacy,Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.,2018-04-17,2018-04-17,49,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88164 - Class III - Drugs - Partner Therapeutics Inc,FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.,2021-07-13,2021-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78661 - Class III - Biologics - Pasadena Hospital Association dba Huntington Memorial Hosp,"Blood product, for which the donor provided disqualifying information and was not deferred, was distributed.",2018-01-10,2018-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83601 - Class III - Biologics - Pasadena Hospital Association dba Huntington Memorial Hosp,"Blood Products, collected from a donor with an increased risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2019-09-06,2019-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85579 - Class III - Biologics - PaxVax, Inc.","Vaxchora, not meeting product specifications, was distributed.",2020-05-01,2020-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90383 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,2022-06-27,2022-06-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72942 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",cGMP Deviations,2015-12-31,2015-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72956 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.","cGMP Deviations: This recall is a result of the original manufacturer's recall, in which the firm did not adequately investigate customer complaints.",2016-01-05,2016-01-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72941 - Class III - Drugs - PD-Rx Pharmaceuticals, Inc.",Failed impurities/Degradation specifications: out of specification results for individual unknown and total impurity at the 12th month room temperature stability test station,2016-01-20,2016-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77847 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",Failed Tablet/Capsule Specification: out of specification for tablet weight.,2017-08-03,2017-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77915 - Class III - Drugs - PD-Rx Pharmaceuticals, Inc.",Failed Impurities/Degradation Specifications:Out of specification results for individual unknown impurities at 30th month Room Temperature Retained Sample stabilities test .,2017-08-23,2017-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79023 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",CGMP deviations.,2018-02-08,2018-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80791 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",Failed Dissolution Specifications: manufacturer West-Ward Pharm Corp. recalled these repackaged lots due to failed dissolution results.,2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84820 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",CGMP Deviations: Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.,2020-02-04,2020-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85724 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",Failed dissolution specifications,2020-05-26,2020-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85827 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85828 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-06-20,2020-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86533 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",CGMP deviations; repackaged product was recalled by the manufacturer because it was manufactured under the same conditions as products found to be sub-potent.,2020-10-02,2020-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86600 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer),2020-11-02,2020-11-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87774 - Class II - Drugs - PD-Rx Pharmaceuticals, Inc.",CGMP deviation: Product found to contain trace amounts of NMBA,2021-04-26,2021-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38551 - Class III - Biologics - Penrose-St Franc Health Services Blood Bank,"Blood products, collected from a donor who was not asked follow-up questions regarding increased risk for vCJD, were distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71486 - Class II - Biologics - Penrose-St Francis Health Services-Donor Services,"Platelet products, which were not prepared in accordance with specifications, were distributed.",2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71490 - Class II - Biologics - Penrose-St Francis Health Services-Donor Services,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2015-07-21,2015-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71488 - Class II - Biologics - Penrose-St Francis Health Services-Donor Services,"Blood product, collected from a donor who gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2015-07-22,2015-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64891 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64892 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66613 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood products, collected from a donor who reported a history of Hepatitis, were distributed.",2013-12-02,2013-12-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68539 - Class III - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, which did not meet the acceptable product specifications, was distributed.",2014-07-18,2014-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68887 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood products, collected in a manner where the sterility of the products may have been compromised, were distributed., Blood products, collected in a manner where the sterility of the products may have been compromised, were distributed",2014-07-30,2014-07-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68881 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69774 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, in which Quality Control and Distribution of product did not meet specifications, was distributed.",2014-12-11,2014-12-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71771 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood products, which did not meet acceptable product specifications, were distributed.",2015-08-27,2015-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74860 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, for which Chagas Disease testing was not performed, was distributed.",2016-08-10,2016-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75106 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Apheresis product, in which platelet yield did not meet specifications, was distributed.",2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76333 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Apheresis products, with unacceptably high platelet concentrations, were distributed.",2017-02-03,2017-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77642 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, in which initial donor Chagas testing was not performed, was distributed.",2017-07-21,2017-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77719 - Class III - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, in which labeling applied to blood unit or product incorrect or missing information, was distributed.",2017-08-18,2017-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78122 - Class II - Biologics - Penrose-St Francis Health Services Blood Bank,"Blood product, for which quality control and distribution of product did not meet specifications, was distributed.",2017-10-16,2017-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65180 - Class II - Drugs - Pentec Health,"Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions., Lack of Assurance of Sterility: Sterility could not be assured for compounded sterile renal nutritional prescriptions",2013-06-06,2013-06-06,15,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88340 - Class I - Drugs - People's Custom Rx and Clinical Care, LLC",Non-Sterility,2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63916 - Class I - Drugs - Performance Plus Marketing, Inc.","Marketed Without an Approved NDA/ANDA: product may contain undeclared sildenafil, tadalafil and analogues of these FDA approved active ingredients, making them unapproved drugs",2013-05-16,2013-05-16,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86429 - Class II - Drugs - Perrigo Company PLC,Defective Delivery System: Sustained trend of failure to dispense complaints.,2020-09-23,2020-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88905 - Class II - Drugs - Perrigo Company PLC,CGMP Deviations: Products were manufactured with contaminated excipient that was recalled from the excipient supplier.,2022-02-23,2022-02-23,51,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72505 - Class III - Drugs - Perrigo Company PLC,Failed Impurity/Degradations Specifications; impurity identified as cetirizine monosaccharide ester,2015-12-24,2015-12-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73044 - Class II - Drugs - Perrigo Company PLC,Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.,2016-01-22,2016-01-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73101 - Class II - Drugs - Perrigo Company PLC,Labeling: label error on declared strength.,2016-02-04,2016-02-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84127 - Class II - Drugs - Perrigo Company PLC,CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.,2020-03-13,2020-03-13,17,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88384 - Class II - Drugs - Perrigo Company PLC,Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.,2022-01-05,2022-01-05,30,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69048 - Class III - Drugs - Perrigo Holland Inc,Failed Dissolution Specifications and Failed Tablet Specifications: High 30 minute dissolution test and presence of broken lozenges.,2014-08-22,2014-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71765 - Class III - Drugs - Perrigo Israel Pharmaceuticals,Subpotent drug,2015-08-05,2015-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80049 - Class II - Drugs - Perrigo New York,Failed Stability Specifications,2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82127 - Class III - Drugs - Perrigo New York, Inc.",Failed Degradation/Impurities Specifications: Out of specification related substance results during stability testing.,2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69674 - Class II - Drugs - Perry Drug Inc.,Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.,2014-11-24,2014-11-24,17,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64635 - Class II - Drugs - Petnet Solution Inc,cGMP Deviation,2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82283 - Class III - Drugs - Petra Hygienic Systems Int Ltd,"Does Not Meet Monograph: product contains, triclosan, an ingredient that can no longer be contained in over-the-counter consumer antiseptic/antibacterial wash products.",2019-03-12,2019-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80876 - Class II - Drugs - Pfizer Global Supply,Labeling Error: Not elsewhere classified. product has a dosage cup  marked in teaspoons and the instructions on the label are described in milliliters.,2018-08-30,2018-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65324 - Class III - Drugs - Pfizer Inc,Failed Dissolution Specification,2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73285 - Class III - Drugs - Pfizer Inc,Labeling: Label Mix-Up,2016-03-31,2016-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76663 - Class III - Drugs - Pfizer Inc,Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.,2017-03-22,2017-03-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67870 - Class II - Drugs - Pfizer Inc.,Presence of Foriegn Tablets/Capsules: A single Tikosyn (dofetilide) 250 mcg capsule was discovered in one bottle of Tikosyn (dofetilide) 500 mcg (0.5 mg).,2014-04-22,2014-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83788 - Class III - Drugs - Pfizer Inc.,Labeling: Incorrect or Missing Lot and/or Exp Date.  The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.,2019-10-01,2019-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89100 - Class II - Drugs - Pfizer Inc.,Lack of sterility assurance: bag has the potential to leak.,2021-12-02,2021-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64835 - Class II - Drugs - Pfizer Inc.,"Chemical contamination: emission of strong odor after package was opened.., Chemical contamination: emission of strong odor after package was opened., Chemical contamination: emission of strong odor after package was opened",2013-04-18,2013-04-18,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83533 - Class II - Drugs - Pfizer Inc.,Microbial Contamination of Non-Sterile Products: contamination with Burkholderia and Pseudomonas.,2019-08-28,2019-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83699 - Class II - Drugs - Pfizer Inc.,Lack of Assurance of Sterility,2019-09-12,2019-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85725 - Class III - Drugs - Pfizer Inc.,Failed Dissolution Specifications,2020-06-24,2020-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87831 - Class II - Drugs - Pfizer Inc.,Presence of Particulate Matter: particulate matter identified as an insect in one vial.,2021-05-14,2021-05-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88077 - Class II - Drugs - Pfizer Inc.,"CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit, CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDAs acceptable interim acceptable intake limit",2021-07-30,2021-07-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88497 - Class II - Drugs - Pfizer Inc.,CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit,2021-09-17,2021-09-17,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89864 - Class II - Drugs - Pfizer Inc.,CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.,2022-04-06,2022-04-06,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90064 - Class II - Drugs - Pfizer Inc.,CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.,2022-05-16,2022-05-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90581 - Class I - Drugs - Pfizer Inc.,Presence of particulate matter: particulate identified as a beetle.,2022-08-03,2022-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90785 - Class I - Drugs - Pfizer Inc.,Presence of particulate matter,2022-09-19,2022-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90903 - Class II - Drugs - Pfizer Inc.,Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.,2022-10-04,2022-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91379 - Class II - Drugs - Pfizer Inc.,Lack of assurance of sterility: Bags have the potential to leak.,2023-01-05,2023-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91346 - Class I - Drugs - Pfizer Inc.,Presence of Particulate Matter: Glass particulate matter detected in injectable.,2023-01-25,2023-01-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64690 - Class III - Drugs - Pfizer Inc.,Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.,2013-03-26,2013-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65393 - Class III - Drugs - Pfizer Inc.,"Failed Dissolution Specifications: Pfizer Inc. is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product  may not meet the dissolution specification for conjugated estrogens., Failed Dissolution Specifications: Pfizer Inc. (Pfizer) is recalling PREMPRO (conjugated estrogens/medroxyprogesterone acetate tablets) because certain lots for this product  may not meet the specification for conjugated estrogens dissolution.",2013-06-28,2013-06-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67137 - Class III - Drugs - Pfizer Inc.,Failed Impurities/Degradation Specifications: Pfizer is recalling certain lots due to out of specification results for azithromycin N-oxide degradant.,2014-01-16,2014-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66816 - Class III - Drugs - Pfizer Inc.,Failed Dissolution Specification; 8 hr stability timepoint,2014-02-03,2014-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67532 - Class II - Drugs - Pfizer Inc.,Defective Container: Tamper evident ring failures discovered on some bottles.,2014-05-30,2014-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68660 - Class III - Drugs - Pfizer Inc.,Labeling: Incorrect or missing lot and or Exp Date: The bottles were labeled with an incorrect expiry date 11/2016.  The correct expiry date is 09/2016.,2014-07-17,2014-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68639 - Class III - Drugs - Pfizer Inc.,Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.,2014-07-28,2014-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68876 - Class III - Drugs - Pfizer Inc.,Failed pH Specification: A pH result of 2.9 was obtained at the 9 month stability test interval at 25C/60%RH. The registered specification for pH is 3.0 - 7.0,2014-08-12,2014-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69479 - Class III - Drugs - Pfizer Inc.,Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this issue.,2014-11-04,2014-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69724 - Class II - Drugs - Pfizer Inc.,Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.,2014-12-09,2014-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70614 - Class III - Drugs - Pfizer Inc.,"Failed Impurities/Degradation Specifications 
",2015-03-05,2015-03-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72199 - Class II - Drugs - Pfizer Inc.,Subpotent Drug,2015-10-29,2015-10-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72716 - Class III - Drugs - Pfizer Inc.,"Failed Dissolution Specification
",2015-12-10,2015-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73043 - Class II - Drugs - Pfizer Inc.,FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.,2016-02-01,2016-02-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73913 - Class II - Drugs - Pfizer Inc.,Failed Tablet/Capsule Specifications: thick tablets exceeding specifications were found.,2016-05-20,2016-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75225 - Class III - Drugs - Pfizer Inc.,Labeling: Incorrect or Missing Lot and/or Exp Date: Bottles were incorrectly labeled with an expiry date of 11/17; the correct date is 09/17.,2016-09-27,2016-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75691 - Class II - Drugs - Pfizer Inc.,Superpotent,2016-11-23,2016-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75321 - Class III - Drugs - Pfizer Inc.,Failed Impurities/Degradations Specifications; Out of specification results for two known degradation products and total impurities at 18 months,2017-01-06,2017-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75871 - Class III - Drugs - Pfizer Inc.,Subpotent Drug: Out of Specification (OOS) for potency at the 6-month stability time point.,2017-03-10,2017-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77862 - Class III - Drugs - Pfizer Inc.,Failed Dissolution Specifications,2017-09-15,2017-09-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77956 - Class II - Drugs - Pfizer Inc.,Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.,2017-09-15,2017-09-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78048 - Class II - Drugs - Pfizer Inc.,"Non-Sterility: cracked or chipped glass at the neck of Sterile Water for Injection vials.  
",2017-09-22,2017-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77731 - Class III - Drugs - Pfizer Inc.,CGMP Deviations: Firm failed to control impurity for color change at the API stage.,2017-10-03,2017-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78000 - Class I - Drugs - Pfizer Inc.,Presence of Particulate Matter: glass particulate found in vial,2017-12-20,2017-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78332 - Class I - Drugs - Pfizer Inc.,SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent,2018-01-04,2018-01-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79114 - Class I - Drugs - Pfizer Inc.,Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.,2018-03-14,2018-03-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80923 - Class III - Drugs - Pfizer Inc.,Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point,2018-09-07,2018-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81050 - Class II - Drugs - Pfizer Inc.,Lack of assurance of sterility -Reports of loose metal ferrule crimps on vials for injection.  The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.,2018-10-02,2018-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81028 - Class II - Drugs - Pfizer Inc.,CGMP Deviations; rejected product was used to manufacture final bulk lot,2018-10-09,2018-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81126 - Class II - Drugs - Pfizer Inc.,"Correct Labeled Product Mispack: confirmed report involving a single unit of properly labeled Heparin in 0.45% Sodium Chloride for Injection (NDC 0409-7651-03, Lot 87903FW) that was found inside a case of Magnesium Sulfate in Water for Injection.",2018-10-11,2018-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81311 - Class II - Drugs - Pfizer Inc.,Lack of assurance of sterility: loss of container integrity.,2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81731 - Class II - Drugs - Pfizer Inc.,Superpotent Drug.,2018-12-18,2018-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82362 - Class I - Drugs - Pfizer Inc.,Presence of Particulate Matter; glass particulates,2019-03-29,2019-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82386 - Class III - Drugs - Pfizer Inc.,Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point,2019-03-29,2019-03-29,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82715 - Class III - Drugs - Pfizer Inc.,"Labeling: Label Error on Declared Strength: an artwork error on the secondary packaging of Relpax 40 mg Tablets, indicates that each tablet contains eletriptan hydrobromide equivalent to 20mg eletriptan, instead of 40mg, on one side of the carton.",2019-05-13,2019-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83267 - Class II - Drugs - Pfizer Inc.,Lack of Assurance of Sterility: Bags have the potential to leak.,2019-07-12,2019-07-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83947 - Class II - Drugs - Pfizer Inc.,Lack of Assurance of Sterility:  Bag has the potential to leak.,2019-10-09,2019-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84366 - Class II - Drugs - Pfizer Inc.,Labeling: Incorrect  or Missing Lot and/or expiration date.,2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84833 - Class II - Drugs - Pfizer Inc.,"Defective Container: confirmed customer reports for vials with loose metal overseal crimp defects, which may result in lack of assurance of sterility.",2020-02-10,2020-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84860 - Class II - Drugs - Pfizer Inc.,"Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.",2020-02-13,2020-02-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85067 - Class II - Drugs - Pfizer Inc.,Lack of Assurance of Sterility--Reports of loose metal ferrule crimps on vials for injection. The entire cap either lifted or dislodged while attempting to flip off the orange color plastic button.,2020-03-05,2020-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85754 - Class II - Drugs - Pfizer Inc.,Presence of Particulate Matter: particulate matter identified after reconstitution.,2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86074 - Class II - Drugs - Pfizer Inc.,Lack of Assurance of Sterility; potential loose metal overseal crimp defects.,2020-08-04,2020-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78682 - Class II - Drugs - Pfizer Manufacturing Deutschland GmbH,Microbial Contamination of Non-Sterile Products,2018-01-08,2018-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87837 - Class I - Drugs - PFIZER, INC","Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP",2021-06-10,2021-06-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86405 - Class II - Drugs - pH-D Feminine Health,Marketed without an Approved NDA/ANDA.,2020-09-30,2020-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75552 - Class III - Drugs - Pharm D Solutions, LLC","Incorrect/Undeclared Excipient; product description section of testosterone cypionate incorrectly states ""in grapeseed oil"" instead of ""in sesame oil"" . The primary panel is correct, Labeling; Error on Declared Strength; product description incorrectly states HCG 7500 units instead of 5000 units. The primary panel is correct",2017-01-09,2017-01-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81002 - Class II - Drugs - Pharm D Solutions, LLC",Lack of Assurance of Sterility,2018-11-01,2018-11-01,79,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81629 - Class II - Drugs - Pharm D Solutions, LLC",Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.,2018-12-20,2018-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82941 - Class II - Drugs - Pharm D Solutions, LLC",Lack of Sterility Assurance.,2019-06-07,2019-06-07,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83190 - Class II - Drugs - Pharma-Natural Inc.,"CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.",2019-07-23,2019-07-23,16,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69547 - Class II - Drugs - Pharmaceutical Associates Inc,Failed Impurities/Degradation Specifications : Out-of-specification result for an unidentified impurity at the 12 month stability test point.,2014-11-06,2014-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80190 - Class III - Drugs - Pharmaceutical Associates Inc,Resuspension problems: Out of specification for appearance and resuspendability.,2018-06-13,2018-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84712 - Class II - Drugs - Pharmaceutical Associates Inc,Subpotent: Out of specification for assay at the 12-month time point.,2020-02-03,2020-02-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65275 - Class II - Drugs - Pharmacia & Upjohn LLC,Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.,2013-06-20,2013-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66100 - Class II - Drugs - Pharmacy Creations,Lack of Assurance of Sterility: Pharmacy Creations is recalling Lidocaine 1% PF Sterile Injection and EDTA disodium 150 mg/mL due to lack of assurance of sterility.,2013-09-12,2013-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68669 - Class I - Drugs - Pharmacy Creations,Non-Sterility: Pharmacy Creations is recalling Ascorbic Acid 500 mg/mL 50 mL vials due to mold contamination.,2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69184 - Class I - Drugs - Pharmacy Creations,Non-Sterility: Failing sterility results were obtained from the recalling firm's contract testing facility indicating that the products may not be sterile.,2014-12-19,2014-12-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91332 - Class II - Drugs - Pharmacy Innovations,Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.,2023-01-26,2023-01-26,59,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90982 - Class II - Drugs - Pharmacy Plus, Inc. dba Vital Care Compounder",Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.,2022-11-02,2022-11-02,32,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75164 - Class II - Drugs - Pharmacy Plus, Inc. dba Vital Care Compounder",Lack of Assurance of Sterility,2016-09-27,2016-09-27,21,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67903 - Class I - Drugs - Pharmakon Pharmaceuticals,Superpotent Drug: Product contains twice the stated amount of midazolam.,2014-06-09,2014-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68191 - Class I - Drugs - Pharmakon Pharmaceuticals,Incorrect/ Undeclared Excipient: Contains undeclared benzyl alcohol.,2014-08-26,2014-08-26,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72177 - Class II - Drugs - Pharmakon Pharmaceuticals,"Stability data does not support expiry., Subpotent drug.",2016-01-27,2016-01-27,22,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73297 - Class I - Drugs - Pharmakon Pharmaceuticals,Super-Potent Drug: Out of specification for potency results (high) were obtained for one lot of morphine sulfate Inj.,2016-05-25,2016-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73960 - Class II - Drugs - Pharmakon Pharmaceuticals, Inc.",Lack of Assurance of Sterility,2016-07-11,2016-07-11,89,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65244 - Class III - Drugs - Pharmalucence, Inc.",Presence of Particulate Matter; particulate found in retain samples,2013-07-19,2013-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79802 - Class II - Drugs - Pharmalucence, Inc.",Failed Stability Specifications,2018-05-15,2018-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80428 - Class II - Drugs - Pharmalucence, Inc.",Lack of assurance of sterility: Technetium TC-99M Medronate Kit has a reported breach of sterility.,2018-08-03,2018-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89635 - Class II - Drugs - Pharmasol Corporation,cGMP deviations,2022-02-22,2022-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74874 - Class II - Drugs - Pharmatech LLC,CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.,2016-09-27,2016-09-27,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77960 - Class II - Drugs - Pharmatech LLC,Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination,2018-01-17,2018-01-17,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80699 - Class II - Drugs - Pharmcore Inc.,Lack of assurance of sterility.,2018-08-28,2018-08-28,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77374 - Class III - Drugs - Pharmedium Services Llc,Labeling: Incorrect or Missing Lot and/or Exp Date,2017-07-02,2017-07-02,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71846 - Class I - Drugs - Pharmedium Services, LLC","Presence of Particulate Matter: The firm produced products using 0.9% Sodium Chloride Injection, USP or 5% Dextrose Injection, USP which were subsequently recalled by the manufacturer due to the presence of particulate matter.",2015-08-25,2015-08-25,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71892 - Class II - Drugs - Pharmedium Services, LLC",Lack of Assurance of Sterility: The firm received a complaint of a sterility failure using a non-validated sterility test on a medication cassette.,2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71844 - Class I - Drugs - Pharmedium Services, LLC","Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).",2015-09-23,2015-09-23,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72478 - Class I - Drugs - Pharmedium Services, LLC",Sub-potent Drug; firm's analysis revealed subpotent result for morphine sulfate assay.,2016-02-10,2016-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72380 - Class I - Drugs - Pharmedium Services, LLC",Subpotent Drug,2016-02-18,2016-02-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72973 - Class III - Drugs - Pharmedium Services, LLC",Subpotent Drug; confirmed results by FDA analysis after customer complaints of discoloration,2016-03-17,2016-03-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74299 - Class II - Drugs - Pharmedium Services, LLC",Labeling: Not Elsewhere Classified: Potassium Chloride was printed on Potassium Phosphate label stock thereby having both names on the label of a 250 mL bag of Potassium Chloride.,2016-06-09,2016-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74057 - Class II - Drugs - Pharmedium Services, LLC",Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.,2016-07-16,2016-07-16,75,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73925 - Class I - Drugs - Pharmedium Services, LLC","Subpotent Drug: confirmed subpotency in one lot of this product that was packaged and stored in syringes., Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes., Subpotent Drug and Stability Data Does Not Support Expiry: confirmed subpotency and potential loss of potency in drugs packaged and stored in syringes., Stability Data Does Not Support Expiry:potential loss of potency in drugs packaged and stored in syringes.",2016-10-12,2016-10-12,69,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75567 - Class II - Drugs - Pharmedium Services, LLC",Lack of Assurance of Sterility: A portion of the batch quantity was compounded outside of the firm's process media validation.,2016-11-03,2016-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76661 - Class III - Drugs - Pharmedium Services, LLC",Labeling; Label Mixup; outer packaging is incorrectly labeled as Buffered Lidocaine 1% instead of correctly as Buffered Lidocaine 0.9%,2017-03-15,2017-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77191 - Class II - Drugs - Pharmedium Services, LLC","Labeling: Not Elsewhere Classified: Incorrect volume printed on the product label.
",2017-06-12,2017-06-12,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78063 - Class II - Drugs - Pharmedium Services, LLC",Subpotent Drug,2017-10-25,2017-10-25,15,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78694 - Class III - Drugs - Pharmedium Services, LLC",Labeling: Incorrect or Missing Lot and/or Exp. Date,2017-12-22,2017-12-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78683 - Class II - Drugs - Pharmedium Services, LLC",Subpotent Drug,2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78695 - Class II - Drugs - Pharmedium Services, LLC",Superpotent Drug,2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78828 - Class II - Drugs - Pharmedium Services, LLC",Lack of sterility assurance.,2018-02-20,2018-02-20,42,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79799 - Class III - Drugs - Pharmedium Services, LLC",cGMP deviations,2018-04-17,2018-04-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81730 - Class II - Drugs - Pharmedium Services, LLC",Sub-potent,2018-12-15,2018-12-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84525 - Class III - Drugs - Pharmedium Services, LLC",Subpotent Drug,2019-12-23,2019-12-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77634 - Class II - Drugs - PharMedium Services, Llc",Lack of Assurance of Sterility; media fill failure at manufacturer,2017-07-14,2017-07-14,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77856 - Class II - Drugs - PharMedium Services, Llc","Labeling: Not Elsewhere Classified-  Diluent used to compound product expired prior to the expiration date assigned to the compounded product.
",2017-09-15,2017-09-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85212 - Class II - Drugs - PharMEDium Services, LLC",Firm is recalling 46 lots of various products because of a lack of sterility assurance.,2020-04-06,2020-04-06,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79063 - Class II - Drugs - PharMEDium Services, LLC",Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.,2018-03-29,2018-03-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80251 - Class II - Drugs - PharMEDium Services, LLC",Superpotent and Subpotent,2018-06-08,2018-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80638 - Class II - Drugs - PharMEDium Services, LLC",CGMP deviations: Product was released while a hood certification discrepancy was being investigated.,2018-08-03,2018-08-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83207 - Class I - Drugs - PharMEDium Services, LLC","Incorrect Product Formulation; Firm's customer resource center (CRC) statement indicates that the product is sulfite free, however the product is produced with a raw material that contains sulfite",2019-07-16,2019-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78503 - Class II - Drugs - PharMEDium Services, LLC.",Superpotent drug: out of specification result for potency,2017-11-14,2017-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81895 - Class II - Drugs - PharMEDium Services, LLC.",Subpotent,2019-01-14,2019-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88530 - Class I - Drugs - Phe Inc,Marketed without an approved NDA/ANDA: Product found to be tainted with Tadalafil.,2021-09-21,2021-09-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77526 - Class II - Drugs - Phillips Co.,"GMP Deviations; FDA inspection found significant manufacturing practices that call into question the safety, identity, strength, quality and purity of unexpired drug products manufactured by the firm.",2017-07-06,2017-07-06,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70703 - Class I - Drugs - Physician Preferred Medical, LLC",Non-Sterility: The recalled lot failed sterility testing.,2015-05-04,2015-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61233 - Class I - Drugs - Physicians Total Care, Inc",Labeling: Label mix-up; Bottles labeled to contain Morphine Sulfate IR may contain Morphine Sulfate ER and vice-versa.,2012-06-18,2012-06-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62135 - Class II - Drugs - Physicians Total Care, Inc.",Tablet Separation: The manufacturer of Arthrotec had recalled the lots that were used to re-package this product because they may contain broken tablets.,2012-06-14,2012-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62239 - Class II - Drugs - Physicians Total Care, Inc.","Chemical Contamination: Complaints of an uncharacteristic odor identified as 2,4,6 tribromoanisole.",2012-06-19,2012-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62122 - Class II - Drugs - Physicians Total Care, Inc.",Impurities/Degradation Products; Product is being recalled due to the potential of not meeting the Impurity C specification through the product shelf life,2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62924 - Class III - Drugs - Physicians Total Care, Inc.",Subpotent (Single ingredient) drug : This is a sub recall of Teva's Enjuvia due to low Out of Specification (OOS) assay results.,2012-12-11,2012-12-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63841 - Class II - Drugs - Physicians Total Care, Inc.",Presence of Particulate Matter: glass delamination,2012-12-14,2012-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63846 - Class II - Drugs - Physicians Total Care, Inc.",Subpotent; 15 month stability (by mfr),2013-03-21,2013-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63891 - Class II - Drugs - Physicians Total Care, Inc.",Presence of Foreign Substance(s): There is a potential for foreign particulate matter in the API.,2013-03-27,2013-03-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65002 - Class III - Drugs - Physicians Total Care, Inc.","Presence of Foreign Tablets/Capsules: One bottle of Percocet 10/325 mg was found to contain a tablet of Endocet 10/25 mg, the generic form.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65004 - Class III - Drugs - Physicians Total Care, Inc.","Chemical Contamination: Uncharacteristic moldy odor due to presence of 2,4,6-tribromoanisole (TBA).",2013-05-09,2013-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64996 - Class III - Drugs - Physicians Total Care, Inc.",Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing,2013-05-30,2013-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65269 - Class II - Drugs - Physicians Total Care, Inc.",Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.,2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65295 - Class III - Drugs - Physicians Total Care, Inc.",Labeling: Incorrect or Missing Lot and/or Expiration Date; This recall is being initiated because the lot number and expiration date on the tube may not be legible.,2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65601 - Class II - Drugs - Physicians Total Care, Inc.","Presence of Foriegn Substance:The manufacturer, West-ward Pharmaceutical, recalled product because of the presence of black spots on tablets. In response, the repackager initiated its own recall.",2013-07-26,2013-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67118 - Class II - Drugs - Physicians Total Care, Inc.","Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.
",2013-12-26,2013-12-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69597 - Class II - Drugs - Physicians Total Care, Inc.",CGMP deviations: Products were manufactured with active pharmaceutical ingredients that were not manufactured with good manufacturing practices.,2014-11-05,2014-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69595 - Class III - Drugs - Physicians Total Care, Inc.",Failed Tablet/Capsule Specifications: Affected lot numbers may contain chipped or broken tablets.,2014-11-06,2014-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91378 - Class II - Drugs - Pine Pharmaceuticals, LLC","CGMP Deviations: Raw material recalled by repackager, due to discoloration.",2023-01-13,2023-01-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72629 - Class II - Drugs - Pine Pharmaceuticals, LLC",Presence of particulate matter: Presence of silicone oil microdroplets in bevacizumab syringes for intravitreal use.,2016-01-20,2016-01-20,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79457 - Class III - Drugs - Pine Pharmaceuticals, LLC",Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.,2018-03-26,2018-03-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90854 - Class II - Drugs - Pine Pharmaceuticals, LLC",Lack of Assurance of Sterility,2022-09-15,2022-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89949 - Class I - Drugs - Pink Toyz,"Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.",2022-04-25,2022-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67688 - Class III - Drugs - Pinnacle Biologics Inc,Stability Data Does Not Support Expiry: Printed expiration date should be Nov 2013 rather than Nov 2014.,2014-03-12,2014-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81558 - Class II - Biologics - Pinnacle Transplant Technologics, LLC","Human tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2018-12-11,2018-12-11,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85452 - Class II - Biologics - Pinnacle Transplant Technologics, LLC","Human tissue allografts, where in-process controls were not performed allowing tissue to be processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission or spread of communicable disease through the use of the tissue, were distributed.",2020-04-14,2020-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83043 - Class II - Biologics - PinnacleHealth Harrisburg Hospital,"Blood products, tested positive for an RBC antigen but labeled as RBC antigen negative, were distributed.",2019-07-15,2019-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68004 - Class II - Drugs - Piramal Critical Care, Inc.",Failed pH Specifications: product was too acidic.,2014-04-25,2014-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83280 - Class II - Drugs - Piramal Critical Care, Inc.",Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.,2019-08-13,2019-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88841 - Class II - Drugs - Piramal Critical Care, Inc.","Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, ""WARNING:  PARALYZING AGENT""",2021-10-20,2021-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63328 - Class III - Biologics - Plasma Biological Services,"Blood products, collected from a donor who was previously deferred, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63329 - Class II - Biologics - Plasma Biological Services,"Blood product, collected from a donor with a history of incarceration, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #58680 - Class II - Biologics - Plasma Biological Services,"Blood products, collected from a donor who was previously deferred, were distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64399 - Class III - Biologics - Plasma Biological Services,"Blood product, collected from a donor whose arm inspection was not documented, was distributed.

",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65268 - Class II - Biologics - Plasma Biological Services,"Blood product, collected from a donor who was previously deferred, was distributed.",2013-07-02,2013-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65567 - Class III - Biologics - Plasma Biological Services,"Blood products, collected from an ineligible donor, were distributed",2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40049 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63000 - Class II - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed..",2012-09-19,2012-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63890 - Class II - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor who received a body piercing within 12 months of donating, were distributed.",2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64324 - Class II - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor who was previously deferred, were distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57156 - Class II - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor who was previously deferred for possibly exposure to vCJD, were distributed.",2013-04-02,2013-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57229 - Class II - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor who was previously deferred after receiving a tattoo within a year of donating, were distributed.

",2013-04-02,2013-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66270 - Class II - Biologics - Plasma Biological Services Inc,"Blood product, collected from a donor who received a body piercing within 12 months of donating, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67537 - Class III - Biologics - Plasma Biological Services Inc,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2014-03-10,2014-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67730 - Class II - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2014-04-09,2014-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67939 - Class II - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor who was previously deferred for high risk behavior, were distributed.",2014-05-12,2014-05-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72066 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from an ineligible donor, were distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72673 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-12-03,2015-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72676 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-12-03,2015-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72678 - Class III - Biologics - Plasma Biological Services Inc,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-12-03,2015-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72670 - Class III - Biologics - Plasma Biological Services Inc,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-12-10,2015-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72671 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2015-12-10,2015-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73112 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74435 - Class II - Biologics - Plasma Biological Services Inc,"Plasma product, collected from a donor who received a tattoo within 12 months of donating, was distributed.",2016-06-28,2016-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74323 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2016-07-08,2016-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76065 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76478 - Class III - Biologics - Plasma Biological Services Inc,"Plasma products, collected from a donor for whom eligibility screening was performed incorrectly, were distributed.",2017-03-01,2017-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79691 - Class III - Biologics - Plasma Biological Services Inc,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-04-05,2018-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81815 - Class II - Biologics - Plasma Biological Services Inc,"Blood product, collected from a donor who received a tattoo within 12 months of donation, was distributed.",2019-02-01,2019-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62267 - Class II - Biologics - Plasma Biological Services, Inc","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62654 - Class II - Biologics - Plasma Biological Services, Inc","Blood products, collected from a donor who was previously deferred by another donor center, were distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65925 - Class II - Biologics - Plasma Biological Services, Inc","Blood products, collected from a donor who had been incarcerated, were distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72674 - Class III - Biologics - Plasma Biological Services, Inc","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-12-03,2015-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73230 - Class III - Biologics - Plasma Biological Services, Inc","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.
",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73231 - Class III - Biologics - Plasma Biological Services, Inc","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81717 - Class II - Biologics - Plasma Biological Services, Inc","Blood products, not meeting product specifications, were distributed.",2018-12-17,2018-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50383 - Class II - Biologics - Plasma Care, Inc. dba Marion Blood Plasma, Inc.","Blood products, which were not quarantined subsequent to receiving disqualifying post donation information, were distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62096 - Class III - Biologics - Plasmacare Inc,"Blood poducts, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62097 - Class III - Biologics - Plasmacare Inc,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62098 - Class III - Biologics - Plasmacare Inc,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.
",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62099 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62100 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62101 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62102 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.

",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62103 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.

",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62104 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.
",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62105 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.


",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62106 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62142 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62143 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62144 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62145 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62146 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62147 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62148 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62150 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62151 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62152 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62153 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62154 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62155 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62156 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62157 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62158 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62159 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62172 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62175 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62176 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62177 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62178 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62182 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62183 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62199 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62211 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62212 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62213 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62214 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62215 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62216 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62217 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62218 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62219 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-22,2012-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62065 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor,  whose suitability to donate was not adequately determined, was distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62066 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62067 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62068 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62069 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62070 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62071 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62072 - Class III - Biologics - Plasmacare Inc,"Blood product, collected from a donor,  whose suitability to donate was not adequately determined, was distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62073 - Class III - Biologics - Plasmacare Inc,"Source plasma, collected from a donor who did not have a complete medical history interview, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62074 - Class III - Biologics - Plasmacare Inc,"Source plasma, collected from a donor who did not have a complete medical history interview, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62075 - Class III - Biologics - Plasmacare Inc,"Source plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62076 - Class III - Biologics - Plasmacare Inc,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62077 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors who did not have a complete medical history interview, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62078 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62174 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62179 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62242 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62243 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62244 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62245 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62246 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62247 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62248 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors,  whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62249 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62250 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62251 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62252 - Class III - Biologics - Plasmacare Inc,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62253 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62254 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62255 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62256 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62257 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-06-25,2012-06-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62160 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62161 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62162 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62163 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62164 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62165 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62166 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62167 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62168 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62169 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62170 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62171 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62173 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor who did not have a complete medical history interview, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62220 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62221 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62223 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-27,2012-06-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61985 - Class III - Biologics - Plasmacare Inc,"Source Plasma, collected from a donor, whose suitability to donate was not adequately determined, was distributed.
",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61986 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61987 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61988 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61989 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61990 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62010 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62180 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62181 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62224 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62225 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62226 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62227 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62228 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.

",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62230 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.

",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62232 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62233 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62234 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62236 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-06-28,2012-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62079 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from  a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62080 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62081 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62082 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.

",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62083 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62084 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62085 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62086 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62087 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62088 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62089 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62090 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62091 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.


",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62092 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.


",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62093 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62094 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62095 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62184 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62185 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62186 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62187 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62188 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62189 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62190 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.

",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62191 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62192 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62193 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62194 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.

",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62196 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62197 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62198 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62200 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62201 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62202 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62203 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62204 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62205 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62206 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62207 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62208 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62209 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62210 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.

",2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62030 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62031 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62032 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62039 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62040 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62041 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62047 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62048 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62033 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62034 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62035 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62036 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62037 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62038 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62042 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62043 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62044 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62045 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62046 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62049 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62050 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62262 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62264 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62265 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62268 - Class III - Biologics - Plasmacare Inc,-,2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62269 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62258 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, was distributed.
",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62259 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62260 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62261 - Class III - Biologics - Plasmacare Inc,"Blood Product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62263 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62195 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-08-07,2012-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62235 - Class III - Biologics - Plasmacare Inc,"Blood Products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-08-21,2012-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62935 - Class III - Biologics - Plasmacare Inc,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62936 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62938 - Class III - Biologics - Plasmacare Inc,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43672 - Class II - Biologics - PlasmaCare Inc,"Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66801 - Class II - Biologics - PlasmaCare, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89879 - Class I - Drugs - Plastikon Healthcare LLC,"Microbial Contamination of Non-Sterile Products, CGMP Deviations: Failure to properly investigate failed microbial testing.",2022-05-13,2022-05-13,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90398 - Class I - Drugs - Plastikon Healthcare LLC,"Microbial Contamination of Non-Sterile Products, Microbial Contamination of Non-Sterile Products., CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled.",2022-09-06,2022-09-06,19,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83693 - Class I - Drugs - Plastikon Healthcare LLC,Microbial Contamination of Non-Sterile Products: product failed bioburden testing for Total Aerobic Microbial Count.,2019-09-24,2019-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87531 - Class I - Drugs - PNHC, LLC.",Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.,2021-04-30,2021-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85944 - Class II - Drugs - POLARIZED LLC,CGMP Deviations: Product was found to be below the label claim for ethanol content and the presence of undeclared methanol.,2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68671 - Class III - Drugs - Poly Pharmaceuticals, Inc","Does Not Meet Monograph: Phenylephrine and pseudoephedrine are below monograph specifications, and label inaccurately contains wording ""Rx Only"".",2014-07-11,2014-07-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69188 - Class II - Biologics - Portland Biologicals, LLC","Blood products, collected from a donor who subsequently reported a tattoo, were distributed.",2014-10-09,2014-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89606 - Class I - Drugs - Positive Health,"Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.",2022-03-04,2022-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40858 - Class II - Biologics - Poudre Valley Health Care, Inc","Blood products, which were collected from a donor who traveled to malarial endemic areas, were distributed.",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40965 - Class II - Biologics - Poudre Valley Health Care, Inc","Blood products, collected from a donor whose arm scrub may have been incorrectly performed, was distributed.",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70979 - Class III - Biologics - Poudre Valley Health Care, Inc. Blood Bank","Blood product, collected from a donor whose hematocrit was tested using a device for which the quality control results were not documented, was distributed.",2015-05-05,2015-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71436 - Class III - Biologics - Poudre Valley Health Care, Inc. Blood Bank","Blood products, in which the concentration of apheresis products exceeded the maximum limit, were distributed.",2015-07-13,2015-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72639 - Class III - Drugs - PQ Corporation,Failed Impurities/Degradation Specifications: Level of iron exceeds the limit set by the USP monograph for it (USP limit is NMT 0.5 ug/g (ppm)).,2016-01-07,2016-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88156 - Class I - Drugs - Prairie Wolf Spirits,Hand sanitizer packaged in bottles that resemble beverage containers.,2021-07-22,2021-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72252 - Class III - Drugs - Praxair Inc.,CGMP Deviations: Confirmed customer compliant of odor when turning on a cylinder of medical air.,2016-03-28,2016-03-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87081 - Class II - Drugs - Precision Dose Inc.,cGMP deviations: The firm was notified of the manufacturer's expanded recall.,2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88976 - Class II - Drugs - Precision Dose Inc.,cGMP Deviations: Product manufactured with contaminated raw ingredient.,2021-11-05,2021-11-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64676 - Class II - Drugs - Precision Dose Inc.,"Labeling: Not Elsewhere Classified: This unit dose product is being recalled because the product's name includes the word ""Children's"" which is misleading since the 650 mg dose of acetaminophen contained within it, is an adult dose.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77732 - Class II - Drugs - Precision Dose Inc.,"Labeling Error: Label mix-up.  Products' unit dose cups are correctly labeled, but the product carton lists incorrect volume and NDC.",2017-07-31,2017-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78359 - Class III - Drugs - Precision Dose Inc.,Subpotent Drug: low out of specification results.,2017-11-01,2017-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85039 - Class II - Drugs - Precision Dose Inc.,CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API.,2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83711 - Class II - Drugs - Preferred Pharmaceuticals, Inc",Failed Impurities/Degradation Specifications,2019-09-24,2019-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82335 - Class II - Drugs - Preferred Pharmaceuticals, Inc","CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.",2019-03-21,2019-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82791 - Class II - Drugs - Preferred Pharmaceuticals, Inc","CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer",2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83101 - Class II - Drugs - Preferred Pharmaceuticals, Inc",CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).,2019-06-20,2019-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83370 - Class II - Drugs - Preferred Pharmaceuticals, Inc",CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.,2019-07-22,2019-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84359 - Class II - Drugs - Preferred Pharmaceuticals, Inc",Presence of foreign substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.,2019-11-27,2019-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84422 - Class II - Drugs - Preferred Pharmaceuticals, Inc",CGMP Deviations: Presence of NDMA impurity detected in product.,2019-12-09,2019-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84671 - Class II - Drugs - Preferred Pharmaceuticals, Inc",CGMP Deviations: Presence of NDMA impurity detected in product.,2020-01-20,2020-01-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80840 - Class II - Drugs - Preferred Pharmaceuticals, Inc",CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-17,2018-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85880 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.,2020-06-26,2020-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86002 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",CGMP Deviations: Contract Manufacturing Organization (CMO) misplaced/lost batch records and test results for the recalled batch.,2020-07-15,2020-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86394 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",CGMP Deviations,2020-09-24,2020-09-24,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86696 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.,2020-11-14,2020-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87719 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",Failed Impurities/degradation specifications: Repackager recall due to Out of Specification detected by manufacturer for Individual Unidentified Impurity found during related substance test analysis of Cephalexin,2021-04-26,2021-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87833 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.,2021-05-16,2021-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89143 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",Defective container: Out of specification for container integrity leading to bottles leaking.,2021-12-13,2021-12-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89656 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",CGMP deviations,2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89924 - Class II - Drugs - Preferred Pharmaceuticals, Inc.","CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.",2022-04-14,2022-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89943 - Class II - Drugs - Preferred Pharmaceuticals, Inc.","CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.",2022-04-14,2022-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89945 - Class II - Drugs - Preferred Pharmaceuticals, Inc.","CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.
",2022-04-15,2022-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91531 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.,2023-01-23,2023-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89950 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",Out of specification results observed in dissolution during long term stability testing.,2022-04-14,2022-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90001 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.,2022-04-26,2022-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90148 - Class II - Drugs - Preferred Pharmaceuticals, Inc.",CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,2022-05-24,2022-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77979 - Class II - Drugs - Premier Pharmacy Labs Inc,Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.,2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78928 - Class II - Drugs - Premier Pharmacy Labs Inc,Labeling: Label Error on Declared Strength,2018-02-02,2018-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79803 - Class II - Drugs - Premier Pharmacy Labs Inc,"Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.",2018-04-26,2018-04-26,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83146 - Class II - Drugs - Premier Pharmacy Labs Inc,"Lack of Assurance of Sterility: FDA inspection found insufficient environmental controls, potential cross contamination and lack of product specific process validations that can result in a lack of sterility assurance.",2019-06-21,2019-06-21,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72522 - Class I - Drugs - Premiere Sales Group,Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.,2016-02-16,2016-02-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40144 - Class II - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-06-12,2013-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43171 - Class II - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-06-12,2013-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43109 - Class II - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-07-11,2013-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43113 - Class II - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-07-11,2013-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43117 - Class III - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43119 - Class III - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43121 - Class III - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43179 - Class III - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43182 - Class III - Biologics - Presbyterian Intercommunity Hospital, Inc. Blood Bank","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79961 - Class II - Drugs - Prescript Pharmaceuticals, Inc.",Labeling: Not Elsewhere Classified:  due to a labeled declaration of; Store at 15C to 30C (59F to 86F) which differs from the original manufacturer declaration of; Store at 20C to 25C (68F to 77F).,2018-05-14,2018-05-14,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88515 - Class II - Drugs - Prescription Labs Inc dba Greenpark,Lack of Assurance of Sterility,2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68130 - Class III - Drugs - Prestige Brands Holdings,Presence of Precipitate; small amounts of diphenhydramine precipitated out of solution,2014-05-28,2014-05-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79055 - Class I - Drugs - Primus Pharmaceuticals, Inc.","Marketed Without An Approved NDA/ANDA: Based on the labeling claims, these products are unapproved drugs for which the safety and efficacy have not been established and, therefore, subject to recall.",2018-02-09,2018-02-09,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80525 - Class II - Drugs - Prinston Pharmaceutical Inc,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-07-20,2018-07-20,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81910 - Class II - Drugs - Prinston Pharmaceutical Inc,"CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.",2019-01-27,2019-01-27,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74423 - Class III - Drugs - Prinston Pharmaceutical Inc,"Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect lot number, 327B160012, appears on the case label, the correct lot number, 327B16002 appears on the immediate container.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78651 - Class II - Drugs - Prinston Pharmaceutical Inc,Failed Tablet/Capsule Specifications: confirmed customer complaint of thicker and heavier tablets in bottle.,2018-01-08,2018-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88097 - Class III - Drugs - Prisma Health Outsourcing Facility,Labeling: Incorrect Exp. Date: Incorrect BUD.,2021-07-02,2021-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63661 - Class II - Drugs - Procter & Gamble Co,"Labeling Illegible: Portions of the product labeling in the area of the dosing directions, the warnings & other information sections is obscured.",2012-11-29,2012-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65650 - Class II - Drugs - Procter & Gamble Co,"Unit Dose Mispackaging: Product packaging defect which could result in code date smearing, incomplete blister card cuts, and missing or incorrectly placed liquicaps within the blisters.",2013-07-26,2013-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66157 - Class II - Drugs - Procter & Gamble Co,"Incorrect/ Undeclared Excipients: NyQuil Liquid Original bottles were inadvertently overwrapped with NyQuil Liquid Cherry information as a result the outer wrap does not correctly identify color additives, particularly FD&C Yellow No. 6 and FD&C Yellow 10.",2013-09-13,2013-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64137 - Class III - Drugs - Procter & Gamble Hair Care Llc,Cross Contamination with Other Products: Product was mixed with another type of mouth wash.,2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80750 - Class I - Drugs - Product Quest Manufacturing LLC,"Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Pseudomonas aeruginosa., Microbial Contamination of Non-Sterile Products: sample tested positive for Staphylococcus aureus., CGMP Deviations: products manufactured under conditions that could impact its product quality., Failed Stability Specifications: separation of product and failure for actives., Superpotent Drug: high out of specification assay results for the camphor ingredient., Subpotent Drug: low out of specification assay results for the bacitracin zinc ingredient., Superpotent Drug: high out of specification assay results for the menthol ingredient., Microbial Contamination of Non-Sterile Products: Failed microbiological testing for Staphalococcus aureus., Microbial Contamination of Non-Sterile Products and Subpotent Drug: failure for microbiological growth exceeding specification and low out of specification assay results for salicylic acid., Subpotent Drug: low out of specification assay re",2018-10-16,2018-10-16,54,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74135 - Class II - Drugs - Profarma Distribution LLC,CGMP Deviations,2016-06-17,2016-06-17,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88326 - Class II - Drugs - Professional Disposables International, Inc",SubPotent: Out of Specification,2021-08-20,2021-08-20,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89547 - Class II - Drugs - Professional Disposables International, Inc.",cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.,2022-02-18,2022-02-18,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62772 - Class II - Drugs - Prometheus Laboratories Inc.,Failed USP Dissolution Test Requirements: The recalled lots do not meet the specification for dissolution.,2012-08-22,2012-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69572 - Class II - Drugs - Prometheus Laboratories Inc.,"Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.  
",2014-11-14,2014-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81351 - Class III - Drugs - Promise Pharmacy LLC,Presence of precipitate,2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88662 - Class II - Drugs - Promise Pharmacy, LLC",Lack of processing controls,2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81810 - Class II - Drugs - Promise Pharmacy, LLC",Lack of sterility assurance.,2019-02-08,2019-02-08,51,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50632 - Class II - Biologics - Providence  Health System - Southern California,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62681 - Class II - Biologics - Providence Health System Southern California,"Blood product, which was collected from a donor who lived in a malarial endemic area, was distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49910 - Class II - Biologics - Puget Sound Blood Center,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49615 - Class II - Biologics - Puget Sound Blood Center,"Blood products, collected from a donor who traveled to a malaria risk area, were distributed.",2013-02-15,2013-02-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62724 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, manufactured from an apheresis unit with platelet yield that did not meet the criteria for a divided unit, were distributed.",2012-09-13,2012-09-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63280 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-10-26,2012-10-26,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45767 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50671 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50672 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2012-11-01,2012-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63220 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, collected from a therapeutic donor and not labeled to indicate the type of donation, was distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63398 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-11-06,2012-11-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63594 - Class III - Biologics - Puget Sound Blood Center and Program,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63595 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2012-12-03,2012-12-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63627 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.
",2012-12-03,2012-12-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41903 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, which was collected in a manner that may have compromised the sterility of the collection system, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49703 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was  distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49719 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49814 - Class III - Biologics - Puget Sound Blood Center and Program,"Blood product, which was collected from a donor who was taking the medication Finasteride, was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49906 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-12-07,2012-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50596 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-12-11,2012-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49819 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, which was collected from a donor who was taking the medication Finasteride, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49820 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49821 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, which was collected from a donor in whom donor suitability was not adequately determined, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64053 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69203 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, labeled leukoreduced which did not meet the QC requirements for leukoreduced products, were distributed., Blood products, labeled  leukoreduced  which did not meet the QC requirements for leukoreduced products, were distributed.",2015-01-08,2015-01-08,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71930 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood product, with a low platelet yield, was distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72031 - Class II - Biologics - Puget Sound Blood Center and Program,"Blood products, which did not meet acceptable product specifications, were distributed.",2015-10-01,2015-10-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72859 - Class II - Biologics - Puget Sound Blood Center and Program,Misbranded red blood cell was distributed.,2016-01-06,2016-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73369 - Class II - Biologics - Puget Sound Blood Center and Program,"Apheresis Platelets, collected from an ineligible donor, were distributed.",2016-04-05,2016-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73753 - Class III - Biologics - Puget Sound Blood Center and Program,"RBC product, not prepared in accordance with specifications, was distributed.",2016-04-25,2016-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74905 - Class III - Biologics - Puget Sound Blood Center and Program,"Blood product, for which unit was outside monitored storage for greater than two hours, was distributed.",2016-09-12,2016-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71732 - Class III - Drugs - Purdue Pharma L.P.,Failed dissolution specifications,2015-07-21,2015-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73709 - Class III - Drugs - Purdue Pharma L.P.,Failed Dissolution Specifications,2016-04-04,2016-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78229 - Class II - Drugs - Purdue Pharma, L.P.",Subpotent Drug: The laminate used to make the pouches was reversed such that the aluminum layer was in contact with the product causing an exothermic reaction between the free iodine and the aluminum.,2017-11-03,2017-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67810 - Class I - Drugs - Pure Edge Nutrition,Marketed without an Approved NDA/ANDA; product was found to contain undeclared sibutramine & phenolphthalein,2014-06-12,2014-06-12,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88280 - Class I - Drugs - Qikmoov LLC,Marketed Without An Approved NDA/ANDA: FDA analysis detected the presence of sibutramine.,2021-08-17,2021-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76890 - Class II - Drugs - Qinhuangdao Zizhu Pharmaceutical, Co.",cGMP Deviations; lack of quality assurance.,2017-04-11,2017-04-11,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87751 - Class II - Drugs - QMart,"Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and/or sildenafil.

",2021-05-06,2021-05-06,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72401 - Class II - Drugs - Qualgen,Lack of Assurance of Sterility: The firm is recalling all sterile preparations within expiry due to deficient practices which may have an impact on sterility assurance.,2015-11-24,2015-11-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77064 - Class II - Drugs - Qualgen,CGMP deviations- Lack of Quality Assurance,2017-06-07,2017-06-07,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80203 - Class III - Drugs - Qualgen, LLC",Labeling: Incorrect or Missing Lot and/or Exp Date.,2018-06-29,2018-06-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81346 - Class II - Drugs - Qualgen, LLC",Lack of Assurance of Sterility,2018-11-07,2018-11-07,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73710 - Class I - Drugs - QuVa Pharma, Inc.",Labeling: Label Error on Declared Strength. Product has correct label on the syringe and the case but some units are incorrectly labeled as .4 mg/10 mL (40 mcg/ml) on the light protective overwrap of each syringe.,2016-07-06,2016-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80980 - Class I - Drugs - QuVa Pharma, Inc.",Subpotent Drug: Product may not have the active ingredient present in the bag.,2018-10-01,2018-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81644 - Class III - Drugs - QuVa Pharma, Inc.",Incorrect excipient: Product was compounded in 250 mL 5% Dextrose instead of 250 mL 0.9% Sodium Chloride,2018-12-12,2018-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84263 - Class II - Drugs - QuVa Pharma, Inc.",Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules,2019-12-03,2019-12-03,27,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85773 - Class II - Drugs - QuVa Pharma, Inc.",Subpotent drug - Product did not contain drug.,2020-06-11,2020-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85547 - Class III - Drugs - QuVa Pharma, Inc.",Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac,2020-06-23,2020-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90898 - Class III - Drugs - QuVa Pharma, Inc.",Incorrect Product Formulation: Oxytocin 30 units was added to an IV bag of 0.45% Sodium Chloride (500mL) instead of 0.9% Sodium Chloride (500mL).,2022-09-26,2022-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73018 - Class I - Drugs - R Thomas Marketing, LLC",Marketed Without An Approved NDA/ANDA,2016-05-26,2016-05-26,24,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61934 - Class III - Drugs - Ranbaxy Inc.,Subpotent (Single Ingredient Drug): out-of-specification result for coal tar content assay.,2012-07-03,2012-07-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63623 - Class II - Drugs - Ranbaxy Inc.,Adulterated Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.,2012-11-21,2012-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63759 - Class II - Drugs - Ranbaxy Inc.,"Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.",2012-11-29,2012-11-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64286 - Class III - Drugs - Ranbaxy Inc.,Crystallization: Recall is due to a non-characteristic gritty/sandy texture to the product which is likely due to some crystallization of the product.,2013-02-12,2013-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67485 - Class II - Drugs - Ranbaxy Inc.,Presence of Foreign Tablets: A product complaint was received by a pharmacist who discovered an Atorvastatin 20 mg tablet inside a sealed bottle of 90-count Atorvastatin 10 mg.,2014-02-21,2014-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71865 - Class II - Drugs - Ranbaxy Inc.,Incorrect/Undeclared Excipients: Product contains undeclared FD&C Yellow No. 5 in the capsule shell.,2015-08-06,2015-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80633 - Class II - Drugs - Ranier's Compounding Laboratory,Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.,2018-08-15,2018-08-15,15,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63384 - Class II - Drugs - Raritan Pharmaceuticals, Inc.",Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.,2012-10-25,2012-10-25,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75757 - Class II - Drugs - Raritan Pharmaceuticals, Inc.",CGMP Deviations,2016-12-23,2016-12-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64652 - Class III - Drugs - RB Health (US) LLC,Subpotent Drug: Product did not conform  to the 18-month stability test specification for active Free Benzocaine.,2013-05-01,2013-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86105 - Class I - Drugs - Real Clean Distribuciones SA de CV,"Chemical Contamination: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol., CGMP Deviations: Other products were recalled because they were manufactured in the same facility as the product found to contain methanol., CGMP Deviations: Born Basic Anti Bac was found to be below the label claim for ethanol content and contained methanol. Other products were recalled because they were manufactured in the same facility as the product found to contain methanol.",2020-09-11,2020-09-11,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70840 - Class III - Drugs - Reckitt Benckiser LLC,Defective container: A customer complaint revealed the presence of a defective seal on the top of a Mucinex pouch,2015-04-21,2015-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71013 - Class I - Drugs - Reckitt Benckiser LLC,"Labeling: Label Mix-Up; Bottles of Mucinex Fast-Max liquid are correctly labeled on the front of the label, however the back of the bottle where the Drug Facts labeling is, is missing certain Active Ingredients such as acetaminophen, phenylephrine, dextromethorphan, diphenhydramine, and/or guaifenesin. As a result certain safety warnings associated with those ingredients may also be missing.",2015-08-25,2015-08-25,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74965 - Class III - Drugs - Reckitt Benckiser LLC,"Labeling: Label Error on Declared Strength; label on outer carton incorrectly states Diphenhydramine 25 mg instead of 12.5 mg. Also, quantity is incorrectly stated as 30 daytime and 30 nighttime instead of 36 daytime and 24 nighttime.",2016-09-22,2016-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85081 - Class II - Drugs - Redline Pharmacy Solutions,Lack Of Processing Controls,2020-03-12,2020-03-12,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72830 - Class I - Drugs - Reesna, Inc","Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: Products were found to be tainted with undeclared hydroxythiohomosildenafil, an analogue of Sildenafil, an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making them unapproved new drugs.",2016-06-06,2016-06-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69729 - Class I - Drugs - REFA Enterprises, LLC",Marketed Without an Approved NDA/ANDA: FDA analysis found product to contain sibutramine and phenolphthalein,2015-05-06,2015-05-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73662 - Class I - Drugs - Reliable Rexall-A Compounding Pharmacy,"Labeling: Label Mix-Up: Products labeled Biotin 100 mg found to contain 4-aminopyridine, Lack of Processing Controls",2016-07-06,2016-07-06,70,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83645 - Class II - Drugs - RemedyRepack Inc.,Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product bottle.,2020-03-16,2020-03-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91345 - Class II - Drugs - RemedyRepack Inc.,Failed Impurities/Degradation specifications,2023-01-06,2023-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70549 - Class II - Drugs - RemedyRepack Inc.,Crystallization,2015-04-09,2015-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71094 - Class II - Drugs - RemedyRepack Inc.,Crystallization,2015-05-01,2015-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72699 - Class II - Drugs - RemedyRepack Inc.,"Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.",2015-12-04,2015-12-04,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76457 - Class II - Drugs - RemedyRepack Inc.,Failed Dissolution Specifications,2017-02-18,2017-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78146 - Class II - Drugs - RemedyRepack Inc.,Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt.,2017-09-22,2017-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80646 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-07-31,2018-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80827 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-16,2018-08-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80891 - Class II - Drugs - RemedyRepack Inc.,"CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.",2018-08-28,2018-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81395 - Class II - Drugs - RemedyRepack Inc.,"CGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.",2018-10-24,2018-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81554 - Class III - Drugs - RemedyRepack Inc.,Failed pH Specifications: High Out-of-Specification results for pH were obtained during stability testing.,2018-11-14,2018-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81638 - Class III - Drugs - RemedyRepack Inc.,"Cross contamination with other products: Product is being recalled due to the potential presence of unrelated ingredients (Benazepril, Haloperidol and Perphenazine).",2018-11-27,2018-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82532 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviations; Detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) - N-Methylnitrosobutyric acid (NMBA).,2019-04-05,2019-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82748 - Class II - Drugs - RemedyRepack Inc.,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.",2019-05-02,2019-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84696 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviation; Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.,2020-01-20,2020-01-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84900 - Class I - Drugs - RemedyRepack Inc.,Presence of Particulate Matter: Medication relabeled at facility was recalled by the manufacturer due to small black particles noticed during routine visual inspection. of retain samples.,2020-03-03,2020-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86006 - Class II - Drugs - RemedyRepack Inc.,FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.,2020-07-14,2020-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86624 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer),2020-10-26,2020-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88536 - Class II - Drugs - RemedyRepack Inc.,"A 500 count bottle of Carvedilol 25 mg tablets contained two Paroxetine Tablets, 40 mg. Product was repackaged into 180 count bottles.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89322 - Class II - Drugs - RemedyRepack Inc.,Failed Impurities/Degradation Specifications,2022-01-05,2022-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89331 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.,2022-01-11,2022-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89968 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.,2022-04-26,2022-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90127 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.,2022-05-20,2022-05-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90134 - Class II - Drugs - RemedyRepack Inc.,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,2022-05-20,2022-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90873 - Class II - Drugs - RemedyRepack Inc.,Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.,2022-09-15,2022-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91263 - Class II - Drugs - RemedyRepack Inc.,Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.,2022-12-07,2022-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78504 - Class III - Drugs - Renaissance Lakewood, LLC",Superpotent,2017-12-20,2017-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79310 - Class III - Drugs - Renaissance Lakewood, LLC",Superpotent and Failed Stability Specifications; out of specification results for assay and water vapor permeability,2018-03-23,2018-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79580 - Class II - Drugs - Renaissance Lakewood, LLC","Labeling: Label mix-up - A complaint was received of one bag of Fluconazole Injection, Iso-Osmotic Sodium Chloride Diluent, USP, 2mg/mL, 50 mL found within the package of 100 mL bags.",2018-04-24,2018-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80442 - Class III - Drugs - Renaissance Lakewood, LLC","Superpotent Drug and Failed Stability Specifications: lot out of specification for elevated sodium chloride and elevated water vapor., Failed Stability Specifications: lot out of specification for elevated water vapor., Superpotent Drug: lots out of specification for elevated sodium chloride and fluconazole assay.",2018-08-02,2018-08-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86125 - Class II - Drugs - RESOURCE RECOVERY & TRADING LLC,cGMP deviations,2020-08-27,2020-08-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81742 - Class I - Drugs - Results RNA, LLC",Lack of Sterility Assurance and Incorrect/Undeclared excipient: Product was found to contain undeclared colloidal silver,2019-01-14,2019-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64182 - Class I - Drugs - Reumofan Plus USA,"Marketed without an approved NDA/ANDA: Product may contain undeclared active pharmaceutical ingredients Diclofenac Sodium, Dexamethasone, and Methocarbamol.",2013-08-02,2013-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89289 - Class II - Drugs - Revive Personal Products Company,Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Menthol with UPC  7 14132 00071 4 instead of Peppermint Oil and Sage Oil with UPC 7 14132 00073 8,2022-01-10,2022-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89873 - Class II - Drugs - Revive Personal Products Company,Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Peppermint Oil and Sage Oil and has the wrong UPC,2022-04-06,2022-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89591 - Class I - Drugs - Revive Rx LLC dba Revive Rx Pharmacy,Non-sterility; bacterial contamination identified as Paenibacillus lautus.,2022-03-08,2022-03-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72020 - Class II - Biologics - Rex Hospital, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74579 - Class II - Biologics - Rex Hospital, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2016-08-08,2016-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64573 - Class II - Biologics - Rhode Island Blood Center,"Blood product, collected from a donor with risk factors for vCJD, was distributed.",2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67158 - Class II - Biologics - Rhode Island Blood Center,"Blood product, collected from a donor who received an ear piercing within 12 months of donation, was distributed.",2014-02-07,2014-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67570 - Class III - Biologics - Rhode Island Blood Center,"Blood product, for which the additive solution was not added during manufacturing, was distributed.",2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68771 - Class III - Biologics - Rhode Island Blood Center,"Blood product, collected from an ineligible donor, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68885 - Class II - Biologics - Rhode Island Blood Center,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69026 - Class III - Biologics - Rhode Island Blood Center,"Blood product, manufactured without additive solution, was distributed.",2014-09-09,2014-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69189 - Class II - Biologics - Rhode Island Blood Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2014-09-15,2014-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69288 - Class III - Biologics - Rhode Island Blood Center,"Plateletpheresis product, labeled with an incorrect volume, was distributed.",2014-10-16,2014-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70716 - Class II - Biologics - Rhode Island Blood Center,"Blood product, which tested positive for red cell antibodies was not labeled for the red cell antibodies, was distributed.",2015-04-24,2015-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72636 - Class II - Biologics - Rhode Island Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2015-12-17,2015-12-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73773 - Class II - Biologics - Rhode Island Blood Center,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2016-05-16,2016-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77970 - Class III - Biologics - Rhode Island Blood Center,"Platelet product, which failed quality control testing for WBC count, and labeled as leukoreduced, was distributed.",2017-09-20,2017-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79881 - Class II - Biologics - Rhode Island Blood Center,"Blood products, not properly tested for relevant transfusion transmitted infections, were distributed",2018-04-26,2018-04-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79883 - Class II - Biologics - Rhode Island Blood Center,"Blood products, not properly tested for relevant transfusion transmitted infections, were distributed.",2018-04-26,2018-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79983 - Class III - Biologics - Rhode Island Blood Center,"Platelet product, for which the label applied to the unit contained incorrect volume information, was distributed.",2018-05-30,2018-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80934 - Class II - Biologics - Rhode Island Blood Center,"Platelets, with a low platelet count, were distributed.",2018-10-12,2018-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81699 - Class II - Biologics - Rhode Island Blood Center,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2019-02-01,2019-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82391 - Class II - Biologics - Rhode Island Blood Center,"Pathogen Reduced Platelets, not manufactured according to product specifications, were distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82357 - Class II - Biologics - Rhode Island Blood Center,"Blood product, collected from a donor who received a tattoo
within 12 months of donation, was distributed.",2019-04-15,2019-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83554 - Class III - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Plateletpheresis product, which was irradiated labeled with an incorrect expiration date, was distributed.
",2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83586 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Blood product, in which donor testing was not performed or incomplete, was distributed.",2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83940 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Irradiated Apheresis Platelets, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-10-11,2019-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84633 - Class III - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Apheresis red cell product, not meeting product specifications, was distributed.
",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85011 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2020-02-19,2020-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85012 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Plateletpheresis product, not meeting product specifications, was distributed.",2020-02-19,2020-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85041 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Blood products, not meeting labeled specification requirements, were distributed.",2020-03-03,2020-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85714 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Leukoreduced, Apheresis Platelets, stored with a volume significantly higher than the limit allowed in a bag, was distributed.",2020-06-09,2020-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85991 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Blood product, which did not meet the acceptable product specifications for release, was distributed.",2020-07-22,2020-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86010 - Class III - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Leukoreduced, Apheresis Red Blood Cells, labeled with a volume significantly lower that the product's actual volume, was distributed.",2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86457 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Platelet product, for which quality control for pH testing was not performed, was distributed.
",2020-09-23,2020-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86638 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2020-11-12,2020-11-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88254 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Plateletpheresis product, for which quality control for residual WBC count was not performed, was distributed.
",2021-07-14,2021-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88713 - Class III - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Leukoreduced Red Blood Cells, which did not meet the minimum requirement for Red Blood Cell recovery following leukoreduction, were distributed.",2021-09-27,2021-09-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88830 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Apheresis Red Blood Cell product, for which quality control for residual WBC count was not performed, was distributed.
",2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89093 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Plateletpheresis products, for which quality control for residual white blood cell count testing was not performed, were distributed.
",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89096 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Apheresis Red Blood Cell products, collected from a donor whose suitability to donate was not adequately determined, were distributed.
",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89245 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Blood products, collected from a donor whose arm preparation was not performed in a manner that ensures sterility, were distributed.
",2022-01-18,2022-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89354 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Platelet product, for which quality control for residual WBC count was not performed, was distributed. 
",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89781 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Blood Products, collected from an ineligible donor, were distributed.",2022-03-30,2022-03-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91215 - Class III - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Apheresis Red Blood Cell products, not meeting product specifications, were distributed.
",2022-11-30,2022-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91305 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Blood products, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-12-19,2022-12-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91366 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Leukoreduced Platelets, Irradiated, collected using apheresis kits that had exceeded the acceptable time periods for use, were distributed.",2022-12-29,2022-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91371 - Class III - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Red Blood Cell products, Irradiated, with an incorrect expiration date on the label, were distributed.
",2023-01-04,2023-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91402 - Class II - Biologics - Rhode Island Blood Center, A Division of New York Blood Center, Inc.","Red Blood Cell products, for which Leukoreduction was not performed in accordance with specifications, were distributed.",2023-01-04,2023-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88506 - Class II - Drugs - Rhodes Pharmaceuticals, L.P.",Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle,2021-09-13,2021-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79820 - Class III - Drugs - Rhodes Pharmaceuticals, L.P.",Failed Dissolution Specification: Low dissolution outside of specifications,2018-05-03,2018-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83538 - Class II - Drugs - Ridge Properties, LLC","Microbial Contamination of Non-Sterile Products: products were found to be contaminated and above specification for lidocaine assay., Superpotent Drug: products were found to be contaminated and above specification for lidocaine assay.",2019-09-13,2019-09-13,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78462 - Class II - Drugs - Ridge Properties, LLC",GMP Deviations: inadequate manufacturing control processes,2017-11-21,2017-11-21,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70003 - Class II - Drugs - Right Value Drug Stores, Inc.",Incorrect Product Formulation: An incorrect gas was used to remove the oxygen from the vial.,2015-01-08,2015-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80655 - Class III - Drugs - Right Value Drug Stores, Inc.",Labeling: Incorrect or Missing Lot and/or Exp Date: Incorrect expiration date on label,2018-08-07,2018-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81198 - Class III - Drugs - Right Value Drug Stores, Inc.",Labeling Not Elsewhere Classified: Misbranding.,2018-11-14,2018-11-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80053 - Class II - Drugs - RIJ Pharmaceutical LLC,CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.,2018-06-08,2018-06-08,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88593 - Class II - Drugs - RISING PHARMACEUTICALS,Labeling: Incorrect Instructions,2021-10-07,2021-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89545 - Class II - Drugs - RISING PHARMACEUTICALS,"Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.",2022-02-22,2022-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82337 - Class II - Drugs - Rising Pharmaceuticals, Inc.",CGMP Deviations; Detection of a trace amount of unexpected impurity N- nitrosodiethylamine (NDEA) found in finished products,2019-03-21,2019-03-21,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85829 - Class III - Drugs - Rising Pharmaceuticals, Inc.","Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had the outer carton for Timolol Maleate Sterile Ophthalmic solution USP 0.5%, 5ml but the bottle inside was Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml.",2020-06-29,2020-06-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86343 - Class I - Drugs - RLC Labs Inc.,"Subpotent Drug: FDA analysis found product to be subpotent, CGMP Deviations: manufactured under the same conditions as those found to be subpotent.",2020-09-24,2020-09-24,24,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84418 - Class II - Biologics - Robert Wood Johnson University Hospital- Blood Services,"Blood product, possibly contaminated with air, was distributed.
",2019-12-17,2019-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82305 - Class II - Drugs - Roberts Home Medical LLC,CGMP Deviations,2019-03-14,2019-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83156 - Class III - Biologics - Roche Molecular Systems, Inc.","Cobas (6800 & 8800) systems,  with a potential for leakage from the processing transfer heads, were distributed.",2019-08-15,2019-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64355 - Class II - Biologics - Rochester Eye and Human Parts Bank, Inc.","Human Cornea, not tested to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, was distributed.",2013-08-13,2013-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89774 - Class II - Drugs - Rock Town Distillery, Inc.",CGMP Deviations: FDA analysis found product to contain acetal and acetaldehyde above specification limits.,2022-03-23,2022-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63022 - Class II - Biologics - Rocky Mountain Lions Eye Bank,"Corneas, recovered in a manner that may increase the risk of the introduction, transmission, or spread of communicable diseases, were distributed.",2012-08-31,2012-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72918 - Class II - Biologics - Rocky Mountain Lions Eye Bank,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2016-02-18,2016-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77749 - Class II - Biologics - Rocky Mountain Lions Eye Bank,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2017-07-24,2017-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70914 - Class II - Drugs - Romark Laboratories, L.C.",Failed Stability Specifications: Product failed to meet 12 months long term stability specification  for viscosity,2015-05-04,2015-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86172 - Class II - Drugs - Roque Plast S.A. De C.V.,CGMP Deviation: Potential contamination with undeclared methanol.,2020-08-31,2020-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70729 - Class III - Biologics - Roswell Park Cancer Institute Corporation. Div. of Pathology,"Blood product, collected from an ineligible donor, was distributed.",2015-03-23,2015-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76142 - Class II - Drugs - Roxane Laboratories, Inc.",Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.,2017-01-23,2017-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75992 - Class III - Drugs - Roxane Laboratories, Inc.",Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..,2017-01-26,2017-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63025 - Class II - Biologics - RTI Biologics, Inc.","Human tendon, with a swab culture positive for coagulase-negative Staphylococcus, was distributed.",2012-09-05,2012-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63026 - Class II - Biologics - RTI Biologics, Inc.","Human tendons, with a culture positive for coagulase negative Staphylococcus, were distributed.",2012-09-05,2012-09-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65634 - Class III - Biologics - RTI Biologics, Inc.","Human tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-08-13,2013-08-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65637 - Class III - Biologics - RTI Biologics, Inc.","Human tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2013-08-13,2013-08-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76584 - Class II - Biologics - RTI Surgical,  Inc.","Human tissue allograft, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, was distributed.",2017-03-28,2017-03-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78200 - Class II - Biologics - RTI Surgical, Inc.","Human tissue allograft, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, was distributed.",2017-10-03,2017-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69564 - Class II - Biologics - RTI Surgical, Inc. (also dba RTI Biologics, Inc.)","Human tissue allografts from two donors, possibly milled together during processing, were distributed under a single donor identifier.",2015-02-27,2015-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89311 - Class II - Drugs - Rubicon Research Private Limited,Complaint received of foreign matter (metal) embedded in tablet.,2022-01-07,2022-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72457 - Class III - Drugs - Rx PAK,Labeling: Not elsewhere classified - Product label incorrectly lists Scopolamine Hydrocodone as an active ingredient on the side panel instead of Scopolamine Hydrobromide.,2015-10-21,2015-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81943 - Class II - Drugs - Rx Pak Division of McKesson Corporation,Labeling: Label mix-up: Secondary carton may be labeled as Gabapentin 300mg instead of Docusate Sodium 100mg softgel caps.,2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64541 - Class II - Drugs - RX South LLC DBA RX3 Pharmacy,CGMP Deviations: Pharmaceutical for injection was not manufactured according to Good Manufacturing Procedures.,2013-03-08,2013-03-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67432 - Class II - Drugs - RX South LLC DBA RX3 Pharmacy,Crystallization; visible crystals from the active ingredient formed due to extreme cold temperatures during shipping,2014-03-17,2014-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78175 - Class II - Drugs - RXQ Compounding LLC,Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.,2017-10-18,2017-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81316 - Class II - Drugs - RXQ Compounding LLC,"Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.",2018-11-01,2018-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83074 - Class II - Drugs - RXQ Compounding LLC,"Crystallization, Lack of Assurance of Sterility",2019-08-08,2019-08-08,86,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87613 - Class II - Drugs - S & B Story LLC,Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.,2021-04-26,2021-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41047 - Class III - Biologics - Sacramento Medical Foundation,"Blood product, collected from a donor whose hematocrit was not recorded  during donor screening, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72970 - Class II - Drugs - Safecor Health, LLC",Presence of Foreign Substance: customer complaint that one unit dose cup contained a small piece of cardboard contaminant.,2016-02-10,2016-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72947 - Class II - Drugs - Safecor Health, LLC",Defective Container: Confirmed customer complaints of leaking bottles.,2016-02-11,2016-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72948 - Class II - Drugs - Safecor Health, LLC",Labeling: Label Error on Declared Strength: Label incorrectly identifies product dose as 5ml instead of 10 ml.,2016-03-29,2016-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74822 - Class II - Drugs - Safecor Health, LLC",CGMP Deviations,2017-06-12,2017-06-12,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69141 - Class II - Drugs - Sage Products Inc,Microbial Contamination of Non-Sterile Products: Comfort Shield Barrier Cream Cloth packages tested positive for bacterial contamination.,2014-09-03,2014-09-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76424 - Class III - Drugs - Sage Products Inc,"Labeling: Incorrect or Missing Lot and/or Exp Date: The expiration date of the Q Care Continue Care kit is printed with an expiration date of November 13, 2017; rather than the correct date of August 28, 2017 (date of expiration of the Corinz Antiseptic Cleansing & Moisturizing Oral Rinse). Note, the correct expiration date of August 28, 2017, is printed on the Corinz Oral Rinse package.",2017-02-21,2017-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77992 - Class II - Drugs - Sage Products Inc,Cross Contamination With Other Products: Oral care solutions were manufactured by a third party supplier on equipment shared with non-pharmaceutical products,2018-02-09,2018-02-09,64,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74819 - Class I - Drugs - Sage Products LLC,"Microbial Contamination of Non-Sterile Products: contamination with the bacteria, Burkholderia cepacia., CGMP Deviations: potential contamination of products manufactured on the same equipment and lines as the contaminated product.",2016-12-22,2016-12-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65339 - Class II - Drugs - Sagent Pharmaceuticals Inc,CGMP Deviations: product was not manufactured under current good manufacturing practices which contributed to Failed Impurities/Degradation Specifications as a high out of specification impurity result was detected during routine quality testing of stability samples.,2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67689 - Class II - Drugs - Sagent Pharmaceuticals Inc,Lack of Assurance of Sterility; leaking of premix bags,2014-09-29,2014-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69485 - Class II - Drugs - Sagent Pharmaceuticals Inc,"Incorrect or Missing Lot and/or Exp Date:  Ketorolac Tromethamine Injection, is being recalled as a result of labeling the product with the incorrect expiration date.",2014-10-16,2014-10-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70600 - Class II - Drugs - Sagent Pharmaceuticals Inc,Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.,2015-03-03,2015-03-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73434 - Class II - Drugs - Sagent Pharmaceuticals Inc,Cross contamination with other products: metronidazole,2016-03-22,2016-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74373 - Class II - Drugs - Sagent Pharmaceuticals Inc,"Presence of Particulate Matter; The firm received two product complaints for small, dark particulate matter identified in solution post reconstitution.",2016-07-28,2016-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79419 - Class II - Drugs - Sagent Pharmaceuticals Inc,Failed Impurities/Degradation Specifications: High out of specification results for an impurity.,2018-03-12,2018-03-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82741 - Class II - Drugs - Sagent Pharmaceuticals Inc,"Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.",2019-05-09,2019-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87492 - Class II - Drugs - Sagent Pharmaceuticals Inc,Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.,2021-03-17,2021-03-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90874 - Class I - Drugs - Salon Technologies International Inc,"Chemical Contamination: product found to contain benzene, GMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits. 
",2022-10-04,2022-10-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63017 - Class I - Drugs - Samantha Lynn, Inc",Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.,2012-11-23,2012-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48920 - Class II - Biologics - San Antonio Eye Bank,"Corneas, recovered from a donor who had not been properly evaluated for hemodilution, were distributed.",2012-07-09,2012-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61567 - Class III - Biologics - San Antonio Eye Bank,"Human Corneas, processed in a manner that may cause the introduction, transmission, or spread of communicable disease, were distributed.",2012-07-18,2012-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63373 - Class II - Biologics - San Diego Blood Bank,"Blood products, which were not tested to verify the White Blood Cell count, were distributed.",2012-10-19,2012-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64648 - Class III - Biologics - San Diego Blood Bank,Unlicensed blood products were distributed in interstate commerce.,2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39573 - Class II - Biologics - San Diego Blood Bank,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39575 - Class II - Biologics - San Diego Blood Bank,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39714 - Class II - Biologics - San Diego Blood Bank,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40404 - Class II - Biologics - San Diego Blood Bank,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2013-06-18,2013-06-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41019 - Class III - Biologics - San Diego Blood Bank,"Blood products, leukoreduced more than five days after collection, were distributed.",2013-07-02,2013-07-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39179 - Class III - Biologics - San Diego Blood Bank,"Blood products, manufactured with an extended time outside of refrigeration, were distributed.",2013-07-11,2013-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42406 - Class II - Biologics - San Diego Blood Bank,"Blood products, collected from a donor in which donor suitability were not adequately determined, were distributed.",2013-07-24,2013-07-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45175 - Class III - Biologics - San Diego Blood Bank,"Blood product, collected from a donor whose body temperature was not documented, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50441 - Class II - Biologics - San Diego Blood Bank,"Blood products, collected from a donor for whom hemoglobin screening test was not performed, were distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41369 - Class III - Biologics - San Diego Blood Bank,"Blood products, which were not prepared in accordance with specifications, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41392 - Class II - Biologics - San Diego Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43815 - Class II - Biologics - San Diego Blood Bank,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45174 - Class II - Biologics - San Diego Blood Bank,"Blood products, possibly air contaminated, were distributed.",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66086 - Class III - Biologics - San Diego Blood Bank,"Blood product, collected from a donor with no documentation of an arm inspection, was distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66038 - Class III - Biologics - San Diego Blood Bank,-,2013-10-01,2013-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67339 - Class II - Biologics - San Diego Blood Bank,"Blood products, collected from a donor who visited a malarial endemic region, were distributed.",2014-03-06,2014-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69273 - Class III - Biologics - San Diego Blood Bank,"Blood product, not prepared in accordance with standard operating procedure, was distributed.",2014-10-03,2014-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69272 - Class III - Biologics - San Diego Blood Bank,"Blood product, not prepared in accordance with standard operating procedure, was distributed.",2014-10-06,2014-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72230 - Class II - Biologics - San Diego Blood Bank,"Plateletpheresis products, collected without the required QC being performed, were distributed.
",2015-10-13,2015-10-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72994 - Class III - Biologics - San Diego Blood Bank,"Red blood cells, not prepared in accordance with specifications, were distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73624 - Class III - Biologics - San Diego Blood Bank,"RBC's, collected using a Whole Blood Collection Scale for which quality control testing was not performed, were distributed.",2016-04-08,2016-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74048 - Class II - Biologics - San Diego Blood Bank,"Blood product, collected from a donor for whom donor suitability was inadequately determined, was distributed.",2016-05-19,2016-05-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74350 - Class II - Biologics - San Diego Blood Bank,"Apheresis products, which were not filtered according to specifications, were distributed.",2016-06-21,2016-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74765 - Class II - Biologics - San Diego Blood Bank,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2016-08-24,2016-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75000 - Class III - Biologics - San Diego Blood Bank,"Blood component, not prepared in accordance with specifications, was distributed.",2016-10-04,2016-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76599 - Class II - Biologics - San Diego Blood Bank,Misbranded red cells collected by apheresis were distributed.,2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76669 - Class II - Biologics - San Diego Blood Bank,"Blood products, possibly contaminated with air, were distributed.",2017-04-21,2017-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77036 - Class II - Biologics - San Diego Blood Bank,"Plateletpheresis products, lacking proper quality control testing, were distributed.",2017-05-03,2017-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77037 - Class II - Biologics - San Diego Blood Bank,"Plateletpheresis products, lacking proper quality control procedures, were distributed.",2017-05-03,2017-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77203 - Class II - Biologics - San Diego Blood Bank,"Platelet products, for which product quality control testing was not performed, were distributed.",2017-05-16,2017-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77765 - Class III - Biologics - San Diego Blood Bank,"Blood product, manufactured without additive solution, was distributed.",2017-07-27,2017-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79544 - Class II - Biologics - San Diego Blood Bank,"Platelet products, that failed to meet product specifications, were distributed.",2018-04-04,2018-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80852 - Class II - Biologics - San Diego Blood Bank,"Apheresis products, collected from an unsuitable donor due to a donor screening deviation, were distributed.
",2018-08-29,2018-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81864 - Class II - Biologics - San Diego Blood Bank,"Blood product, collected from an ineligible donor, was distributed.",2019-01-28,2019-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84130 - Class II - Biologics - San Diego Blood Bank,"Apheresis Platelets, Leukoreduced, collected by automated equipment that was not validated for use, were distributed.",2019-11-15,2019-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85648 - Class III - Biologics - San Diego Blood Bank,"Deglycerolyzed Red Blood Cells, not tested for product specifications, were distributed.",2020-05-12,2020-05-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85606 - Class II - Biologics - San Diego Blood Bank,"Blood products, collected from a donor who lived with an individual who had Hepatitis B, were distributed.
",2020-05-15,2020-05-15,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85921 - Class III - Biologics - San Diego Blood Bank,"Deglycerolyzed Red Blood Cell product, not tested for product specifications, was distributed.",2020-07-06,2020-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89519 - Class II - Biologics - San Diego Blood Bank,"Leukoreduced Apheresis Platelets, which were labeled as irradiated but were not irradiated, were distributed.",2022-02-10,2022-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67703 - Class III - Biologics - San Diego Eye Bank,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2014-03-13,2014-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70415 - Class III - Biologics - San Diego Eye Bank,"Human Corneas, recovered from an ineligible donor, were distributed.",2015-03-03,2015-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89033 - Class I - Drugs - Sandoz Inc,Temperature Abuse; temperature excursion during shipping,2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66791 - Class III - Drugs - Sandoz Inc,"Failed Moisture Limit; Out of Specification (OOS) results were obtained for moisture content during stability testing at the 12 month time point, controlled room temperature conditions.",2013-12-06,2013-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66554 - Class II - Drugs - Sandoz Inc,Subpotent; Hydrochlorothiazide at the 9 month time point.,2013-12-30,2013-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73035 - Class III - Drugs - Sandoz Inc,Failed Impurities/Degradation Specifications; 9 month stability timepoint,2016-02-11,2016-02-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74326 - Class III - Drugs - Sandoz Inc,Labeling: Incorrect or Missing Package Insert,2016-06-16,2016-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75032 - Class II - Drugs - Sandoz Inc,Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.,2016-09-19,2016-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75168 - Class II - Drugs - Sandoz Inc,Defective Delivery System; reports of damaged product that may alter the predicted release of scopolamine following transdermal application.,2016-11-09,2016-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75654 - Class II - Drugs - Sandoz Inc,Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.,2016-11-17,2016-11-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75563 - Class III - Drugs - Sandoz Inc,Labeling: Missing Label,2016-11-19,2016-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75987 - Class III - Drugs - Sandoz Inc,Subpotent Drug: out of specification results for assay test.,2017-01-19,2017-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76435 - Class II - Drugs - Sandoz Inc,"Labeling: Incorrect Instructions:outer carton contains the incorrect instructions for Step 2 stating ""Do cut the patch"" rather than the correct instructions of ""Do not cut the patch"". The pouch containing the patch is labeled correctly.",2017-02-17,2017-02-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76515 - Class II - Drugs - Sandoz Inc,Failed Dissolution Specifications,2017-03-09,2017-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77117 - Class III - Drugs - Sandoz Inc,Subpotent Drug; Clavulanic Acid,2017-05-26,2017-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78169 - Class III - Drugs - Sandoz Inc,Labeling: Missing Label: customer complaint that some vials of ampicillin within the shrink wrap pack are missing labels.,2017-09-28,2017-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81457 - Class II - Drugs - Sandoz Inc,Cross Contamination with Other Products,2018-11-20,2018-11-20,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84082 - Class III - Drugs - Sandoz Inc,Labeling: Incorrect or missing package insert.,2019-10-28,2019-10-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63160 - Class III - Drugs - Sandoz Incorporated,Impurities/Degradation Products: An out of specification result for a known impurity of the product occurred during 12 month stability testing.,2012-09-19,2012-09-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63224 - Class III - Drugs - Sandoz Incorporated,Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&amp;2),2012-10-18,2012-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64118 - Class III - Drugs - Sandoz Incorporated,Tablet/Capsule Imprinted with Wrong ID; a portion of the tablets could contain the incorrect debossing on one side of the tablet U2 instead of U3.,2013-02-06,2013-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64936 - Class II - Drugs - Sandoz Incorporated,"Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.",2013-04-23,2013-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65318 - Class II - Drugs - Sandoz Incorporated,"Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a customer complaint for broken/cracked vials which was confirmed through review of retained samples.",2013-06-11,2013-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65511 - Class II - Drugs - Sandoz Incorporated,Contraceptive Tablets out of Sequence: A placebo tablet was found in a row of active tablets.,2013-07-17,2013-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65200 - Class I - Drugs - Sandoz Incorporated,Presence of Particulate Matter: Found during examination of  retention samples.,2013-08-02,2013-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65877 - Class III - Drugs - Sandoz Incorporated,"Contraceptive tablets out of sequence: Contraceptive tablets out of sequence: Introvale (levonorgestrel and ethinyl estradiol tablets USP 0.15mg/0.03mg) is voluntarily being recalled due to inactive placebo tablets incorrectly placed in Week 9, and active tablets placed in Week 13 on the blister card",2013-08-08,2013-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66373 - Class III - Drugs - Sandoz Incorporated,"Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.",2013-10-10,2013-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66531 - Class II - Drugs - Sandoz Incorporated,Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manufactured product fluvastatin,2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68900 - Class II - Drugs - Sandoz Incorporated,Presence of Foreign Substance; tablets may contain stainless steel metal particulates,2014-07-31,2014-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69942 - Class III - Drugs - Sandoz Incorporated,Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.,2014-12-09,2014-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76077 - Class II - Drugs - Sandoz Incorporated,Failed dissolution specification: recalled due to an out of specification dissolution result of 40% (Specification: NLT 80%),2016-12-27,2016-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77567 - Class III - Drugs - Sandoz Incorporated,Cross Contamination With Other Product: Imipramine,2017-07-06,2017-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79788 - Class III - Drugs - Sandoz Incorporated,"Cross Contamination With Other Products: presence of unrelated ingredients (i.e. traces of Lisinopril, Mannitol, Iron, Calcium and Phosphorous).",2018-04-16,2018-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81485 - Class II - Drugs - Sandoz, Inc","CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product above  the interim acceptable daily intake level of 0.083 parts per million.",2019-01-14,2019-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83875 - Class II - Drugs - Sandoz, Inc","CGMP Deviations: Detection of a trace amount of an unexpected impurity, N-nitrosodimethylamine (NDMA).",2019-10-07,2019-10-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85538 - Class II - Drugs - Sandoz, Inc",Defective Container: Sub-optimal crimping in vial of Pediatric Infuvite Multiple Vitamins,2020-05-01,2020-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88937 - Class II - Drugs - Sandoz, Inc",CGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.,2022-04-06,2022-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66458 - Class II - Drugs - Sandoz, Inc","Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.",2013-11-04,2013-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68360 - Class II - Drugs - Sandoz, Inc",Presence of Foreign Substance: Presence of stainless steel particles.,2014-05-23,2014-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68860 - Class III - Drugs - Sandoz, Inc",Failed Dissolution Specifications: Product found to be out of specification (OOS) during stability testing.,2014-07-23,2014-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69688 - Class III - Drugs - Sandoz, Inc",Failed Impurities/Degradation Specifications: An Out of Specification (OOS) result was generated for the 18 month stability time point for ketone cilexetil impurity and total impurities.,2014-12-02,2014-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71055 - Class III - Drugs - Sandoz, Inc",Failed Impurities/Degradation Specifications: An out of specification (OOS) result was reported for impurity at the 21 month stability time point.,2015-06-03,2015-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74068 - Class III - Drugs - Sandoz, Inc",Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.,2016-06-20,2016-06-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63515 - Class II - Biologics - Sanford Medical Center (blood Bank),"Blood product, collected from a donor who emigrated from an area considered endemic for malaria, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69862 - Class II - Biologics - Sanford Medical Center (Blood Bank),"Blood products, misbranded for Rh antigen typing, was distributed.",2014-12-17,2014-12-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71943 - Class II - Biologics - Sanford Medical Center (Blood Bank),"Blood product, for which the manufacturer's instructions for  leukoreduction were not followed, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87511 - Class I - Drugs - Sanit Technologies, LLC dba Durisan","Microbial Contamination of Non-Sterile Products: firm's internal testing found certain lots of the product to be contaminated with Burkholderia contaminans and/or yeast and mold., CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.",2021-07-13,2021-07-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88754 - Class II - Drugs - Sanitor Corporation,"CGMP Deviations: Use of this product may cause
possible infection/ irritation of the skin and/or soft tissues.",2021-10-15,2021-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72527 - Class I - Drugs - Sanofi-Aventis U.S. LLC,Defective Delivery System; potential to have inaccurate dosage delivery,2016-05-25,2016-05-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80387 - Class II - Drugs - Sanofi-Aventis U.S. LLC,Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.,2018-07-16,2018-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84122 - Class II - Drugs - Sanofi-Aventis U.S. LLC,CGMP Deviations: Presence of NDMA impurity detected in product.,2019-12-01,2019-12-01,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86219 - Class II - Drugs - Sanofi-Aventis U.S. LLC,Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.,2020-08-17,2020-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65701 - Class II - Drugs - Sanofi-Aventis U.S. LLC,Subpotent drug: low fill volume in some of the capsules,2013-08-05,2013-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76896 - Class III - Drugs - Sanofi-Aventis U.S. LLC,Labeling: Incorrect or Missing Package Insert,2017-05-11,2017-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77478 - Class III - Drugs - Sanofi-Aventis U.S. LLC,Superpotent Drug: high out-of-specification result for magnesium.,2017-06-29,2017-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78232 - Class III - Drugs - Sanofi-Aventis U.S. LLC,Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.,2017-10-30,2017-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78637 - Class III - Drugs - Sanofi-Aventis U.S. LLC,Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL,2018-01-05,2018-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79964 - Class II - Drugs - Sanofi-Aventis U.S. LLC,Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.,2018-05-14,2018-05-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62350 - Class II - Drugs - sanofi-aventis US, Inc.","CGMP Deviations:  Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues in Good Manufacturing Practices.",2012-07-05,2012-07-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65954 - Class II - Drugs - Sanofi-Synthelabo,"Subpotent Drug:  During review of retain samples, the manufacturer observed low fill in some capsules, which was related to an issue detected with the encapsulating equipment.",2013-08-13,2013-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75522 - Class III - Biologics - Sanofi Pasteur S.A.,"Sanofi Pasteur's IMOGAM RABIES-HT (Rabies Immune Globulin [Human] USP, Heat Treated), with an antibody content that has declined below the stability specification limit, was distributed.",2016-11-14,2016-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65368 - Class III - Biologics - Sanofi Pasteur, Inc.","Lots of Typhim Vi (Typhoid Vi Polysaccharide Vaccine), with potentially low antigen content, were distributed.",2013-07-11,2013-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72292 - Class III - Biologics - Sanofi Pasteur, Inc.","Three lots of Sanofi Pasteur's 2014-2015 Fluzone Quadrivalent (Influenza Vaccine) supplied in Multidose vials, with antigen content that declined below the stability specification limit for two strains prior to product expiry, were distributed. 
 
",2015-10-08,2015-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86197 - Class II - Drugs - Santa Cruz Biotechnology, Inc",Subpotent drug,2020-08-28,2020-08-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77161 - Class II - Drugs - Sato Pharmaceutical Inc.,Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.,2017-05-23,2017-05-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84019 - Class III - Drugs - Sato Pharmaceutical Inc.,Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.,2019-11-07,2019-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83964 - Class III - Drugs - Sato Pharmaceutical Inc.,Subpotent Drug,2019-11-13,2019-11-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70251 - Class III - Biologics - Saturn Biomedical, Inc","Source Plasma, collected from an ineligible donor, was distributed.",2015-02-20,2015-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70496 - Class III - Biologics - Saturn Biomedical, Inc","Blood products, for which the donor did not meet eligibility criteria, were distributed.",2015-03-23,2015-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68410 - Class II - Biologics - Saving Sight,"Human Corneas, processed using an expired viewing chamber, were distributed.",2014-06-13,2014-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68929 - Class III - Biologics - Saving Sight,"Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2014-07-31,2014-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73122 - Class II - Biologics - Saving Sight,"Human Cornea, recovered in a manner that may have caused contamination or cross-contamination otherwise increasing the risk of the introduction, transmission, or spread of communicable disease, was distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79144 - Class III - Biologics - Saving Sight,"Human cornea, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, was distributed.",2018-02-14,2018-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70167 - Class II - Drugs - SCA Pharmaceuticals,"Labeling: Incorrect or missing Lot and/or Exp Date: Printing error caused an overlap in the ""y"" and ""3"" making the actual ""Use By 3/2015"" date appear to read ""Use By8/2015"".",2015-01-14,2015-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70583 - Class II - Drugs - SCA Pharmaceuticals,Presence of particulate.,2015-04-22,2015-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71166 - Class II - Drugs - SCA Pharmaceuticals,Labeling: Label Mix-Up: Product is incorrectly labeled as phenylephrine 50 mg in 0.9% sodium chloride rather than phenylephrine 50 mg in 5% dextrose.,2015-06-10,2015-06-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76395 - Class I - Drugs - SCA Pharmaceuticals,Presence of particulate matter - this recall is due to a recent Hospira recall of vancomyicn hydrochloride 10gm vials due to presence of particulate matter.,2017-04-05,2017-04-05,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77314 - Class II - Drugs - SCA Pharmaceuticals,Lack of assurance of sterility: Product bags leaking at seam.,2017-05-31,2017-05-31,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77600 - Class II - Drugs - SCA Pharmaceuticals,Lack of sterility assurance,2017-07-13,2017-07-13,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77777 - Class II - Drugs - SCA Pharmaceuticals,Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.,2017-07-25,2017-07-25,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77770 - Class II - Drugs - SCA Pharmaceuticals,Lack of Assurance of Sterility; product has the potential to leak.,2017-07-26,2017-07-26,30,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78708 - Class II - Drugs - SCA Pharmaceuticals,Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date.,2018-01-05,2018-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80425 - Class II - Drugs - SCA Pharmaceuticals,Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.,2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85865 - Class II - Drugs - SCA Pharmaceuticals,Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.,2020-06-17,2020-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86194 - Class II - Drugs - SCA Pharmaceuticals,Subpotent Drug: Out-of-Specification potency results at the 30-day stability timepoint.,2020-08-12,2020-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86193 - Class I - Drugs - SCA Pharmaceuticals,"Cross Contamination with Other Product(s): containers labeled as having methylparaben and propylparaben as preservatives, actually contained undeclared benzyl alcohol and did not contain any parabens.",2020-08-27,2020-08-27,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86802 - Class III - Drugs - SCA Pharmaceuticals,Subpotency: Out-of-specification stability test result for low potency was obtained.,2020-12-14,2020-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86990 - Class II - Drugs - SCA Pharmaceuticals,"Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit",2021-01-07,2021-01-07,32,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90080 - Class II - Drugs - SCA Pharmaceuticals,CGMP Deviations,2022-05-02,2022-05-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80915 - Class I - Drugs - SCA Pharmaceuticals, Inc.",Presence of Precipitate: Customer complaint for visible precipitate in product believed to be the active ingredient furosemide.,2018-09-12,2018-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86982 - Class II - Drugs - SCA Pharmaceuticals, Inc.",Subpotent drug.,2020-12-21,2020-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78320 - Class II - Drugs - SCA Pharmaceuticals, LLC",Lack Of Assurance Of Sterility.,2017-11-02,2017-11-02,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80303 - Class II - Drugs - SCA Pharmaceuticals, LLC",Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.,2018-07-02,2018-07-02,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83580 - Class II - Drugs - SCA Pharmaceuticals, LLC",Lack of Assurance of Sterility.,2019-08-26,2019-08-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84326 - Class II - Drugs - SCA Pharmaceuticals, LLC",Presence of Foreign Substance: Foreign material found inside the vial (manufacturer).,2019-12-10,2019-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79265 - Class III - Drugs - SCA Pharmaceuticals, LLC.",Labeling; Incorrect or Missing Lot number/Expiration Date; some product labels incorrectly indicates a compounding date of 12/27/2018 and use-by date of 03/27/2019 instead of 12/27/2017 and use-by-date of 03/27/2018,2018-03-19,2018-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62021 - Class II - Biologics - SCC Soft Computer,"Software, with a glitch or defect, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #35009 - Class II - Biologics - SCC Soft Computer,"Software, with a glitch or defect, was distributed.",2012-08-16,2012-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66975 - Class II - Biologics - SCC Soft Computer,"Blood Bank software with a defect or glitch, was distributed.",2013-12-06,2013-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87828 - Class I - Drugs - Scentsational Soaps & Candles Inc,"Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.",2021-07-19,2021-07-19,19,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63879 - Class II - Drugs - Schering-Plough Products, LLC",Failed Impurities/Degradation Specifications: The recall is being initiated due to an out-of-specification result in the degradation product testing detected during stability monitoring.,2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67228 - Class I - Drugs - Schindele Enterprises dba Midwest Wholesale,"Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.",2014-05-20,2014-05-20,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81458 - Class II - Drugs - Sciegen Pharmaceuticals Inc,"CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.",2018-11-20,2018-11-20,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81453 - Class II - Drugs - SCJohnson Professional,CGMP Deviations: Product was released to market prior to microbiological testing.,2018-11-06,2018-11-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83185 - Class II - Biologics - Scott & White Memorial Hospital,"Leukoreduced Red Blood Cells, collected from a donor in which the donor was not tested for Chagas, was distributed.",2019-07-12,2019-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83045 - Class II - Biologics - Scott & White Memorial Hospital,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2019-07-17,2019-07-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83149 - Class III - Biologics - Scott & White Memorial Hospital,"Blood product, in which donor testing was not performed or incomplete, was distributed.",2019-08-01,2019-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61075 - Class II - Biologics - Seattle Sperm Bank LLC,"Human semen, collected from donors that did not have repeat physical exam within 6 months prior to donation, was distributed.",2012-07-10,2012-07-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90189 - Class III - Biologics - Secure Transfusion Services Inc,"Blood products, for which the quality control testing was incomplete, were distributed.",2022-06-14,2022-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82594 - Class I - Drugs - SELECT DISTRIBUTIONS LLC,Marketed without an approved NDA/ANDA: FDA analysis has found the product to be tainted with sildenafil,2019-06-13,2019-06-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72746 - Class II - Drugs - Sentara Enterprises,Lack of Assurance of Sterility: Product sterility cannot be guaranteed.,2016-01-28,2016-01-28,34,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91466 - Class II - Drugs - Sentara Infusion Services,Lack of sterility assurance,2023-02-15,2023-02-15,53,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79976 - Class III - Drugs - Septodont Inc.,"Failed Impurities/Degradation: This recall has been initiated due to an out of specification (OOS) result that was obtained for related substance (Phentolamide), a known degradation product impurity at the 15 month stability test point.",2018-05-22,2018-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82760 - Class II - Drugs - Septodont Inc.,"Labeling: Not Elsewhere Classified. This recall has been initiated due to mislabeling. The printed carton used in manufacturing both batches contained text for both 2% Xylocaine DENTAL and Articadent DENTAL. Xylocaine DENTAL is a trade name for Lidocaine HCL 2% and Epinephrine 1: 100,000 formulation, while Articadent DENTAL is a trade name for Articaine HCI 4% and Epinephrine 1 :100,000. The cartridges contained within the
printed carton are labeled appropriately as Articadent DENTAL.",2019-05-28,2019-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73574 - Class II - Drugs - Sesderma, SL",cGMP Deviations; product does not comply with cGMP requirements,2016-05-10,2016-05-10,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86270 - Class I - Drugs - SG24 LLC,Marketed without an Approved NDA/ANDA; product labeled to contain 0.56% methanol making it an unapproved new drug,2020-09-11,2020-09-11,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80184 - Class II - Drugs - Shadow Holdings DBA Bocchi Labs,CGMP Deviations: products may be contaminated with bacteria.,2018-06-12,2018-06-12,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64611 - Class I - Drugs - Shamrock Medical Solutions Group LLC,"Labeling: Label Mix Up; packages labeled as Thiamine actually contain Diltiazem Capsules, Labeling: Label Mix up; product labeled as Morphine Sulfate 20 mg/mL actually contained OxyCODONE HCl 20 mg/mL, Labeling: Label Mix up; product labeled did not indicated Extended Release, Labeling: Label Mix up; product labeled to contain Nebivolol tablets actually contained Pramipexole Dihydrochloride tablets, Labeling: Label Mix up; product labeled to contain Sulfamethoxazole and Trimethoprim Tablets, 400 mg/80 mg instead of Sulfamethoxazole and Trimethoprim Tablets, 800 mg/160 mg, Labeling: Label Mix up; product labeled to contain Docusate Sodium 240mg instead of Docusate Calcium 240mg",2014-07-23,2014-07-23,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84757 - Class II - Drugs - Shandex Personal Care Manufacturing Inc.,Presence of Foreign Substance; Metal contaminant visible in product (screen wire from manufacturing).,2020-01-30,2020-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87037 - Class II - Drugs - Shane Erickson Inc,CGMP Deviations: product manufactured at the same facility that produced product that FDA sampled and found to be subpotent for ethanol and contained methanol.,2021-01-22,2021-01-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78257 - Class II - Drugs - Shata Trading, Inc.",Marketed Without an Approved NDA/ANDA,2017-11-19,2017-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86749 - Class II - Drugs - Shilpa Medicare Limited,CGMP Deviations,2020-12-09,2020-12-09,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62004 - Class II - Drugs - Shionogi Inc.,Failed USP Dissolution Test Requirements: Out of Specification dissolution result at 18 month time point,2012-06-26,2012-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71828 - Class III - Drugs - Shionogi Inc.,Failed Dissolution Specifications,2015-08-04,2015-08-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77605 - Class III - Drugs - Shionogi Inc.,Failed Dissolution Specifications: Low dissolution results were obtained during stability testing,2017-07-14,2017-07-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78851 - Class III - Drugs - Shionogi Inc.,Presence of foreign substance: The recall was initiated due to black particles being observed while performing routine post-release stability testing on Mefenamic acid capsules,2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75170 - Class III - Drugs - Shire,Presence of Foreign Tablets/Capsules,2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76761 - Class II - Drugs - Shire,Presence of Particulate Matter: Glass,2017-03-31,2017-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67690 - Class I - Drugs - Shire Human Genetic Therapies, Inc.",Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.,2014-04-18,2014-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75880 - Class III - Drugs - Shire Human Genetic Therapies, Inc.",Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules,2017-01-17,2017-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83792 - Class I - Drugs - Shire Human Genetic Therapies, Inc.",Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing,2019-10-01,2019-10-01,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78791 - Class II - Drugs - SHISEIDO AMERICA INC.,GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.,2018-01-12,2018-01-12,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80128 - Class I - Drugs - Shoreside Enterprises Inc.,"Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.",2018-06-18,2018-06-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65951 - Class II - Drugs - Showline Automotive Products, Inc. dba US Soaps Mfg. Company","Microbial Contamination of a Non-Sterile Products: Product was found to be contaminated with the bacteria, Sarcina Lutea.",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80892 - Class II - Drugs - Sichuan Friendly Pharmaceutical Co., Ltd.",CGMP Deviations:  Thyroid Powder has inconsistent levels of the active ingredients  levothyroxine and liothyronine.,2018-10-02,2018-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61861 - Class II - Biologics - Siemens Healthcare Diagnostics Inc.,"Trugene HIV-1 Genotype kits, not meeting current performance claims due to variation during manufacture, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63020 - Class II - Biologics - Siemens Healthcare Diagnostics Inc.,"Trugene MicroCel 500 buffer chambers, with the potential to leak buffer and could cause electrical arcing posing a hazard to the operator, were distributed.",2012-09-14,2012-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64773 - Class II - Biologics - Siemens Healthcare Diagnostics Inc.,"MicroCel 500 and MicroCel 300 buffer chambers, with the potential to leak buffer and could cause electrical arcing posing a hazard to the operator, were distributed.",2013-04-08,2013-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77591 - Class II - Drugs - Sigan Industries Inc.,Microbial Contamination of Non Sterile Products; out of specification Total Plate Count,2017-07-13,2017-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84678 - Class III - Drugs - Sigan Industries Inc.,Microbial contamination of non-sterile product.,2020-01-16,2020-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64356 - Class II - Biologics - Sight Society of Northeastern New York Lions Eye Bank@Albany,"Human Corneas, not tested to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71758 - Class III - Biologics - Sight Society Of Northeastern New York Lions Eye Bank@Albany,"Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2015-07-27,2015-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78054 - Class II - Biologics - Sight Society Of Northeastern New York, Inc.","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2017-08-31,2017-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80494 - Class II - Biologics - Sightlife,"Human tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85286 - Class II - Biologics - Sightlife,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2020-03-23,2020-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62305 - Class II - Biologics - SightLife,"Human Corneas, recovered from a donor with evidence of infection due to a communicable disease agent, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66741 - Class II - Drugs - Sigma-Tau Pharmaceuticals, Inc.","Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.",2014-01-15,2014-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68123 - Class II - Drugs - SigmaPharm Laboratories LLC,"Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87748 - Class III - Drugs - SigmaPharm Laboratories LLC,Incorrect Product Formulation; product was manufactured with the incorrect Art Cherry Flavor flavoring agent instead of Art Black Cherry Flavor flavoring agent,2021-05-14,2021-05-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88474 - Class II - Drugs - SigmaPharm Laboratories LLC,Failed Impurities Specifications: Out of Specification impurity results obtained during routine testing.,2021-08-24,2021-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88736 - Class II - Drugs - SigmaPharm Laboratories LLC,Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing.,2021-09-30,2021-09-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76714 - Class II - Drugs - Signature Club A Ltd,Microbial Contamination of Non-Sterile Products: odor complaint of product due to microbial contamination.,2017-04-12,2017-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71952 - Class III - Drugs - Silarx Pharmaceutical, Inc.",Labeling: Incorrect or Missing Lot and/or Exp. Date - Firm received a customer complaint that the expiration date printed on the unit carton (5/18) does not match the expiration date on the bottle label (5/17).,2015-09-03,2015-09-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81228 - Class I - Drugs - Silver Star Brands,"Microbial Contamination of Non-Sterile Products, Microbial Contamination of Non-Sterile Product, CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.",2018-11-19,2018-11-19,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86858 - Class II - Drugs - Simex Logistics SA de CV,Subpotent drug,2020-12-16,2020-12-16,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78657 - Class II - Drugs - Simple Diagnostics, Inc.",Lack of Assurance of Sterility and cGMP Deviations,2017-12-26,2017-12-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42235 - Class III - Biologics - Siouxland Community Blood Bank,"Blood product, stored at an unacceptable temperature, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42157 - Class II - Biologics - Siouxland Community Blood Bank,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-01-03,2013-01-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41921 - Class II - Biologics - Siouxland Community Blood Bank,"Blood products, collected from a donor who received a MMR vaccine, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42114 - Class III - Biologics - Siouxland Community Blood Bank,"Blood products, collected from a donor without a documented result for body temperature, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42233 - Class II - Biologics - Siouxland Community Blood Bank,"Blood products,  which did not meet the acceptable product specifications, were distributed.",2013-02-21,2013-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67260 - Class I - Drugs - Slim Beauty USA,"Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Sibutramine and phenolphthalein are not currently marketed in the United States, making this product an unapproved new drug., Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and phenolphthalein. Sibutramine and phenolphthalein are not currently marketed in the United States, making this product an unapproved new drug., Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine and . Sibutramine is not currently marketed in the United States, making this product an unapproved new drug.",2014-04-07,2014-04-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88445 - Class I - Biologics - Smiths Medical ASD Inc.,"Fast Flow Fluid Warming and Irrigation System Disposables, contain aluminum heat exchangers which have the potential to leach high levels of aluminum during the infusion of blood products, were distributed.",2021-09-08,2021-09-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64211 - Class II - Biologics - Smiths Medical ASD, Inc.","Level 1 Fast Flow Fluid Warmer, with a circuit board component that may result in false over temperature alarm, was distributed.",2013-02-21,2013-02-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76751 - Class III - Biologics - Smiths Medical ASD, Inc.","Level 1 H-1200 Fluid Warmers, with a mislabeled part number 8002950, were distributed.",2017-04-18,2017-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62027 - Class II - Biologics - So Ca Permamente Med Group Blood Donor Cntr,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65728 - Class II - Biologics - So Ca Permamente Med Group Blood Donor Cntr,"Blood product, not appropriately labeled as a low volume unit, was distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69861 - Class II - Biologics - So Ca Permamente Med Group Blood Donor Cntr,"Blood product, which did not meet the acceptable product specifications, was distributed.",2014-12-23,2014-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75309 - Class II - Biologics - Soft Computer Consultants, Inc.","Softbank Blood Bank Software, with a defect or glitch, was distributed.",2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77975 - Class II - Biologics - Soft Computer Consultants, Inc.",Name of the worksheet header did not match the name in the worksheet unit line when using the Joint worksheet with the Auto Clear feature.,2017-08-31,2017-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69135 - Class II - Drugs - Solace International Inc,Labeling: Labeling Bears Unapproved Claims; Dermatend is not FDA approved and therefore has not been shown to be safe and effective for the uses suggested in the labeling.,2014-09-16,2014-09-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78697 - Class II - Drugs - Solco Healtcare US LLC,Labeling: Label Mix-Up.some bottles labeled as Gabapentin 800 mg contain Gabapentin 600 mg,2018-01-05,2018-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86042 - Class II - Drugs - Soluciones Cosmeticas, SA de CV",cGMP Deviations,2020-09-02,2020-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72592 - Class II - Drugs - Solutions Rx Pharmacy,Penicillin Cross Contamination - Possible presence of penicillin in bulk budesonide powder used to compound prescription nasal rinse/nebulizer capsules.,2015-11-18,2015-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85826 - Class III - Drugs - SOMERSET THERAPEUTICS LLC,Failed Impurities/Degradation Specification: There is  a slow leaching process from the product label on the bottle which may impact the product over the shelf life.,2020-07-07,2020-07-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74144 - Class I - Drugs - SOS Telecom Inc.,Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements,2016-10-14,2016-10-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64052 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64553 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-04-15,2013-04-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64906 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68334 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2014-06-26,2014-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68621 - Class III - Biologics - South Bend Medical Foundation, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2014-07-31,2014-07-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69097 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2014-10-06,2014-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69439 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, collected from an ineligible donor, were distributed.",2014-11-21,2014-11-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70230 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2015-02-04,2015-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70234 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, which tested reactive for syphilis, were distributed.",2015-02-04,2015-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70229 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-02-09,2015-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70233 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, which was labeled with an incorrect expiration date, was distributed.",2015-02-09,2015-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70377 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-03-04,2015-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70864 - Class III - Biologics - South Bend Medical Foundation, Inc.","Blood product, which tested negative for HTLV-I/II, but was collected from a donor who was previously deferred for testing positive for HTLV-I/II, was distributed.",2015-05-06,2015-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70865 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-05-06,2015-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71236 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2015-06-16,2015-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71237 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2015-06-16,2015-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74029 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2016-06-14,2016-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79356 - Class II - Biologics - South Bend Medical Foundation, Inc.","Apheresis products, with unacceptably high platelet concentrations, were distributed.
",2018-03-07,2018-03-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79305 - Class III - Biologics - South Bend Medical Foundation, Inc.","Blood products, collected from an ineligible donor, were distributed.",2018-03-22,2018-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79690 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2018-04-05,2018-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79706 - Class II - Biologics - South Bend Medical Foundation, Inc.","Red blood cell, for which the donor gave travel history to a malarial endemic area within 12 months of donating, was distributed.",2018-04-13,2018-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79705 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2018-04-27,2018-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79943 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-06-05,2018-06-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80742 - Class III - Biologics - South Bend Medical Foundation, Inc.","Blood product, which failed to meet the minimum specification for percent red blood cell recovery, was distributed.",2018-09-06,2018-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82220 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-02-28,2019-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83725 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-09-16,2019-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84146 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84669 - Class II - Biologics - South Bend Medical Foundation, Inc.",Red Blood Cells were identified subsequent to distribution as unsuitable due to positive testing.,2020-04-14,2020-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85521 - Class II - Biologics - South Bend Medical Foundation, Inc.","Red Blood Cell product, for which donor eligibility was incomplete, was distributed.
",2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85522 - Class II - Biologics - South Bend Medical Foundation, Inc.","Red Blood Cell product, for which donor eligibility was incomplete, was distributed.",2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86139 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, for which donor eligibility was incomplete, were distributed.",2020-08-07,2020-08-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87588 - Class III - Biologics - South Bend Medical Foundation, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2021-04-10,2021-04-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89018 - Class II - Biologics - South Bend Medical Foundation, Inc.","Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-12-09,2021-12-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89839 - Class II - Biologics - South Bend Medical Foundation, Inc.","Leukoreduced Red Blood Cells, which tested RR for anti-HBc, were distributed.",2022-04-08,2022-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66083 - Class II - Drugs - South Coast Specialty Compounding, Inc.","Lack of Assurance of Sterility: Park Compounding is recalling Methylcobalamin 5 mg/mL, Multitrace-5 Concentrate, and Testosterone Cypionate (sesame oil) for injection due to lack of sterility assurance., Lack of Assurance of Sterility: Park Compounding is voluntarily recalling two lots of  Methylcobalamin 5mg/ml and Multitrace-5 Concentrate, and one lot of Testosterone Cypionate (sesame oil) for injection due lack of sterility assurance.",2013-09-12,2013-09-12,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71078 - Class II - Drugs - South Coast Specialty Compounding, Inc.",Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.,2015-09-02,2015-09-02,15,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62304 - Class II - Biologics - South Dakota Lions Eye and Tissue Bank, Inc.","Human Corneas, recovered from a donor who had not been properly evaluated, were distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69385 - Class II - Biologics - South Dakota Lions Eye Bank, Inc","Human Cornea, recovered from a donor whose donor eligibility determination failed to assure the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2014-10-28,2014-10-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73728 - Class II - Biologics - South Dakota Lions Eye Bank, Inc","Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2016-04-07,2016-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61939 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, with pH below the acceptable level, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62411 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-07-13,2012-07-13,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62655 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62813 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-09-19,2012-09-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63374 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-10-19,2012-10-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64026 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who may be at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-03-22,2013-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64955 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed. 

",2013-05-24,2013-05-24,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65416 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-07-22,2013-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65758 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who reported high risk behavior, were distributed.",2013-08-29,2013-08-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66478 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67075 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2014-01-23,2014-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68427 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2014-06-26,2014-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68429 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2014-06-26,2014-06-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69694 - Class II - Biologics - South Texas Blood & Tissue Center,"Platelet product, collected from a donor who disclosed a history of drug use, was distributed.",2014-11-12,2014-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70172 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, collected from a donor who disclosed travel history to a malarial endemic area, was distributed.",2015-01-23,2015-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70494 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, which did not meet acceptable product specifications, was distributed.",2015-02-25,2015-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70945 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2015-05-13,2015-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74334 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from an ineligible donor, were distributed.",2016-06-21,2016-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75519 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2016-11-14,2016-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76094 - Class III - Biologics - South Texas Blood & Tissue Center,"Apheresis products, collected from an unsuitable donor due to a donor screening deviation, were distributed.",2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76191 - Class III - Biologics - South Texas Blood & Tissue Center,"Blood products, which were collected in a system in which sterility may have been compromised, were distributed.",2017-02-21,2017-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76832 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, for which the leukoreduction procedure was not performed in accordance with specifications, were distributed.",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77966 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, collected using equipment that had not been validated, were distributed.",2017-09-18,2017-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78296 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78534 - Class II - Biologics - South Texas Blood & Tissue Center,"Plateletpheresis products, not meeting product specifications, were distributed.",2017-12-21,2017-12-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79959 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-05-16,2018-05-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79882 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2018-05-30,2018-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80120 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from an ineligible donor, were distributed.",2018-06-29,2018-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80450 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from an ineligible donor, were distributed.",2018-08-15,2018-08-15,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80779 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-08-16,2018-08-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80871 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, for which donor screening was  incorrectly performed, were distributed.",2018-09-07,2018-09-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81292 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-11-08,2018-11-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81200 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-11-13,2018-11-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82041 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, which was collected from a donor who had traveled to a malarial endemic area, was distributed.",2019-03-04,2019-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82056 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who had traveled to a malarial endemic area, were distributed.",2019-03-04,2019-03-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82697 - Class II - Biologics - South Texas Blood & Tissue Center,"Red blood cells product, collected from a donor who emigrated from a malarial endemic area, was distributed.",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82733 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2019-06-03,2019-06-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83264 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected using equipment that had not been fully validated, were distributed.",2019-08-05,2019-08-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83742 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2019-09-20,2019-09-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84277 - Class III - Biologics - South Texas Blood & Tissue Center,"Blood product, where donor testing was not performed or incomplete, was distributed.",2019-12-20,2019-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84601 - Class III - Biologics - South Texas Blood & Tissue Center,"Irradiated Red Blood Cells, labeled with the incorrect expiration date, were distributed.",2020-01-14,2020-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84505 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, which was collected from a donor who traveled to a malarial endemic area, were distributed.",2020-01-23,2020-01-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84506 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84805 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2020-02-05,2020-02-05,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84856 - Class III - Biologics - South Texas Blood & Tissue Center,"Red Blood Cell product, labeled with a combination of incorrect or missing information, was distributed.
",2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85191 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2020-03-20,2020-03-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85177 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, collected from a donor who traveled to a malarial area, was distributed.",2020-04-01,2020-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85457 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2020-04-24,2020-04-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85792 - Class III - Biologics - South Texas Blood & Tissue Center,"Blood product, for which donor eligibility was incomplete, was distributed.
",2020-06-12,2020-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86307 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2020-09-08,2020-09-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86435 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood product, collected from a donor for whom donor suitability was incomplete, was distributed.",2020-09-16,2020-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86458 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2020-09-22,2020-09-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86505 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who lived in a malarial endemic area, was distributed.
",2020-09-29,2020-09-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86506 - Class III - Biologics - South Texas Blood & Tissue Center,"Red Blood Cell product for which a visual inspection was not performed, was distributed.
",2020-09-29,2020-09-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86507 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products collected from a donor who traveled to a malarial endemic area, were distributed.
",2020-09-29,2020-09-29,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86553 - Class II - Biologics - South Texas Blood & Tissue Center,"Red Blood Cell product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2020-10-15,2020-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87187 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who was taking Finasteride, were distributed.",2021-01-26,2021-01-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87397 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2021-03-11,2021-03-11,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88492 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who reported testing positive for Hepatitis C antibody, were distributed.",2021-08-24,2021-08-24,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89080 - Class II - Biologics - South Texas Blood & Tissue Center,"Red Blood Cell product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2021-12-09,2021-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89526 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor who had recently traveled to a malarial endemic area, were distributed.",2022-02-10,2022-02-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89974 - Class II - Biologics - South Texas Blood & Tissue Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2022-04-19,2022-04-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90180 - Class II - Biologics - South Texas Blood & Tissue Center,"Leukoreduced Red Blood Cells, collected from a donor who had recently traveled to a malarial endemic area, were distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91212 - Class II - Biologics - South Texas Blood & Tissue Center,"Red Blood Cell product, lacking proper documentation of antigen phenotyping, was distributed.",2022-11-30,2022-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91213 - Class II - Biologics - South Texas Blood & Tissue Center,"Red Blood Cell products, lacking proper documentation of antigen phenotyping, were distributed.
",2022-11-30,2022-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91541 - Class III - Biologics - South Texas Blood & Tissue Center,"Red Blood Cell products, stored at an unacceptable temperature, were distributed.",2023-01-31,2023-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67020 - Class II - Biologics - Southern California Permanente Medical Group,"Blood product, which did not meet the acceptable product specifications, was distributed.",2013-12-27,2013-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67360 - Class II - Biologics - Southern California Permanente Medical Group,"Blood product, which did not meet the acceptable product specifications, was distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68450 - Class II - Biologics - Southern California Permanente Medical Group,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2014-07-16,2014-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69028 - Class II - Biologics - Southern California Permanente Medical Group,"Blood product, labeled 'leukoreduced', but which had not undergone leukoreduction, was distributed.",2014-09-10,2014-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69029 - Class II - Biologics - Southern California Permanente Medical Group,"Blood product, labeled ""leukoreduced"", but which had not undergone leukoreduction, was distributed.",2014-09-10,2014-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39191 - Class II - Biologics - Southern California Permanente Medical Group Blood Bank,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.
",2013-05-13,2013-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41094 - Class II - Biologics - Southern California Permanente Medical Group Blood Bank,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2013-05-13,2013-05-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46569 - Class II - Biologics - Southern California Permanente Medical Group Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.
",2013-05-13,2013-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39175 - Class III - Biologics - Southern California Permanente Medical Group Blood Donor Center,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-05-10,2013-05-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49317 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Center,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.
",2013-05-13,2013-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49812 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Center,"Blood product, which did not meet the acceptable product specifications for release, was distributed.
",2013-05-13,2013-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49622 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Center,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.
",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45172 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43282 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Center,"Blood products, which were collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2013-07-29,2013-07-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43747 - Class III - Biologics - Southern California Permanente Medical Group Blood Donor Center,"Blood product, collected from a donor who did not meet acceptance criteria, was distributed.",2013-07-29,2013-07-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63514 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Ctr,"Blood products, which were collected from a donor who lived in a malarial endemic area, were distributed.",2012-11-14,2012-11-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40132 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Ctr,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2013-05-10,2013-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66021 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Ctr,"Blood product, labeled as leukoreduced without the assurance that it met the criteria for a leukoreduced product, was distributed.",2013-09-10,2013-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66641 - Class II - Biologics - Southern California Permanente Medical Group Blood Donor Ctr,"Blood product, which did not meet the acceptable product specifications, was distributed.",2013-12-02,2013-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90953 - Class II - Drugs - Southwest Iowa Renewable Energy LLC,"CGMP Deviations and Superpotent Drug: Levels of acetal and acetaldehyde above allowable limits. Additionally, lot 001 was superpotent.",2023-01-19,2023-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85978 - Class I - Drugs - Spartan Chemical Co Inc,Microbial contamination of non-sterile products: positive microbial contamination in product.,2020-08-14,2020-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87633 - Class I - Drugs - Spartan Chemical Co Inc,"Microbial Contamination of Non-Sterile Products; lot tested positive for Bulkholderia multivorans, CGMP Deviations",2021-04-30,2021-04-30,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65953 - Class I - Drugs - Specialty Compounding, LLC","Non Sterility: Microbial contamination, Lack of Assurance of Sterility",2014-10-30,2014-10-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66566 - Class II - Drugs - Specialty Medicine Compounding Pharmacy,Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.,2014-01-10,2014-01-10,51,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67214 - Class I - Drugs - Specialty Medicine Compounding Pharmacy, P.C.","Non-Sterility: 50% dextrose is being recalled after particulate matter, later identified as mold, was found floating in the product.",2014-03-12,2014-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84509 - Class II - Drugs - Spectrum Laboratory Products,Subpotent Drug: Supplier indicated assay results did not meet specifications.,2019-12-23,2019-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84799 - Class II - Drugs - Spectrum Laboratory Products,CGMP Deviations: Presence of NDMA impurity detected in product.,2020-02-04,2020-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69808 - Class II - Drugs - Spectrum Laboratory Products,"CGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83796 - Class II - Drugs - Spectrum Laboratory Products,CGMP Deviations: Received notice from supplier that there is potential glass contamination.,2019-10-15,2019-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91381 - Class I - Drugs - Spectrum Laboratory Products, Inc.",Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product,2023-01-25,2023-01-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74888 - Class II - Drugs - Spectrum Laboratory Products, Inc.",Does not meet monograph: product exhibits lead levels in excess of the USP monograph limits.,2016-08-10,2016-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77398 - Class II - Drugs - Spectrum Laboratory Products, Inc.",CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.,2017-06-02,2017-06-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74878 - Class I - Drugs - Sperian Eye & Face Protection, Inc",Non Sterility; contaminated with Klebsiella pneumoniae,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79361 - Class II - Drugs - Spirit Pharmaceuticals,CGMP deviations: Ibuprofen is being recalled in response to previous recall,2018-03-09,2018-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88322 - Class II - Drugs - Spirit Pharmaceuticals,cGMP deviations: Discolored acetaminophen,2021-08-16,2021-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81218 - Class II - Drugs - Sprayology,CGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.,2018-10-30,2018-10-30,22,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66840 - Class I - Drugs - SS Wholesale Inc. dba Jobbers Wholesale,"Marketed Without An Approved NDA/ANDA: FDA analysis found Rhino 5 which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine.  Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug.  Dapoxetine is an active ingredient not approved by, Marketed Without An Approved NDA/ANDA: FDA analysis found MaXtremeZEN which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine.  Desmethyl carbondenafil is a phosphodiesterase (PDE)-5 inhibitors which is a class of drugs used to treat male erectile dysfunction, making this product an unapproved new drug.  Dapoxetine is an active ingredient not approved, Marketed Without An Approved NDA/ANDA: FDA analysis found eXtenZone which is marketed as a dietary supplement to contain undeclared desmethyl carbondenafil and dapoxetine.  Desmethyl carbondenafil ",2014-01-30,2014-01-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78678 - Class II - Drugs - SSM Health Care St. Louis DBA SSM St. Clare Health Center,"Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product
have been identified as actually containing microorganisms., Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.",2017-12-28,2017-12-28,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88758 - Class II - Drugs - SSM Health Care St. Louis DBA SSM St. Clare Health Center,Lack of Assurance of Sterility,2021-10-08,2021-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68891 - Class II - Drugs - SST Corporation,"CGMP Deviations; Stored/dispensed in a non-GMP compliant warehouse at S.I.M.S., Italy.",2014-08-06,2014-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63919 - Class III - Biologics - St Joseph'S Medical Ctr Blbank,"Blood product, which may have reached an unacceptable temperature during storage, was distributed.",2014-01-02,2014-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63860 - Class II - Biologics - St Mary's Hospital and Medical Center, Inc.","Blood product, with platelet yield that did not meet the specified minimum requirement, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66071 - Class II - Biologics - St Mary's Hospital and Medical Center, Inc.","Blood product, collected from a donor who received a body piercing within 12 months of donating, was distributed.",2013-09-13,2013-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66348 - Class III - Biologics - St Mary's Hospital and Medical Center, Inc.","Blood products, for which the expiration date was extended by one day, were distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66349 - Class III - Biologics - St Mary's Hospital and Medical Center, Inc.","Blood product, for which the expiration date was extended by one day, was distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69154 - Class III - Biologics - St Mary's Hospital and Medical Center, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2014-10-06,2014-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73521 - Class III - Biologics - St Mary's Hospital and Medical Center, Inc.",Apheresis products collected from a donor who should have been deferred for reactive syphilis test were distributed.,2016-03-22,2016-03-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80593 - Class III - Biologics - St Mary's Hospital and Medical Center, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2018-08-24,2018-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86621 - Class II - Biologics - St Mary's Hospital and Medical Center, Inc.","Blood product, collected from a donor whose donor eligibility was incomplete, was distributed.",2020-10-19,2020-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88416 - Class II - Biologics - St Mary's Hospital and Medical Center, Inc.","Blood product, component modification not prepared in accordance with specifications, was distributed.",2021-08-13,2021-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57800 - Class III - Biologics - St. Thomas More Hospital Blood Bank,"Blood products, collected from a donor with polycythemia, were distributed.",2013-06-06,2013-06-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77009 - Class I - Drugs - Standard Homeopathic Company,"Superpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels., Superpotent Drug: FDA analysis found inconsistent amounts of belladonna alkaloids that may differ from the calculated amount on the product labels.",2017-05-24,2017-05-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81989 - Class III - Biologics - Stanford Blood Center,"Plateletpheresis products, lacking assurance of proper storage and shipment temperatures, were distributed.",2019-01-30,2019-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81990 - Class III - Biologics - Stanford Blood Center,Plateletpheresis products were re-distributed without meeting product specification requirements.,2019-01-30,2019-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84094 - Class II - Biologics - Stanford Blood Center,"Apheresis Platelets, Leukoreduced and Irradiated, collected in a manner that compromises the sterility of the collection system, were distributed.",2019-11-19,2019-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84554 - Class III - Biologics - Stanford Blood Center,"Plateletpheresis product, identified as unsuitable due to a collection deviation, was distributed.

",2020-01-28,2020-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63236 - Class II - Biologics - Stanford Medical School Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65662 - Class II - Biologics - Stanford Medical School Blood Center,"Blood product, collected from a donor who visited a malarial endemic area, was distributed.",2013-08-22,2013-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73987 - Class III - Biologics - Stanford Medical School Blood Center,"Blood product, collected from an ineligible donor, was distributed.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75073 - Class III - Biologics - Stanford Medical School Blood Center,"Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2016-10-05,2016-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87255 - Class II - Drugs - Stanley Specialty Pharmacy Compounding and Wellness Center,Superpotent Drug. Lidocaine   higher concentration than listed,2021-02-10,2021-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89550 - Class I - Drugs - STAQ Pharma, Inc.",Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A,2022-02-25,2022-02-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75025 - Class III - Drugs - Stason Pharmaceuticals, Inc.","Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.",2016-09-02,2016-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62639 - Class III - Drugs - Stat Rx USA,"Labeling: Label Mix-Up; Some bottles of Tizanidine 4mg Tablets, had the incorrect manufacturer (Actavis) printed on the label.",2012-07-26,2012-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62940 - Class III - Drugs - Stat Rx USA,"Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as ""ointment"" instead of ""solution.""",2012-11-09,2012-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63659 - Class III - Drugs - Stat Rx USA,"Labeling: Label Mix-up: Product was incorrectly labeled,""Tabs"" instead of ""Capsules.""",2012-11-09,2012-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64223 - Class III - Drugs - Stat Rx USA,Labeling: Incorrect or missing lot and/or expiration date. The product was mistakenly labeled with an expiration date of 10/16 instead of 01/16.,2013-02-04,2013-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65663 - Class III - Drugs - Stayma Consulting Service, LLC.",Subpotent; Beta carotene (Vitamin A),2013-08-16,2013-08-16,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72479 - Class II - Drugs - Steris Corp,Labeling: Not Elsewhere Classified; Incorrect/Undeclared Excipients: Outdated previous version of label applied to products that incorrectly states one inactive ingredient.,2015-12-04,2015-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89059 - Class II - Drugs - SterRx, LLC",Lack of Assurance of Sterility,2021-12-29,2021-12-29,26,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90653 - Class II - Drugs - SterRx, LLC",Lack of Assurance of Sterility,2022-08-09,2022-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88436 - Class I - Drugs - SterRx, LLC","Non-Sterility: firm's third party lab confirmed microbial contamination., Lack of Assurance of Sterility",2021-08-25,2021-08-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82704 - Class I - Drugs - Stiff Boy LLC,Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis.,2019-06-05,2019-06-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78994 - Class II - Biologics - StimLabs,"Human tissue allograft, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2018-03-08,2018-03-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83781 - Class I - Biologics - Stratus BioSystems, LLC","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2019-09-23,2019-09-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74519 - Class III - Drugs - Stratus Pharmaceuticals Inc,Crystallization; Complaints that cream appears to have crystallized,2016-08-23,2016-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86283 - Class II - Drugs - Strides Inc.,Failed Dissolution Specifications,2020-10-01,2020-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77311 - Class III - Drugs - Strides Pharma INC,Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.,2017-05-23,2017-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90229 - Class II - Drugs - Strides Pharma Inc.,CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits,2022-05-28,2022-05-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90634 - Class II - Drugs - Strides Pharma Inc.,Presence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone Tablets,2022-08-09,2022-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87027 - Class III - Drugs - Strides Pharma Inc.,Failed Moisture Limits,2020-12-30,2020-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88759 - Class II - Drugs - Strides Pharma Inc.,Failed Dissolution Specifications,2021-10-08,2021-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84968 - Class III - Drugs - Strides Pharma Science Limited,Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.,2020-03-13,2020-03-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71168 - Class I - Drugs - Stroheckers Inc Pharmacy,Incorrect Product Formulation: Vials labeled as Testosterone Cypionate 200 mg/mL in Sesame Oil are being recalled because they contains Estradiol Valerate 20 mg/mL.,2015-05-28,2015-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68636 - Class II - Biologics - Stryker Medical Division of Stryker Corporation,"Blood/Fluid Warmer Cassettes, associated with complaints in regards to malformed threads on the female luer fitting of specific models, were distributed.",2014-07-31,2014-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85574 - Class I - Drugs - Summitt Labs,Chemical Contamination; product contains elevated levels of lead,2020-08-06,2020-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70339 - Class II - Drugs - Sun Pharma Global Fze,Failed Dissolution Specifications: 6 month time point.,2015-02-12,2015-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70382 - Class II - Drugs - Sun Pharma Global Fze,Presence of Particulate Matter: lot is not meeting the specification limit for number of particles present in the solution.,2015-02-20,2015-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71949 - Class III - Drugs - Sun Pharma Global Fze,"Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it was noticed that the drug release results at the 4 hour time point are not meeting specifications.",2015-08-14,2015-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73420 - Class II - Drugs - Sun Pharma Global Fze,Failed Impurities/Degradation Specifications: Observed levels of highest unknown impurity exceeding specification limit at the 3 month stability time point.,2016-03-03,2016-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69370 - Class II - Drugs - Sun Pharma Global Inc.,Failed Dissolution Specifications; 12 month stability time point,2014-11-04,2014-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85995 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Cross contamination with other products - OOS discovered during routine stability testing for highest unknown impurity later identified as clozapine,2020-07-30,2020-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87545 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Failed Impurities/Degradation Specifications,2021-04-02,2021-04-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87869 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Presence of foreign substance: identified as activated carbon.,2021-05-07,2021-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88376 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,"Presence of Forein Tablets/Capsules; Venlafaxine Tablets, USP 37.5 mg found in bottles labeled as Venlafaxine Tablets, USP, 50 mg
  
",2021-08-06,2021-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88806 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Failed Moisture Limits,2021-10-26,2021-10-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88927 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.,2022-01-06,2022-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89529 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup,2022-02-23,2022-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89917 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter.,2022-04-14,2022-04-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90088 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,"Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.",2022-05-10,2022-05-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90151 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Lack of assurance of sterility,2022-06-10,2022-06-10,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90361 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,CGMP Deviations: lots made with same active pharmaceutical ingredient (API) as lots that were rejected due to manufacturing issues that could cause the product to be out of specification for impurities.,2022-06-21,2022-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90340 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Failed Tablet/Capsule Specification; oversized tablet found in a bottle,2022-06-22,2022-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90391 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Lack of Assurance of Sterility: Manufacturing deviation which was reported due to a microbial excursion,2022-06-22,2022-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90412 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,CGMP Deviations: Manufacturing deviations were reported due to an abnormal appearance on parts of machinery.,2022-07-07,2022-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90451 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,cGMP - Water leakage,2022-07-11,2022-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90495 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.,2022-07-26,2022-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90891 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Superpotent Drug: Out of specification for assay at the 12-month timepoint.,2022-10-06,2022-10-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91033 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Presence of Foreign Substance,2022-10-31,2022-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91146 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Discoloration,2022-11-22,2022-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91311 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Presence of foreign substance,2022-12-19,2022-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91500 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory.,2023-02-02,2023-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86464 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,CGMP Deviations: Detection of N-nitrosodimethylamine (NDMA) impurity in finished drug product.,2020-10-01,2020-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87168 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Incorrect Labeling: Incorrect lot number on secondary packaging,2021-01-24,2021-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87260 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Failed Impurity/Degradation Specifications,2021-02-09,2021-02-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87349 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Subpotent,2021-02-26,2021-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87617 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Failed Moisture Limits: Out of specification for water content,2021-04-07,2021-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87650 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Microbial Contamination of Non-Sterile Product,2021-04-13,2021-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87922 - Class III - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Subpotent and Presence of Particulates .,2021-05-20,2021-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88873 - Class II - Drugs - SUN PHARMACEUTICAL INDUSTRIES INC,Incorrect Product Formulation: An incorrect grade of Crospovidone was used to manufacture the product.,2021-11-12,2021-11-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65501 - Class II - Drugs - Sun Pharmaceutical Industries Inc.,Crystallization; crystallized nimodipine,2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74696 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Dissolution Specifications,2016-07-20,2016-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74694 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Impurities/Degradation Specifications,2016-09-16,2016-09-16,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75206 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Dissolution Specifications,2016-10-06,2016-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75769 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Stability Specifications: Low Out of Specification results for alcohol content.,2016-11-22,2016-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76282 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Dissolution Specifications; 18 month stability time point,2017-01-25,2017-01-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76230 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Dissolution Specifications,2017-02-02,2017-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76543 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Presence of Foreign Substance: consumer complaint for foreign matter embedded in the tablet identified as a broken piece of wire rope from the manufacturing equipment.,2017-03-01,2017-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76742 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Presence of Particulate Matter,2017-03-23,2017-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76819 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Impurities/Degradation Specifications: out of specification results for the related substances test parameter (impurities).,2017-05-10,2017-05-10,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77103 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.,2017-05-23,2017-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78217 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Microbial Contamination of Non-Sterile Products,2017-12-13,2017-12-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78947 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Lack Of Assurance Of Sterility,2018-01-19,2018-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79145 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.","Sun Pharmaceutical is recalling Azelastine HCl Nasal Solution, 0.1% (30 mL Bottle) following a failure to meet the % RSD requirement in the test for Droplet Size during the 6 month long term stability test station",2018-02-13,2018-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79909 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.","Presence of Foreign Substance:Sun Pharma is recalling one (1) lot of Sulfamethoxazole and Trimethoprim Tablets USP, 800 mg/160 mg (500 ct.)  because a foreign matter identified as polyethylene was detected in two (2) tablets.",2018-05-11,2018-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79979 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Labeling: Not Elsewhere Classified: Sun Pharma has decided to initiate this recall in response to identified labeling discrepancies in the patient literature.,2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80440 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.","Presence of foreign substance: One lot fo Metformin Hydrochloride Extended Release Tablets, USP, 500 mg (500 Count) contains foreign matter identified as a piece of rubber glove detected in one tablet.",2018-07-13,2018-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80485 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Presence of Particulate Matter: organic and inorganic compounds detected in vials of product.,2018-07-24,2018-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81891 - Class I - Drugs - Sun Pharmaceutical Industries, Inc.",Presence of Particulate Matter:  Foreign matter identified as glass detected in Vecuronium Bromide for Injection.,2019-01-14,2019-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81893 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Labeling Not Elsewhere Classified:  The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets.,2019-01-23,2019-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81958 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.","Bromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.",2019-01-30,2019-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81765 - Class III - Drugs - Sun Pharmaceutical Industries, Inc.",Subpotent Drug: Isotretinoin content results were lower than the specification limit obtained during routing product monitoring.,2019-04-22,2019-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83025 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit,2019-06-14,2019-06-14,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84570 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.,2020-01-13,2020-01-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84672 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",cGMP Deviations; released lots were manufactured under similar manufacturing conditions to a previously rejected OOS Lot.,2020-01-16,2020-01-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85230 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.,2020-03-18,2020-03-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85184 - Class II - Drugs - Sun Pharmaceutical Industries, Inc.",Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.,2020-03-19,2020-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63628 - Class II - Drugs - Sun Pharmaceutical Industries, LTD.","Adulterated Presence of Foreign Tablets: A customer complaint was received that a bottle of Tramadol HCl Tablets USP 50 mg contained some tablets of Metoprolol Tartrate Tablets USP, 50 mg.",2012-12-06,2012-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67433 - Class II - Drugs - Sun Pharmaceutical Industries, LTD.",Presence of Foreign Tablet; customer complaint of some tablets of Gabapentin found in a bottle of Metformin HCl ER,2014-02-26,2014-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67784 - Class II - Drugs - Sun Pharmaceutical Industries, LTD.",Failed Dissolution Specifications: Stability results found the product did not meet the drug release dissolution specifications.,2014-04-29,2014-04-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67971 - Class III - Drugs - Sun Pharmaceutical Industries, LTD.",Failed Impurities/Degradation Specifications: out of specification results for impurities/degradation testing for N-Oxide,2014-05-01,2014-05-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68209 - Class II - Drugs - Sun Pharmaceutical Industries, LTD.",Lack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.,2014-06-20,2014-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68637 - Class II - Drugs - Sun Pharmaceutical Industries, LTD.",Failed Dissolution Specifications: Stability results found the product did not meet the drug dissolution specifications.,2014-07-02,2014-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68786 - Class II - Drugs - Sun Pharmaceutical Industries, LTD.",CGMP Deviations: These products are being recalled because they were manufactured with active pharmaceutical ingredients (APIs) that were not manufactured with good manufacturing practices.,2014-08-01,2014-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62600 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, collected from a donor who lived with a hepatitis B positive individual, were distributed.",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62722 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-09-13,2012-09-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62878 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, which did not meet acceptable product specifications, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63021 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood product, which was labeled as leukoreduced, but exceeded the acceptable White Blood Cell ( WBC) count, was distributed.",2012-09-19,2012-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63131 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-10-10,2012-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63687 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63755 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63923 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #41096 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-02-13,2013-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49757 - Class III - Biologics - Suncoast Communities Blood Bank, Inc.","Blood product, collected from a donor with no documentation of an arm inspection, was distributed.",2013-03-04,2013-03-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49299 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-04-15,2013-04-15,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69696 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Platelet product that did not meet specifications, was distributed.",2014-11-20,2014-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70779 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, with a platelet yield that exceeded the maximum specification, were distributed.",2015-03-23,2015-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70517 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2015-03-24,2015-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70650 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, for which the donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2015-04-16,2015-04-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74698 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood product, collected from a donor who gave history which warranted deferral and was not deferred, was distributed.",2016-08-10,2016-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77234 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, for which the donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2017-05-25,2017-05-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82816 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84256 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2019-11-26,2019-11-26,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84567 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Leukoreduced Red Blood Cells, collected from a donor who emigrated from a malarial endemic area, were distributed.",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87404 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Misbranded plateletpheresis products were distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89233 - Class III - Biologics - Suncoast Communities Blood Bank, Inc.","Blood product, mislabeled with the incorrect product code, was distributed",2021-12-23,2021-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89417 - Class II - Biologics - Suncoast Communities Blood Bank, Inc.","Leukoreduced Red Blood Cells, collected from a donor who recently traveled to a malarial endemic area, were distributed.",2022-01-31,2022-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91398 - Class III - Biologics - Suncoast Communities Blood Bank, Inc.","Leukoreduced Red Blood Cells, Irradiated, with an incorrect expiration date on the label, were distributed.",2022-12-30,2022-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68122 - Class I - Drugs - Sung Soo Kim,"Marketed Without an Approved NDA/ANDA; Product contains undeclared indomethacin, diclofenac, and chlorzoxazone.",2014-08-08,2014-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62501 - Class III - Biologics - Sunquest Information Systems, Inc.","Software, with a glitch or defect, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62752 - Class II - Biologics - Sunquest Information Systems, Inc.","Software, with a defect or glitch, was distributed.",2012-09-13,2012-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86656 - Class I - Drugs - Sunstar Americas, Inc.",Microbial Contamination of Non-sterile Products: contamination with Burkholderia lata.,2020-11-23,2020-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87052 - Class II - Drugs - Sunstar Americas, Inc.","cGMP Deviations; FDA inspection of manufacturing facility observed potential Burkholderia cepacia complex (BCC) contamination, inadequate cleaning, inadequate microbiological testing, and insanitary conditions",2021-01-11,2021-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85127 - Class II - Drugs - Sunstar Guangzhou Ltd.,cGMP Deviation,2020-03-09,2020-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73361 - Class I - Drugs - Super Herbs,"Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90827 - Class II - Drugs - SUPERIOR GLOVE WORKS, LTD.","CGMP Deviations: FDA analysis found product to contain acetaldehyde impurity and the Sum of All Impurities, above specification limits.",2022-09-15,2022-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74988 - Class II - Drugs - Supernus Pharmaceuticals, Inc.",Superpotent Drug: Failure of assay specifications in the capsule.,2016-10-20,2016-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84401 - Class II - Drugs - Surgery Pharmacy Services Inc,Lack of sterility assurance.,2019-12-09,2019-12-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63348 - Class II - Biologics - Surgical Biologics LLC,"Amniotic membrane allografts, recovered from a donor whose preprocessing tissue culture indicated growth of Group D Enterococcus, were distributed.",2012-10-25,2012-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #60076 - Class II - Biologics - Surgical Tissue Network, Inc. dba TissueNet","Human allografts, recovered from donors whose donor eligibility may have been determined with inaccurate and/or incomplete donor records, were distributed.",2012-07-03,2012-07-03,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76472 - Class II - Drugs - Synergy Rx,Lack of Assurance of Sterility: There are also CGMP Deviations.,2017-03-15,2017-03-15,81,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81128 - Class II - Drugs - Syntec Pharma Corp,CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.,2018-10-11,2018-10-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82969 - Class II - Drugs - Synthetopes Inc,Lack of Processing Controls.,2019-06-20,2019-06-20,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81867 - Class II - Drugs - Syntho Pharmaceuticals, Inc.",CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.,2019-01-16,2019-01-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50613 - Class II - Biologics - Tacoma-Pierce County Blood Bank,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70886 - Class II - Biologics - Tacoma-Pierce County Blood Bank,"Blood products, in which Donor Screening/Deferral screening was not done or incorrectly performed, including incorrect ID used during search,prior deferral due to history, were distributed.",2015-04-24,2015-04-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72369 - Class II - Biologics - Tacoma-Pierce County Blood Bank,"Blood product, possibly contaminated with air, was distributed.",2015-11-19,2015-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78292 - Class III - Biologics - Tacoma-Pierce County Blood Bank,"Blood product, in which donor gave history which warranted deferral or follow up questions was not asked, was distributed.",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79865 - Class II - Biologics - Tacoma-Pierce County Blood Bank,"Blood product, for which a labeling error occurred and was not quarantined, was distributed.",2018-05-16,2018-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80015 - Class II - Biologics - Tacoma-Pierce County Blood Bank,"Blood product, collected from a donor who did not answer the question regarding receiving a tattoo, was distributed.",2018-05-17,2018-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84763 - Class II - Biologics - Tacoma-Pierce County Blood Bank,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2020-02-28,2020-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88283 - Class III - Biologics - Tacoma-Pierce County Blood Bank,"Plateletpheresis products, which were exposed to unacceptable storage conditions, were distributed.
",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50416 - Class III - Biologics - Tacoma Pierce County Blood Bank,"Blood products, collected using a copper sulfate solution which had unacceptable specific gravity QC results, were distributed.",2013-03-22,2013-03-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65169 - Class II - Biologics - Tacoma Pierce County Blood Bank,"Blood product, which was  irradiated but labeled with incorrect irradiation status and expiration date, was distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66179 - Class III - Biologics - Tacoma Pierce County Blood Bank,"Blood products, collected using equipment for which quality control was not performed, were distributed.",2013-10-18,2013-10-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81337 - Class II - Drugs - Tailor Made Compounding LLC,Labeling: Incorrect or Missing Lot and/or Expiration Date; vial indicates a 1 year expiration date instead of a 6 month expiration date,2018-11-07,2018-11-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80964 - Class II - Drugs - Takeda Development Center Americas, Inc.","Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.",2018-10-15,2018-10-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81518 - Class III - Drugs - Takeda Development Center Americas, Inc.",Failed Impurities/Degradation Specifications:Elevated levels of a known impurity in the 20-month stability sample testing.,2018-11-28,2018-11-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71516 - Class II - Drugs - Takeda Pharmaceuticals North America, Inc.",Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.,2015-07-02,2015-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62661 - Class II - Biologics - Talecris Plasma Resources,"Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-08-08,2012-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63526 - Class II - Biologics - Talecris Plasma Resources,"Blood products, collected from a donor, whose suitability to donate was not adequately determined, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60159 - Class II - Biologics - Talecris Plasma Resources,"Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65694 - Class III - Biologics - Talecris Plasma Resources,"Blood products, collected from donors whose donor suitability was not adequately determined, were distributed.",2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66731 - Class II - Biologics - Talecris Plasma Resources,"Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73797 - Class III - Biologics - Talecris Plasma Resources,"Blood products, collected from an ineligible donor, were distributed.",2016-05-17,2016-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73931 - Class II - Biologics - Talecris Plasma Resources,"Blood products, collected from an ineligible donor, were distributed.",2016-05-17,2016-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82770 - Class II - Biologics - Talecris Plasma Resources,"Source Plasma, identified as unsuitable due to a collection deviation or unexpected event, was distributed.",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #54058 - Class III - Biologics - Talecris Plasma Resources Inc,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64060 - Class II - Biologics - Talecris Plasma Resources Inc,"Blood products, which were not tested for viral markers, were distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64613 - Class III - Biologics - Talecris Plasma Resources Inc,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65038 - Class III - Biologics - Talecris Plasma Resources Inc,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65103 - Class III - Biologics - Talecris Plasma Resources Inc,"Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #55398 - Class II - Biologics - Talecris Plasma Resources Inc,"Blood products, collected from donors who did not have a complete physical examination, were distributed.",2013-08-12,2013-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66282 - Class II - Biologics - Talecris Plasma Resources Inc,"Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66308 - Class II - Biologics - Talecris Plasma Resources Inc,"Blood product, collected from a donor who received a tattoo within one year of donation, was distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79346 - Class II - Biologics - Talecris Plasma Resources Inc,"Source Plasma, with a failure to meet product specifications, was distributed.",2018-03-22,2018-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48297 - Class III - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48872 - Class III - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Source Plasma, which reached unacceptable temperatures during storage and was not relabeled as Source Plasma, Salvaged, was distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39189 - Class II - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Blood products, collected from a donor whose annual physical exam was not performed, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45177 - Class II - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48296 - Class III - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Blood product, collected from a donor whose arm inspection was not documented, was distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48873 - Class III - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Blood product, collected from a donor whose arm inspection was not documented, was distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #52248 - Class III - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Blood products, collected from a donor who was deferred for a history of Hepatitis A, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45176 - Class III - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Blood product, collected from a donor whose arm inspection was not documented, was distributed.",2013-05-24,2013-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67189 - Class II - Biologics - Talecris Plasma Resources Inc Dba International Bioresources,"Blood product, collected from a donor who was incarcerated for more than 72 hours within 12 months of donating, was distributed.",2014-02-05,2014-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56178 - Class III - Biologics - Talecris Plasma Resources, Inc","Blood products, exposed to multiple storage temperature excursions and not re-labeled as Source Plasma Salvaged, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #58363 - Class II - Biologics - Talecris Plasma Resources, Inc","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67585 - Class III - Biologics - Talecris Plasma Resources, Inc","Blood products, collected from a donor who was previously deferred, were distributed.",2014-03-05,2014-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71773 - Class II - Biologics - Talecris Plasma Resources, Inc","Blood product, collected from a donor who had been incarcerated, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #55441 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose routine physical examination was inadequately performed, were distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62356 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49766 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2012-07-20,2012-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56478 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-07-23,2012-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56477 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62725 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who had previously been deferred, were distributed.",2012-09-07,2012-09-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50573 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood product, collected from a donor who did not have a complete physical examination, was distributed.",2012-09-13,2012-09-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50428 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2012-09-14,2012-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63088 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50658 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50667 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who may have received a tattoo within one year of donation, were distributed.",2012-10-26,2012-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50662 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50954 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #51460 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52276 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56479 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52279 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors who did not have a complete physical examination, were distributed.",2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50609 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood product, which exceeded time allowed for storage and shipping temperatures, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #51468 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who may have received a body piercing within 12 months of donating, were distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52271 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood product, collected from a donor whose donor suitability was not adequately determined, was distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #58946 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50608 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, which may have been exposed to unacceptable temperatures during storage, were distributed.",2013-01-23,2013-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #57154 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors, whose suitability to donate was not adequately determined, were distributed.",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #57787 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from  a donor, whose suitability to donate was not adequately determined, were distributed.",2013-01-28,2013-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52269 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, which were collected from a donor with a history of high risk behaviors, were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53201 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors who did not have a complete physical examination, were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56583 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors who did not have a complete physical exam, were distributed.",2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #51354 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products collected from a donor whose scheduled physical exam had not been performed, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #51461 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products collected from a donor who was previously deferred for unsuitable lab test results, were distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50957 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2013-02-13,2013-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54065 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54938 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-02-14,2013-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #58427 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products,  collected from a donor, whose suitability to donate were not adequately determined, were distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64096 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50638 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2013-02-26,2013-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #38821 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-02-28,2013-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50639 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2013-02-28,2013-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54067 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2013-02-28,2013-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50354 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor with a history of intravenous drug use, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50644 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who received a body piercing  within 12 months of donation, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50735 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor with a history of intravenous drug use, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50955 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor with a history of hepatitis, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50959 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who may have received a piercing within 12 months of donation, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52877 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who failed arm inspection and/or general appearance, were distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50659 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49628 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, which were not tested for viral markers, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50640 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor with a history of incarceration, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50956 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was not asked follow-up questions regarding increased risk for vCJD, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50960 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50961 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor with a history of high-risk behavior, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #53628 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose donor suitability was not adequately determined, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59790 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose physical exam was incomplete, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49741 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, which reached unacceptable temperatures during storage, were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52257 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50962 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was deferred due to risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2013-04-15,2013-04-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52268 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors whose donor suitability was not adequately determined, were distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #55443 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors whose  physical examinations were incomplete, were distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52243 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50656 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor with a history of incarceration, were distributed.",2013-05-03,2013-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #57153 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-05-13,2013-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59414 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors whose suitability to donate were not adequately determined, were distributed.",2013-06-04,2013-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50729 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-06-12,2013-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50668 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who was previously deferred, were distributed.",2013-10-31,2013-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #38820 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-11-14,2013-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66732 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood product, collected from a donor who did not appropriately answer questions regarding risk factors for CJD, was distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67382 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donating, were distributed.",2014-03-07,2014-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52876 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, for which the sample tubes for NAT testing may have been stored at an unacceptable temperature, were distributed.",2014-05-20,2014-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56288 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #55401 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2014-06-02,2014-06-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68920 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood product, for which donor eligibility was not complete, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68918 - Class II - Biologics - Talecris Plasma Resources, Inc.","Source Plasma, collected from an ineligible donor, was distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68924 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68925 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood product, collected from a donor who did not have a complete physical examination, was distributed.",2014-09-09,2014-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68999 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, in which donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2014-09-10,2014-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54213 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2014-10-22,2014-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #55917 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2014-10-22,2014-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52879 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from donors who did not receive a complete physical examination, were distributed.",2015-03-23,2015-03-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70875 - Class II - Biologics - Talecris Plasma Resources, Inc.","Blood products, collected from a donor who received a tattoo within 12 months of donation, were distributed.",2015-05-06,2015-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73930 - Class III - Biologics - Talecris Plasma Resources, Inc.","Blood products, in which donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, were distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #56177 - Class III - Biologics - Talercris Plasma Resources, Inc.","Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-09-18,2013-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #54211 - Class III - Biologics - Talercris Plasma Resources, Inc.","Blood products, collected from donors whose suitability was not adequately determined, were distributed.",2013-10-25,2013-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74745 - Class II - Drugs - Talon Compounding Pharmacy,Lack of Assurance of Sterility,2016-08-22,2016-08-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70577 - Class II - Drugs - Tarmac Products, Inc.",Microbial Contamination of Non-Sterile Products: Lots failed microbiological testing at the 12-month time point.,2015-03-18,2015-03-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71031 - Class II - Drugs - Tarmac Products, Inc.","Products failed the Antimicrobial Effectiveness Test, Products failed the Antimicrobial Effectiveness Test.",2015-04-22,2015-04-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64963 - Class II - Drugs - Tarmac Products, Inc. d.b.a. Axara Pharmaceuticals",Microbial Contamination of Non-Sterile Products: Lot in question had an elevated microbial count outside of specifications and E. Coli contamination.,2013-05-02,2013-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83887 - Class II - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Presence of Foreign Substance: Ibuprofen Oral Suspension USP may have small particles of an inert plastic material introduced during manufacturing.,2019-11-05,2019-11-05,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84645 - Class I - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.,2020-02-07,2020-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84916 - Class I - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Resuspension Problems: Two lots of Phenytoin Oral Suspension USP 125mg/5mL may coagulate and may not resuspend as per the label copy instructions.,2020-03-02,2020-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86101 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.,2020-08-12,2020-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86833 - Class II - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.,2020-12-16,2020-12-16,10,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87152 - Class II - Drugs - Taro Pharmaceuticals U.S.A., Inc.",CGMP deviations.,2021-02-01,2021-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89241 - Class I - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria,2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89678 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Failed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropionate assay of a stability sample,2022-03-29,2022-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63685 - Class II - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.,2012-12-04,2012-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66519 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Subpotent. drug,2013-12-12,2013-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69075 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Failed Content Uniformity Specifications.,2014-09-12,2014-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69413 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Marketed without an Approved NDA/ANDA: One lot was on hold-pending release status when it was erroneously made available for sale in the inventory control system.  An alternate manufacturing site for the Carbamazepine API final intermediate was pending approval.,2014-10-27,2014-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70183 - Class II - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Presence of Foreign Substance: Presence of blue plastic floating in loratadine syrup.,2015-02-05,2015-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73829 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Subpotent Drug,2016-05-31,2016-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74730 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.","Subpotent Drug: Out of Specification assay values on stability for the active ingredient, zinc pyrithione.",2016-11-10,2016-11-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76954 - Class II - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability,2017-04-20,2017-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76837 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.,2017-05-18,2017-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78157 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Cross contamination with other products: traces of Dapsone were found in the finished product.,2017-12-29,2017-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79029 - Class III - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Failed Content Uniformity Specifications,2018-02-01,2018-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81483 - Class II - Drugs - Taro Pharmaceuticals U.S.A., Inc.",Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.,2018-11-20,2018-11-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71845 - Class III - Drugs - Taro Pharmaceuticals, Inc.",Failed Impurities/Degradation Specifications: Out of specification results for impurities testing was obtained at the 6 and 9 month time points.,2015-08-25,2015-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75349 - Class II - Drugs - Taro Pharmaceuticals, Inc.",Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).,2016-11-01,2016-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69682 - Class II - Biologics - TBI dba New England Eye & Tissue Transplant Bank,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-11-06,2014-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82983 - Class III - Drugs - Teligent Pharma, Inc.",Failed Impurities/Degradation Specifications,2019-06-14,2019-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86705 - Class III - Drugs - Teligent Pharma, Inc.","Subpotent Drug: One lot of Triamcinolone Acetonide Lotion, 0.025% 60 mL.does not meet assay results.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86714 - Class III - Drugs - Teligent Pharma, Inc.",Superpotent and Subpotent; low and high assay results,2020-12-08,2020-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87631 - Class III - Drugs - Teligent Pharma, Inc.",Failed Stability Specifications: product did not meet viscosity results.,2021-04-12,2021-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87266 - Class III - Drugs - Teligent Pharma, Inc.",Failed Impurities/ Degradation Specifications -  OOS for know impurity Betamethasone 17- propionate.,2021-04-23,2021-04-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87694 - Class II - Drugs - Teligent Pharma, Inc.",Failed Impurities/Degradation Specifications:,2021-04-28,2021-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88145 - Class III - Drugs - Teligent Pharma, Inc.",Failed Impurities/Degradation Specifications,2021-07-19,2021-07-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88293 - Class II - Drugs - Teligent Pharma, Inc.",Correct Labeled Product Mispack,2021-08-18,2021-08-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88377 - Class II - Drugs - Teligent Pharma, Inc.",Defective container: possibility for lack of seal integrity.,2021-08-25,2021-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88382 - Class III - Drugs - Teligent Pharma, Inc.","Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.",2021-08-31,2021-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88454 - Class I - Drugs - Teligent Pharma, Inc.",Superpotent Drug,2021-09-15,2021-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88884 - Class II - Drugs - Teligent Pharma, Inc.",Defective Container,2021-11-23,2021-11-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88850 - Class I - Drugs - Teligent Pharma, Inc.","Superpotent Drug, CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent., CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.
",2021-12-13,2021-12-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88550 - Class II - Drugs - Teligent Pharma, Inc.","Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing",2021-12-28,2021-12-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89135 - Class I - Drugs - Teligent Pharma, Inc.","Superpotent Drug, Superpotent Drug: Minimally superpotent",2021-12-28,2021-12-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89798 - Class II - Drugs - Teligent Pharma, Inc.",cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.,2022-03-21,2022-03-21,37,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89560 - Class II - Drugs - Teligent Pharma, Inc.",Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.,2022-03-24,2022-03-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86508 - Class III - Drugs - Teligent Pharma, Inc.",Failed Impurities/Degradation - Out-of-specification results for Fluocinolone Acetonide impurity.,2020-11-05,2020-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87950 - Class II - Drugs - Teligent Pharma, Inc.",Presence of Foreign Substance: Foreign particles observed during routine stability testing.,2021-06-23,2021-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77061 - Class III - Drugs - Teligent, Inc.",Superpotent Drug,2017-05-18,2017-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73506 - Class III - Biologics - Temptime Corporation,Updated Instructions for Use with revised storage instructions for some lots of Safe-T-Vue 6 and Safe-TuVue 10 was distributed.,2016-03-25,2016-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66897 - Class I - Drugs - Tendex,"Marketed Without an Approved NDA/ANDA: FDA analysis found the product to contain undeclared active ingredient, tadalafil, thus making these products unapproved drugs.",2014-05-21,2014-05-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89705 - Class I - Drugs - Tennessee Technical Coatings, Corp.","Chemical Contamination: FDA analysis found 1 lot of 
HAND SANITIZER Isopropyl Alcohol Antiseptic 75%, to contain methanol., CGMP Deviations: lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.


",2022-04-04,2022-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67723 - Class II - Drugs - Terra-Medica Inc.,"Penicillin Cross Contamination, Penicillin Cross Contamination.",2014-04-07,2014-04-07,22,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62932 - Class II - Biologics - Terrebonne General Medical Center Blood Bank,"Blood product, which tested positive for the HCV screen, Multiplex and NAT tests was distributed.",2012-10-05,2012-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64890 - Class II - Biologics - Terumo BCT, Inc.","Terumo BCT's Trima Accel systems, with a  potential risk for an air embolism should a donor be prematurely connected to the Trima Accel system, were distributed.",2013-05-01,2013-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68784 - Class III - Biologics - Terumo BCT, Inc.","Spectra Optia Apheresis Systems Return Line Air Detector (RLAD) Sensors, associated with component failure which may disrupt or end an ongoing apheresis procedure, were distributed.",2014-09-22,2014-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69012 - Class III - Biologics - Terumo BCT, Inc.","Spectra Optia Apheresis Systems with version 11 software, associated with unexpected behavior regarding rinseback,  were distributed.",2014-09-22,2014-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76829 - Class III - Biologics - Terumo BCT, Inc.","Spectra Optia and Trima Accel Automated Blood Collection System devices with a potential for a non-recoverable power failure, were distributed.",2017-05-15,2017-05-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78654 - Class III - Biologics - Terumo BCT, Inc.","Terumo BCT's Vista Information System (version 4) with a defect or glitch on the Trima Accel Automated Blood Collection  System, was distributed.",2017-12-07,2017-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79757 - Class II - Biologics - Terumo BCT, Inc.","Spectra Optia Apheresis Systems, containing a software defect or glitch that is associated with a potential safety risk, were distributed.",2018-05-31,2018-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83014 - Class III - Biologics - Terumo BCT, Inc.","TerumoBCT's Spectra Optia Apheresis System, with the potential for electronic connection intermittency, were distributed.",2019-09-17,2019-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86644 - Class III - Biologics - Terumo BCT, Inc.","Terumo Blood and Cell Technologies' Spectra Optia Aheresis System with mislabeled disposable tubing sets, were distributed.",2020-11-17,2020-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87886 - Class III - Biologics - Terumo BCT, Inc.","Terumo APC 30 Kits, manufactured with 60mL Process Disposable but labeled as a 30mL Process Disposable, were distributed.",2021-05-21,2021-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73513 - Class I - Biologics - Test Valley LLC. dba. Amniotic Therapies LLC.,"Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2016-04-29,2016-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73778 - Class III - Drugs - Teva API, Inc.",Failed Impurities/Degradation Specifications: Firm voluntarily recalled products due to out-of-specification results for an unknown impurity at or near the expiration (24-month).,2016-06-30,2016-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72912 - Class II - Drugs - Teva Branded Pharmaceutical Products R&D,Failed Dissolution Specifications: low test results at the 18 month time-point,2016-03-01,2016-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74180 - Class II - Drugs - Teva Branded Pharmaceutical Products R&D,Lack of Assurance of Sterility:  Due to potential for leaking bags.,2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74509 - Class III - Drugs - Teva Branded Pharmaceutical Products R&D,Failed Tablet/Capsule Specifications,2016-07-27,2016-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74514 - Class III - Drugs - Teva Branded Pharmaceutical Products R&D,Failed Impurities/Degradation Specifications: High out of specification results for Impurity D.,2016-07-28,2016-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74700 - Class III - Drugs - Teva Branded Pharmaceutical Products R&D,Failed Content Uniformity Specifications: out of specification test result for spray content uniformity.,2016-08-02,2016-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74502 - Class II - Drugs - Teva Branded Pharmaceutical Products R&D,Presence of Foreign Substance; presence of black particles describes generically as cellulose-based bundles of brown fibrous material.,2016-08-09,2016-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74540 - Class II - Drugs - Teva Branded Pharmaceutical Products R&D,Superpotent drug: Out of specification test result for assay during stability testing.,2016-08-24,2016-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74497 - Class II - Drugs - Teva Branded Pharmaceutical Products R&D,CGMP Deviations,2016-09-07,2016-09-07,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74842 - Class III - Drugs - Teva Branded Pharmaceutical Products R&D,Failed Impurities/Degradation Specifications.,2016-10-05,2016-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72607 - Class III - Drugs - Teva Pharmaceutical Industries,Labeling: Incorrect or Missing Lot AND/OR Exp Date.,2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77393 - Class I - Drugs - Teva Pharmaceuticals,"Failed Dissolution Specifications: Drug release test result, obtained during routine 9-month stability testing, which was below specification for one tablet. Teva cannot at this time exclude the potential for additional tablets to be below specification.",2017-07-11,2017-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88938 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications,2021-11-16,2021-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80538 - Class II - Drugs - Teva Pharmaceuticals USA,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-07-24,2018-07-24,9,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81646 - Class II - Drugs - Teva Pharmaceuticals USA,"CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine (NDEA) in product.",2018-12-14,2018-12-14,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83050 - Class II - Drugs - Teva Pharmaceuticals USA,CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.,2019-07-09,2019-07-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85306 - Class II - Drugs - Teva Pharmaceuticals USA,CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.,2020-04-07,2020-04-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85797 - Class II - Drugs - Teva Pharmaceuticals USA,CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level,2020-06-19,2020-06-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87298 - Class II - Drugs - Teva Pharmaceuticals USA,Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.,2021-02-21,2021-02-21,15,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87875 - Class II - Drugs - Teva Pharmaceuticals USA,Lack of Assurance of Sterility,2021-05-14,2021-05-14,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88442 - Class II - Drugs - Teva Pharmaceuticals USA,Lack of Assurance of Sterility,2021-08-16,2021-08-16,19,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89326 - Class II - Drugs - Teva Pharmaceuticals USA,"
Lack of Assurance of Sterility",2022-01-13,2022-01-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89192 - Class II - Drugs - Teva Pharmaceuticals USA,Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.,2022-01-14,2022-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89368 - Class III - Drugs - Teva Pharmaceuticals USA,Mislabeling,2022-02-02,2022-02-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66672 - Class II - Drugs - Teva Pharmaceuticals USA,Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.,2013-11-20,2013-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67010 - Class III - Drugs - Teva Pharmaceuticals USA,Defective Delivery System: There is a potential for some units in certain lots of Qnasl Nasal Aerosol 80 mcg metered spray to have clogged stem valves.,2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66594 - Class II - Drugs - Teva Pharmaceuticals USA,Presence of Precipitate; precipitation of drug product,2013-12-30,2013-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66955 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Tablet/Capsule Specifications: There is a potential for broken tablets.,2014-01-02,2014-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67141 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications:There is a potential for the tablets to be out of specification for impurities throughout shelf life.,2014-02-04,2014-02-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67412 - Class II - Drugs - Teva Pharmaceuticals USA,"CGMP Deviations: Ethambutol Hydrochloride Tablets, USP, 400 mg were manufactured using unapproved material: the incorrect gelatin excipient than specified in the product formulation., CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing., CGMP Deviations: Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, CII, 10 mg were manufactured using unapproved material: the finished product was not properly quarantined as rejected due to inadequate cleaning of equipment., CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.",2014-02-28,2014-02-28,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67664 - Class II - Drugs - Teva Pharmaceuticals USA,"Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.",2014-04-01,2014-04-01,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67564 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurity/Degradation Specification; for 17-BMP at the 9 and 18 month stability time point,2014-04-03,2014-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67563 - Class II - Drugs - Teva Pharmaceuticals USA,Chemical Contamination: Recall due to a customer complaint trend regarding capsule odor.,2014-04-28,2014-04-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67811 - Class II - Drugs - Teva Pharmaceuticals USA,"CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements, CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements.",2014-05-12,2014-05-12,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68069 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: High out of specification impurity test results were obtained during stability testing.,2014-05-16,2014-05-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68121 - Class II - Drugs - Teva Pharmaceuticals USA,Defective Delivery System; defective valve,2014-05-20,2014-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67809 - Class II - Drugs - Teva Pharmaceuticals USA,Non-sterility: due to a failed sterility test,2014-05-28,2014-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68225 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.,2014-06-23,2014-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68441 - Class II - Drugs - Teva Pharmaceuticals USA,"Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint trend regarding capsule breakage.",2014-07-10,2014-07-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68610 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: out of specification impurity test results.,2014-07-17,2014-07-17,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67882 - Class II - Drugs - Teva Pharmaceuticals USA,"Failed Impurities/Degradation Specifications: This recall is due to out of specification for impurities test results obtained during stability testing for Lansoprazole.

  
",2014-07-31,2014-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68522 - Class II - Drugs - Teva Pharmaceuticals USA,"Failed Tablet/Capsule Specifications: Teva is recalling one lot of Carbidopa and Levodopa Tablets USP, 25mg/100mg due to the potential for superpotent tablets.",2014-08-13,2014-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69483 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: Out of specification for unknown impurities.,2014-10-27,2014-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70976 - Class II - Drugs - Teva Pharmaceuticals USA,Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.,2015-04-27,2015-04-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71140 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: out of specification test results for an impurity during stability testing.,2015-05-28,2015-05-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71316 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Dissolution Specifications: OOS result during stability testing,2015-06-01,2015-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71128 - Class I - Drugs - Teva Pharmaceuticals USA,Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.,2015-07-07,2015-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71594 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: out of specification for unknown impurity,2015-08-03,2015-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71799 - Class I - Drugs - Teva Pharmaceuticals USA,Presence of Particulate Matter: silcone rubber and fluorouracil crystals found floating in solution,2015-08-24,2015-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72988 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.,2016-01-11,2016-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72999 - Class III - Drugs - Teva Pharmaceuticals USA,Labeling: Not Elsewhere Classified: Lack of leaflets and approved labels on bottles.,2016-03-11,2016-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73346 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: Out of specification test results for impurities during stability testing.,2016-03-11,2016-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73455 - Class I - Drugs - Teva Pharmaceuticals USA,Presence of Particulate Matter:  particulate matter identified as glass in one vial.,2016-05-23,2016-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74816 - Class II - Drugs - Teva Pharmaceuticals USA,CGMP Deviations,2016-10-12,2016-10-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75236 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: potential failure to meet the specification for Impurity D throughout shelf-life.,2016-10-12,2016-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75300 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.,2016-10-19,2016-10-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75565 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.,2016-12-08,2016-12-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75872 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Dissolution Specifications,2017-01-13,2017-01-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76038 - Class II - Drugs - Teva Pharmaceuticals USA,"Subpotency: due to a low, out of specification test result for assay during stability testing.",2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76383 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: out of  specification test results for the norethindrone impurity.,2017-02-16,2017-02-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76513 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Dissolution Specifications: low out of specification dissolution results found during stability testing.,2017-03-03,2017-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76432 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications,2017-03-10,2017-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76871 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Stability Specifications,2017-05-11,2017-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77109 - Class II - Drugs - Teva Pharmaceuticals USA,Microbial Contamination of Non-Sterile Products,2017-05-11,2017-05-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77725 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications:  out of specification test results for related compounds largest unknown impurity.,2017-07-14,2017-07-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77832 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: high out of specification results for related compound D.,2017-07-31,2017-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77835 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Tablet/Capsule Specification; out of specification for tablet weight,2017-08-03,2017-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77881 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Moisture Limits: out of specification test results for water content obtained during stability testing.,2017-08-08,2017-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78060 - Class II - Drugs - Teva Pharmaceuticals USA,Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.,2017-09-28,2017-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78308 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Dissolution Specifications: Low out of specification results for dissolution.,2017-10-26,2017-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78364 - Class II - Drugs - Teva Pharmaceuticals USA,Failed dissolution specifications; all lots within expiry are being recalled due to out of specification dissolution results.,2017-11-02,2017-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78552 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Tablet/Capsule Specifications; potential presence of broken tablets.,2017-11-27,2017-11-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78641 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.,2017-12-13,2017-12-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78590 - Class II - Drugs - Teva Pharmaceuticals USA,"Labeling: Incorrect Instructions. ""TABLETS IN WEEK 4 ARE INACTIVE""  printed on the blister foil and package insert, however,all tablets are active.",2017-12-20,2017-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78753 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability testing.,2018-01-08,2018-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79062 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits,2018-02-22,2018-02-22,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79118 - Class III - Drugs - Teva Pharmaceuticals USA,"Failed impurities/ degradation specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling all lots within expiry due to out of specification (OOS) test result for the lactoside impurity obtained during routine stability testing activities.",2018-03-05,2018-03-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79542 - Class II - Drugs - Teva Pharmaceuticals USA,Defective Container: This recall is being initiated due to product complaints regarding difficulty in dispensing the tablet from the applicator.,2018-04-06,2018-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80004 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Stability Specifications,2018-06-11,2018-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80437 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities and Degradation Specifications and Subpotent Drug: out-of-specification (OOS) test results for below assay and above specification for degradants.,2018-07-06,2018-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80550 - Class II - Drugs - Teva Pharmaceuticals USA,API material used in the manufacturing of the product did not receive regulatory approval prior to release.,2018-08-08,2018-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81068 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.,2018-10-01,2018-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81069 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.,2018-10-18,2018-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80790 - Class II - Drugs - Teva Pharmaceuticals USA,Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.,2018-10-25,2018-10-25,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81326 - Class II - Drugs - Teva Pharmaceuticals USA,Failed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.,2018-11-01,2018-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81120 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing,2018-11-14,2018-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81840 - Class II - Drugs - Teva Pharmaceuticals USA,Failed dissolution specifications,2019-01-16,2019-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82367 - Class III - Drugs - Teva Pharmaceuticals USA,Subpotent Drug.,2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82619 - Class II - Drugs - Teva Pharmaceuticals USA,Subpotent Product: assay results for Amoxicillin were below the specification limits.,2019-04-18,2019-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83730 - Class III - Drugs - Teva Pharmaceuticals USA,GMP Deviation: lot not intended for commercial distribution.,2019-10-09,2019-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84798 - Class II - Drugs - Teva Pharmaceuticals USA,GMP Deviations: Product bottle may be absent of desiccant.,2020-02-06,2020-02-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84797 - Class II - Drugs - Teva Pharmaceuticals USA,CGMP deviations: Product bottle may be absent of desiccant.,2020-02-10,2020-02-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84816 - Class III - Drugs - Teva Pharmaceuticals USA,Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets contain language relative to a 25 mg dosing titration that necessitates the use of a scored 50 mg tablet.,2020-02-19,2020-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85017 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Dissolution Specifications: Low out of specification dissolution result observed during stability testing.,2020-03-02,2020-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85146 - Class II - Drugs - Teva Pharmaceuticals USA,CGMP Deviations: Precautions taken due to Out-of-specification for trigger force for a non-marketed lot number that shares the same component.,2020-05-05,2020-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85712 - Class II - Drugs - Teva Pharmaceuticals USA,Some bottles may contain mixed strengths of the product.,2020-06-04,2020-06-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86017 - Class II - Drugs - Teva Pharmaceuticals USA,Labeling: Incorrect or Missing Lot and/or Exp date on the individual transdermal pouches but not in the carton.,2020-08-10,2020-08-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86379 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Stability Specifications: Below specification result for buprenorphine release rate.,2020-10-01,2020-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86285 - Class II - Drugs - Teva Pharmaceuticals USA,"CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits., Sub-Potent Drug: Out of specification test results for potency (below specification).",2020-10-02,2020-10-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86667 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing.,2020-11-06,2020-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86738 - Class III - Drugs - Teva Pharmaceuticals USA,Superpotent Drug: High out-of-specification assay results were obtained during stability testing.,2020-11-20,2020-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87330 - Class II - Drugs - Teva Pharmaceuticals USA,Chemical contamination; Unknown brown residue adhering to the inside of one vial.,2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87452 - Class III - Drugs - Teva Pharmaceuticals USA,Failed Impurity/Degradation Specifications: Out-of-specifications results observed for impurities during stability testing.,2021-03-19,2021-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88154 - Class I - Drugs - Teva Pharmaceuticals USA,"Presence of Particulate Matter: Complaint received of a glass particle observed inside the vial. The vial was returned to Teva for further analysis where two other particulates were found and identified as one (1) grey silicone particle and one (1) translucent, colorless cotton fiber.",2021-07-15,2021-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88370 - Class II - Drugs - Teva Pharmaceuticals USA,CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC)  for an excipient batch of Dibasic Calcium Phosphate.,2021-08-27,2021-08-27,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88738 - Class II - Drugs - Teva Pharmaceuticals USA,Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol,2021-10-21,2021-10-21,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88936 - Class II - Drugs - Teva Pharmaceuticals USA,Labelling: Incorrect Exp. Date,2021-11-15,2021-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89255 - Class II - Drugs - Teva Pharmaceuticals USA,Subpotent,2021-12-23,2021-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89422 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient,2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89385 - Class II - Drugs - Teva Pharmaceuticals USA,Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.,2022-02-02,2022-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89876 - Class I - Drugs - Teva Pharmaceuticals USA Inc,"Presence of Particulate Matter: Product was found to contain silica and iron oxide
",2022-04-11,2022-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89944 - Class II - Drugs - Teva Pharmaceuticals USA Inc,cGMP Deviations,2022-04-27,2022-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90239 - Class III - Drugs - Teva Pharmaceuticals USA Inc,Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing,2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90182 - Class I - Drugs - Teva Pharmaceuticals USA Inc,Failed Dissolution Specifications- Low Out-Of-Specification results obtained during stability testing.,2022-06-08,2022-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90430 - Class II - Drugs - Teva Pharmaceuticals USA Inc,Failed Dissolution Specifications; Low Out of Specification (OOS) results for dissolution.,2022-06-23,2022-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90534 - Class II - Drugs - Teva Pharmaceuticals USA Inc,Superpotent Drug: Out of specification assay result was obtained during stability testing.,2022-07-25,2022-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90635 - Class II - Drugs - Teva Pharmaceuticals USA Inc,Failed Dissolution Specifications: below specification limits for dissolution.,2022-08-04,2022-08-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90594 - Class III - Drugs - Teva Pharmaceuticals USA Inc,Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.,2022-08-11,2022-08-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90792 - Class II - Drugs - Teva Pharmaceuticals USA Inc,"CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.",2022-08-30,2022-08-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90803 - Class II - Drugs - Teva Pharmaceuticals USA Inc,Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.,2022-09-16,2022-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61759 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",Contraceptive Tablets Out of Sequence: This recall has been initiated due to the potential that some regimen packages may not contain placebo tablets.,2012-06-19,2012-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61664 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.,2012-06-26,2012-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61776 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Impurities/Degradation:  This recall is being carried out due to the potential for some lots not meeting impurity specifications.,2012-06-26,2012-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61871 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight),2012-07-05,2012-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62241 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Presence of Foreign Substance: Recall is being initiated due to the presence of a foreign particle identified from a customer complaint.,2012-08-03,2012-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61725 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life,2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64233 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Presence of Foreign Tablets/Capsules: Recall is being conducted due to a foreign capsule found in one bottle.,2013-03-08,2013-03-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64305 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.,2013-04-01,2013-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64480 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Defective Container: This recall is being carried out due to the potential for improperly sealed bottles.,2013-04-10,2013-04-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64607 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",Failed Tablet/Capsule Specifications: This recall is being carried out due to an out of specification result for appearance.,2013-04-10,2013-04-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63819 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Presence of Foreign Substance: Product is being recalled due to receiving an elevated number of patient complaints related to a visible presence of medical grade silicone oil essential to the functionality of the syringe and plunger stopper system.,2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64608 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.","Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing, Failed Impurity/Degradation Specifications; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) detected during impurity testing",2013-05-30,2013-05-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64680 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",CGMP Deviation; cotton coil is missing in some packaged bottles,2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65050 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",Discoloration: This recall is being carried out due to a yellow to brown discolored Amoxicillin powder on the inner foil seal of the bottles.,2013-06-11,2013-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65298 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Failed Dissolution Specification; during stability testing,2013-06-19,2013-06-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64644 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing,2013-07-05,2013-07-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64643 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing,2013-07-11,2013-07-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65516 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",Discoloration:  This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of RES 65050.,2013-07-17,2013-07-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65826 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.","Labeling -label error on declared strength: unopened, sealed bottle of Terazosin Hydrochloride (HCl) 10mg Capsules contained Terazosin HCl 5 mg Capsules",2013-08-06,2013-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65515 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Failed Dissolution Specifications: Product is being recalled due to out of specification dissolution results obtained during routine stability testing.,2013-08-07,2013-08-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65912 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.","Failed Tablet/Capsule Specification: Teva is recalling certain lots of Propanolol HCl Tablets, 10 mg due to the potential of some tablets not conforming to weight specification.",2013-08-27,2013-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65959 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Lack of Assurance of Sterility: The required reduction of endotoxin was not met during the annual revalidation of the vial washer.,2013-09-03,2013-09-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66899 - Class III - Drugs - Teva Pharmaceuticals USA, Inc.",Failed Stability Specifications: this product is below specification for preservative content.,2014-01-17,2014-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66872 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Presence of Foreign Tablets/Capsules: Potential of Pravastatin tablet fragments in bottles of Valacyclovir 1 gm Tablets.,2014-02-04,2014-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84242 - Class II - Drugs - Teva Pharmaceuticals USA, Inc.",Presence of foreign substance: Brown/black particles found during stability testing.,2019-11-21,2019-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72958 - Class II - Drugs - TexasStar Pharmacy,Lack of  assurance of sterility,2016-03-02,2016-03-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82905 - Class II - Biologics - Texoma Regional Blood Center,"Blood product, collected from a donor who had been incarcerated, was distributed.",2019-06-24,2019-06-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86769 - Class III - Biologics - Texoma Regional Blood Center,"Blood products, which were not quarantined from a donor who reported having had a shingles vaccination, were distributed., Blood products, which were not quarantined after the donor reported having had a shingles vaccination prior to donation, were distributed.",2020-11-23,2020-11-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72294 - Class I - Drugs - Tf Supplements,Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.,2016-03-09,2016-03-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64188 - Class II - Drugs - TG United, Inc.",CGMP Deviations: Products are underdosed or have an incorrect dosage regime.,2013-06-04,2013-06-04,44,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74146 - Class II - Drugs - The Aloe Source,CGMP Deviations,2016-06-26,2016-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61949 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-06-11,2012-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62524 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor who reported living in a malarial endemic area within the past three years, were distributed.",2012-07-25,2012-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44996 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2012-08-16,2012-08-16,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62824 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood product, collected from a donor in whom donor suitability was not adequately determined, was distributed.",2012-09-06,2012-09-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63036 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood products, which were exposed to unacceptable temperature during storage, were distributed.",2012-10-10,2012-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38756 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood products, collected under conditions where the sterility of the products may have been compromised, were distributed.
",2013-01-29,2013-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48782 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-29,2013-01-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48783 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-01-29,2013-01-29,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64239 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood products, stored at unacceptable storage temperatures, were distributed.",2013-03-11,2013-03-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64815 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, misbranded as Jkb negative, and subsequently determined to be JKb positive, was distributed.",2013-04-08,2013-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65727 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood product, collected from an ineligible donor, was distributed.",2013-08-21,2013-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67890 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, collected from a donor with an incomplete donor suitability determination, was distributed.",2014-05-07,2014-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68857 - Class III - Biologics - The American National Red Cross - Southern Region,"Platelets with incorrect or missing information, were distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68940 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood products, labeled with an incorrect expiration date, were distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69402 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2014-11-05,2014-11-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70697 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-03-23,2015-03-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70940 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, labeled with an incorrect expiration date, was distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72152 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72882 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed",2016-01-07,2016-01-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73061 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-01-20,2016-01-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73113 - Class II - Biologics - The American National Red Cross - Southern Region,"Apheresis product, for which product QC test for pH and platelet yield were not performed, was distributed.",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73063 - Class III - Biologics - The American National Red Cross - Southern Region,Mislabelled RBC was distributed.,2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73062 - Class III - Biologics - The American National Red Cross - Southern Region,Mislabelled RBC was distributed.,2016-02-25,2016-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73730 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, for which donor eligibility was inadequately determined, was distributed.",2016-04-26,2016-04-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75074 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2016-10-05,2016-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76254 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, in which donor screening and/or deferral screening not done or incorrectly performed, were distributed, Blood products, in which donor screening and/or deferral screening not done or incorrectly performed, were distributed.",2017-02-27,2017-02-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76866 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, in which donor screening/deferral screening not done or incorrectly performed during search, were distributed.",2017-04-19,2017-04-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77255 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2017-06-23,2017-06-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78562 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, in which donor suitability was not adequately determined, was distributed.
",2017-12-05,2017-12-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78532 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78750 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-01-05,2018-01-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78749 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, in which donor suitability was not adequately determined, was distributed.
",2018-01-12,2018-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80089 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2018-05-30,2018-05-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79944 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor in which donor suitability was not adequately determined, were distributed.",2018-06-05,2018-06-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80595 - Class II - Biologics - The American National Red Cross - Southern Region,"Platelet products, which may have been collected in a manner that compromised the sterility of the units, were distributed.",2018-08-09,2018-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81357 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2018-10-30,2018-10-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81697 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, collected from an ineligible donor, was distributed.",2018-12-04,2018-12-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82270 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from an ineligible donor, were distributed.",2019-03-01,2019-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82417 - Class II - Biologics - The American National Red Cross - Southern Region,"Apheresis products, in which the WBC count was not performed, were distributed.
",2019-03-20,2019-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83388 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-07-31,2019-07-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83474 - Class II - Biologics - The American National Red Cross - Southern Region,Misbranded Leukoreduced Red Blood Cells were distributed.,2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83625 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2019-10-07,2019-10-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84775 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85250 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood product, for which donor eligibility was incomplete, was distributed.
",2020-03-19,2020-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85176 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2020-04-01,2020-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85577 - Class II - Biologics - The American National Red Cross - Southern Region,"Red Blood Cell product in which routine testing/testing performed, interpreted, documented, or labeled incorrectly, was distributed.
",2020-05-15,2020-05-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85739 - Class III - Biologics - The American National Red Cross - Southern Region,"Red Blood Cell product for which a visual inspection was not performed or documented was distributed.
",2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87105 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood and Blood Products for Reprocessing, for which donor eligibility screening was incomplete, were distributed.",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87124 - Class II - Biologics - The American National Red Cross - Southern Region,Misbranded Leukoreduced Red Blood Cells were distributed.,2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87174 - Class II - Biologics - The American National Red Cross - Southern Region,"Plateletpheresis products, for which quality control for WBC count was not performed, were distributed.
",2021-01-26,2021-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87144 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood products, collected from a donor with a history of high risk behavior, were distributed.",2021-02-19,2021-02-19,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87238 - Class II - Biologics - The American National Red Cross - Southern Region,"Leukoreduced Red Blood Cells, for which donor eligibility screening was incomplete, were distributed.",2021-02-19,2021-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87344 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood product, for which donor eligibility was incomplete, was distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87884 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89003 - Class III - Biologics - The American National Red Cross - Southern Region,"Blood and Blood Products for Reprocessing, for which donor eligibility screening was incomplete, were distributed.",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89157 - Class II - Biologics - The American National Red Cross - Southern Region,"Leukoreduced Apheresis Red Blood Cells, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89279 - Class II - Biologics - The American National Red Cross - Southern Region,Misbranded Blood Products were distributed.,2022-01-18,2022-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89298 - Class II - Biologics - The American National Red Cross - Southern Region,"Plateletpheresis, not meeting product specifications, was distributed.
",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91013 - Class II - Biologics - The American National Red Cross - Southern Region,"Blood product, for which donor eligibility was incomplete, was distributed
",2022-10-24,2022-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91015 - Class II - Biologics - The American National Red Cross - Southern Region,"Red Blood Cell products, for which donor eligibility was incomplete, were distributed.
",2022-10-24,2022-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91189 - Class III - Biologics - The American National Red Cross - Southern Region,"Misbranded Apheresis Red Blood Cell products were distributed.
",2022-11-25,2022-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91454 - Class II - Biologics - The American National Red Cross - Southern Region,"Apheresis Red Blood Cell products, for which arm prep may have been performed inappropriately, were distributed.
",2023-01-10,2023-01-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91462 - Class II - Biologics - The American National Red Cross - Southern Region,"Leukoreduced Red Blood Cells, which initially tested RPR reactive for syphilis, but had no confirmatory testing, were distributed.",2023-01-19,2023-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46005 - Class III - Biologics - The American National Red Cross South Carolina Region,"Blood products, which failed to meet the minimum specification for product volume, were distributed.",2013-02-13,2013-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46436 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood products,  where quality control and distribution of products did not meet specifications, were distributed.",2013-02-13,2013-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #46980 - Class III - Biologics - The American National Red Cross South Carolina Region,"Blood products, for which shipping and storage conditions were undocumented, were distributed.",2013-02-13,2013-02-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47571 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-02-13,2013-02-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50643 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2013-02-13,2013-02-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44351 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood products, collected from a donor who received a piercing within 12 months of donation, were distributed.",2013-02-25,2013-02-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64302 - Class III - Biologics - The American National Red Cross South Carolina Region,"Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41826 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-05-10,2013-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48246 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood products, collected from a donor in whom donor suitability was not adequately determined, were distributed.",2013-05-10,2013-05-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49844 - Class III - Biologics - The American National Red Cross South Carolina Region,"Blood products, lacking assurance of having been maintained at an acceptable temperature during shipping, were distributed.",2013-05-10,2013-05-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65520 - Class III - Biologics - The American National Red Cross South Carolina Region,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2013-07-22,2013-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65660 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood product, labeled as leukoreduced which did not meet the requirements for a leukoreduced product, was distributed.",2013-08-22,2013-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66891 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood product, collected from a donor who reported post donation diagnosis of a sexually transmitted disease, was distributed.",2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43934 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood product, which contained an insufficient plasma volume, was distributed.",2014-01-02,2014-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38768 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood products, which were labeled as leukoreduced, but were not tested to verify white blood cell count, were distributed.",2014-02-20,2014-02-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38767 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-07-13,2015-07-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78561 - Class II - Biologics - The American National Red Cross South Carolina Region,"Blood product in which routine testing/testing performed, interpreted, or documented incorrectly, was distributed.
",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84874 - Class II - Biologics - The American National Red Cross South Carolina Region,"Misbranded Red Blood Cells, Leukocytes Reduced, were distributed.",2020-02-19,2020-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87930 - Class II - Biologics - The American National Red Cross South Carolina Region,Misbranded Leukoreduced Red Blood Cells  were distributed.,2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87931 - Class II - Biologics - The American National Red Cross South Carolina Region,"Misbranded Apheresis Red Blood Cell products were distributed.
",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77859 - Class I - Drugs - The Ampt Life, LLC","Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil and tadalafil and undeclared milk. The presence of sildenafil and tadalafil makes AMPT Natural Herbal Coffee an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall. Additionally, this product has been found to contain undeclared milk, milk is recognized as one of the foods reported to have caused deaths due to anaphylactic shock in persons with underlying hypersensitivities.",2017-12-21,2017-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71618 - Class II - Drugs - The Apothecary Shoppe LLC,"Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced., Lack of Assurance of Sterility: Due to lack of documentation of proper environmental monitoring during the time in which the medication was produced..",2015-08-06,2015-08-06,28,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75212 - Class II - Drugs - The Apothecary Shoppe LLC,Lack of Assurance of Sterility; medication was sterilized with a recalled filter,2016-10-04,2016-10-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66089 - Class II - Biologics - The Aroostook Medical Center Blood Bank,"Blood product, incorrectly identified as Jka negative, was distributed.",2013-09-17,2013-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63924 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43899 - Class II - Biologics - The Blood Alliance, Inc.","Blood product, which was collected from a donor who traveled to malarial endemic area, was distributed.",2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61069 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, collected from donors who may have traveled to an area considered endemic for malaria, were distributed.",2013-02-25,2013-02-25,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44607 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, collected from a donor who was previously deferred for being at increased risk for vCJD, were distributed.",2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45629 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49196 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #50271 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, which did not meet the acceptable product specifications, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64814 - Class II - Biologics - The Blood Alliance, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49827 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, collected from a donor with a history of high risk behavior, was distributed.",2013-05-03,2013-05-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #46676 - Class III - Biologics - The Blood Alliance, Inc.","Blood products, for which there was no documentation for the time period out of controlled storage, were distributed.",2013-05-08,2013-05-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #47561 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, recovered from an ineligible donor, was distributed.",2013-05-08,2013-05-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64854 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, collected from a donor who reported a post donation illness, were distributed.",2013-05-08,2013-05-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66258 - Class II - Biologics - The Blood Alliance, Inc.","Blood product, incorrectly determined to be negative for the Jka antigen, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68181 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68056 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, not prepared in accordance with specifications and which failed to meet product specifications, were distributed.",2014-06-11,2014-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68057 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, not prepared in accordance with specifications and which failed to meet product specifications, were distributed.",2014-06-11,2014-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68058 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, which were not manufactured in accordance to acceptable product specifications, were distributed.",2014-06-11,2014-06-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68930 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, which did not meet acceptable product specifications, were distributed.",2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69061 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, collected from a donor who had previously tested reactive for hepatitis, were distributed",2014-09-12,2014-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69551 - Class III - Biologics - The Blood Alliance, Inc.","Blood products, not prepared in accordance with specifications, were distributed.",2014-11-05,2014-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70696 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2015-04-16,2015-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72504 - Class II - Biologics - The Blood Alliance, Inc.","Apheresis products, in which platelet yield did not meet specifications, were distributed.

",2015-11-16,2015-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73929 - Class III - Biologics - The Blood Alliance, Inc.","Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2016-05-24,2016-05-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74444 - Class II - Biologics - The Blood Alliance, Inc.","Blood product, collected from a donor who was not deferred after testing reactive for anti-HTLV, was distributed.",2016-06-30,2016-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76007 - Class II - Biologics - The Blood Alliance, Inc.","Blood products, collected from a donor at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2017-01-27,2017-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65613 - Class II - Biologics - The Blood Center,"Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-08-09,2013-08-09,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65680 - Class II - Biologics - The Blood Center,"Blood product, manufactured from an apheresis unit with insufficient platelet yield for the unit to be split, was distributed.
",2013-08-23,2013-08-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65681 - Class II - Biologics - The Blood Center,"Blood products, collected from a donor who had been temporarily deferred, were distributed.",2013-08-23,2013-08-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67218 - Class III - Biologics - The Blood Center,"Blood product, which did not meet the manufacturer's instructions for preparing a leukoreduced product, was distributed.",2014-02-18,2014-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72189 - Class III - Biologics - The Blood Center,"Blood products, collected on instruments for which there was no documentation of quality control, were distributed.",2015-10-01,2015-10-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72995 - Class II - Biologics - The Blood Center,"Blood products, collected from a donor whose suitability to donate was inadequately determined, were distributed.",2016-02-18,2016-02-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74169 - Class II - Biologics - The Blood Center,"Blood product, collected from a donor who disclosed travel history to a malarial endemic area, was distributed.",2016-06-03,2016-06-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76391 - Class II - Biologics - The Blood Center,"Blood products, collected from a donor for whom eligibility to donate was incorrectly performed, were distributed.",2017-02-21,2017-02-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77365 - Class II - Biologics - The Blood Center,"Red blood cell, for which the antigen labeling tag was incorrect , was distributed.",2017-06-07,2017-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78253 - Class II - Biologics - The Blood Center,"Blood products, collected from a donor who was previously deferred, were distributed.",2017-11-08,2017-11-08,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79491 - Class II - Biologics - The Blood Center,"Blood products, collected from a donor with a history of multiple high risk behaviors, were distributed.",2018-04-20,2018-04-20,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80778 - Class II - Biologics - The Blood Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2018-08-16,2018-08-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82767 - Class III - Biologics - The Blood Center,Misbranded red blood cells were distributed.,2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82769 - Class III - Biologics - The Blood Center,Misbranded red blood cells were distributed.,2019-05-16,2019-05-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82945 - Class III - Biologics - The Blood Center,"Blood product, which was irradiated labeled with an incorrect expiration date, was distributed.
",2019-06-17,2019-06-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84129 - Class II - Biologics - The Blood Center,"Red Blood Cell products, for which Chagas Disease testing was not performed, were distributed.
",2019-11-01,2019-11-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84907 - Class III - Biologics - The Blood Center,"Misbranded Apheresis Red Blood Cells, Leukoreduced, were distributed.",2020-02-26,2020-02-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89278 - Class II - Biologics - The Blood Center,"Blood product, collected from a donor who previously tested positive for Hepatitis B core antigen (anti-HBc) on two separate occasions, was distributed.",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91682 - Class II - Biologics - The Blood Center,"Blood Products, collected from a donor who initially tested reactive for syphilis but did not have confirmatory testing performed according to SOPs, were distributed.",2023-02-16,2023-02-16,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62353 - Class III - Biologics - The Blood Connection, Inc.","Blood products, which were not frozen within six hours of collection, were distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63670 - Class II - Biologics - The Blood Connection, Inc.","Blood product, collected from a donor for whom a hemoglobin screening test was not performed, was distributed.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64872 - Class II - Biologics - The Blood Connection, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64881 - Class II - Biologics - The Blood Connection, Inc.","Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed",2013-04-29,2013-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66618 - Class II - Biologics - The Blood Connection, Inc.","Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2013-12-02,2013-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68154 - Class III - Biologics - The Blood Connection, Inc.","Blood product, collected from a donor without documenting the body temperature, was distributed.",2014-06-11,2014-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68274 - Class III - Biologics - The Blood Connection, Inc.","Blood product, collected from a donor with an unacceptable temperature, was distributed.",2014-06-23,2014-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72144 - Class III - Biologics - The Blood Connection, Inc.","Blood product, in which quality control and distribution of product did not meet specifications, was distributed.",2015-10-19,2015-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72404 - Class II - Biologics - The Blood Connection, Inc.","Platelet Pheresis products, in which the white blood cell count was too high and labeled as leukocyte reduced, were distributed.

",2015-10-23,2015-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72458 - Class II - Biologics - The Blood Connection, Inc.","Blood product, for which donor screening was incorrectly performed for a prior deferral due to HCV testing, was distributed.",2015-11-17,2015-11-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73004 - Class III - Biologics - The Blood Connection, Inc.","Blood component, not prepared in accordance with specifications, was distributed.",2016-02-12,2016-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74741 - Class III - Biologics - The Blood Connection, Inc.","Blood product, for which donor suitability was not adequately determined, was distributed.",2016-08-31,2016-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76380 - Class II - Biologics - The Blood Connection, Inc.","Blood product, which did not meet product specifications, was distributed.",2017-02-28,2017-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77883 - Class II - Biologics - The Blood Connection, Inc.","Blood product collected from an ineligible donor who lived in a malarial endemic area and was allowed to donate, was distributed.",2017-08-22,2017-08-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77764 - Class III - Biologics - The Blood Connection, Inc.","Blood products, lacking assurance of proper storage and transport temperatures, were distributed.",2017-08-24,2017-08-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80269 - Class II - Biologics - The Blood Connection, Inc.","Blood products, collected from an ineligible donor, were distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80775 - Class II - Biologics - The Blood Connection, Inc.","Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2018-08-16,2018-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80626 - Class II - Biologics - The Blood Connection, Inc.","Blood products, collected from a donor who had previously tested reactive for Hepatitis C (HCV), were distributed.
, Blood products, collected from a donor who had previously tested reactive for Hepatitis C (HCV), were distributed.",2018-08-24,2018-08-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81102 - Class II - Biologics - The Blood Connection, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2018-10-31,2018-10-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81331 - Class II - Biologics - The Blood Connection, Inc.","Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81249 - Class II - Biologics - The Blood Connection, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2018-11-08,2018-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81659 - Class III - Biologics - The Blood Connection, Inc.","Apheresis products, labeled with an incorrect volume, were distributed.
",2018-12-20,2018-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81996 - Class II - Biologics - The Blood Connection, Inc.","Apheresis products, in which platelet yield did not meet specifications, were distributed.",2019-02-07,2019-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82136 - Class II - Biologics - The Blood Connection, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82080 - Class II - Biologics - The Blood Connection, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82081 - Class III - Biologics - The Blood Connection, Inc.","Platelets, not meeting product specifications, were distributed.",2019-03-22,2019-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82545 - Class II - Biologics - The Blood Connection, Inc.","Apheresis product for which white blood cell count testing was not performed, was distributed.
",2019-04-05,2019-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82560 - Class II - Biologics - The Blood Connection, Inc.","Blood products, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-04-12,2019-04-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82930 - Class II - Biologics - The Blood Connection, Inc.","Plateletpheresis products in which quality control for white blood cell count testing was not performed, were distributed.
",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83010 - Class II - Biologics - The Blood Connection, Inc.","Blood products, collected from an ineligible donor, were distributed",2019-07-11,2019-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83305 - Class II - Biologics - The Blood Connection, Inc.","Blood product, which did not meet the acceptable product specifications, was distributed.",2019-08-05,2019-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83697 - Class II - Biologics - The Blood Connection, Inc.","Blood products, collected from an ineligible donor, were distributed.",2019-09-04,2019-09-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83678 - Class II - Biologics - The Blood Connection, Inc.","Blood products, collected from an ineligible donor, were distributed.",2019-09-23,2019-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83782 - Class II - Biologics - The Blood Connection, Inc.","Leukoreduced Red Blood Cells, collected from a donor who lived in an area considered endemic for malaria, were distributed.",2019-10-08,2019-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84479 - Class II - Biologics - The Blood Connection, Inc.","Red Blood Cells, collected from a donor who emigrated from a malarial endemic area, was distributed.",2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85044 - Class III - Biologics - The Blood Connection, Inc.","Blood products, mislabeled as to product specifications, were distributed.",2020-03-03,2020-03-03,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85267 - Class II - Biologics - The Blood Connection, Inc.","Apheresis Platelets, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85715 - Class II - Biologics - The Blood Connection, Inc.","Apheresis, Leukoreduced Platelets, labeled as leukocytes reduced but failed the monthly QC residual white cell count, were distributed.",2020-06-09,2020-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86480 - Class II - Biologics - The Blood Connection, Inc.","Red Blood Cells, not prepared in accordance with specifications, were distributed.",2020-09-24,2020-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86686 - Class II - Biologics - The Blood Connection, Inc.","Leukoreduced Platelets, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-11-09,2020-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86742 - Class II - Biologics - The Blood Connection, Inc.","Red Cell Blood products, for which Leukoreduction was not performed in accordance with specifications, were distributed.",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86754 - Class II - Biologics - The Blood Connection, Inc.","Red Blood Cell product , collected from a donor who traveled to a malaria endemic area, was distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87119 - Class III - Biologics - The Blood Connection, Inc.","Blood products, for which storage temperature was not documented,  were distribtuted.",2021-01-14,2021-01-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87345 - Class II - Biologics - The Blood Connection, Inc.","Blood product, collected from an ineligible donor, was distributed.",2021-02-23,2021-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87328 - Class III - Biologics - The Blood Connection, Inc.","Leukoreduced, Platelets, stored without documenting the temperature, were distributed.",2021-03-15,2021-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87518 - Class III - Biologics - The Blood Connection, Inc.","Platelet products, for which storage temperature was not documented, were distributed.",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88081 - Class II - Biologics - The Blood Connection, Inc.","Leukoreduced Apheresis Red Blood Cells, collected from a donor considered to be at increased risk due to travel, were distributed.",2021-06-22,2021-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88094 - Class III - Biologics - The Blood Connection, Inc.","Blood products, which may have been exposed to unacceptable storage temperatures, were distributed.",2021-06-28,2021-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88419 - Class III - Biologics - The Blood Connection, Inc.","Platelets, exposed to unacceptable temperatures during shipment/storage, were distributed.",2021-08-20,2021-08-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88533 - Class III - Biologics - The Blood Connection, Inc.","Apheresis Platelets, Leukoreduced and Irradiated, which were exposed to unacceptable shipping temperatures, were distributed.",2021-09-02,2021-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88534 - Class II - Biologics - The Blood Connection, Inc.","Red Blood Cell products, collected from a donor who lived in a malarial endemic area, were distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88789 - Class III - Biologics - The Blood Connection, Inc.","Red Blood Cell products prepared from overweight whole blood units, were distributed.",2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89317 - Class II - Biologics - The Blood Connection, Inc.","Leukoreduced Red Blood Cells, which were made from a unit not stored at the correct temperature, were distributed.",2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90208 - Class II - Biologics - The Blood Connection, Inc.","Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90219 - Class II - Biologics - The Blood Connection, Inc.","Plateletpheresis products, not meeting product specifications, were distributed",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91027 - Class II - Biologics - The Blood Connection, Inc.","Apheresis Red Blood Cell product, for which WBC count was not performed, was distributed.
",2022-10-24,2022-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64087 - Class II - Biologics - The Children's Hospital Assoc. Transfusion Medicine Services,"Blood product, collected from an autologous donor but incorrectly labeled as a homologous unit, was distributed.",2013-02-19,2013-02-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88055 - Class III - Biologics - The Community Blood Center, Inc.","Blood product, exposed to unacceptable temperatures during storage, was distributed.",2021-06-28,2021-06-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88420 - Class II - Biologics - The Community Blood Center, Inc.","Leukoreduced Irradiated Red Blood Cells, which were not labeled as Irradiated, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91248 - Class III - Biologics - The Community Blood Center, Inc.","Leukoreduced Red Blood Cells, which had an incorrect expiration date on the label, were distributed.",2022-12-09,2022-12-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91473 - Class II - Biologics - The Community Blood Center, Inc.","Red Blood Cell products, for which arm prep may have been performed inappropriately, were distributed.
",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91539 - Class II - Biologics - The Community Blood Center, Inc.","Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2023-01-31,2023-01-31,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71535 - Class II - Drugs - the Compounder,Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.,2015-11-10,2015-11-10,47,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71371 - Class II - Drugs - The Compounding Pharmacy of America,Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility,2015-09-15,2015-09-15,382,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79168 - Class I - Drugs - The Compounding Pharmacy of America,Non-Sterility,2018-03-14,2018-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65125 - Class II - Drugs - THE COMPOUNDING SHOP, INC.","Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes., Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes",2013-06-04,2013-06-04,25,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87384 - Class II - Drugs - The General Hospital Corporation,Lack of Assurance of Sterility,2021-02-24,2021-02-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80473 - Class II - Drugs - The Hain Celestial Group, Inc. - Worldwide HQ",Incorrect Product Formulation: wrong sunscreen product in the package.,2018-07-13,2018-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80648 - Class II - Drugs - The Hain Celestial Group, Inc. - Worldwide HQ",Microbial Contamination of a Non-Sterile Product,2018-08-14,2018-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77869 - Class II - Drugs - The Harvard Drug Group,Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination,2017-08-24,2017-08-24,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88811 - Class II - Drugs - The Harvard Drug Group,Failed Impurities/Degradation Specifications,2021-12-21,2021-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89681 - Class II - Drugs - The Harvard Drug Group,Failed Dissolution Specifications,2022-03-09,2022-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89663 - Class II - Drugs - The Harvard Drug Group,Failed Impurities/Degradation Specifications: Out of specification result obtained during routine stability testing for Impurities.,2022-03-14,2022-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74723 - Class I - Drugs - The Harvard Drug Group,Microbial contamination of Non-Sterile Products; positive findings of Burkholderia cepacia,2016-10-12,2016-10-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77106 - Class II - Drugs - The Harvard Drug Group,Failed Dissolution Specifications,2017-04-28,2017-04-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77105 - Class III - Drugs - The Harvard Drug Group,Superpotent Drug; out of specification results for assay (manufacturer),2017-05-02,2017-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78162 - Class II - Drugs - The Harvard Drug Group,Failed Impurities/Degradation Specifications: Out-of-specification result for an unknown impurity.,2017-10-19,2017-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80557 - Class II - Drugs - The Harvard Drug Group,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-07-20,2018-07-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80463 - Class III - Drugs - The Harvard Drug Group,"Failed Impurities/Degradation Specifications: Sub-recall because this repackaged product was recalled by the manufacturing firm, Wockhardt, due to out-of-specification results for the Enalapril DiKetopiperazine degradation product.",2018-07-24,2018-07-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80659 - Class II - Drugs - The Harvard Drug Group,Failed Dissolution Specifications,2018-08-02,2018-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83208 - Class II - Drugs - The Harvard Drug Group,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer",2019-07-09,2019-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83460 - Class II - Drugs - The Harvard Drug Group,cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.,2019-08-01,2019-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84955 - Class III - Drugs - The Harvard Drug Group,Failed Dissolution Specifications: High out of specification result observed at stability studies.,2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85138 - Class III - Drugs - The Harvard Drug Group,Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets.,2020-03-11,2020-03-11,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85566 - Class III - Drugs - The Harvard Drug Group,Failed dissolution specifications: Low stage 3 results obtained for dissolution during routine stability testing.,2020-05-13,2020-05-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85757 - Class II - Drugs - The Harvard Drug Group,Failed Dissolution Specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out-of-specification result.,2020-06-04,2020-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85861 - Class II - Drugs - The Harvard Drug Group,CGMP Deviation:  Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.,2020-06-26,2020-06-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86787 - Class II - Drugs - The Harvard Drug Group,Failed Dissolution Specifications: Out of specification for dissolution.,2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88224 - Class II - Drugs - The Harvard Drug Group,Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.,2021-07-09,2021-07-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88583 - Class II - Drugs - The Harvard Drug Group,Failed Dissolution Specifications,2021-09-17,2021-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88638 - Class II - Drugs - The Harvard Drug Group,Failed Dissolution Specifications,2021-09-17,2021-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71454 - Class II - Drugs - The Harvard Drug Group, LLC",Superpotent Drug: Confirmed customer complaint of a single unit dose blister cavity containing 2 OXYCODONE HCl 5 mg tablets.,2015-06-29,2015-06-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71025 - Class II - Biologics - The Medical Foundation,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-05-07,2015-05-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85234 - Class II - Drugs - The Medicine Shoppe Pharmacy,Lack of Assurance of Sterility,2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85404 - Class II - Drugs - The Medicine Shoppe Pharmacy,Lack of Processing Control,2020-04-10,2020-04-10,54,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67314 - Class II - Drugs - The Mentholatum Co.,"Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.",2014-01-28,2014-01-28,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72246 - Class II - Drugs - The Mentholatum Co.,"Labeling: Incorrect Instructions; The word not is missing from the following sentences ""do bandage tightly or cover with any type of wrap except clothing and ""do use with a heating pad or with other heat sources in the Drug Facts panel ""Warning"" section",2015-10-14,2015-10-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86154 - Class III - Drugs - The Mentholatum Company,"Labeling; Not Elsewhere Classified: The Mentholatum Company is initiating a voluntary recall due to an error in the labeling of the cotton pellet box found within the Red Cross Oral Pain blister pack. The cotton pellet box states that the product contains ""Natural Eugenol Oil"" in which it does not. 
",2020-08-24,2020-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63684 - Class I - Drugs - The Menz Club, LLC","Marketed without an Approved NDA/ANDA; product found to contain sulfoaildenafil, an analogue of sildenafil, the active ingredient in a FDA approved product used for erectile dysfunction, making it an unapproved new drug",2013-04-18,2013-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61957 - Class I - Drugs - The Menz Club, LLC","Marketed Without An Approved NDA/ANDA: Samples tested by FDA were found to contain sulfoaildenafil, an analogue of sildenafil, an FDA approved drug used in the treatment of male erectile dysfunction, making these products unapproved new drugs.",2012-08-20,2012-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72058 - Class I - Drugs - The One Minute Miracle Inc,"Marketed Without An Approved NDA/ANDA: Miracle Rock 48 was found to contain undeclared thiosildenafil, an analogue of an FDA approved drug for male erectile dysfunchtion making this product an unapproved drug., Marketed Without An Approved NDA/ANDA: Miracle Diet 30 was found to contain undeclared phenolphthalein, a drug product once contained in over-the-counter laxatives but was taken off the U.S. market due to safety concerns, making this product an unapproved drug.",2015-11-12,2015-11-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90586 - Class III - Drugs - The Procter & Gamble Company,Labeling: Missing label: the product tube was missing a label and contained a different formulation.,2022-07-26,2022-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86377 - Class I - Drugs - The Protein Shoppe,"Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.",2020-09-24,2020-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89937 - Class III - Drugs - The Ritedose Corporation,"Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.",2022-04-05,2022-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66342 - Class II - Drugs - The W.S. Badger Company, Inc.",Microbial Contamination of Non-Sterile Products; Selected lots of Badger Baby and Kids Sunscreen Lotion were recalled due to microbial contamination.,2013-12-05,2013-12-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68222 - Class II - Drugs - Thorne Research Inc,Marketed Without An Approved NDA/ANDA: Captomer and Captomer-250 are marketed as dietary supplements and labeled to be sourced from Dimercaptosuccinic Acid (DMSA) which is the active ingredient in an FDA approved drug making these products unapproved new drugs.,2014-06-13,2014-06-13,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77576 - Class II - Drugs - Time-Cap Laboratories, Inc.","Presence of  foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.",2017-08-03,2017-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79349 - Class II - Drugs - Time-Cap Laboratories, Inc.",CGMP Deviations: Various strengths of ibuprofen tablets/caplets are being recalled due to complaints of odor related to CGMP deficiencies.,2018-04-22,2018-04-22,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63120 - Class I - Biologics - Tissue Banks International,"Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed.",2012-12-19,2012-12-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69681 - Class III - Biologics - Tissue Banks International - National,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-11-06,2014-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74028 - Class II - Biologics - Tissue Banks International - National,"Human tendon allografts, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2016-05-05,2016-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65189 - Class II - Biologics - TissueTech, Inc. dba Bio-Tissue, Inc.","Amniotic membrane allografts, not tested  adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2013-05-20,2013-05-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89909 - Class II - Drugs - TMC Acquisition LLC dba Tailor Made Compounding,Lack of Assurance of Sterility,2022-07-14,2022-07-14,52,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73571 - Class II - Drugs - TMIG Inc,Marketed Without An Approved NDA/ANDA: product is an unapproved drug and additionally 3 lots were found to be subpotent.,2016-05-17,2016-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82247 - Class I - Drugs - Todd Holiday dba Sunstone Organics,MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS: Analysis of samples were positive for Salmonella.,2019-03-11,2019-03-11,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90580 - Class II - Drugs - Tolmar, Inc.",Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time,2022-08-01,2022-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66402 - Class III - Drugs - Tolmar, Inc.",Subpotent,2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88910 - Class II - Drugs - TOLMAR, Inc.",Superpotent Drug,2021-12-14,2021-12-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90067 - Class II - Drugs - Torco Race Fuels,CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.,2022-04-25,2022-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89992 - Class II - Drugs - Torrent Pharma Inc,CGMP deviations: tablets cracking,2022-05-05,2022-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65780 - Class II - Drugs - Torrent Pharma Inc,Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is approved in the application.,2013-08-01,2013-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82889 - Class II - Drugs - Torrent Pharma Inc,cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).,2019-06-13,2019-06-13,41,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86878 - Class I - Drugs - Torrent Pharma Inc,Failed Dissolution Specifications,2020-12-16,2020-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80847 - Class II - Drugs - Torrent Pharma Inc.,CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.,2018-08-28,2018-08-28,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81838 - Class II - Drugs - Torrent Pharma Inc.,"CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.",2019-02-15,2019-02-15,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82585 - Class II - Drugs - Torrent Pharma Inc.,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA)  in the finished product above the interim acceptable daily intake level.",2019-04-10,2019-04-10,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82661 - Class II - Drugs - Torrent Pharma Inc.,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the
finished product above the interim acceptable daily intake level.",2019-05-01,2019-05-01,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83840 - Class II - Drugs - Torrent Pharma Inc.,"CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 9.82 parts per million.",2019-10-02,2019-10-02,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89141 - Class III - Drugs - Torrent Pharma Inc.,Superpotent; Hydrochlorothiazide,2021-12-16,2021-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89146 - Class II - Drugs - Torrent Pharma Inc.,Failed Dissolution Specifications,2022-01-11,2022-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80985 - Class II - Drugs - Torrent Pharma Inc.,Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing.,2018-09-20,2018-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83733 - Class II - Drugs - Torrent Pharma Inc.,Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.,2019-09-16,2019-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85644 - Class II - Drugs - Torrent Pharma Inc.,Failed Dissolution Specifications,2020-06-18,2020-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73466 - Class III - Drugs - Torrent Pharmaceuticals Limited,Presence of Foreign Substance: Product complaint for the presence of foreign matter identified as silicone within the tablet.,2016-04-18,2016-04-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64929 - Class II - Drugs - Total Resources Intl,CGMP Deviations: The first aid kits that are subject to the voluntary recall is being initiated due to failure in stability testing of the active ingredient Benzalkonium Chloride.,2013-08-13,2013-08-13,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66889 - Class II - Drugs - Tower Pharmacy and Compounding,Microbial Contamination of Non Sterile Products: Tower Pharmacy is recalling the Phenylephrine Nasal Spray 1% because of possible microbial contamination.,2013-12-20,2013-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74938 - Class I - Drugs - Town and Country Compounding and Consultation Services,Non-Sterility; microbial contamination identified as Bacillus circulans,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75700 - Class III - Drugs - Town and Country Compounding and Consultation Services, LLC",Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).,2017-01-19,2017-01-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85957 - Class I - Drugs - Transliquid Technologies, LLC",Chemical Contamination: Presence of Undeclared Methanol,2020-07-24,2020-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63562 - Class III - Biologics - Transplant Services Center UT Southwestern Medical Center,"Human allografts, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-11-15,2012-11-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76793 - Class II - Biologics - Transplant Services Center UT Southwestern Medical Center,"Human cornea, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, was distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77096 - Class II - Biologics - Transplant Services Center UT Southwestern Medical Center,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2017-04-25,2017-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78476 - Class II - Biologics - Transplant Services Center UT Southwestern Medical Center,"Human corneas, not tested adequately and appropriately to reduce the risk of transmission of relevant communicable diseases, were distributed.",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67661 - Class II - Drugs - Traxx International Corp,Presence of Foreign Matter: Guaifenesin API powder is being recalled due to the possibility that the product contains polyethylene fibers from a screen used to sift the Guaifenesin.,2014-03-18,2014-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75763 - Class II - Drugs - Tri-Coast Pharmacy,Lack of Assurance of Sterility,2017-01-04,2017-01-04,80,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62739 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63239 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, collected from a donor who may be at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42591 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, which did not have the required volume of red blood cells, was distributed.",2013-06-06,2013-06-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #35757 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, for which the quality control testing for red blood cell volume was not performed, was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38569 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38570 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, collected from a donor who traveled to an area considered endemic for malaria, was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38571 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, which may have been out of controlled storage for greater than 30 minutes, was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38572 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, collected from a donor who traveled to an area considered endemic for malaria, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #39944 - Class III - Biologics - Tri-counties Blood Bank,"Blood product, which was not quarantined after receiving post donation information concerning an illness following donation, was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43129 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, which did not meet the acceptable product specifications, was distributed.

",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #43506 - Class III - Biologics - Tri-counties Blood Bank,"Blood product, which was outside the acceptable quality control ranges, was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44407 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, released from quarantine prior to post leukoreduction, were distributed.
",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47185 - Class II - Biologics - Tri-counties Blood Bank,"Blood Products, which were contaminated with Corynebacterium species, were distributed.
",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47629 - Class III - Biologics - Tri-counties Blood Bank,"Blood products,  without any coolant in the shipping container, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #48864 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, which did not meet the acceptable product specifications, were distributed.	
",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #50436 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, which did not meet the acceptable product specifications, were distributed.
",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40807 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, positive for the c-antigen but labeled as c-antigen negative, was distributed.
",2013-06-12,2013-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41089 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.
",2013-06-12,2013-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41720 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, which failed to meet the minimum specification for product volume, was distributed.
",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41722 - Class III - Biologics - Tri-counties Blood Bank,"Blood products, were not quarantined or measured to confirm an acceptable RBC volume, were distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42016 - Class III - Biologics - Tri-counties Blood Bank,"Blood products, quality control and distribution of products that did not meet specifications, were distributed.
",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42060 - Class III - Biologics - Tri-counties Blood Bank,"Blood products,  which were not frozen within 1 hour of production, were distributed.
",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42243 - Class III - Biologics - Tri-counties Blood Bank,"Blood product, during irradiation process was out of storage greater than 30 minutes, was distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #47622 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, quality control and distribution of products which did not meet specifications, were distributed.
.

",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44409 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, collected using manufacturer collection kit greater than 24 hours, were distributed.",2013-07-11,2013-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42935 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, with discrepancies documented on the irradiator worksheet, were documented. 
, Blood products, with discrepancies documented on the irradiator worksheet, were documented.",2013-07-24,2013-07-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #42589 - Class II - Biologics - Tri-counties Blood Bank,"Blood products, which quality control and distribution of products did not meet specifications, were distributed.
",2013-08-15,2013-08-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66385 - Class II - Biologics - Tri-counties Blood Bank,"Blood product, which was not tested for platelet yield and pH, was distributed.",2013-10-21,2013-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40223 - Class II - Biologics - Tri-Counties Blood Bank,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2013-06-18,2013-06-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #57147 - Class III - Biologics - Tri-Counties Blood Bank,"Blood products, which labels were applied to products with incorrect or missing information, were distributed.
, Blood products, which labels were applied to products with incorrect or missing information, were distributed.

",2013-06-18,2013-06-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40532 - Class II - Biologics - Tri-Counties Blood Bank,"Blood product, with a low platelet count, was distributed.",2013-07-22,2013-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40709 - Class II - Biologics - Tri-Counties Blood Bank,"Blood products, collected from a donor who was taking the medication Avodart (Dutasteride), were distributed.",2013-07-22,2013-07-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #40181 - Class II - Biologics - Tri-Counties Blood Bank dba UBS- Central Coast,"Blood products, collected from a donor who traveled to a malarial endemic area, were distributed. 
",2013-06-12,2013-06-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #38573 - Class II - Biologics - Tri-Counties Blood Bank dba UBS- Central Coast,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.
",2013-07-26,2013-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66297 - Class II - Drugs - Triangle Compounding,Lack of Assurance of Sterility:The product lots are being recalled due to laboratory results (from a contract lab) indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable. Hence the sterility of the products cannot be assured.,2013-09-30,2013-09-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72346 - Class III - Drugs - Tribute Pharmaceuticals US Inc.,"Chemical Contamination: The product may contain trace amounts of benzophenone, a component of the label varnish that may leach through the bottle and into the drug product.",2015-10-14,2015-10-14,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68685 - Class III - Drugs - Trigen Laboratories, Inc.","Labeling: Not Elsewhere Classified: Label indicates that the product contains Vitamin B12 (12 micrograms) on the Supplement Facts panel, however, the formulation of this product does not contain Vitamin B12.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82977 - Class II - Biologics - Trinity Biotech Plc,"Multiple lots of Trinity Biotech's Uni-Gold Recombigen HIV-1/2 test, associated with a performance issue that could lead to reporting of incorrect results including the potential for false negative results, were distributed.",2019-07-22,2019-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85704 - Class II - Drugs - TRIOVA PHARMACEUTICALS LLC,Failed impurities/ degradation specifications: Out of specification for organic impurities.,2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63138 - Class I - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Superpotent (Multiple Ingredient) Drug: Confirmed customer complaints of oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.,2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62496 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Impurities/Degradation Products: Out of specificiation results for impurities at the 18-month room temperature time point.,2012-07-11,2012-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62495 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Impurities/Degradation Products: High Out of Specification results for a known impurity resulted at the 12-month room temperature time point.,2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63502 - Class II - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Tablet Separation: Possibility of cracked or split coating on the tablets.,2012-10-22,2012-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63818 - Class I - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Superpotent (Multiple Ingredient) Drug: Complaint received of oversized tablets.,2013-01-30,2013-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64960 - Class II - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.,2013-04-25,2013-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65948 - Class II - Drugs - TriRx Huntsville Pharmaceutical Services, LLC","LABELING: Label Mix-up: 30 count Effervescent Potassium/Chloride Tablets, may be labeled as 30 count K Effervescent Tablets.",2013-09-12,2013-09-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67102 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Failed impurities/degradation specifications; out of specification for the known impurity 4-chlorobenzophenone.,2013-12-31,2013-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69157 - Class II - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Failed Tablet/Capsule Specifications: Broken tablets found in sealed bottles.,2014-09-03,2014-09-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69233 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Subpotent; 6 month stability time point,2014-09-22,2014-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69014 - Class II - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Superpotent Drug: Qualitest Pharmaceuticals is initiating a recall of three flavors of Acetaminophen Oral Suspension Liquid 160mg/5mL for failure of the product assay at the 12 month timepoint.,2014-10-21,2014-10-21,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70168 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Failed Impurities/Degradation Specifications: High out of specification results for the known impurity p-Aminophenol.,2015-01-06,2015-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70503 - Class II - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Failed tablet specifications: One lot was found to contain oversized tablets.,2015-03-03,2015-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70598 - Class II - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Presence of Foriegn Substance: Plastic cap closure particulates may be present in the product.,2015-03-12,2015-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70852 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Failed Impurities/Degradation Specifications: A stability lot was out of specification for a known impurity at the 8 month Controlled Room Temperature stability time-point.,2015-04-06,2015-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71563 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC","Failed Dissolution Specifications: During routine stability testing
at the 12 month time point, one product lot was found to be
out of specification for dissolution.",2015-06-30,2015-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71646 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Failed Tablet/Capsule Specifications; The identification codes on some tablets may be unreadable,2015-07-15,2015-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71776 - Class III - Drugs - TriRx Huntsville Pharmaceutical Services, LLC",Failed Tablet/Capsule Specifications; report of oversized and discolored tablets,2015-09-01,2015-09-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81960 - Class II - Drugs - Tris Pharma Inc.,Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.,2019-02-14,2019-02-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77798 - Class II - Drugs - Tris Pharma Inc.,Defective container: Oral solution leaking from container.,2017-08-29,2017-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81354 - Class II - Drugs - Tris Pharma Inc.,Superpotent Drug: recalled lots may have higher concentration of ibuprofen.,2018-12-17,2018-12-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83346 - Class II - Drugs - Tris Pharma Inc.,"Superpotent Drug and Failed Stability Specifications: High out-of-specification results for the active ingredients, hydrocodone and chlorpheniramine, as well as high out-of-specification results for the preservatives.",2019-07-24,2019-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70084 - Class II - Drugs - Tropichem Research Labs, Inc.",Microbial Contamination of Non Sterile Product; microbial assay reported unacceptable high plate counts and positive for E. Coli,2014-12-29,2014-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89554 - Class II - Drugs - Tsm Brands LLC,Labeling - product contains undeclared ethyl alcohol,2022-02-25,2022-02-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90619 - Class II - Drugs - Tsm Brands LLC,Labeling: Product Contains Undeclared API - product contains undeclared ethyl alcohol,2022-08-31,2022-08-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83757 - Class II - Drugs - Tuscano and Delucia Group (DBA Entropic Labs),Marketed Without An Approved NDA/ANDA: product  contains Selective Androgen Receptor Modulators (SARMs),2020-01-22,2020-01-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66233 - Class III - Drugs - Tween Brands Inc,"Labeling: Label Error on Declared Strength; the label states that the product contains 62% ethyl alcohol, but the ethyl alcohol content is 20%.",2013-12-13,2013-12-13,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66124 - Class II - Drugs - U.S. Pharmaceuticals Group,Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.,2013-11-20,2013-11-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67617 - Class III - Drugs - U.S. Pharmaceuticals Group,Subpotent Drug: This lot is being recalled because of out-of-specification test results for Diphenhydramine citrate.,2014-03-18,2014-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67636 - Class I - Drugs - U.S. Pharmaceuticals Group,Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.,2014-05-20,2014-05-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68001 - Class II - Drugs - U.S. Pharmaceuticals Group,Presence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a bottle of 50 mg Pristiq.,2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88971 - Class II - Biologics - UC Health Poudre Valley Hospital,"Blood products, collected from a donor who previously tested positive for viral marker(s), were distributed.",2021-11-18,2021-11-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71986 - Class II - Drugs - UCB Biosciences Inc.,Failed Dissolution Testing: Failed 24 month dissolution testing.,2015-08-19,2015-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83368 - Class II - Drugs - UCB Biosciences Inc.,Failed Dissolution Specifications.,2019-08-21,2019-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75832 - Class I - Drugs - Ultimate Body Tox,"Marketed Without An Approved NDA/ANDA: The product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was removed from the U.S. market in October 2010 for safety reasons, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90973 - Class II - Drugs - Ultra Chem Labs Corp,Chemical Contamination and CGMP Deviations: trace amounts of methanol found in one of the components during the manufacturing process.,2022-10-21,2022-10-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89464 - Class II - Drugs - Ultra Seal Corporation,cGMP deviations,2022-01-31,2022-01-31,56,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86264 - Class III - Drugs - Ultra Seal Corporation,Failed Stability Specifications: Out-of-Specification (OOS) results for the Aspirin related compound Salicylic Acid was observed.,2020-08-20,2020-08-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88843 - Class III - Drugs - Ultra Seal Corporation,Failed Stability Specifications: Out-of-Specification results observed for Aspirin related compound Salicylic Acid.,2021-10-26,2021-10-26,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90659 - Class I - Drugs - Ultra Supplement LLC,Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.,2022-08-17,2022-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70661 - Class I - Drugs - Ultra ZX Supplements,Marketed Without An Approved NDA/ANDA: FDA laboratory analysis confirmed that ULTRA ZX contains undeclared sibutramine and phenolphthalein,2015-05-05,2015-05-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89214 - Class II - Drugs - ULTRAtab Laboratories, Inc.","CGMP Deviations: failed stability results, inadequate laboratory investigations,",2022-01-04,2022-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89334 - Class II - Drugs - ULTRAtab Laboratories, Inc.",CGMP Deviations,2022-02-09,2022-02-09,33,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87624 - Class I - Drugs - Ummzy, LLC",Marketed Without An Approved NDA/ANDA: Products found to contain undeclared tadalafil and/ or sildenafil and vardenafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.,2021-07-16,2021-07-16,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75814 - Class II - Biologics - UMTB Biomedical, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2016-12-07,2016-12-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75920 - Class II - Biologics - UMTB Biomedical, Inc.","Human tissue allograft, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, was distributed.",2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77969 - Class II - Biologics - UMTB Biomedical, Inc.","Human tissue allografts, that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2017-11-20,2017-11-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78168 - Class I - Biologics - UMTB Biomedical, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2017-12-20,2017-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78604 - Class I - Biologics - UMTB Biomedical, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2017-12-20,2017-12-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78398 - Class I - Biologics - UMTB Biomedical, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2018-03-15,2018-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78474 - Class I - Biologics - UMTB Biomedical, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2018-03-15,2018-03-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78477 - Class II - Biologics - UMTB Biomedical, Inc.","Human tissue allografts, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2018-03-15,2018-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71860 - Class II - Drugs - Unichem Pharmaceuticals Usa Inc,Presence of Foreign Tablet: A pharmacist found a clopidogrel tablet in  the 1000-count bottle of hydrochlorothiazide 25 mg tablets.,2015-08-25,2015-08-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75205 - Class III - Drugs - Unichem Pharmaceuticals Usa Inc,Tablets/Capsules Imprinted With Wrong ID: incorrect imprint debossed on the tablets.,2016-09-23,2016-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78218 - Class II - Drugs - Unichem Pharmaceuticals Usa Inc,Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity  was observed during the 18 month stability testing.,2017-10-18,2017-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78786 - Class II - Drugs - Unichem Pharmaceuticals Usa Inc,Cross Contamination With Other Products: metronidazole powder was found in one bottle of Divalproex Sodium.,2018-01-17,2018-01-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90709 - Class III - Drugs - UNICHEM PHARMACEUTICALS USA INC,"Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,",2022-09-22,2022-09-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84836 - Class III - Drugs - UNICHEM PHARMACEUTICALS USA INC,Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.,2020-02-06,2020-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85764 - Class III - Drugs - UNICHEM PHARMACEUTICALS USA INC,Failed Impurities/Degradation Specifications: potential migration of benzophenone at very low level into the product from container.,2020-06-08,2020-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88891 - Class III - Drugs - UNICHEM PHARMACEUTICALS USA INC,Discoloration,2021-11-19,2021-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67904 - Class II - Drugs - Unique Pharmaceutical, Ltd",Lack of Assurance of Sterility: A mold like substance was discovered on the surface of an unopened bag of Sodium Chloride 0.9% while prepping the bag for production.,2014-09-16,2014-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68841 - Class I - Drugs - Unique Pharmaceutical, Ltd","Non-Sterility: One lot of N-Acetyl Cysteine vials tested positive for Herbaspirillum huttiense., Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products intended to be sterile.",2014-10-09,2014-10-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68917 - Class II - Drugs - Unit Dose Solutions, Inc.",Presence of Foreign Tablets/Capsules:179 doses of Valacyclovir HCl 500 mg tablets were repacked in unit dose packslabeled as Atorvastatin Calcium,2014-10-10,2014-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68273 - Class III - Biologics - United Blood Services,"Blood products, positive for the M-antigen but labeled  negative for the M-antigen, were distributed.",2014-06-23,2014-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68824 - Class III - Biologics - United Blood Services,"Blood product, in which an antibody identified was labeled and distributed without antibody documented on final label, was distributed.",2014-08-19,2014-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68826 - Class III - Biologics - United Blood Services,"Blood product, labeled with an incorrect expiration date, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68882 - Class III - Biologics - United Blood Services,Misbranded Red Blood Cell was distributed.,2014-08-21,2014-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69027 - Class II - Biologics - United Blood Services,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2014-09-10,2014-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69098 - Class II - Biologics - United Blood Services,"Blood products, which were collected from a donor with a history of high risk behaviors, were distributed.",2014-10-06,2014-10-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70028 - Class II - Biologics - United Blood Services,"Blood products, which were collected from a donor in which donor suitability was not adequately determined, were distributed.",2015-01-26,2015-01-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70416 - Class III - Biologics - United Blood Services,"Misbranded recovered plasma product, was distributed.",2015-02-10,2015-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70461 - Class III - Biologics - United Blood Services,"Blood product, in which quality control and distribution/distribution of product did not meet specifications, was distributed.",2015-02-25,2015-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70462 - Class III - Biologics - United Blood Services,"Blood product, quality control and distribution/distribution of product did not meet specifications, was distributed.",2015-02-25,2015-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70495 - Class III - Biologics - United Blood Services,"Blood products, in which quality control and distribution/distribution of products did not meet specifications, were distributed.",2015-02-25,2015-02-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70715 - Class II - Biologics - United Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-04-24,2015-04-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71884 - Class III - Biologics - United Blood Services,"Blood product, in which component not prepared in accordance with specifications, was distributed.",2015-09-02,2015-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72127 - Class II - Biologics - United Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2015-09-18,2015-09-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72679 - Class II - Biologics - United Blood Services,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2015-12-03,2015-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73025 - Class II - Biologics - United Blood Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2016-02-18,2016-02-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73566 - Class II - Biologics - United Blood Services,"Blood products, collected from donors who were not appropriately evaluated for travel to a malarial endemic area, were distributed.",2016-04-08,2016-04-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74332 - Class II - Biologics - United Blood Services,"Blood products, collected from a donor with a history of Viral Hepatitis, were distributed.",2016-06-10,2016-06-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74322 - Class II - Biologics - United Blood Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2016-06-23,2016-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74333 - Class II - Biologics - United Blood Services,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2016-07-18,2016-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74675 - Class II - Biologics - United Blood Services,"Apheresis products, collected from an unsuitable donor due to a donor screening deviation, were distributed.",2016-07-28,2016-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75720 - Class II - Biologics - United Blood Services,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2016-12-09,2016-12-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75748 - Class III - Biologics - United Blood Services,"Blood products, in which quality control and distribution of products did not meet specifications, were distributed.",2016-12-21,2016-12-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76224 - Class II - Biologics - United Blood Services,"Blood product, collected from a donor for whom eligibility was incorrectly determined, was distributed.",2017-01-31,2017-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76239 - Class II - Biologics - United Blood Services,"Blood product, in which quality control and distribution of product did not meet specifications, was distributed.",2017-02-27,2017-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76328 - Class III - Biologics - United Blood Services,"Blood product, labeled with an incorrect expiration date, was distributed.",2017-02-28,2017-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76300 - Class II - Biologics - United Blood Services,"Blood products, collected from an ineligible donor, were distributed.",2017-03-02,2017-03-02,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76583 - Class II - Biologics - United Blood Services,"Red Blood Cells, misbranded as to leukoreduction status, were distributed.",2017-03-29,2017-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77147 - Class II - Biologics - United Blood Services,"Blood products, in which donor suitability was not adequately determined, were distributed.",2017-04-27,2017-04-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76815 - Class II - Biologics - United Blood Services,"Blood products, which did not meet the acceptable product specifications for release, were distributed.",2017-05-01,2017-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76816 - Class III - Biologics - United Blood Services,"Blood product, collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2017-05-09,2017-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77125 - Class III - Biologics - United Blood Services,"Blood product, collected from a donor in which donor suitability was not adequately determined, was distributed.",2017-05-30,2017-05-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77268 - Class III - Biologics - United Blood Services,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.",2017-06-23,2017-06-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77762 - Class II - Biologics - United Blood Services,"Blood product in which routine testing/testing performed, interpreted, or documented incorrectly, was distributed.",2017-08-02,2017-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80449 - Class II - Biologics - United Blood Services,"Apheresis product, identified as unsuitable due to a collection deviation, was distributed.",2018-07-24,2018-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80709 - Class III - Biologics - United Blood Services,"Blood Products, labeled with an incorrect volume, were distributed.
",2018-08-16,2018-08-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75092 - Class I - Drugs - United Exchange Corporation,"Non-Sterility: Direct evidence of contamination for 2 lots based on FDA samples., Lack of assurance of sterility",2017-02-27,2017-02-27,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79693 - Class II - Drugs - United Pacific Co Ltd,CGMP Deviations: the product was produced with substandard GMP manufacturing processes.,2018-04-10,2018-04-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78183 - Class II - Drugs - United Pharmacy,CGMP Deviations; FDA analysis deterrmined that the product does not contain glutamine and two unknown impurities were observed,2017-10-10,2017-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #59219 - Class II - Biologics - United States Blood Bank, Inc.","Blood product, which tested positive for anti-HBc, was distributed.",2013-03-04,2013-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62378 - Class II - Biologics - United States Blood Bank, Inc.","Blood product, labeled as leukoreduced but failed to meet QC levels for White Blood Cell counts, was distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72265 - Class III - Biologics - United States Blood Bank, Inc.","Blood products, collected from a donor who did not have a satisfactory arm inspection, were distributed.",2015-10-23,2015-10-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72266 - Class III - Biologics - United States Blood Bank, Inc.","Blood products, collected from a donor who did not have a satisfactory arm inspection, were distributed.",2015-10-23,2015-10-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67892 - Class II - Drugs - United Therapeutics Corp.,"Defective Delivery System: United Therapeutics is voluntarily recalling a small number of Tyvaso Inhalation Systems with Optineb ON-100/7 and TD-100/A medical devices. These devices may have been programmed with a different software version than intended for the device. If the device has the incorrect software, it may not operate as indicated in the Instructions for Use.",2014-07-07,2014-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78170 - Class II - Drugs - United Therapeutics Corp.,CGMP Deviations,2017-11-19,2017-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80834 - Class III - Drugs - United Therapeutics Corp.,Defective Delivery System: Water ingress through the lower water cup sensor of the device.,2018-09-12,2018-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #41806 - Class III - Biologics - University of Colorado Hospital,"Blood products, which were labeled with incorrect or missing information were distributed.",2012-08-27,2012-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64964 - Class II - Biologics - University of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, were distributed.",2013-11-19,2013-11-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64825 - Class II - Biologics - University of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, whose donor eligibilities were not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.",2013-12-04,2013-12-04,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64824 - Class II - Biologics - University of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, whose donor eligibilities  were not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.",2013-12-13,2013-12-13,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64823 - Class III - Biologics - University of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, whose donor eligibilities were not determined by using appropriate FDA-licensed, approved, or cleared donor screening tests, in accordance with the manufacturer's instructions, to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents or diseases, were distributed.",2014-01-27,2014-01-27,8,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68516 - Class II - Biologics - University of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, recovered from a donor with a medical history that indicated risk factors for communicable disease agents and diseases, were distributed.",2014-10-22,2014-10-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68517 - Class II - Biologics - University of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-12-17,2014-12-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64363 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"HCT/P allografts, mislabeled with an incorrect expiration date, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64364 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"HCT/P allografts, mislabeled with an incorrect expiration date, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64373 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"HCT/P allografts, mislabeled with an incorrect expiration date, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64374 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"HCT/P allografts, mislabeled with an incorrect expiration date, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64799 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"HCT/P allografts, mislabeled with an incorrect expiration date, were distributed.",2013-04-08,2013-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64431 - Class II - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human tissue allograft was processed in a manner that could cause contamination or cross-contamination during processing, and well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P.",2013-04-09,2013-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65087 - Class II - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human tissue allograft, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, was distributed.",2013-05-22,2013-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65157 - Class II - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human tissue allograft, processed in a manner that could cause contamination or cross-contamination during processing, as well as the introduction, transmission, or spread of communicable disease through the use of the HCT/P, was distributed.",2013-05-22,2013-05-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64847 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, mislabeled with extended expiration dates, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65599 - Class II - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, associated with positive culture results, were distributed.",2013-07-30,2013-07-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66153 - Class II - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human tissue allograft, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease, was distributed.",2013-10-18,2013-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66770 - Class I - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Tissue allografts, associated with positive pre-processing cultures for Clostridium, were distributed.",2013-12-19,2013-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67604 - Class II - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human tissue allografts, not processed in a manner that prevents the introduction, transmission, or spread of communicable disease through the use of the HCT/P, were distributed.",2014-02-28,2014-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68146 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human bone allografts, mislabeled with an extended expiration date, were distributed.",2014-04-29,2014-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68509 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human bone allografts, mislabeled with an incorrect expiration date, were distributed.",2014-07-14,2014-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69115 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"HCTP allografts, mislabeled with an extended expiration date, were distributed.",2014-10-02,2014-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69155 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"HCTP allografts, mislabeled with an extended expiration date, were distributed.",2014-10-02,2014-10-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70330 - Class III - Biologics - University Of Miami Miller School of Medicine Tissue Bank,"Human bone allografts, mislabeled with an incorrect expiration date, were distributed.",2015-03-03,2015-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #45352 - Class II - Biologics - University of Texas Medical Branch at Galveston (The),"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2012-11-26,2012-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #44134 - Class II - Biologics - University of Texas Medical Branch at Galveston (The),"Blood product, which was labeled as leukoreduced, but was not tested to verify the White Blood Cell count, was distributed.
.",2012-12-03,2012-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66206 - Class II - Drugs - University Rx Specialist, dba University Compounding Pharmacy",Lack of Assurance of Sterility: University Compounding Pharmacy is voluntarily recalling certain pharmacy products due to lack of assurance of sterility concerns.,2013-09-12,2013-09-12,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #64085 - Class III - Drugs - Upsher Smith Laboratories, Inc.",Labeling: Label Error On Declared Strength; Some bottles of product were missing the color-coded strength on the primary display panel of the label.,2013-01-16,2013-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63908 - Class II - Drugs - Upsher Smith Laboratories, Inc.",Failed Dissolution Test Requirements,2013-02-08,2013-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68049 - Class III - Drugs - Upsher Smith Laboratories, Inc.","Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.",2014-04-23,2014-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81174 - Class II - Drugs - Upsher Smith Laboratories, Inc.",Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.,2018-11-21,2018-11-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83501 - Class II - Drugs - Upsher Smith Laboratories, Inc.",Failed Dissolution Specifications,2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63024 - Class II - Biologics - Upstate New York Transplant Services,"Human corneas, recovered from donors whose donor eligibility may have been determined with inaccurate and/or  incomplete donor records, were distributed.",2012-08-31,2012-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63754 - Class II - Biologics - Upstate New York Transplant Services,"Blood product, which did not meet acceptable product specifications, was distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64381 - Class II - Biologics - Upstate New York Transplant Services,"Blood product, collected from a donor who reported living in a malarial endemic area within the past three years, was distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64450 - Class II - Biologics - Upstate New York Transplant Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2013-04-11,2013-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64472 - Class II - Biologics - Upstate New York Transplant Services,"Blood product, with platelet yield below the specified minimum requirement, was distributed.",2013-04-12,2013-04-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #49339 - Class III - Biologics - Upstate New York Transplant Services,"Blood products, collected from donors whose hematocrits were determined using an analyzer with an invalid QC control, were distributed.",2013-04-22,2013-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65858 - Class II - Biologics - Upstate New York Transplant Services,"Blood products, which were labeled as leukoreduced, but were not tested to verify the White Blood Cell count, were distributed.",2013-08-29,2013-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66573 - Class II - Biologics - Upstate New York Transplant Services,"Blood product, collected from a donor who had traveled to a malarial endemic area, was distributed.",2013-11-14,2013-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67654 - Class II - Biologics - Upstate New York Transplant Services,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-03-06,2014-03-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67743 - Class II - Biologics - Upstate New York Transplant Services,"Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2014-04-11,2014-04-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68324 - Class III - Biologics - Upstate New York Transplant Services,"Blood products, processed more than eight hours after collection, were distributed.",2014-06-24,2014-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69230 - Class III - Biologics - Upstate New York Transplant Services,"Plasma products, not prepared in accordance with specifications, were distributed.",2014-10-23,2014-10-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69650 - Class II - Biologics - Upstate New York Transplant Services,"Human corneas, recovered from a donor whose donor eligibility determination failed to ensure that the donor was free from risk factors for, and clinical evidence of infection due to relevant communicable disease agents and diseases, were distributed.",2014-11-06,2014-11-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61097 - Class II - Biologics - Upstate New York Transplant Services, Inc.","Corneas, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-08-14,2012-08-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76006 - Class II - Biologics - Upstate New York Transplant Services, Inc.","Blood product, did not meet the acceptable product specifications for release, was distributed.",2017-01-27,2017-01-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78485 - Class III - Biologics - Upstate New York Transplant Services, Inc.","Plasma product,  which was labeled with incorrect volume information, was distributed.",2017-11-29,2017-11-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79703 - Class II - Biologics - Upstate New York Transplant Services, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2018-04-27,2018-04-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84493 - Class II - Biologics - Upstate New York Transplant Services, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85989 - Class II - Biologics - Upstate New York Transplant Services, Inc.","Human corneas, recovered from a donor with risk factors for relevant communicable disease agents and diseases, were distributed.",2020-07-07,2020-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85990 - Class II - Biologics - Upstate New York Transplant Services, Inc.","Human corneas, recovered from a donor with risk factors for relevant communicable disease agents and diseases, were distributed.",2020-07-07,2020-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86311 - Class II - Biologics - Upstate New York Transplant Services, Inc.","Leukoreduced Red Blood Cells, Irradiated, collected from a donor who traveled to a malarial endemic area, were distributed.",2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91576 - Class II - Drugs - Urban Electric Power,CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.,2023-02-08,2023-02-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68336 - Class II - Drugs - US Compounding Inc,"Labeling: Label Error on Declared Strength; The outer light protective bags, where the ephedrine sulfate injection syringes are stored, were mislabeled with 25 mg/mL in big font and 5 mg/mL in small font, however, the actual syringes were correctly labeled as 25 mg/5 mL.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72179 - Class II - Drugs - US Compounding Inc,"Lack of Assurance of Sterility; The firm is recalling all sterile preparations that are within expiry due to deficient practices which may have an impact on sterility assurance. 	
",2015-11-17,2015-11-17,59,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74792 - Class I - Drugs - US Compounding Inc,Microbial Contamination of Non-Sterile Products;  microbial contamination with B. cepacia,2016-12-22,2016-12-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81982 - Class II - Drugs - US Compounding Inc,Labeling: Incorrect or Missing Lot and/or Exp Date: Labels are missing lot and expiration date and are printed as Lot# YYYDDYY@XX with a Beyond Use Date: MM/DD/YYY.,2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82012 - Class II - Drugs - US Compounding Inc,Lack of assurance of sterility.,2019-02-15,2019-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86929 - Class III - Drugs - US Compounding Inc,Labelling: Missing label.,2020-12-29,2020-12-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86997 - Class III - Drugs - US Compounding Inc,Labeling: Incorrect or Missing lot and/or expiration date: The lot number and BUD were printed in the incorrect position on the product label making it illegible.,2021-01-11,2021-01-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81784 - Class II - Drugs - US Pharmaceuticals Inc.,GMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sample,2019-02-04,2019-02-04,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83316 - Class II - Drugs - US Pharmaceuticals Inc.,CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.,2019-08-13,2019-08-13,18,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86868 - Class II - Drugs - US Pharmaceuticals Inc.,Lack Of CGMP:s Low weight fill tubes were identified in one lot of CVS Healing Ointment.,2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90257 - Class II - Drugs - US Specialty Formulations LLC,Lack of Assurance of Sterility,2022-06-06,2022-06-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82660 - Class II - Drugs - US WorldMeds, Llc",Presence of Precipitate: Appearance is Out of Specification for the reconstituted solution during 24-month stability time point analysis.,2019-05-10,2019-05-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82336 - Class I - Drugs - USA LESS Inc.,"Marketed Without An Approved NDA/ANDA: product tainted with undeclared sildenafil, an FDA approved drug for the treatment of male erectile dysfunction. The presence of sildenafil in Leopard Miracle Honey renders it an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.",2019-04-16,2019-04-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71011 - Class III - Biologics - Utah Lions Eye Bank,"Human Corneas, recovered from an ineligible donor, were distributed.",2015-04-21,2015-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85942 - Class I - Drugs - UVT INC,Chemical Contamination: Product contains undeclared methanol.,2020-07-24,2020-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69359 - Class III - Drugs - Valeant Pharmaceuticals International,"Subpotent Drug; for the active, HCB, and preservatives, Propylparaben and Butylparaben at the 18 month stability test point",2014-10-16,2014-10-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68572 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,"Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset, Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package insert.",2014-10-10,2014-10-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69445 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,Labeling: Incorrect or Missing Package Insert,2014-10-28,2014-10-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70123 - Class II - Drugs - Valeant Pharmaceuticals North America LLC,"Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.",2015-01-22,2015-01-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71328 - Class II - Drugs - Valeant Pharmaceuticals North America LLC,Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.,2015-06-08,2015-06-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72214 - Class II - Drugs - Valeant Pharmaceuticals North America LLC,Failed Dissolution Specifications: Failed 24 month dissolution testing.,2015-11-03,2015-11-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74223 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,"Labeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather than pseudoephedrine, on the carton face and carton top.",2016-06-15,2016-06-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70112 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,Failed Impurities/Degradation Specifications,2016-06-16,2016-06-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74532 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,Labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis.,2016-06-30,2016-06-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76743 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,Discoloration.,2017-04-17,2017-04-17,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77659 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.,2017-07-14,2017-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80662 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.,2018-08-03,2018-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81004 - Class II - Drugs - Valeant Pharmaceuticals North America LLC,"CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.",2018-10-22,2018-10-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82021 - Class III - Drugs - Valeant Pharmaceuticals North America LLC,Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.,2019-02-14,2019-02-14,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89209 - Class II - Drugs - Valgene Incorporated dba Cape Drugs,Lack of Processing Controls,2021-12-15,2021-12-15,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80326 - Class III - Drugs - Validus Pharmaceuticals, Inc.",Subpotency: lower than expected potency result was obtained at the 18 month stability time point.,2018-09-05,2018-09-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89186 - Class I - Drugs - Valisa MFG LLC,Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol,2022-01-10,2022-01-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90289 - Class I - Drugs - Valor Compounding Pharmacy, Inc DBA  Valor Compounding Pharmacy",Subpotent drug,2022-06-27,2022-06-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90539 - Class I - Drugs - Valor Compounding Pharmacy, Inc DBA  Valor Compounding Pharmacy",Subpotent and Superpotent Drug,2022-07-22,2022-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69633 - Class II - Drugs - Vann Healthcare Services Inc,Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.,2014-12-19,2014-12-19,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68075 - Class II - Biologics - Vascular Transplant Services, Inc","Ineligible tissue allograft, due to organism growth found through the sharing of information from same-zone microbiology reports via MS tissue, was distributed.",2014-12-19,2014-12-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80553 - Class II - Drugs - Vensun Pharmaceuticals Inc,Failed Tablet/Capsule Specifications: Tablet breakage,2018-07-27,2018-07-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82845 - Class II - Biologics - Versiti Illinois Inc,"Apheresis platelet product collected in which instrument validation and quality control testing was not performed, was distributed",2019-05-23,2019-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83635 - Class II - Biologics - Versiti Illinois Inc,"Plateletpheresis products, collected on an instrument undergoing equipment qualification, and for which quality control testing was not performed, were distributed.
",2019-09-06,2019-09-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85396 - Class II - Biologics - Versiti Illinois Inc,"Apheresis Red Blood Cell products with a high white blood cell count, were distributed.
",2020-04-25,2020-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85738 - Class III - Biologics - Versiti Illinois Inc,"Red Blood Cell products for which a visual inspection was not performed or documented was distributed.

",2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86398 - Class III - Biologics - Versiti Illinois Inc,"Red Blood Cells, not meeting product specifications, were distributed.",2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86862 - Class III - Biologics - Versiti Illinois Inc,"Blood product, not meeting product specifications, was distributed.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86871 - Class III - Biologics - Versiti Illinois Inc,"Apheresis Red Blood Cell product, for which a visual inspection was not performed or documented, was distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87007 - Class III - Biologics - Versiti Illinois Inc,"Leukoreduced, Red Blood Cells were distributed without a final visual check.",2020-12-23,2020-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87021 - Class II - Biologics - Versiti Illinois Inc,"Red Blood Cell products, which were exposed to unacceptable storage/shipping conditions, were distributed.",2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87122 - Class II - Biologics - Versiti Illinois Inc,"Leukoreduced, Apheresis Red Blood Cells, collected by automated equipment that was not validated for use, were distributed.",2021-02-05,2021-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87285 - Class III - Biologics - Versiti Illinois Inc,"Red Blood Cell products, for which a visual inspection was not performed or documented, were distributed.
",2021-02-12,2021-02-12,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88274 - Class III - Biologics - Versiti Illinois Inc,"Blood products, that lacked documented assurance of visual inspection, were distributed.",2021-08-09,2021-08-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89095 - Class II - Biologics - Versiti Illinois Inc,"Apheresis Red Blood Cells, which did not fall within the acceptable QC volume range, were distributed.",2021-12-10,2021-12-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90188 - Class II - Biologics - Versiti Illinois Inc,"Blood product, which did not meet acceptable product specifications, was distributed.",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91217 - Class II - Biologics - Versiti Illinois Inc,"Red Blood Cell product, collected from donor who received a piercing within 3 months of donation, was distributed.",2022-12-02,2022-12-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91394 - Class III - Biologics - Versiti Illinois Inc,"Leukoreduced Red Blood Cells, Irradiated, shipped without documenting the temperature, were distributed.",2022-12-30,2022-12-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91627 - Class III - Biologics - Versiti Illinois Inc,"Blood Product, returned to the blood center without confirmation that the product had been stored properly, was distributed.",2023-02-13,2023-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91629 - Class II - Biologics - Versiti Illinois Inc,"Leukoreduced Red Blood Cells, collected in a manner that compromises the sterility of the collection system, were distributed.",2023-02-13,2023-02-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82886 - Class II - Biologics - Versiti Indiana Inc,"Red Blood Cell product, collected from an unsuitable donor due to a donor screening deviation, was distributed.
",2019-06-11,2019-06-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84050 - Class III - Biologics - Versiti Indiana Inc,"Red Blood Cell product, labeled with an extended expiration date and visual inspection was not documented, was distributed.",2019-11-04,2019-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84060 - Class II - Biologics - Versiti Indiana Inc,"Blood product, collected from a donor who lived in a malarial endemic area, was distributed.
",2019-11-04,2019-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84417 - Class III - Biologics - Versiti Indiana Inc,"Platelet products, not meeting product specifications, were distributed.",2019-12-12,2019-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84651 - Class II - Biologics - Versiti Indiana Inc,"Blood products, which did not meet the acceptable product specifications, were distributed.",2020-02-21,2020-02-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85175 - Class III - Biologics - Versiti Indiana Inc,"Red Blood Cell product for which a visual inspection was not performed or documented was distributed.
",2020-03-11,2020-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85395 - Class II - Biologics - Versiti Indiana Inc,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2020-04-25,2020-04-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85716 - Class III - Biologics - Versiti Indiana Inc,"Apheresis Fresh Frozen Plasma, shipped at an unacceptable temperature, was distributed.",2020-06-09,2020-06-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85975 - Class III - Biologics - Versiti Indiana Inc,"Leukoreduced, Apheresis Red Blood Cells, labeled with a volume significantly higher than the product's actual volume, were distributed.",2020-07-20,2020-07-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86140 - Class II - Biologics - Versiti Indiana Inc,"Plateletpheresis product, for which the pH did not meet specifications, was distributed.",2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86860 - Class III - Biologics - Versiti Indiana Inc,"Red Blood Cells, not meeting product specifications, were distributed.",2020-11-25,2020-11-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86744 - Class III - Biologics - Versiti Indiana Inc,"Red Blood Cell products for which a visual inspection was not performed or documented, were distributed.
",2020-12-01,2020-12-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87111 - Class II - Biologics - Versiti Indiana Inc,"Apheresis Platelets, leukoreduced, with a platelet count lower than expected, were distributed.",2021-02-05,2021-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87253 - Class III - Biologics - Versiti Indiana Inc,"Misbranded plateletpheresis products were distributed.
",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87262 - Class II - Biologics - Versiti Indiana Inc,"Plateletpheresis product, for which the pathogen reduction process was not performed in accordance with specifications, was distributed.
",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87525 - Class II - Biologics - Versiti Indiana Inc,"Frozen Plasma, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2021-03-30,2021-03-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87821 - Class II - Biologics - Versiti Indiana Inc,"Plateletpheresis products, in which platelet yield did not meet specifications as a result of a component preparation deviation, were distributed.
",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88125 - Class III - Biologics - Versiti Indiana Inc,"Blood products, collected in a manner that may have compromised the sterility of the collection system, were distributed.",2021-07-13,2021-07-13,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88253 - Class II - Biologics - Versiti Indiana Inc,"Platelets, Pathogen Reduced, which were not manufactured in accordance to acceptable product specifications, were distributed.",2021-07-14,2021-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88236 - Class II - Biologics - Versiti Indiana Inc,"Frozen Plasma, which tested repeat reactive (RR) for Hepatitis, was distributed.",2021-07-21,2021-07-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88273 - Class II - Biologics - Versiti Indiana Inc,"Apheresis Red Blood Cell product with a high white blood cell count, was distributed.
",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88965 - Class II - Biologics - Versiti Indiana Inc,"Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89406 - Class II - Biologics - Versiti Indiana Inc,"Platelets, Pathogen Reduced, inappropriately prepared by recording the incorrect volume on label, were distributed.",2022-01-31,2022-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89518 - Class II - Biologics - Versiti Indiana Inc,"Leukoreduced Red Blood Cells, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2022-02-10,2022-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91430 - Class II - Biologics - Versiti Indiana Inc,"Plasma Frozen, Cryo Reduced, which was labeled as Fresh Frozen Plasma, was distributed.",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85428 - Class III - Biologics - Versiti Indiana Inc.,Leukoreduced Red Blood Cells were distributed without a final visual check.,2020-04-24,2020-04-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86223 - Class III - Biologics - Versiti Indiana Inc.,"Red Blood Cell products, identified as unsuitable due to a component preparation deviation or unexpected event, were distributed.
",2020-08-24,2020-08-24,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89729 - Class III - Biologics - Versiti Indiana Inc.,"Blood Products, which were irradiated longer than the allowed time frame, were distributed.",2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91667 - Class II - Biologics - Versiti Indiana Inc.,"Leukoreduced Red Blood Cells, Irradiated, for which documentation of irradiation was incomplete, were distributed.",2023-02-15,2023-02-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82051 - Class II - Biologics - Versiti Michigan Inc,"Blood product, collected from an ineligible donor, was distributed.",2019-02-08,2019-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84061 - Class II - Biologics - Versiti Michigan Inc,"Red Blood Cell products, not meeting product specifications, were distributed.
",2019-11-04,2019-11-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84063 - Class II - Biologics - Versiti Michigan Inc,"Plateletpheresis product, with a high platelet yield, was distributed.
",2019-11-04,2019-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84313 - Class III - Biologics - Versiti Michigan Inc,"Irradiated Red Blood Cells, Leukoreduced, which were missing an expiration date on the label, were distributed.",2019-11-26,2019-11-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83215 - Class III - Biologics - Versiti Michigan Inc,Red Blood Cells were issued without a documented visual inspection.,2020-01-08,2020-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85759 - Class II - Biologics - Versiti Michigan Inc,"Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
",2020-06-01,2020-06-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86950 - Class II - Biologics - Versiti Michigan Inc,"Blood products, collected from unsuitable donors due to a donor screening deviation or unexpected event, were distributed.
",2020-12-09,2020-12-09,12,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87212 - Class III - Biologics - Versiti Michigan Inc,"Leukoreduced, Red Blood Cells were distributed without a final visual check.",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87359 - Class II - Biologics - Versiti Michigan Inc,"Platelet products, not meeting product specifications, was distributed.
",2021-03-03,2021-03-03,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87360 - Class III - Biologics - Versiti Michigan Inc,"Misbranded Red Blood Cell product was distributed.
",2021-03-03,2021-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87896 - Class II - Biologics - Versiti Michigan Inc,"Apheresis Red Blood Cell products, labeled with incorrect or missing information, were distributed.",2021-06-07,2021-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88295 - Class III - Biologics - Versiti Michigan Inc,"Red Blood Cell products, for which a visual inspection was not performed or documented, were distributed.
",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88301 - Class III - Biologics - Versiti Michigan Inc,"Red Blood Cell products for which a visual inspection was not performed or documented, were distributed.
",2021-08-09,2021-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89408 - Class III - Biologics - Versiti Michigan Inc,"Blood products, for which storage temperature was not documented, were distributed.
",2022-01-28,2022-01-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89409 - Class III - Biologics - Versiti Michigan Inc,"Red Blood Cell products, for which storage temperature was not documented, were distributed.
",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90930 - Class III - Biologics - Versiti Michigan Inc,"Leukoreduced Apheresis Platelets, Irradiated, with no record of proper temperature during shipping, were distributed.",2022-10-17,2022-10-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91025 - Class II - Biologics - Versiti Michigan Inc,"Blood Products, collected by automated equipment that was not validated for use, were distributed.",2022-11-04,2022-11-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91510 - Class II - Biologics - Versiti Michigan Inc,"Blood products, collected in a manner with a potential for air contamination, were distributed.
",2023-01-20,2023-01-20,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91512 - Class III - Biologics - Versiti Michigan Inc,"Blood Products, exposed to unacceptable shipping temperatures, were distributed.",2023-01-20,2023-01-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91585 - Class II - Biologics - Versiti Michigan Inc,"Leukoreduced Apheresis Platelets, PAS, collected in a manner that compromised the sterility of the collection system, was distributed.",2023-02-10,2023-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91587 - Class III - Biologics - Versiti Michigan Inc,"Leukoreduced Apheresis Red Blood Cells, Irradiated, which were stored at a higher temperature than acceptable, were distributed.",2023-02-10,2023-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87279 - Class II - Biologics - Versiti Wisconsin, Inc","Plateletpheresis products, for which white blood cell count testing was not performed, were distributed.
",2021-02-12,2021-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89019 - Class II - Biologics - Versiti Wisconsin, Inc","Blood products, which were not quarantined subsequent to receiving information regarding a post donation illness, were distributed.",2021-11-18,2021-11-18,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88995 - Class II - Biologics - Versiti Wisconsin, Inc","Red Blood Cell product, possibly contaminated with air, was distributed.
",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90055 - Class II - Biologics - Versiti Wisconsin, Inc","Leukoreduced Red Blood Cells, collected from a donor who may have recently traveled to a malarial endemic area, were distributed.",2022-05-09,2022-05-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90351 - Class II - Biologics - Versiti Wisconsin, Inc","Red Blood Cell product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2022-06-12,2022-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90352 - Class II - Biologics - Versiti Wisconsin, Inc","Leukoreduced Red Blood Cells, collected from an ineligible donor, were distributed.",2022-09-20,2022-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91545 - Class II - Biologics - Versiti Wisconsin, Inc","Platelets, Pathogen Reduced, not tested for pH, were distributed.",2023-02-01,2023-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91588 - Class II - Biologics - Versiti Wisconsin, Inc","Platelet products, collected in which instrument validation and quality control testing was not performed, were distributed.
",2023-02-01,2023-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91589 - Class II - Biologics - Versiti Wisconsin, Inc","Platelet products, collected in which instrument validation and quality control testing was not performed, were distributed.
",2023-02-01,2023-02-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #91547 - Class II - Biologics - Versiti Wisconsin, Inc","Leukoreduced Apheresis Platelets, in which component preparation was not done in accordance with specifications, was distributed.",2023-02-02,2023-02-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61518 - Class III - Drugs - Vertrauen Chemie Solutions Inc,Subpotent (Single Ingredient Drug): The firm is recalling the product because the product is subpotent and does not meet the labeled 0.25% zinc pyrithione level.,2012-06-14,2012-06-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88653 - Class II - Drugs - Vi-Jon, Inc.","Labeling: Label Mix-Up.The recall has been initiated after receiving one complaint about incorrect labeling.The primary label on the front and back label on some of the bottles have 70% Isopropyl Alcohol affixed to the containers. However, the product inside the bottle is Hydrogen Peroxide, Topical Solution USP with active ingredient Hydrogen Peroxide (stabilized) 3%, 32 FL Ounces",2021-09-15,2021-09-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89706 - Class II - Drugs - Vi-Jon, Inc.","Labeling: Label Mix-Up-The primary label on the front of the bottles have 50% Isopropyl Alcohol affixed to the containers. However, the product inside the bottle is Hydrogen Peroxide, Topical Solution USP with active ingredient Hydrogen Peroxide (stabilized) 3%, 32 FL Ounces.  The back label is correct. Product is packaged in dark bottles.",2022-03-03,2022-03-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65761 - Class III - Drugs - Vi-Jon, Inc.",Microbial Contamination of Non-Sterile Products: This product is being recalled because a stability sample was found to be contaminated with Burkholderia contaminans.,2013-07-22,2013-07-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77517 - Class II - Drugs - Vi-Jon, Inc.",Presence of foreign substance: glass particle,2017-06-21,2017-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77771 - Class II - Drugs - Vi-Jon, Inc.","Microbial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis.",2017-08-03,2017-08-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78099 - Class III - Drugs - Vi-Jon, Inc.",Failed Impurities/Degradation Specifications.,2017-10-05,2017-10-05,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78101 - Class III - Drugs - Vi-Jon, Inc.",Failed Stability Specifications,2017-11-10,2017-11-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82215 - Class II - Drugs - Vi-Jon, Inc.",Cross Contamination: Presence of IPA in finished product.,2019-03-07,2019-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90128 - Class II - Drugs - Vi-Jon, LLC","Superpotent Drug: product complaint for milky blue appearance and consistency, further investigation by the firm found the recalled lots out of specification for the four active ingredients.",2022-05-27,2022-05-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90453 - Class II - Drugs - Vi-Jon, LLC",Defective Container: Product may leak when squeezed or when not in an upright position determined to be due to defects in the bottle neck finish and insufficient tightening.,2022-06-21,2022-06-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90443 - Class I - Drugs - Vi-Jon, LLC",Microbial Contamination of a Non-Sterile Products: Testing of product  onfirmed the presence of Gluconacetobacter Liquefaciens,2022-07-05,2022-07-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90509 - Class II - Drugs - Vi-Jon, LLC","Labeling: Label Mix-Up-The primary label on the front of the bottles have Hydrogen Peroxide affixed to the front and back of the containers. However, the product inside the bottle is 70% Isopropyl Alcohol.",2022-07-14,2022-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90546 - Class II - Drugs - Vi-Jon, LLC",Cross Contamination With Other Products: Product is cross contaminated with low levels of isopropyl alcohol.,2022-07-15,2022-07-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90599 - Class I - Drugs - Vi-Jon, LLC","Microbial contamination of non-sterile products., CGMP Deviations, CGMP Deviations;",2022-09-09,2022-09-09,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63051 - Class II - Biologics - Viacord Processing Laboratory,"Umbilical cord blood stem cells, not tested in accordance with the manufacturer's instructions to adequately and appropriately reduce the risk of transmission of relevant communicable disease agents, were distributed.",2012-08-31,2012-08-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88609 - Class III - Drugs - Viatris,Failed Impurities/Degradation Specifications; out of specification for Related Compound,2021-09-14,2021-09-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88542 - Class II - Drugs - Viatris,Failed Dissolution Specifications,2021-09-24,2021-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90045 - Class II - Drugs - Viatris Inc,Failed Dissolution Specifications: low out-of-specification dissolution test results observed.,2022-05-03,2022-05-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90091 - Class II - Drugs - Viatris Inc,Failed Dissolution Specifications: low out of specification results for dissolution.,2022-05-06,2022-05-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90886 - Class II - Drugs - Viatris Inc,Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.,2022-09-23,2022-09-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90974 - Class I - Drugs - Viatris Inc,Presence of Particulate Matter: Product complaint for the presence of glass particles in a syringe.,2022-11-08,2022-11-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91038 - Class II - Drugs - Viatris Inc,Failed Tablet/Capsule Specifications: Tablets exceeds specification for weight and thickness.,2022-11-16,2022-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62541 - Class II - Drugs - Victus, Inc.",Misbranded,2012-08-17,2012-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67606 - Class III - Drugs - ViiV Healthcare Company,Cross Contamination with Other Products: Product contains Promacta (eltrombopag).,2014-04-01,2014-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86069 - Class II - Drugs - Vilvet Pharmaceuticals Inc.,cGMP deviations,2020-08-06,2020-08-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71863 - Class II - Drugs - Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals,Failed Dissolution Specifications,2015-09-01,2015-09-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76272 - Class III - Drugs - Vintage Pharmaceuticals LLC dba Qualitest Pharmaceuticals,Failed Impurities/ Degradation Specifications,2017-01-24,2017-01-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71980 - Class III - Drugs - Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals",Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.,2015-08-20,2015-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72493 - Class III - Drugs - Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals",Failed Stability Specifications: Out of Specification results obtained for preservative butylparaben.,2015-11-02,2015-11-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #72397 - Class II - Drugs - Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals",Presence of Particulate Matter.,2015-11-13,2015-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76087 - Class III - Drugs - Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals",Failed Stability Specifications,2017-01-03,2017-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77210 - Class III - Drugs - Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals",Superpotent Drug: above specification for the assay.,2017-05-23,2017-05-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88033 - Class II - Drugs - VIONA PHARMACEUTICALS INC,CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.,2021-06-24,2021-06-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89305 - Class II - Drugs - VIONA PHARMACEUTICALS INC,CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.,2022-01-21,2022-01-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88960 - Class I - Drugs - VIRGIN SCENT INC,"Chemical Contamination: presence of benzene, acetaldehyde, and acetal., CGMP Deviations: Other lots recalled because they were manufactured using common ingredients as the contaminated lot",2022-04-22,2022-04-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63832 - Class II - Biologics - Virginia Blood Services,"Blood product, labeled as leukoreduced without the assurance that it met the criteria for a leukoreduced product, was distributed.",2012-12-31,2012-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64254 - Class II - Biologics - Virginia Blood Services,"Blood products, which did not meet the acceptable product specifications, were distributed.",2013-03-11,2013-03-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65975 - Class III - Biologics - Virginia Blood Services,"Blood products, labeled with an incorrect expiration date, were distributed.",2013-09-09,2013-09-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67273 - Class II - Biologics - Virginia Blood Services,"Blood products, collected from a donor who received a tattoo within one year of donation, were distributed.",2014-02-20,2014-02-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67766 - Class II - Biologics - Virginia Blood Services,"Blood products, collected from a donor who was taking the medication Propecia, were distributed.",2014-04-11,2014-04-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68851 - Class III - Biologics - Virginia Blood Services,"Blood product, labeled with an incorrect expiration date, was distributed.",2014-08-20,2014-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69169 - Class III - Biologics - Virginia Blood Services,"Blood product, collected from a donor whose  suitability to donate was not adequately determined, was distributed.",2014-10-22,2014-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69352 - Class III - Biologics - Virginia Blood Services,"Blood product, collected from a donor whose suitability to donate was not adequately determined, was distributed.",2014-11-06,2014-11-06,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70206 - Class III - Biologics - Virginia Blood Services,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2015-02-04,2015-02-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70907 - Class II - Biologics - Virginia Blood Services,"Blood product, inappropriately released from quarantine for which malarial travel history was disclosed, was distributed.",2015-04-29,2015-04-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71150 - Class II - Biologics - Virginia Blood Services,"Blood product,  in which labeling/labels applied to blood unit or product incorrect or missing information, was distributed.",2015-05-29,2015-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71981 - Class II - Biologics - Virginia Blood Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2015-09-10,2015-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72256 - Class II - Biologics - Virginia Blood Services,"Blood products, with a possibility of air contamination, were distributed.",2015-10-08,2015-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72807 - Class III - Biologics - Virginia Blood Services,"Blood products, collected from a therapeutic donor with polycythemia and hemochromatosis, were distributed.",2015-12-17,2015-12-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73988 - Class II - Biologics - Virginia Blood Services,"Plateletpheresis products, not meeting product specifications, were distributed.",2016-05-26,2016-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74643 - Class III - Biologics - Virginia Blood Services,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2016-08-24,2016-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75184 - Class II - Biologics - Virginia Blood Services,"Platelet units, for which product testing did not meet specifications, were distributed.",2016-10-25,2016-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75401 - Class II - Biologics - Virginia Blood Services,"Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2016-10-26,2016-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76850 - Class II - Biologics - Virginia Blood Services,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2017-04-04,2017-04-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78475 - Class II - Biologics - Virginia Blood Services,"Apheresis product, in which residual WBC count was not performed, was distributed.
",2017-11-09,2017-11-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78322 - Class III - Biologics - Virginia Blood Services,"Red cell products, for which the labeling applied to blood units contained incorrect expiration dates, were distributed.",2017-11-16,2017-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81307 - Class II - Biologics - Virginia Blood Services,"Blood products, not meeting product specifications, were distributed.",2018-10-25,2018-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81334 - Class II - Biologics - Virginia Blood Services,"Blood product, not meeting product specifications, was distributed.",2018-10-25,2018-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75146 - Class I - Drugs - VIRTUS PHARMACEUTICALS OPCO II L,Failed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.,2016-12-22,2016-12-22,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76103 - Class III - Drugs - VIRTUS PHARMACEUTICALS OPCO II L,cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.,2016-12-28,2016-12-28,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73480 - Class III - Drugs - Virtus Pharmaceuticals, Llc","Tablets/Capsules Imprinted with Wrong ID; product debossed with an incorrect punch. Bottles could contain tablets debossed with V259 (debossing for PreTab) instead of the correct punch, V264 (debossing for Virt-Nate).",2016-03-14,2016-03-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73295 - Class III - Drugs - Virtus Pharmaceuticals, Llc",Defective Delivery System: Product may contain leaking capsules.,2016-04-01,2016-04-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74251 - Class III - Drugs - Virtus Pharmaceuticals, Llc",Chemical Contamination: Bottles may contain broken dessicants,2016-06-20,2016-06-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74339 - Class III - Drugs - Virtus Pharmaceuticals, Llc",Defective delivery system: Softgel capsules are leaking.,2016-06-22,2016-06-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89395 - Class II - Drugs - VistaPharm, Inc.",Failed Stability Specifications,2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90943 - Class II - Drugs - VistaPharm, Inc.",cGMP Deviations: Out of specification for assay of one of the preservative ingredients.,2022-10-21,2022-10-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62405 - Class II - Drugs - VistaPharm, Inc.","Impurities/Degradation Products: exceeded specification at 3 month stability testing
",2012-07-12,2012-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62421 - Class II - Drugs - VistaPharm, Inc.","Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume.
",2012-08-02,2012-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62893 - Class II - Drugs - VistaPharm, Inc.",Defective container; lidding deformity allows the contained product to transpire causing potential viscosity and assay failures. The viscosity and assay failures were due to the loss of moisture. The loss of moisture caused the viscosity to increase and assay to increase relative to the sample volume,2012-08-21,2012-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62887 - Class III - Drugs - VistaPharm, Inc.","Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed ""5 mL x 50,"" instead of ""10 mL x 50,""",2012-08-29,2012-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65756 - Class II - Drugs - VistaPharm, Inc.",Failed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.,2013-08-21,2013-08-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66945 - Class II - Drugs - VistaPharm, Inc.",Defective Container: A lidding deformity allowed for the product to have out of specification results for assay and viscosity at the12 month stability timepoint.,2013-12-06,2013-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69250 - Class II - Drugs - VistaPharm, Inc.",Defective Container: Product leaks when inverted.,2014-10-09,2014-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71601 - Class III - Drugs - VistaPharm, Inc.",Defective Container: Lids on unit dose cups are not fully qualified.,2015-09-28,2015-09-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73909 - Class II - Drugs - VistaPharm, Inc.",Defective Container: Excess lidding material accumulation between the seal and the cup resulting in the lid not properly adhering and allowing leakage.,2016-05-04,2016-05-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75752 - Class II - Drugs - VistaPharm, Inc.","Microbial Contamination of Non-Sterile Products: bulk solution tested positive for the presence of the bacteria, Burkholderia cepacia.",2016-11-22,2016-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75650 - Class II - Drugs - VistaPharm, Inc.",CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.,2017-02-02,2017-02-02,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75640 - Class II - Drugs - VistaPharm, Inc.",Defective Container: Leakage of unit dose cups that may occur at the seal.,2017-02-06,2017-02-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77319 - Class III - Drugs - VistaPharm, Inc.",Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification.,2017-05-31,2017-05-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77638 - Class II - Drugs - VistaPharm, Inc.",Microbial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.,2017-08-01,2017-08-01,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77998 - Class III - Drugs - VistaPharm, Inc.",Labeling: Not Elsewhere Classified; product is incorrectly labeled as Class III controlled substance instead of  Class II controlled substance,2017-09-12,2017-09-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #81684 - Class III - Drugs - VistaPharm, Inc.",Failed Impurities/Degradation Specifications:Out of specification for impurities.,2019-01-07,2019-01-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85888 - Class III - Drugs - VistaPharm, Inc.",Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification.,2020-07-08,2020-07-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86486 - Class III - Drugs - VistaPharm, Inc.",Failed Impurties/Degradation Specifications: out of specification results for an impurity for one lot,2020-10-05,2020-10-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88862 - Class II - Drugs - Vita Pharmacy, LLC dba Talon Compounding Pharmacy",Lack of assurance of sterility,2021-11-08,2021-11-08,130,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89803 - Class II - Drugs - Vitae Enim Vitae Scientific, Inc.",Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.,2022-04-05,2022-04-05,4,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74539 - Class II - Drugs - Vital Care Compounder,Lack of Assurance of Sterility:  Aluminum crimps do not fully seal the rubber stopper to the vials.,2016-06-28,2016-06-28,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #74591 - Class II - Drugs - Vital Care Compounder, LLC",Lack of Assurance of Sterility:  Aluminum crimps do not fully seal the rubber stopper to the vial on all containers.,2016-07-07,2016-07-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77978 - Class II - Drugs - Vital Rx, Inc. dba Atlantic Pharmacy and Compounding",Lack of Assurance of Sterility .,2018-01-02,2018-01-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80000 - Class II - Drugs - Vitalab Pharmacy, Inc","Lack of assurance of sterility: Upon review of recent 3rd party environmental certification documentation, it was determined that airflow patterns may not be sufficient to support the aseptic production of certain injectable drug products.",2018-05-09,2018-05-09,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81305 - Class II - Biologics - Vitalant,"Blood products, not meeting product specifications, were distributed.",2018-10-25,2018-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81306 - Class II - Biologics - Vitalant,"Blood product, not meeting product specifications, was distributed.

",2018-10-25,2018-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81330 - Class II - Biologics - Vitalant,"Blood products, not meeting product specifications, were distributed.",2018-10-25,2018-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81333 - Class II - Biologics - Vitalant,"Blood products, not meeting product specifications, were distributed.",2018-10-25,2018-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81338 - Class II - Biologics - Vitalant,"Blood products, not meeting product specifications, were distributed.",2018-10-25,2018-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81388 - Class II - Biologics - Vitalant,"Blood products, not meeting product specifications, were distributed.",2018-10-25,2018-10-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81137 - Class III - Biologics - Vitalant,"Blood product, which may have reached an unacceptable temperatures during storage, was distributed.",2018-10-31,2018-10-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81410 - Class II - Biologics - Vitalant,"Blood products, not meeting product specifications, were distributed.",2018-11-13,2018-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81411 - Class II - Biologics - Vitalant,"Blood products, not meeting product specifications, were distributed.",2018-11-13,2018-11-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81467 - Class II - Biologics - Vitalant,"Blood products, not meeting product specifications, were distributed.",2018-11-27,2018-11-27,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81651 - Class III - Biologics - Vitalant,"Blood product, for which the labeling was missing information, was distributed.",2018-12-12,2018-12-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81998 - Class III - Biologics - Vitalant,"Blood products, collected for a donor who did not meet acceptance criteria, were distributed.",2019-02-20,2019-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82492 - Class III - Biologics - Vitalant,"Blood products, where donor testing was incorrectly performed for evidence of infection due to a relevant transfusion-transmitted infection and were distributed.",2019-04-23,2019-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82495 - Class III - Biologics - Vitalant,"Blood products, where donor testing was incorrectly performed for evidence of infection due to a relevant transfusion-transmitted infection and were distributed.",2019-04-23,2019-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82589 - Class III - Biologics - Vitalant,"Blood products, where donor testing was incorrectly performed for evidence of infection due to a relevant transfusion-transmitted infection and were distributed.",2019-04-23,2019-04-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83222 - Class III - Biologics - Vitalant,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-07-01,2019-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83552 - Class III - Biologics - Vitalant,"Red Blood Cells, not meeting product specifications, were distributed.",2019-08-12,2019-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83394 - Class II - Biologics - Vitalant,"Red Blood Cell products, for which the manufacturer's instructions for  leukoreduction were not followed, were distributed.",2019-08-13,2019-08-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83463 - Class III - Biologics - Vitalant,"Blood product, for which donor eligibility screening was incorrectly performed, was distributed.",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83522 - Class III - Biologics - Vitalant,Red Blood Cell product for which a visual inspection was not performed or documented was distributed.,2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83541 - Class III - Biologics - Vitalant,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2019-08-19,2019-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83512 - Class II - Biologics - Vitalant,"Plateletpheresis products, in which residual WBC count was not performed, were distributed.
",2019-08-28,2019-08-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83656 - Class II - Biologics - Vitalant,"Apheresis Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83726 - Class III - Biologics - Vitalant,"Apheresis Red Blood Cell product for which a visual inspection was not performed or documented, was distributed
",2019-09-20,2019-09-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83974 - Class III - Biologics - Vitalant,Misbranded red blood cells were distributed.,2019-10-04,2019-10-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83860 - Class III - Biologics - Vitalant,Leukoreduced Red Blood Cells were distributed without a final visual check.,2019-10-11,2019-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83859 - Class II - Biologics - Vitalant,"Blood Product, collected from a donor who was at a higher risk for variant Creutzfeldt-Jakob disease (vCJD).",2019-10-25,2019-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83981 - Class III - Biologics - Vitalant,Plasma frozen within 24 hours after phlebotomy held at room temperature for up to 24 hours was distributed without a final visual check.,2019-10-25,2019-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83982 - Class III - Biologics - Vitalant,Apheresis Leukoreduced Red Blood Cells were distributed without a final visual check.,2019-10-25,2019-10-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84164 - Class III - Biologics - Vitalant,"Blood product for which a visual inspection was not performed or documented was distributed
",2019-11-05,2019-11-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83938 - Class II - Biologics - Vitalant,"Blood products, labeled as leukoreduced without White Blood Cell count testing, were distributed.",2019-11-15,2019-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84355 - Class II - Biologics - Vitalant,"Blood products, labeled with the incorrect RBC antigen phenotype, were distributed.",2019-12-20,2019-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84553 - Class III - Biologics - Vitalant,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84565 - Class III - Biologics - Vitalant,"Apheresis Red Blood Cell product for which a visual inspection was not performed or documented, was distributed.
",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84592 - Class II - Biologics - Vitalant,"Apheresis Red Blood Cells, Leukoreduced and Irradiated, for which donor eligibility screening was incorrectly performed, were distributed.",2020-01-15,2020-01-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84667 - Class II - Biologics - Vitalant,"Blood products, for which donor eligibility screening was incorrectly performed, were distributed.",2020-01-21,2020-01-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84504 - Class III - Biologics - Vitalant,"Blood product, that lacked assurance of proper distribution and storage requirements, was distributed.",2020-01-23,2020-01-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84623 - Class II - Biologics - Vitalant,"Blood products, collected from a donor whose suitability to donate was not adequately determined, were distributed.",2020-02-10,2020-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84903 - Class III - Biologics - Vitalant,"Red Blood Cell product for which a visual inspection was not performed or documented, was distributed.",2020-02-18,2020-02-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84868 - Class III - Biologics - Vitalant,"Blood product, lacking a documented visual inspection, was distributed.",2020-03-12,2020-03-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85130 - Class III - Biologics - Vitalant,"Blood product, collected from a donor whose donor eligibility was incomplete, was distributed.",2020-04-08,2020-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85543 - Class II - Biologics - Vitalant,"Red Blood cells, possibly misbranded for a membrane antigen, were distributed.",2020-04-23,2020-04-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85458 - Class II - Biologics - Vitalant,"Blood Products, with lack of assurance of sterility, were distributed.",2020-04-24,2020-04-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85345 - Class III - Biologics - Vitalant,"Blood product, collected from a donor for whom donor eligibility was not adequately determined, was distributed.",2020-04-28,2020-04-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86029 - Class II - Biologics - Vitalant,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2020-08-07,2020-08-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86195 - Class II - Biologics - Vitalant,"Blood products, where associated blood sample collection tubes were mislabeled, were distributed.",2020-08-11,2020-08-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86303 - Class III - Biologics - Vitalant,Leukoreduced Red Blood Cells were distributed without a final visual check,2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86304 - Class II - Biologics - Vitalant,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2020-09-08,2020-09-08,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86671 - Class II - Biologics - Vitalant,"Blood product, labeled incorrectly for RBC antigen phenotyping, was distributed.",2020-11-12,2020-11-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86728 - Class III - Biologics - Vitalant,"Apheresis Red Blood Cell products,  for which a visual inspection was not performed or documented were distributed.
",2020-12-01,2020-12-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87117 - Class III - Biologics - Vitalant,"Plateletpheresis products, for which was reissued without a record of proper temperature maintenance, were distributed.",2021-01-14,2021-01-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87235 - Class II - Biologics - Vitalant,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2021-02-19,2021-02-19,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87460 - Class III - Biologics - Vitalant,"Blood Product, for which donor eligibility was incomplete, was distributed.
",2021-03-09,2021-03-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87611 - Class II - Biologics - Vitalant,"Blood product, which did not meet the acceptable product specifications for release, was distributed.",2021-03-29,2021-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88201 - Class II - Biologics - Vitalant,"Apheresis Red Blood Cell products, for which donor eligibility was incomplete, were distributed.
",2021-07-12,2021-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88518 - Class II - Biologics - Vitalant,"Leukoreduced Apheresis Platelets, with a platelet yield below the acceptable yield, were distributed.",2021-09-02,2021-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88566 - Class II - Biologics - Vitalant,"Leukoreduced Apheresis Platelets, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count, were distributed.",2021-09-10,2021-09-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88433 - Class III - Biologics - Vitalant,"Apheresis Red Blood Cell product, not meeting product specifications, was distributed. 
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88569 - Class III - Biologics - Vitalant,"Blood product, for which donor eligibility was incomplete, was distributed.
",2021-09-16,2021-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88714 - Class II - Biologics - Vitalant,"Blood product, with the incorrect phenotype, was distributed.",2021-09-24,2021-09-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88969 - Class II - Biologics - Vitalant,"Red Blood Cell products, for which routine testing/testing performed was labeled incorrectly, were distributed.
",2021-11-23,2021-11-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89047 - Class II - Biologics - Vitalant,"Blood Products, for which donor eligibility was incomplete, were distributed.
",2021-12-09,2021-12-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89339 - Class II - Biologics - Vitalant,Misbranded Leukoreduced Red Blood Cells were distributed.,2022-01-18,2022-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89372 - Class III - Biologics - Vitalant,"Leukoreduced Red Blood Cells, in which the donor's hemoglobin was documented non-concurrently, was distributed.",2022-01-28,2022-01-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89505 - Class II - Biologics - Vitalant,"Blood products, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count, were distributed.",2022-02-10,2022-02-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89589 - Class II - Biologics - Vitalant,"Red Blood Cell product, for which donor eligibility was incomplete, was distributed.
",2022-03-01,2022-03-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90217 - Class II - Biologics - Vitalant,"Red Blood Cell product, for which donor eligibility was incomplete, was distributed. 
",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90310 - Class III - Biologics - Vitalant,"Red Blood Cell products, collected from a donor for whom donor suitability was not adequately determined, were distributed.
",2022-06-12,2022-06-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91470 - Class III - Biologics - Vitalant,"Plateletpheresis products, for which Syphilis testing was incorrectly documented, were distributed.",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91471 - Class III - Biologics - Vitalant,"Red Blood Cell product, for which Syphilis testing was incorrectly documented, was distributed.",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #61256 - Class I - Drugs - Vitamin Best Buy,"Marketed Without an Approved ANDA/NDA:  presence of sildenafil, Marketed Without an Approved ANDA/NDA: presence of sildenafil., Marketed Without an Approved ANDA/NDA: presence of sibutramine",2012-09-26,2012-09-26,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77841 - Class I - Drugs - Vitility,"Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared sildenafil, an FDA approved drug for the treatment of erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and therefore, subject to recall.",2017-10-24,2017-10-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87987 - Class I - Biologics - Vivex Biologicals Inc.,"Bone, with positive bacterial detection testing, was distributed.",2021-06-04,2021-06-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89946 - Class II - Biologics - Vivex Biologicals Inc.,"Bone, processed without conducting the antibiotic soak for bioburden reduction, was distributed.",2022-04-06,2022-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90036 - Class II - Biologics - Vivex Biologicals Inc.,"Bone, processed without conducting the antibiotic soak for bioburden reduction, was distributed.",2022-04-20,2022-04-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90156 - Class II - Biologics - Vivex Biologicals Inc.,"HCT/Ps, processed without conducting the antibiotic soak for bioburden reduction, were distributed.",2022-05-17,2022-05-17,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90157 - Class II - Biologics - Vivex Biologicals Inc.,"Bone, processed without conducting the antibiotic soak for bioburden reduction, was distributed.",2022-05-17,2022-05-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86428 - Class I - Drugs - Volu-Sol, Inc.",Marketed Without an Approved NDA/ANDA: product lists methanol as an inactive ingredient on the label.,2020-10-14,2020-10-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74606 - Class II - Drugs - W & C dba The Apothecary,"Lack of assurance of sterility:  This recall includes of all unexpired lots medications containing Calcium Gluconate, Papaverine, Phentolamine, and /or Prostaglandin) due to unsubstantiated validation of beyond use dating.",2016-09-16,2016-09-16,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66330 - Class II - Drugs - Walgreen Company,Lack of Assurance of Sterility: Walgreens Specialty Pharmacy is recalling one lot of Progesterone in Ethyl Oleate sterile injection due to concerns of sterility assurance with the specialty pharmacy's independent testing laboratory.,2013-09-26,2013-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70118 - Class II - Drugs - Walgreens Infusion Services,Lack of sterility assurance.,2015-01-16,2015-01-16,36,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72594 - Class II - Drugs - Walgreens Infusion Services,Lack of Assurance of Sterility,2015-12-30,2015-12-30,33,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85955 - Class II - Drugs - WALKER EMULSIONS INC,Incorrect/Undeclared Excipients: Notification received from Health Canada that DA-2I Ethanol is a type not an approved for use in Hand Sanitizer.,2020-07-28,2020-07-28,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70155 - Class I - Drugs - Wallcur Incorporated,Non-sterility: Product is made in a non-sterile facility and is not intended for use in humans or animals.,2015-04-06,2015-04-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90359 - Class I - Drugs - Walmart Inc,"Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain and inflammation., Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.",2022-06-24,2022-06-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89686 - Class I - Drugs - Walmart Stores,"Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.",2022-03-29,2022-03-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73336 - Class II - Drugs - Walter's Pharmacy,Lack of Assurance of Sterility,2016-03-29,2016-03-29,13,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62141 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62298 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.",2012-07-19,2012-07-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #62840 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, which were collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), were distributed",2012-09-06,2012-09-06,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #68922 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, collected from a donor considered to be at increased risk for Creutzfeldt-Jakob Disease (CJD), were distributed.",2014-08-21,2014-08-21,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69017 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood product, in which donor gave history which warranted deferral or follow up and was not deferred or follow up questions were not asked, was distributed.",2014-09-09,2014-09-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69019 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2014-09-09,2014-09-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70214 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, collected from a donor considered to be at increased risk for variant Creutzfeld-Jakob Disease (vCJD), were distributed.",2015-01-30,2015-01-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71108 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2015-06-04,2015-06-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #71768 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2015-08-27,2015-08-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73757 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, collected from an ineligible donor, were distributed.",2016-04-07,2016-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #79720 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, for which donor eligibility screening for vCJD risk was performed incorrectly, were distributed.",2018-04-30,2018-04-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83309 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Leukoreduced Pooled Platelets, in which platelet yield did not meet product specifications, was distributed.",2019-08-01,2019-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83577 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2019-08-29,2019-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84391 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood product, which did not meet acceptable product specifications, was distributed.",2019-12-31,2019-12-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87361 - Class II - Biologics - Walter L. Shepeard Community Blood Center, Inc.","Blood products, associated with a blood bank software glitch, were distributed.",2021-02-23,2021-02-23,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70419 - Class II - Biologics - Walter Reed National Military Medical Center,"Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.",2015-03-04,2015-03-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71639 - Class III - Biologics - Walter Reed National Military Medical Center,"Blood products, which donor screening/donor record incomplete or incorrect, were distributed.",2015-08-20,2015-08-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72443 - Class II - Biologics - Walter Reed National Military Medical Center,"Blood product, collected from a donor for whom donor suitability was not adequately determined, was distributed.
",2015-11-04,2015-11-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77973 - Class II - Biologics - Walter Reed National Military Medical Center,"Platelets, not meeting product specification requirements, were distributed.",2017-08-29,2017-08-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81994 - Class II - Biologics - Walter Reed National Military Medical Center,"Blood products, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.
",2019-02-07,2019-02-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88212 - Class II - Biologics - Walter Reed National Military Medical Center,"Plasma, Frozen, for which donor eligibility screening was incomplete, were distributed.",2021-07-12,2021-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89224 - Class II - Biologics - Walter Reed National Military Medical Center,"Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2021-12-23,2021-12-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91432 - Class II - Biologics - Walter Reed National Military Medical Center,"Leukoreduced Red Blood Cells, which were labeled as leukocytes reduced but failed the monthly QC residual white blood cell count, were distributed.",2023-01-12,2023-01-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64014 - Class III - Drugs - Warner Chilcott Company LLC,Failed Impurity/Degradation Specifications due to moisture ingress in individual bottles,2013-01-31,2013-01-31,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64459 - Class III - Drugs - Warner Chilcott Company LLC,Chemical contamination: Firm's inspection discovered the  presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.,2013-04-30,2013-04-30,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65461 - Class II - Drugs - Warner Chilcott US LLC,Failed Impurities/Degradation Specifications: unspecified degradation product,2013-07-26,2013-07-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90202 - Class II - Drugs - Washington Homeopathic Products, Inc.",cGMP deviations,2022-06-10,2022-06-10,17,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84213 - Class II - Drugs - Washington Homeopathic Products, Inc.",CGMP Deviations: products were not manufactured under current good manufacturing practices.,2019-11-18,2019-11-18,16,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87547 - Class III - Drugs - Washington Homeopathic Products, Inc.",An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.,2021-04-05,2021-04-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88528 - Class II - Drugs - Washington Homeopathic Products, Inc.",Out-of-specification test results obtained for identification testing based on HPTLC analysis.,2021-09-29,2021-09-29,39,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62383 - Class III - Drugs - Watson Laboratories Inc,Labeling: Incorrect or Missing Package Insert:  An outdated version of a patient outsert was used when packaged.,2012-06-29,2012-06-29,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62407 - Class III - Drugs - Watson Laboratories Inc,Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.,2012-08-01,2012-08-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63509 - Class II - Drugs - Watson Laboratories Inc,"Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).",2012-10-24,2012-10-24,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63246 - Class I - Drugs - Watson Laboratories Inc,Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.,2012-11-16,2012-11-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63906 - Class III - Drugs - Watson Laboratories Inc,Impurities/Degradation Products: Out-of-specification results were obtained for a known  impurities.,2012-12-18,2012-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64312 - Class II - Drugs - Watson Laboratories Inc,Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate  because an out of specification result for an impurity diphenyl sulfone .,2013-03-19,2013-03-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64358 - Class II - Drugs - Watson Laboratories Inc,Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .,2013-03-19,2013-03-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65747 - Class III - Drugs - Watson Laboratories Inc,"Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.",2013-07-25,2013-07-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66169 - Class III - Drugs - Watson Laboratories Inc,"Defective Container:  Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened or tampered with.",2013-09-17,2013-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66251 - Class II - Drugs - Watson Laboratories Inc,"Presence of Foreign Tablets/Capsules: 20 tablets of Oxycodone/APAP 7.5/500 mg were found in a sealed 100 count bottle of Oxycodone and Acetaminophen Tablets, USP 10/650 mg lot# 705791A.",2013-10-03,2013-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66360 - Class II - Drugs - Watson Laboratories Inc,Failed Tablet/Capsule Specifications: Multiple complaints for push through tablet breakage.,2013-10-09,2013-10-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67200 - Class II - Drugs - Watson Laboratories Inc,Presence of Foreign Substance; metal particulates were visually observed in the tablets.,2014-01-06,2014-01-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67348 - Class II - Drugs - Watson Laboratories Inc,Failed Tablet/Capsule Specifications; Product contains broken tablets.,2014-01-30,2014-01-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #65541 - Class II - Drugs - Watson Laboratories, Inc.-(Actavis) - Florida",Failed Tablet/Capsule Specifications: Broken tablets,2013-07-23,2013-07-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67259 - Class II - Drugs - Watson Laboratories, Inc.-(Actavis) - Florida",Failed Tablet/Capsule Specifications: Split tablets were found in the 12-month stability samples.,2014-02-07,2014-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64056 - Class II - Drugs - Watson Pharmaceuticals,Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).,2013-02-04,2013-02-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82119 - Class II - Biologics - We Are Blood,"Blood product, collected from a donor who received a tattoo within 12 months of donation, was distributed.",2019-03-15,2019-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84321 - Class II - Biologics - We Are Blood,"Apheresis Red Blood Cell products in which quality control procedures were not performed, were distributed.",2019-12-03,2019-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84200 - Class III - Biologics - We Are Blood,"Blood products, which did not meet the acceptable product specifications, were distributed.",2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84855 - Class III - Biologics - We Are Blood,"Red Blood Cell products, labeled with an incorrect expiration date, were distributed.
",2020-02-14,2020-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86302 - Class II - Biologics - We Are Blood,"Apheresis Red Blood Cells, which were labeled as leukoreduced but were not tested to verify white blood cell count, were distributed.",2020-09-08,2020-09-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86629 - Class II - Biologics - We Are Blood,"Blood products, not meeting product specifications, were distributed.",2020-10-20,2020-10-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87450 - Class III - Biologics - We Are Blood,"Blood products, which did not meet the acceptable product specifications, were distributed.",2021-03-10,2021-03-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88829 - Class II - Biologics - We Are Blood,"Leukoreduced Apheresis Platelets, in which the platelet yield did not meet specifications, were distributed.",2021-10-26,2021-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89049 - Class II - Biologics - We Are Blood,"Blood Products, in which CMV testing was performed incorrectly, were distributed.",2021-12-17,2021-12-17,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89730 - Class III - Biologics - We Are Blood,Leukoreduced Red Blood Cells were distributed without a final visual check.,2022-03-18,2022-03-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90083 - Class II - Biologics - We Are Blood,"Blood products, for which donor eligibility screening was incomplete, were distributed.",2022-05-09,2022-05-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90179 - Class III - Biologics - We Are Blood,"Red Blood Cell products, for which a visual inspection was not performed or documented, were distributed.
",2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90259 - Class III - Biologics - We Are Blood,Leukoreduced Red Blood Cells were distributed without a final visual check.,2022-06-07,2022-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #91373 - Class II - Biologics - We Are Blood,"Plateletpheresis products, for which quality control for residual WBC count was not performed, were distributed.
",2023-01-04,2023-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #79172 - Class III - Drugs - Webrx dba RxPalace.com,CGMP Deviations: not manufactured according to current good manufacturing practices.,2018-02-14,2018-02-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90403 - Class II - Drugs - Wedgewood Village Pharmacy, LLC","Lack of Processing Controls: Insanitary conditions observed during recent FDA Inspection

",2022-07-07,2022-07-07,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74187 - Class II - Drugs - Well Care Compounding Pharmacy,Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.,2016-06-09,2016-06-09,51,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73058 - Class II - Biologics - Wellcare Rx Investments LLC dba Denson's Specialty Pharmacy,"Autologous Drops (serum tears), that may be associated with lack of stability and sterility assurance, were distributed.",2016-04-22,2016-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65404 - Class II - Biologics - Wellmont Health System Dba Marsh Regional Blood Center,"Blood product, collected from a donor who reported travel to a malarial endemic area, was distributed.",2013-07-08,2013-07-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65594 - Class II - Biologics - Wellmont Health System Dba Marsh Regional Blood Center,"Blood products, collected from a donor who reported testing positive for hepatitis, were distributed",2013-08-05,2013-08-05,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80333 - Class II - Biologics - Wellmont Health System Dba Marsh Regional Blood Center,"Platelet, with unacceptable pH, was distributed.",2018-07-12,2018-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #66188 - Class II - Drugs - Wellness Pharmacy, Inc.","The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable., Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.",2013-09-12,2013-09-12,6,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75289 - Class II - Drugs - Wells Pharmacy Network LLC,Lack of Assurance of Sterility,2017-01-04,2017-01-04,97,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75247 - Class II - Drugs - Wells Pharmacy Network, LLC",Superpotent and Subpotent drugs,2016-11-08,2016-11-08,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85555 - Class II - Drugs - West-Ward Columbus Inc,Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.,2020-05-26,2020-05-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74253 - Class III - Drugs - West-Ward Columbus Inc,Failed Impurities/Degradation Specification; 9 month stability,2016-07-14,2016-07-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80364 - Class II - Drugs - West-Ward Columbus Inc,Failed Dissolution Specifications:,2018-08-02,2018-08-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83698 - Class II - Drugs - West-Ward Columbus Inc,Failed Impurities/Degradation Specificattion,2019-09-16,2019-09-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #85709 - Class III - Drugs - West-Ward Columbus Inc,Failed Impurities/Degradation Specifications: Out of Specification for impurity 6 and total degradants.,2020-05-29,2020-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86079 - Class III - Drugs - West-Ward Columbus Inc,Failed Tablet/Capsule Specifications: Tablets are imprinted with the incorrect identification code.,2020-08-07,2020-08-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #76822 - Class III - Drugs - West-Ward Columbus, Inc.","Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.",2017-04-07,2017-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75260 - Class II - Drugs - West-Ward Pharmaceutical,Failed Tablet/Capsule Specifications: Discovery of an underweight tablet.,2016-10-06,2016-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62627 - Class II - Drugs - West-ward Pharmaceutical Corp.,Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.,2012-08-02,2012-08-02,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63871 - Class II - Drugs - West-ward Pharmaceutical Corp.,"Presence of Foreign Substance: Uncharacteristic black spots identified as a food grade lubricant with trace amounts of foreign particulates and stainless steel inclusions have been found in the tablets., Presence of Foreign Substance: Uncharacteristic spots identified as steel corrosion, degraded tablet material and hydrocarbon oil with trace amounts of iron were found in tablets.",2013-01-18,2013-01-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63967 - Class II - Drugs - West-ward Pharmaceutical Corp.,Presence of Foreign Substance: Reports of gray smudges identified as minute stainless steel particulates were found in the recalled tablets.,2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63971 - Class II - Drugs - West-ward Pharmaceutical Corp.,Presence of Foreign Substance: A complaint was received for black specks identified as stainless steel inclusions and cellulose with trace amounts of aluminum and iron-rich inclusions.,2013-01-18,2013-01-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #63969 - Class II - Drugs - West-ward Pharmaceutical Corp.,Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.,2013-02-05,2013-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64103 - Class II - Drugs - West-ward Pharmaceutical Corp.,Presence of Foreign Substance: Uncharacteristic blacks spots on tablets.,2013-02-05,2013-02-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64108 - Class III - Drugs - West-ward Pharmaceutical Corp.,Subpotent Drug,2013-02-12,2013-02-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64106 - Class II - Drugs - West-ward Pharmaceutical Corp.,Failed Dissolution Specifications; 36 month stability timepoint,2013-02-27,2013-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64107 - Class II - Drugs - West-ward Pharmaceutical Corp.,Presence of Foreign Substance: Uncharacteristic blacks spots were found in tablets.,2013-02-27,2013-02-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64105 - Class II - Drugs - West-ward Pharmaceutical Corp.,Discoloration: Ethambutol Tablets USP 400 mg have tablets cores that may be discolored.,2013-03-07,2013-03-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64104 - Class III - Drugs - West-ward Pharmaceutical Corp.,"Labeling: Not elsewhere classified: On 12/12/11, DEA published a final rule in the Federal Register making this product a schedule IV (C-IV)controlled substance.  This product is being recalled because this controlled product was not relabeled with the required ""C-IV"" imprint on the label for products distributed after the 06/11/12 deadline.",2013-03-15,2013-03-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64100 - Class II - Drugs - West-ward Pharmaceutical Corp.,Presence of Foreign Substance(s): A complaint was received for a rubber-like material in a 500 mg Ciprofloxacin tablet.,2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64821 - Class II - Drugs - West-ward Pharmaceutical Corp.,Subpotent Drug: Out Of Specification results for assay at the stability time-point of 24 months.,2013-04-03,2013-04-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64753 - Class II - Drugs - West-ward Pharmaceutical Corp.,Labeling: Incorrect or Missing Lot and/or Exp Date: Bottled product is labeled with an expiration date of Apr 2015.  The correct expiration is Apr 2013.,2013-04-30,2013-04-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65287 - Class III - Drugs - West-ward Pharmaceutical Corp.,Failed Impurity/Degradation Specifications; out of specification value for impurity Nitrophenylpuridine Derivative (NPP-D),2013-07-11,2013-07-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65445 - Class II - Drugs - West-Ward Pharmaceutical Corp.,"Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.

, Cross contamination with other products: Belladonna Alkaloids with Phenobarbital Tablets contained a  trace amount of Methocarbamol.",2013-07-25,2013-07-25,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65582 - Class II - Drugs - West-Ward Pharmaceutical Corp.,Discoloration: Ethambutol HCl Tablets 400 mg is being recalled due to a Out of Specification result for description  testing  for a surface defect of ink.,2013-08-02,2013-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65807 - Class II - Drugs - West-Ward Pharmaceutical Corp.,Failed Impurities/Degradation Specifications: Out of Specification results for Individual Other Unknown Related Compounds were obtained at the 48 month time-point.,2013-08-08,2013-08-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65844 - Class II - Drugs - West-Ward Pharmaceutical Corp.,Presence of Foreign Substance: black specks comprised of degraded organic material found on tablets,2013-08-12,2013-08-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66447 - Class II - Drugs - West-Ward Pharmaceutical Corp.,Superpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will result in an assay higher than the labeled claim.,2013-11-04,2013-11-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67022 - Class II - Drugs - West-Ward Pharmaceutical Corp.,"Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing",2013-12-16,2013-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68502 - Class II - Drugs - West-Ward Pharmaceutical Corp.,Failed Dissolution Specifications: Stability lots cannot support dissolution past the 36 month time point.,2014-07-01,2014-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69539 - Class II - Drugs - West-Ward Pharmaceutical Corp.,Subpotency: Out of Specification (OOS) result at the 36 month routine stability time point.,2014-10-30,2014-10-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71378 - Class III - Drugs - West-Ward Pharmaceutical Corp.,Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).,2015-06-16,2015-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70548 - Class III - Drugs - West-Ward Pharmaceutical Corporation,Failed Impurities/Degradation Specifications; 12 month stability testing.,2015-03-20,2015-03-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75083 - Class III - Drugs - West-Ward Pharmaceuticals Corp.,Labeling: Label Error on Declared Strength- bottles missing colored coded panel where strength of the product is displayed.,2016-09-19,2016-09-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75261 - Class II - Drugs - West-Ward Pharmaceuticals Corp.,Failed Dissolution Specifications: Phenobarbital Tablets have an out of specification for dissolution at the 12 month stability time point,2016-11-18,2016-11-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75604 - Class III - Drugs - West-Ward Pharmaceuticals Corp.,Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.,2016-11-22,2016-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75784 - Class III - Drugs - West-Ward Pharmaceuticals Corp.,Subpotent Drug: Product has an an out of specification in iron assay analysis found during 18 month stability testing.,2016-12-08,2016-12-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78415 - Class III - Drugs - West-Ward Pharmaceuticals Corp.,Failed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).,2017-11-22,2017-11-22,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64191 - Class II - Biologics - West Tennessee Regional Blood Center Inc,"Blood product, which wase collected from a donor who traveled to a malarial endemic area, was distributed.",2013-02-25,2013-02-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64491 - Class II - Biologics - West Tennessee Regional Blood Center Inc,"Blood product, which was collected from a donor who traveled to a malarial endemic area, was distributed.",2013-03-22,2013-03-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #66106 - Class II - Biologics - West Tennessee Regional Blood Center Inc,"Blood product, with no documentation of QC testing for platelet pH, was distributed.",2013-09-17,2013-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #83780 - Class II - Biologics - West TN Regional Blood Center, dba Lifeline Blood Services","Leukoreduced Red Blood Cells, collected from a donor who traveled to a malarial endemic area, were distributed.",2019-10-08,2019-10-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84138 - Class II - Biologics - West TN Regional Blood Center, dba Lifeline Blood Services","Blood products, which did not meet the acceptable product specifications, were distributed.",2019-12-06,2019-12-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85541 - Class III - Biologics - West TN Regional Blood Center, dba Lifeline Blood Services",Misbranded red blood cells were distributed.,2020-04-23,2020-04-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #87778 - Class II - Biologics - West TN Regional Blood Center, dba Lifeline Blood Services","Plateletpheresis products, collected from a donor taking aspirin, were distributed.",2021-05-18,2021-05-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88415 - Class II - Biologics - West TN Regional Blood Center, dba Lifeline Blood Services","Platelet products, for which pH testing was not performed, were distributed.",2021-08-20,2021-08-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #89292 - Class III - Biologics - West TN Regional Blood Center, dba Lifeline Blood Services","Blood products, bearing an incorrect donor classification, were distributed.",2022-01-19,2022-01-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #90410 - Class II - Biologics - West TN Regional Blood Center, dba Lifeline Blood Services","Platelet products, with a low platelet count, were distributed.
",2022-09-26,2022-09-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69562 - Class II - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Blood products, collected from a donor considered to be at increased risk for Creutzfeldt-Jakob Disease (CJD), were distributed.",2014-12-04,2014-12-04,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70615 - Class II - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Blood product, that did not meet homologous criteria, was distributed.",2015-04-07,2015-04-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #73134 - Class III - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Apheresis products, lacking assurance of leukoreduction, were distributed. 
",2016-02-08,2016-02-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75244 - Class II - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Blood products, collected from a donor who traveled to a malarial endemic area, were distributed.",2016-10-18,2016-10-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #75462 - Class II - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Blood products, which were collected from a donor who traveled to a malarial endemic area, were distributed.",2016-11-01,2016-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #77785 - Class II - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.",2017-08-23,2017-08-23,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80477 - Class II - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Blood product, which did not meet acceptable product specifications, was distributed.",2018-08-09,2018-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82029 - Class II - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-02-07,2019-02-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #82205 - Class II - Biologics - West TN Regional Blood Ctr, Inc dba Lifeline Blood Services","Blood product collected from a donor who traveled to a malarial endemic area, was distributed.
",2019-02-28,2019-02-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72520 - Class II - Drugs - Western Drug,Lack of Assurance of Sterility,2015-12-01,2015-12-01,91,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80838 - Class II - Drugs - Westlab Pharmacy, Inc. dba Westlab Pharmacy","Incorrect Product Formulation, Lack of Process Controls",2018-10-24,2018-10-24,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81668 - Class II - Drugs - Westminster Pharmaceuticals Llc,CGMP Deviations: FDA laboratory testing confirmed traces of NDEA  impurity in specific lots of Irbesartan.,2018-12-14,2018-12-14,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80719 - Class I - Drugs - Westminster Pharmaceuticals LLC,"Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.",2018-09-07,2018-09-07,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87268 - Class II - Drugs - Wilshire Pharmaceuticals Inc,Failed Dissolution Specifications,2021-02-16,2021-02-16,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #67145 - Class II - Biologics - Winter Haven Hospital Community Blood Center, Inc.","Blood product, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), was distributed.",2014-01-31,2014-01-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70607 - Class II - Biologics - Winter Haven Hospital, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed, Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-04-07,2015-04-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70586 - Class II - Biologics - Winter Haven Hospital, Inc.","Blood products, collected from a donor for whom donor suitability was not adequately determined, were distributed.",2015-04-09,2015-04-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #70799 - Class II - Biologics - Winter Haven Hospital, Inc.","Blood product, in which Quality Control and Distribution of product did not meet specifications, was distributed.",2015-04-13,2015-04-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78579 - Class II - Biologics - Winter Haven Hospital, Inc.","Red blood cell, for which the donor gave travel history to a malarial endemic area within 12 months of donating, was distributed.",2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85278 - Class II - Biologics - Winter Haven Hospital, Inc.","Leukoreduced Red Blood Cells, lacking assurance of sterility, were distributed.",2020-03-31,2020-03-31,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #69497 - Class II - Drugs - Wisconsin Pharmacal Company, LLC",Microbial Contamination of Non-Sterile Products: CVS Pharmacy Pain Relieving Antiseptic Spray tested positive for microbial growth.,2014-10-27,2014-10-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #84291 - Class II - Drugs - Wisconsin Pharmacal Company, LLC",cGMP violations,2020-01-16,2020-01-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #83397 - Class II - Drugs - Wise Pharmacy,Lack of Processing Controls,2019-07-31,2019-07-31,11,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86709 - Class I - Drugs - Wishgarden Herbs, Incorporated",Microbial Contamination of a Non-Sterile Product: Product tested positive for Cronobacter Sakazakii.,2021-01-07,2021-01-07,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #80356 - Class III - Drugs - Wockhardt Limited,Failed Impurities/Degradation Specifications,2018-07-09,2018-07-09,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67238 - Class II - Drugs - Wockhardt Usa Inc.,Failed Dissolution Specifications; 12 month acid dissolution test results were above upper limit specifications.,2014-01-29,2014-01-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67933 - Class II - Drugs - Wockhardt Usa Inc.,Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.,2014-05-02,2014-05-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68402 - Class II - Drugs - Wockhardt Usa Inc.,Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.,2014-05-29,2014-05-29,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68813 - Class III - Drugs - Wockhardt Usa Inc.,Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzoic acid were observed.,2014-08-05,2014-08-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68941 - Class II - Drugs - Wockhardt Usa Inc.,Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.,2014-08-18,2014-08-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69506 - Class III - Drugs - Wockhardt Usa Inc.,Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.,2014-12-18,2014-12-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70740 - Class II - Drugs - Wockhardt Usa Inc.,Failed Tablet/Capsule Specifications: out of specification for thickness.,2015-05-01,2015-05-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71104 - Class II - Drugs - Wockhardt Usa Inc.,CGMP Deviations: Firm did not adequately investigate customer complaints.,2015-07-17,2015-07-17,35,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71946 - Class II - Drugs - Wockhardt Usa Inc.,CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints.,2015-08-19,2015-08-19,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77951 - Class III - Drugs - Wockhardt Usa Inc.,Failed Impurities/Degradation Specifications: 5mg strength being recalled for out of specification results for related compound.,2017-10-26,2017-10-26,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #71281 - Class II - Biologics - Womack Army Medical Center Department of Pathology,"Blood product, collected from a donor with a low hemoglobin, was distributed.",2015-07-01,2015-07-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76916 - Class III - Biologics - Womack Army Medical Center Department of Pathology,"Blood products, for which the donor deferral screening was incorrectly performed, were distributed.",2017-04-21,2017-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90846 - Class III - Drugs - Woodbine Products Co Inc,Labeling: Not Elsewhere Classified - Incorrect label-incorrect scent listed on label.,2022-10-06,2022-10-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #78757 - Class II - Drugs - Woodfield Pharmaceutical, LLC",Microbial Contamination of Non-Sterile Products: potentially contamination with the bacteria Burkholderia cepacia,2018-01-08,2018-01-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85926 - Class II - Drugs - WORLD EVENT PROMOTIONS, LLC",Subpotent Drug: Product was found to be subpotent. Product also has high pH levels,2020-07-28,2020-07-28,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #80365 - Class I - Drugs - World Organix, LLC",Microbial Contamination of Non-Sterile Products: The firm is initiating a recall of some of its products due to the potential of high microbial loads.,2018-08-23,2018-08-23,5,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88070 - Class II - Drugs - World Source Llc,Subpotent,2021-06-16,2021-06-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78643 - Class I - Drugs - www.blankterrmall.com,Marketed without an approved NDA/ANDA: Product contains undeclared active pharmaceutical ingredient (API) - Sildenafil.,2018-02-20,2018-02-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68729 - Class III - Drugs - X-Gen Pharmaceuticals Inc.,"Labeling: Label Error On Declared Strength: The side label description incorrectly states ""Each mL contains 500 mcg Clonidine Hydrochloride"" instead of stating ""Each mL contains 100 mcg Clonidine Hydrochloride"".",2014-07-18,2014-07-18,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76410 - Class I - Drugs - X-Gen Pharmaceuticals Inc.,Presence of Particulate Matter,2017-04-05,2017-04-05,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77834 - Class II - Drugs - X-Gen Pharmaceuticals Inc.,Presence of Foreign Substance:  potential presence of plastic particles.,2017-08-09,2017-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82504 - Class III - Drugs - X-Gen Pharmaceuticals Inc.,"Labeling: Label Error on Declared Strength: Side carton panel incorrectly lists the concentration as ""500 mcg Clonidine Hydrochloride"" rather than the correct concentration of ""100 mcg Clonidine Hydrochloride"" per mL.",2019-04-08,2019-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84027 - Class III - Drugs - X-Gen Pharmaceuticals Inc.,Labeling: Incorrect or Missing Package Insert - the  incorrect package insert version was attached.,2019-11-21,2019-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87500 - Class II - Drugs - X-Gen Pharmaceuticals Inc.,"Failed Stability Specifications:  Out of Specification (OOS) result reported for microbiological assay and Neomycin C for the 3-month 25C/65% RH stability timepoint for the representative 2020 annual stability Lot CFPXF that utilized the same API Lot (CM8254) and was manufactured in the same campaign as Lot CFMBX. The OOS for microbiological assay was reported as 87.0%, outside the stability specifications of 90.0 to 120.0%.
Lot CFMBX had a reported microbiological assay value of 93.4% at time of release and, although within specifications, is on the lower end of the specification and is not expected to meet its expiry dating of 24 months.
",2021-04-08,2021-04-08,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #88457 - Class II - Drugs - XELLIA PHARMACEUTICALS USA, LLC","Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.",2021-08-20,2021-08-20,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81044 - Class III - Drugs - Xiromed LLC,Labeling: Not Elsewhere Classified: mislabeling of the Altavera generic name on the packaging component that may cause confusion.,2018-10-11,2018-10-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #61669 - Class I - Drugs - XRock Industries, LLC","Marketed Without an Approved NDA/ANDA: product tested positive for PDE-5 Sildenafil and PDE-5 Hydroxythiohomosildenafil.  Hydroxythiohomosildenafil is an analog of sildenafil, an FDA approved prescription drug for Erectile Dysfunction (ED).",2012-11-01,2012-11-01,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #60075 - Class III - Biologics - XTANT Medical,"Human allografts, recovered from a donor whose donor eligibility was initially determined with inaccurate and/or incomplete donor records, were distributed.",2012-07-10,2012-07-10,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #72227 - Class I - Drugs - XTREME Z DISTRIBUTORS INC,Marketed Without an Approved NDA/ANDA: FDA sampling and analysis confirmed the presence of sibutramine and desmethylsibutramine.,2016-07-06,2016-07-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77443 - Class II - Drugs - Xttrium Laboratories Inc,CGMP Deviations,2017-07-02,2017-07-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85232 - Class I - Drugs - Y-O Management LLC, dba Natural Remedy Store","Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction",2020-04-04,2020-04-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67769 - Class III - Biologics - Yale Blood Plasma LLC,"Source Plasma, collected from an ineligible donor, was distributed.",2014-04-21,2014-04-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87918 - Class I - Drugs - Yamtun7,Marketed Without An Approved NDA/ANDA: Product found to contain undeclared sildenafil and tadalafil making them unapproved drugs for which the safety and efficacy have not been established and therefore subject to recall.,2021-07-12,2021-07-12,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #89579 - Class I - Drugs - Your Favorite Shop,"Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.",2022-02-23,2022-02-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85323 - Class II - Drugs - Yusef Manufacturing Laboratories, LLC",Superpotent drug: This lot of SPF containing lip balm contains up to 150% of the label claim for active ingredient Oxybenzone.,2020-04-22,2020-04-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #86007 - Class II - Drugs - Yusef Manufacturing Laboratories, LLC",Superpotent Drug: The beginning portion of the batch appears to be approximately 25% superpotent for active ingredient Meradimate.,2020-08-06,2020-08-06,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #85814 - Class II - Drugs - Yusef Manufacturing Laboratories, LLC",Superpotent Drug: Active Ingredient Octisalate found at 15% above label claim.,2020-08-24,2020-08-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69538 - Class II - Drugs - Zee Medical Products Inc,Incorrect/Undeclared Excipients: ZEE Medical is recalling ZEE Aspirin due to the incorrect listing of inactive ingredients on the product label.,2014-10-22,2014-10-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #81436 - Class II - Drugs - Zero Xtreme USA,Marketed Without an Approved NDA/ANDA: Undeclared Sibutramine,2018-11-15,2018-11-15,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #63525 - Class I - Drugs - Zi Xiu Tang Success, LLC","Marketed Without An Approved NDA/ANDA: Products were found to contain undeclared sibutramine, the active ingredient in a previously approved FDA product indicated for weight loss but removed from the market for safety reasons, making these products unapproved new drugs.",2013-12-18,2013-12-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #67080 - Class I - Drugs - Zions RX Formulations Services LLC dba RX Formuations Serv.,"Non-Sterility: RX Formulation initiated this recall due to a report of microbial contamination found in Calcium Gluconate saturated solution that was observed upon drawing the vial contents into a syringe.  
, Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm., Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.  
",2014-04-07,2014-04-07,7,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42196 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who had been incarcerated, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45051 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who did not have a physical examination, were distributed.",2012-07-13,2012-07-13,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40918 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who was permanently deferred, were distributed.",2012-07-16,2012-07-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #38672 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor whose scheduled physical examination was incomplete, were distributed.",2012-09-04,2012-09-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43231 - Class III - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from donors for whom donor suitability was not adequately determined, were distributed.",2012-09-17,2012-09-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #44175 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood product, collected from a donor who received a tattoo within 12 months of donation, was distributed.",2012-10-19,2012-10-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49241 - Class III - Biologics - ZLB Bioplasma, Inc.","Blood product, which was collected from a donor in which donor suitability was not adequately determined, was distributed.",2012-11-14,2012-11-14,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43196 - Class III - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who was previously deferred by another donor center, were distributed.
",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43225 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #43614 - Class III - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who was previously deferred due to testing, were distributed.",2012-12-27,2012-12-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40103 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who received a body piercing within 12 months of donating, were distributed.",2013-01-03,2013-01-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #40188 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor whose physical was overdue, were distributed.",2013-01-04,2013-01-04,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #45071 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who did not have a complete physical examination, were distributed.",2013-03-27,2013-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #39995 - Class III - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42198 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor with a history of incarceration, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #42837 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood product, collected from a donor, whose suitability to donate was not adequately determined, was distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52146 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor whose physical was improperly documented, were distributed.",2013-06-07,2013-06-07,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #52871 - Class III - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor, whose suitability to donate were not adequately determined, were distributed.",2013-07-24,2013-07-24,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,"Event ID #49951 - Class II - Biologics - ZLB Bioplasma, Inc.","Blood products, collected from a donor whose physical was overdue, were distributed.",2013-08-09,2013-08-09,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #88482 - Class II - Drugs - Zydus Pharmaceuticals (USA) Inc,Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle,2021-08-19,2021-08-19,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #90618 - Class II - Drugs - Zydus Pharmaceuticals (USA) Inc,Failed Impurities/Degradation Specifications,2022-08-17,2022-08-17,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86663 - Class II - Drugs - Zydus Pharmaceuticals (USA) Inc,Failed Dissolution Specification,2020-11-10,2020-11-10,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #86925 - Class II - Drugs - Zydus Pharmaceuticals (USA) Inc,Failed Dissolution Specifications,2020-12-11,2020-12-11,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #87364 - Class I - Drugs - Zydus Pharmaceuticals (USA) Inc,Crystallization: customer complaints for crystallization in finished product.,2021-03-30,2021-03-30,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #62605 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks.  The same complainant also reported that metal shaving like material was observed on the surface of one tablet.,2012-07-27,2012-07-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #64604 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Failed Tablet/Capsule Specifications: Pharmacist complaint of an excessive amount of broken and/or chipped tablets in the bottle.,2013-03-25,2013-03-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #65394 - Class I - Drugs - Zydus Pharmaceuticals USA Inc,Failed Tablet/Capsule Specifications: A product complaint was received from a pharmacist who discovered that 3 tablets in a 1000-count bottle were oversized.,2013-08-02,2013-08-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68285 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Presence of Foreign Tablets: Presence of atenolol 25 mg tablet mixed into promethazine 25 mg tablet bottles.,2014-05-21,2014-05-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #68988 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Superpotent Drug: A complaint was reported by a pharmacist who stated several tablets  were noticeably thicker in appearance.,2014-10-03,2014-10-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69387 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.,2014-10-10,2014-10-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69676 - Class III - Drugs - Zydus Pharmaceuticals USA Inc,"Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.",2014-11-21,2014-11-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69585 - Class III - Drugs - Zydus Pharmaceuticals USA Inc,Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.,2014-12-03,2014-12-03,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #69911 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.,2014-12-16,2014-12-16,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #70101 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.,2014-12-23,2014-12-23,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #73221 - Class III - Drugs - Zydus Pharmaceuticals USA Inc,Failed Impurities/Degradation Specifications: Out of specification for a known degradant.,2016-02-22,2016-02-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74753 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Failed Dissolution Specifications: out of specification dissolution results in retained samples,2016-08-18,2016-08-18,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #74233 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of two batches.,2016-09-02,2016-09-02,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75696 - Class III - Drugs - Zydus Pharmaceuticals USA Inc,Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.,2016-11-22,2016-11-22,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #75764 - Class III - Drugs - Zydus Pharmaceuticals USA Inc,Failed Dissolution Specifications; 6 month time point,2016-12-20,2016-12-20,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76673 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.,2017-03-21,2017-03-21,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #76737 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Failed Dissolution Specifications; 9 month long term stability,2017-03-27,2017-03-27,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77674 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Failed Dissolution Specifications,2017-07-31,2017-07-31,3,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #77963 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets,2017-09-11,2017-09-11,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #78612 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets,2017-11-30,2017-11-30,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82682 - Class III - Drugs - Zydus Pharmaceuticals USA Inc,"Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.",2019-04-25,2019-04-25,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82714 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg,2019-05-07,2019-05-07,2,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #82827 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.,2019-07-01,2019-07-01,14,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
G10,FDA Drug and Biologic Recalls,Event ID #84848 - Class II - Drugs - Zydus Pharmaceuticals USA Inc,cGMP Deviations,2020-02-10,2020-02-10,1,FDA Dashboards - Recalls. https://datadashboard.fda.gov/ora/cd/recalls.htm. Accessed 20 February 2023.,2022-02-20
